Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6407670993406938,-2.384161533819916,0.0,0.0,0.0,67/91,19.83%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;SSR1;RPL10A;RPL3;RPL12;TRAM1;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10;SSR2;ARL6IP1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6507416280630155,-2.383472332774443,0.0,0.0,0.0,63/87,19.40%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10
prerank,protein targeting to ER (GO:0045047),-0.6168052426574109,-2.3293972879355036,0.0,0.0,0.0,67/99,19.73%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;SRP14;RPL7;RPL36;ZFAND2A;RPS17;RPL32;RPL39;RPL14;SPCS3;RPS2;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;SEC61G;RPS27A;RPS12;RPL27;RPS28;RPL5;RPS10;SPCS1
prerank,cytoplasmic translation (GO:0002181),-0.6215594952374381,-2.2994655577116543,0.0,0.0,0.0,64/91,19.40%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;EIF3M;RPL8;RPL24;RPL29;RPL10A;RPL3;RPL12;EIF3I;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;RPS10
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5355455232804919,-2.0442864048717135,0.0,0.012524075295931159,0.06,66/110,19.40%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;SMG7;CTIF;RPL10A;RPL3;RPL12;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;MAGOH;RPS10
prerank,bicarbonate transport (GO:0015701),0.8637130309831754,2.019813114180732,0.0,0.029036472003862373,0.024,3/25,0.03%,SLC4A10;SLC26A7;SLC4A4
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6278514043085047,-2.019622974413569,0.0034129692832764505,0.016575982009320655,0.094,16/46,9.25%,ATP1A2;CDH2;SHANK3;GRM7;GRM3;NRXN1;DGKI;GRM5;GRM1;MEF2C;GRIK1;OPHN1;CACNG4;GRM8;CACNG7;SYT1
prerank,organic anion transport (GO:0015711),0.7390039430166283,1.975986724967486,0.0,0.04666575857763595,0.075,9/76,2.41%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;LRRC8D;SLCO2A1;SLCO4A1;ABCG2
prerank,response to glucocorticoid (GO:0051384),0.8475473056680837,1.966479300920384,0.0,0.04044365743395116,0.091,7/26,7.15%,SLIT3;SLIT2;ADAM9;ANXA1;FAM107A;ISL1;IL10
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6248657461201307,-1.9618341625732036,0.0,0.03854573594230913,0.232,19/41,18.02%,IL34;TGFA;GRM5;NEDD9;ACE;DOCK3;EPHA4;GPRC5B;ADRA2A;LRP8;NTRK2;GAS6;HBEGF;CSF1R;AGT;NOX4;FCGR1A;RELN;ERBB3
prerank,regulation of intracellular pH (GO:0051453),0.7972181982099786,1.9322788139392464,0.0,0.07622073901013872,0.213,10/34,8.86%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC4A8;SLC9A1
prerank,regulation of BMP signaling pathway (GO:0030510),0.707529440896988,1.9252390661708785,0.0,0.07321339012402442,0.252,22/73,9.05%,BMPER;BMP4;CRIM1;FSTL1;HTRA3;SMAD9;FOXD1;VWC2;CCN1;SMAD6;SULF1;SKIL;BMPR1A;ZNF423;SFRP4;NOG;SKI;BAMBI;GDF5;NBL1;CHRD;UBE2D3
prerank,ion homeostasis (GO:0050801),0.8065187524398292,1.9243890711367202,0.0,0.06256668372260821,0.257,5/30,1.93%,SLC4A10;SLC4A4;FHL1;CAMK2D;WNK1
prerank,cation transport (GO:0006812),0.6500557019020894,1.9108009253249143,0.0,0.07673924743877912,0.333,18/167,3.29%,SLC47A1;SLC4A4;PIEZO2;SLC23A1;SLC9B2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC5A6;KCNMB3;KCNMB2;ATP1B1;KCNJ15;KCNS3;ANO6;TRPM6;FGF13
prerank,response to ketone (GO:1901654),0.8274584472225888,1.902012565633471,0.0,0.08555389072566591,0.41,4/24,1.84%,SLIT3;SLIT2;THBS1;TGFB3
prerank,regulation of cellular pH (GO:0030641),0.8012074992287047,1.8994406013822691,0.0,0.07996552210587493,0.422,11/29,8.86%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC4A8;ATP1A4;SLC9A1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6960133182561141,1.8889770620055686,0.0,0.09561295424128967,0.513,21/79,9.33%,SLIT2;BMPER;THBS1;CRIM1;HTRA3;SMAD9;VWC2;NEDD4;SMAD6;SULF1;SKIL;BMPR1A;FGF2;ATP2B4;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3;NIBAN2
prerank,positive regulation of blood coagulation (GO:0030194),0.8739580889605758,1.8841869173091337,0.0016339869281045752,0.0961597449478559,0.549,5/17,2.98%,F3;ST3GAL4;THBS1;ANO6;THBD
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7982732781761736,-1.8795964769904856,0.0,0.12823363859988338,0.612,7/12,14.45%,IL34;LYN;CSF1;BST2;PTK2;MAPK3;CSF1R
prerank,chloride transport (GO:0006821),0.6900106357464729,1.8747916378497913,0.0,0.10828184351440343,0.614,11/74,4.00%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;SLC12A8;ANO6;GLRB;ANO9;SLC26A6;GABRA3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.9262424935726559,1.871799237663738,0.0,0.10633411313502347,0.632,3/11,1.53%,EGFR;BMP4;DDX5
prerank,cellular component maintenance (GO:0043954),-0.781209550326738,-1.8543745865296137,0.002551020408163265,0.16831784200822517,0.751,4/12,7.80%,IGF1R;ITGA3;INSR;CLDN1
prerank,cellular response to drug (GO:0035690),-0.6513383927585319,-1.852423868236556,0.014285714285714285,0.1565509411991395,0.762,11/25,13.77%,PDE4B;PPM1E;ACER2;TFRC;RAP2A;MEF2C;AIM2;GAS6;KCNQ1;CERS1;PPM1F
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.7172171914832961,1.8493377106921085,0.0,0.16036724971520927,0.768,15/51,9.05%,BMPER;CRIM1;FSTL1;HTRA3;SMAD9;VWC2;SMAD6;SKIL;BMPR1A;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3
prerank,ion transport (GO:0006811),0.650319948345408,1.8441553313675678,0.0,0.16682144510790453,0.793,11/111,3.83%,SLC26A7;PIEZO2;SLC9A2;SLC26A2;SLC12A7;SLC12A2;SLC24A3;WNK1;ANO6;GLRB;SLC26A6
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8211912056376978,-1.8409556801865965,0.0,0.16684814214432356,0.812,6/10,13.42%,LYN;RAPGEF2;CXCL12;GAS6;AXL;CCL19
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.681278509041061,-1.8380437845767292,0.010443864229765013,0.1587764202652057,0.823,5/19,2.83%,TJP1;PRKCH;CLDN5;OCLN;F11R
prerank,endodermal cell differentiation (GO:0035987),0.7571941036107391,1.8242669319470846,0.0014388489208633094,0.23332879288817976,0.897,10/31,6.67%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;ITGAV;COL11A1;SETD2
prerank,cellular response to copper ion (GO:0071280),-0.7273983389014665,-1.8167601295647422,0.0027100271002710027,0.19572409526390155,0.895,11/16,19.05%,SNCA;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;MT3
prerank,inorganic anion transport (GO:0015698),0.698529244772781,1.8156911787104884,0.0013297872340425532,0.2576071875468714,0.925,6/53,3.83%,SLC4A10;SLC26A7;CLIC4;ANO6;ANO9;SLC26A6
prerank,regulation of phagocytosis (GO:0050764),-0.5358140118883152,-1.8149160790567624,0.004032258064516129,0.18628246448569877,0.901,27/53,23.30%,CAMK1D;MERTK;TGM2;IL15RA;DYSF;CD47;SYT7;SIRPA;GATA2;SYT11;GAS6;SPHK1;DOCK2;CALR;CYBA;SCARB1;HCK;LYAR;RACK1;SNX3;PRTN3;TREM2;SYK;AHSG;RAB27A;PLA2G5;PYCARD
prerank,sulfate transport (GO:0008272),0.8302229039937933,1.8119400854947707,0.001652892561983471,0.2611554118918812,0.938,3/14,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.8402399070307927,1.8047394799681533,0.0,0.2801037111350032,0.952,8/15,10.33%,BMP4;SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,endoderm formation (GO:0001706),0.732939427191578,1.8040170627070797,0.0,0.2697799354215999,0.953,12/35,9.32%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;ITGAV;COL11A1;SETD2;DUSP5;MMP14
prerank,monosaccharide transmembrane transport (GO:0015749),0.837192244808982,1.8027703818834704,0.0,0.2619208290960646,0.956,2/16,0.16%,SLC23A1;SLC23A2
prerank,neuron cell-cell adhesion (GO:0007158),-0.7293451019621738,-1.793849268513716,0.0,0.2291169068843877,0.942,6/14,7.64%,NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.7874151884934085,1.7905592708540334,0.0014727540500736377,0.30544860159907167,0.978,4/23,3.16%,SLC12A7;SLC12A2;SLC12A8;ATP6V0A4
prerank,response to copper ion (GO:0046688),-0.6720141993689419,-1.7857499464749995,0.0030120481927710845,0.23874018532868774,0.961,14/20,24.84%,SNCA;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;ATP5F1D;MT3;AQP1;IL1A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6251749322258928,1.7821149604246085,0.001199040767386091,0.33531714641727406,0.99,28/104,11.05%,BMPER;CRIM1;CCN3;HTRA3;SMAD9;VWC2;CD109;SMAD6;SKIL;BMPR1A;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;NOG;SKI;BAMBI;IL17RD;TGFB1I1;NBL1;IGSF1;CHRD;UBE2D3;ACVR1;LDLRAD4;BCL9L;SMAD2
prerank,positive regulation of heart contraction (GO:0045823),-0.658401037710426,-1.775665775593246,0.005076142131979695,0.25237745157328406,0.971,8/19,14.09%,ATP1A2;RYR2;KCNQ1;EDN1;ADM;ATP2A2;GSK3A;CHGA
prerank,collagen fibril organization (GO:0030199),0.6444720378498613,1.7704778953356253,0.0012091898428053204,0.3850789263369367,0.993,22/88,6.23%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;COL6A1;COL5A2;CYP1B1;PLOD2;BMP1;DDR2;COL3A1;COL23A1;LOXL1;COL6A3;TGFBR1;P3H2;P4HA1;COL11A1;P4HA2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7521280852977339,-1.764318754429401,0.007481296758104738,0.27063871860896993,0.982,5/11,5.95%,PLCB1;IGF1;IGF1R;PIK3R1;GHR
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8007996460183356,1.759041399951487,0.006299212598425197,0.4356715220808092,0.995,6/20,7.01%,SMOC2;THBS1;SULF1;FGF2;NOG;LRIT3
prerank,aerobic electron transport chain (GO:0019646),-0.5031363889975059,-1.758376564604002,0.0,0.272631283048037,0.987,37/68,27.98%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX6C;COX8A;CYCS;AFG1L;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;CYC1;UQCRC1;NDUFA2;NDUFA6;UQCRB;SDHC;NDUFA10;NDUFS6;NDUFV3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5033370755584119,-1.7575670738208338,0.004761904761904762,0.2613940274080926,0.987,38/69,28.21%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX6C;COX8A;CYCS;AFG1L;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;CYC1;UQCRC1;NDUFA2;NDUFA6;UQCRB;SDHC;NDUFA10;NDUFS6;NDUFV3;COA6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8042576563357205,1.757481933749303,0.007874015748031496,0.42844750311193625,0.995,8/18,15.38%,EGFR;BMP4;DDX5;ESR1;NCOR1;ZC3H12A;NCOR2;MAP2K2
prerank,acute inflammatory response (GO:0002526),0.7855417985084461,1.7502840840149316,0.006230529595015576,0.45828463485461085,0.996,5/23,6.56%,F3;LBP;ANO6;VNN1;PLSCR1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6670006215170248,-1.7501755721487824,0.0,0.2709164467026005,0.991,12/17,21.55%,COX4I1;COX7C;COX5B;COX6B1;COX6C;COX8A;CYCS;AFG1L;NDUFA4;COX6A1;COX4I2;COX10
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6882219760423627,1.7494994873871783,0.005509641873278237,0.4473616649676704,0.998,4/45,1.53%,SLC38A2;EGFR;BMP4;DDX5
prerank,regulation of fibrinolysis (GO:0051917),0.8316087400669196,1.747764910604304,0.008576329331046312,0.4425916428470499,0.998,2/13,2.98%,THBS1;THBD
prerank,mesonephric tubule development (GO:0072164),0.8192607418669033,1.7437861075344947,0.006329113924050633,0.4523467531458845,0.998,5/15,2.04%,SLIT2;BMP4;SIX1;PKD1;WNT11
prerank,cGMP-mediated signaling (GO:0019934),-0.7301831975410178,-1.7430875310829737,0.007537688442211055,0.28095452334989957,0.994,6/13,7.70%,IRAG1;APOE;GUCY1B1;KCNC2;PDE2A;HTR2C
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7099536878743001,1.7410643071075604,0.002857142857142857,0.45341053172851453,0.999,7/40,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6
prerank,carbohydrate transport (GO:0008643),0.8633520977858841,1.7409728180600477,0.0033277870216306157,0.4398571813710088,0.999,3/11,3.83%,SLC23A1;SLC23A2;SLC26A6
prerank,ureteric bud development (GO:0001657),0.7892273729085834,1.7408244843599223,0.01592356687898089,0.42750234322569663,0.999,5/17,2.20%,SLIT2;BMP4;SIX1;WNT11;GPC3
prerank,positive regulation of coagulation (GO:0050820),0.869873804526089,1.737486069713883,0.0051813471502590676,0.42230289333780646,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),0.869873804526089,1.737486069713883,0.0051813471502590676,0.42230289333780646,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8292038667725439,1.7365372108017803,0.011725293132328308,0.41595898386485375,1.0,1/13,0.01%,SLC4A10
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.7012946852066166,1.7361309184406473,0.0,0.4071832676371743,1.0,7/39,2.75%,STK39;FHL1;PTPN3;NEDD4;ANK2;FXYD5;WWP2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.6395955922982872,-1.7350241023585582,0.0055248618784530384,0.2932026962663168,0.994,9/21,9.40%,ITGA1;PDGFRB;CALM1;MEF2C;BMP2;CD300A;HSP90AB1;PPP1R15B;PLEK
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6950179332019129,-1.7291906973967923,0.01278772378516624,0.30013271128913466,0.997,7/15,21.27%,ATP1A2;ADRA2A;SLC30A1;TMBIM6;STC1;TRIM27;INPP5K
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5645139447602223,-1.7287734810066713,0.003355704697986577,0.2893798103671623,0.997,15/35,7.70%,KSR1;IRAG1;APOE;PDE7B;ADCY1;RAPGEF3;RAPGEF2;GUCY1B1;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A;HTR2C
prerank,extracellular matrix organization (GO:0030198),0.56733904226767,1.7270311078202298,0.0,0.44763651342044597,1.0,53/276,6.52%,COL25A1;COL8A1;ADAMTSL3;COL12A1;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;TLL1;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;CYP1B1;MMP28;PLOD2;BMP1;DDR2;FN1;DSPP;CD44;SMOC1;GSN;COL3A1;COL23A1;ITGB1;CAPN2;FGF2;ADAMTSL5;LOXL1;COL6A3;HTRA1;TGFBR1;ITGB5;P3H2;ITGA10;P4HA1;ITGA5;ADAM12;MMP16;ITGAV;TIMP2;COL11A1;P4HA2;ADAMTS5;FLRT2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.6138523242602427,-1.7259538093886249,0.008547008547008548,0.28650238990041615,0.999,12/26,16.57%,LYN;PICALM;MBP;GRIN2B;EPHA4;AIM2;GRIN1;ROCK2;APH1B;PSME2;TTBK1;VSIR
prerank,digestive tract development (GO:0048565),0.6996939720451018,1.7245755646987981,0.00583941605839416,0.44932079113669077,1.0,15/32,12.18%,PCSK5;RARB;PKD1;COBL;SMO;GLI3;STRA6;CLMP;GATA4;AGR2;EPHB3;GLI2;CCDC40;MEGF8;NIPBL
prerank,chemical homeostasis (GO:0048878),0.6501386596059839,1.7237949229294116,0.003973509933774834,0.4427543472160371,1.0,8/61,8.08%,SLC4A10;SLC4A4;WNK1;PNPLA3;RBP1;SLC4A2;ACOX3;SLC4A8
prerank,embryonic skeletal system development (GO:0048706),0.7072470357944208,1.7217258810352056,0.00423728813559322,0.44434907679778235,1.0,11/35,6.72%,KIAA1217;SIX1;PCSK5;WNT9A;WNT11;HOXA3;SULF1;NOG;XYLT1;HOXB3;HOXC4
prerank,renal water homeostasis (GO:0003091),-0.6149159664909367,-1.7187990760782872,0.008450704225352112,0.2964235795123576,0.999,9/23,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;AQP4;ADCY2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8569294520933519,1.718106149196484,0.006956521739130435,0.4532010575092635,1.0,2/11,0.41%,SLIT2;CCN3
prerank,positive regulation of chemotaxis (GO:0050921),0.6836845597042214,1.717375765882828,0.010914051841746248,0.4467372154481284,1.0,7/43,3.98%,SMOC2;F3;THBS1;MET;NTRK3;FGF2;NRP1
prerank,sprouting angiogenesis (GO:0002040),0.6664786643819993,1.7137210567797667,0.006702412868632708,0.4577722367946581,1.0,11/51,3.98%,RSPO3;SLIT2;BMPER;THBS1;BMP4;PGF;PTK2B;SEMA3E;PARVA;FGF2;NRP1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.664196925094174,-1.709228268785086,0.005479452054794521,0.3155685463877612,1.0,6/16,6.29%,APOE;NOS3;GUCY1B1;NDNF;KCNC2;GUCY1A1
prerank,organic cation transport (GO:0015695),0.7819980294760911,1.7088098787845825,0.009584664536741214,0.4768664406158128,1.0,1/20,0.02%,SLC47A1
prerank,sulfur compound transport (GO:0072348),0.7251495079534125,1.7075555551466535,0.015408320493066256,0.4734207391934083,1.0,5/27,3.83%,SLC26A7;SLC5A6;LRRC8D;ABCG2;SLC26A6
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7292908431997136,-1.706667120753193,0.011933174224343675,0.31278433485020773,1.0,7/11,17.94%,MERTK;CXCL12;GAS6;AXL;CCL19;SELENOS;IRF7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7886062096846486,1.7051765531256062,0.016556291390728478,0.47585835236116997,1.0,3/14,1.93%,STK39;PTK2B;WNK1
prerank,peptide biosynthetic process (GO:0043043),-0.42082003881285057,-1.7032391572975012,0.0,0.3138385927098044,1.0,72/153,19.67%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;GGT5;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;MRPS11;MRPL51;RPL10A;RPL3;RPL12;GGT1;PCSK1;RPS27A;RPS12;RPL27;RPS28;RPL5;GSPT2;RPS10;GGT7
prerank,positive regulation of phagocytosis (GO:0050766),-0.5192868303435256,-1.7026528621911154,0.007407407407407408,0.305764485343974,1.0,23/47,23.30%,CAMK1D;MERTK;IL15RA;CD47;SIRPA;GATA2;GAS6;C4B;DOCK2;CALR;CYBA;MYO18A;C2;RAB31;LYAR;C3;CCL2;TREM2;PTPRJ;AHSG;RAB27A;PLA2G5;PYCARD
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.8184398825336338,1.6986488359203216,0.013333333333333334,0.5033852661383879,1.0,7/12,10.33%,SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,regulation of cellular senescence (GO:2000772),-0.5831195509053163,-1.697036348262035,0.01238390092879257,0.31307310465173505,1.0,10/28,14.15%,SLC30A10;B2M;AKT3;CDK6;NUAK1;YPEL3;ABI3;YBX1;RBL1;VASH1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7589387641452917,-1.6949255645026469,0.00954653937947494,0.3095857650023625,1.0,5/10,13.41%,PDE4B;CALM1;CACNA2D1;NOS1AP;CALM3
prerank,regulation of acrosome reaction (GO:0060046),-0.7514370248928707,-1.6947055634503254,0.007462686567164179,0.3009949151463732,1.0,2/10,8.26%,PLCB1;GLRA1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.663214018690631,1.6926727969112023,0.011111111111111112,0.5300214321171496,1.0,13/43,8.58%,BMP4;KLF5;NFIB;SOX9;DDX5;FOXO3;KLF4;FGF2;NFATC4;STAT3;IL10;TEAD1;ATOH8
prerank,negative regulation of leukocyte migration (GO:0002686),0.8565440761439175,1.692660125975716,0.014492753623188406,0.5194417438119522,1.0,2/10,1.20%,SLIT2;BMP5
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.728588075469759,1.6922778841628052,0.007320644216691069,0.5112493106394339,1.0,5/27,5.94%,EGFR;BMP4;DDX5;EIF4G1;STAT3
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6583122791544915,-1.6911103429954113,0.013262599469496022,0.3030510488624687,1.0,4/18,7.60%,IGF1;IGFBP2;RPS3;IL18
prerank,regulation of multicellular organism growth (GO:0040014),-0.6618570446113416,-1.6905948144886584,0.01288659793814433,0.296065456444255,1.0,6/15,11.54%,IGF1;PTCH1;APP;GHR;MFSD2A;PPIB
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6755978278700944,1.686960589740029,0.015341701534170154,0.5332260909610386,1.0,11/39,6.04%,SLIT2;BMP4;SIX1;MET;PKD1;LRP6;SEMA3E;FGF2;NRP1;TGFBR2;GDNF
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5832084733297941,-1.6852684608112023,0.02346041055718475,0.303021893338557,1.0,8/25,10.06%,ERRFI1;PPARA;SLC6A9;CBLB;CNRIP1;SOCS5;ZFYVE28;ACE2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6694508040149808,-1.683819786047131,0.013054830287206266,0.2996278385427493,1.0,5/15,12.71%,PLTP;APOE;ABCA5;ABCG1;SCARB1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7763606342024495,1.6807561930596582,0.029209621993127148,0.5606152263171594,1.0,6/17,8.58%,BMP4;SOX9;FGF2;TMEM100;SFRP4;ATOH8
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7612082082872149,-1.6803508842556432,0.00975609756097561,0.30212206525535296,1.0,3/10,11.66%,ATP1A2;ADRA2A;BIN1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7358983495351293,1.6800636274153922,0.020440251572327043,0.5546311825023473,1.0,7/21,4.10%,BMP4;CCN3;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,ureteric bud morphogenesis (GO:0060675),0.7765666650112227,1.6768013547439502,0.024154589371980676,0.5659095264441072,1.0,5/16,6.04%,BMP4;SIX1;WNT11;FGF2;GDNF
prerank,transepithelial transport (GO:0070633),0.7981451008297623,1.6740564948532675,0.01948051948051948,0.57304440443847,1.0,6/15,3.83%,SLC23A1;SLC23A2;SLC12A2;CXADR;ABCG2;SLC26A6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6965115259661752,1.6737147939158918,0.014245014245014245,0.5649194813232647,1.0,10/35,6.36%,NR3C2;NEDD4;DDX5;RBFOX2;ESR2;PMEPA1;DDX17;ESR1;UBR5;TADA3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6556978248058768,-1.6726881242955902,0.0158311345646438,0.31549619091073644,1.0,9/17,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7367645786038249,-1.6721107041722607,0.00437636761487965,0.30932848811973446,1.0,2/10,1.97%,LYN;KIT
prerank,response to interferon-alpha (GO:0035455),-0.6610473349038455,-1.67125848760816,0.010126582278481013,0.3045069287638164,1.0,7/16,10.81%,IFNAR1;IFITM1;BST2;IFNAR2;IFITM3;GAS6;AXL
prerank,ceramide transport (GO:0035627),-0.7312321472891745,-1.6678902935386788,0.007518796992481203,0.30594893925730604,1.0,6/12,21.19%,PLTP;CERT1;ABCB4;PSAP;ABCA2;SGPP1
prerank,circulatory system development (GO:0072359),0.5867734173713183,1.6676942302980282,0.0023584905660377358,0.5940497428130094,1.0,31/118,9.96%,MICAL2;PLCE1;NXN;ZFPM2;PCSK5;NTRK3;PKD1;SOX9;CACNA1C;FN1;AKAP13;CXADR;HDAC9;PDLIM7;COL3A1;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;PDLIM5;ID2;CDKN1B;FOXC1;GLI2;TNNI3;NF1;ACVR1
prerank,positive regulation of wound healing (GO:0090303),0.6827293407205061,1.667271864768673,0.0056022408963585435,0.5867054694242892,1.0,8/36,3.69%,SMOC2;ST3GAL4;THBS1;ANXA1;PLPP3;ITGB1;PRKCE;FOXC2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8366907770889851,1.6638170356895983,0.011986301369863013,0.5992574745939977,1.0,6/11,6.70%,BMP4;ZFPM2;BMPR1A;ISL1;GATA4;JAG1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.7485355898233161,-1.6620999953508024,0.00510204081632653,0.3156133948239337,1.0,3/10,2.60%,ERRFI1;ENG;ENPP1
prerank,axon extension (GO:0048675),0.7257684026053417,1.660889972227085,0.023255813953488372,0.6069098656545003,1.0,5/23,3.98%,SLIT3;SLIT2;ULK2;ALCAM;NRP1
prerank,heart development (GO:0007507),0.5694914023315512,1.6605260406409714,0.002285714285714286,0.5993622913516153,1.0,38/150,10.33%,MICAL2;BMP4;PLCE1;ZFPM2;SGCD;PCSK5;NTRK3;PKD1;SOX9;BMP5;CACNA1C;CSRP3;FN1;AKAP13;GPC3;CXADR;HDAC9;PDLIM7;COL3A1;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;GATA4;PDLIM5;FLRT2;ID2;CDKN1B;FOXC1;GLI2;TNNI3;NF1;ACVR1;VEGFA
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6677866577713644,-1.6604596384042405,0.014669926650366748,0.31312234657359916,1.0,8/15,13.90%,IL31RA;NR1H3;GRN;LRFN5;CD300A;CD84;CD200;HAVCR2
prerank,regulation of T cell chemotaxis (GO:0010819),0.8101472995927246,1.6575515523612434,0.02533783783783784,0.6085478287884307,1.0,2/11,1.93%,STK39;WNK1
prerank,central nervous system neuron development (GO:0021954),-0.6502145241758133,-1.6574856431107565,0.033766233766233764,0.3138225772682495,1.0,6/15,8.24%,RAPGEF2;MAP2;LHX6;NTRK2;MAPT;HSP90AB1
prerank,response to glucagon (GO:0033762),-0.6386560985300066,-1.6555485392401752,0.014285714285714285,0.31321944255437345,1.0,9/19,11.28%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2
prerank,positive regulation of potassium ion transport (GO:0043268),0.6780445095057446,1.6549689009479776,0.01544943820224719,0.6142056405013432,1.0,6/38,2.72%,KCNJ2;FHL1;KCNMB3;KCNMB2;ANK2;KCNJ15
prerank,aorta development (GO:0035904),-0.690300198445636,-1.6544503100308576,0.009852216748768473,0.3098979599497182,1.0,7/14,9.85%,ROBO1;PDGFRB;ADAMTS9;ROBO2;TBX1;PDE2A;EFEMP2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7662221623485472,1.6531177294855535,0.028523489932885907,0.6156370229038688,1.0,5/16,6.04%,BMP4;SIX1;FOXD1;FGF2;GDNF
prerank,organic acid transport (GO:0015849),0.5940158395485398,1.6521852156259964,0.004784688995215311,0.6119813571853007,1.0,9/94,2.41%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;SLC16A1;ABCG2
prerank,vesicle transport along actin filament (GO:0030050),-0.629024999994057,-1.6469349590100577,0.011695906432748537,0.3238330453544265,1.0,7/19,17.23%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7484996753544821,1.6456603167492854,0.03130148270181219,0.6428730621963878,1.0,5/17,7.01%,SLIT2;FSTL1;SULF1;SFRP4;LRIT3
prerank,nucleotide biosynthetic process (GO:0009165),0.7422299148842587,1.6454579139359624,0.031446540880503145,0.634654316655849,1.0,4/18,8.12%,ME1;NMNAT2;PRPS2;NMNAT1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.550670234281527,-1.6438673020664103,0.0,0.32652842782582875,1.0,17/37,9.82%,PLCB1;GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRIN2A;GRM1;APP;GRIN2B;GRIK1;GRIA3;GRM8;GRIN1;CPEB4;GRIA2
prerank,negative regulation of cartilage development (GO:0061037),0.8005307564866564,1.6410243345042033,0.014516129032258065,0.652133310931466,1.0,7/13,7.23%,WNT9A;SOX9;WNT11;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,epiboly involved in wound healing (GO:0090505),0.7837786413417049,1.6401031304708285,0.020967741935483872,0.6481207212739668,1.0,5/16,9.06%,TMEFF2;CCN1;CD44;MRTFA;RHOA
prerank,base conversion or substitution editing (GO:0016553),-0.7033305900236579,-1.639446826199037,0.029953917050691243,0.33309056658598923,1.0,5/11,21.08%,APOBEC1;ADARB2;ADARB1;ADAR;METTL3
prerank,xenobiotic transport (GO:0042908),0.7575650156297165,1.6385898087286606,0.022435897435897436,0.6482962003840217,1.0,2/17,2.41%,SLC47A1;ABCG2
prerank,B cell receptor signaling pathway (GO:0050853),-0.5362327373397483,-1.6378447364540303,0.012779552715654952,0.33098835871175536,1.0,9/32,11.67%,BCL2;RFTN1;TEC;PRKCB;MEF2C;VAV3;CD38;BMX;BLNK
prerank,histone H4 deacetylation (GO:0070933),0.8328485298030249,1.6368261341183643,0.013114754098360656,0.6502239725269676,1.0,3/10,5.36%,HDAC4;HDAC9;HDAC8
prerank,secretion (GO:0046903),-0.6736651633693026,-1.6363804110993745,0.016587677725118485,0.3283920964110696,1.0,6/14,9.99%,RIMS1;SLC22A6;NPR1;SLC22A4;FBLN5;SLC22A2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.7844519848512741,1.633810376590369,0.013333333333333334,0.6598552468588097,1.0,2/12,1.48%,BMP4;NEDD4
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.8148873321432479,1.6334000041214918,0.02901023890784983,0.6536289223958247,1.0,2/10,1.93%,STK39;WNK1
prerank,amino acid transmembrane transport (GO:0003333),0.6407261714865796,1.6330982095674336,0.017783857729138167,0.6465592701774325,1.0,4/45,1.31%,SLC47A1;SLC38A2;SLC38A1;LRRC8D
prerank,ventricular septum morphogenesis (GO:0060412),0.7031383465856603,1.6321575328137836,0.01925925925925926,0.6441375629165089,1.0,9/27,5.48%,SLIT3;SLIT2;BMP4;ZFPM2;HES1;BMPR1A;TGFBR1;TGFBR2;NOG
prerank,carboxylic acid transport (GO:0046942),0.6353844795168573,1.6311140452758344,0.010269576379974325,0.6422770639444326,1.0,8/55,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC6A7;SLC38A6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.6075675988227504,-1.6309532520978915,0.01876675603217158,0.3379488019328265,1.0,7/19,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7815540732584756,1.6257638550250917,0.0231023102310231,0.6654856255280819,1.0,6/14,15.05%,THBS1;CMKLR1;IL10;IRAK3;PIBF1;TLR8
prerank,extracellular structure organization (GO:0043062),0.5426441274807011,1.624024550036703,0.0010695187165775401,0.6674581790146429,1.0,39/204,6.39%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;SMOC1;COL3A1;COL23A1;ITGB1;FGF2;ADAMTSL5;LOXL1;COL6A3;TGFBR1;ITGB5;ITGA10;ITGA5;ADAM12;MMP16;ITGAV;COL11A1;ADAMTS5
prerank,regulation of cell junction assembly (GO:1901888),-0.5710214533397504,-1.6221338737843758,0.022284122562674095,0.35735473133831386,1.0,9/27,11.32%,TJP1;PRKCH;CLDN5;OCLN;RAPGEF2;F11R;MEF2C;RAPGEF1;ROCK2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.7050781749043157,1.6214726132441184,0.02936630602782071,0.6742942860254075,1.0,8/23,7.86%,BMP4;SIX1;SOX9;SMO;FGF2;NOG;GDNF;SIX4
prerank,regulation of T cell migration (GO:2000404),-0.6209803273633989,-1.6211705658625255,0.030379746835443037,0.3541307267566669,1.0,5/18,4.62%,APOD;LRCH1;CXCL12;RIPOR2;APP
prerank,detection of mechanical stimulus (GO:0050982),0.7368163304881378,1.6208465871687978,0.0334855403348554,0.6696184282266373,1.0,5/19,7.62%,PIEZO2;PKD1;CSRP3;PKD2L2;JUP
prerank,cartilage development (GO:0051216),0.6312087560943138,1.62027417945181,0.011627906976744186,0.6650186760989123,1.0,11/49,4.23%,BMP4;CCN3;NFIB;PKD1;SOX9;ITGB8;ZBTB16;CD44;SULF1;FGF2;SLC39A14
prerank,sodium ion transport (GO:0006814),0.5759457870160519,1.6170213118969745,0.020050125313283207,0.676922124224294,1.0,11/85,4.49%,SLC4A4;SLC23A1;SLC9B2;SLC12A2;SLC5A6;SLC24A3;ATP1B1;SLC6A7;ANO6;FGF13;NALCN
prerank,melanocyte differentiation (GO:0030318),-0.6962407123492033,-1.6149264696237617,0.020134228187919462,0.3656894276617671,1.0,6/11,8.34%,LRMDA;KIT;ENPP1;MITF;MEF2C;SLC24A5
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6390926826447609,1.6147662013805684,0.027359781121751026,0.682949673152069,1.0,10/39,5.27%,STK39;PTPN3;NEDD4;FXYD5;CAMK2D;SLMAP;WNK1;FGF13;PRKCE;DMD
prerank,regulation of membrane depolarization (GO:0003254),0.7306441321515333,1.6120320449083605,0.027649769585253458,0.6922148523340937,1.0,3/18,1.74%,FHL1;PTPN3;CAMK2D
prerank,vasculature development (GO:0001944),-0.6253002158120109,-1.6108508321012234,0.012919896640826873,0.3717529145270439,1.0,11/16,18.39%,ERRFI1;PDGFRB;NOTCH4;ACVR2B;PDGFRA;SOX18;FLT4;ACVRL1;APLNR;FOXF1;CDH5
prerank,negative regulation of T cell differentiation (GO:0045581),0.8158683675982933,1.6100333940486242,0.028985507246376812,0.6958503695709659,1.0,3/10,7.56%,BMP4;GLI3;IRF1
prerank,response to zinc ion (GO:0010043),-0.5750984214724263,-1.6094160915775142,0.012779552715654952,0.36933847672933584,1.0,16/25,21.70%,PAM;CRIP1;GLRA1;MT2A;SLC30A4;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;MT3;HVCN1;KHK
prerank,regulation of activated T cell proliferation (GO:0046006),-0.5406476415748627,-1.609391533470399,0.01764705882352941,0.36327492423945423,1.0,5/30,7.60%,IGF1;IGFBP2;RPS3;PRKAR1A;IL18
prerank,skeletal system development (GO:0001501),0.5525899127004966,1.6085669349510714,0.0033519553072625698,0.6966130939448788,1.0,31/148,6.24%,KIAA1217;TNFRSF11B;CDH11;TLL1;EXT1;PCSK5;PKD1;SOX9;BMP5;ITGB8;BMP1;AKAP13;WNT11;DSPP;ZBTB16;CD44;SULF1;ALPL;FGFR1;BMP6;PAPSS2;HHIP;CMKLR1;TGFBR1;NPR3;PHEX;NOG;MMP16;SLC10A7;XYLT1;PTHLH
prerank,external encapsulating structure organization (GO:0045229),0.5370168575870047,1.60785848783049,0.0021436227224008574,0.6933046905045596,1.0,38/205,6.39%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;COL5A2;ITGB8;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;SMOC1;COL3A1;COL23A1;ITGB1;FGF2;ADAMTSL5;LOXL1;COL6A3;ITGB5;ITGA10;ITGA5;ADAM12;MMP16;ITGAV;COL11A1;ADAMTS5
prerank,protein hydroxylation (GO:0018126),0.7619451562678988,1.606135604364771,0.03278688524590164,0.6961762156046425,1.0,7/15,14.53%,EGLN3;PLOD2;P3H2;P3H1;P3H4;JMJD4;P3H3
prerank,cellular response to zinc ion (GO:0071294),-0.6548967140778789,-1.605564848967168,0.01912568306010929,0.3689439201509904,1.0,12/15,19.43%,GLRA1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;MT3;HVCN1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6549632838272331,1.6036344961817426,0.032210834553440704,0.7031204740554323,1.0,12/32,18.55%,FZR1;FOXN3;ATM;CLSPN;UIMC1;CHEK1;MRNIP;TRIM39;NBN;TICRR;CDKN1A;TOPBP1
prerank,peptide cross-linking (GO:0018149),0.6909038075380376,1.6016651268999116,0.024883359253499222,0.7074050377204711,1.0,7/25,8.15%,THBS1;FN1;ANXA1;DSP;COL3A1;TGM3;SPRR1A
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6138994907479881,1.6014367347780019,0.02077922077922078,0.7012713778137787,1.0,16/56,10.06%,BMPER;BMP4;BMP5;TGFB3;SMAD6;BMP6;BMPR1A;INHBA;TGFBR1;PMEPA1;NOG;GDF6;GDF5;GDF10;ACVR1;LDLRAD4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.6799943332107442,-1.6008638888218147,0.03286384976525822,0.37615299676168956,1.0,8/12,20.56%,MAP2;SNCA;ARHGEF7;STMN1;TUBB4A;STMN2;CDH5;DYRK1A
prerank,vitamin transport (GO:0051180),0.6709616941018303,1.6005380011695018,0.02391629297458894,0.6993619384063917,1.0,3/29,2.41%,SLC23A1;SLC5A6;ABCG2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6422280577934777,1.600529853715692,0.014986376021798364,0.691977078256179,1.0,8/44,2.86%,KCNJ2;KCNMB3;KCNMB2;ANK2;ATP1B1;WNK1;KCNJ15;ANO6
prerank,response to hydrogen peroxide (GO:0042542),0.6287643601463061,1.6004951579463265,0.013679890560875513,0.6848568485151585,1.0,9/45,9.08%,MAP3K5;CYP1B1;ADAM9;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.6709431103704196,-1.6004414098241875,0.02558139534883721,0.37157095474156177,1.0,5/12,18.55%,SERINC3;SERINC5;GGT1;CBS;SEPHS2
prerank,alcohol catabolic process (GO:0046164),-0.6960736157977422,-1.5999219166577374,0.01937046004842615,0.36731915688709865,1.0,2/10,1.88%,APOE;CYP27A1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6217310794104545,1.5978153695888735,0.02717391304347826,0.6938831023690846,1.0,7/42,11.35%,STK39;PTK2B;WNK1;CXCL2;FOXC1;CCL3;CCL1
prerank,pharyngeal system development (GO:0060037),0.7550388973654897,1.5977634659340114,0.03215434083601286,0.6870183225008113,1.0,8/15,7.86%,BMP4;BMP5;HES1;BMPR1A;TGFBR1;NOG;ISL1;SIX4
prerank,regulation of smooth muscle contraction (GO:0006940),0.7180662230842847,1.597714665586162,0.034161490683229816,0.6803994582275317,1.0,3/20,2.69%,KCNB2;PLCE1;ADRB2
prerank,cellular response to chemokine (GO:1990869),0.6176654167029277,1.597486413709375,0.02021563342318059,0.6749408503235454,1.0,10/46,12.52%,STK39;SLC12A2;PTK2B;WNK1;CXCL2;FOXC1;RHOA;CCL3;CCL1;ZC3H12A
prerank,negative regulation of endocytosis (GO:0045806),-0.5729735631826464,-1.59696777819891,0.027777777777777776,0.3702110990474855,1.0,7/24,8.24%,PRKD1;MCTP1;PICALM;NR1H3;SYT11;RAC1;CD300A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.592599882766762,-1.5958341353776102,0.013736263736263736,0.36834120291587197,1.0,7/19,11.66%,IGF1;APOE;PICALM;RTN1;NTRK2;RTN4;BIN1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6853785218786002,-1.5951857324814172,0.036057692307692304,0.36469909339578294,1.0,4/11,5.14%,MECOM;WNT5A;ETV6;CD34
prerank,response to hexose (GO:0009746),0.6824305931918113,1.5936220886745252,0.03111111111111111,0.6907776689718859,1.0,2/25,0.74%,THBS1;TCF7L2
prerank,regulation of cholesterol storage (GO:0010885),-0.6298070244342123,-1.5935075778412786,0.03561643835616438,0.3644684671706264,1.0,10/15,20.32%,PPARA;NR1H3;ABCA1;PPARD;ABCG1;SCARB1;MSR1;LPL;NR1H2;TREM2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6755646468108987,1.59341807267475,0.041791044776119404,0.6850163729426046,1.0,2/27,0.29%,SLC47A1;SLC38A1
prerank,gland development (GO:0048732),0.6063571796173303,1.5920403083698256,0.018641810918774968,0.6867796639821103,1.0,20/59,11.99%,SIX1;MET;SOX9;IGSF3;COBL;EZR;TGFB3;ANXA1;WNT11;HES1;TGFBR1;STRA6;EPHB3;GLI2;RIPK3;NF1;DKK3;FOXE1;PRKCSH;NKX2-1
prerank,cellular response to peptide (GO:1901653),-0.4723256855982786,-1.5913712469023769,0.004201680672268907,0.3654590300815036,1.0,17/56,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;NOD1;CASP4;APP;GJA1;EPHA4;VIM;CACNA2D1;ITGA4;GRIN1;RPL23;LGMN;CACNB1
prerank,entry into host (GO:0044409),0.7571327550659085,1.5907977339154682,0.04852686308492201,0.6876428576254494,1.0,3/13,5.85%,CDH1;MET;ITGAV
prerank,negative regulation of cell growth (GO:0030308),0.5567788547121129,1.5901664658721775,0.004667444574095682,0.6847402365993245,1.0,12/121,4.05%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ULK2;ESR2;INHBA;FGF13;IP6K2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.6115267065155165,1.5895035086457803,0.028,0.6819719144009186,1.0,8/54,2.75%,STK39;KCNJ2;FHL1;KCNMB3;KCNMB2;NEDD4;KCNJ15;WWP2
prerank,neutral amino acid transport (GO:0015804),0.6779818605006562,1.5891596084262098,0.04129793510324484,0.6774850694971257,1.0,4/28,3.56%,SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5949991011900456,1.5886158441930862,0.014397905759162303,0.6744292435930489,1.0,24/59,20.10%,STK39;CIT;CAMK2D;WNK1;PRKCD;HIPK1;GSK3B;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;CHEK1;PRKDC;CDC42BPG;DYRK2;PRKCA;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1;DYRK3;MAPK8
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.6320296561313223,-1.5885252864045076,0.03278688524590164,0.36847355563417633,1.0,7/18,14.30%,CAMK1D;PRKD1;RPS6KA5;ADCY1;LRP8;CD200;EPHA5
prerank,response to progesterone (GO:0032570),0.7220186008053147,1.5871192655246396,0.03949447077409163,0.6772776298916774,1.0,2/18,1.84%,THBS1;TGFB3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5687570451941625,1.5870517666603468,0.005924170616113744,0.6715587972924748,1.0,16/92,5.01%,SMOC2;FOXP1;THBS1;BMP4;DOCK5;SOX9;PTK2B;ADAM9;ANXA3;MAPRE2;FGF2;PRKCE;ABL1;FOXC2;NRP1;BCAS3
prerank,response to estradiol (GO:0032355),0.6541381367133247,1.5863016197942639,0.03188405797101449,0.6696866315799893,1.0,8/31,8.46%,EGFR;ANXA1;ESR1;STAT3;MYOG;LCOR;SOCS2;STRN3
prerank,peptidyl-threonine modification (GO:0018210),0.5823056845371148,1.5861398113001386,0.015364916773367477,0.6645689831154266,1.0,24/66,18.52%,STK39;CIT;CAMK2D;WNK1;PRKCD;HIPK1;GSK3B;GALNT13;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;GALNT11;CHEK1;PRKDC;CDC42BPG;DYRK2;PRKCA;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.773193687490507,1.5837782813044892,0.05509181969949917,0.6712554562704114,1.0,2/12,2.63%,BDH2;GCLC
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6876059961542647,-1.58314138492274,0.03233830845771144,0.3791204648923652,1.0,5/11,16.62%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.754612061305715,1.582712736114285,0.028892455858747994,0.6713537008351933,1.0,6/14,7.23%,WNT9A;SOX9;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6260633417432303,1.5824745383946655,0.027624309392265192,0.6665653266149809,1.0,15/43,18.55%,FZR1;FOXN3;RAD17;ATM;CLSPN;NABP1;UIMC1;CHEK1;MRNIP;TRIM39;CHFR;NBN;TICRR;CDKN1A;TOPBP1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.761173885653121,1.5809202097856812,0.03672787979966611,0.6691283640070185,1.0,3/14,3.29%,THBS1;SULF1;FGF2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6098949332899533,-1.5804722168315566,0.02531645569620253,0.38158012906332744,1.0,7/17,13.41%,ITGA1;PDGFRB;CALM1;CD300A;HSP90AB1;PPP1R15B;CALM3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7452570417517622,1.5793345134434074,0.044850498338870434,0.6721120807248708,1.0,4/15,3.29%,SMOC2;THBS1;MET;FGF2
prerank,response to alcohol (GO:0097305),0.6733741442416087,1.5792799437370246,0.033625730994152045,0.6666422981765875,1.0,5/27,4.97%,SLIT3;SLIT2;ADH7;TGFBR1;TGFBR2
prerank,regulation of endothelial cell migration (GO:0010594),0.5699792544960408,1.578149634719724,0.006075334143377886,0.6670039696359389,1.0,14/85,5.01%,SLIT2;SMOC2;BMPER;FOXP1;THBS1;BMP4;RHOJ;PTK2B;ANXA3;FGF2;ABL1;FOXC2;NRP1;BCAS3
prerank,glycine transport (GO:0015816),-0.7028893188473697,-1.5773691399039562,0.03044496487119438,0.38556188290173243,1.0,6/10,19.57%,SLC6A9;SLC38A5;SLC6A17;SLC6A5;SLC36A2;SLC25A38
prerank,regulation of sensory perception of pain (GO:0051930),0.7838368902741293,1.5766645479248977,0.043327556325823226,0.6693377375968369,1.0,6/11,12.57%,CCN3;MGLL;TMEM100;ACP3;CCL3;SCN11A
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7625675996576315,1.5758484707303386,0.04201680672268908,0.668452424396059,1.0,4/13,5.80%,BMP4;NR3C2;ESR2;ESR1
prerank,mesenchyme development (GO:0060485),0.7470495962372615,1.5758358566945647,0.03372681281618887,0.6629794465179403,1.0,5/15,6.17%,BMP4;WNT11;TGFBR1;ISL1;GATA4
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6785204676852443,1.575441316856451,0.0315955766192733,0.6598232257903445,1.0,7/26,3.09%,STK39;FHL1;NEDD4;ANK2;ATP1B1;WWP2;ITGB1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5505764961187556,1.5748965351717026,0.008158508158508158,0.6573337910142665,1.0,37/128,11.64%,BMP4;SMAD9;BMP5;DDX5;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMP6;BMPR1A;INHBA;ID1;TGFBR1;ITGB5;LTBP2;PDCD4;TMEM100;TGFBR2;GCNT2;SKI;BAMBI;TGFB1I1;GDF6;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;JUN;SMAD2;MEGF8;INHBB;RNF111;RGMB
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6798787136716536,1.5736892610490125,0.03566121842496285,0.6585391565299938,1.0,3/24,2.86%,SLIT2;CCN3;ANO6
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5210381397248459,-1.5732457966800182,0.01892744479495268,0.3924226851966347,1.0,14/32,26.77%,CEMIP;CALM1;AKAP6;SNCA;JPH2;PLCG1;CALM3;TRPC1;APLNR;CX3CL1;GPER1;F2R;HAP1;CASQ1
prerank,positive regulation of DNA replication (GO:0045740),0.7285970790862423,1.5731721122332802,0.041254125412541254,0.6559753832415421,1.0,4/16,9.08%,EGFR;BCAR3;STN1;GLI2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.6086665678752636,-1.5718055040588714,0.018469656992084433,0.39142646701861716,1.0,7/17,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6763077217555313,1.571450295034958,0.03255813953488372,0.6595921029856967,1.0,11/26,16.01%,FOXP1;CRY2;ISL1;PIAS2;STRN3;KANK2;NCOR1;PER1;SMARCA4;NCOR2;ZBTB7A
prerank,epidermal cell differentiation (GO:0009913),0.6226224435935886,1.5698486439802506,0.03017832647462277,0.6631518665134079,1.0,11/41,8.15%,CLIC4;ADAM9;ANXA1;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;PITX2;SPRR1A
prerank,regulation of mononuclear cell migration (GO:0071675),0.6771582141730516,1.5691640216194025,0.040123456790123455,0.6616653651103347,1.0,4/23,3.93%,SLIT2;THBS1;BMP5;CMKLR1
prerank,negative regulation of growth (GO:0045926),0.5496609135955387,1.56883044731859,0.010380622837370242,0.6584092376889092,1.0,11/121,4.05%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ESR2;INHBA;NOTCH2;IP6K2
prerank,aortic valve morphogenesis (GO:0003180),0.6470058646694807,1.5685879901345814,0.04512372634643377,0.6546049255793819,1.0,5/30,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,negative regulation of myotube differentiation (GO:0010832),0.7630959440439926,1.5682782112240896,0.05509181969949917,0.6511753409393988,1.0,2/12,1.24%,CCN3;HDAC4
prerank,negative chemotaxis (GO:0050919),0.6440409908476249,1.5663335624049768,0.041726618705035974,0.6571544399835172,1.0,7/33,2.43%,SLIT3;SLIT2;NTN1;SEMA3E;UNC5C;SEMA3D;SEMA3C
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7700759129711177,1.5656463573897628,0.03620689655172414,0.6554258422783756,1.0,4/12,3.85%,ANK2;PTK2B;UBASH3B;DIAPH1
prerank,cellular response to estradiol stimulus (GO:0071392),0.7292678329392759,1.5653443598303551,0.04383116883116883,0.6522139528436858,1.0,4/18,7.52%,EGFR;ESR1;MYOG;LCOR
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5514380098076126,-1.5643640721189023,0.02967359050445104,0.4086682348160509,1.0,5/26,13.41%,ATP1A2;CALM1;ADRA2A;CASQ2;CALM3
prerank,regulation of viral life cycle (GO:1903900),-0.5683118881298435,-1.563809161321793,0.02694610778443114,0.4050591159261769,1.0,8/21,14.72%,HS3ST5;TRIM14;PPIA;TRIM62;NECTIN2;AXL;TYRO3;TRIM21
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7499789082694301,1.5632399730702167,0.03636363636363636,0.6579987183541922,1.0,6/13,4.10%,BMP4;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,regulation of response to stress (GO:0080134),0.8022962356585025,1.5620384547365094,0.03511705685618729,0.6600459794113274,1.0,3/10,7.15%,SLC38A2;EIF4G1;IL10
prerank,activation of protein kinase A activity (GO:0034199),-0.6243452711380753,-1.561679726475203,0.031746031746031744,0.4067490969979453,1.0,7/16,6.79%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6916302841822246,-1.5614354766839975,0.03365384615384615,0.4022648123485559,1.0,3/10,4.97%,SLC1A3;SLC1A1;SLC1A2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5697259121872245,1.5613245515363512,0.013431013431013432,0.658823621949992,1.0,23/86,11.42%,THBS1;BMP4;BMP5;FOXD1;CCN1;TGFB3;SULF1;GIPC1;BMP6;BMPR1A;INHBA;ZNF423;NUP93;TGFBR1;CREBBP;TGFB1I1;GDF6;GDF5;GDF10;ACVR1;SMAD2;INHBB;RNF111
prerank,lymphocyte mediated immunity (GO:0002449),0.7746859572487997,1.5611642139867157,0.044596912521440824,0.6548310576833776,1.0,5/12,8.82%,CD55;GNL1;JAG1;KLRC2;CD46
prerank,regulation of protein import into nucleus (GO:0042306),0.6323804633341806,1.5607994470178475,0.03486750348675035,0.6520970894063706,1.0,8/36,7.62%,BMP4;CDH1;PRKCD;ZIC1;MDFIC;UBR5;MAVS;JUP
prerank,inorganic anion transmembrane transport (GO:0098661),0.5897033215356908,1.5604164836135486,0.021437578814627996,0.6495873594006925,1.0,9/63,4.00%,SLC26A2;SLC12A7;SLC12A2;SLC5A6;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,heterochromatin organization (GO:0070828),-0.6480954372552055,-1.5595301874662728,0.03526448362720403,0.4026582296430809,1.0,3/14,9.50%,MECOM;PRDM16;HP1BP3
prerank,ganglioside biosynthetic process (GO:0001574),-0.6190225891162182,-1.559491430885877,0.041463414634146344,0.3977894612648287,1.0,4/15,5.35%,ST6GALNAC3;ST3GAL1;ST8SIA4;ST8SIA6
prerank,embryonic digestive tract development (GO:0048566),0.7088566341689501,1.558743881791203,0.04433497536945813,0.6534382957586514,1.0,7/18,12.18%,PCSK5;RARB;GLI3;STRA6;ID2;GLI2;NIPBL
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7293458111482665,1.5550460500863195,0.04516129032258064,0.6672254094972037,1.0,4/16,6.63%,DPYSL3;NT5E;NT5C1A;UPP2
prerank,cellular response to osmotic stress (GO:0071470),0.6848736165753735,1.5545811935091782,0.04636785162287481,0.6648945984380933,1.0,3/21,2.92%,STK39;LRRC8D;YBX3
prerank,sodium ion import across plasma membrane (GO:0098719),0.7159149019655682,1.5533942310755273,0.0491283676703645,0.6666001970648602,1.0,5/17,8.86%,SLC9A2;SLC12A2;TRPM4;SLC9C1;SLC9A1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7678005039219321,1.5531090491109645,0.04537521815008726,0.6633975632035146,1.0,3/12,1.20%,SLIT2;CCN3;BMP5
prerank,import into cell (GO:0098657),0.6237555301879382,1.5498471367085582,0.03972602739726028,0.6752897511798452,1.0,5/41,1.31%,SLC47A1;SLC12A7;SLC38A1;SLC5A6;LRRC8D
prerank,purine nucleotide metabolic process (GO:0006163),0.6758188396271825,1.5493307296613283,0.05239520958083832,0.6733272854423342,1.0,4/24,2.82%,NT5E;NT5C1A;FHIT;PRPS2
prerank,keratinocyte differentiation (GO:0030216),0.6542078511154231,1.548662384789528,0.050445103857566766,0.6721761090257049,1.0,10/29,8.15%,CLIC4;ADAM9;ANXA1;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;SPRR1A
prerank,response to amyloid-beta (GO:1904645),-0.49484785315112095,-1.5457203381476843,0.016835016835016835,0.4366468540002685,1.0,15/44,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;CACNA1B;CACNA2D1;ITGA4;GRIN1;LGMN;CACNB1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5282132730495851,-1.5439379453933482,0.024691358024691357,0.4368115205535168,1.0,14/30,7.80%,TJP1;GJB6;PECAM1;CLDN5;LAMA2;ESAM;OCLN;MBP;F11R;SLC1A1;ACTB;GJA1;JAM3;CLDN1
prerank,cellular response to amyloid-beta (GO:1904646),-0.5257661501412947,-1.5422110464400145,0.022727272727272728,0.4374765622235057,1.0,14/35,10.16%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;CACNA2D1;ITGA4;GRIN1;LGMN;CACNB1
prerank,anterior/posterior pattern specification (GO:0009952),0.594249828042779,1.5420772018286966,0.024291497975708502,0.7018585768833885,1.0,18/53,11.05%,PCSK5;HOXA5;HOXA3;HES1;HOXB6;HOXA6;TGFBR1;HOXC6;BHLHE40;SKI;HOXB3;GATA4;DDIT3;HOXB5;HOXC4;HOXB4;LRP5;SMAD2
prerank,regulation of muscle cell differentiation (GO:0051147),0.6402186182948945,1.5409290099758042,0.037868162692847124,0.7028900258649254,1.0,8/31,7.45%,CDON;BOC;HDAC9;CTNNA1;ABL1;MEF2A;MYOG;ID2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7713403400418771,1.5394819468137457,0.03880070546737213,0.7057414788393824,1.0,7/12,18.46%,FOXP1;PIAS2;NCOR1;SMARCA4;NCOR2;ZBTB7A;HEYL
prerank,BMP signaling pathway (GO:0030509),0.580179527663653,1.5393852174757483,0.025032938076416336,0.7014463892399215,1.0,19/62,11.64%,BMP4;SMAD9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;NOG;GDF6;GDF5;CHRD;USP15;ACVR1;SMAD2;MEGF8;RGMB
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6674711316163555,1.5389176409091176,0.047058823529411764,0.6994915928437451,1.0,4/25,3.08%,SLIT2;PRKCD;LIMK2;ARHGAP44
prerank,sensory perception of sound (GO:0007605),-0.4324874750048199,-1.5383940143376011,0.0,0.44464800890623424,1.0,19/88,9.29%,COL4A3;CEMIP;CACNA1D;DCDC2;GRM7;KIT;ADGRV1;USP53;RIPOR2;PCDH15;TBX1;EPS8L2;ALDH7A1;CLIC5;EYA1;KCNQ1;CCDC50;GRAP;NDUFB9
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5600550097820847,-1.5377280177016304,0.04504504504504504,0.4417691949460807,1.0,12/23,18.49%,ACSL1;ELOVL7;FAR2;ELOVL6;HSD17B12;ACSL5;ACOT7;DGAT1;HACD2;ACSBG1;ACSL4;HACD1
prerank,neurotransmitter secretion (GO:0007269),-0.4770395184063343,-1.5376202134184354,0.0078125,0.43708303008357446,1.0,22/44,27.02%,NRXN1;RIMS1;LIN7A;RIMS2;HSPA8;SYN2;SNCA;SNAP25;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;PPFIA3;SNAPIN;UNC13A
prerank,stem cell development (GO:0048864),-0.595581764291849,-1.5367215504458298,0.0395778364116095,0.4351509216499878,1.0,7/16,24.39%,CDH2;TAPT1;NRG1;NOLC1;SHH;SNAI2;WNT7A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5986514009993894,1.53649050401367,0.04632152588555858,0.7074879161905836,1.0,9/45,4.91%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5889875237289202,1.536468452617668,0.043478260869565216,0.703037215354346,1.0,17/46,18.05%,CDH1;TCF7L2;NEDD4;PRKCD;ZIC1;GSK3B;UBR5;MAVS;JUP;EMD;ZC3H12A;BAG3;DHX9;XPO4;HCLS1;EFCAB7;KHDRBS1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5636502417628676,1.5360665350615998,0.02736318407960199,0.7005979527085767,1.0,19/76,13.94%,EGFR;NR3C2;CCN3;RASSF2;TCIM;EZR;NFAT5;PDCD4;TRIM44;DLG1;IFI35;TLR4;RHOA;LIMS1;ZC3H12A;TRIP6;PPM1A;EP300;TRADD
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7559531295609481,1.5347459777508068,0.0676818950930626,0.7027407482791004,1.0,1/12,0.33%,FZR1
prerank,epithelial tube morphogenesis (GO:0060562),0.632884232768869,1.534275673478571,0.04190751445086705,0.7006558452432902,1.0,5/32,2.38%,SLIT2;BMP4;MET;PKD1;HES1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5404152310366377,-1.5331516827124805,0.035422343324250684,0.44158126355291977,1.0,4/23,3.51%,ENG;TGFBR3;NREP;ITGA3
prerank,response to prostaglandin E (GO:0034695),-0.6771885776951043,-1.5309120609375944,0.05045871559633028,0.4439395873076513,1.0,3/10,13.42%,TGFBR3;GNG2;CCL19
prerank,hippo signaling (GO:0035329),-0.532767391488067,-1.5305891598223678,0.03823529411764706,0.440154052194995,1.0,7/26,13.13%,TJP1;AMOTL1;TEAD2;TEAD4;AMOTL2;YWHAB;CASP3
prerank,positive regulation of nuclear division (GO:0051785),-0.5388332290334134,-1.5301161376062697,0.030303030303030304,0.43709142898611414,1.0,6/25,9.16%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,aortic valve development (GO:0003176),0.6240445109808413,1.5298601389553823,0.05028735632183908,0.7195853450552865,1.0,5/34,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6897534030732819,1.5298444365210904,0.05546995377503852,0.7151786756237031,1.0,3/19,4.55%,SLC26A2;PAPSS2;SULT1A1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7583436437485143,1.529558967693172,0.05410122164048865,0.7121149671257799,1.0,3/11,3.11%,RSPO3;MLLT3;PLEKHA4
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5601324051073894,-1.5285263125415711,0.022988505747126436,0.4369959605945873,1.0,8/23,10.71%,IGF1;EFNB2;PIEZO1;AKAP6;MEF2C;EDN1;PROX1;MYOCD
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5701865661896336,1.5284029362752363,0.026888604353393086,0.713947698206079,1.0,8/68,6.65%,SLC23A1;SLC23A2;AOX1;SLC5A6;VNN1;RFK;PNPO;MMACHC
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.6252649765339563,1.5278711073288438,0.039589442815249266,0.7123415120193817,1.0,10/38,7.62%,KCNJ2;ANK2;CACNA1C;CAMK2D;DSP;DSG2;CACNA1G;TRPM4;ISL1;JUP
prerank,transition metal ion transport (GO:0000041),-0.5060198590625078,-1.5278611505932331,0.033783783783783786,0.4343162000113549,1.0,14/35,13.73%,CP;SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP2C1;ATOX1;TRPC4;TRPC6;SLC30A1;SLC31A1;TTYH1;TRPC1
prerank,regulation of ion transmembrane transport (GO:0034765),0.6318771068161967,1.5267716281940142,0.03483309143686502,0.7137584683911099,1.0,6/33,2.86%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;ANO6
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5466193001734835,1.5262882957097417,0.015643802647412757,0.711996919357046,1.0,14/84,5.01%,SMOC2;FOXP1;THBS1;BMP4;MET;PTK2B;ANXA3;PLPP3;FGFR1;FGF2;ABL1;FOXC2;NRP1;BCAS3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7328633938581056,1.525886468794362,0.056105610561056105,0.709856780077212,1.0,4/13,5.30%,BMP4;NFIB;SOX9;NFATC4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.6759017870846047,-1.5258205584203368,0.058004640371229696,0.43613250442301454,1.0,5/10,17.36%,SNCA;KLF15;NOC2L;SET;CTBP1
prerank,rRNA metabolic process (GO:0016072),-0.3827797882565392,-1.5256816059691092,0.0,0.43201153111791957,1.0,69/160,23.15%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;MAPT;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;NIFK;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;DIS3L;NOC4L;RRP9
prerank,basement membrane organization (GO:0071711),-0.6031487510955738,-1.5253436321394724,0.04702970297029703,0.4288109710177521,1.0,7/14,14.92%,NID1;NID2;COL4A1;LAMB1;CTSS;RAMP2;LAMB2
prerank,negative regulation of potassium ion transport (GO:0043267),0.7145882899042318,1.5243762093585151,0.05102040816326531,0.7135048558998704,1.0,2/13,1.67%,STK39;PTK2B
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6691630982797234,1.5241897041427737,0.06354009077155824,0.7101898838138556,1.0,4/25,3.98%,EGFR;THBS1;FZD7;NRP1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6900220208357202,1.523161220338702,0.06635071090047394,0.7111358439289133,1.0,7/19,9.96%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;MDM4;ACVR1
prerank,translation (GO:0006412),-0.3684682501679233,-1.5227464905242767,0.0,0.43229108637006086,1.0,77/208,19.70%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;EEF1B2;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;LARS2;RPL11;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;FASTKD2;RPL8;RPL24;RPL29;IARS1;MRPS11;MRPL51;RPL10A;RPL3;RPL12;EEF2;EEF1G;PPA1;RPS27A;RPS12;RPL27;RPS28;DARS2;RPL5;GSPT2;RPS10;MRPL2
prerank,regulation of cell death (GO:0010941),0.5513970249455383,1.522550252665303,0.024154589371980676,0.7101308435684096,1.0,19/94,8.46%,BMP4;CCN3;ACER3;CCN1;CCN5;WNT11;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;WNT16;LRP1;CLU;RIPK2;AGR2;SRSF6;CELF1;CDKN1B
prerank,regulation of interleukin-1 production (GO:0032652),0.7281571219952084,1.5214059261169912,0.060955518945634266,0.7117634940846523,1.0,4/15,8.02%,FOXP1;ANXA1;IL10;TLR4
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.6438123332129668,-1.5213031483524122,0.046296296296296294,0.4319801372125988,1.0,2/12,7.60%,IL1R1;IL18
prerank,postsynaptic membrane organization (GO:0001941),-0.58857075505718,-1.5211470436716,0.03814713896457766,0.4280194821173415,1.0,5/17,13.65%,SHANK3;APOE;NRXN1;GPHN;MUSK
prerank,Rac protein signal transduction (GO:0016601),-0.5767570302508762,-1.5205664550075693,0.04415584415584416,0.4255687350302758,1.0,7/18,12.41%,EPS8;ELMO1;CDH13;RHOH;RAC1;HACD3;HACE1
prerank,cellular response to reactive oxygen species (GO:0034614),0.5791158947194184,1.5200872733808293,0.03014416775884666,0.7141609521033019,1.0,11/59,10.16%,EGFR;MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3;CHUK;JUN
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7104572288153808,1.5200138176623785,0.07023411371237458,0.7104224847253825,1.0,4/15,6.02%,PIEZO2;TMEM120A;TMC1;COL11A1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.7387211210736895,1.5197128637603905,0.054770318021201414,0.7078832024340626,1.0,3/13,3.22%,BMP4;SOX9;PRICKLE1
prerank,potassium ion transmembrane transport (GO:0071805),0.5268756570625707,1.5194087776788168,0.01366742596810934,0.7052366468676866,1.0,13/135,3.00%,SLC9A2;KCNB2;KCNK5;SLC12A7;KCNJ2;SLC12A2;SLC24A3;ATP1B1;KCNQ5;SLC12A8;KCNJ15;KCNS3;KCNB1
prerank,thymus development (GO:0048538),0.7398195457824032,1.519336456266145,0.06239737274220033,0.701612609645275,1.0,6/13,10.53%,SIX1;HES1;TGFBR1;EPHB3;RIPK3;FOXE1
prerank,positive regulation of cytokinesis (GO:0032467),0.62625916954724,1.5162138122887705,0.05196629213483146,0.7131922317510417,1.0,9/32,13.95%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6540658037729556,1.516177699790941,0.07430340557275542,0.7093311822548674,1.0,13/25,12.24%,ANK2;CACNA1C;CAMK2D;CXADR;DSP;DSG2;FGF13;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,chordate embryonic development (GO:0043009),0.5798943102791587,1.5159799030322976,0.03994845360824742,0.7064170418577331,1.0,18/55,10.33%,KIAA1217;PCSK5;MBNL1;PKD1;BMP5;FUT8;TGFB3;WNT11;SULF1;FGFR1;TGFBR1;NOG;ISL1;XYLT1;SIX4;GRHL2;DACT1;VEGFA
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7175604685099074,1.5143067781595134,0.07378335949764521,0.7107079807278702,1.0,3/15,1.54%,F3;NTRK3;PGF
prerank,aorta morphogenesis (GO:0035909),-0.58409054802255,-1.514211886280994,0.04735376044568245,0.439362834686051,1.0,9/17,9.85%,ENG;MYLK;PDGFRB;ADAMTS9;TBX1;RBPJ;HEY2;PROX1;EFEMP2
prerank,ventricular septum development (GO:0003281),0.6215494219289068,1.5138462007971005,0.0460431654676259,0.7090788966341781,1.0,10/37,6.17%,SLIT3;SLIT2;ZFPM2;HES1;BMPR1A;TGFBR1;STRA6;TGFBR2;NOG;GATA4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.6503053474310786,1.5133224008899013,0.05217391304347826,0.7077697029889655,1.0,15/27,22.92%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;MTA1;ATOH7;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5423269488737881,-1.5133020427403698,0.04776119402985075,0.43786878042420657,1.0,11/24,17.11%,RAPGEF2;PEX5L;PRKAR2B;PRKAR1B;PDE4D;PRKAR1A;PDE2A;RNF157;MGRN1;APLNR;PDE3B
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7141782025912211,1.5132301732360267,0.05910543130990415,0.7043157823747169,1.0,6/16,6.36%,DDX5;RBFOX2;ESR2;DDX17;ESR1;TADA3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7364625021079843,1.5131218822090418,0.052884615384615384,0.7010515753277246,1.0,3/14,8.12%,ME1;NMNAT2;NMNAT1
prerank,regulation of interleukin-13 production (GO:0032656),-0.6360612226431805,-1.5125864535555813,0.04433497536945813,0.4359075952654094,1.0,4/13,7.60%,LEF1;TNFRSF21;PRKCZ;IL18
prerank,cAMP-mediated signaling (GO:0019933),-0.5457184759853901,-1.5122808256892346,0.0377906976744186,0.43271206369093246,1.0,11/24,7.31%,KSR1;PDE7B;ADCY1;RAPGEF3;RAPGEF2;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.7078365768902268,1.5122639288091324,0.07628524046434494,0.701561523188301,1.0,6/14,11.77%,THBS1;MEOX2;KLF4;RHOA;STARD13;ITGB1BP1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.6501001400355252,1.5116495190657135,0.03215926493108729,0.7006944493144032,1.0,11/30,18.46%,FOXP1;DDX5;KDM1A;PIAS2;NCOR1;SMARCA4;EP300;NCOR2;ZBTB7A;RNF14;HEYL
prerank,positive regulation of DNA metabolic process (GO:0051054),0.582044839702473,1.511576688955575,0.030065359477124184,0.6972357884976341,1.0,23/61,19.56%,SMOC2;EGFR;EYA2;FGF2;EYA4;EYA3;WRN;APLF;STPG4;USP7;UIMC1;ATRX;RNF168;ERCC8;DHX9;PML;NBN;SIRT6;RAD51;DHX36;USP9X;PARP3;UBE2N
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6255351496928538,1.5115580118496759,0.05891016200294551,0.6936153442487982,1.0,8/33,9.08%,MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3
prerank,negative regulation of insulin secretion (GO:0046676),0.7047670658678702,1.5112012177330107,0.06435643564356436,0.6914268744457135,1.0,4/17,3.88%,CCN3;KCNB1;IRS1;KLF7
prerank,muscle cell migration (GO:0014812),0.7483018677966835,1.5109866009534851,0.07861060329067641,0.6888193445066629,1.0,2/10,0.70%,CCN3;SIX1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5608037074690937,1.5107486441871976,0.038944723618090454,0.6863368478833669,1.0,12/74,6.67%,THBS1;BMP4;EYA2;TCF7L2;BMP5;GSK3B;EYA4;TGFBR1;ITGAV;GDNF;BIRC6;EYA3
prerank,cellular response to BMP stimulus (GO:0071773),0.5673257679522153,1.509596225411875,0.03398692810457516,0.6884603683862205,1.0,18/66,11.64%,BMP4;SMAD9;SOX9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;GDF6;GDF5;USP15;ACVR1;SMAD2;MEGF8;RGMB
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.740375008839011,1.5091582382454098,0.06070826306913996,0.6869672499329778,1.0,5/11,11.45%,MAP3K5;CYP1B1;PRKCD;DIABLO;ARL6IP5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6108453476398796,-1.5089643213514474,0.04218362282878412,0.43847294968156325,1.0,5/15,7.51%,GRM7;GRM3;GRM5;GRM1;GRM8
prerank,skeletal system morphogenesis (GO:0048705),0.5991238654625226,1.5083107890789818,0.04076086956521739,0.687702539808708,1.0,13/42,11.10%,SIX1;LRP6;HOXA3;FGFR1;HHIP;TGFBR1;SFRP4;SKI;HOXB3;HOXC4;HOXB4;LRP5;MEGF8
prerank,sensory perception (GO:0007600),-0.4601630086154614,-1.508114727971643,0.022556390977443608,0.4370258517400278,1.0,17/45,20.59%,RETREG1;ADGRV1;PCDH15;ADORA2A;TTC8;P2RX7;TRPV2;WHRN;MME;PENK;KCNA2;NTSR2;SCN9A;TRPA1;CCL2;CHRNA7;KCNK4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.5524049183118046,1.507428434891311,0.02857142857142857,0.6882228848783591,1.0,15/75,8.86%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15;SLC39A14;TRPM4;ATP2B4;SLC9C1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,neuron remodeling (GO:0016322),-0.6694238112762413,-1.5067245301020218,0.05429864253393665,0.437481434646201,1.0,7/10,23.39%,APP;EPHA8;ADGRB3;C1QA;C3;CX3CL1;RND1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6972052612720308,1.5066367947476644,0.06869009584664537,0.6885209933087868,1.0,2/17,1.11%,EGFR;PKD1
prerank,negative regulation of coagulation (GO:0050819),-0.6130562216406443,-1.5064707277904354,0.04987531172069826,0.43432959180283665,1.0,6/14,8.69%,VTN;APOE;HS3ST5;CD34;TFPI;EDN1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5759563040470929,-1.5059395595187521,0.04533333333333334,0.43175410109428997,1.0,7/18,13.57%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7453214698540926,1.5051048986039208,0.07295373665480427,0.6921903280775704,1.0,4/10,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5639984724437751,-1.5048863351615815,0.05817174515235457,0.43056071787773936,1.0,12/20,28.25%,PLCB1;CHRM2;CHRM3;GRK2;LYPD1;CHRNA7;CDK5R1;LY6G6D;RGS8;RGS10;AGRN;CHRM1
prerank,cardiac muscle cell contraction (GO:0086003),0.6848458606980474,1.5045936397488964,0.08193979933110368,0.6912083975897786,1.0,5/19,3.27%,KCNJ2;CACNA1C;CAMK2D;GSN;CACNA1G
prerank,nucleoside catabolic process (GO:0009164),0.7430649078318678,1.5042840525417738,0.07450331125827815,0.6891315740730021,1.0,4/11,7.58%,NT5E;NT5C1A;UPP2;DERA
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6931690547616278,1.503921173629874,0.07298136645962733,0.6873140326685678,1.0,3/18,3.62%,CCN3;KCNB1;IRS1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5938502963836644,1.5033627757014068,0.049315068493150684,0.6863864958994039,1.0,9/43,7.45%,FOXP1;THBS1;BMP4;IGFBP5;BMPR1A;FGF2;NR4A3;IL10;ID2
prerank,positive regulation of organelle organization (GO:0010638),0.6312566800155417,1.5031470803721574,0.04190751445086705,0.6839023498830505,1.0,9/32,10.90%,SORBS3;ANXA1;ANXA2;ATL3;ADRB2;GSK3B;RAB3GAP2;C2CD5;SMCR8
prerank,skin development (GO:0043588),0.5638917934819918,1.5021348466444633,0.03959131545338442,0.685268912823032,1.0,16/65,8.15%,CLIC4;MET;PKD1;COL5A2;ADAM9;ANXA1;DSP;COL3A1;BCR;WNT16;PIP5K1A;JAG1;TGM3;ASPRV1;PDGFA;SPRR1A
prerank,positive regulation of cellular senescence (GO:2000774),-0.6752678918474402,-1.5019496243259967,0.06367924528301887,0.434996194545193,1.0,3/10,10.01%,B2M;YPEL3;ABI3
prerank,negative regulation of heart contraction (GO:0045822),-0.6500798533484256,-1.5017440923696805,0.055,0.431643787170933,1.0,2/11,5.79%,ATP1A2;PDE4D
prerank,photoperiodism (GO:0009648),0.6401850687016633,1.501698784170428,0.05483405483405483,0.6838312827212139,1.0,15/28,22.92%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;MTA1;ATOH7;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7150954242558731,1.5015692117025319,0.0632279534109817,0.6810165581045247,1.0,2/15,2.18%,CD55;GLI3
prerank,response to purine-containing compound (GO:0014074),-0.5684467161036951,-1.5014689647269743,0.06315789473684211,0.4286006108433407,1.0,8/17,17.79%,TRPC3;ABCC9;RYR2;P2RY1;P2RX7;STAT1;VGF;NDUFS4
prerank,nucleotide metabolic process (GO:0009117),0.6735239393154405,1.5005034623000137,0.06055900621118013,0.6829712477052717,1.0,6/23,10.50%,ME1;FHIT;NMNAT2;CTPS2;NMNAT1;NUDT5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6401552779691989,-1.5002509440214313,0.04316546762589928,0.42819685313256195,1.0,7/12,19.92%,APOE;PICALM;ROCK2;RANBP9;ABCA2;TMED10;CHRNA7
prerank,negative regulation of complement activation (GO:0045916),0.7496183661117893,1.5000569448609828,0.060658578856152515,0.6818010105875861,1.0,4/10,9.24%,CD55;CD46;CR1L;SERPING1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6710993841101848,1.4999628313102262,0.07742998352553541,0.678956873356797,1.0,7/19,14.18%,PLCE1;PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6541431598136097,1.4993882044571594,0.04874446085672083,0.6782536808899465,1.0,6/25,3.53%,BMP4;FOXD1;CCN1;SULF1;BMPR1A;ZNF423
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5235148417592099,1.4985871326800162,0.020047169811320754,0.6786781513351743,1.0,15/113,4.29%,F3;EGFR;BMP4;TCF7L2;SOX9;BMP5;PGF;NRAS;BMP6;FGF2;NOTCH2;FZD7;NRP1;TGFBR1;NR4A3
prerank,negative regulation of peptidase activity (GO:0010466),-0.4553165689612989,-1.498352587261992,0.01824817518248175,0.43013403123994814,1.0,9/47,7.55%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;CST3;SPOCK1;SERPIND1;GAPDH
prerank,histone deacetylation (GO:0016575),0.6002738233737399,1.497946116354008,0.042876901798063624,0.6782925757828453,1.0,16/43,19.05%,HDAC4;HDAC9;RCOR3;HDAC8;TBL1X;PER1;MIER1;MTA1;HDAC10;REST;BAZ2A;PRDM5;SIRT6;RBM14;PER2;BRMS1L
prerank,response to chemokine (GO:1990868),0.7233332723681555,1.4964460590526065,0.06140350877192982,0.6822299107780803,1.0,3/13,1.93%,STK39;SLC12A2;WNK1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6845322724210768,-1.496239181109473,0.053811659192825115,0.43225060778151553,1.0,5/10,15.05%,APOD;LRCH1;RIPOR2;CD200;AKT1
prerank,L-serine metabolic process (GO:0006563),-0.6777964369912837,-1.4919579663244913,0.060810810810810814,0.44094921633269096,1.0,2/10,2.79%,SERINC3;SERINC5
prerank,histone H3 deacetylation (GO:0070932),0.7039466786732322,1.4909122001864137,0.07911392405063292,0.7043730086570744,1.0,6/15,18.44%,HDAC4;HDAC9;HDAC8;PER1;SIRT6;PER2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.43942852721713005,-1.4907903987995463,0.02631578947368421,0.4410201749351933,1.0,14/57,15.34%,ADCY5;GRM7;ADCY1;LPAR1;ADCY7;CHRM2;ADRA2A;PDE2A;GRM8;CHRM3;ADCY2;GPR37;ADCY4;PSAP
prerank,negative regulation of histone acetylation (GO:0035067),-0.6360285560936043,-1.4903798916807673,0.05787037037037037,0.43841170194929613,1.0,5/11,19.91%,SNCA;NOC2L;SET;CTBP1;SPI1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6043533177737161,1.4896002575118799,0.06936416184971098,0.70724065079234,1.0,13/32,11.77%,THBS1;RHOJ;ANXA1;HDAC9;MEOX2;KLF4;FGF2;FOXC2;MAP3K3;RHOA;STARD13;VEGFA;ITGB1BP1
prerank,regulation of DNA repair (GO:0006282),0.5976254861116985,1.4890362570798281,0.052269601100412656,0.7068451599252523,1.0,13/44,15.49%,EGFR;EYA2;EYA4;UBR5;EYA3;TRIP12;USP1;RAD52;UIMC1;RNF168;ERCC8;DHX9;PML
prerank,regulation of synapse maturation (GO:0090128),-0.6418399585519116,-1.4880959157439062,0.06030150753768844,0.44124229061266457,1.0,5/10,17.88%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;RELN
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5677637887658508,1.4866658917212152,0.04479578392621871,0.7149078989998575,1.0,18/57,18.55%,FZR1;FOXN3;CHEK2;RAD17;ATM;WAC;CLSPN;UIMC1;CHEK1;PRKDC;MRNIP;CCND1;ATF2;TRIM39;NBN;TICRR;CDKN1A;TOPBP1
prerank,membrane repolarization during action potential (GO:0086011),0.7317217460501104,1.486041986224555,0.09153713298791019,0.7144424892326241,1.0,2/13,1.55%,KCNJ2;ATP1B1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.48817192941265763,-1.4860112792592597,0.041237113402061855,0.44355093571571047,1.0,22/34,25.71%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SYN1;SYT13;SYT10;RAB15;SYT9;SYT6;SYT15;RAB3A;SYT2;RIMS4;SYT4;RAB27A;SYT5;SYT17;DOC2A;SNAPIN
prerank,odontogenesis (GO:0042476),0.5979852167274688,1.4859066107000247,0.06512301013024602,0.7117741207395017,1.0,9/35,9.82%,BMP4;LRP6;EDA;TGFB3;INHBA;PITX2;FOXC1;GLI2;AQP6
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.626260497475784,-1.4844379180383904,0.08780487804878048,0.4442872287249802,1.0,9/11,32.86%,UQCRH;UQCR10;CYCS;UQCR11;CYC1;UQCRC1;UQCRB;UQCRC2;UQCRQ
prerank,regulation of RNA splicing (GO:0043484),0.5616276513496644,1.483134627170717,0.03836317135549872,0.7220525821117014,1.0,12/69,7.99%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK1;CLK2;SON;HNRNPH1;CELF1;MBNL2;RBM39;FUS
prerank,anion transport (GO:0006820),0.601584802307794,1.4831057939437193,0.06432748538011696,0.718935504874852,1.0,3/33,2.41%,SLC26A7;LRRC8D;ABCG2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4376714397815197,-1.480897805796698,0.025,0.45087116656266407,1.0,15/49,15.46%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18;IL6ST;CSF1R;CD40;TNFRSF1A;FLT3
prerank,spinal cord development (GO:0021510),0.7304436381732149,1.4805520048287395,0.07809847198641766,0.7274133629668301,1.0,4/12,9.78%,VIT;PKD1;GLI2;NF1
prerank,positive regulation of protein sumoylation (GO:0033235),0.7448258217054606,1.480288101481038,0.07881773399014778,0.7252297980192485,1.0,3/10,8.88%,HDAC4;SAE1;PIAS3
prerank,lung epithelium development (GO:0060428),0.7456332392913592,1.479547618708344,0.08422939068100359,0.7254560707153327,1.0,4/10,8.57%,BMP4;PKD1;STRA6;GRHL2
prerank,rRNA processing (GO:0006364),-0.36649062483080974,-1.4783149379587808,0.0,0.4545576293142638,1.0,68/172,23.15%,NSA2;RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;TSR3;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9
prerank,negative regulation of cell death (GO:0060548),0.5338740492814915,1.4781769342583504,0.031476997578692496,0.7284719354629712,1.0,16/88,6.62%,BMP4;CCN3;CCN1;CCN5;WNT11;GSK3B;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;WNT16;GATA4;CLU;AGR2;SRSF6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.689522406262529,1.4781352632459497,0.0853462157809984,0.7254416857879253,1.0,2/16,2.14%,ST3GAL4;NFAT5
prerank,positive regulation of nervous system development (GO:0051962),-0.4656351142409606,-1.4771272492560805,0.020905923344947737,0.45434123527752135,1.0,15/42,24.39%,IL1RAPL1;TGM2;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2;MME;CLSTN3;GPER1;SYNDIG1;BDNF;CX3CR1;WNT7A
prerank,regulation of cell killing (GO:0031341),0.6893613628330012,1.4762755872173814,0.07475083056478406,0.7314869128469847,1.0,5/16,8.99%,CFH;CD55;FZD7;IL10;CR1L
prerank,metanephros development (GO:0001656),0.6259765681356363,1.4760707136631228,0.06534954407294832,0.7291324912171891,1.0,8/26,9.78%,BMP4;SIX1;PKD1;FOXD1;GDNF;GDF6;SIX4;NF1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6576334037698233,-1.475974634885776,0.07345971563981042,0.45415000227811514,1.0,4/10,12.71%,SEMA6A;DCN;DAB2IP;CADM4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.36928601482172385,-1.475893469874261,0.0,0.45083937179430505,1.0,75/168,19.40%,RPS14;RPL38;CNOT6L;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;RPS18;RPL11;DCP2;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;NBDY;POLR2G;RPL24;CNOT9;RPL29;SMG7;CTIF;RPL10A;PAN2;RPL3;RPL12;RPS27A;RPS12;AGO1;RPL27;EXOSC9;RPS28;RPL5;GSPT2;MAGOH;CNOT2;RPS10
prerank,sodium ion transmembrane transport (GO:0035725),0.5282196521714891,1.4758754386265707,0.03875,0.7267805291305094,1.0,16/84,8.86%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;SLC6A7;ANO6;NALCN;TRPM4;SLC6A19;SLC9C1;SLC4A8;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,metal ion homeostasis (GO:0055065),0.5983441002935078,1.4752779339422863,0.04755434782608696,0.7263510605120886,1.0,7/40,7.65%,SLC12A7;SLC12A2;CNNM2;SLC12A8;CNNM4;CLDN16;FAM20A
prerank,histone modification (GO:0016570),0.5226686611499087,1.4746051559064435,0.029171528588098017,0.7262229051537435,1.0,39/109,21.00%,EYA2;HDAC4;CCNA2;PRKCD;HDAC9;EYA4;RCOR3;KAT6B;UBE2B;CREBBP;TBL1X;EYA3;TRRAP;EHMT1;SGF29;CPA4;PRMT8;CTCFL;MIER1;MTA1;KAT2A;EP300;PRMT6;HDAC10;BAZ2A;PRDM5;NSD1;BRD8;RBM14;CARM1;EHMT2;USP22;BRMS1L;PHF20;UBE2N;USP21;USP36;MIER2;HUWE1
prerank,negative regulation of nuclear division (GO:0051784),0.7251694498468109,1.4735889106280733,0.09391304347826086,0.7278152422934729,1.0,1/11,0.28%,BMP4
prerank,lipid catabolic process (GO:0016042),-0.5565356282498554,-1.47309897071102,0.0663265306122449,0.4554540173026128,1.0,9/18,32.52%,PLA1A;LIPE;LPL;PLAAT3;MT3;HSD11B1;PPT1;HSD17B14;SIRT2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6356955232391895,-1.4729059374839295,0.08878504672897196,0.45250305759546755,1.0,6/11,10.71%,EFNB2;SOX6;MEF2C;FRS2;BMP2;MYOCD
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4985382783336165,-1.4727889484949221,0.065625,0.4494635868159219,1.0,18/27,24.10%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SDF4;SYT13;PPP3CB;SYT10;SYT9;SYT6;SYT15;SYT2;DOC2B;SYT4;SYT5;SYT17
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7364464759763796,1.472737476100045,0.10149750415973377,0.7284149442348232,1.0,3/10,6.63%,NT5E;NT5C1A;UPP2
prerank,endothelial cell proliferation (GO:0001935),0.6786582932331974,1.4725856522061587,0.0812603648424544,0.7259652086900673,1.0,2/17,0.28%,BMPER;BMP4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6534412101033624,1.4712138968147401,0.07462686567164178,0.7294394300897026,1.0,1/21,0.11%,SLIT2
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5597837075691426,-1.4705870723485372,0.06336088154269973,0.45233734070721066,1.0,6/17,11.66%,IGF1;APOE;RTN1;NTRK2;RTN4;BIN1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5162541900517382,-1.4699057554655652,0.039886039886039885,0.45092348720008674,1.0,15/26,19.05%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A7;MT3
prerank,signal release from synapse (GO:0099643),-0.46006260861737047,-1.4695460833560956,0.023529411764705882,0.44855486971325004,1.0,21/43,27.02%,NRXN1;RIMS1;LIN7A;HSPA8;SYN2;SNCA;SNAP25;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;PPFIA3;SNAPIN;UNC13A
prerank,eye development (GO:0001654),0.5578543332606667,1.469000224771452,0.05080213903743316,0.7367806193284002,1.0,16/54,13.40%,PBX3;COL5A2;CACNA1C;PBX1;SMOC1;HIPK1;STRA6;EFEMP1;TSKU;SKI;PITX2;FOXC1;SCO2;ATF6;NIPBL;PAX6
prerank,cellular response to purine-containing compound (GO:0071415),-0.6582594036711416,-1.4681722164794109,0.06619385342789598,0.4492568621950034,1.0,5/10,16.82%,SLC8A1;RYR2;P2RY1;CASQ2;RYR3
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6514083508589116,1.4678422894567789,0.0890302066772655,0.739010729128568,1.0,4/20,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,regulation of cholesterol efflux (GO:0010874),-0.4909448387667754,-1.4670689540843231,0.03939393939393939,0.4493255776856617,1.0,6/30,7.26%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.506612310331666,-1.4668966708111366,0.041916167664670656,0.44661046093401574,1.0,11/27,20.32%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1;ABCB4;SCP2;NR1H2;GPS2;TREM2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5591938595081053,1.4654446673931345,0.06535947712418301,0.7471159506888915,1.0,13/53,14.40%,EGFR;EYA2;DDX5;PRKCD;EYA4;SPRED2;EYA3;BCLAF1;ATM;UIMC1;RNF168;ERCC8;DHX9
prerank,dopaminergic neuron differentiation (GO:0071542),0.6628282105716329,1.4652642723478277,0.0794392523364486,0.7447828925708582,1.0,6/19,13.81%,LRP6;NR4A2;PITX3;PHOX2A;VEGFA;CDNF
prerank,regulation of fibroblast migration (GO:0010762),0.648205785250713,1.4651968946197094,0.09379968203497616,0.7419747139277455,1.0,9/20,12.07%,THBS1;DDR2;ITGB1;FGF2;PRKCE;DMTN;HAS1;ITGB1BP1;CORO1C
prerank,potassium ion homeostasis (GO:0055075),0.6354408725801958,1.4651710269041023,0.09161490683229814,0.7389652497875814,1.0,5/23,2.62%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.67284920424955,1.4637019645773903,0.0873015873015873,0.742822489926906,1.0,4/18,5.64%,ANXA1;FAM107A;KLF9;ISL1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5477117099453662,-1.4634352247558011,0.07712082262210797,0.4531435725945766,1.0,5/19,6.40%,VCAM1;GRM5;KDR;RYR2;PTGFR
prerank,vasculogenesis (GO:0001570),-0.4923259293359611,-1.4633239601867836,0.04229607250755287,0.45029430264168907,1.0,12/32,9.87%,ENG;TGFBR3;PDGFRB;KDR;RASIP1;NOTCH1;SOX17;SPRED1;HEY2;ADM;SOX18;RAMP2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6691907448429765,1.462874184947959,0.078003120124805,0.7435796534129591,1.0,5/20,5.19%,THBS1;GSN;ANO6;PDCD4;SFRP4
prerank,regulation of ossification (GO:0030278),0.5962787043048359,1.461780927997038,0.06990014265335236,0.7457900903073162,1.0,8/36,4.55%,BMP4;SOX9;LRP6;DDR2;SMAD6;ZBTB16;SGMS2;TXLNG
prerank,motor neuron axon guidance (GO:0008045),0.7038338391896407,1.461521832300022,0.0875796178343949,0.7439023425427462,1.0,4/15,6.82%,SLIT2;NTN1;TMEFF1;NTN5
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5052282609508199,-1.4605736120768615,0.057057057057057055,0.4546949731651982,1.0,15/28,23.31%,PRKAG2;MITF;CD47;PRKAA2;SIRPA;RAC1;FGFR4;NOS1AP;NR1H4;MED1;SIRT5;C3;PDK4;MFSD12;CX3CR1
prerank,atrioventricular valve development (GO:0003171),0.7015146155653185,1.459441054410862,0.09210526315789473,0.7509568153803572,1.0,5/14,9.96%,SLIT3;BMPR1A;TGFBR2;MDM4;ACVR1
prerank,actin filament-based transport (GO:0099515),-0.5459274899394564,-1.4585963341658523,0.07536231884057971,0.457106542494225,1.0,7/21,17.23%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6394567142671226,1.4576262569077212,0.0661764705882353,0.7562087112887427,1.0,6/24,7.11%,CDON;BOC;CTNNA1;ABL1;MEF2A;MYOG
prerank,cellular response to organic substance (GO:0071310),0.5067998087338395,1.4574238655739404,0.029585798816568046,0.753991025770624,1.0,25/116,12.45%,SLIT3;SLIT2;DPYSL3;RAMP1;CYP1B1;PID1;NFAT5;IGFBP5;SHC1;KLF4;BMPR1A;TGFBR1;PTPN2;TGFBR2;STAT3;SOCS2;RHOA;ACVR1;IL18BP;EMD;CCL3;ERBB2;ARL6IP5;PTPN9;CPNE3
prerank,regulation of histone acetylation (GO:0035065),-0.48744127476580246,-1.457417651092261,0.04983388704318937,0.45742187599586187,1.0,12/33,19.91%,RPS6KA5;RAPGEF3;PPARGC1A;SNCA;MYOCD;NOC2L;SET;ARRB1;MAPK3;CTBP1;RUVBL2;SPI1
prerank,establishment of endothelial barrier (GO:0061028),-0.49657287906271025,-1.4574097907490313,0.04956268221574344,0.4542424409446197,1.0,11/29,9.84%,TJP1;PECAM1;RAPGEF3;PPP1R16B;RAPGEF2;F11R;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,negative regulation of protein processing (GO:0010955),0.7232453613506726,1.4559090617205417,0.07035175879396985,0.7579882368393053,1.0,5/12,15.59%,THBS1;GAS1;SNX12;ACP4;SERPINE2
prerank,regulation of integrin activation (GO:0033623),-0.5919418850546599,-1.4546081187034072,0.059431524547803614,0.45916493374584216,1.0,5/15,12.01%,RASIP1;PIEZO1;JAM3;PLEK;FBLIM1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6973012192475779,1.454174905867457,0.08731466227347612,0.7633277014853572,1.0,3/14,4.43%,THBS1;ANO6;PDCD4
prerank,mesenchymal to epithelial transition (GO:0060231),0.7454422673711071,1.4539010933136034,0.08797127468581688,0.7614980705710072,1.0,2/10,3.31%,BMP4;FZD7
prerank,cell differentiation in spinal cord (GO:0021515),-0.639021645583479,-1.452988430956537,0.08428246013667426,0.4605519108696957,1.0,4/10,8.02%,SOX13;SOX6;MDGA2;ZC4H2
prerank,androgen receptor signaling pathway (GO:0030521),0.7255323522782338,1.4524438312376757,0.10281923714759536,0.765223415224156,1.0,9/11,25.50%,DDX5;PMEPA1;DDX17;PLPP1;ZMIZ1;RNF14;TMF1;ARID1A;AR
prerank,regulation of interleukin-12 production (GO:0032655),0.5730370162265465,1.4515243698750933,0.05939226519337017,0.7665406391121679,1.0,10/47,11.40%,FOXP1;THBS1;CMKLR1;ISL1;RIPK2;IL10;TLR4;PLCG2;IRAK3;MAST2
prerank,potassium ion transport (GO:0006813),0.5091478693980037,1.4507989987768832,0.03146853146853147,0.766859619876145,1.0,11/120,3.00%,SLC9A2;KCNB2;KCNK5;KCNJ2;SLC24A3;KCNMB3;KCNMB2;KCNQ5;KCNJ15;KCNS3;KCNB1
prerank,negative regulation of transmembrane transport (GO:0034763),0.717760540860387,1.4504027327961442,0.08488964346349745,0.7657593769747506,1.0,1/10,0.27%,THBS1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6421153003931139,-1.450057049018721,0.07906976744186046,0.46600080929627824,1.0,3/10,10.07%,TGFA;ADRA2A;HBEGF
prerank,neuron maturation (GO:0042551),-0.5596865937227716,-1.4500273989769863,0.060209424083769635,0.4628871166548386,1.0,11/18,29.10%,APP;EPHA8;ADGRB3;C1QA;ACTL6B;C3;CX3CL1;RND1;SRRM4;B4GALT5;B4GALT6
prerank,endothelial cell migration (GO:0043542),0.5872363726150728,1.4499862001618753,0.06685236768802229,0.7646718301622193,1.0,11/37,10.33%,CCN3;FSTL1;CYP1B1;GIPC1;ABL1;ID1;NRP1;RHOA;STARD13;S100A2;VEGFA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5587843737539909,-1.448759364289289,0.07161803713527852,0.46343683034392325,1.0,10/18,28.25%,PLCB1;CHRM2;CHRM3;GRK2;CDK5R1;GNA15;RGS8;RGS10;AGRN;CHRM1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6067414416114986,1.4483936754237265,0.05614567526555387,0.7689358471324161,1.0,13/31,16.69%,SIX1;HOXA3;TGFBR1;TGFBR2;NOG;HOXB3;HOXC4;HOXB4;MEGF8;HOXD3;TWIST1;TFAP2A;DYNC2I1
prerank,endothelial tube morphogenesis (GO:0061154),0.722842362200105,1.44799929169133,0.08093525179856115,0.767771772382283,1.0,3/10,9.12%,BMP4;RHOA;STARD13
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7286981223915109,1.44637880375751,0.10481099656357389,0.7721032641425707,1.0,4/11,6.23%,EGLN3;P3H2;P4HA1;P4HA2
prerank,regulation of endopeptidase activity (GO:0052548),-0.41973766423349185,-1.4462210559065642,0.029914529914529916,0.4675638295932611,1.0,15/59,16.57%,VTN;TIMP3;SPOCK2;PICALM;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH;APH1B;PSMB8;PSME2;AGT;AKT1;VSIR
prerank,positive regulation of vasoconstriction (GO:0045907),0.6955545104778272,1.4453211955684742,0.09777015437392796,0.7739829367317457,1.0,2/13,4.96%,ADRA1B;TRPM4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.682753811823021,1.4447749196437227,0.10714285714285714,0.7736185640578501,1.0,4/14,6.11%,SLIT2;IGFBP5;BMPR1A;LRP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6177521586722154,1.4442587461531426,0.09104704097116843,0.7731099734591593,1.0,12/27,12.24%,ANK2;CACNA1C;CAMK2D;DSP;DSG2;FGF13;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,regulation of cell growth (GO:0001558),0.4859691004431364,1.4439885760004976,0.023504273504273504,0.771366386314165,1.0,19/204,5.38%,SLIT3;SLIT2;EGFR;CCN3;PLCE1;FHL1;NDRG3;OSGIN2;CAMK2D;WNT11;ESR2;INHBA;FAM107A;IP6K2;TGFBR1;AGTR1;EIF4G1;SGK3;KLHL22
prerank,visual perception (GO:0007601),0.5220067469244912,1.4429618812029545,0.04702970297029703,0.7731926713347876,1.0,13/84,13.62%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;PAX6;CRYBB3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.603522465533292,1.4429055406917881,0.08985507246376812,0.7704799563946955,1.0,6/28,7.62%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP
prerank,zinc ion homeostasis (GO:0055069),-0.49783874813850515,-1.4423382061459258,0.055232558139534885,0.4756078986155819,1.0,15/28,19.05%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A7;MT3
prerank,actin filament depolymerization (GO:0030042),0.7219728099325944,1.4419268610929792,0.11611785095320624,0.772092313050411,1.0,2/11,2.48%,MICAL2;GSN
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5612337096571233,1.4412834563832546,0.06989247311827956,0.7721058329609208,1.0,6/46,4.29%,FOXP1;THBS1;BMP4;TCF7L2;IGFBP5;NR4A3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6946161221933582,1.4404615921886323,0.09540034071550256,0.77310966095677,1.0,4/15,3.29%,SMOC2;MET;FGFR1;FGF2
prerank,positive regulation of transporter activity (GO:0032411),0.6952866269955738,1.4404303938983574,0.10551948051948051,0.7703758325854162,1.0,1/13,0.13%,STK39
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5216293002571412,-1.4402063653907438,0.061971830985915494,0.478745829180898,1.0,8/22,11.35%,SLC16A2;TOX;NES;TAFA1;GATA2;KDM2B;PROX1;MDK
prerank,response to UV (GO:0009411),0.515021845622491,1.439926141878395,0.041469194312796206,0.7698597263902437,1.0,31/95,20.10%,EGFR;SCARA3;NEDD4;PRKCD;UBE4B;UBE2B;CREBBP;KDM1A;ERCC5;WRN;USP1;UVSSA;USP47;EP300;EIF2AK4;ERCC8;CCND1;ZBTB1;ERCC3;XPA;YY1;USP28;EIF2S1;ATR;MAP3K4;DHX36;INO80;CIRBP;REV1;FMR1;MAPK8
prerank,pancreas development (GO:0031016),0.6868204724911804,1.4397961349898587,0.10662358642972536,0.7676306041846483,1.0,5/12,12.95%,TCF7L2;MET;ISL1;CCDC40;SELENOT
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6881517294911149,1.4385527906664541,0.11551724137931034,0.7705188314815123,1.0,3/13,9.08%,BMP4;VNN1;GLI2
prerank,catecholamine biosynthetic process (GO:0042423),-0.6322247727089176,-1.4382610987204374,0.08780487804878048,0.48129115014709134,1.0,3/11,8.39%,MOXD1;SNCA;DDC
prerank,regulation of dendrite extension (GO:1903859),-0.5564032147267436,-1.437946010403798,0.08142493638676845,0.47900013661865126,1.0,10/18,27.02%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17;UNC13A
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5787845273743137,1.4376079563463608,0.08038147138964577,0.7722115527245667,1.0,5/41,2.72%,KCNJ2;KCNMB3;KCNMB2;ANK2;KCNJ15
prerank,positive regulation of dendrite extension (GO:1903861),-0.5664228288520516,-1.437518753285499,0.07035175879396985,0.4770677650445893,1.0,10/17,27.02%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17;UNC13A
prerank,mesonephros development (GO:0001823),0.7057799823066144,1.4374289696473193,0.08657243816254417,0.7701996372358884,1.0,2/11,2.37%,BMP4;ZBTB16
prerank,response to nitric oxide (GO:0071731),-0.6069469695427796,-1.435917421603767,0.09898477157360407,0.47847552369915364,1.0,9/13,25.17%,FOXO1;GUCY1B1;KCNC2;EGLN1;CCL19;MT3;MMP3;AQP1;TXN
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.41883016308712906,-1.4357078337518905,0.04205607476635514,0.47597507314584536,1.0,18/57,15.46%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18;NF2;INPP5F;IL6ST;CSF1R;CD40;TNFRSF1A;SH2B3;FLT3
prerank,protein localization to cilium (GO:0061512),0.5940696709636655,1.4354784437085726,0.09064327485380116,0.7763433680646857,1.0,8/32,10.04%,BBS9;ZNF423;INVS;ARL3;RABEP1;TULP2;WDR35;EHD1
prerank,regulation of B cell proliferation (GO:0030888),-0.4556948352996937,-1.4351735617253496,0.033210332103321034,0.4744684220509402,1.0,14/44,15.03%,LYN;BCL2;TFRC;AHR;TNFRSF21;MEF2C;VAV3;CD81;CD38;CD300A;MIF;CD74;CD40;TYROBP
prerank,amino sugar metabolic process (GO:0006040),-0.6538384835903537,-1.4346390771630055,0.06018518518518518,0.4728642744016153,1.0,3/10,3.26%,ST6GAL1;ST3GAL1;CSGALNACT1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.700361186505645,1.4345127259308743,0.11418685121107267,0.7779851302136158,1.0,3/11,8.82%,THBS1;BMPR1A;CD46
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5591358025290979,1.4344356954306008,0.06141522029372497,0.7755120157957035,1.0,11/55,17.11%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;USP47;PSMD11;PSMD1;CUL1;PSMC1;PSMD7
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6136514258494836,1.434161997124422,0.08905109489051095,0.7740675684546925,1.0,1/29,0.01%,SLC4A10
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7064860386690437,1.4332569175196908,0.11073825503355705,0.7751327980527468,1.0,3/10,5.02%,CD55;TGFBR2;ZBTB7B
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.657397389174118,1.4327039440329072,0.1048252911813644,0.7749043420170546,1.0,3/17,4.70%,EZR;UBASH3A;PTPN2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6950211572288472,1.432575763772564,0.09612141652613827,0.7727516293609531,1.0,3/12,8.02%,FOXP1;KLF4;TLR4
prerank,potassium ion import across plasma membrane (GO:1990573),0.5770648050104294,1.4302871613669375,0.08831521739130435,0.7803976252954692,1.0,6/41,2.72%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.37826591033460855,-1.4302121140041664,0.013245033112582781,0.48239466860807734,1.0,29/107,10.31%,ATP1A2;CDH2;GRM7;LRRC4C;GRM3;MCTP1;NRG3;DGKI;GRM5;GRID2;RIMS1;GRIK2;RIMS2;GRM1;APP;MCTP2;MEF2C;GRIK1;OPHN1;DLGAP1;LRP8;CACNA1B;GRM8;EIF4EBP2;ABR;SYT1;TMEM108;CAMK2A;SYN1
prerank,regulation of neuron projection development (GO:0010975),-0.3662208223230851,-1.4301782331462598,0.0,0.47944876852098234,1.0,60/163,15.05%,CAMK1D;EFNB2;LYN;IL1RAPL1;CDH2;SHANK3;APOE;PRKD1;ITGA6;PTK7;LRRC4C;CTNNA2;CSMD3;PPFIA2;PAK1;RAPGEF2;WNT5A;TENM3;SERPINI1;LPAR1;DCC;FUT9;SPOCK1;ROR2;TOX;CHN1;ATP1B2;NDNF;RIT2;EPHA4;DAB2IP;LRRC7;CCDC88A;DENND5A;SETX;NTRK2;MAG;PLK5;CRMP1;PAK3;CFL1;RAPGEF1;ABI3;TWF2;PTPRO;MFSD2A;BRSK2;MDK;CAMK2B;FES;KNDC1;RTN4RL1;NDRG4;CAMSAP2;GSK3A;KIF1A;MYLIP;TRPV4;FKBP4;AKT1
prerank,primary neural tube formation (GO:0014020),0.5976220160472259,1.4299756561585484,0.07982583454281568,0.7790350111613764,1.0,6/30,8.57%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2
prerank,positive regulation of leukocyte activation (GO:0002696),0.6447973823946859,1.4298105771625207,0.10789049919484701,0.7770224401154731,1.0,5/18,9.65%,THBS1;LBP;CD2;TLR4;IL33
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.608917980894747,1.429652433669474,0.08472012102874432,0.7750532538475627,1.0,6/25,5.58%,STK39;ANK2;ATP1B1;WNK1;DMD;COA8
prerank,activation of phospholipase C activity (GO:0007202),0.604331137873751,1.4291463511246303,0.08408408408408409,0.7746952562564318,1.0,2/29,0.91%,EGFR;EDNRA
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5219852327580856,-1.4290409014394785,0.07065217391304347,0.4798169091842242,1.0,5/21,7.26%,PLTP;APOE;PTCH1;NR1H3;EEPD1
prerank,chondrocyte differentiation (GO:0002062),0.5886917755168801,1.4288765662885565,0.09728183118741059,0.7731468301657793,1.0,6/32,4.23%,BMP4;CCN3;NFIB;SOX9;SULF1;SLC39A14
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6322262033241164,-1.4287196772606283,0.08908685968819599,0.4777589108214553,1.0,3/10,2.96%,BCL2;DCN;KDR
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6325581552622818,1.427949495209233,0.1095890410958904,0.7746624322862197,1.0,3/22,2.48%,SLIT2;PRKCD;GSN
prerank,positive regulation of angiogenesis (GO:0045766),0.4987107994437513,1.4274221014601336,0.03274853801169591,0.7742735133262064,1.0,18/108,6.17%,SMOC2;BMPER;F3;THBS1;ITGB8;PGF;CYP1B1;ANXA3;PTGIS;KLF4;HIPK1;ITGB1;FGF2;FOXC2;ITGA5;ADAM12;ISL1;GATA4
prerank,organic substance transport (GO:0071702),0.4966875342088068,1.427328167938297,0.03876852907639681,0.7720823741541095,1.0,7/121,2.41%,SLC47A1;SLC23A1;ABCD3;RAMP1;SLCO2A1;DISP1;ABCG2
prerank,hexose transmembrane transport (GO:0008645),-0.532313120602323,-1.4269533232845806,0.06647398843930635,0.47983343695147296,1.0,5/21,10.87%,SLC2A1;PPARD;SLC2A12;SLC5A3;SLC50A1
prerank,glucose transmembrane transport (GO:1904659),-0.5480275263208656,-1.4260916419135123,0.08446866485013624,0.4793502222864757,1.0,4/18,6.19%,SLC2A1;SORT1;PPARD;SLC5A3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6841899221985663,1.425483146286943,0.12,0.7774872971053902,1.0,3/13,6.35%,CYFIP2;PERP;RIPK2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6686533511168011,1.4252338605701735,0.11842105263157894,0.7760128997409261,1.0,4/16,14.53%,SOX9;NCOR1;ERLIN1;WDTC1
prerank,positive regulation of macrophage activation (GO:0043032),0.6613676911866985,1.4240075415829812,0.11201298701298701,0.7789878854803317,1.0,5/17,10.91%,THBS1;LBP;TLR4;IL33;CCL3
prerank,positive regulation of T cell migration (GO:2000406),0.6385474211477247,1.4238214967503808,0.10584518167456557,0.7771645001316557,1.0,2/20,1.93%,STK39;WNK1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6450784330887913,1.4233959423087064,0.10778443113772455,0.7764892991324415,1.0,4/21,8.13%,LRP6;GSK3B;FZD1;CSNK1A1
prerank,positive regulation of DNA repair (GO:0045739),0.5650812426162263,1.423376482118592,0.06500691562932227,0.7739379841784925,1.0,11/46,14.40%,EGFR;EYA2;EYA4;EYA3;DDX11;SPIDR;UIMC1;RNF168;HDAC10;ERCC8;DHX9
prerank,tube closure (GO:0060606),0.5921577646860873,1.422918042088771,0.08080808080808081,0.7733763419291277,1.0,6/31,8.57%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2
prerank,ganglion development (GO:0061548),0.7127752471340292,1.4227241871252678,0.1,0.7715510167346648,1.0,2/11,3.98%,UNC5C;NRP1
prerank,response to fatty acid (GO:0070542),0.6471233634144299,1.4224495041423255,0.09794628751974724,0.770228611094784,1.0,7/17,12.83%,SOX9;PID1;FOXO3;IRS1;SCD;PPP5C;PDK3
prerank,regulation of blood coagulation (GO:0030193),0.5998134116289546,1.4222855267558774,0.09467455621301775,0.7683358475823744,1.0,3/27,2.98%,ST3GAL4;THBS1;THBD
prerank,regulation of interleukin-8 production (GO:0032677),0.5281876597467763,1.421185571149874,0.05962732919254658,0.7705519190796399,1.0,11/69,8.02%,F3;LBP;ANXA1;ANXA4;KLF4;CD2;STAT3;MAVS;DDIT3;IL10;TLR4
prerank,ERBB signaling pathway (GO:0038127),0.5370663582480544,1.42077829096707,0.06535947712418301,0.7698110319752035,1.0,9/64,4.91%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6870473269524915,1.4207275906187176,0.12013536379018612,0.7674680186621626,1.0,4/13,7.15%,MET;NFE2L2;NR4A3;IL10
prerank,regulation of MAPK cascade (GO:0043408),-0.3587396860697735,-1.4204505150371114,0.0,0.49245735642236266,1.0,33/157,7.99%,FLT1;IGF1;IGF1R;KSR1;PHLPP1;LYN;TEK;TGFBR3;KIT;EPHA7;TNIK;JCAD;PAK1;KDR;EPHB1;LPAR1;PELI2;INSR;ROR2;TBX1;NRK;RIT2;LBH;MAP4K4;DAB2IP;EPHA8;PAK5;SPRED1;FAS;BMP2;ADRA2A;NTRK2;ZDHHC17
prerank,limb morphogenesis (GO:0035108),0.6395789599992727,1.4196676688253709,0.11256117455138662,0.7695212680684138,1.0,5/20,5.66%,PCSK5;MBNL1;LRP6;GLI3;SKI
prerank,cardiac muscle tissue development (GO:0048738),0.548201637220656,1.4195862863205506,0.07095046854082998,0.7673617732308323,1.0,8/50,3.31%,BMP4;SGCD;BMP5;CSRP3;AKAP13;BMPR1A;CACNA1G;NOTCH2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.7093171970712381,1.4194996035145155,0.10082644628099173,0.7652504395678341,1.0,3/12,8.98%,TMEFF2;IL10;AP2A1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.48040951807620197,-1.4184210706375484,0.06129032258064516,0.4952601639438121,1.0,14/32,11.40%,GRIA4;SLC6A9;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;GRIA3;GRIN1;ACTN2;GRIA2;CAMK2A;GRIA1;CAMK2B
prerank,regulation of T cell mediated immunity (GO:0002709),0.7218986291460016,1.4182351896825722,0.10118043844856661,0.7684057686372257,1.0,4/10,15.14%,TRPM4;RIPK3;TNFRSF1B;ZBTB1
prerank,positive regulation of synapse assembly (GO:0051965),-0.4945319623640641,-1.4180937584644229,0.08206686930091185,0.4932319650052213,1.0,7/27,12.18%,IL1RAPL1;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6413556789290017,1.4169920356951395,0.10793650793650794,0.7714763616205355,1.0,2/20,1.11%,EGFR;PKD1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6115327505559054,1.4167453983003075,0.09049773755656108,0.770035520598718,1.0,9/27,11.39%,PTPN3;FXYD5;CAMK2D;SLMAP;ATP2B4;SNTA1;DLG1;COMMD1;RANGRF
prerank,AMP metabolic process (GO:0046033),0.6765345578206666,1.415082811644785,0.10876623376623376,0.7750878777979688,1.0,7/13,20.35%,NT5E;NT5C1A;AMPD3;XDH;AK4;AK3;AK9
prerank,negative regulation of cell aging (GO:0090344),-0.5612398332772968,-1.4146030378839742,0.07008086253369272,0.5008259749489419,1.0,6/16,14.00%,SLC30A10;AKT3;CDK6;YBX1;MIF;RBL1
prerank,sulfation (GO:0051923),0.7097695973867747,1.4135713506816674,0.10517529215358931,0.7792345378548042,1.0,3/11,4.55%,UST;CHST5;SULT1A1
prerank,cellular response to ketone (GO:1901655),-0.4688885599146702,-1.4128213547372757,0.06985294117647059,0.5029464626759684,1.0,8/35,11.32%,ADCY5;ADCY1;GNG2;AHR;PTGFR;SPP1;ADCY2;ROCK2
prerank,skeletal muscle organ development (GO:0060538),0.6115931730902466,1.4124426534341024,0.09800918836140889,0.7815939367516463,1.0,7/26,7.86%,SIX1;CSRP3;DISP1;LARGE1;STRA6;MYOG;SIX4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7227756545175377,1.412360742310073,0.11744386873920552,0.7795076232492929,1.0,2/11,1.55%,KCNJ2;ATP1B1
prerank,neuromuscular junction development (GO:0007528),-0.49304589837717927,-1.4117317659292967,0.07122507122507123,0.5032977334862716,1.0,9/24,10.16%,UNC13C;PDZRN3;PPFIBP2;ANK3;PPFIBP1;CACNB4;ZC4H2;GPHN;CACNB1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6946962804338848,1.4107235855227325,0.11702127659574468,0.7840211887861693,1.0,1/11,0.13%,STK39
prerank,integrin-mediated signaling pathway (GO:0007229),0.5243119098006074,1.4106341769740471,0.05408805031446541,0.781960249411567,1.0,15/73,6.31%,ITGBL1;ITGB8;PTK2B;FN1;ADAM9;PLPP3;COL3A1;ITGB1;ABL1;NRP1;ITGB5;ITGA10;ITGA5;ITGAV;PTPRA
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.646380887295364,1.4105574221281645,0.10064935064935066,0.7797642501010016,1.0,3/18,2.85%,SLIT2;PTK2B;MTUS1
prerank,blood vessel morphogenesis (GO:0048514),-0.42447260428234224,-1.4102883895781442,0.05485232067510549,0.5048404345294851,1.0,19/54,9.87%,FLT1;EFNB2;ENG;LAMA1;TGFBR3;CDH2;CCBE1;KDR;RASIP1;SLC1A1;TBX1;COL4A1;SOX17;RBPJ;HEY2;PROX1;ADM;SOX18;RAMP2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.4055055544242659,-1.410146744606743,0.05741626794258373,0.5024032376642836,1.0,13/67,7.70%,ITPR1;RAPGEF4;CHD7;SLC2A1;CACNA1D;RAPGEF3;CACNA1E;KCNC2;DPP4;SYT7;ADRA2A;SNAP25;HTR2C
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5791847059136555,1.40969746167748,0.09425625920471281,0.7809327641129196,1.0,10/33,12.62%,KLF5;FOXO3;KLF4;FGF2;STAT3;IL10;TEAD1;ATOH8;JUN;SMARCA4
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5583871507638474,-1.4094300009617307,0.09641873278236915,0.5015485474894703,1.0,7/15,19.67%,GGT5;ABHD12;ALDH4A1;SARDH;GGT1;GOT2;GGT7
prerank,modulation by symbiont of host process (GO:0044003),-0.6325868737083823,-1.4087655073694396,0.08958837772397095,0.5005290301882156,1.0,5/10,19.06%,B2M;UBC;MRC1;RPS27A;ENO1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5361120101358255,1.4086620595384998,0.06443298969072164,0.7830131541780619,1.0,16/65,19.37%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;NABP1;USP47;CHEK1;PSMD11;PSMD1;CHFR;CUL1;PSMC1;PSMD7;ZFYVE19;PSMD14
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.620021145905778,1.4084513766143587,0.09794628751974724,0.781428073613378,1.0,5/22,7.15%,WNK1;CD44;KLF4;GCNT2;IL10
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6178203424630323,1.4083825663055962,0.11885895404120443,0.7792450244242983,1.0,4/21,3.93%,THBS1;PTK2B;MTUS1;CMKLR1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6167317936580411,-1.4083078558656268,0.10444444444444445,0.4990159917282151,1.0,6/11,9.52%,KDR;NDNF;CD34;GATA2;MCAM;PRCP
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6041740019959985,1.4080754930569594,0.09658246656760773,0.7782260598686966,1.0,7/26,11.10%,EGFR;SOX9;GAREM1;FOXC1;IQGAP1;SYAP1;ERBB2
prerank,linoleic acid metabolic process (GO:0043651),-0.5473638585743572,-1.4079268352839422,0.09142857142857143,0.49740503590090235,1.0,4/17,10.64%,ACSL1;FADS2;PNPLA8;ALOX12
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5387521537519847,1.4062141212321417,0.10039630118890357,0.7834032393245004,1.0,16/50,14.90%,SMO;GLI3;GPC3;ZIC1;HHIP;VCP;GLIS2;CREBBP;GAS1;RORA;KIF7;MEGF8;EVC;ARMC9;HERC4;TTC23
prerank,osteoclast differentiation (GO:0030316),0.6318199557340238,1.4061843908910439,0.08188976377952756,0.7811023525289228,1.0,3/22,3.34%,FOXP1;ANXA2;GAB2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.610854965348069,-1.4050233363435962,0.10638297872340426,0.5025394470377562,1.0,3/11,2.83%,TJP1;RAPGEF2;F11R
prerank,response to laminar fluid shear stress (GO:0034616),0.7173888959694505,1.4049346557202118,0.11379310344827587,0.7841324307155376,1.0,3/10,3.18%,SMAD6;KLF4;NFE2L2
prerank,positive regulation of cell cycle (GO:0045787),0.5364834770774084,1.4045567283457252,0.07722007722007722,0.7832453894930744,1.0,15/62,15.08%,SMOC2;EGFR;PKD1;LRP6;USP2;CDC25B;CDKN1B;RARA;CCNYL1;CHEK1;PKN2;HCFC1;CCND1;TGM1;PRKCA
prerank,outflow tract septum morphogenesis (GO:0003148),0.6186726006040679,1.4044373798330696,0.11027190332326284,0.781377843266135,1.0,9/24,5.64%,BMP4;ZFPM2;SMAD6;SEMA3C;PARVA;BMPR1A;NRP1;TGFBR2;ISL1
prerank,kidney development (GO:0001822),0.5256704226214877,1.403055855748205,0.05821474773609314,0.7847386489974606,1.0,17/65,10.33%,BMP4;SIX1;PCSK5;PKD1;ZBTB16;SULF1;TGFBR1;STRA6;AGTR1;ARL3;GDNF;GDF6;FOXC1;KANK2;GLI2;NF1;VEGFA
prerank,negative regulation of hemostasis (GO:1900047),-0.5890333867770259,-1.4029338854087514,0.11165048543689321,0.5058933835148003,1.0,5/12,8.69%,VTN;APOE;CD34;TFPI;EDN1
prerank,negative regulation of cell motility (GO:2000146),0.4943073377998437,1.4020407115570945,0.059453032104637336,0.7867881780548535,1.0,19/108,6.70%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;FOXO3;SULF1;IGFBP5;SRGAP2;SRGAP3;CCDC125;VCL;NOG;ZMYND8;SLURP1;JAG1
prerank,action potential (GO:0001508),0.552174086288913,1.4016468321185906,0.0896358543417367,0.7861631118319258,1.0,6/44,5.27%,KCNJ2;KCNMB3;KCNMB2;KCNB1;CACNA1G;DMD
prerank,B cell homeostasis (GO:0001782),-0.6172344308559633,-1.3990691343275121,0.12652068126520682,0.514308169296023,1.0,4/10,5.56%,DOCK10;LYN;DOCK11;MEF2C
prerank,aminoglycan biosynthetic process (GO:0006023),0.5411540494591192,1.3988353393441717,0.07785234899328859,0.7963091693686242,1.0,11/49,8.42%,GPC6;EXT1;GPC3;HS3ST1;B3GNT2;HS6ST2;HEXA;GCNT2;XYLT1;GPC4;HAS1
prerank,protein deacetylation (GO:0006476),0.5612601468174457,1.3986836694444886,0.10719131614654002,0.7945780284251736,1.0,15/41,23.60%,HDAC4;HDAC9;RCOR3;TBL1X;MIER1;MTA1;HDAC10;BAZ2A;PRDM5;SIRT6;RBM14;BRMS1L;MIER2;FLNA;BRMS1
prerank,positive regulation of cell communication (GO:0010647),-0.48667962370202744,-1.3982712953434393,0.057692307692307696,0.5138554422889402,1.0,7/28,9.25%,WLS;RIMS1;ANK3;GRIK2;RIMS2;EDN1;SYT1
prerank,myoblast differentiation (GO:0045445),0.6676765942164573,1.3982275737623775,0.0929853181076672,0.7941919976421113,1.0,10/14,15.44%,TCF7L2;MBNL1;DDX5;DDX17;PLEKHM3;JAG1;MAPK12;RB1;REST;HINFP
prerank,"wound healing, spreading of cells (GO:0044319)",0.6187421825070705,1.3964176713262044,0.1111111111111111,0.7999023281545941,1.0,6/24,9.06%,TMEFF2;CCN1;CD44;ITGA5;MRTFA;RHOA
prerank,positive regulation of embryonic development (GO:0040019),-0.5206507844376858,-1.3958085086240086,0.08611111111111111,0.5178137338798707,1.0,9/19,18.30%,PLCB1;WNT4;TENM4;OSR1;CFL1;NR2C2;RBM19;RACK1;LHX1
prerank,cAMP biosynthetic process (GO:0006171),-0.6226988307662088,-1.3953157468952078,0.11136363636363636,0.5163549951316155,1.0,5/10,15.24%,ADCY5;ADCY1;ADCY7;ADCY2;ADCY4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5455172883089223,1.3948828623971443,0.09973045822102426,0.8040773349846916,1.0,13/50,13.94%,EGFR;NR3C2;TCIM;NFAT5;PDCD4;TRIM44;IFI35;TLR4;RHOA;LIMS1;TRIP6;EP300;TRADD
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6392115275983316,1.3947235094679786,0.14423076923076922,0.8023281440827719,1.0,3/17,3.88%,SOX9;DSPP;KLF7
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4591087604023564,-1.3944876979966216,0.060126582278481014,0.51582302242423,1.0,9/35,10.40%,VTN;SGIP1;B2M;PICALM;TNK2;HIP1R;RAC1;SNAP91;HIP1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5764379561898296,-1.3941088166210691,0.13316582914572864,0.5140606401338624,1.0,5/13,16.62%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,vascular transport (GO:0010232),0.5147791866498541,1.393988695438267,0.07257072570725707,0.8032794487951235,1.0,10/81,2.41%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,response to UV-A (GO:0070141),0.6608065484549521,1.3927597951424004,0.1342062193126023,0.8062559156582668,1.0,1/14,0.24%,EGFR
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.33659551226760853,-1.392693949477568,0.014705882352941176,0.5154483294489951,1.0,58/224,11.06%,SLC1A3;UNC13C;DTNA;PDE7B;GRM7;NOVA1;GRM3;NRXN1;CACNA1E;MBP;GRM5;GRIA4;SLC6A1;GABRG3;GRIK2;PRKAR2B;GRIN2A;KCND2;GRM1;SLC1A1;PLP1;CALM1;APBA1;GRIN2B;SLC1A2;RIT2;KCNQ3;PRKAR1B;GABRA2;GABRB1;GRIK1;APBA2;GABRB2;PRKACB;DLGAP1;PRKAR1A;CHRM2;GRIA3;CACNB4;SYN2;CACNA1B;SNCA;SNAP25;GABRB3;HTR2C;GRIN1;CHRM3;GLRA1;GABRA1;RPS6KA1;SYT1;GRIA2;CACNB1;SYN1;HTR2A;GRIA1;SDCBP;GLRA3
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4551023731374816,-1.3926792402938257,0.06529209621993128,0.5127414650033676,1.0,18/34,20.67%,IGF1;APOE;PICALM;RTN1;EPHA4;ABCG1;LRRTM3;NTRK2;RTN4;ROCK2;BIN1;CASP3;GSK3A;ABCA2;GSAP;TMED10;CHRNA7;GGA3
prerank,calcineurin-mediated signaling (GO:0097720),0.7018185995042246,1.3925116457432372,0.1299638989169675,0.8026663880213928,1.0,6/10,14.18%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7018185995042246,1.3925116457432372,0.1299638989169675,0.8026663880213928,1.0,6/10,14.18%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,regulation of cell communication (GO:0010646),0.5719809971470241,1.3924258008331674,0.09251101321585903,0.8007269071128321,1.0,6/35,2.23%,GRK5;ANK2;CAMK2D;MGLL;ANXA1;CXADR
prerank,transport across blood-brain barrier (GO:0150104),0.5114267288498878,1.3922719339649048,0.07588739290085679,0.799015388435695,1.0,10/83,2.41%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,positive regulation of protein import (GO:1904591),0.5776856487661552,1.3916772359830676,0.11159420289855072,0.7992389275533176,1.0,9/30,13.85%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP;ARHGEF5;ZC3H12A;BAG3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.6514729352906716,1.3915534557528526,0.12186978297161936,0.7974689954619675,1.0,7/16,17.68%,DDX5;DDX17;SRSF6;DHX9;HNRNPM;CDK13;SCNM1
prerank,atrial septum development (GO:0003283),0.6858138867600186,1.3910040163797748,0.12941176470588237,0.7975385241952165,1.0,5/13,8.35%,ANK2;NOTCH2;ISL1;GATA4;MDM4
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.45860021622756275,-1.3909199721582093,0.04745762711864407,0.5151899910484548,1.0,15/34,15.60%,GRID2;GABRG3;GRIN2A;GRIN2B;GABRA2;MEF2C;GRIN1;GLRA1;GABRA1;GABRG1;GSK3A;GABRA4;AKT1;ARRB2;GABRA5
prerank,dendritic spine organization (GO:0097061),-0.48096217187621365,-1.390715279071792,0.07886435331230283,0.5129933344775808,1.0,6/26,3.90%,IGF1R;DOCK10;SHANK3;EPHB1;ITGA3;INSR
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.616498614188731,1.3905044508163324,0.1263482280431433,0.7972519277929259,1.0,4/21,6.54%,RASSF2;NCK2;DMD;DMTN
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6465434064817747,1.390493629222476,0.13071895424836602,0.7949891461753131,1.0,5/17,9.48%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,early endosome to Golgi transport (GO:0034498),0.6930468618614122,1.390105209653236,0.1271186440677966,0.7943189467745273,1.0,8/11,23.16%,RAB6A;SNX2;STX5;EHD3;TRAPPC10;RBSN;SNX8;SURF4
prerank,regulation of protein catabolic process (GO:0042176),0.4977561074914642,1.3899230850539024,0.07255139056831923,0.7928397324274051,1.0,24/99,15.11%,EGFR;WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;NSF;CHEK2;MDM4;CDKN1B;DACT1;IRAK3;ASB11;SNX12;ZDHHC2;SMURF1;AZIN1;SEC22B;HMGCR
prerank,dicarboxylic acid transport (GO:0006835),0.5795859442357708,1.389847344788312,0.1083086053412463,0.7909250092209708,1.0,3/28,3.83%,SLC26A7;GIPC1;SLC26A6
prerank,supramolecular fiber organization (GO:0097435),0.45511779336437436,1.3897496887775345,0.011351909184726523,0.789086629330505,1.0,50/333,9.34%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;SNCAIP;COL6A1;COL5A2;CYP1B1;PLOD2;BMP1;DDR2;CLIP4;DSP;GSN;COL3A1;SHROOM3;COL23A1;MAP7D3;RHOBTB1;FGF13;LOXL1;COL6A3;TGFBR1;LTBP2;LTBP3;TMOD3;FAT1;P3H2;CLIP1;HDGFL3;NLRP5;P4HA1;TLE6;COL11A1;PCM1;P4HA2;DLG1;TNXB;P3H1;ARHGAP17;PLK3;SHROOM4;P3H4;OPTC;RHOA;RIPK3;RND3
prerank,sensory perception of light stimulus (GO:0050953),0.4984494184295404,1.3897069996651532,0.07872078720787208,0.7870365365699961,1.0,13/87,13.62%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;PAX6;CRYBB3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.5146989102070354,-1.3891141305603476,0.08982035928143713,0.5147714577556517,1.0,9/22,22.78%,APOD;ADRA2A;PPP2R5A;ASXL3;PDE3B;CCDC3;GPER1;APOC1;ALK
prerank,pyroptosis (GO:0070269),-0.5526067371710638,-1.3889724944864423,0.10263157894736842,0.5125274250168486,1.0,6/15,20.32%,CASP4;AIM2;GSDMD;CASP1;ZBP1;TREM2
prerank,cell-cell junction maintenance (GO:0045217),-0.5924030167073073,-1.3883023837187722,0.12469437652811736,0.5117002753435749,1.0,5/11,23.89%,TJP1;CSF1R;MYADM;PRTN3;F2R
prerank,T cell migration (GO:0072678),0.6681164040303016,1.3881839159305878,0.12956810631229235,0.7910843210502833,1.0,1/13,0.48%,SLC12A2
prerank,cellular response to mechanical stimulus (GO:0071260),0.544950180552572,1.3870554815826592,0.0962566844919786,0.7936331253758596,1.0,10/46,13.06%,PIEZO2;SOX9;CRADD;IRF1;TLR4;SLC9A1;NFKB1;MYD88;MAP2K4;CHEK1
prerank,embryonic organ morphogenesis (GO:0048562),0.5498623896285819,1.3870077963226033,0.0997191011235955,0.7916433926791594,1.0,14/42,12.18%,SIX1;MFAP5;HOXA3;HES1;EFEMP1;HOXB3;HOXC4;ID2;RARG;HOXB4;ACVR1;FOXE1;MEGF8;NIPBL
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6373097974333151,1.3866663401781651,0.13915857605177995,0.7909743548994027,1.0,2/16,1.84%,BMP4;TGFB3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6427052095981995,1.3866429183506972,0.12295081967213115,0.788854341572135,1.0,7/17,10.12%,CD55;STAT3;GNL1;JAG1;TLR4;CD46;IL18BP
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5610035282687653,-1.3862835191671719,0.11662531017369727,0.514747552431803,1.0,7/13,18.49%,ELOVL7;ELOVL6;HACD3;ELOVL4;TECRL;HACD2;HACD1
prerank,Wnt signaling pathway (GO:0016055),0.5038892221756665,1.3861738846843605,0.08082026537997587,0.7886484069933474,1.0,22/92,10.95%,TCF7L1;NXN;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;STRN;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;GPC4;CSNK1G3;USP34;RARG;PLCG2;LRP5;BCL9L
prerank,regulation of DNA replication (GO:0006275),0.5429914797697251,1.3861373330721556,0.09659863945578231,0.7865816434611721,1.0,13/49,18.66%,EGFR;CCNA2;BCAR3;STN1;RAD17;GLI2;WAPL;GTPBP4;DHX9;ANKRD17;EHMT2;ATR;EGF
prerank,protein localization to centrosome (GO:0071539),0.6466505523572579,1.3859539495589093,0.1302250803858521,0.7851810791938286,1.0,10/17,20.28%,GOLGB1;PCM1;CEP131;PIBF1;STIL;NUDCD3;HOOK3;C2CD3;CSNK1D;CCDC14
prerank,regulation of cardiac conduction (GO:1903779),-0.40800054042653694,-1.3855054160294142,0.04263565891472868,0.5144375579496014,1.0,13/54,10.07%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;RYR2;ATP1B2;DMPK;ATP2B1;FXYD6;ACE2;ATP2A2
prerank,gastrulation (GO:0007369),0.653597681057228,1.3849856912850471,0.1416382252559727,0.7871073491815,1.0,5/15,11.10%,GPC3;NR4A3;LRP5;SMAD2;MEGF8
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5488411075980216,-1.3847090682686314,0.11315789473684211,0.514054809770152,1.0,4/17,10.82%,KCNAB1;ANK3;AKAP6;NOS1AP
prerank,regulation of myotube differentiation (GO:0010830),0.5986069284246164,1.3840968945691345,0.1111111111111111,0.7887809470692076,1.0,7/24,14.50%,CCN3;HDAC4;HDAC9;MYOG;MMP14;ATP11A;CEACAM5
prerank,positive regulation of protein catabolic process (GO:0045732),0.5077046546634235,1.383471790091065,0.07204968944099378,0.7892588796997619,1.0,20/84,12.34%,WWP1;FZR1;NEDD4;EZR;ADAM9;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;RDX;NSF;PLK3;CDKN1B;DACT1;ASB11;SH3D19;TNFRSF1B
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6175963051427621,-1.3828994246248372,0.11471861471861472,0.516547268427206,1.0,5/10,15.48%,LYN;FAS;MAPK3;RNF13;GREM1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5729761571305947,-1.3819455112745656,0.10275689223057644,0.5167026772939426,1.0,5/13,14.00%,SLC30A10;AKT3;CDK6;YBX1;RBL1
prerank,actin polymerization or depolymerization (GO:0008154),0.5399732573903232,1.3803424251654586,0.09605263157894736,0.8001730928901785,1.0,7/50,3.85%,MICAL2;VILL;COBL;ABI1;GSN;FAM107A;DIAPH1
prerank,cellular response to organonitrogen compound (GO:0071417),0.4895669930688561,1.380293890050148,0.058682634730538925,0.7981144558842036,1.0,15/99,8.65%,SLIT2;CDH1;SOX9;EZR;IGFBP5;CTNNA1;CAPN2;SLC26A6;DIAPH1;RAP1A;GOLPH3;DMTN;RRAGB;JUP;P2RX4
prerank,epithelial cell differentiation (GO:0030855),0.4952654795171382,1.3795234947623132,0.08182912154031288,0.7990100927452151,1.0,9/88,4.84%,BMP4;SIX1;FSTL1;BDH2;ANXA1;ANXA4;FZD7;EHF;CASP6
prerank,negative regulation of macrophage activation (GO:0043031),-0.5456687444288616,-1.3789731721353164,0.11940298507462686,0.5225267470343689,1.0,6/16,11.73%,IL31RA;NR1H3;SYT11;GRN;LRFN5;CD200
prerank,regulation of neutrophil migration (GO:1902622),-0.6145020934422918,-1.3782292405810928,0.1225,0.5221573861404099,1.0,7/10,31.18%,JAM3;RHOH;RAC1;RHOG;BST1;RAC2;OLFM4
prerank,carboxylic acid metabolic process (GO:0019752),0.5718459892027667,1.378047907511808,0.11789772727272728,0.803304510212529,1.0,5/33,5.77%,SLC23A1;SLC23A2;PTGIS;CYP2S1;PON3
prerank,positive regulation of cell junction assembly (GO:1901890),-0.41759231743581243,-1.377572737823983,0.048582995951417005,0.5214492966935453,1.0,17/56,16.00%,TEK;IL1RAPL1;CLDN5;CNTNAP2;NRXN1;GRID2;KDR;EPHB1;MAP4K4;RAC1;SRPX2;LRRC4B;ACE2;CUX2;PPM1F;AGT;CLSTN3
prerank,regulation of lamellipodium assembly (GO:0010591),0.5641964961679786,1.37751455751944,0.10201149425287356,0.8033650591419907,1.0,2/34,0.43%,SLIT2;PLCE1
prerank,regulation of protein sumoylation (GO:0033233),0.6314795219782224,1.377358871268027,0.13145539906103287,0.8018033498318392,1.0,5/17,19.06%,HDAC4;SAE1;PIAS3;ZMIZ1;PIAS1
prerank,regulation of protein localization to membrane (GO:1905475),0.5912632919776913,1.3766535322425122,0.1263001485884101,0.8027496768560037,1.0,6/28,9.32%,GPC6;GPC3;GSN;GPC4;STX8;MMP14
prerank,fatty acid beta-oxidation (GO:0006635),0.5274246838646133,1.3766491105426373,0.10317460317460317,0.8005854448521369,1.0,9/51,8.43%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;DECR1;ACOX3;ACOT8;ACADM
prerank,establishment of epithelial cell polarity (GO:0090162),0.6241213985906554,1.376352740253963,0.1328,0.79964930414575,1.0,7/19,10.59%,CYTH3;EZR;GOLPH3;RHOA;PARD3;SYNE4;MYO9A
prerank,positive regulation of catabolic process (GO:0009896),0.5168156603465495,1.3758306107331641,0.09718670076726342,0.7997328653277882,1.0,13/65,9.55%,WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;NSF;CDKN1B;DACT1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6433127951405179,1.3750200505802257,0.14695945945945946,0.80090317234847,1.0,4/15,5.23%,BMPER;KLF4;FGF2;ITGA5
prerank,negative regulation of phosphorylation (GO:0042326),0.5045099228443128,1.3749614914905588,0.07625,0.7989839557531577,1.0,9/85,3.19%,SLIT2;BMP4;NTRK3;HDAC4;LRP6;PID1;PLPP3;NIBAN1;INHBA
prerank,protein K11-linked ubiquitination (GO:0070979),0.5949768044495259,1.3746515931077916,0.1228878648233487,0.7980926097990559,1.0,5/27,9.05%,FZR1;ANAPC5;UBE2B;CDC16;UBE2D3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6218553231099495,1.3743407377755892,0.1407766990291262,0.7972779175254807,1.0,2/17,1.84%,BMP4;TGFB3
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.521586390090397,-1.3740771616964467,0.11388888888888889,0.5285159774882949,1.0,9/18,27.40%,APOE;TMCC2;ABCG1;NSG1;APH1B;ADAM19;NCSTN;ACHE;PSENEN
prerank,reverse cholesterol transport (GO:0043691),-0.569778016478761,-1.3736331519664313,0.11330049261083744,0.5271235583472578,1.0,5/13,12.71%,APOE;ABCA5;ABCA1;ABCG1;SCARB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6473653102752057,1.373611173605028,0.13050570962479607,0.7982768221745741,1.0,7/17,10.23%,BMP4;BMPR1A;NOTCH2;NOG;JAG1;ACVR1;GALNT11
prerank,organelle disassembly (GO:1903008),0.5643250614075531,1.3734323014338785,0.1366906474820144,0.7968498046918232,1.0,17/33,19.41%,ULK2;VCP;STX5;GBF1;PLK3;KIF9;KLC1;MRRF;EIF2D;RB1CC1;MTIF3;DDRGK1;GFM2;UBA5;MTIF2;ATG2A;DYRK3
prerank,purine-containing compound catabolic process (GO:0072523),0.6647017985335668,1.3718030249272377,0.13964686998394862,0.8016085438163788,1.0,2/13,1.29%,NT5E;NT5C1A
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6046864297917287,1.3708167809453176,0.13258785942492013,0.8037509968140374,1.0,3/22,8.46%,BMP4;INHBA;CDKN1B
prerank,regulation of protein phosphorylation (GO:0001932),0.4503093803505541,1.3705528316921527,0.025157232704402517,0.8027192723285806,1.0,21/256,3.61%,SLIT2;BMPER;EGFR;BMP4;PLCE1;SLCO3A1;CARD14;NTRK3;SOX9;LRP6;PGF;CCN1;EFNA5;PID1;FN1;PLPP3;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,activation of protein kinase B activity (GO:0032148),-0.468441386668664,-1.3700871506370782,0.09634551495016612,0.534776009241848,1.0,10/29,7.99%,IGF1;OSBPL8;WNT5A;INSR;PPIA;FGF1;CCDC88A;ADRA2A;IL18;GAS6
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6250888799348134,-1.3699513027295946,0.11951219512195121,0.5325680656574261,1.0,5/10,19.56%,APOE;DBI;ABCB4;TRIAP1;TMEM30A
prerank,NAD biosynthetic process (GO:0009435),0.6069849139637055,1.3692235381417863,0.15,0.8061649288023975,1.0,5/20,8.31%,PTGIS;NMNAT2;QPRT;NMNAT1;NNMT
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.49184705600617373,1.3691577678630702,0.06610576923076923,0.8043585962348925,1.0,20/101,13.80%,THBS1;CYFIP2;SAMD4A;PERP;EZR;NIBAN1;KLF4;INHBA;AGTR1;EIF4G1;RDX;LARP4B;FBXW11;DACT1;ERBB2;EIF3E;EIF6;MTOR;PRKDC;TBC1D10A
prerank,muscle tissue development (GO:0060537),0.6509789325451237,1.369045530223851,0.16055846422338568,0.8027051998516455,1.0,6/13,9.78%,BMP4;SMO;CSRP3;STRA6;CSRP2;NF1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5397990897812863,-1.3682574423441987,0.12030075187969924,0.5349997504947295,1.0,11/16,40.22%,TNFRSF21;TYROBP;JAK3;VSIR;DLL1;TRIB2;FCGR2B;IL23A;FOXP3;IL12B;CD274
prerank,regulation of autophagosome maturation (GO:1901096),0.6667472039504281,1.3675880396480082,0.15257048092868988,0.8065884709153265,1.0,7/13,21.03%,ADRB2;CLEC16A;TMEM39A;SMCR8;TBC1D25;CLN3;RUBCN
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4850630912435391,1.3670936987453253,0.059788980070339975,0.8065809373918909,1.0,21/108,9.55%,RSPO3;TCF7L1;NXN;TRABD2B;CTNND2;GPC3;SULF1;GRB10;FZD7;MDFIC;FOXL1;MDFI;SFRP4;TSKU;SKI;ESR1;LRP1;RSPO4;NLK;DISC1;DACT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.6708898735913568,1.3664870990552676,0.14519056261343014,0.8069925481606384,1.0,5/10,10.84%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,negative regulation of cellular component movement (GO:0051271),-0.5496653497045593,-1.3654508984021727,0.11407766990291263,0.5404443955445416,1.0,4/15,2.97%,FRMD5;TGFBR3;SPOCK3;FBLN1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6551929605469393,1.365368890315136,0.13445378151260504,0.8096261247433537,1.0,2/15,1.55%,KCNJ2;ATP1B1
prerank,regulation of stem cell proliferation (GO:0072091),-0.5415702639980765,-1.3647157398470164,0.09448818897637795,0.5399532262615439,1.0,3/17,4.99%,FBLN1;ACE;GJA1
prerank,regulation of B cell differentiation (GO:0045577),0.6466389066166187,1.3646368335169812,0.15894039735099338,0.8106344737020852,1.0,4/17,9.32%,PPP2R3C;INHBA;ID2;MMP14
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.44370052759186457,-1.364341018149976,0.08695652173913043,0.5384702862120673,1.0,16/38,19.58%,IL34;GRM5;NEDD9;ACE;APP;EPHA4;GPRC5B;LRP8;GAS6;CSF1R;AGT;NOX4;FCGR1A;RELN;ERBB3;HYAL2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6440850613101627,1.363890364843902,0.1388888888888889,0.811821582211549,1.0,3/15,5.64%,ANXA1;FAM107A;ISL1
prerank,urogenital system development (GO:0001655),0.6736986234672445,1.3637801563143577,0.16666666666666666,0.810234565681402,1.0,3/11,6.81%,SOX9;ANXA1;EPHB3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5549909485811284,-1.363129379162832,0.11633663366336634,0.5393303889987776,1.0,4/14,6.18%,ZEB1;OSR1;NOTCH4;SPRED1
prerank,inorganic cation transmembrane transport (GO:0098662),0.4447224533948316,1.3628449017665567,0.024494142705005325,0.8119762425997866,1.0,36/268,8.86%,SLC4A4;SLC9A2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC24A3;PKD1;ATP1B1;CACNA1C;ATP2C2;SLC6A7;KCNQ5;KCNS3;ANO6;TRPM6;KCNB1;ATP6V0A4;CACNA1G;SLC39A11;SCARA5;SLC39A14;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7;SLC9A8;SLC6A19;SLC9C1;SLC4A8;P2RX4;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,response to cholesterol (GO:0070723),0.6216346108681389,1.3626467607067132,0.15196078431372548,0.8106932190815977,1.0,8/17,12.83%,LRP6;SMO;TGFBR1;TGFBR2;GRAMD1C;CCL3;SMAD2;GRAMD1A
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5853865336867711,1.3626455422791988,0.11456628477905073,0.8086356639025467,1.0,11/25,12.24%,CXADR;DSP;PARVA;ITGB1;DSG2;ITGA5;CD2;ITGAV;JUP;ITGB3;DSC2
prerank,regulation of telomere maintenance (GO:0032204),0.5827383025229367,1.362508833549769,0.11946902654867257,0.8070833733923457,1.0,12/26,18.25%,SMG6;HDAC8;USP7;ATRX;SMG1;XRCC5;PML;NBN;YLPM1;SIRT6;ERCC1;DHX36
prerank,regulation of mRNA metabolic process (GO:1903311),0.6800295055637424,1.3625041590143294,0.15463917525773196,0.8050690032962386,1.0,4/11,17.05%,SLTM;DHX9;CDK11B;SRPK1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5135168613518281,-1.3623350205094393,0.12430939226519337,0.5389617542211861,1.0,9/18,18.49%,ACSL1;ELOVL7;ELOVL6;HSD17B12;ACSL5;HACD2;ACSBG1;ACSL4;HACD1
prerank,pulmonary valve morphogenesis (GO:0003184),0.6273298326757298,1.3621627459976253,0.14701378254211334,0.8044579708472671,1.0,6/17,6.70%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6;JAG1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5689334686469318,-1.3613730674253746,0.13157894736842105,0.5393684220059316,1.0,4/13,8.52%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,smoothened signaling pathway (GO:0007224),0.5588998612904044,1.3610892934697099,0.12129760225669958,0.8068957638907069,1.0,8/32,14.43%,SMO;GLI3;HIPK1;GLI2;TMEM231;EVC2;DYRK2;STIL
prerank,metal ion export (GO:0070839),0.5816889667031898,1.360467100061925,0.12184249628528974,0.8073541013730063,1.0,8/31,8.86%,SLC4A4;KCNK5;ATP1B1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,neural tube closure (GO:0001843),0.5575071373585062,1.3602497359389283,0.10826210826210826,0.8062013358236731,1.0,15/34,24.19%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2;STIL;BCL10;FUZ;SCRIB;DVL1;TGFB2;CELSR1;PHACTR4;MTHFR
prerank,potassium ion export across plasma membrane (GO:0097623),0.662838296949665,1.3601346776997119,0.1564625850340136,0.8046006392270262,1.0,1/13,0.19%,KCNK5
prerank,defense response to symbiont (GO:0140546),-0.3714915248902123,-1.3598987440323922,0.03067484662576687,0.5409408936712057,1.0,23/92,12.65%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;TLR7;RNASEL;STAT1;TLR3
prerank,negative regulation of vascular permeability (GO:0043116),0.6646350756060802,1.3598747375330522,0.14726027397260275,0.8036984087004224,1.0,1/12,0.11%,SLIT2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5358511469644427,-1.3596184021831357,0.1002710027100271,0.5392146097340174,1.0,6/18,9.82%,UNC13C;CDH8;GRID2;GRIK2;GRIK1;GRIA2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.619394771644682,-1.359472457168653,0.145933014354067,0.5371673084846255,1.0,6/10,14.99%,SHANK3;APP;SYP;NETO1;CAMK2B;SYNGR1
prerank,response to estrogen (GO:0043627),0.5660331160359362,1.3591548982441837,0.14697406340057637,0.8046683290835811,1.0,14/31,25.61%,SERPINB9;BCAS3;KRT19;ESR1;SLC34A2;RARA;KMT2D;EP300;CYP27B1;TRIM25;GATA3;SRA1;AR;CITED2
prerank,visual system development (GO:0150063),0.5415303573791862,1.358878325670187,0.12285714285714286,0.8037678349201022,1.0,7/37,11.05%,PBX3;PBX1;SMOC1;HIPK1;FOXC1;SCO2;ATF6
prerank,nucleotide catabolic process (GO:0009166),0.6373499779380984,1.3588112571123736,0.13479623824451412,0.802083768511925,1.0,7/16,17.85%,NT5E;NT5C1A;VCP;DERA;NUDT15;XDH;DNPH1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5912453445726322,-1.3585026241169236,0.11398963730569948,0.5373811156131759,1.0,4/12,5.71%,SEMA6A;DCN;ADAMTS12;DAB2IP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6634696269570969,1.3583321106394968,0.147005444646098,0.8021901511543247,1.0,6/12,7.62%,CACNA1C;DSP;DSG2;TRPM4;DLG1;JUP
prerank,axon development (GO:0061564),-0.3774329176171846,-1.3583035169144415,0.03553299492385787,0.5354813164917981,1.0,28/78,18.02%,NREP;GRM7;CTNNA2;ANK3;DCC;CNTN4;PLP1;ACTB;BAIAP2;APP;ZDHHC17;MAPT;PLPPR4;PAK3;RTN4;BRSK2;DSCAML1;RTN4RL1;ADGRB1;LMTK2;CAMSAP2;NRCAM;APBB1;SLITRK5;NEFH;RAB3A;S100A6;SPTBN4
prerank,embryonic organ development (GO:0048568),0.5070041450388231,1.3580836452725795,0.10921052631578948,0.8012462217434556,1.0,13/61,9.08%,PBX3;PCSK5;RARB;COBL;PBX1;GLI3;BMPR1A;STRA6;TGFBR2;GDNF;TEAD1;PDGFA;GLI2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6669301822318631,1.357803965981787,0.13666666666666666,0.8004088489250015,1.0,4/13,11.74%,GLI3;TGFBR2;ZBTB7B;CBFB
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6246670288859189,-1.3576387534311558,0.14350797266514806,0.534937806238552,1.0,2/10,3.16%,KCNAB1;ANK3
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.358814310627743,-1.3575152642453094,0.02631578947368421,0.5328418589580904,1.0,33/124,14.45%,PTPRM;LYN;FRYL;APOE;CNTNAP2;RAPGEF2;MAP2;GPM6A;CNTN4;PLP1;RASGRF1;APP;ATP1B2;SH3GL2;EPHA8;LAMB1;GPM6B;OPHN1;STMN4;STMN3;MICALL1;RAC1;MAPT;PLEK;TMEM108;UHMK1;BICDL1;ATXN10;STMN1;BLOC1S6;WDPCP;PRMT1;CSF1R
prerank,positive regulation of locomotion (GO:0040017),0.5779911231378041,1.357115797186777,0.1293233082706767,0.801166690072956,1.0,2/27,0.80%,THBS1;NTN1
prerank,embryonic eye morphogenesis (GO:0048048),0.6693841957573913,1.3570961731250617,0.15881326352530542,0.7992889831031762,1.0,4/11,9.77%,LRP6;MFAP5;EFEMP1;RARG
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5339484177922009,1.3570153239734493,0.1077762619372442,0.7976986597144705,1.0,7/49,8.02%,F3;LBP;CD2;STAT3;MAVS;DDIT3;TLR4
prerank,regulation of lipid storage (GO:0010883),0.6078534711929452,1.3568196175638703,0.12042682926829268,0.7964920252759164,1.0,8/22,12.52%,FTO;PTPN2;ITGAV;IKBKE;NFKB1;HILPDA;ITGB3;ZC3H12A
prerank,regulation of protein localization to nucleus (GO:1900180),0.5279170654541447,1.3561729692681335,0.13443072702331962,0.7970959596615066,1.0,4/43,3.24%,BMP4;CTNNA1;LIMK2;GSK3B
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5817556447260217,-1.3551425674631297,0.14146341463414633,0.536928330600589,1.0,2/11,3.43%,IL34;CSF1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5828777105258397,1.3549885644757282,0.13126843657817108,0.8000296296200813,1.0,7/26,9.70%,EYA2;FGFR1;INHBA;EYA4;GDNF;EYA3;GATA1
prerank,neuron projection development (GO:0031175),-0.3366942433480106,-1.3549459408615778,0.023255813953488372,0.5349433544596006,1.0,40/168,9.53%,PTPRM;DOCK10;LYN;FRYL;SHANK3;APOE;GRM7;CNTNAP2;ADGRV1;TNIK;PAK1;RAPGEF2;MAP2;EPB41L3;EPHB1;GPM6A;CNTN4;PLP1;BMP7;RASGRF1;APP;NRK;EPHA4;MAP4K4;SH3GL2;SGK1;DAB2IP;EPHA8;LAMB1;GPM6B;OPHN1;STMN4;MYO16;STMN3;MICALL1;NYAP2;MAPT;PAK3;TMEM108;UHMK1
prerank,calcium-mediated signaling (GO:0019722),0.4783223355581907,1.3547415942235952,0.10379746835443038,0.7990114690483118,1.0,23/93,14.55%,EGFR;PLCE1;ANK2;ATP1B1;PPP3CA;CACNA1C;AGTR1;TRPM4;DMTN;NUDT4;P2RX4;SLC9A1;TNNI3;PLCG2;MCU;CCL3;PPP3CC;SAMD14;RCAN1;TNFSF11;HTR2B;BCAP31;CXCR4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.527888266262089,1.353013192472976,0.10923276983094929,0.8039579386590923,1.0,4/48,4.22%,SLC26A2;GUCY2C;PAPSS2;ADCY9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.518827043217548,-1.3525982493155784,0.12535612535612536,0.5390961421667695,1.0,9/16,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME;ATP5MC3
prerank,regulation of muscle contraction (GO:0006937),0.5821890352436387,1.352386334303669,0.12835820895522387,0.8047076314470131,1.0,3/26,3.94%,KCNB2;PLCE1;PPP1R12B
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5470040687991363,1.3523365717362519,0.10863509749303621,0.8029892592681686,1.0,5/44,3.74%,THBS1;NGF;CD44;KLF4;CAST
prerank,pulmonary valve development (GO:0003177),0.6157422367249165,1.352023576547128,0.15629742033383914,0.8023508584450729,1.0,5/18,4.15%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6
prerank,signal peptide processing (GO:0006465),0.681875356128048,1.351628742800322,0.14067796610169492,0.8019456780739422,1.0,1/11,0.88%,PCSK5
prerank,acidic amino acid transport (GO:0015800),-0.5086890680620837,-1.3515894408928526,0.12169312169312169,0.5393194508507699,1.0,6/17,4.99%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;SLC1A2;GJA1
prerank,chemical synaptic transmission (GO:0007268),-0.3176625846533536,-1.351567279754011,0.0,0.5369481579660894,1.0,65/284,11.06%,SLC1A3;UNC13C;DTNA;APOE;PDE7B;GRM7;NOVA1;GRM3;NRXN1;CDH8;CACNA1E;MBP;GRM5;GRIA4;GRID2;SLC6A1;GABRG3;RIMS1;LIN7A;GRIK2;PRKAR2B;GRIN2A;KCND2;GRM1;SLC1A1;HSPA8;PLP1;CALM1;APBA1;GRIN2B;SLC1A2;RIT2;KCNQ3;PRKAR1B;GABRA2;GABRB1;GRIK1;APBA2;GABRB2;PRKACB;DLGAP1;PRKAR1A;CHRM2;GRIA3;CACNB4;SYN2;CACNA1B;SNCA;SNAP25;GABRB3;HTR2C;GRIN1;CHRM3;GLRA1;GABRA1;RPS6KA1;SYT1;GRIA2;CACNB1;SYN1;HTR2A;GRIA1;SDCBP;NSG1;GLRA3
prerank,retina homeostasis (GO:0001895),-0.4962242928630306,-1.3513575028177933,0.1027190332326284,0.5350936773347639,1.0,10/23,24.76%,B2M;ACTB;POTEF;ATP1B2;WHRN;ACTG1;HSPB1;CDH3;JCHAIN;TULP1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5789572228729377,1.3508744310913634,0.138763197586727,0.8031473341741799,1.0,8/27,10.96%,VPS13A;VPS13C;RAB6A;GAK;GOLPH3;GBF1;VPS13D;ZDHHC15
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6204204967053579,1.3498468383588604,0.1470113085621971,0.8034521553445174,1.0,7/16,12.07%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6204204967053579,1.3498468383588604,0.1470113085621971,0.8034521553445174,1.0,7/16,12.07%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4877247642595446,1.3495137665543426,0.09003601440576231,0.8028398189254344,1.0,15/93,10.33%,EGFR;RASSF2;NTRK3;NGF;CD44;DOCK7;EIF4G1;NCK2;ATP2B4;DMD;RIPK2;DMTN;BCAR3;AKAP9;VEGFA
prerank,regulation of intracellular protein transport (GO:0033157),0.5558792556355687,1.3488300605818841,0.1357142857142857,0.8036807270091951,1.0,6/32,10.51%,BMP4;NDEL1;BCAS3;PCM1;PLK3;CEP131
prerank,regulation of axon regeneration (GO:0048679),-0.5882909424476593,-1.3482193571506496,0.13513513513513514,0.5413011902785793,1.0,5/12,12.50%,EPHA4;GRN;INPP5F;CERS2;RTN4RL1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4665969094913124,1.3476756987005174,0.06538895152198422,0.8065136303237512,1.0,28/136,12.52%,TCF7L2;PKD1;HDAC4;CYP1B1;PTGIS;HES1;ANXA4;WWP2;KLF4;TAX1BP1;ID1;CMKLR1;MDFI;SFRP4;BHLHE40;GLIS2;ESR1;KDM1A;DDIT3;ID2;CHUK;COMMD1;ERBIN;IRAK3;USP7;RB1;CHP1;ZC3H12A
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.45334325437573364,-1.3475025269794045,0.08524590163934426,0.540884525051793,1.0,11/32,14.71%,ITGA1;PDGFRB;PPP1R16B;CALM1;PPIA;CD300A;HSP90AB1;PPP1R15B;PPP2R5A;CALM3;SMPD1
prerank,purine nucleotide catabolic process (GO:0006195),0.6625572851681432,1.3474619909505838,0.15121951219512195,0.8054602434351085,1.0,2/13,1.29%,NT5E;NT5C1A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5397496438710798,1.3473063363940925,0.12482662968099861,0.8041786437958293,1.0,12/45,11.38%,BMP4;BMP5;TGFB3;BMP6;BMPR1A;INHBA;TGFBR1;GDF6;GDF5;GDF10;ACVR1;INHBB
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.45355906885000785,-1.3471946738812992,0.09473684210526316,0.5394284174832609,1.0,3/33,3.43%,IL34;LEF1;CSF1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5633824815412145,1.3471224666017698,0.12464183381088825,0.8029829898471315,1.0,6/33,5.23%,BMPER;THBS1;RHOJ;KLF4;FGF2;ITGA5
prerank,integrated stress response signaling (GO:0140467),0.6371845588476036,1.3467607182834522,0.19015280135823429,0.802479420036814,1.0,8/14,22.63%,NFE2L2;DDIT3;OMA1;EIF2AK4;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.41811873153962914,-1.346741868762494,0.05138339920948617,0.538212318447521,1.0,8/47,7.55%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH
prerank,glycosaminoglycan metabolic process (GO:0030203),0.513003322711366,1.3462780601213586,0.10604026845637583,0.8026462242011184,1.0,14/54,11.67%,GPC6;EXT1;GPC3;HS3ST1;HS6ST2;HEXA;GCNT2;XYLT1;NAGLU;GPC4;HAS1;B3GALT6;SGSH;GLB1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.43339683973089577,1.3455654102332752,0.006036217303822937,0.8036519733187,1.0,126/572,14.21%,FOXP2;FOXP1;BMP4;KLF12;ZFHX3;ZFPM2;TCF7L2;RARB;NFIB;SOX9;HDAC4;PRDM6;NEDD4;DDX5;EZR;FOXP4;CUX1;GLI3;FOXO3;HDAC9;ZBTB16;HES1;SKIL;WWP2;USP2;ESR2;KLF4;BMP6;ZNF148;CRY2;NR2F1;FOXC2;ID1;MEF2A;KLF7;JDP2;GLIS1;NR4A3;NR4A2;TCF25;MDFI;SMYD2;KLF10;ZBTB7B;NFATC4;HDAC8;BHLHE40;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;ESR1;STAT3;KDM1A;DDIT3;TBL1X;NFIL3;PHF21A;DLG1;SOX14;ID2;LCOR;NFIX;PLK3;MDM4;RXRA;ZNF8;FOXC1;KANK2;ZMYM5;PHF12;UBE2D3;GLI2;PER3;NFKB1;DACT1;IL33;GATA1;RARG;RARA;CBX5;JUN;MTDH;VEGFA;FOXE1;ZNF25;NCOR1;ZBTB32;TCERG1;PER1;MIER1;SMAD2;OTUD7B;MXD1;EED;GTF2IRD1;RB1;BPTF;DCAF1;CBFB;MTA1;ID4;NKX2-1;NIPBL;NCOA5;NR6A1;SMARCA4;CTR9;ATRX;NFATC3;MXD4;TCF3;PPM1A;PAX6;EP300;CHD3;HCFC1;NCOR2;BAG3;VPS72;RNF2;HDAC10;REST
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5291467153867685,-1.3451612672485282,0.12105263157894737,0.5401613318665975,1.0,7/17,4.99%,ATP1A2;GJC1;GJD3;SLC8A1;RYR2;ATP1B2;GJA1
prerank,positive regulation of cell division (GO:0051781),0.5345695582778776,1.344839711039131,0.12033195020746888,0.8047178797439466,1.0,10/38,14.30%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3;HTR2B
prerank,cellular response to type I interferon (GO:0071357),-0.41677768905997725,-1.3445848595803713,0.09177215189873418,0.5371298827285974,1.0,23/41,26.04%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;IFIT3;RNASEL;STAT1;PSMB8;SP100;IFIT1;ADAR;IRF7;OASL;XAF1;RSAD2;JAK1;IFITM2;IRF8
prerank,type I interferon signaling pathway (GO:0060337),-0.41677768905997725,-1.3445848595803713,0.09177215189873418,0.5371298827285974,1.0,23/41,26.04%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFNAR2;IFITM3;OAS2;IFIT3;RNASEL;STAT1;PSMB8;SP100;IFIT1;ADAR;IRF7;OASL;XAF1;RSAD2;JAK1;IFITM2;IRF8
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5085359670546958,1.3441110364820412,0.12082262210796915,0.805752518274781,1.0,12/66,9.55%,EGFR;FHL1;PKD1;ANXA1;KLF4;FAM107A;EIF4G1;DLG1;RDX;ID2;KANK2;DACT1
prerank,muscle cell differentiation (GO:0042692),-0.45243283092106057,-1.3437299088863983,0.11,0.5370809524347561,1.0,13/32,10.98%,WNT5B;MRTFB;SGCZ;SPEG;TBX18;TBX1;TMEM204;MEF2C;HEY2;GATA6;MEGF10;MYOCD;NINJ1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4684924769851491,1.3431563406687048,0.07210401891252956,0.8076664815985467,1.0,22/122,13.69%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;SORBS1;KLF4;FGF2;IRS1;TLR4;BCAR3;STN1;LARP4B;GLI2;NFKB1;IL33;ERBB2;EIF3E;EIF6;MTOR;PRKDC;DYRK2
prerank,neuron differentiation (GO:0030182),0.455221495540608,1.3430879956033743,0.05493273542600897,0.8060672432973692,1.0,25/165,9.20%,VSX1;PBX3;MET;WNT9A;LRP6;PBX1;WNK1;WNT11;INHBA;FZD7;TGFBR1;ACSL3;NR4A2;ITM2C;WNT16;THOC2;PITX3;PHOX2A;LHX2;ID2;FZD1;PITX2;ATOH8;GLI2;CTF1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5149922707538819,-1.3423763293305477,0.1343669250645995,0.5384137757879026,1.0,4/17,5.41%,PPARA;PRKAG2;PPARD;PRKAA2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4803842352574557,1.3422853817021776,0.07496977025392987,0.807343786662437,1.0,26/95,13.41%,THBS1;HTRA3;CD109;SMAD6;SKIL;GIPC1;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;CREBBP;SKI;BAMBI;IL17RD;TGFB1I1;LTBP4;DKK3;LDLRAD4;BCL9L;SMAD2;RNF111;NKX2-1;PPM1A;SMURF1;EP300
prerank,cytosolic transport (GO:0016482),0.4688662659112861,1.341287309084736,0.09918319719953325,0.8093382637912132,1.0,50/108,25.05%,VPS13A;VPS13C;ERC1;EEA1;RAB6A;SNX2;STX5;BECN1;GAK;EHD3;ANKRD27;DOP1B;VPS54;GBF1;RGP1;RNF126;AP2A1;STX8;SNX32;KIF16B;VTI1A;WDR81;TBC1D10A;TBC1D5;MON2;HOOK3;TMEM87A;BET1L;TMEM87B;TBC1D17;SNF8;RBSN;WASHC1;AP4M1;VPS52;CLN3;RAB5A;VPS51;EMP2;HOOK2;VPS53;UBE2O;CORO7;PHETA2;TBC1D23;SYS1;ARL1;VPS29;SPAG9;RAB7A
prerank,regulation of microtubule-based movement (GO:0060632),-0.5915621012679562,-1.3412368373531205,0.14108910891089108,0.5392371677214288,1.0,6/11,28.08%,MAP2;LAMP1;NEFH;HAP1;CFAP298;DYNLT2B
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5229393669897122,1.3412127112703442,0.11989100817438691,0.8077698385066651,1.0,2/48,0.11%,SLIT3;SLIT2
prerank,negative regulation of lipid storage (GO:0010888),-0.49448508874380603,-1.3411702788978483,0.10857142857142857,0.5371137646239557,1.0,6/19,7.19%,OSBPL8;PPARA;NR1H3;ABCA1;PPARD;ABCG1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5249261142139372,-1.340937798109926,0.13783783783783785,0.5354003002291873,1.0,5/15,6.24%,PPARA;LPGAT1;NR1H3;PPARD;PPARGC1A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.43169315630712135,-1.3406597863645626,0.08214285714285714,0.5339588931627679,1.0,18/38,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB11;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5116042509382039,-1.3405330033801355,0.1132596685082873,0.5321138903578099,1.0,7/18,12.58%,FLT1;COL4A3;AKT3;MEF2C;ITGA4;MDK;PLCG1
prerank,negative regulation of protein catabolic process (GO:0042177),0.5369342415318332,1.3402633948741391,0.12926136363636365,0.8096314229641874,1.0,14/40,16.62%,EGFR;PTPN3;NELL1;TIMP2;IL10;RGP1;MDM4;IRAK3;TIMP1;SNX12;SNRNP70;AZIN1;HMGCR;MAD2L1
prerank,Golgi to endosome transport (GO:0006895),0.6189071891358694,1.340146726194543,0.15548281505728315,0.8082273699997164,1.0,6/16,11.13%,VPS13A;VPS13C;DOP1B;GBF1;AP2A1;KIF16B
prerank,negative regulation of cell differentiation (GO:0045596),0.4511658203624179,1.3390581578251752,0.06080347448425624,0.8108037401525551,1.0,32/181,9.09%,EGFR;BMP4;CRIM1;ZFPM2;WNT9A;SOX9;BMP5;COL5A2;PTK2B;SMAD6;ZBTB16;HES1;TWIST2;TGFBR1;SPRED2;EFEMP1;PDCD4;TRPM4;TSKU;NOG;SKI;TRIO;ITGAV;BAMBI;PTHLH;IL17RD;JAG1;GDF5;ID2;RORA;CHRD;GDF10
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.6653833774854138,1.338995195807956,0.16842105263157894,0.8092344622446821,1.0,8/11,27.10%,UBN1;CABIN1;HIRA;ATRX;IPO4;RBBP4;NASP;HAT1
prerank,regulation of osteoblast differentiation (GO:0045667),0.48745715649123156,1.33882160448741,0.10918114143920596,0.8081170393225859,1.0,16/82,6.21%,BMP4;CRIM1;SOX9;DDX5;CCN1;DDR2;SMAD6;SMOC1;TWIST2;BMP6;BMPR1A;NELL1;TRPM4;NOG;SKI;BAMBI
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.502386092302443,-1.3386408793532916,0.12103746397694524,0.5349120468862145,1.0,9/17,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME;ATP5MC3
prerank,lipid phosphorylation (GO:0046834),-0.6024718907740862,-1.3375292816933304,0.17136150234741784,0.5356176799432041,1.0,6/10,19.64%,DGKB;DGKI;DGKD;DGKG;DGKE;DGKZ
prerank,endocardial cushion morphogenesis (GO:0003203),0.6103554781981088,1.337022536932853,0.16139240506329114,0.8134486352182418,1.0,8/18,9.96%,BMP4;SOX9;BMPR1A;TGFBR2;NOG;ISL1;MDM4;ACVR1
prerank,protein localization to nucleus (GO:0034504),0.47218636142304016,1.3367566789729062,0.08343265792610251,0.8126926332387608,1.0,30/102,20.34%,BMP4;SIX1;PRICKLE1;NUP93;LMNA;STAT3;IPO7;TOR1AIP1;E2F3;SIX4;TNPO2;WRN;CNEP1R1;MORC3;TBRG1;SEC13;NUP153;PML;NUP214;ZBTB7A;XPA;TOR1B;NUP188;NUP88;ABCA7;NUTF2;RAN;TNPO3;DVL1;HEATR3
prerank,in utero embryonic development (GO:0001701),0.5731646470674602,1.3367446552562352,0.15844544095665172,0.8109332314941595,1.0,5/25,4.10%,MBNL1;PKD1;FUT8;TGFB3;TGFBR1
prerank,cardiac conduction system development (GO:0003161),0.5690132775953388,1.3366506649571843,0.13963963963963963,0.8094925748555198,1.0,5/24,6.17%,BMP4;BMPR1A;CACNA1G;NOTCH2;GATA4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.45439496013606545,-1.3361529456820895,0.10457516339869281,0.5371922762196552,1.0,15/32,26.77%,CEMIP;TRPC3;AKAP6;SNCA;GRIN1;P2RX7;PLCG1;TRPC1;APLNR;CX3CL1;GPER1;F2R;P2RX3;RAMP3;CASQ1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4864095925550561,1.3354193671171846,0.09987819732034105,0.8126091870889589,1.0,24/87,11.05%,SMAD9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;TGFBR1;ITGB5;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;JUN;SMAD2
prerank,autonomic nervous system development (GO:0048483),0.6198553978620565,1.3353981732626778,0.16693679092382496,0.8109079189490997,1.0,5/17,9.78%,FN1;NRP1;GDNF;PHOX2A;NF1
prerank,regulation of chromatin organization (GO:1902275),0.6274691690966643,1.3351566953958798,0.15932203389830507,0.8100668703058486,1.0,5/14,17.39%,MLLT3;TLK1;SETD5;TLK2;ALKBH4
prerank,embryonic limb morphogenesis (GO:0030326),0.5464330020480136,1.3349469029294572,0.15373352855051245,0.8091283789920125,1.0,14/34,15.71%,MBNL1;LRP6;CACNA1C;GLI3;AFF3;NOG;CREBBP;SKI;RARG;MEGF8;NIPBL;ECE1;TWIST1;TFAP2A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.58120590848007,1.33488991686067,0.15207373271889402,0.8076067033134944,1.0,12/25,24.65%,RNF185;VCP;ZYG11B;YME1L1;CLPP;OMA1;CUL3;UFD1;UBE2W;UGGT2;FBXL17;POMT2
prerank,cation transmembrane transport (GO:0098655),-0.4110132240420764,-1.334692742348687,0.08270676691729323,0.5388340486501503,1.0,6/44,5.81%,ATP1A2;TRPM3;SLC6A9;ABCC9;SLC7A5;SLC38A5
prerank,engulfment of apoptotic cell (GO:0043652),0.628212369926258,1.3342215284348322,0.1617161716171617,0.8083740986240844,1.0,2/15,3.26%,THBS1;RHOBTB1
prerank,mesenchymal cell development (GO:0014031),-0.49912310794924425,-1.3339453432308779,0.1401098901098901,0.5388297696367758,1.0,4/18,7.41%,CDH2;NOTCH1;TAPT1;HEY2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.49503974994096844,1.333785392153812,0.10947109471094711,0.8083226617569865,1.0,13/67,10.17%,DOCK5;VIT;PTK2B;FN1;GSK3B;ABL1;NRP1;DMTN;AGR2;JUP;S100A10;LIMS1;LIMS2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.49713565645053487,-1.3333133426858155,0.12928759894459102,0.5382987628102293,1.0,8/19,22.96%,IGF1;IL18;SPHK1;CD200;NUPR1;PTGS2;TREM2;MMP3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.49624453487217013,1.3331542241379064,0.1122715404699739,0.8091329726828254,1.0,19/65,13.35%,HTRA3;CD109;SMAD6;SKIL;TGFBR1;SPRED2;PMEPA1;TGFBR2;HTRA4;SKI;BAMBI;IL17RD;TGFB1I1;LDLRAD4;BCL9L;SMAD2;NKX2-1;PPM1A;SMURF1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6701018186794763,1.3330470305520683,0.19148936170212766,0.8077542620698519,1.0,6/10,22.63%,NFE2L2;DDIT3;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,ncRNA processing (GO:0034470),-0.32124225912179893,-1.3328517889684646,0.013513513513513514,0.537349405860894,1.0,75/200,23.22%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;LIN28B;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;AGO4;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;RPL8;RPL24;RPL29;TARBP2;RPL10A;DDX10;RPL3;LYAR;RPL12;ADAR;PIH1D1;AGO1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;METTL3;NOLC1;POP7;EMG1;SMAD3;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9;SARS1
prerank,endocrine system development (GO:0035270),0.5934945742751556,1.332500232564186,0.13957055214723926,0.8081515483275675,1.0,9/21,11.99%,SIX1;WNT11;TGFBR1;STRA6;GLI2;NF1;DKK3;FOXE1;NKX2-1
prerank,regulation of glycogen metabolic process (GO:0070873),0.6660676039106501,1.331899018509701,0.16555183946488294,0.8087350307133155,1.0,2/12,3.16%,PPP1R3B;PPP1R3C
prerank,canonical Wnt signaling pathway (GO:0060070),0.5027916928740805,1.331885015970226,0.10817610062893082,0.8070318224509537,1.0,16/68,10.95%,TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;RARG;LRP5;BCL9L
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5272655802662766,1.3312331603961869,0.11885245901639344,0.8078924914335511,1.0,22/45,22.06%,BMP4;PTPN3;GAS1;IL10;CDKN1B;FOXC1;BTG3;NABP1;ANGEL2;CHEK1;BCL6;CHFR;PRCC;MAD2L1;HECA;ZWILCH;TRIM35;ZW10;SCRIB;TOM1L1;WEE1;FZD3
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5996710659652275,1.3311196365338709,0.15248796147672553,0.8065966604803937,1.0,5/20,9.48%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5633144537500101,-1.3308606940462444,0.145679012345679,0.5406889877684279,1.0,5/12,7.19%,PPARA;ABCA5;NR1H3;ABCA1;ABCG1
prerank,negative regulation of cell migration (GO:0030336),0.46040874157781003,1.3299350410217416,0.08032596041909197,0.8093086059740718,1.0,34/137,12.07%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;ARHGDIB;FOXO3;PHLDB2;SULF1;COL3A1;IGFBP5;BMPR1A;FGF2;SRGAP2;SRGAP3;VCL;NOG;ZMYND8;LRP1;SLURP1;JAG1;RAP2C;HAS1;CHRD;NF1;LDLRAD4;TIMP1;DUSP10;ITGB1BP1;NKX2-1;CORO1C
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4623412545980482,-1.3297639288704957,0.11635220125786164,0.5415232568848953,1.0,11/27,14.87%,PRKCH;PPARA;CSF1;ABCA5;NR1H3;ABCA1;ABCG1;IL18;MSR1;LPL;AGT
prerank,regulation of plasminogen activation (GO:0010755),0.658193547206126,1.3296217009555145,0.16695352839931152,0.8087813178126116,1.0,1/12,0.27%,THBS1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6631405790344639,1.3293326047018403,0.1710758377425044,0.8081333801881612,1.0,4/10,17.51%,SMYD2;SETD2;EHMT1;KMT5A
prerank,retinol metabolic process (GO:0042572),0.62566334804358,1.3290161870391517,0.17412935323383086,0.8077090136263337,1.0,2/14,2.10%,CYP1B1;ADH7
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.36130770360668907,-1.3289318698699066,0.047058823529411764,0.541590199411598,1.0,25/91,13.83%,CP;SLC30A10;SLC39A10;FTH1;TFRC;APP;SLC40A1;SLC39A8;FTL;ATOX1;SLC30A1;SLC31A1;MT2A;ABCB7;SLC22A17;BOLA2;ATP6AP1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of cartilage development (GO:0061035),0.610370204829971,1.32882525902601,0.15639810426540285,0.8067301288645139,1.0,5/18,2.37%,BMP4;SOX9;BMP1;WNT11;ZBTB16
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4678908942799651,-1.3280106980819912,0.09850746268656717,0.5417345804892044,1.0,8/26,10.07%,ERRFI1;TGFA;CBLB;APP;SOCS5;ADRA2A;ZFYVE28;HBEGF
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4583794635196394,-1.327927881016357,0.109375,0.5397660469201987,1.0,9/29,14.78%,BCL2;TFRC;MEF2C;VAV3;CD81;CD38;MIF;CD74;CD40
prerank,regulation of collagen biosynthetic process (GO:0032965),0.6031379653793233,1.3279055308906986,0.18035426731078905,0.8085778098310182,1.0,2/19,1.84%,BMP4;TGFB3
prerank,regulation of response to biotic stimulus (GO:0002831),0.5556687273712723,1.3274194160742814,0.15201192250372578,0.8086958808401719,1.0,2/28,1.39%,FOXP1;CD55
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6460738948567337,1.3264744157600852,0.16808149405772496,0.8106486807395702,1.0,3/12,7.15%,CD44;GCNT2;IL10
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6307395660082908,1.3264466417025258,0.1697530864197531,0.8090209787416569,1.0,5/17,5.01%,NTRK3;BAIAP2L1;ABL1;NRP1;BCAS3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.532122488967905,1.3263913483604879,0.14265927977839335,0.8075234855505452,1.0,16/38,22.22%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;SREBF1;CSNK2A2;RNF31;USP36;HUWE1;PARL;ATP5IF1
prerank,activin receptor signaling pathway (GO:0032924),0.6252815883424834,1.3262151627412284,0.14545454545454545,0.8065244812628513,1.0,6/15,11.38%,INHBA;TGFBR1;GDF6;ACVR1;SMAD2;INHBB
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6126825079366601,1.326123313595322,0.17065390749601275,0.8051745283022099,1.0,3/15,5.19%,RSPO3;GPC3;SFRP4
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6619447099964418,1.3252546474294848,0.16695059625212946,0.8068384953514469,1.0,4/12,4.29%,DOCK5;IGFBP5;DOCK7;NR4A3
prerank,myelination in peripheral nervous system (GO:0022011),0.6286592837450744,1.3251940394295563,0.17434210526315788,0.8053909552319435,1.0,5/13,9.90%,SKI;ARHGEF10;PARD3;NF1;ADGRG6
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6050404865440246,1.3251114445631837,0.16045380875202594,0.8039974265643289,1.0,4/19,8.02%,LBP;PRKCE;PIK3AP1;TLR4
prerank,histone deubiquitination (GO:0016578),0.6038995285650557,1.3247846913122687,0.18124006359300476,0.8035728402973658,1.0,11/18,24.66%,TRRAP;USP49;USP15;USP7;KAT2A;UIMC1;USP22;USP21;USP36;BRCC3;USP3
prerank,regulation of bone mineralization (GO:0030500),0.5022623645288331,1.324631385660087,0.14191852825229961,0.8025230475466782,1.0,12/55,4.96%,BMP4;CCN1;PTK2B;TGFB3;DDR2;ANO6;SGMS2;BMP6;BMPR1A;NELL1;TXLNG;TRPM4
prerank,fatty acid oxidation (GO:0019395),0.5079553190372766,1.324550486505407,0.12468193384223919,0.8011767083290583,1.0,9/57,8.75%,ABCD3;EHHADH;BDH2;ADH7;AUH;ECHDC1;DECR1;ACADM;PECR
prerank,positive regulation of cartilage development (GO:0061036),0.6060952598770385,1.3240243877231301,0.1592356687898089,0.8014822431191114,1.0,6/17,7.23%,BMP4;SOX9;BMP1;ZBTB16;GDF6;GDF5
prerank,microglial cell activation (GO:0001774),-0.4797705008974691,-1.3239269510602776,0.12919896640826872,0.5485471308586696,1.0,9/21,23.31%,APP;SNCA;MAPT;GRN;C1QA;TYROBP;CX3CL1;TREM2;CX3CR1
prerank,neuron projection regeneration (GO:0031102),-0.5981915491971301,-1.3238680656711066,0.1386861313868613,0.5464717504037833,1.0,3/10,18.93%,NREP;RTN4RL1;OMG
prerank,regulation of filopodium assembly (GO:0051489),0.5366170418741351,1.3237316942837216,0.15586206896551724,0.8008788482490914,1.0,10/38,6.54%,DPYSL3;ARAP1;TGFB3;PRKCD;PALM;ARHGAP44;NRP1;BCAS3;RHOQ;DMTN
prerank,negative regulation of chemotaxis (GO:0050922),0.5588194037748468,1.3218214119957286,0.14809384164222875,0.8066872376271615,1.0,6/31,4.70%,SLIT2;THBS1;SEMA3E;SEMA3D;SEMA3C;PTPN2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6753688449633016,1.32155291216722,0.19152542372881357,0.806019742046878,1.0,2/10,1.38%,BMP5;LRP6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.6054050626865098,1.3214452954184064,0.16692913385826771,0.8047507924116508,1.0,3/18,3.31%,CCN3;HDAC4;FZD7
prerank,cellular response to hormone stimulus (GO:0032870),0.49565546019515755,1.3206314852063137,0.12483745123537061,0.8061512467010469,1.0,14/69,9.88%,SLIT3;SLIT2;RAMP1;NR4A3;SERPINB9;BCAS3;KLF9;STAT3;RDX;SOCS2;ATP1A3;ATP1A1;GATA1;RARA
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.49713733174353913,-1.3197621051951314,0.1358695652173913,0.5554306070420358,1.0,7/17,6.08%,MAML3;MAML2;NOTCH3;NOTCH1;PLXND1;RBPJ;NOTCH4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.5891478604344658,1.3194995695415104,0.1721958925750395,0.8086384329294328,1.0,3/21,5.19%,BMP4;KLF7;SFRP4
prerank,protein localization to organelle (GO:0033365),0.45845857256221945,1.3186998687132763,0.09027777777777778,0.8099719180801667,1.0,30/133,16.80%,BMP4;SIX1;BBS9;ANK2;CSRP3;CNTLN;ZNF423;LMNA;RAB6A;STX5;GAK;ARL3;TOR1AIP1;GBF1;SIX4;TULP2;WDR35;EHD1;EMD;CNEP1R1;TRAM2;COG3;DDRGK1;FAM83H;DHX9;DCP1A;ZBTB7A;XPA;RPA1;TOR1B
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5967785809213165,1.3185658528261104,0.1621212121212121,0.8087923973663661,1.0,3/20,2.37%,HOXA5;PTK2B;ZBTB16
prerank,negative regulation of telomere maintenance (GO:0032205),0.6215134735891737,1.3182232168214316,0.1702127659574468,0.8084808212381296,1.0,7/15,21.84%,SMG6;TNKS2;ATM;SLX4;NBN;ERCC1;RAD50
prerank,nucleosome assembly (GO:0006334),0.5557310574317255,1.3177748922030748,0.14798206278026907,0.8084985527938421,1.0,15/31,27.51%,SOX9;CHAF1B;KAT6B;UBN1;CABIN1;HIRA;ATRX;NAP1L2;SMARCA5;CHAF1A;IPO4;RBBP4;NASP;HAT1;NAA60
prerank,dendrite self-avoidance (GO:0070593),-0.515125249876402,-1.3176597590629766,0.16272965879265092,0.5588879520428522,1.0,7/16,13.34%,BSG;CNTN4;ROBO4;PALLD;CNTN2;DSCAML1;NEXN
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.615252921384207,1.3175792050214887,0.16611295681063123,0.8076143665060306,1.0,3/15,8.68%,BMP4;SFRP4;FOXC1
prerank,protein import into peroxisome membrane (GO:0045046),0.5933805479224084,1.3167078096440643,0.17214397496087636,0.8093368554038236,1.0,8/22,23.91%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;SLC25A17;PEX2;PEX26
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5213302205189565,-1.3166402874021956,0.16381418092909536,0.5592689922996031,1.0,2/15,1.94%,OSBPL8;PPARA
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5620343571954873,-1.3154769003257505,0.1527777777777778,0.5600081765109702,1.0,4/11,8.73%,NEDD4L;PICALM;GPM6B;ACTN2
prerank,positive regulation of RNA splicing (GO:0033120),0.5577964752107534,1.3149048891173354,0.16379310344827586,0.8144873433891296,1.0,1/29,0.04%,SLC38A2
prerank,epithelial cell-cell adhesion (GO:0090136),0.6571631915368995,1.314876799366874,0.1809872029250457,0.812930949458626,1.0,5/11,7.62%,CCN3;DSP;ITGB5;VCL;JUP
prerank,endocardial cushion development (GO:0003197),0.5869568176412638,1.314559305083077,0.17246835443037975,0.8124115758950783,1.0,8/21,9.96%,BMP4;SOX9;BMPR1A;NOG;ISL1;GATA4;MDM4;ACVR1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.33681104967202424,-1.3144929413910853,0.03546099290780142,0.5605545304931505,1.0,24/121,7.99%,IGF1;IL34;VTN;LYN;IL31RA;PECAM1;ENPP2;KIT;GRM5;NEDD9;TEC;PARP14;ACE;IL6R;ERBB4;EPHA4;TNK2;GHR;GPRC5B;LRP8;CD81;ARL2BP;IL18;GAS6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5794336841567175,1.3143942280981127,0.154434250764526,0.8113757881511302,1.0,6/21,5.99%,EXT1;HS3ST4;SULF1;HS6ST2;GLCE;XYLT1
prerank,protein localization to cell surface (GO:0034394),0.5742584868215991,1.3139759000651654,0.1437125748502994,0.8113331947046449,1.0,9/26,14.72%,ANK2;PTPRU;WNT11;VCL;RIC3;USP4;SMURF1;PIGU;GGA2
prerank,regulation of leukocyte activation (GO:0002694),-0.5299540189677003,-1.3139159661882764,0.15023474178403756,0.5599141696447136,1.0,6/14,13.57%,LYN;MFHAS1;CD200;MIF;MYO18A;CD74
prerank,regulation of interleukin-4 production (GO:0032673),-0.48072521605772495,-1.3138903464826737,0.1400560224089636,0.5578082076771346,1.0,4/21,7.50%,LEF1;SLC7A5;PRKCQ;PRKCZ
prerank,positive regulation of vasculature development (GO:1904018),0.4665195761754463,1.3135485643211147,0.10059880239520957,0.8113469961216929,1.0,14/94,6.17%,SMOC2;F3;THBS1;ITGB8;PGF;CYP1B1;ANXA3;PTGIS;HIPK1;ITGB1;FGF2;ADAM12;ISL1;GATA4
prerank,T-helper cell differentiation (GO:0042093),0.6401611571025452,1.3128901464546228,0.19141914191419143,0.8122003310207198,1.0,1/14,0.25%,FOXP1
prerank,base-excision repair (GO:0006284),0.5149969255195002,1.3127792691169207,0.14605263157894738,0.8110280697084526,1.0,19/48,25.16%,MPG;APEX2;SMUG1;ERCC5;WRN;APEX1;USP47;PRMT6;POLB;XPA;RPA1;NEIL3;RFC1;TDG;HUWE1;POLD3;MBD4;RFC5;POLQ
prerank,regulation of axon guidance (GO:1902667),0.6603075208256222,1.3123244084132444,0.18384879725085912,0.8109451124996581,1.0,3/10,10.33%,NRP1;MYCBP2;VEGFA
prerank,renal system development (GO:0072001),0.5113869801287524,1.312050056254443,0.13667117726657646,0.8103129908095505,1.0,12/52,10.33%,BMP4;SIX1;PCSK5;PKD1;SULF1;TGFBR1;STRA6;AGTR1;ARL3;FOXC1;GLI2;VEGFA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6191293630248352,1.3120181465454832,0.1669449081803005,0.8088071754395938,1.0,6/15,15.71%,SIX1;TGFBR1;TGFBR2;NIPBL;TWIST1;TFAP2A
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.646155320857154,1.3118554521501566,0.18274111675126903,0.807807325797929,1.0,3/12,8.02%,SOX9;MUC6;TLR4
prerank,regulation of cell morphogenesis (GO:0022604),0.5569062703081767,1.3113194007732578,0.15527065527065528,0.8082488850659274,1.0,9/30,12.98%,FMNL2;EFNA5;CD44;MOV10;MYO9A;BCL9L;ZMYM4;SH3D19;ZRANB1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3724286215945848,-1.311049103839275,0.05803571428571429,0.5632776108709988,1.0,15/66,7.12%,ROBO1;FLT1;IL34;SASH1;PDGFD;PDGFRB;KIT;PAK1;TPD52L1;DAB2IP;FGF1;PIK3R6;RPS3;ADRA2A;TNFRSF11A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.47593208469919907,1.3107100915415886,0.10585305105853052,0.8088751981194525,1.0,16/86,9.81%,PLCE1;ARHGEF28;NGF;AKAP13;ARHGDIB;STK19;SHC1;ARHGAP44;NOTCH2;BCR;SHOC2;RDX;ARHGAP17;KANK2;STARD13;ERBIN
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5564480224766792,1.3106243784931009,0.15606936416184972,0.8076234104151208,1.0,5/28,9.33%,EGFR;TCIM;WWP2;MMP14;NIBAN2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5748739547256452,1.3102294729394657,0.1589895988112927,0.8075870844662537,1.0,4/26,6.52%,SMOC2;HES1;USP2;CDC25B
prerank,respiratory tube development (GO:0030323),0.5607385542195958,1.3101919382375353,0.15813953488372093,0.8061369725703236,1.0,8/28,11.99%,BMP4;PCSK5;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5026609757140464,-1.3089745159709505,0.1348314606741573,0.5668171215593188,1.0,10/20,30.70%,RPS6KA5;PRKAA2;PPARGC1A;ARRB1;MAPK3;RUVBL2;RPS6KA4;NOS1;DIP2A;SOX4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5715819271272524,1.3088916124619525,0.17027863777089783,0.8096315943413089,1.0,3/22,4.70%,EZR;UBASH3A;PTPN2
prerank,clathrin coat assembly (GO:0048268),-0.5140228056347226,-1.308587661726812,0.17438692098092642,0.5656721455219933,1.0,7/15,15.26%,SGIP1;PICALM;PIK3C2A;HIP1R;HIP1;NSG1;EPS15
prerank,cAMP metabolic process (GO:0046058),-0.5358533768141421,-1.3085703796154247,0.15827338129496402,0.5635552696027218,1.0,6/13,15.24%,ADCY5;ADCY1;ADCY7;PDE4D;ADCY2;ADCY4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4975799944982854,1.3072764306856828,0.12975098296199214,0.8140866443861746,1.0,7/63,6.64%,THBS1;BMP4;TCF7L2;FGFR1;TGFBR1;ITGAV;BIRC6
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6273005048310001,1.3065204874840692,0.18302828618968386,0.8154517243673982,1.0,4/14,8.84%,PKD1;MDFI;IL10;G3BP2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.43686571020109555,-1.3062812013209983,0.12345679012345678,0.5675855740872134,1.0,14/33,19.06%,IGF1;IGF1R;PIK3R1;PIK3C2A;MYO16;NYAP2;EDN1;HTR2A;PIK3R5;TYRO3;AKT1;ERBB3;PIK3CG;TPTE
prerank,response to interferon-gamma (GO:0034341),-0.3803314072500827,-1.3062254855393287,0.07906976744186046,0.565582133622319,1.0,24/67,19.67%,WNT5A;CD47;GBP7;GBP4;SIRPA;IFITM1;BST2;SNCA;GAPDH;IFITM3;AQP4;RPL13A;STAT1;CCL19;CD74;TRIM21;CD40;GBP3;SP100;GCH1;CASP1;GBP5;CX3CL1;CCL2
prerank,regulation of platelet activation (GO:0010543),-0.4755895966504663,-1.3061100753757628,0.15076923076923077,0.5637397655056693,1.0,7/21,9.40%,LYN;APOE;NOS3;TEC;PRKCQ;PDGFRA;PLEK
prerank,DNA double-strand break processing (GO:0000729),0.5962286239104835,1.3060391648348084,0.1768595041322314,0.8156491340700666,1.0,11/18,24.83%,RNF138;ATM;RAD52;SLX4;RBBP8;BARD1;NBN;UBE2N;EXD2;RAD50;KAT5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4942440061354068,1.3054973716499745,0.1543450064850843,0.8161746350729905,1.0,14/55,16.23%,THBS1;CYP1B1;PID1;COQ7;AGTR1;TGFBR2;ARF4;AATF;EIF6;ZC3H12A;PDK3;TFAP2A;ACOD1;XDH
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5504983788447521,1.3054147242022163,0.14285714285714285,0.8149341598254604,1.0,10/33,18.45%,PKD1;TCIM;ATP2B4;ID2;CDKN1B;PLCG2;DDRGK1;TRIM39;CDKN1A;INO80
prerank,regulation of calcium ion import (GO:0090279),-0.480053646561447,-1.3051024101436908,0.142433234421365,0.5643692588089899,1.0,8/21,21.23%,PDGFRB;CXCL12;SLC30A1;PLPP4;STC1;CCL2;SPHK2;TRIM27
prerank,response to sterol (GO:0036314),0.651786135298805,1.305078172227168,0.19217081850533807,0.8146631594655076,1.0,5/11,11.05%,TGFBR1;TGFBR2;RORA;CCL3;SMAD2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5423475672232903,1.3047286228733124,0.1673881673881674,0.8143470732506273,1.0,11/31,10.84%,CRIM1;SOX9;SMAD6;TWIST2;TRPM4;NOG;SKI;BAMBI;CHRD;GDF10;LRP5
prerank,nitrogen compound transport (GO:0071705),0.4505735159083336,1.304462927600698,0.09427609427609428,0.8138220013261239,1.0,7/141,2.41%,SLC38A2;SLC23A1;SLC38A1;SLC12A2;RAMP1;LRRC8D;ABCG2
prerank,negative regulation of wound healing (GO:0061045),0.562072141062931,1.3044453603532915,0.17040358744394618,0.8123458563822101,1.0,5/28,3.29%,SLC12A2;CD109;PHLDB2;THBD;FGF2
prerank,carnitine shuttle (GO:0006853),-0.5659662498376372,-1.3041091611492097,0.1848341232227488,0.5649250564404198,1.0,3/11,5.41%,PRKAG2;ACACB;PRKAA2
prerank,artery morphogenesis (GO:0048844),0.5463377632063416,1.3040317063193634,0.15743440233236153,0.8123810576250943,1.0,11/30,10.33%,BMP4;HES1;BMPR1A;NRP1;TGFBR1;STRA6;NOG;LRP1;JAG1;NF1;VEGFA
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5864980757668692,1.3039101380821112,0.16666666666666666,0.811307451205807,1.0,3/20,6.43%,ST3GAL4;FUT8;B4GALT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6210805440138191,1.303655571775165,0.205,0.8106829616234346,1.0,1/14,0.57%,CARD14
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6259674084374082,1.3035523335449286,0.20195439739413681,0.8095175664201633,1.0,3/14,6.63%,NT5E;NT5C1A;UPP2
prerank,"phagocytosis, engulfment (GO:0006911)",0.5310869152451255,1.303417649019651,0.15781710914454278,0.8084872359172488,1.0,4/36,3.26%,THBS1;GULP1;GSN;RHOBTB1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4649132820300071,1.3028118252379808,0.11510791366906475,0.8092188209647835,1.0,19/95,8.42%,ST3GAL4;GPC6;EXT1;UST;DSE;GPC3;HS3ST1;B3GNT2;HS6ST2;CHST13;GLCE;HEXA;CHST5;GCNT2;SLC10A7;XYLT1;B4GALT1;GPC4;HAS1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5729260156979222,1.3021399961437143,0.17111459968602827,0.8101763200529064,1.0,10/22,23.33%,NEDD4;RNF115;RNF126;VPS37A;MVB12B;VPS37B;TSG101;SNF8;TOM1L1;UBAP1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.49724797769258516,-1.302113497150127,0.14945652173913043,0.5682118808058233,1.0,6/16,7.89%,RANBP3L;PLCB1;IGFBP3;RIPOR2;MEF2C;BTG1
prerank,regulation of heart contraction (GO:0008016),-0.36057304280530517,-1.3018298444492016,0.06358381502890173,0.5669451426194947,1.0,23/90,13.73%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;CALM1;RYR2;ATP1B2;DMPK;PDE4D;ATP2B1;DES;FXYD6;KCNQ1;ACE2;ATP2A2;KCNJ12;CELF2;CASQ2;GSK3A;CALM3;TRPC1
prerank,detection of calcium ion (GO:0005513),0.6316616827824119,1.3013892457486906,0.1915966386554622,0.8114351903264228,1.0,3/13,6.34%,KCNMB3;KCNMB2;CASR
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.47683018242174063,1.3013886678005044,0.13070283600493218,0.809898381253835,1.0,18/87,17.70%,FBXL7;FHL1;KLF4;FAM107A;PSMB2;DLG1;KANK2;AURKA;DACT1;PSMC6;RB1;USP47;PSMD11;PSMD1;CUL1;PSMC1;PSMD7;CDKN1A
prerank,cGMP biosynthetic process (GO:0006182),0.6820618679586754,1.301233207735341,0.19250425894378195,0.8090005704100691,1.0,1/10,0.24%,GUCY2C
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.46658167457715416,-1.3009182432790454,0.15088757396449703,0.5674477067565237,1.0,14/23,34.83%,ELOVL6;ALOX12;ACOT7;LTA4H;ACSBG1;GPX4;PTGS2;GSTM1;CYP2E1;ASAH2;GSTM2;CYP1A1;LTC4S;GSTP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6474986297644072,1.3008655498485246,0.1835334476843911,0.8088301026962681,1.0,2/12,4.38%,SOAT1;ACSL3
prerank,protein targeting to peroxisome (GO:0006625),0.5663778674005455,1.3007712901583985,0.1865671641791045,0.8076330249419738,1.0,12/29,23.91%,ABCD3;PXMP2;ACBD5;LONP2;HACL1;PEX13;ZFAND6;ABCD1;SLC25A17;PEX2;PEX7;PEX26
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4201199406560775,-1.3007710913815294,0.10437710437710437,0.5657785675661889,1.0,14/41,14.66%,ITPR1;SLC24A2;GRIN2A;SLC8A1;RYR2;GRIN2B;CACNA2D1;HTR2C;GRIN1;HTR2A;TRPV2;ERO1A;CCL19;TRPV4
prerank,positive regulation of histone acetylation (GO:0035066),-0.4672640852422295,-1.299576525881067,0.12876712328767123,0.5670536459883797,1.0,11/23,28.85%,RPS6KA5;PPARGC1A;ARRB1;MAPK3;PIH1D1;RUVBL2;SPHK2;MUC1;RPS6KA4;NOS1;WBP2
prerank,sodium-independent organic anion transport (GO:0043252),0.6588365680498516,1.2989270778974509,0.2048611111111111,0.8129081578793451,1.0,3/10,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.44206769383994043,1.2976846058124882,0.09875141884222474,0.8157509246461669,1.0,17/150,5.80%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;FGFR1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;STRN;TGFBR1;CD80;GCNT2;ESR1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4381732389034789,1.2975746487151216,0.09613259668508287,0.8146350007680722,1.0,34/144,13.98%,CDH1;TCF7L2;ABLIM3;PRKCD;KCNB1;NPEPPS;ZIC1;GSK3B;BCAS3;HPS4;UBR5;MAVS;PCM1;JUP;PLK3;SEC16A;SAE1;UBE2D3;HSPA1L;C2CD5;EMD;CEP131;ERBB2;MIEF1;ITGB1BP1;TMEM30B;PPP3CC;CHP1;ZC3H12A;ZDHHC2;ARIH2;SH3GLB1;BAG3;BAP1
prerank,regulation of microtubule-based process (GO:0032886),0.5228128677168928,1.29750152441134,0.16258992805755396,0.8133933791672079,1.0,9/36,11.10%,EFNA5;PHLDB2;GSK3B;FAM107A;DIAPH1;MARK2;MEMO1;AURKA;ERBB2
prerank,peptidyl-serine modification (GO:0018209),0.4392667001103169,1.2968910697246034,0.07856341189674523,0.8140659718971979,1.0,42/166,13.69%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;GALNT13;TGFBR1;MKNK2;TGFBR2;SGK3;VRK3;POGLUT3;MARK2;IKBKE;CSNK1A1;CSNK1G3;CHUK;AURKA;MARK3;ATM;TOP1;MBOAT4;CAB39;MAPK12;CLSPN;MORC3;MAST2;PDK3;MTOR;CSNK1G1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;DYRK2
prerank,regulation of actin nucleation (GO:0051125),0.6263689712428345,1.296356704038956,0.20521739130434782,0.8145738446989355,1.0,5/12,18.07%,GSN;WASHC5;ARFIP1;ARFIP2;WHAMM
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.46085700213292896,-1.2948626406135508,0.13595166163141995,0.5775046495607904,1.0,14/25,28.65%,TNFSF10;PDCD5;BMF;BIK;GPER1;DNM1L;PLAUR;PMAIP1;PYCARD;MFF;MLLT11;PINK1;HRK;BCL2L11
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5949811847520756,1.2945095439343706,0.21639344262295082,0.8198871158212211,1.0,3/16,4.28%,THBS1;FGF2;AGTR1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.43963922932942406,1.293894395966002,0.08641975308641975,0.8206555071836384,1.0,40/153,13.69%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;TGFBR1;MKNK2;TGFBR2;SGK3;VRK3;MARK2;IKBKE;CSNK1A1;CSNK1G3;NLK;CHUK;AURKA;MARK3;ATM;TOP1;CAB39;MAPK12;CLSPN;MORC3;MAST2;PDK3;MTOR;CSNK1G1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;DYRK2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5510770451166593,-1.293612549027929,0.19791666666666666,0.5787578730638777,1.0,2/11,1.40%,LYN;MFHAS1
prerank,regulation of cell cycle (GO:0051726),0.4262840059167206,1.2932443051526201,0.057651991614255764,0.8215170727314987,1.0,66/271,19.23%,THBS1;BMP4;TCF7L2;PLAGL1;GRK5;PKD1;SOX9;LRP6;INHBA;NOTCH2;NEK7;TTC28;ABL1;TGFBR1;PDCD4;SON;TXLNG;GADD45G;STAT3;GBF1;MYOG;BIRC7;ID2;IRF1;CDKN1B;CDC14A;IQGAP1;RARA;PIM2;ATM;JUN;MAPK12;FBXL6;TBRG1;RB1;CDKN3;NR4A1;CHEK1;EP300;HCFC1;TMEM8B;BAP1;CCND1;TGM1;CDK11B;PUM1;ADAM10;PML;KAT2B;PRCC;ANKRD17;UHRF2;BARD1;NBN;SMIM22;WDR12;CDKN1A;GAS2L1;CDK10;WHAMM;PER2;CSNK2A2;CSNK2A1;BIRC3;NEK6;FBXL8
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5680271888925063,1.2930732388541215,0.17391304347826086,0.8206771224445226,1.0,17/27,28.31%,KAT6B;CREBBP;TRRAP;ATAT1;SGF29;CPA4;KAT2A;EP300;KAT2B;BRD8;PHF20;PHF20L1;KAT5;NAA50;KAT6A;MORF4L2;TAF6L
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5553216277958298,1.292860654653864,0.17921686746987953,0.8199952501391216,1.0,6/27,9.99%,SMOC2;FGF2;SMG6;PDGFA;NIBAN2;ATM
prerank,defense response to virus (GO:0051607),-0.34596856785486696,-1.2918414818436614,0.05555555555555555,0.5815021923031396,1.0,24/100,12.65%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;ZDHHC1;IFNAR2;IFITM3;OAS2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;TLR7;RNASEL;STAT1;TLR3
prerank,positive regulation of binding (GO:0051099),0.47120167595750917,1.291760797290301,0.12195121951219512,0.8225243392791026,1.0,20/84,12.28%,BMP4;TCF7L2;MET;PKD1;NGF;HES1;GSK3B;SKI;LRP1;BAMBI;RIPK2;IDE;FOXC1;DACT1;RARA;MARK3;DDX11;TIAM1;ADD1;USP33
prerank,embryonic appendage morphogenesis (GO:0035113),0.6336249468201003,1.2911159043210334,0.18864774624373956,0.8233742281520655,1.0,3/12,5.66%,MBNL1;LRP6;SKI
prerank,positive regulation of ossification (GO:0045778),0.5212919294817505,1.290536389826874,0.16899441340782123,0.8240897061242977,1.0,8/39,3.97%,BMP4;CCN1;TGFB3;ZBTB16;ANO6;BMP6;BMPR1A;NELL1
prerank,protein modification by small protein removal (GO:0070646),0.427560748508144,1.2903726770000785,0.06050955414012739,0.8231406773088644,1.0,96/252,24.95%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;PSMB2;TRRAP;MDM4;USP34;USP49;RHOA;USP15;IL33;USP25;RAD23B;USP1;PSMC6;USP10;USP32;DESI1;DESI2;CLSPN;COPS7B;USP7;SMAD2;OTUD7B;USP47;COPS5;FOXK2;USP4;USP33;KAT2A;ZC3H12A;UIMC1;IFIH1;ZRANB1;JOSD1;EP300;HCFC1;PSMD11;BAP1;SENP5;POLB;TNIP1;PSMD1;OTUD3;OTUD5;KAT2B;IKBKG;VCPIP1;YY1;PSMC1;PSMD7;USP28;BARD1;INO80;WDR48;USP22;USP9X;BIRC3;UFD1;USP40;TRAF3;PSMD14;RNF123;SENP3;PSMD3;SENP1;USP21;USP36;SMAD4;GATA3;HGS;USP48;RHOT1;ASXL2;BRCC3;STAMBP;CDC20;SMAD7;TOMM20;ADRM1;MCRS1;USP3;COPS3;PSMD12;MAP3K7
prerank,positive regulation of glucose import (GO:0046326),-0.4767168669790892,-1.289955458891516,0.15846994535519127,0.5845068953983132,1.0,5/21,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,regulation of gene expression (GO:0010468),0.41346688228380274,1.2893104037279637,0.0,0.8256644801322883,1.0,193/903,16.23%,SLC38A2;BNC2;F3;FOXP1;BMP4;CDH1;VSX1;TCF7L1;ZFHX3;AHNAK2;SLC24A3;SIX1;PRRX2;MBNL1;NTRK3;SOX9;FOXD1;HDAC4;HOXA5;PRDM6;NGF;FOXN3;ITGB8;ANK2;ATP1B1;EZR;SMO;AHNAK;PID1;FN1;WNT11;NFIA;AFF3;GSN;KRAS;WWP2;YBX3;USP13;COQ7;CLK1;ESR2;KLF4;JMJD1C;BMP6;NFE2L2;BMPR1A;INHBA;ZNF148;GSK3B;FGF2;NOTCH2;FZD7;ZNF423;ERC1;ABL1;NELL1;TGFBR1;EFEMP1;SERPINB9;CLK2;SON;ZFP64;KAT6B;ZBTB7B;ATP2B4;SFRP4;TSKU;GCNT2;BHLHE40;NOG;CREBBP;WNT16;ZC3H7A;HMG20A;ESR1;STAT3;UBR5;GDNF;C1D;GATA4;DDIT3;CLU;PTHLH;TADA3;NFIL3;TRIM44;PLSCR1;TOB2;AGR2;TRRAP;AFF4;HNRNPH1;IL10;PITX3;PKP1;CELF1;SOX14;MOV10;RDX;ID2;MBNL2;TNRC6C;REL;CRABP2;CHEK2;FUS;TLR4;IGSF1;NLK;ATOH8;FOXC1;NFYA;RORA;CD46;SERTAD3;PHF12;NFKB1;AURKA;TOB1;IL33;CTCFL;PCBP4;PLCG2;ATF7;ATM;LIMS1;VEGFA;BRCA2;TRIM26;SMCR8;CCL3;GON4L;PER1;MEGF8;GTF2IRD1;RB1;NFKB2;FOXK2;RBMS3;MTA1;FGF22;MYD88;SNX12;NKX2-1;TCF19;ZC3H12A;DDRGK1;SNRNP70;CTR9;ATRX;KMT2D;MTOR;PIK3R3;TCF3;PAX6;EP300;CHD3;PUM2;HCFC1;ANXA7;TDRD7;SP3;GPBP1;GCFC2;HDAC10;REST;ZNF507;GPBP1L1;CNOT7;CDK11B;CREB3L1;ATF2;TRIM39;HOXD3;BAZ2A;PCGF1;PUM1;TWIST1;MAP2K2;ADAM10;HINFP;CLK4;PML;TFAP2A;ZNF462;WWTR1;ZNF219;AGO2;CPNE1;BCL6;CREBL2;CALCOCO1;XDH
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3688460551872078,-1.288951614913458,0.058823529411764705,0.5851727238902131,1.0,15/72,10.09%,SHANK3;ADCY1;NRXN1;SLC24A2;RIMS1;GRIK2;GRIN2A;RIMS2;APP;GRIN2B;CACNG4;PRKCZ;CACNG7;SYT1;LGMN
prerank,extracellular matrix disassembly (GO:0022617),0.5004644683540809,1.2882012850611386,0.1584553928095872,0.828220704060116,1.0,12/53,11.24%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,cellular response to heat (GO:0034605),0.5304536679309354,1.2877759504254964,0.1685878962536023,0.8282629083147015,1.0,4/35,8.52%,THBS1;TCIM;VCP;CLPB
prerank,muscle organ development (GO:0007517),0.48560737143132937,1.2865519054573458,0.16046213093709885,0.8311765530513405,1.0,13/54,11.28%,FHL1;MKX;SGCD;MRAS;LARGE1;COL6A3;MEF2A;DMD;COPRS;CTF1;EMD;MAPK12;EVC
prerank,regulation of protein kinase activity (GO:0045859),0.45134192784852073,1.285490177571209,0.11435239206534423,0.8335413518521256,1.0,19/106,14.11%,PLCE1;RASSF2;LRP6;CCN1;PTK2B;DDR2;UBASH3B;RAP1A;RAP2C;IQGAP1;NF1;SMCR8;RB1;CEP85;ITGB1BP1;CHP1;PAK2;XRCC5;MRNIP
prerank,cellular response to interleukin-2 (GO:0071352),0.6330939757754839,1.2852408745374453,0.20379965457685664,0.8315112454260283,1.0,2/11,2.97%,PTK2B;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6330939757754839,1.2852408745374453,0.20379965457685664,0.8315112454260283,1.0,2/11,2.97%,PTK2B;SHC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.6177599110095335,1.2840689820629894,0.17781690140845072,0.8344054770784999,1.0,3/14,6.55%,FOXO3;EARS2;FASTKD1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5723062436054389,1.283670637589989,0.21371610845295055,0.834309023414453,1.0,1/21,0.33%,FZR1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4146203278765839,-1.2833306206973398,0.125,0.5986765045053001,1.0,11/39,7.28%,ROBO1;EPN2;MAML3;MAML2;NOS3;ROBO2;TSPAN5;NOTCH1;RBPJ;NOTCH4;JAG2
prerank,positive regulation of gene expression (GO:0010628),0.4164464665043287,1.283293990824547,0.026530612244897958,0.8341942653237069,1.0,81/442,13.52%,SLC38A2;F3;EGFR;THBS1;BMP4;SLC24A3;SAMD4A;NTRK3;SOX9;FOXD1;HOXA5;NGF;ITGB8;ANK2;DDX5;EZR;SMO;PID1;FN1;WNT11;GSN;KRAS;NIBAN1;KLF4;BMP6;NFE2L2;INHBA;GSK3B;FGF2;POLR1G;TGFBR1;SERPINB9;ZBTB7B;SFRP4;NOG;WNT16;STAT3;UBR5;CLU;TADA3;PLSCR1;AGR2;IL10;PKP1;CELF1;MOV10;RDX;ID2;TNRC6C;TLR4;LARP4B;CD46;POLR1A;IL33;CTCFL;PLCG2;HILPDA;ATM;LIMS1;U2AF2;VEGFA;CCL3;ERBB2;EIF3E;TAF1D;TAF1C;RBMS3;FGF22;MYD88;NKX2-1;KAT2A;EIF6;ZC3H12A;DDRGK1;MTOR;PIK3R3;PRKDC;PAX6;EP300;POLR1F;HCFC1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4343641015516665,-1.2828650699670858,0.13753581661891118,0.5978905880391002,1.0,6/29,9.22%,ENG;TGFBR3;NOTCH1;BMP2;S1PR1;PROX1
prerank,mitochondrion localization (GO:0051646),0.5868550237661937,1.2827400780986458,0.19129082426127528,0.8347240985234468,1.0,4/19,7.72%,MARK1;MEF2A;TLE6;MARK2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6340165880518527,1.2824347408450056,0.22942206654991243,0.8344268794811933,1.0,4/11,17.02%,DDIT3;ATF6;CREB3L1;CREB3L3
prerank,cellular component disassembly (GO:0022411),0.4983048114331528,1.28194393666029,0.1711229946524064,0.8347725983113974,1.0,12/53,11.24%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,regulation of protein binding (GO:0043393),0.4487218577324779,1.2818404488883908,0.11004784688995216,0.8336485924889514,1.0,25/114,12.54%,BMP4;TCF7L2;PKD1;HDAC4;PRKCD;GSK3B;LRPAP1;KDM1A;LRP1;BAMBI;RIPK2;IDE;SLPI;MARK2;PRMT8;DISC1;AURKA;DACT1;MARK3;DDX11;TIAM1;ITGB1BP1;ADD1;USP33;CARD16
prerank,cellular protein metabolic process (GO:0044267),-0.3015287332412411,-1.2813703912145071,0.0,0.6000176598842145,1.0,103/396,13.32%,CP;IGF1;LTBP1;IGFBP2;IGFBP7;CDH2;SPARCL1;APOE;ST3GAL1;ST3GAL6;ST8SIA4;MSRA;IGFBP3;PAPPA;RPS14;CTSH;CST3;ITIH2;CSF1;IGFBP4;EEF1A1;RPL38;TNC;RPLP1;APP;RPS9;RPL21;LGALS1;RPS13;PLAT;RPL41;VWA1;RPL37A;RPLP2;RPS21;NOTUM;RPL27A;DAB2IP;RPS29;LAMB1;RPS19;RPL34;RPS3;RPS8;RPN2;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;SERPIND1;RPS27;RPL30;RPL37;RPS11;QSOX1;RPS24;RPL19;ADORA2A;RPL18;GATA6;SPP1;RPL18A;GAS6;CHRM3;F5;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;PDIA6;RPL26;RPL35A;MRPL3;RPS18;LGMN;RPL11;RPL13A;RPL7;CSF2RA;RPL36;RPS17;RPL32;APH1B;RPL39;RPL14;SPCS3;MSRB1;HSP90B1;MMP2;ERO1A;FAM20C;RPS2;MFGE8;RPL8;LTA4H;RPL24
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6303389973109049,1.280301527200601,0.1857379767827529,0.8378615592955606,1.0,6/12,10.64%,NFIB;PAFAH1B1;TSKU;MYCBP2;GLI2;EPHB6
prerank,positive regulation of phosphorylation (GO:0042327),0.4220875594111906,1.279039410620082,0.06922257720979766,0.8409597788058129,1.0,22/240,3.98%,SLC4A4;EGFR;THBS1;BMP4;SLCO3A1;CARD14;MET;NTRK3;SOX9;PGF;CCN1;EFNA5;LMO4;DDR2;KRAS;FGFR1;NIBAN1;LIMK2;FGF2;FZD7;ABL1;NRP1
prerank,respiratory electron transport chain (GO:0022904),-0.5133672973684592,-1.2786736434953385,0.17435897435897435,0.6055706325840862,1.0,3/14,6.24%,GPD2;SDHA;PPARGC1A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.35847924115258906,-1.2782837272413912,0.05583756345177665,0.6044224803201654,1.0,13/72,4.05%,FLT1;IGF1;IGF1R;LYN;TEK;PDGFD;PIK3R1;PDGFRB;KIT;DCN;KDR;INSR;ROR2
prerank,chloride transmembrane transport (GO:1902476),0.5057816742634385,1.2781137651300143,0.16981132075471697,0.842766838183151,1.0,7/48,4.00%,SLC12A7;SLC12A2;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.41818327866976024,-1.278073531098474,0.12237762237762238,0.6027943390849262,1.0,9/34,6.10%,FLT1;TEK;PIK3R1;PDGFRB;PRKD1;KIT;DAB2IP;EPHA8;PTK2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5441366481431116,1.2773017257182124,0.18405797101449275,0.8443450089816138,1.0,13/29,15.73%,TCF7L1;TCF7L2;TLE2;CREBBP;TRRAP;BCL9L;SMARCA4;KMT2D;EP300;TLE3;PYGO1;TLE4;PYGO2
prerank,sphingosine metabolic process (GO:0006670),0.5722713297986901,1.2772204990131175,0.20993589743589744,0.8430965403973555,1.0,2/17,2.22%,ACER3;PLPP3
prerank,regulation of actin filament polymerization (GO:0030833),0.4679313803196013,1.2765992114882483,0.15117719950433706,0.8439796504499727,1.0,15/69,13.07%,SLIT2;BAIAP2L1;CDC42EP5;PTK2B;PRKCD;PRKCE;NCK2;WASHC5;KANK4;NCKAP1;CTTN;FCHSD2;ARHGAP40;FCHSD1;SSH3
prerank,protein localization to microtubule organizing center (GO:1905508),0.604816100643682,1.2763451996636064,0.2079207920792079,0.843374534914905,1.0,11/15,29.61%,PCM1;CEP131;PIBF1;STIL;HOOK3;C2CD3;CSNK1D;CCDC14;CEP192;BBS4;CEP83
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5392100971890759,1.2760710559444084,0.17488789237668162,0.8429742065316478,1.0,7/31,11.31%,FHL1;KLF4;FAM107A;DLG1;KANK2;DACT1;RB1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.417881341086468,-1.2743164536599636,0.12297734627831715,0.6112393365936991,1.0,6/32,8.25%,OSBPL8;PLA1A;SERINC5;OSBPL10;ABHD12;SERINC1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5226649973747108,1.2742842300269401,0.1873198847262248,0.8479444446129174,1.0,8/33,9.12%,THBS1;MEOX2;KLF4;FGF2;ATP2B4;JUP;RHOA;STARD13
prerank,DNA replication (GO:0006260),0.44743806094340616,1.2737425476196595,0.13105076741440377,0.8484326127925559,1.0,45/105,26.26%,REV3L;EXO1;MCM7;RAD17;WRN;MCMBP;MCM2;ATM;TOP1;CLSPN;IGHMBP2;TBRG1;CDC45;BAZ1A;CHEK1;POLG2;POLB;RNASEH2A;POLE2;MCM9;KIN;RBBP8;RPA1;RMI2;TOP3A;RECQL5;BARD1;NBN;TICRR;ATR;TOPBP1;RFC1;REV1;HELB;POLA1;RAD9B;RAD50;TOP1MT;CDK2;RFC5;BRIP1;KAT5;ORC3;FAM111A;CDK2AP1
prerank,connective tissue development (GO:0061448),0.5327397216884632,1.27342288398417,0.17048710601719197,0.8481072558030811,1.0,6/35,2.53%,PKD1;SOX9;ITGB8;ZBTB16;CD44;SULF1
prerank,response to calcium ion (GO:0051592),0.4540680439933441,1.2732585881355698,0.1359338061465721,0.8472065130677386,1.0,18/102,12.45%,THBS1;CLIC4;KCNMB3;KCNMB2;NEDD4;PPP3CA;CAMK2D;ADAM9;MEF2A;CASR;DMTN;SYT8;IQGAP1;PLCG2;CARF;SEC31A;ADD1;CPNE3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4140754614245017,1.2722068954537329,0.054933875890132246,0.8494796883418666,1.0,90/417,14.21%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HDAC9;ZBTB16;HES1;TWIST2;GCLC;WWP2;SHC1;KLF4;ZNF148;PRICKLE1;CRY2;RCOR3;ZNF423;MDFIC;ID1;L3MBTL3;BTAF1;PDCD4;FOXK1;PHC2;KAT6B;ARID4A;SAMD7;KLF10;TLE2;BHLHE40;GLIS2;SCMH1;SPINDOC;KDM1A;MBD1;DDIT3;NFIL3;DMBX1;SOX14;ID2;IRF1;MBTD1;SIX4;EHMT1;CDKN1B;ATOH8;ATP8B1;CIPC;PHF12;NIBAN2;FBXW11;BCLAF1;RARA;CBX5;DKK3;LIMS1;JUN;ELF3;FOXE1;NCOR1;PER1;SMAD2;EED;RB1;USP47;FOXK2;ID4;NKX2-1;NIPBL;SMARCA4;UIMC1;HNF4A;XRCC5;ERN2;NCOR2;SP3;BAP1;GCFC2;PRMT6;HDAC10;REST
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4526830422516796,-1.2708048437161434,0.18075801749271136,0.6190886941563,1.0,9/26,12.18%,SHANK3;NRXN1;RIMS1;RIMS2;APP;PRKCZ;GRIN1;TMEM108;CUX2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6289805409155632,1.2701280535119073,0.21061946902654868,0.8554323149316075,1.0,5/12,11.37%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,regulation of RNA metabolic process (GO:0051252),0.4847828910785065,1.2697437433616194,0.16942675159235668,0.8554757844914334,1.0,13/59,12.55%,AHNAK2;MBNL1;AHNAK;CLK1;CLK2;SON;HNRNPH1;CELF1;MBNL2;FUS;PCBP4;TNFRSF1B;SNRNP70
prerank,negative regulation of protein polymerization (GO:0032272),0.536963678179223,1.2686593080732382,0.19011976047904192,0.8578956000798892,1.0,2/27,2.06%,SLIT2;PRKCD
prerank,regulation of signal transduction (GO:0009966),0.4248669181174719,1.2684715315023654,0.09130434782608696,0.8571438570895045,1.0,40/190,12.58%,RSPO3;PLCE1;TCF7L1;GRK5;CD55;MGLL;SULF1;IGFBP5;UBASH3B;ZIC1;ELF1;MDFIC;HHIP;FOXL1;PTPN2;NCK2;CD80;CREBBP;ESR1;GDNF;CLU;PLSCR1;GAS1;LRIT3;GDF5;SOCS2;FRMPD1;RORA;CD46;SIK2;ACVR1;IGFBP6;GALNT11;SRMS;TIMP1;CBFB;ITGB1BP1;USP33;CSK;CASTOR2
prerank,superoxide anion generation (GO:0042554),-0.5257766256384337,-1.267662146706496,0.18581907090464547,0.6259236345644659,1.0,5/13,17.91%,ALOX12;CYBA;NCF2;NOX4;TAFA4
prerank,protein kinase B signaling (GO:0043491),-0.46536651913237026,-1.267641166342293,0.1554959785522788,0.6237780113317795,1.0,10/23,21.77%,IGF1;KDR;SETX;GAS6;THEM4;TYRO3;AKT1;MT3;CCL2;EPHA2
prerank,macromolecule catabolic process (GO:0009057),0.5509174931757247,1.2675970183945564,0.19659442724458204,0.8588096368947611,1.0,8/26,13.51%,NEDD4;BECN1;IDE;LRSAM1;KIF16B;MTOR;SMURF1;SH3GLB1
prerank,endothelial cell development (GO:0001885),-0.4487633950727729,-1.2673322239719862,0.15384615384615385,0.622494633019781,1.0,12/25,9.84%,COL22A1;PECAM1;COL18A1;RAPGEF3;PPP1R16B;RAPGEF2;COL15A1;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,response to glucose (GO:0009749),0.49639945064696167,1.2669345087472326,0.17473118279569894,0.8597621987065178,1.0,5/46,4.23%,THBS1;TCF7L2;KCNB1;UNC13B;SLC39A14
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.41325096995671656,1.2667230154196132,0.057435897435897436,0.8590093378083523,1.0,45/348,8.02%,SLC38A2;F3;BMP4;SLC24A3;NTRK3;SOX9;FOXD1;HOXA5;NGF;ITGB8;ANK2;EZR;SMO;PID1;FN1;ANXA2;WNT11;GSN;KRAS;KLF4;BMP6;NFE2L2;INHBA;GSK3B;FGF2;TGFBR1;SERPINB9;ZBTB7B;SFRP4;NOG;WNT16;STAT3;UBR5;CLU;TADA3;PLSCR1;AGR2;PKP1;CELF1;MOV10;RDX;ID2;TNRC6C;NSF;TLR4
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5618455118560862,-1.2665232200806988,0.21481481481481482,0.6226572311601923,1.0,7/10,15.60%,GABRG3;GABRA2;GABRB2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5250419659692935,1.2663695826616752,0.2,0.8589176902357168,1.0,8/33,11.31%,FHL1;KLF4;FAM107A;DLG1;PLK3;KANK2;DACT1;RB1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6394280796929186,1.2661919701047661,0.23392857142857143,0.8565759241139399,1.0,3/10,7.15%,WNK1;KLF4;IL10
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6394280796929186,1.2661919701047661,0.23392857142857143,0.8565759241139399,1.0,3/10,7.15%,WNK1;KLF4;IL10
prerank,regulation of hippo signaling (GO:0035330),0.5829272480483232,1.2661703884904465,0.1930379746835443,0.8551819887835197,1.0,2/17,1.73%,MOB3B;CIT
prerank,positive regulation of mRNA processing (GO:0050685),0.5733438202395111,1.266081532785703,0.18731117824773413,0.8540782202645234,1.0,15/21,30.20%,CELF3;RBMX;THRAP3;DHX36;CIRBP;DAZAP1;SNW1;TRA2B;NUP98;RBM3;PAF1;CELF4;NCBP2;RBMXL1;PRDX6
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.43547199999619324,-1.2657800865320354,0.1458966565349544,0.6226186529788333,1.0,5/28,8.96%,ARHGAP28;ESAM;CXCL12;PAK3;COTL1
prerank,positive regulation of integrin activation (GO:0033625),-0.5559113345258488,-1.2655521232880886,0.1951219512195122,0.6211562865023872,1.0,3/11,9.40%,RASIP1;PIEZO1;PLEK
prerank,cell-cell junction assembly (GO:0007043),-0.36475405462503274,-1.2652227681308665,0.06278026905829596,0.619902620950549,1.0,16/63,6.57%,TJP1;GJB6;TLN2;CDH2;CLDN5;CDH8;EPB41L3;CDH10;GJB2;GJC1;GJD3;ARVCF;ACTB;GJA1;JAM3;TLN1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.47001810502393726,-1.2646682643565132,0.16129032258064516,0.619345821538246,1.0,3/21,3.39%,OSBPL8;PLA1A;OSBPL10
prerank,lung development (GO:0030324),0.5311581164477096,1.2632797068909656,0.2015151515151515,0.8630298498451738,1.0,9/33,11.99%,BMP4;PKD1;WNT11;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5484528313624631,1.2629407890676432,0.21758569299552907,0.8628192249208059,1.0,7/24,6.03%,DPYSL3;ARAP1;TGFB3;PALM;NRP1;BCAS3;RHOQ
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.40195023872305213,1.2629199305320538,0.0,0.8614541360650261,1.0,366/1646,17.26%,BNC2;FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;WWP1;CDH1;VSX1;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;ZFPM2;TCF7L2;SLTM;PLAGL1;MAP3K5;PRRX2;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;MLLT3;LRP6;FOXN3;DDX5;TCIM;RBFOX2;CAMK2D;TGFB3;PBX1;KLF3;FOXP4;CUX1;WNT11;NFIA;NFAT5;SMAD6;GLI3;FOXO3;HDAC9;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;ANXA4;GCLC;PURG;HOXB6;WWP2;TCF20;USP13;ESR2;SHC1;KLF4;JMJD1C;NFE2L2;INHBA;ZNF148;PRICKLE1;ZIC1;FGF2;FZD7;ELF1;CRY2;RCOR3;PRRX1;ZNF423;MDFIC;ERC1;ABL1;NR2F1;FOXC2;ID1;MEF2A;KLF7;L3MBTL3;JDP2;HOXA6;TGFBR1;GLIS1;BTAF1;EFEMP1;EHF;NR4A3;FOXL1;NR4A2;PDCD4;SP140;FOXK1;PHC2;HDGFL3;KAT6B;ARID4A;SAMD7;DDX17;KLF10;ZBTB7B;HOXC6;ATP2B4;CD80;FOXO6;NFATC4;TLE2;BHLHE40;ARID4B;BRD3;KLF9;GLIS2;CREBBP;ISL1;CCNL2;HMG20A;ESR1;MNAT1;SCMH1;STAT3;ATF1;SPINDOC;HOXB3;KDM1A;E2F5;MBD1;GATA4;DDIT3;BAMBI;HOXB5;TBL1X;TASP1;TADA3;NFIL3;HIF3A;E2F3;TRIM44;TGFB1I1;HOXC4;TRRAP;ELP3;DMRT3;GDF6;MYOG;DMBX1;NOBOX;IL10;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;ID2;LCOR;IRF1;NFIX;MBTD1;REL;SRCAP;SIX4;TEAD1;CRABP2;EHMT1;CHEK2;FUS;FZD1;PITX2;IGSF1;MLXIP;MDM4;HIVEP3;PIAS2;CAMTA2;CDKN1B;NLK;RXRA;ZNF8;GRHL2;ATOH8;ATP8B1;FOXC1;CIPC;NFYA;RORA;PIAS3;SERTAD3;PHF12;GLI2;CHUK;EGR2;NFKB1;NIBAN2;BAZ2B;MED13;FBXW11;TOX4;BCLAF1;GATA1;CTCFL;CCNL1;HOXB4;MED27;ATF7;RARA;CBX5;ACVR1;PIM2;DKK3;LIMS1;JUN;LBX1;MTDH;NFE2L1;NRF1;VEGFA;WAC;CARF;ELF3;FOXE1;ZNF25;BRCA2;PRDM15;NCOR1;ZBTB32;MYNN;LRP5;GON4L;PER1;SMAD2;ATF6;ERBB2;MXD1;EED;GTF2IRD1;RB1;NFKB2;BPTF;RNF111;USP47;SP110;FOXK2;RGMB;CBFB;BRD9;ATOH7;HTATIP2;ID4;NKX2-1;AATF;KDM3B;ELOA;NIPBL;BCL11B;KAT2A;NR4A1;HIRA;CDC45;NR6A1;SMARCA4;UIMC1;BAZ1A;CTR9;ATRX;KMT2D;NFATC3;MXD4;TCF3;PPM1A;SETD5;HNF1A;HNF4A;RFX2;XRCC5;PAX6;EP300;ERN2;CHD3;HCFC1;CC2D1B;NCOR2;SP3;E2F2;BAP1;GPBP1;GCFC2;EBF4;ZXDC;PRMT6;NFATC1;HDAC10;REST;ZNF691;ETV3;DHX9;FOXD2;MED14;GPBP1L1;STAT5A;ELP4;CNOT7;CDK11B;URI1;CREB3L1;ATF2;RFX7;CDK16;ZBTB1;HOXD3;KDM2A;BAZ2A;PCGF1;TWIST1;ZNF585B;ZNF585A;MAP2K2;HINFP;PML;EPC1;TFAP2A;THRAP3;WWTR1;BRWD1;ZNF219;ZBTB7A;TRIM16;HSF2;BCL6;ZFP1;CREBL2;CALCOCO1;RBBP8;JMJD6;POU6F1;ZMIZ1;SMARCAL1;PRDM5;MED24;RRM2;NAA15;NSD1;HR;RNF14;YY1;RET;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;SBNO2;POU3F4;HOXA2;BCL10;SREBF1;PITHD1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6085894622579564,1.2627358566475568,0.2125984251968504,0.8606377201916084,1.0,2/13,4.59%,PKD1;MDFI
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5915719564171933,1.2624934403588588,0.22375215146299485,0.8601562687550942,1.0,3/14,6.75%,EHHADH;ACOX3;ACOT8
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4663761082670445,1.2623781889549728,0.15920398009950248,0.8591324952832431,1.0,9/75,4.28%,F3;BMP4;PGF;NRAS;FGFR1;FGF2;NRP1;TGFBR1;AGTR1
prerank,regulation of nervous system process (GO:0031644),-0.48453433831091824,-1.2618680761261063,0.17894736842105263,0.62530480280928,1.0,11/18,20.57%,NOS3;APP;DLGAP1;HTR2C;TMEM108;ROCK2;NPTXR;DLGAP2;CHRNA7;DLGAP3;BEGAIN
prerank,cellular response to fatty acid (GO:0071398),0.6119588257681849,1.2608408495347776,0.22203672787979967,0.8633007682272862,1.0,4/12,12.83%,PID1;IRS1;ZC3H12A;PDK3
prerank,nuclear migration (GO:0007097),0.6157627188990074,1.2607543275574284,0.21844660194174756,0.8621719678631786,1.0,8/13,17.93%,DOCK7;PAFAH1B1;CLMN;PCM1;FBXW11;SYNE2;HOOK3;TMEM201
prerank,ribosome biogenesis (GO:0042254),-0.3101353271137011,-1.2606826975950773,0.04878048780487805,0.6264004289898889,1.0,68/187,23.15%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;RPL37;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;RPL22;RPL23A;RPS25;RPL26;RPL35A;RPL11;SNU13;RPL13A;RPL7;RPL36;RPS17;NOC2L;RPL32;RPL39;RPL14;NPM1;RPS2;RPL8;RPL24;RPL29;RPL10A;DDX10;RPL3;LYAR;RPL12;PIH1D1;RPL27;EXOSC9;RPS28;DDX27;DDX54;RPL5;LAS1L;MTREX;POP5;NOLC1;EMG1;RPL4;RPL36A;WDR36;RPL31;NOC4L;RRP9
prerank,positive regulation of bone mineralization (GO:0030501),0.5193935282705503,1.2604159506787962,0.19827586206896552,0.8619932024104758,1.0,7/35,3.97%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.46692524664967006,1.2600229050422553,0.1628498727735369,0.8620363843053026,1.0,9/77,6.64%,THBS1;BMP4;TCF7L2;TGFBR1;NR4A2;ITGAV;GATA4;CLU;BIRC6
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6030142501455018,1.2597346256735928,0.21262458471760798,0.8616044118950499,1.0,9/14,26.38%,SEC24B;SEC23A;SEC31A;SEC13;SEC24D;RAB1A;SEC24A;MIA3;TBC1D20
prerank,positive regulation of protein metabolic process (GO:0051247),0.4447982604622017,1.2594656260295192,0.14370546318289787,0.8611078788553899,1.0,19/110,8.46%,WWP1;FZR1;NEDD4;GPC3;WWP2;KLF4;INHBA;GSK3B;AGTR1;EIF4G1;VCP;STX5;CD80;ISL1;CLU;IDE;ASB9;NSF;CDKN1B
prerank,regulation of myeloid cell differentiation (GO:0045637),0.47833523053925364,1.259264943456937,0.165374677002584,0.860427453277854,1.0,16/62,14.16%,THBS1;HOXA5;PTK2B;ZBTB16;NR4A3;CREBBP;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;CTR9;KMT2D;EP300;PRMT6
prerank,regulation of cellular protein catabolic process (GO:1903362),0.57517640310397,1.2578500479139483,0.22926829268292684,0.8640652979446524,1.0,5/18,9.55%,EZR;NELL1;RDX;RGP1;DACT1
prerank,L-amino acid transport (GO:0015807),0.5251145193764091,1.257515278639034,0.2005813953488372,0.8638765227891967,1.0,1/28,0.04%,SLC38A2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6391108761024371,1.2574858582814075,0.24285714285714285,0.8625530062996648,1.0,4/10,9.88%,RARB;RXRA;RARG;RARA
prerank,striated muscle tissue development (GO:0014706),0.5347819323889612,1.2571287282117742,0.21216617210682492,0.8624345525717672,1.0,4/29,1.77%,SIX1;SGCD;BMP5;CSRP3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.43288047308030625,1.257088319549625,0.12341407151095732,0.8611573717222253,1.0,15/142,5.80%,SLC35G1;PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;ATP2B4;PTGER1;ESR1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5605214926080426,1.2565534861586902,0.20508744038155802,0.8617489899930576,1.0,2/21,1.56%,ST3GAL4;FUT8
prerank,glucose import (GO:0046323),-0.526706126599794,-1.256428961347522,0.19072164948453607,0.6364330870275352,1.0,2/13,1.89%,SLC2A1;SORT1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5358711618730754,-1.2563254673187079,0.1990632318501171,0.6345475671884552,1.0,5/11,12.02%,PARP14;PARP16;PARP8;TIPARP;PARP11
prerank,negative regulation of histone modification (GO:0031057),-0.50470863932833,-1.256192398284501,0.1856763925729443,0.6328014011854283,1.0,7/14,19.98%,JARID2;SNCA;NOC2L;SET;CTBP1;AASS;SPHK2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5176122676052606,-1.2561858014602902,0.20050125313283207,0.6307096476801768,1.0,5/14,10.06%,NOS3;ACE;ENPEP;EDN1;ACE2
prerank,positive regulation of protein modification process (GO:0031401),0.4212584224989958,1.2560186746734265,0.09554831704668838,0.8623455088108113,1.0,17/203,3.61%,EGFR;BMP4;SLCO3A1;CARD14;TRABD2B;NTRK3;SOX9;RAMP1;PGF;CCN1;EFNA5;PRKCD;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,ether lipid metabolic process (GO:0046485),0.5912262286129085,1.2556391351369864,0.2360655737704918,0.8623565230312576,1.0,5/14,10.49%,NCEH1;PAFAH1B1;AGPS;PEDS1;GNPAT
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.46884305029696555,1.255190877937939,0.16558861578266496,0.8626220569935392,1.0,15/69,15.28%,THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,regulation of cytokinesis (GO:0032465),0.4619351304899636,1.2549222437476135,0.18024691358024691,0.862235170713377,1.0,19/78,13.95%,CIT;KIF13A;GIPC1;PRKCE;RAB11FIP3;BECN1;CDC25B;BIRC6;SETD2;PLK3;KLHL13;CDC14A;RHOA;AURKA;DRD3;ENTR1;PKN2;SH3GLB1;CUL3
prerank,fat cell differentiation (GO:0045444),0.47011416828458874,1.2547607146156186,0.17569352708058125,0.8613761712743252,1.0,14/57,13.41%,TCF7L2;BBS9;PID1;SMAD6;TMEM120A;KLF4;NR4A3;NR4A2;GDF6;EGR2;ERAP1;INHBB;NR4A1;EP300
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4837851676841151,1.2546103696719946,0.1865079365079365,0.8605335884479558,1.0,10/52,6.71%,EGFR;EPB41L2;SORBS1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;AGR2;DLG1
prerank,negative regulation of signal transduction (GO:0009968),0.4133949623800905,1.25457942986256,0.08795811518324607,0.8592219294830082,1.0,46/249,11.31%,EGFR;THBS1;NXN;TRABD2B;NTN1;BMP5;NEDD4;TCIM;PID1;PRKCD;GLI3;GPC3;SULF1;GRB10;IGFBP5;WWP2;UBASH3B;PALM;FGF2;LRPAP1;IRS1;HHIP;NR4A2;MDFI;PTPN2;VCP;SFRP4;TSKU;NOG;GLIS2;LRP1;GATA4;IL10;NLK;KANK2;MMP14;NIBAN2;DACT1;KIF7;IRAK3;ACVR1;DKK3;SRMS;MEGF8;ERBB2;RB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.60643335079197,1.2541138595924253,0.21475409836065573,0.8594666933272096,1.0,5/14,12.35%,ATP1B1;WNK1;DMD;SLC9A1;CHP1
prerank,ATP transport (GO:0015867),-0.5588796462489134,-1.2539204424220842,0.1990521327014218,0.6351026114345247,1.0,2/10,5.11%,ABCC6;CD47
prerank,negative regulation of protein phosphorylation (GO:0001933),0.43051420580166555,1.253617823271715,0.12763596004439512,0.8598849044937789,1.0,33/150,13.30%,SLIT2;RASSF2;NTRK3;LRP6;PID1;PRKCD;SMAD6;PLPP3;UBASH3B;NIBAN1;SPRED2;EIF4G1;NCK2;PMEPA1;DMD;NOG;DNAJC3;DMTN;KLHL31;IBTK;PARD3;PPEF2;NF1;LDLRAD4;SMCR8;RB1;CEP85;ITGB1BP1;CORO1C;CHP1;ZC3H12A;PAK2;PRKDC
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5398764857810182,1.253556199004894,0.20958083832335328,0.858693870594445,1.0,3/26,6.41%,ST3GAL4;LARGE1;GOLPH3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5324501719631693,-1.2529140105192544,0.18877551020408162,0.6358470824955944,1.0,4/13,10.09%,SHANK3;ADCY1;APP;LGMN
prerank,regulation of establishment of cell polarity (GO:2000114),0.5852613344338017,1.2528790641554,0.23240589198036007,0.8597611677617504,1.0,4/16,5.51%,PTK2B;GSN;BCAS3;SHTN1
prerank,substrate-dependent cell migration (GO:0006929),0.5915131984157549,1.2525921458076146,0.22596964586846544,0.8593991014997515,1.0,3/14,5.51%,NTN1;NRP1;SHTN1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5120806495018826,1.2524300581998198,0.18950437317784258,0.8586163430195136,1.0,3/38,3.24%,THBS1;BMP5;GSK3B
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5229814127388706,1.252244598145369,0.20545977011494254,0.8578998825288179,1.0,13/30,21.00%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;CSNK2A2;RNF31;USP36;HUWE1
prerank,positive chemotaxis (GO:0050918),0.5704350376615976,1.2515090009496,0.21303656597774245,0.8592145372806883,1.0,3/17,10.33%,MET;NRP1;VEGFA
prerank,regulation of dopamine secretion (GO:0014059),-0.43969220418488686,-1.2513911096041939,0.19937694704049844,0.6383430187294326,1.0,15/25,24.10%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,amino acid import across plasma membrane (GO:0089718),0.5412682811493448,1.2510911317889788,0.2113095238095238,0.8593775422364325,1.0,1/24,0.02%,SLC47A1
prerank,protein deubiquitination (GO:0016579),0.4174753079742383,1.2508738472236136,0.09829059829059829,0.8588369882439854,1.0,98/242,27.03%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;PSMB2;TRRAP;MDM4;USP34;USP49;RHOA;USP15;IL33;USP25;RAD23B;USP1;PSMC6;USP10;USP32;DESI2;CLSPN;USP7;SMAD2;OTUD7B;USP47;COPS5;FOXK2;USP4;USP33;KAT2A;ZC3H12A;UIMC1;IFIH1;ZRANB1;JOSD1;EP300;HCFC1;PSMD11;BAP1;POLB;TNIP1;PSMD1;OTUD3;OTUD5;KAT2B;IKBKG;VCPIP1;YY1;PSMC1;PSMD7;USP28;BARD1;INO80;WDR48;USP22;USP9X;BIRC3;UFD1;USP40;TRAF3;PSMD14;RNF123;PSMD3;USP21;USP36;SMAD4;GATA3;HGS;USP48;RHOT1;ASXL2;BRCC3;STAMBP;CDC20;SMAD7;TOMM20;ADRM1;MCRS1;USP3;PSMD12;MAP3K7;TRAF6;AR;MBD5;OGT;USP30;PSMD4;ASXL1;PSME3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5518503860906887,1.2505708025609548,0.21495327102803738,0.8571934734783879,1.0,4/23,6.69%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5518503860906887,1.2505708025609548,0.21495327102803738,0.8571934734783879,1.0,4/23,6.69%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,regulation of mitotic cell cycle (GO:0007346),0.42445629337638746,1.2505581730365127,0.1087912087912088,0.8558613131385702,1.0,51/171,22.25%,SMOC2;FZR1;PTPN3;USP2;NEK7;TTC28;ANAPC5;CCDC8;CDC25B;PSMB2;CDC16;GAS1;GBF1;IL10;ANAPC16;CDKN1B;FOXC1;IQGAP1;PIM2;BTG3;PSMC6;RB1;ANGEL2;PKN2;PSMD11;TMEM8B;UBE2S;PSMD1;CDK11B;PRKCA;ERCC3;CUL1;MAD2L1;CDK13;PSMC1;PSMD7;HECA;CDK10;USP22;NEK6;PSMD14;TRIM35;SCRIB;PSMD3;PDXP;FOXA1;CUL7;ANAPC11;ANAPC10;THAP1;PRMT5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4603955364385096,-1.2504926791996014,0.16986301369863013,0.6387345264071977,1.0,6/23,8.16%,CEMIP;PRKAG2;BMP7;CALM1;APP;SPHK1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5527562642759731,1.2497049875754684,0.21752738654147105,0.8574868397213754,1.0,4/21,11.57%,NT5E;NT5C1A;NUDT4;AMPD3
prerank,regulation of inclusion body assembly (GO:0090083),0.6152150297689482,1.2496432820483228,0.26,0.8562992758469017,1.0,1/11,1.14%,SNCAIP
prerank,cell differentiation in hindbrain (GO:0021533),-0.5422744788620915,-1.2495750622755142,0.20334928229665072,0.6392203939438625,1.0,7/11,18.52%,GRID2;OPHN1;FAIM2;PROX1;KNDC1;LHX1;ATP7A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6278684339384466,1.2495278507331404,0.25249169435215946,0.8552825474275066,1.0,3/11,8.00%,LRP6;NR4A2;FZD1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3733116223339369,-1.24933668681385,0.13970588235294118,0.6377375081983075,1.0,20/57,13.10%,GRIA4;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;DLGAP1;GRIA3;CACNG4;GRIN1;CACNG7;ACTN2;GRIA2;CAMK2A;GRIA1;NETO1;CAMK2B;NPTXR;DLGAP2;GSG1L
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5974838700589421,1.249200287868908,0.24006359300476948,0.8551062664658827,1.0,12/16,30.20%,CELF3;RBMX;THRAP3;CIRBP;DAZAP1;SNW1;TRA2B;NUP98;RBM3;CELF4;RBMXL1;PRDX6
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5719237372459542,1.2490536178640752,0.2465331278890601,0.8542282102748814,1.0,5/17,11.11%,ANXA1;ANXA4;KLF4;IL10;OTUD7B
prerank,actin nucleation (GO:0045010),-0.4600192477431776,-1.2489402032343306,0.18994413407821228,0.6367097112734168,1.0,10/21,25.07%,IQGAP2;LMOD1;SPIRE1;ARPC4;ARPC3;ARPC5;ARPC5L;TRIM27;ARPC1A;SPIRE2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4665490740309603,1.2488042305241611,0.1675,0.8538006694768361,1.0,11/73,10.33%,EGFR;NTRK3;NGF;CD44;DOCK7;EIF4G1;ATP2B4;RIPK2;BCAR3;AKAP9;VEGFA
prerank,positive regulation of neuron migration (GO:2001224),-0.5509303705922197,-1.2487554191288295,0.21052631578947367,0.6351606743658361,1.0,4/11,11.35%,SEMA6A;RAPGEF2;DAB2IP;MDK
prerank,gene expression (GO:0010467),-0.2901439007348418,-1.2485331576942387,0.0,0.6337383020735219,1.0,103/348,19.40%,RBPMS;RBMS1;NOVA1;ATXN1;TSPAN5;RPS14;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;APOBEC1;RPL41;RPL37A;RPLP2;RPS21;RPL27A;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;ADARB2;RPS4X;RPL13;ANGPT2;RPL9;RPS16;ELAVL4;RPS15;SETX;RPS27;RPL30;DTX1;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;RPL7;RNASEL;RPL36;RPS17;RPL32;RPL39;RPL14;RPS2;CELF2;NUP160;HHEX;FASTKD2;RPL8;POLR2G;RPL24;NUP210;HNRNPH3;RPL29;MRPS11;SMG7;MRPL51;ADARB1;NOX4;RPL10A;RPL3;DDX20;RPL12;TFIP11;ADAR;PABPN1;RPS27A;POLR2K;NUP62;BCL3;RPS12;RPL27;RPS28;NUP205;DDX54;RPL5;RBM15B;PWP1;GSPT2;MAGOH;RPS10
prerank,positive regulation of ERAD pathway (GO:1904294),0.6117943683117996,1.2480883428476492,0.23168654173764908,0.8550031426045616,1.0,3/13,4.79%,USP13;NFE2L2;RNF185
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6161427110168334,1.2478016630097315,0.2482638888888889,0.8546069047646726,1.0,1/12,0.20%,F3
prerank,regulation of vasoconstriction (GO:0019229),0.5250014443592714,1.2473958334012427,0.21406727828746178,0.8546378657534925,1.0,4/27,4.96%,KCNMB2;ADRA1B;AGTR1;TRPM4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.40734797003276324,-1.2468873613780536,0.152317880794702,0.6364318788303567,1.0,18/36,27.94%,WNT5A;CSF1;PARP14;CASP4;HIF1A;GAS6;EDN1;NLRC5;AXL;CD74;CASP1;ZBP1;IL7;C1QTNF4;TSLP;LAPTM5;CD300LF;TRIM6
prerank,glycerophospholipid catabolic process (GO:0046475),-0.42634200752243484,-1.2464122346656406,0.18075801749271136,0.6357275279366802,1.0,6/27,10.55%,GPCPD1;ENPP2;ENPP6;ABHD12;INPP5F;PNPLA8
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3954362136820898,1.2460816255314606,0.001,0.8580316733299965,1.0,381/1668,17.15%,FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;ZFPM2;TCF7L2;SLTM;MET;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;PKD1;SOX9;BMP5;ZIC4;FOXD1;HDAC4;HOXA5;PRDM6;LRP6;DDX5;CCN1;PPP3CA;EZR;CAMK2D;CSRP3;TGFB3;PBX1;KLF3;FOXP4;PID1;CUX1;NFIA;NFAT5;SMAD6;GLI3;FOXO3;HDAC9;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;ANXA4;SKIL;PURG;HOXB6;WWP2;TCF20;USP2;ESR2;KLF4;JMJD1C;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;ZNF148;ZIC1;FGF2;ELF1;CRY2;RCOR3;PRRX1;ABL1;NR2F1;FOXC2;ID1;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;TCF25;SP140;MDFI;ZFP64;FOXK1;MLLT10;HDGFL3;KAT6B;ARID4A;NCK2;DDX17;SMYD2;KLF10;BCAS3;ZBTB7B;HOXC6;ATP2B4;FOXO6;NFATC4;HDAC8;BHLHE40;ARID4B;BRD3;KLF9;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;CCNL2;MRTFA;ESR1;MNAT1;MED15;CDK12;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;HOXB5;TBL1X;RIPK2;TADA3;NFIL3;HIF3A;E2F3;PHF21A;MYSM1;PLSCR1;JAG1;DLG1;HOXC4;ELP3;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;MOV10;ID2;LCOR;TNRC6C;IRF1;JUP;NFIX;REL;SRCAP;SIX4;TEAD1;FUS;PLK3;TLR4;GABPB1;GABPB2;PITX2;MLXIP;MDM4;HIVEP3;PIAS2;CAMTA2;RXRA;THAP3;ZNF8;GRHL2;ATOH8;FOXC1;KANK2;ZMYM5;NFYA;RORA;PAXBP1;SLC9A1;PIAS3;PHF12;UBE2D3;GLI2;CHUK;PER3;EGR2;NFKB1;BAZ2B;SSBP3;MED13;TOX4;BCLAF1;DACT1;LPIN2;IL33;GATA1;CTCFL;CCNL1;RARG;HOXB4;MED27;ATF7;RARA;RBMX;CBX5;ACVR1;ATM;PPP1R12A;JUN;LBX1;MTDH;NFE2L1;NRF1;VEGFA;SLC30A9;APEX1;ARF4;CARF;ELF3;FOXE1;ZNF25;PRDM15;NCOR1;ZBTB32;MYNN;TCERG1;LRP5;BCL9L;PER1;MIER1;SMAD2;ATF6;ERBB2;OTUD7B;MXD1;EED;GTF2IRD1;KANSL3;ZBED4;RB1;NFKB2;BPTF;RNF111;COPS5;SP110;FOXK2;DCAF1;CBFB;ITGB1BP1;MTA1;BRD9;ATOH7;HTATIP2;ID4;NKX2-1;AATF;KDM3B;ELOA;NIPBL;BCL11B;KAT2A;NR4A1;HIRA;NCOA5;NR6A1;ZC3H12A;DDRGK1;SMARCA4;BAZ1A;CTR9;ATRX;KMT2D;NFATC3;MXD4;PPRC1;TCF3;PPM1A;HNF1A;HNF4A;PRKDC;RFX2;PAX6;EP300;CHD3;HCFC1;CC2D1B;TNFSF11;NCOR2;SP3;E2F2;VPS72;RNF2;CRTC1;EBF4;ZXDC;NFATC1;HDAC10;REST;ZNF691;TNIP1;ETV3;DHX9;FOXD2;CCND1;ZNF507;DNMT3A;MED14;STAT5A;ELP4;URI1;CREB3L1;ATF2;RFX7;ZBTB1;HOXD3;KDM2A;PCGF1;TWIST1;ZNF585B;ZNF585A;SQSTM1;GALR1;HINFP;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;BRWD1;ZNF219;KAT2B;ZBTB7A;AGO2;HSF2;BCL6;ZFP1;CALCOCO1;RBBP8;IKBKG;JMJD6;POU6F1;ZMIZ1;SMARCAL1;PRDM5;MED24;NSD1;HR;RNF14;YY1;CDK13;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;SBNO2;BRD8;POU3F4;HOXA2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.39796251665432353,1.2460761694253615,0.017,0.8566967733225049,1.0,203/834,17.11%,MICAL2;EGFR;BMP4;KLF5;ZFHX3;SIX1;ZFPM2;TCF7L2;MET;PLAGL1;RARB;NFIB;SMAD9;PKD1;SOX9;BMP5;HDAC4;HOXA5;LRP6;CCN1;PPP3CA;CSRP3;TGFB3;PBX1;PID1;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;TCF20;KLF4;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;FGF2;ELF1;ABL1;NR2F1;FOXC2;MEF2A;KLF7;GLIS1;EHF;NR4A3;NR4A2;ZFP64;MLLT10;KAT6B;NCK2;DDX17;KLF10;BCAS3;HDAC8;GLIS2;CREBBP;ISL1;SKI;MRTFA;ESR1;CDK12;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;TBL1X;RIPK2;E2F3;MYSM1;PLSCR1;JAG1;HOXC4;MYOG;IL10;PHOX2A;IRF1;JUP;NFIX;REL;TEAD1;TLR4;GABPB1;GABPB2;PITX2;MLXIP;CAMTA2;RXRA;THAP3;GRHL2;ATOH8;FOXC1;RORA;PAXBP1;SLC9A1;GLI2;CHUK;EGR2;NFKB1;SSBP3;MED13;BCLAF1;LPIN2;IL33;GATA1;CTCFL;RARG;HOXB4;RARA;RBMX;ACVR1;ATM;PPP1R12A;JUN;NRF1;VEGFA;SLC30A9;APEX1;ARF4;ELF3;PRDM15;TCERG1;LRP5;BCL9L;PER1;SMAD2;ATF6;KANSL3;ZBED4;NFKB2;BPTF;RNF111;COPS5;FOXK2;ITGB1BP1;HTATIP2;NKX2-1;AATF;BCL11B;KAT2A;NR4A1;ZC3H12A;DDRGK1;SMARCA4;ATRX;KMT2D;NFATC3;PPRC1;TCF3;HNF1A;HNF4A;PRKDC;PAX6;EP300;HCFC1;TNFSF11;SP3;E2F2;CRTC1;NFATC1;REST;TNIP1;DHX9;FOXD2;ZNF507;MED14;ATF2;HOXD3;TWIST1;SQSTM1;GALR1;HINFP;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;KAT2B;AGO2;HSF2;CALCOCO1;IKBKG;JMJD6;ZMIZ1;MED24;YY1;CDK13;ZNF76;CREB3L3;SBNO2;BRD8
prerank,peptidyl-lysine modification (GO:0018205),0.4476194560648781,1.2458745303154175,0.16868932038834952,0.8560574156852996,1.0,31/99,20.88%,HDAC4;PLOD2;HDAC9;LOXL1;NUP93;TRPM4;P3H4;PIAS2;SAE1;PIAS3;EGR2;RANBP2;IFIH1;NUP153;EP300;HDAC10;SENP5;P3H3;LOXL4;ETFBKMT;NUP214;KAT2B;LIPT2;NUP188;LOX;NUP88;PIAS1;NDUFAB1;SENP3;SENP1;NUP98
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4916295798916206,-1.2458209826774995,0.18783068783068782,0.6353978384190913,1.0,9/16,21.03%,AUTS2;ARHGAP24;RASGRF1;STMN3;CADM4;GABARAP;PIK3CG;ARF6;KBTBD7
prerank,substantia nigra development (GO:0021762),-0.4005785054077747,-1.24558136511346,0.1423841059602649,0.6340814884402327,1.0,12/37,14.73%,MBP;GNB4;MAOB;PLP1;ACTB;CALM1;ATP5PF;BASP1;COX6B1;DYNLL1;CALM3;TTBK1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.512025666073837,1.2451969233076978,0.22377622377622378,0.8571180381068355,1.0,7/34,10.17%,DOCK5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2
prerank,actin filament bundle organization (GO:0061572),0.5192600232920828,1.2451366146147989,0.19596541786743515,0.8559810210265343,1.0,8/33,6.54%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4824620696558468,-1.245045275369953,0.2152230971128609,0.6336444212576109,1.0,4/16,5.65%,APOD;PPARA;ADCY7;SIRPA
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5224505993965574,1.2449885713781228,0.21052631578947367,0.855155908855535,1.0,8/31,20.57%,FZR1;DCUN1D5;UBE2S;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;RAB1A
prerank,DNA geometric change (GO:0032392),0.5515047788395063,1.244943309910049,0.22870662460567823,0.8539704192600219,1.0,10/24,21.84%,ANXA1;WRN;DDX11;DHX9;MCM9;RECQL5;NBN;DHX36;DDX1;RAD50
prerank,fatty acid transport (GO:0015908),-0.47846225033953993,-1.2447708163868787,0.2,0.6324036278481687,1.0,7/17,18.23%,ACSL1;APOE;PPARD;FABP5;MFSD2A;GOT2;SLC27A1
prerank,amino acid import (GO:0043090),0.556330599078198,1.2447691488293156,0.21962616822429906,0.8532238197016376,1.0,1/21,0.02%,SLC47A1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.505503359765667,-1.244667042607078,0.19904076738609114,0.6307088068206079,1.0,1/14,0.56%,AUTS2
prerank,O-glycan processing (GO:0016266),0.47970502283729255,1.2440026236018427,0.18438761776581428,0.8546246525195549,1.0,6/54,6.76%,ST3GAL4;B3GNT2;GXYLT2;GALNT15;GALNT13;MUC6
prerank,triglyceride homeostasis (GO:0070328),-0.4308635392475636,-1.24361133406855,0.17404129793510326,0.6316824648980917,1.0,9/26,18.17%,APOE;NR1H3;C1QTNF3;IL18;PNPLA8;SCARB1;NR1H4;LPL;XBP1
prerank,estrogen metabolic process (GO:0008210),0.5882802254633642,1.2434133230689628,0.2512396694214876,0.8554114977205391,1.0,2/15,4.55%,CYP1B1;SULT1A1
prerank,negative regulation of ion transport (GO:0043271),0.5304727953831176,1.243340398280457,0.24283559577677225,0.854374678704153,1.0,3/24,1.93%,NEDD4;PTK2B;WNK1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.35551736328135686,-1.2432926914620566,0.11210762331838565,0.6305758035144038,1.0,12/66,6.26%,ROBO1;MCC;PTPRM;MTSS1;NR2F2;TGFBR3;APOE;B2M;CDK6;DAB2IP;AQP11;SPARC
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.39947681151466724,1.2428769645878968,0.022044088176352707,0.8547157248831277,1.0,170/807,14.21%,FOXP2;FOXP1;BMP4;KLF12;WWP1;ZFHX3;ZFPM2;TCF7L2;RARB;SOX9;FOXD1;HDAC4;PRDM6;FOXN3;DDX5;EZR;RBFOX2;FOXP4;CUX1;WNT11;GLI3;FOXO3;HDAC9;ZBTB16;HES1;TWIST2;SKIL;GCLC;WWP2;USP2;ESR2;SHC1;KLF4;BMP6;ZNF148;PRICKLE1;CRY2;RCOR3;ZNF423;MDFIC;NR2F1;FOXC2;ID1;MEF2A;KLF7;L3MBTL3;JDP2;GLIS1;BTAF1;NR4A3;NR4A2;PDCD4;TCF25;MDFI;FOXK1;PHC2;KAT6B;ARID4A;SAMD7;SMYD2;KLF10;ZBTB7B;TLE2;HDAC8;BHLHE40;NOG;GLIS2;TLE6;CREBBP;FRK;ISL1;SKI;ESR1;SCMH1;STAT3;SPINDOC;KDM1A;MBD1;DDIT3;TBL1X;NFIL3;PHF21A;DLG1;DMBX1;SOX14;ID2;LCOR;IRF1;NFIX;MBTD1;SIX4;EHMT1;PLK3;MDM4;CDKN1B;RXRA;ZNF8;ATOH8;ATP8B1;FOXC1;CIPC;KANK2;ZMYM5;PHF12;UBE2D3;GLI2;PER3;NFKB1;NIBAN2;FBXW11;BCLAF1;DACT1;IL33;GATA1;RARG;RARA;CBX5;DKK3;LIMS1;JUN;MTDH;VEGFA;ELF3;FOXE1;ZNF25;NCOR1;ZBTB32;TCERG1;PER1;MIER1;SMAD2;OTUD7B;MXD1;EED;GTF2IRD1;RB1;BPTF;USP47;FOXK2;DCAF1;CBFB;MTA1;ID4;NKX2-1;NIPBL;NCOA5;NR6A1;SMARCA4;UIMC1;CTR9;MXD4;TCF3;PPM1A;HNF4A;XRCC5;PAX6;EP300;ERN2;CHD3;HCFC1;NCOR2;SP3;VPS72;PRDX5;BAP1;RNF2;GCFC2;PRMT6;HDAC10;REST
prerank,regulation of endothelial cell proliferation (GO:0001936),0.44735291883182415,1.242739426586945,0.16725978647686832,0.8538742223015504,1.0,9/88,4.10%,F3;THBS1;BMP4;PGF;NRAS;SULF1;FGF2;NRP1;TGFBR1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42309900181118903,1.242658715364787,0.1493212669683258,0.8528734373437411,1.0,19/140,10.21%,PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;GPR4;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;PTGER1;ESR1;LPAR4;P2RX2;P2RX4;DRD3;PROK2
prerank,nerve growth factor signaling pathway (GO:0038180),0.6321145636827208,1.241932570583984,0.24048442906574394,0.8541914254760566,1.0,3/10,4.43%,NGF;RAP1A;KIDINS220
prerank,epithelial cell migration (GO:0010631),0.5010039370769936,1.2419254994844144,0.2157676348547718,0.8528944343771525,1.0,10/37,9.86%,FSTL1;FAT2;CYP1B1;GIPC1;ABL1;NRP1;KANK2;RHOA;STARD13;S100A2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.49909957681557243,1.2417064151098511,0.1971631205673759,0.8523736127261281,1.0,6/40,5.80%,EGFR;EDNRA;NTRK3;FGFR1;FGF2;ESR1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.40511692409849864,-1.2416405600140605,0.16149068322981366,0.6331075280932422,1.0,9/34,11.32%,MFHAS1;NEDD4L;PICALM;RIPOR2;GPM6B;ANKRD13A;MAPT;ACTN2;ROCK2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4894274959551529,1.2411301225720202,0.19008264462809918,0.8530745983807553,1.0,10/44,12.84%,BAIAP2L1;CDC42EP5;PTK2B;GSN;PRKCE;NCK2;NCKAP1;CTTN;FCHSD2;FCHSD1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5015257032827765,-1.2403099930514117,0.2044334975369458,0.6348930204301447,1.0,3/14,11.39%,MOXD1;SLC22A2;ALDH9A1
prerank,macrophage differentiation (GO:0030225),0.5924743774217666,1.2402783106906412,0.23985890652557318,0.8548629376794439,1.0,1/13,0.28%,BMP4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4551453634918936,1.240238361368155,0.18079800498753118,0.853695145279166,1.0,18/78,14.52%,FZR1;NFE2L2;PRICKLE1;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;PLK3;CSNK1A1;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;BCAP31
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42315024966961157,1.2398864480338203,0.14580941446613088,0.8536472236010996,1.0,27/140,9.40%,SLIT2;PLCE1;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;AKAP13;ARHGDIB;VAV2;ARHGAP44;ARHGAP31;BCR;SRGAP2;SRGAP3;TIAM2;ARAP2;TRIO;ITGAV;RHOQ;ARHGEF6;OCRL;ARHGAP17;RHOA;STARD13;ARHGAP5;GNA13
prerank,regulation of vasculature development (GO:1901342),0.5384690975270631,1.238861002819292,0.22072072072072071,0.8558223057565878,1.0,6/26,11.89%,BMPER;FGF2;NF1;PROK2;ERBB2;HTATIP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4940586511897876,-1.2388503505344253,0.19473684210526315,0.6371047751874098,1.0,4/16,6.14%,CXCL12;BCL2L1;TPT1;RPS3
prerank,positive regulation of glycolytic process (GO:0045821),0.5511180507322703,1.238809351329551,0.2360655737704918,0.8534080507006027,1.0,1/20,0.03%,SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5511180507322703,1.238809351329551,0.2360655737704918,0.8534080507006027,1.0,1/20,0.03%,SLC4A4
prerank,regulation of tissue remodeling (GO:0034103),-0.4781612140176561,-1.2387319335894371,0.19414893617021275,0.6354614134542385,1.0,6/18,11.35%,LEPR;CST3;SYT7;IL18;FLT4;MDK
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5039049961961048,-1.2383756765424923,0.23741007194244604,0.6344631567984417,1.0,2/15,4.83%,IGF1;BCL2L1
prerank,gliogenesis (GO:0042063),0.5928022608589943,1.2383712648246739,0.23613312202852615,0.8536981235343126,1.0,3/15,2.62%,NFIB;ANXA1;CD9
prerank,calcium ion transmembrane transport (GO:0070588),0.44273858459210547,1.2380316429003302,0.17121588089330025,0.8536867542353852,1.0,21/86,13.76%,SLC35G1;SLC24A3;PKD1;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7;P2RX4;MCUB;MCU;MCOLN3;SLC8B1;PMPCB;YME1L1;GRIN2C
prerank,peptidyl-proline modification (GO:0018208),0.5374511684209813,1.2370714614094769,0.23636363636363636,0.8555766169605602,1.0,3/25,6.59%,FKBP5;P3H2;NKTR
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5897784837615516,1.2368361575882518,0.2625607779578606,0.8550400095855316,1.0,1/15,0.24%,EGFR
prerank,regulation of protein kinase B signaling (GO:0051896),0.4135494949607948,1.2359224831091031,0.125,0.8569377834704835,1.0,21/193,6.18%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;NTRK3;FGFR1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;PHLPP2;STRN;TGFBR1;CD80;GCNT2;ESR1;GATA4;DDIT3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5791008714220629,1.2353287830244828,0.24673202614379086,0.8576645571948862,1.0,2/14,4.97%,CD55;TGFBR2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5831943490573311,1.2351484221663322,0.2512998266897747,0.8569741760696727,1.0,5/15,17.08%,TCF7L2;GSK3B;EMD;BAG3;XPO4
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5675810029945816,1.2350206557222678,0.24794745484400657,0.8561829493048652,1.0,7/16,26.01%,SMG6;TNKS2;ATM;SLX4;DHX36;NAF1;HNRNPA2B1
prerank,negative regulation of cell projection organization (GO:0031345),-0.38594835415466844,-1.2348644332882805,0.12987012987012986,0.6421297082957093,1.0,16/48,14.77%,EFNB2;APOE;RAPGEF2;LPAR1;DCC;SPOCK1;GRIN2B;EPHA4;DENND5A;MAG;CRMP1;PTPRO;RTN4RL1;MYLIP;TRPV4;FKBP4
prerank,ceramide biosynthetic process (GO:0046513),-0.4037987037259248,-1.2348511052151299,0.16838487972508592,0.640176248945704,1.0,9/40,12.05%,ST6GALNAC3;CERS4;ST8SIA4;SGMS1;DEGS2;ST8SIA6;SPTSSA;CERS1;CERS2
prerank,cognition (GO:0050890),0.4879120777965742,1.234815841390686,0.1989100817438692,0.8556261038692833,1.0,10/42,13.20%,ST3GAL4;SOBP;FAM107A;STRA6;MGAT3;DOP1B;SHROOM4;NF1;NIPBL;SETD5
prerank,response to ATP (GO:0033198),-0.4707144864983788,-1.2346705021664082,0.21467391304347827,0.6386683365673276,1.0,6/18,16.82%,TRPC3;ABCC9;P2RY1;P2RX7;HSP90B1;RYR3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5540299307244003,1.234548852280767,0.22784810126582278,0.8552714906158011,1.0,4/18,6.04%,ABL1;RFK;AGTR1;GDNF
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.40027850066260595,1.2343880445819075,0.06875631951466127,0.8544910234562632,1.0,99/497,14.21%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SAMD4A;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HDAC9;ZBTB16;HES1;TWIST2;GCLC;IGFBP5;WWP2;SHC1;KLF4;ZNF148;PRICKLE1;GSK3B;CRY2;RCOR3;ZNF423;MDFIC;ID1;L3MBTL3;BTAF1;PDCD4;FOXK1;PHC2;PAIP2;KAT6B;ARID4A;SAMD7;KLF10;TLE2;BHLHE40;GLIS2;SCMH1;SPINDOC;KDM1A;MBD1;DDIT3;NFIL3;SYNCRIP;DMBX1;SOX14;ID2;IRF1;MBTD1;SIX4;EHMT1;CDKN1B;ATOH8;ATP8B1;CIPC;RAD17;PHF12;NIBAN2;TOB1;FBXW11;BCLAF1;RARA;CBX5;DKK3;LIMS1;JUN;ELF3;FOXE1;NCOR1;PER1;SMAD2;EED;RB1;USP47;FOXK2;WAPL;ID4;NKX2-1;NIPBL;SMARCA4;UIMC1;GTPBP4;HNF4A;XRCC5;ERN2;NCOR2;SP3;BAP1;GCFC2;PRMT6;HDAC10;REST
prerank,positive regulation of dendrite development (GO:1900006),0.6348216418512664,1.2337793786829163,0.259581881533101,0.8552986417665568,1.0,2/10,1.25%,BMP5;COBL
prerank,non-motile cilium assembly (GO:1905515),0.5090054724083651,1.2335792133459647,0.18625954198473282,0.8547061981981262,1.0,20/30,32.41%,PCM1;ARL13A;TOGARAM1;DISC1;RPGRIP1;PIBF1;CEP89;C2CD3;GORAB;FUZ;CSNK1D;BBS4;IFT88;CEP290;TMEM80;RPGRIP1L;IFT122;DCTN1;TMEM17;TMEM107
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6060953016062198,1.2333910056442936,0.2411467116357504,0.8540351555396185,1.0,2/11,7.42%,EZR;RDX
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.48318310753029964,1.2332095384335515,0.19840213049267644,0.8533923440892818,1.0,14/49,17.26%,THBS1;NR4A3;RAB7B;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;KMT2D;EP300;PRMT6;KAT2B;PITHD1
prerank,protein localization to chromatin (GO:0071168),0.5732880277956255,1.2329852161321189,0.23633440514469453,0.8529425128963053,1.0,8/18,18.84%,ESR1;SGF29;WAPL;NIPBL;MRNIP;MCM9;LEMD2;TASOR
prerank,keratan sulfate catabolic process (GO:0042340),-0.5350301371807935,-1.2325608456721164,0.20207253886010362,0.6427430242826815,1.0,7/11,16.83%,FMOD;OGN;LUM;OMD;HEXB;PRELP;GALNS
prerank,protein localization to plasma membrane (GO:0072659),0.430016607788907,1.2325156678419866,0.15903890160183065,0.853318706477644,1.0,26/129,10.04%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;NECTIN3;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;SEC16A;S100A10;C2CD5;FCHO2;EHD1
prerank,amino acid transport (GO:0006865),0.4836837021382684,1.2324250135472334,0.20272108843537415,0.8523602585489347,1.0,5/49,7.03%,SLC38A2;SLC38A1;SLC38A6;SLC7A2;SLC6A19
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.42657914032151173,-1.2323812697598535,0.19047619047619047,0.6412393013150363,1.0,6/28,15.03%,SH3KBP1;CD47;SIRPA;PRKCQ;TNIP2;TYROBP
prerank,T cell differentiation in thymus (GO:0033077),0.5886368270665423,1.232030184331117,0.24217462932454695,0.8524999569692726,1.0,2/14,9.08%,GLI3;RIPK3
prerank,monoacylglycerol metabolic process (GO:0046462),0.595913305646333,1.2318359838686457,0.24918032786885247,0.8518993916689203,1.0,4/13,11.78%,MGLL;MOGAT3;ABHD6;DGAT2L6
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5230402794946776,1.2314824931537964,0.22238372093023256,0.8518527558908084,1.0,2/29,3.19%,THBS1;INHBA
prerank,endochondral bone morphogenesis (GO:0060350),0.6040048568496184,1.231353365456992,0.25996533795493937,0.8510426220904813,1.0,1/11,0.28%,BMP4
prerank,regulation of DNA metabolic process (GO:0051052),0.4946161170611719,1.231222470425987,0.2083916083916084,0.8502424961605763,1.0,17/44,21.48%,SMG6;HDAC8;KPNA1;PDGFA;GRHL2;USP1;SMG1;XRCC5;WDR18;NBN;YLPM1;TICRR;UBE2N;HELB;WDR70;TOM1L1;MPV17
prerank,sodium ion export across plasma membrane (GO:0036376),0.6040341712381383,1.2309166913019043,0.24493243243243243,0.8500340380362919,1.0,6/13,8.86%,SLC4A4;ATP1B1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,T cell proliferation (GO:0042098),-0.5084135046599912,-1.2308236108273656,0.23017902813299232,0.643554640273794,1.0,5/13,19.01%,CADM1;CTPS1;PPP3CB;DOCK8;PIK3CG
prerank,early endosome to late endosome transport (GO:0045022),0.5519925865457459,1.2306025483454879,0.2416,0.8498079445952348,1.0,12/20,25.05%,EEA1;BECN1;ANKRD27;STX8;KIF16B;WDR81;HOOK3;SNF8;RAB5A;EMP2;HOOK2;RAB7A
prerank,regulation of protein transport (GO:0051223),0.5248333858352088,1.2305003214033836,0.24283559577677225,0.8489691093921584,1.0,9/27,14.14%,DISP1;WWP2;NDEL1;P3H1;DNAJC1;GAPVD1;SNX12;CHP1;ARFIP1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.47650832214667777,1.2303996848581382,0.21003963011889035,0.8480978564737145,1.0,14/52,12.77%,EGFR;SORBS1;ITGB1;PRKCE;ACSL3;ATP2B4;LRP1;PLS1;AGR2;DLG1;CNST;RANGRF;PTPN9;ZDHHC2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.466366538756223,-1.2301557474022387,0.19607843137254902,0.6433955380997068,1.0,8/19,5.71%,ROBO1;SEMA6A;CCBE1;DCN;JCAD;TSPAN12;CD63;DAB2IP
prerank,response to X-ray (GO:0010165),0.5806383768087622,1.2295910112087878,0.2569558101472995,0.8497406962152205,1.0,4/14,13.34%,ANXA1;ATM;NIPBL;XRCC5
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4769526334968171,-1.2292903722552715,0.20161290322580644,0.6438485348714629,1.0,7/16,16.62%,APOE;HIF1A;NOS1AP;NUS1;SCARB1;AKT1;GCH1
prerank,actin filament bundle assembly (GO:0051017),0.512442970064092,1.229205322316561,0.21951219512195122,0.8498413612871384,1.0,8/33,6.54%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,cGMP metabolic process (GO:0046068),0.6245195049273908,1.228978441621718,0.2533557046979866,0.8493907709252113,1.0,1/12,0.24%,GUCY2C
prerank,regulation of ruffle assembly (GO:1900027),-0.4495075998990114,-1.2288318559937499,0.19117647058823528,0.6431636819380181,1.0,6/23,13.71%,EPS8;ARHGAP24;EVL;EPS8L2;ABI3;PLEKHM1
prerank,sulfur compound biosynthetic process (GO:0044272),0.43999958818675466,1.2284628870028917,0.18903150525087514,0.8498458655852208,1.0,12/104,6.43%,SLC26A2;ST3GAL4;UST;DSE;GCLC;B3GNT2;CHST13;PAPSS2;GLCE;CHST5;SLC10A7;B4GALT1
prerank,negative regulation of locomotion (GO:0040013),-0.5272222525025636,-1.2284437353650468,0.23658536585365852,0.6423026603089571,1.0,3/12,2.97%,FRMD5;SPOCK3;FBLN1
prerank,myeloid cell development (GO:0061515),0.5679733463872954,1.227651736934466,0.26578073089701,0.8515037226494461,1.0,4/18,9.70%,FOXP1;ANXA2;DMTN;GATA1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.49705739692281964,1.2274716810184076,0.21915820029027577,0.8509670155467343,1.0,8/39,7.42%,CDH1;FXYD5;WNK1;KLF4;BMP6;JAG1;IL10;RDX
prerank,protein localization to cell periphery (GO:1990778),0.4251687054773936,1.2268278197133318,0.1536723163841808,0.8519446158338118,1.0,27/133,10.04%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;ARL3;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;RABEP1;SEC16A;S100A10;C2CD5;FCHO2;EHD1
prerank,macrophage activation (GO:0042116),0.5059269965073818,1.2268095450637413,0.23303834808259588,0.8507629351119281,1.0,6/34,9.84%,FOXP1;LBP;CLU;IFI35;TLR4;PLCG2
prerank,regulation of B cell apoptotic process (GO:0002902),0.5912961952813416,1.2266367259032815,0.2529313232830821,0.8501263676133912,1.0,1/12,0.25%,FOXP1
prerank,sensory organ development (GO:0007423),0.4719221962486364,1.2263862534964278,0.21721311475409835,0.849714279432912,1.0,11/51,14.13%,PBX3;PBX1;SMOC1;HIPK1;STRA6;SIX4;FOXC1;SCO2;ATF6;PAX6;ECE1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4893623602258358,1.22624304590793,0.22040816326530613,0.8489795891205348,1.0,7/40,3.97%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5078775399320967,1.2262110589381605,0.225,0.8478760082667236,1.0,7/32,6.70%,THBS1;SEMA3E;PHLDB2;FAM107A;BCAS3;DMTN;JAG1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5036393511804765,1.225736261524083,0.23504867872044508,0.8482589596488042,1.0,9/35,5.01%,NTRK3;BAIAP2L1;PTK2B;SEMA3E;ARHGDIB;NOTCH2;ABL1;NRP1;BCAS3
prerank,synaptic membrane adhesion (GO:0099560),0.5861469429882276,1.225451780139222,0.25210084033613445,0.8480316777726479,1.0,3/14,8.23%,GPC6;PTPRF;GPC4
prerank,glutathione biosynthetic process (GO:0006750),0.6022063536704773,1.2245353256617246,0.2504201680672269,0.8499087513576883,1.0,1/11,2.63%,GCLC
prerank,vesicle transport along microtubule (GO:0047496),0.5385713553727033,1.224387606205625,0.2409090909090909,0.8492056971639799,1.0,6/23,9.47%,KIF13A;NDEL1;PAFAH1B1;KIF1C;DYNC1I1;FBXW11
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4611016445336881,-1.2239652668414036,0.21761658031088082,0.6530920319097753,1.0,7/18,17.12%,MSRA;ASPA;ASPG;ASS1;SMS;ASNS;GOT2
prerank,organelle transport along microtubule (GO:0072384),0.503903040959332,1.223506012336154,0.23949579831932774,0.8511245587514866,1.0,15/31,26.18%,ARHGAP21;NDEL1;RAB6A;PAFAH1B1;DYNC1I1;FBXW11;COPG1;TMEM201;CLN3;RAB1A;CDC42;RHOT1;TRAK1;BICD1;MAP1S
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4148000016101683,-1.2229795249350535,0.19805194805194806,0.6539792875447111,1.0,7/27,6.10%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4791288203443881,1.2228428068842605,0.2391304347826087,0.8521619549265396,1.0,4/50,2.97%,THBS1;NGF;CD44;KLF4
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5232215839417935,-1.2228007405081274,0.2482598607888631,0.6525411584335896,1.0,3/10,5.33%,CST3;NOTCH1;DPP4
prerank,heart morphogenesis (GO:0003007),-0.361069881056756,-1.2227713932539332,0.16049382716049382,0.6506621086211574,1.0,14/50,7.41%,ENG;CHD7;TGFBR3;NOS3;TBX3;INSR;NOTCH1;TBX1;RYR2;SOX17;EPHB4;PTK2;BMP2;HEY2
prerank,dendritic cell differentiation (GO:0097028),-0.4398522671171564,-1.2227317919653764,0.1834862385321101,0.6488515951449341,1.0,9/22,26.04%,LYN;GAS6;AXL;CCL19;FLT3;PRTN3;TREM2;BATF;IRF8
prerank,regulation of cytoskeleton organization (GO:0051493),0.4283290234973059,1.2224743803241438,0.18705035971223022,0.8520944771545955,1.0,24/108,9.47%,CLIC4;SORBS3;EZR;EFNA5;PRKCD;PHLDB2;ARHGAP44;GSK3B;CAPN2;RHOBTB1;ABL1;FAM107A;DIAPH1;RHOQ;LRP1;DMTN;ARHGAP17;MARK2;PDGFA;CAPN6;RHOA;IQGAP1;RND3;MLST8
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5479667566103622,1.2223469862921699,0.21939586645468998,0.8512759430734621,1.0,7/19,9.81%,CLIC4;DLG2;DLG1;MARK2;PATJ;PARD3;ERBIN
prerank,epithelial to mesenchymal transition (GO:0001837),-0.38192504875090294,-1.2220928137434104,0.144,0.6485884242621363,1.0,17/47,11.32%,LEF1;WNT4;ENG;TGFBR3;TBX3;WNT5A;BMP7;NOTCH1;LOXL3;RBPJ;HIF1A;NOTCH4;BMP2;HEY2;FOXF2;OLFM1;ROCK2
prerank,metal ion transport (GO:0030001),-0.33633177144497695,-1.2220542999506623,0.11173184357541899,0.6467947093443539,1.0,27/86,15.94%,ITPR1;CACNA1D;CACNA1E;TRPC3;CALCRL;SLC8A1;RYR2;SLC39A8;ATP2C1;TPT1;SLC41A1;CACNA1B;CACNA2D1;CACNG7;TRPC4;MMGT1;SLC30A1;RAMP2;CAMK2A;NDFIP2;TRPC1;SLC3A2;GRIN3A;SELENOK;TRPV4;CCR5;ATP2A3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4792170249229396,1.22203586414618,0.20781032078103207,0.8510981215940623,1.0,10/43,11.37%,PID1;PRKCD;GRB10;SORBS1;IRS1;PTPN2;ZBTB7B;C1QTNF12;SIK2;ERFE
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5247966024923227,1.2217605335670025,0.22672672672672672,0.8508179834899444,1.0,4/27,5.27%,ANK2;CAMK2D;AHNAK;DMD
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4934236629279557,-1.2215609136982672,0.20812182741116753,0.6463495416242259,1.0,4/14,11.73%,IGF1;SYT11;GRN;CD200
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3971877229003019,-1.2213851783753724,0.16554054054054054,0.6449266848471642,1.0,18/40,28.65%,IGF1;BCL2L1;TNFSF10;PDCD5;BMF;AKT1;BIK;TRIAP1;GPER1;DNM1L;PLAUR;PMAIP1;PYCARD;MFF;MLLT11;PINK1;HRK;BCL2L11
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4182190901802979,1.2210789795994446,0.14949037372593432,0.8519130152181893,1.0,34/152,13.71%,RSPO3;EGFR;WNK1;GPC3;SULF1;PLEKHA4;VCP;TRPM4;TMEM198;SFRP4;UBE2B;SKI;UBR5;BAMBI;TBL1X;PSMB2;RSPO4;JUP;CSNK1G3;USP34;DISC1;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;RNF146;USP47;SMARCA4;CSNK1G1;ZRANB1;PPM1A;CSNK1E;PSMD11
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45197270484862934,-1.2207762314798045,0.1994535519125683,0.6448207790285988,1.0,1/19,0.18%,IGF1
prerank,cell junction maintenance (GO:0034331),-0.511058782494848,-1.22063817722732,0.23351648351648352,0.6433462405221027,1.0,6/14,23.89%,CLDN1;CSF1R;MYADM;CHCHD10;PRTN3;F2R
prerank,negative regulation of cellular process (GO:0048523),0.39383535612277626,1.2205571897750433,0.055499495459132187,0.8524498273809457,1.0,58/521,7.56%,SLIT3;SLIT2;ZBTB7C;BMP4;CCN3;FHL1;NDRG3;WNT9A;OSGIN2;TES;BMP5;NGF;CYP1B1;CCN1;CCN5;PTK2B;ABI1;PTPRU;TGFB3;WNT11;ARHGDIB;SMAD6;VPS13C;CD9;ESR2;KLF4;INHBA;FGF2;LRPAP1;LMNA;SRGAP2;STRN;IP6K2;PDCD4;P3H2;PTPN2;NCK2;SMYD2;KLF10;SFRP4;BECN1;CLMN;WNT16;FRK;SKI;CLU;PTHLH;PLSCR1;AGR2;SLURP1;SRSF6;TGFB1I1;IFI35;MYOG;IL10;CELF1;P3H1;IRF1
prerank,mitochondrion morphogenesis (GO:0070584),0.613005550050863,1.2201742269054043,0.2508833922261484,0.8525887478756502,1.0,1/11,1.88%,PID1
prerank,relaxation of muscle (GO:0090075),0.593681034761443,1.219841606607146,0.2773972602739726,0.8525417824804055,1.0,6/13,8.77%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4;ATP1A1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5994837781265945,1.2196534819587996,0.25383304940374785,0.8520194674864502,1.0,4/10,3.42%,STK39;NEDD4;CAMK2D;PRKCE
prerank,cell projection assembly (GO:0030031),0.5514022270334215,1.2190468304290987,0.2329803328290469,0.8527861518349447,1.0,6/22,10.17%,RHOJ;GSN;PARVA;RHOQ;PDGFA;NCKAP1
prerank,positive regulation of programmed cell death (GO:0043068),0.40300140628936415,1.2189640812232216,0.125,0.8518824410866678,1.0,39/272,12.21%,SLIT2;BMP4;RASSF2;MAP3K5;HOXA5;NGF;CYP1B1;TGFB3;AKAP13;PAWR;FOXO3;VAV2;ANO6;CRADD;ITGB1;UNC13B;ABL1;IP6K2;TIAM2;SFRP4;GADD45G;TRIO;CLU;ARHGEF6;CALHM2;GNA13;BCLAF1;RARG;NF1;ATM;JUN;DIABLO;ATF6;ARHGEF5;ARL6IP5;TIAM1;UBE2Z;HTATIP2;SOS2
prerank,superoxide metabolic process (GO:0006801),0.5239552442722525,1.2188047673909927,0.22288261515601784,0.8512354325394,1.0,1/29,0.12%,SH3PXD2A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5275090612704675,-1.2187777673986013,0.22946859903381642,0.6467524143287843,1.0,5/12,9.25%,UNC13C;RIMS1;RIMS2;SYT7;SYT1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5932738645171761,1.2185165787600996,0.2627257799671593,0.8498700748831997,1.0,6/12,13.69%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5932738645171761,1.2185165787600996,0.2627257799671593,0.8498700748831997,1.0,6/12,13.69%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5178607171224162,-1.2183648564232734,0.23834196891191708,0.6460255429610049,1.0,5/11,22.55%,NOVA1;NOVA2;PCBP1;PCBP3;IGF2BP1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.41551588468263945,1.2181751857542635,0.15736607142857142,0.849840376688059,1.0,30/166,13.69%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;SORBS1;KLF4;GIPC1;FGF2;IRS1;PTPN2;LDLR;CLU;TLR4;BCAR3;STN1;LARP4B;NNMT;STARD4;P2RX4;GLI2;CNEP1R1;ELOVL5;ERBB2;EIF3E;CHP1;EIF6;MTOR;PRKDC;DYRK2
prerank,protein depolymerization (GO:0051261),0.5304530446629016,1.218079896148648,0.2404870624048706,0.8490048344678871,1.0,2/27,2.48%,MICAL2;GSN
prerank,sphingoid biosynthetic process (GO:0046520),0.5904018536821346,1.218025646509241,0.2546689303904924,0.8468322865590724,1.0,1/11,0.61%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.5904018536821346,1.218025646509241,0.2546689303904924,0.8468322865590724,1.0,1/11,0.61%,ACER3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5973750897863356,1.2179288676888718,0.2725752508361204,0.8459756269736355,1.0,5/13,16.06%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,contractile actin filament bundle assembly (GO:0030038),0.5737868549255272,1.217813717865035,0.28046744574290483,0.8439968952918755,1.0,5/15,9.06%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,stress fiber assembly (GO:0043149),0.5737868549255272,1.217813717865035,0.28046744574290483,0.8439968952918755,1.0,5/15,9.06%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,regulation of cellular response to stress (GO:0080135),0.43139526726485744,1.2175989055759915,0.16803760282021152,0.8436031869918512,1.0,32/115,20.88%,SLC38A2;CAMK2D;GSK3B;ABL1;NUP93;EIF4G1;CREBBP;HSPA1L;MLST8;RANBP2;ATM;HSPB8;CHORDC1;SEC13;NUP153;MTOR;SMG1;EP300;BAG3;MAPKAPK2;NUP214;RPA1;NUP188;ABCD1;NUP88;ATR;AIFM2;NEK6;DYRK3;CLN3;MCL1;NUP98
prerank,regulation of myoblast differentiation (GO:0045661),0.49885141414663076,1.2173237864897086,0.23735955056179775,0.8433779178489331,1.0,3/32,1.12%,BMP4;BOC;SOX9
prerank,myotube differentiation (GO:0014902),-0.45877302449982865,-1.2168514975377485,0.23076923076923078,0.648443473478299,1.0,5/17,8.51%,IGF1;SORT1;MEF2C;ADGRB3;ADAMTS15
prerank,relaxation of cardiac muscle (GO:0055119),0.5874492036260611,1.2167200321744864,0.2752902155887231,0.8442017133224474,1.0,4/13,2.48%,KCNJ2;ATP1B1;CAMK2D;GSN
prerank,mesenchymal cell differentiation (GO:0048762),-0.36775567980817303,-1.2164153803235433,0.1568627450980392,0.6478618802589444,1.0,15/51,7.41%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;BMP7;NOTCH1;LOXL3;RBPJ;MEF2C;HIF1A;NOTCH4;BMP2;HEY2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5100396258419331,-1.2158571251283088,0.24,0.6476461629800709,1.0,6/12,24.22%,ASS1;ACLY;IDH2;ACO1;GLUD1;IDH3A
prerank,protein localization to mitochondrion (GO:0070585),-0.5259447126241361,-1.2154991645875537,0.23990498812351543,0.6468063225056913,1.0,8/11,40.71%,HK2;AKT1;COX18;RALA;PINK1;HK1;LRRK2;ISG15
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4738617849259982,-1.2154071188728817,0.22938144329896906,0.645226677483445,1.0,4/18,4.27%,SLC2A1;OCLN;PRKAG2;PRKCB
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5261995401154171,1.2153544098580789,0.2674050632911392,0.8475979542381141,1.0,1/23,0.03%,SLC4A4
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.48752524292614435,-1.215008085084248,0.2144638403990025,0.6444719766881217,1.0,4/14,6.10%,LYN;PIK3R1;GHR;PTK2
prerank,polyamine metabolic process (GO:0006595),0.5875822298336919,1.2147173229657442,0.2727272727272727,0.8485276476803733,1.0,6/13,24.26%,SMOX;SRM;HDAC10;SAT1;ODC1;OAZ2
prerank,glycolipid biosynthetic process (GO:0009247),0.4883194671718047,1.2145544937553823,0.20815752461322082,0.847965412403212,1.0,11/38,20.00%,ST3GAL4;LARGE1;PGAP2;PIGB;A4GALT;DPM1;PIGU;ST3GAL2;ST6GALNAC5;PIGL;PIGN
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4680005777511631,1.2140385023137754,0.22506738544474394,0.8485695857473171,1.0,7/47,9.84%,THBS1;PID1;PRKCD;AGTR1;TGFBR2;TLR4;PLCG2
prerank,DNA repair (GO:0006281),0.398150314497841,1.2138538242828658,0.11506276150627615,0.8479634352759758,1.0,109/284,26.06%,MPG;ABL1;HERC2;APEX2;FTO;VCP;UBE2B;SMUG1;MNAT1;EXO1;SETD2;EYA3;TRRAP;CHEK2;ERCC5;CHD1L;RAD17;WRN;APLF;COMMD1;ATM;RAD23B;USP1;SLC30A9;APEX1;BRCA2;IGHMBP2;NABP1;USP47;SMC1A;MTA1;PPP5C;RAD52;UIMC1;SLX4;CHEK1;RNF168;PRKDC;XRCC5;CSNK1E;MLH3;BAP1;PRMT6;ERCC8;POLB;RNASEH2A;POLE2;FANCL;EID3;ZBTB1;HINFP;ERCC3;NSMCE1;RBBP8;SMARCAL1;XPA;VCPIP1;RPA1;RMI2;RECQL5;BARD1;NBN;TICRR;RAD51;ERCC1;ATR;FANCM;NEIL3;SMARCA5;TNKS1BP1;INO80;WDR48;TOPBP1;PARP3;UBE2N;MAPK8;ASCC1;PARP4;EXD2;RAD51C;FAAP24;TDG;POLA1;KMT5B;RNF8;HUWE1;DDX1;POLD3;ALKBH5;NUDT1;RAD9B;RAD50;MBD4;BRCC3;PARP2;RFC5;UBE2V1;BRIP1;ERCC2;USP3;ASCC2;KAT5;POLK;POLQ;PWWP3A;MDC1;XPC;RAD51AP1;FAM111A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5469838817575025,1.2136051617399057,0.26226993865030673,0.8464575822813721,1.0,5/21,9.70%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5469838817575025,1.2136051617399057,0.26226993865030673,0.8464575822813721,1.0,5/21,9.70%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.44523625094714875,1.21349044276599,0.1960542540073983,0.8456688803289159,1.0,30/80,24.33%,PLPP3;ERGIC1;RAB6A;ERGIC2;GOLPH3;GBF1;ARF3;KIF1C;NSF;KLC1;ARF4;COPA;ARCN1;COG3;ATP9B;SEC22B;ARFGAP3;ARFGAP1;COPG1;KIF3B;BNIP1;ZW10;RAB1A;NBAS;PITPNB;TMED3;KIF2C;SURF4;ATP9A;STX18
prerank,morphogenesis of an epithelium (GO:0002009),0.5199354217948442,1.2134591107872637,0.26825633383010433,0.8446071975829018,1.0,4/25,8.14%,SOX9;LRP6;VCL;RIPK4
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5314947733543007,-1.2133862727481395,0.22811671087533156,0.6453363194166961,1.0,2/12,5.49%,IGF1;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5314947733543007,-1.2133862727481395,0.22811671087533156,0.6453363194166961,1.0,2/12,5.49%,IGF1;AKAP6
prerank,central nervous system neuron differentiation (GO:0021953),-0.40351384689285774,-1.2130308388180358,0.18874172185430463,0.644468041269791,1.0,11/33,9.22%,MAP2;GRID2;SPOCK1;TOX;MDGA2;OPHN1;NTRK2;ZC4H2;MAPT;FAIM2;PROX1
prerank,negative regulation of protein secretion (GO:0050709),0.4842258578838445,1.2129233736460845,0.24558823529411763,0.8452617320433357,1.0,9/38,15.11%,CCN3;KCNB1;IRS1;RAB11FIP3;DRD3;INHBB;REST;SERGEF;HMGCR
prerank,positive regulation of defense response to virus by host (GO:0002230),0.5197460414042075,1.2124359349045257,0.2399403874813711,0.845628853354585,1.0,6/24,14.01%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;EIF2AK4
prerank,regulation of transport (GO:0051049),-0.39484542839389786,-1.212325422400626,0.2007168458781362,0.6446163344839068,1.0,6/36,7.40%,LEPR;EPB41;ICA1;ACTB;MYO6;SNCA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4445990317577257,1.21203887661417,0.2004950495049505,0.8458263591299316,1.0,23/76,21.00%,HDAC4;TANK;PRICKLE1;FAM107A;RIPK2;BIRC7;MYCBP2;SAE1;PIAS3;DCUN1D5;COMMD1;ZC3H12A;FBXO4;CUL3;TNIP1;BCL10;WDR48;BIRC3;DCUN1D4;PIAS1;DCUN1D2;DCUN1D1;HUWE1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.31860348064508903,-1.2119363493147028,0.13194444444444445,0.6437782376073141,1.0,25/110,11.28%,ADGRL4;ADGRL3;ADCY5;ADCY1;LGR4;RAPGEF2;LPAR1;GNG2;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;ADGRB3;ADRA2A;ADGRG1;ADORA2A;S1PR1;PTH1R;ADM;RAMP2;TBXA2R;LPAR2;S1PR3;ADCY2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5419672801669106,-1.2119328129624904,0.25183374083129584,0.6419800962576544,1.0,2/10,1.28%,ACSL1;SLC2A1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4177113983223689,-1.211651433266726,0.19287833827893175,0.6409353987145251,1.0,9/26,12.59%,SLC30A10;PPARA;SLC5A3;SNCA;GRIN1;SLC25A33;ABCB7;CYBA;ADGRB1
prerank,apoptotic cell clearance (GO:0043277),0.5005592739534312,1.2112290068361715,0.26666666666666666,0.8474013419584571,1.0,7/30,10.86%,THBS1;ANXA1;RHOBTB1;ITGAV;LRP1;RARA;ITGB3
prerank,bile acid and bile salt transport (GO:0015721),-0.4300570856868994,-1.211219144564286,0.23708206686930092,0.6403018144906506,1.0,3/24,1.62%,SLCO2B1;NCOA1;SLCO1C1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5307837065792679,1.2110638481833185,0.25225225225225223,0.8467522914524016,1.0,8/24,7.23%,WNT9A;SOX9;ZBTB16;TGFBR1;EFEMP1;PTHLH;GDF6;GDF5
prerank,T cell differentiation (GO:0030217),-0.38466285154925484,-1.2109259422105427,0.1758957654723127,0.6393366493082636,1.0,8/40,9.17%,LEPR;CHD7;SOX13;KIT;RHOH;JAG2;TCF7;LFNG
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.40943236232799535,-1.2107683708759758,0.20761245674740483,0.6379686815443245,1.0,9/29,9.13%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2;CD81;PDGFRA
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4497123560061116,1.2106472811854727,0.1956241956241956,0.8470230535770996,1.0,15/73,15.28%,THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5924618465328054,1.2103537854527717,0.256140350877193,0.8468346741203454,1.0,5/13,11.37%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5423067243531816,1.2102790076546253,0.24845679012345678,0.8459168423655503,1.0,4/20,12.51%,PLOD2;GCLC;PLSCR1;FPGS
prerank,negative regulation of protein modification process (GO:0031400),0.4430132739283174,1.2098020501514921,0.21914357682619648,0.8463047181713295,1.0,13/79,8.59%,SLIT2;NTRK3;LRP6;PID1;PLPP3;NIBAN1;GSK3B;ATP2B4;DMD;SNTA1;KLHL31;P3H1;IBTK
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.39384848988797605,1.2087920912476096,0.088659793814433,0.8484871926271497,1.0,76/327,17.73%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;NFIA;USP13;ESR2;JMJD1C;FZD7;ZNF423;ERC1;ABL1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;HMG20A;ESR1;STAT3;GATA4;DDIT3;NFIL3;TRRAP;PITX3;SOX14;CRABP2;CHEK2;FUS;IGSF1;NLK;FOXC1;NFYA;RORA;SERTAD3;PHF12;ATF7;BRCA2;GON4L;GTF2IRD1;RB1;NFKB2;FOXK2;CTR9;ATRX;KMT2D;TCF3;EP300;CHD3;HCFC1;SP3;GPBP1;GCFC2;HDAC10;REST;GPBP1L1;CDK11B;ATF2;BAZ2A;PCGF1;HINFP;PML;WWTR1;ZNF219;CREBL2;ZMIZ1;NSD1;RNF14;POU6F2;SBNO2;HCLS1;UTP4;CARM1
prerank,cell-matrix adhesion (GO:0007160),0.43106282200382956,1.2079110177415846,0.19588875453446192,0.8502787574068594,1.0,16/95,6.03%,MSLN;ITGBL1;PKD1;ITGB8;FN1;ADAM9;CD44;COL3A1;SORBS1;ITGB1;BCR;ITGB5;ITGA10;VCL;ITGAV;PIP5K1A
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4102879537629362,1.2078266644240978,0.15,0.8493889947027716,1.0,15/151,6.17%,BMPER;EGFR;TNFAIP8L3;NTRK3;PDGFC;PTK2B;CD44;SHC1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A;GCNT2;GATA4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5533845678664019,1.2077987974055533,0.26732673267326734,0.8483394038611255,1.0,5/17,4.96%,KCNJ2;ANK2;CACNA1C;CACNA1G;TRPM4
prerank,response to organophosphorus (GO:0046683),-0.46883535922966535,-1.2077372746258779,0.2192513368983957,0.6445045036816183,1.0,6/16,17.79%,TRPC3;ABCC9;P2RX7;STAT1;VGF;NDUFS4
prerank,regulation of sodium ion transport (GO:0002028),0.4975937306784313,1.2076665975278094,0.23982558139534885,0.8476512102794512,1.0,10/34,11.39%,NEDD4;SLMAP;WNK1;ATP2B4;SNTA1;DLG1;P2RX4;ATP1A1;PER1;RANGRF
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5919794565138989,1.2070527802100885,0.2766726943942134,0.8484761311140053,1.0,5/11,10.84%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,somite development (GO:0061053),0.6005294786987336,1.2069687782400427,0.24352331606217617,0.8476280289938606,1.0,2/11,2.30%,SMO;MEOX2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4291775532029423,-1.2069468520475433,0.1901840490797546,0.6449868334829691,1.0,9/25,15.10%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GLRA1;GSK3A;AKT1;ARRB2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.519916937778531,1.206443470237487,0.25997045790251105,0.84828254727925,1.0,8/23,13.45%,GLI3;GPC3;HHIP;VCP;GLIS2;KIF7;MEGF8;HERC4
prerank,central nervous system development (GO:0007417),0.4013531210109616,1.205570224708032,0.136986301369863,0.8499530634676405,1.0,28/250,8.60%,SLC23A1;WWP1;PBX3;DCLK1;VIT;ZFHX3;NFIB;PKD1;SOX9;ZIC4;ADGRL2;PDGFC;SMO;PBX1;ZBTB16;GSN;ZIC1;ECRG4;NR4A2;TGFBR2;GLIS2;STAT3;ELP3;DMBX1;SNTG2;SHROOM4;GRHL2;PAFAH1B2
prerank,intestinal absorption (GO:0050892),-0.49105845029359585,-1.2053435298766288,0.23918575063613232,0.6476245278724001,1.0,4/13,8.64%,F11R;UGCG;ADRA2A;KCNQ1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3364677726598734,-1.2052437280330874,0.08421052631578947,0.6461151270518941,1.0,26/75,18.02%,DCDC2;CTNNA2;MAP2;ANK3;DCC;CNTN4;ACTB;BAIAP2;APP;MEF2C;OPHN1;ZDHHC17;PLPPR4;PAK3;MFSD2A;BRSK2;DSCAML1;ADGRB1;LMTK2;NRCAM;APBB1;SLITRK5;NEFH;RAB3A;S100A6;SPTBN4
prerank,negative regulation of phagocytosis (GO:0050765),-0.473158746367561,-1.2050892191617137,0.2273972602739726,0.6447825521609818,1.0,8/17,19.72%,DYSF;CD47;SIRPA;SYT11;CD300A;RACK1;SNX3;PRTN3
prerank,glial cell differentiation (GO:0010001),0.5074575881069704,1.2049064142717694,0.2345132743362832,0.8509603540499114,1.0,5/28,9.90%,NFIB;SOX9;STAT3;EGR2;ADGRG6
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.44270576716204973,1.2048775705703676,0.2147239263803681,0.8499239073724685,1.0,10/76,5.01%,NTRK3;BAIAP2L1;CDC42EP5;SORBS3;PTK2B;PRKCE;ABL1;NRP1;NCK2;BCAS3
prerank,negative regulation of neuron projection development (GO:0010977),-0.3629336511604238,-1.2048219678740668,0.15217391304347827,0.6438035131788431,1.0,23/56,19.05%,EFNB2;APOE;LPAR1;DCC;SPOCK1;EPHA4;DENND5A;ARHGDIA;MAG;CRMP1;RTN4;LINGO1;PTPRO;EFNB3;RTN4RL1;NGEF;MYLIP;TRPV4;FKBP4;STMN2;BCL11A;OMG;MT3
prerank,regulation of cellular protein localization (GO:1903827),0.4716078510937722,1.2045820350859742,0.25069252077562326,0.8497735873477289,1.0,11/45,13.46%,GPC6;GPC3;NDEL1;VCP;KDM1A;SETD2;GBF1;GPC4;CCDC66;SPIDR;CSNK1E
prerank,regulation of DNA recombination (GO:0000018),0.4969761499857332,1.2044042877605303,0.26453488372093026,0.84922228277988,1.0,9/32,17.86%,KDM1A;SETD2;KPNA1;IL10;SPIDR;CHEK1;PPP4R2;SIRT6;RAD51
prerank,proteolysis (GO:0006508),0.40079739321262414,1.2042820324491215,0.1475237091675448,0.8485164698840704,1.0,50/252,15.41%,F3;TRABD2B;CAPN5;HTRA3;PCSK5;BMP1;NPEPPS;CPQ;CAPN2;HTRA1;DDI2;CASP6;PHEX;HTRA4;MMP16;SPPL2A;TBL1X;TASP1;XPNPEP1;IDE;CPA5;CNDP1;ASPRV1;XPNPEP3;CAPN6;CPA4;CPA3;NLN;BACE2;MMP14;USP25;FBXL6;DESI1;DESI2;PGPEP1;LONP2;CAPN10;ERAP1;ADAMTS3;CAPN12;YME1L1;CLPP;TMPRSS2;PITRM1;ECE1;PCSK7;LAP3;DPP3;CPB1;ADAM10
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5406612187161908,1.2040317962860467,0.2519561815336463,0.8481909801704193,1.0,6/20,7.95%,SLIT2;IGFBP5;BMPR1A;NRP1;LRP1;PDGFA
prerank,protein stabilization (GO:0050821),0.40720970918225685,1.2036590276903973,0.1657271702367531,0.8482920697184771,1.0,38/168,15.15%,RASSF2;ANK2;ATP1B1;PRKCD;PLPP3;PARVA;USP2;USP13;TELO2;HPS4;UBE2B;COA8;CLU;TBL1X;TRIM44;P3H1;CHEK2;MDM4;SEC16A;NLK;PER3;IFT46;AAK1;PIM2;USP7;MORC3;TBRG1;WDR81;USP33;CHP1;COG3;GTPBP4;EP300;HCFC1;BAG3;GOLGA7;OTUD3;TRIM39
prerank,amide transport (GO:0042886),0.5179299055766518,1.2032558913808267,0.2648809523809524,0.8485087233319395,1.0,3/26,2.41%,SLC5A6;DISP1;ABCG2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5478178990266651,1.2032442415370188,0.26666666666666666,0.8474237740283581,1.0,2/20,6.59%,FKBP5;NKTR
prerank,protein methylation (GO:0006479),0.47663423523028114,1.2030387911045357,0.2544704264099037,0.8469451227368866,1.0,18/40,25.98%,RAB6A;EHMT1;PRMT8;ETF1;CTCFL;GSPT1;PCMT1;PRMT6;METTL22;ETFBKMT;NSD1;CARM1;EHMT2;EEF1AKMT1;PRMT5;METTL21A;PRMT2;METTL21C
prerank,neuronal action potential (GO:0019228),0.5273295243894096,1.2028682388547813,0.2619047619047619,0.8463347039723383,1.0,3/22,3.27%,KCNMB3;KCNMB2;CACNA1G
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5044549241835169,1.2023079204689668,0.24499229583975346,0.8470868809754228,1.0,5/30,5.73%,KCNJ2;ANK2;CACNA1C;CACNA1G;SNTA1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4353426583070091,1.2019923291954748,0.2026378896882494,0.8469828412801387,1.0,33/95,22.64%,REV3L;RNF138;ERCC5;MCM7;WRN;MCM2;BRCA2;NABP1;SMC5;SPIDR;NIPBL;RAD52;CDC45;SLX4;KDM4D;MCM9;NSMCE1;RBBP8;YY1;RPA1;RECQL5;NBN;RAD51;FANCM;INO80;PSMD14;SWSAP1;UBE2N;EXD2;RAD51C;SMC6;RAD50;ZFYVE26
prerank,regulation of membrane repolarization (GO:0060306),0.569816596339304,1.2019841691878057,0.27692307692307694,0.8459096581594572,1.0,1/13,0.28%,KCNJ2
prerank,autophagy of peroxisome (GO:0030242),0.5890047366056771,1.2017366881504368,0.27177700348432055,0.8456062301705165,1.0,5/12,17.63%,ACBD5;RB1CC1;ATM;SQSTM1;NBR1
prerank,ameboidal-type cell migration (GO:0001667),0.4716718942379777,1.2013478270037719,0.23529411764705882,0.8457472565405136,1.0,9/51,6.04%,CCN3;FAT2;SEMA3E;GPC3;SEMA3D;SEMA3C;SRGAP2;PDXDC1;GDNF
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5344198819995366,1.2012328925371063,0.26025236593059936,0.8450367547201972,1.0,6/18,6.78%,RHOJ;ANXA1;HDAC9;FGF2;FOXC2;MAP3K3
prerank,cell junction assembly (GO:0034329),-0.32200655365484393,-1.2012029488711604,0.12643678160919541,0.6519986353509175,1.0,22/100,6.57%,TJP1;ADGRL3;DNM3;TLN2;CDH2;SHANK3;SPOCK2;ITGA6;CLDN5;NRXN1;CDH8;CDH10;GPM6A;GJC1;VASP;ARVCF;ACTB;PLXND1;KIRREL3;OPHN1;TLN1;OBSL1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4658037171138899,1.2011570722202904,0.25168236877523553,0.8441747627337467,1.0,13/48,16.62%,EGFR;LDLR;ITGAV;CLU;MDM4;NFKB1;IRAK3;ITGB3;INHBB;SNX12;AZIN1;HMGCR;MAD2L1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.38959404679424164,1.2010990216118023,0.09670781893004116,0.8432814217350435,1.0,83/366,17.88%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;CCNA2;NFIA;FOXO3;USP13;ESR2;JMJD1C;FZD7;ZNF423;ERC1;ABL1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;HMG20A;ESR1;STAT3;GATA4;DDIT3;NFIL3;TRRAP;PITX3;SOX14;CRABP2;CHEK2;PDGFA;FUS;IGSF1;NLK;FOXC1;NFYA;RORA;SERTAD3;PHF12;GATA1;ATF7;BRCA2;ATXN2;GON4L;GTF2IRD1;RB1;NFKB2;FOXK2;CTR9;ATRX;KMT2D;TCF3;EP300;CHD3;HCFC1;SP3;GPBP1;GCFC2;HDAC10;REST;GPBP1L1;CDK11B;ATF2;BAZ2A;PCGF1;HINFP;PML;WWTR1;ZNF219;CREBL2;ANKRD17;NSD1;RNF14;POU6F2;SBNO2;HCLS1;UTP4;CARM1;EHMT2;PUM3
prerank,regulation of angiogenesis (GO:0045765),0.4049644791111577,1.200920518768179,0.16630901287553648,0.8427418777591151,1.0,22/192,6.17%,SMOC2;BMPER;F3;THBS1;HOXA5;RHOJ;ITGB8;PGF;CYP1B1;ANXA3;SEMA3E;PTGIS;SULF1;KLF4;HIPK1;ITGB1;FGF2;ISM1;ATP2B4;ADAM12;ISL1;GATA4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5680730550914602,1.2008180314128938,0.2845117845117845,0.8420094547698096,1.0,3/15,3.61%,EGFR;PTK2B;ABL1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.5114075008137735,-1.200067482755386,0.26184538653366585,0.6533462490382581,1.0,4/12,9.63%,NKD1;PROM1;RORB;SDK2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.4307198157339863,-1.199842669947894,0.2012012012012012,0.6522624031805802,1.0,7/23,9.37%,PDE4B;TGM2;GNG2;RYR2;SNCA;KCNQ1;APLP1
prerank,response to lipid (GO:0033993),0.42906385622320053,1.199753086564715,0.19951923076923078,0.8443337728529566,1.0,19/105,9.95%,FOXP1;SOX9;LBP;ANXA1;SMAD6;FOXO3;ALPL;ESR1;STAT3;SLPI;SOCS2;TLR4;STRN3;RXRA;SCD;RARG;ERBIN;RARA;IRAK3
prerank,peroxisomal membrane transport (GO:0015919),0.5277416973192448,1.1995685540216843,0.26046511627906976,0.8437989677061284,1.0,9/27,23.91%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;SLC25A17;PEX2;PEX7;PEX26
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4896370939889257,-1.1992754752199148,0.25829383886255924,0.6520283405415374,1.0,5/14,14.66%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,inner ear morphogenesis (GO:0042472),0.5329100443533619,1.1983728560548519,0.27426810477657937,0.8465581010370419,1.0,3/22,3.23%,SIX1;SOX9;ZIC1
prerank,monocarboxylic acid transport (GO:0015718),0.4680342996517731,1.1981856120771406,0.2138200782268579,0.8460791275187133,1.0,10/51,8.62%,SLCO3A1;SLC5A6;SLC16A9;SLCO2A1;SLC16A1;ABCG2;SLC26A6;SLC10A2;RXRA;ATP8B1
prerank,positive regulation of protein binding (GO:0032092),0.46322457615287255,1.197601367845097,0.24353741496598638,0.8468540574788671,1.0,14/56,12.28%,BMP4;TCF7L2;PKD1;GSK3B;ABL1;LRP1;BAMBI;RIPK2;IDE;DACT1;MARK3;TIAM1;ADD1;USP33
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.408108470809958,-1.1967810062360253,0.18874172185430463,0.6570683621221569,1.0,11/29,20.68%,ACSL1;ELOVL7;ELOVL6;HSD17B12;ACSL5;HACD2;ACLY;ACSBG1;ACSL4;HACD1;GCDH
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5873515642527259,1.1967685296505068,0.2751677852348993,0.8484153991524148,1.0,2/12,2.77%,FUT8;GMDS
prerank,DNA duplex unwinding (GO:0032508),0.4657723943101545,1.1966888881904179,0.23324396782841822,0.84760659137267,1.0,23/50,28.47%,ANXA1;CHD1L;MCM7;WRN;MCM2;RAD23B;DDX11;DHX9;MCM9;ERCC3;XPA;RPA1;RECQL5;NBN;RAD51;DDX1;RAD50;CUL4A;ERCC2;XPC;GTF2H3;MCM6;RECQL
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.43130414915478843,-1.1965953523092399,0.22777777777777777,0.6557980895427193,1.0,7/24,10.60%,TEK;KDR;NDNF;GATA2;GAS6;RAMP2;TNIP2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4535670497842087,-1.1964760652203303,0.2398843930635838,0.6543696379701497,1.0,7/18,11.35%,IL34;DAAM2;TNFRSF21;NOTCH1;TENM4;OPALIN;MDK
prerank,thyroid hormone generation (GO:0006590),0.599839464187645,1.1964081015426933,0.296551724137931,0.8474881024733448,1.0,3/10,10.53%,CPQ;IYD;FOXE1
prerank,cytosolic calcium ion transport (GO:0060401),0.5067965901259155,1.1963900662525293,0.2632375189107413,0.8464640164442863,1.0,2/28,1.62%,SLC35G1;CACNA1C
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4787026961802123,-1.1963052753886545,0.24277456647398843,0.6531133367755411,1.0,5/16,14.72%,HS3ST5;TRIM14;TRIM62;NECTIN2;TRIM21
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5990372648257667,1.1950437185764393,0.272887323943662,0.8474353989393326,1.0,6/10,17.92%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,t-circle formation (GO:0090656),0.5990372648257667,1.1950437185764393,0.272887323943662,0.8474353989393326,1.0,6/10,17.92%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5990372648257667,1.1950437185764393,0.272887323943662,0.8474353989393326,1.0,6/10,17.92%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,acylglycerol biosynthetic process (GO:0046463),0.5209107463726413,1.1948612297920558,0.2563718140929535,0.8469278460592894,1.0,7/23,13.90%,PLCE1;PNPLA3;MOGAT3;PLA2G15;LPIN2;DGAT2L6;MOGAT1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.53245238567564,1.1947568207434176,0.28032786885245903,0.8461846993612887,1.0,11/20,27.57%,MCUB;MCU;SLC8B1;PMPCB;YME1L1;SPG7;PARL;MICU3;MICU1;MICU2;STOML2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6104417653087562,1.1942662697321467,0.2929824561403509,0.8467420076042126,1.0,3/10,7.85%,ANXA2;NELL1;RGP1
prerank,negative regulation of programmed cell death (GO:0043069),0.38871529521806203,1.193826890855952,0.13687436159346272,0.8470865635300375,1.0,76/355,16.62%,EGFR;THBS1;BMP4;CARD14;MET;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;ANXA1;WNT11;SMAD6;CD44;ANXA4;GCLC;SHC1;TAX1BP1;GSK3B;NOTCH2;ERC1;SERPINB9;SON;DNAJC3;GDNF;RIPK2;GOLPH3;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;KANK2;RIPK3;NFKB1;NIBAN2;NTSR1;GATA1;PIM2;PROK2;MTDH;VEGFA;ARF4;KRT18;USP47;COPS5;UBE2Z;HTATIP2;MYD88;AATF;DDRGK1;YME1L1;PAK2;PRKDC;BAG3;FATE1;PRDX5;HTR2B;STIL;CEACAM5;PIDD1;SQSTM1;ADAM10;ZFAND6;TFAP2A;DPEP1;CLEC5A;TMBIM4;BFAR;CASP2;NAA15;MAD2L1
prerank,cellular response to alcohol (GO:0097306),0.4771747423803875,1.1937304270199347,0.25137362637362637,0.8463027710246198,1.0,8/42,7.62%,CDH1;LRP6;SMO;CTNNA1;KLF9;GOLPH3;GRAMD1C;JUP
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5894025092794672,1.193483434653929,0.28664495114006516,0.8459818541742191,1.0,5/12,13.77%,ESR1;STAT3;NCOR1;ZC3H12A;NCOR2
prerank,extracellular matrix assembly (GO:0085029),-0.4424289322391381,-1.1931776279067887,0.228486646884273,0.6596251375062492,1.0,9/23,9.87%,FBLN5;MYH11;LAMB1;GPM6B;MFAP4;QSOX1;GAS6;EFEMP2;RAMP2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4228244253905995,1.1920630622263935,0.2091121495327103,0.8495260402834219,1.0,23/114,19.37%,TNFRSF11B;CARD14;EDA;PTK2B;FOXO3;PSMB2;TNFRSF13B;CHUK;LIMS1;PSMC6;CDIP1;TRAF5;TNFRSF1B;TNFSF11;PSMD11;TRADD;PSMD1;PSMC1;PSMD7;TNFRSF4;BIRC3;TRAF3;PSMD14
prerank,blood vessel diameter maintenance (GO:0097746),0.4810843881026896,1.191423641637104,0.23444283646888567,0.8504517779630713,1.0,4/34,4.28%,KCNMB2;EDNRA;GCLC;AGTR1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.39020604145567594,1.1911249495564582,0.12332990750256938,0.8503355610381773,1.0,100/341,22.88%,FBXL7;WWP1;FZR1;NEDD4;FBXO10;UBE4B;WWP2;NFE2L2;RNF144A;RNF115;ANAPC5;RNF185;UBR4;VCP;UBE2B;KLHL22;ARIH1;DDIT3;TBL1X;RNF19A;PSMB2;BIRC6;TGFB1I1;CDC16;RNF114;TRIP12;CBLC;ANAPC16;RNF126;UBE2D3;AURKA;FBXW11;UBE4A;FEM1B;RAD23B;PSMC6;PPP2R5C;OTUD7B;RNF146;RNF111;SPSB2;MTA1;VPS37A;WDR81;MVB12B;USP33;COP1;RNF122;ZRANB1;RNF168;ARIH2;ANKIB1;SMURF1;PSMD11;CUL3;NPLOC4;ERCC8;UBE2S;PSMD1;SPOP;NTAN1;SQSTM1;PML;UBE2K;APPBP2;CHFR;BFAR;MAD2L1;RNF14;UBE3C;VPS37B;OS9;PSMC1;PSMD7;TSG101;FBXL19;USP9X;UFD1;TRIM25;PSMD14;UBE2W;FBXL4;CNOT4;PSMD3;TRPC4AP;MIB1;RNF8;HUWE1;RNF130;TOM1L1;RBCK1;CUL4A;RMND5A;ANAPC11;KCTD17;ANAPC10;FBXL17;HERPUD1;ANKRD9;FBXO11
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3905273505935452,1.1907249410283112,0.13917525773195877,0.8505844159146505,1.0,80/314,23.08%,FBXL7;WWP1;FZR1;NEDD4;UBE4B;WWP2;NFE2L2;ECRG4;ANAPC5;RNF185;VCP;UBE2B;KLHL22;DDIT3;TBL1X;PSMB2;FBXL20;CDC16;ANAPC16;ANKZF1;RNF126;UBE2D3;AURKA;FBXW11;UBE4A;FEM1B;RAD23B;PSMC6;FBXL6;PPP2R5C;FBXO17;RB1;SPSB2;MTA1;COP1;UBXN4;RNF122;FBXO4;ERLIN1;SMURF1;PSMD11;CUL3;NPLOC4;ERCC8;UBE2S;PSMD1;SPOP;AMN1;PML;UBE2K;APPBP2;BFAR;CUL1;MAD2L1;OS9;PSMC1;PSMD7;FBXL19;UFD1;TRIM25;FBXL8;PSMD14;UBE2W;FBXL4;ECPAS;PSMD3;HUWE1;RBCK1;CUL4A;RMND5A;ANAPC11;KCTD17;ANAPC10;FBXL17;FAF2;HERPUD1;ANKRD9;FBXO27;CDK2;CCNB1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.47130275840829294,1.1905475630876294,0.24836601307189543,0.8500610641335071,1.0,11/47,13.69%,DOCK5;EFNA5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2;ITGB1BP1;CORO1C;TRIOBP
prerank,regulation of chromosome segregation (GO:0051983),0.5547431156517952,1.1905432827360176,0.2807017543859649,0.8490166170227087,1.0,9/16,22.96%,SMC5;PUM2;PUM1;IHO1;RMI2;CSNK2A2;CSNK2A1;SMC6;KIF2C
prerank,calcium ion import into cytosol (GO:1902656),-0.4768964288632177,-1.1900369339578454,0.24878048780487805,0.6663393321993206,1.0,5/15,14.66%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,positive regulation of apoptotic process (GO:0043065),0.3912333978281136,1.1898980907764276,0.15328467153284672,0.8500786695613146,1.0,44/293,12.85%,SLIT2;BMP4;RASSF2;MAP3K5;HOXA5;NGF;CYP1B1;TGFB3;AKAP13;PAWR;FOXO3;PTGIS;VAV2;ANO6;CRADD;ITGB1;UNC13B;ABL1;IP6K2;TGFBR1;TIAM2;SFRP4;GADD45G;TRIO;DDIT3;CLU;ARHGEF6;CALHM2;GNA13;BCLAF1;RARG;NF1;ATM;JUN;DIABLO;CCL3;ATF6;ARHGEF5;ARL6IP5;TIAM1;UBE2Z;SOS2;ZC3H12A;RNF122
prerank,peptidyl-lysine acetylation (GO:0018394),0.6047604310491941,1.189749066663963,0.3126079447322971,0.8494866176233541,1.0,6/10,25.87%,CREBBP;KAT2A;EP300;KAT2B;KAT5;ESCO1
prerank,response to interleukin-4 (GO:0070670),-0.5313504613872814,-1.1893138395914966,0.26184538653366585,0.6665425522907278,1.0,4/10,18.17%,LEF1;TCF7;JAK3;XBP1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.49451912533119996,1.189295258458588,0.2732824427480916,0.8499887308931601,1.0,5/32,8.16%,SLC4A4;PID1;VCP;PFKFB2;PFKFB1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.39201001098842664,-1.1892207269281623,0.19155844155844157,0.6649782474856138,1.0,8/33,9.25%,DNAJC6;DNM3;PICALM;OPHN1;SNCA;DNM1;SNAP91;SYT1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5122918160956479,1.1890457885112937,0.2669683257918552,0.8497215271557784,1.0,6/23,7.25%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;CACNG6
prerank,"phototransduction, visible light (GO:0007603)",0.5549249263989537,1.1888728877210197,0.27887788778877887,0.8492031604299847,1.0,2/14,4.42%,RP1;PDE6A
prerank,mesoderm development (GO:0007498),-0.4561070188437375,-1.1884755108479232,0.2035623409669211,0.6652348709723064,1.0,8/18,16.61%,TIE1;TBX3;TBX1;BMX;IKZF1;HCK;GDF11;BTK
prerank,fatty acid elongation (GO:0030497),-0.4824891924706891,-1.1883014371653127,0.23366834170854273,0.6639843385480441,1.0,6/13,18.49%,ELOVL7;ELOVL6;HACD3;ELOVL4;HACD2;HACD1
prerank,skeletal muscle tissue development (GO:0007519),0.5049167089158172,1.188086245049098,0.27111111111111114,0.8506982054340536,1.0,6/32,9.26%,SIX1;CSRP3;SKI;MYOG;SIX4;EGR2
prerank,regulation of dendritic spine development (GO:0060998),-0.4464509975467766,-1.1874065346688059,0.24495677233429394,0.6646327539196791,1.0,7/19,14.15%,SHANK3;APOE;PPFIA2;MEF2C;CAMK2B;KIF1A;GRIN3A
prerank,cellular response to estrogen stimulus (GO:0071391),0.5669959263128279,1.187120649481537,0.28780487804878047,0.8528027286170761,1.0,3/14,9.88%,SERPINB9;BCAS3;RARA
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3755606643069517,-1.1856129487307825,0.19791666666666666,0.6676821903322109,1.0,8/39,5.76%,TJP1;APOE;RAPGEF2;TIE1;HSPA8;NOTCH1;DAB2IP;GFAP
prerank,regulation of cell cycle phase transition (GO:1901987),0.42889572748669397,1.1856064297740876,0.22400990099009901,0.8565411853358424,1.0,32/91,27.16%,FZR1;TCIM;ANAPC5;ATP2B4;PSMB2;CDC16;ANAPC16;CDKN1B;PSMC6;PSMD11;UBE2S;PSMD1;TRIM39;ERCC3;CUL1;MAD2L1;PSMC1;PSMD7;CDKN1A;PSMD14;PSMD3;ANAPC11;ANAPC10;CCNB1;CDC20;ERCC2;BUB3;PSMD12;XPC;PSMD4;PSME3;TAF1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5005071782197842,-1.1854286043967455,0.26184538653366585,0.666497406249192,1.0,3/11,5.72%,LYN;ANK3;PRKCQ
prerank,protein O-linked glycosylation (GO:0006493),0.4196851624859779,1.1853752171534817,0.2164090368608799,0.856199411178149,1.0,8/96,3.90%,ST3GAL4;TMTC1;PLOD2;B3GNT2;GXYLT2;LARGE1;GALNT15;GALNT13
prerank,cellular potassium ion homeostasis (GO:0030007),0.5713897517907892,1.1853501173304533,0.28125,0.8552283155741567,1.0,6/13,8.77%,KCNJ2;SLC12A2;ATP1B1;ATP1A3;ATP1A4;ATP1A1
prerank,regulation of defense response to virus by host (GO:0050691),0.4955753901106091,1.1853116171773899,0.2536231884057971,0.8542955125081272,1.0,8/30,14.40%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;IFNLR1;EIF2AK4;DHX9
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5467862567535723,1.1848913506378422,0.2802653399668325,0.8545531011083799,1.0,4/15,9.08%,LRP6;EDA;FOXC1;GLI2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4459032559598245,1.1848602162685498,0.2391304347826087,0.8535889063844605,1.0,7/66,7.62%,CDH1;PRKCD;LIMK2;ZIC1;UBR5;MAVS;JUP
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5506223634039114,1.1847016913205093,0.2847571189279732,0.8530855705782893,1.0,2/17,2.27%,PCSK5;HDAC9
prerank,response to nutrient levels (GO:0031667),0.5569968713049998,1.18448778856379,0.27450980392156865,0.852645974621588,1.0,3/17,4.82%,KCNB1;FAM107A;EIF4G1
prerank,DNA metabolic process (GO:0006259),0.38919213886003506,1.184382288935088,0.15119916579770595,0.8519361017623225,1.0,91/270,25.94%,TCF7L2;NT5E;MPG;VCP;UBE2B;SMUG1;MNAT1;EXO1;TRRAP;STN1;ERCC5;CHD1L;MCM7;RAD17;WRN;MCM2;ATM;TOP1;APEX1;IGHMBP2;USP7;NABP1;SMC1A;RAD52;CDC45;SLX4;CHEK1;PRKDC;XRCC5;CSNK1E;PRIM2;POLB;NUDT15;RNASEH2A;POLE2;FANCL;EID3;ZBTB1;HINFP;ERCC3;DFFB;DDX21;RBBP8;SMARCAL1;XPA;UHRF2;RPA1;RMI2;TOP3A;RECQL5;BARD1;NBN;TICRR;PRIM1;RAD51;ERCC1;ATR;NEIL3;INO80;TOPBP1;RFC1;PARP3;UBE2N;HELB;RAN;PARP4;EXD2;RAD51C;TDG;POLA1;KMT5B;POLD3;NUDT1;RAD9B;RAD50;TOP1MT;MBD4;NOC3L;DNASE2;CDK2;PARP2;RFC5;USP3;KAT5;POLK;POLQ;PWWP3A;ORC3;XPC;SRPK2;RAD51AP1
prerank,aminoglycan catabolic process (GO:0006026),0.5038338887912159,1.1843664959316829,0.27565084226646247,0.8509353158583256,1.0,9/28,16.85%,GPC6;GPC3;NAGLU;GPC4;SGSH;GLB1;IDUA;SDC4;HPSE
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4471998111033153,1.1842913906826698,0.23853211009174313,0.8501631948714903,1.0,13/63,7.85%,MET;PTPN3;EIF4G3;DAPL1;NELL1;FOXK1;TAB3;EIF4G1;KLHL22;TIMP2;STAT3;IL10;RGP1
prerank,stabilization of membrane potential (GO:0030322),0.5562777639003014,1.1842294007808616,0.2917316692667707,0.8493358455901582,1.0,1/16,0.19%,KCNK5
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.539645983638827,-1.1841596749714842,0.28193832599118945,0.6682129959696748,1.0,2/10,1.27%,ST6GAL1;ST3GAL1
prerank,regulation of phosphorylation (GO:0042325),0.41835665182816784,1.1840902490561764,0.21133412042502953,0.8487387135861771,1.0,26/120,17.93%,EGFR;THBS1;BMP4;FN1;INHBA;FZD7;NUP93;NRP1;MCM7;CDKN1B;RAD17;RANBP2;CORO1C;EIF6;SEC13;NUP153;EP300;KDM4D;PML;NUP214;ZBTB7A;NUP188;BCL10;BARD1;CDKN1A;NUP88
prerank,synaptic vesicle cycle (GO:0099504),-0.40276230110950284,-1.1838769789766395,0.23717948717948717,0.6672500760329372,1.0,16/30,26.35%,RIMS1;SYT7;SNCA;SNAP25;PIP5K1C;SYT10;RAB3A;PLD2;SLC32A1;CPLX1;SYNDIG1;OTOF;WNT7A;SNAPIN;SLC17A8;SLC18A2
prerank,actin crosslink formation (GO:0051764),0.5857753646421462,1.183726614662245,0.2931323283082077,0.8488571759308096,1.0,4/12,9.22%,DPYSL3;BAIAP2L1;GAS2L2;GAS2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5718916281887415,1.1831558806329712,0.2897822445561139,0.8495773249819984,1.0,2/12,1.65%,UST;DSE
prerank,modification-dependent protein catabolic process (GO:0019941),0.39963673870299493,1.1830579165105766,0.18669527896995708,0.8488582956145664,1.0,54/193,21.16%,FBXL7;FZR1;NEDD4;FBXO10;UBE4B;RNF144A;ANAPC5;RNF185;UBR4;UBE2B;ARIH1;RNF19A;BIRC6;CDC16;RNF114;TRIP12;CBLC;ANAPC16;RNF126;AURKA;UBE4A;RNF146;RNF111;SPSB2;WDR81;USP33;RNF168;ARIH2;ANKIB1;SMURF1;PSMD11;CUL3;NPLOC4;UBE2S;NTAN1;SQSTM1;UBE2K;CHFR;BFAR;MAD2L1;RNF14;UBE3C;OS9;PCYOX1L;UFD1;TRIM25;PSMD14;FBXL4;CNOT4;PSMD3;TRPC4AP;MIB1;RNF8;RNF130
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5846795970634209,1.1830253634001233,0.3083475298126065,0.8479088854162281,1.0,5/12,18.55%,CHEK2;RAD17;CLSPN;TICRR;TOPBP1
prerank,regulation of JNK cascade (GO:0046328),-0.31850536102959554,-1.1828989711645,0.10897435897435898,0.6681362877607051,1.0,17/101,5.71%,PLCB1;IGF1R;MECOM;PHLPP1;TNFRSF19;TGFBR3;MFHAS1;CCN2;EPHB1;RAP2A;MTURN;SH3RF1;TPD52L1;APP;MAP4K4;SIRPA;DAB2IP
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4103265277464035,-1.1826230079380686,0.23870967741935484,0.6671785290303656,1.0,11/26,19.60%,SHANK3;SYNPO2;SYNPO;FHOD1;RAC1;PLEK;ROCK2;ALMS1;LIMK1;ACTG1;CX3CL1
prerank,camera-type eye development (GO:0043010),0.5168580005451929,1.1819646709152896,0.26947040498442365,0.8502265584470651,1.0,9/25,10.33%,CYP1B1;CACNA1C;STRA6;EFEMP1;TSKU;SKI;PITX2;NF1;VEGFA
prerank,B cell proliferation (GO:0042100),-0.4617914284116731,-1.1817994299816472,0.25135135135135134,0.6677029028461711,1.0,5/17,16.85%,BCL2;MEF2C;CTPS1;CD40;CD180
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4203529593133392,1.1815136700437323,0.2271604938271605,0.8505400832795725,1.0,19/86,10.86%,EGFR;PTK2B;EFNA5;PRKCD;CD44;BMP6;ABL1;NRP1;ITGA5;CD80;RIPK2;DMTN;RAP2C;PDGFA;GATA1;PLCG2;ACVR1;VEGFA;ITGB3
prerank,positive regulation of axonogenesis (GO:0050772),0.4689881190763309,1.1813051226942037,0.25866666666666666,0.8501514475593192,1.0,5/43,5.51%,SLIT2;NTN1;NGF;TIAM2;SHTN1
prerank,regulation of catecholamine secretion (GO:0050433),-0.40542501961638977,-1.1811606662715686,0.24203821656050956,0.6677712273737775,1.0,17/29,24.10%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;GRK2;CHGA;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.36694851449677085,-1.1790518874733196,0.22895622895622897,0.6719490473437355,1.0,15/39,18.62%,RPS14;RPS19;RPS5;RPS16;RPS15;RPS27;RPS24;RPS7;RPS25;SNU13;RPS17;NPM1;MRPS11;RPS28;TSR3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.49422900066104714,1.178798456918017,0.2608695652173913,0.8571069872260826,1.0,8/32,17.16%,DDX5;FHIT;HIPK1;CDIP1;EP300;DYRK2;PML;USP28
prerank,membrane assembly (GO:0071709),-0.3871084160986578,-1.1783673720680299,0.2375886524822695,0.6721565403187123,1.0,6/34,3.38%,IL1RAPL1;NRXN1;PICALM;RFTN1;ANK3;UGCG
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.31447230611823174,-1.1781489656350703,0.15822784810126583,0.6710320248785927,1.0,17/102,6.79%,TBC1D4;ADCY5;PIK3R1;SLC30A10;ADCY1;FOXO1;CPEB2;ENPP1;PRKAR2B;INSR;ADCY7;PRKAR1B;INSIG2;LPIN3;PRKACB;MYO5A;PRKAR1A
prerank,positive regulation of calcium ion transport (GO:0051928),-0.39042007195082473,-1.177994491821969,0.17880794701986755,0.6697893418565991,1.0,10/36,10.70%,MYLK;PDGFRB;CACNA1D;TRPC3;CXCL12;ATP2B1;GRIN1;TRPC6;CAMK2A;P2RX7
prerank,Golgi localization (GO:0051645),0.5851543310470754,1.1776983597417776,0.29769736842105265,0.8596054679194907,1.0,4/11,16.27%,ARHGAP21;ARCN1;COPG1;HOOK3
prerank,positive regulation of type 2 immune response (GO:0002830),-0.48227100885871826,-1.1776959864990015,0.24438902743142144,0.6689026551623398,1.0,4/14,13.57%,CD81;PRKCZ;IL18;CD74
prerank,positive regulation of lipid transport (GO:0032370),-0.5043951203754156,-1.1776948350246332,0.2772511848341232,0.6672228089411156,1.0,4/12,11.76%,APOE;SPP1;DBI;ABCB4
prerank,mitochondrion disassembly (GO:0061726),0.49426829348666407,1.1776862895548768,0.2768361581920904,0.8586073750106905,1.0,16/34,26.30%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG5;ATG7;USP30
prerank,positive regulation of neuron projection development (GO:0010976),-0.32547394503149696,-1.1772807567337995,0.16853932584269662,0.6667181926967533,1.0,28/85,11.43%,CAMK1D;LYN;APOE;PRKD1;ITGA6;PTK7;RAPGEF2;WNT5A;TENM3;SERPINI1;FUT9;ROR2;BMP7;TOX;ATP1B2;NDNF;RIT2;DAB2IP;LRRC7;SETX;LRP8;NTRK2;PLK5;RAPGEF1;TWF2;MDK;CAMK2B;FES
prerank,recombinational repair (GO:0000725),0.43336356872196735,1.1768807548716345,0.24049079754601227,0.8601085364239048,1.0,28/77,22.64%,REV3L;RNF138;ERCC5;WRN;BRCA2;NABP1;SMC5;SPIDR;RAD52;SLX4;KDM4D;MCM9;NSMCE1;RBBP8;YY1;RPA1;RECQL5;NBN;RAD51;INO80;PSMD14;SWSAP1;UBE2N;EXD2;RAD51C;SMC6;RAD50;ZFYVE26
prerank,positive regulation of chemokine production (GO:0032722),-0.36844818112366196,-1.1766573906395805,0.20212765957446807,0.6667390284511209,1.0,11/44,14.82%,MBP;WNT5A;IL6R;APP;HIF1A;IL18;TLR7;TLR3;CD74;CSF1R;LPL
prerank,positive regulation of immune system process (GO:0002684),0.5474462535917053,1.1764076470760325,0.2706270627062706,0.8606065462604313,1.0,5/16,25.49%,ANXA1;VEGFA;TGFB2;IL15;MIA3
prerank,sensory perception of pain (GO:0019233),-0.43048683072549415,-1.1761599748672797,0.2630057803468208,0.6664112533212553,1.0,8/21,20.59%,RETREG1;P2RX7;MME;KCNA2;SCN9A;TRPA1;CCL2;KCNK4
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.38374442107804296,-1.1760581240654582,0.2484472049689441,0.6650399093125622,1.0,6/34,9.16%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,homeostasis of number of cells (GO:0048872),0.5753498263530795,1.1760217325785725,0.27967479674796747,0.8608512788107437,1.0,1/12,0.41%,CCN3
prerank,positive regulation of protein polymerization (GO:0032273),0.4378648577208875,1.1756889347975896,0.2591623036649215,0.8609271571052469,1.0,14/65,12.84%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;TOGARAM1;AKAP9;NCKAP1;CTTN;SLAIN2;FCHSD2;FCHSD1
prerank,protein neddylation (GO:0045116),0.5646578880133221,1.1755471986669797,0.29200652528548127,0.8603305973931222,1.0,6/13,21.42%,UBE2F;DCUN1D5;DCUN1D4;DCUN1D2;DCUN1D1;UBE2M
prerank,negative regulation of cell junction assembly (GO:1901889),0.5003126496050223,1.1749178178257869,0.26506024096385544,0.8612698553324472,1.0,5/25,6.54%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.42656495861124377,-1.1748129777968723,0.24260355029585798,0.6667710579795241,1.0,4/22,4.85%,APOE;PPARA;ZBTB20;PPARD
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4682202939956224,1.1747132678528218,0.2698191933240612,0.8609711368779122,1.0,15/40,15.79%,TCF7L2;TGFB3;TGFBR1;TGFBR2;GCNT2;BAMBI;TGFB1I1;JAG1;FOXC1;BCL9L;SMAD2;TIAM1;MTOR;TWIST1;WWTR1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5512928748880704,1.174027204341747,0.2964169381107492,0.8621132964236308,1.0,4/17,8.08%,KCNB1;CACNA1G;CLTRN;SLC4A8
prerank,cellular metal ion homeostasis (GO:0006875),0.4129217980408086,1.1739772799933772,0.2246376811594203,0.8612356856434896,1.0,21/102,11.41%,KCNJ2;SLC12A2;SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;CLDN16;ATP1A3;ATP1A4;ATP1A1;SLC9A1;TNNI3;DRD3;CCL3;CCL1;SLC8B1
prerank,microvillus organization (GO:0032528),0.5573256191706544,1.1737620013297423,0.2973421926910299,0.8608675404159087,1.0,5/13,7.78%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4306775560377403,-1.1736159004551203,0.2722063037249284,0.6682141205274772,1.0,4/23,8.52%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,zymogen activation (GO:0031638),0.4671982409411058,1.1734469853179914,0.2633802816901408,0.860821636753701,1.0,7/39,13.80%,CYFIP2;PERP;PRSS12;RIPK2;MMP14;OMA1;TBC1D10A
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5733154561363009,1.1726980249921546,0.3065068493150685,0.8620610025626287,1.0,2/12,6.15%,DPYSL3;CTPS2
prerank,monocyte differentiation (GO:0030224),0.5739477261988295,1.1722773544478033,0.29856115107913667,0.8623997417321768,1.0,1/10,0.28%,BMP4
prerank,regulation of osteoblast proliferation (GO:0033688),0.5383253324284756,1.1715342723001276,0.29838709677419356,0.8635948778783619,1.0,4/17,9.06%,CCN1;NELL1;NPR3;RHOA
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4891030005568195,1.170992531360125,0.2643171806167401,0.8642692852354513,1.0,5/28,4.70%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,microtubule polymerization (GO:0046785),0.4920557400921567,1.170980946584965,0.2754491017964072,0.863282130283417,1.0,9/28,16.89%,MAP7D3;FGF13;NDEL1;HDGFL3;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,response to iron ion (GO:0010039),-0.493198988160062,-1.170919115566701,0.2819277108433735,0.673742602640769,1.0,4/12,7.40%,B2M;BCL2;HIF1A;SNCA
prerank,erythrocyte differentiation (GO:0030218),-0.36431389011926374,-1.170809019582237,0.19548872180451127,0.6723986013478358,1.0,14/44,16.12%,LYN;TGFBR3;MFHAS1;KIT;RPS14;RPS19;ALAS1;TAL1;CASP3;IKZF1;MED1;JAK3;SH2B3;LYAR
prerank,ether lipid biosynthetic process (GO:0008611),0.5898488078467041,1.170693454295204,0.31382978723404253,0.8631477883396661,1.0,5/10,22.95%,AGPS;PEDS1;GNPAT;PLA2G4A;PEX7
prerank,regulation of chromatin binding (GO:0035561),0.5927576676085266,1.1706130847271063,0.3106312292358804,0.8623653220063008,1.0,4/10,14.85%,BTAF1;DDX11;WAPL;KDM4D
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4961747311896342,-1.1704642482419045,0.2863741339491917,0.6717138169113115,1.0,5/11,19.74%,EFNB2;MEF2C;MYOCD;GREM1;GPER1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.40807468131274427,-1.1704487779669075,0.2434017595307918,0.6701205906948156,1.0,5/26,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.44416062197917955,1.1702488347004363,0.2526595744680851,0.8625041834090444,1.0,14/60,18.08%,SMOC2;KLF4;FGF2;NEK7;GRHL2;TNKS2;ATM;CHTF18;FBXO4;XRCC5;POLG2;CHTF8;ATR;MAP3K4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4560754581316614,1.1699740354620358,0.2726027397260274,0.8623455532798017,1.0,6/48,5.27%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;DMD
prerank,regulation of striated muscle contraction (GO:0006942),-0.4178225901931498,-1.1699256847489383,0.2515527950310559,0.669876929517266,1.0,3/27,4.69%,ATP1A2;CALM1;RYR2
prerank,cellular response to metal ion (GO:0071248),0.41224362663266656,1.16982296530221,0.23453908984830804,0.8617939877350277,1.0,17/123,10.40%,EGFR;CDH1;SLC12A2;CLIC4;CAMK2D;BMP6;MEF2A;DLG2;DMTN;SYT8;CDKN1B;P2RX4;CHUK;IQGAP1;PLCG2;JUN;CARF
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5183763176546905,1.1697921019617692,0.273972602739726,0.8608679538832502,1.0,5/24,3.62%,PPP1R3B;SORBS1;PPP1R3C;GSK3B;IRS1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.588687610733508,1.169643985740607,0.31216931216931215,0.8603157651656376,1.0,2/10,8.02%,DDIT3;TLR4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.37254861930000155,1.169417967019454,0.042,0.8600277783477994,1.0,255/1082,17.26%,EGFR;BMP4;CDH1;KLF5;ZFHX3;SIX1;ZFPM2;TCF7L2;MET;PLAGL1;MAP3K5;RARB;NFIB;PKD1;SOX9;BMP5;HDAC4;HOXA5;MLLT3;LRP6;CCN1;PPP3CA;CSRP3;TGFB3;PBX1;PID1;WNT11;NFIA;NFAT5;GLI3;FOXO3;MEOX2;ZBTB16;HES1;GRHL1;TCF20;ESR2;SHC1;KLF4;BMP6;DCAF6;NFE2L2;BMPR1A;INHBA;ZIC1;FGF2;FZD7;ELOF1;ELF1;ZNF423;MDFIC;ABL1;NR2F1;FOXC2;MEF2A;KLF7;TGFBR1;GLIS1;EHF;NR4A3;NR4A2;ZFP64;FOXK1;MLLT10;KAT6B;NCK2;DDX17;KLF10;BCAS3;CD80;HDAC8;GLIS2;CREBBP;ISL1;SKI;MRTFA;ESR1;STAT3;MAVS;RHOQ;GDNF;ATF1;HOXB3;KDM1A;E2F5;GATA4;DDIT3;CEBPZ;KMT2C;BAMBI;TBL1X;TASP1;RIPK2;TADA3;NFIL3;E2F3;TRIM44;MYSM1;PLSCR1;TGFB1I1;JAG1;HOXC4;GDF6;MYOG;IL10;PITX3;PHOX2A;LHX2;ID2;SCAF8;IRF1;JUP;NFIX;REL;SIX4;TEAD1;CHEK2;FZD1;TLR4;GABPB1;GABPB2;PITX2;MLXIP;HIVEP3;CAMTA2;RXRA;THAP3;GRHL2;ATOH8;FOXC1;NFYA;RORA;WDR43;PAXBP1;SLC9A1;SERTAD3;GLI2;CHUK;EGR2;NFKB1;NIBAN2;SSBP3;MED13;FBXW11;BCLAF1;LPIN2;IL33;GATA1;CTCFL;RARG;HOXB4;RARA;RBMX;ACVR1;PIM2;ATM;PPP1R12A;JUN;NRF1;VEGFA;SLC30A9;APEX1;WAC;ARF4;ELF3;FOXE1;BRCA2;PRDM15;TCERG1;LRP5;BCL9L;PER1;SMAD2;ATF6;ERBB2;KANSL3;ZBED4;NFKB2;BPTF;RNF111;COPS5;FOXK2;RGMB;ITGB1BP1;HTATIP2;NKX2-1;AATF;BCL11B;KAT2A;NR4A1;ZC3H12A;DDRGK1;SMARCA4;ATRX;KMT2D;NFATC3;MTOR;PPRC1;TCF3;CHEK1;PPM1A;HNF1A;HNF4A;PRKDC;PAX6;EP300;HCFC1;TNFSF11;SP3;E2F2;CRTC1;ZXDC;NFATC1;REST;TNIP1;DHX9;FOXD2;ZNF507;MED14;ATF2;HOXD3;TWIST1;MAP2K2;SQSTM1;GALR1;HINFP;PML;CAPRIN2;EPC1;TFAP2A;THRAP3;ZNF462;WWTR1;KAT2B;TRIM16;AGO2;HSF2;CREBL2;CALCOCO1;IKBKG;JMJD6;ZMIZ1;MED24;NAA15;NSD1;RNF14;YY1;RET;ZNF76;CREB3L3;SBNO2;BRD8;BCL10;SREBF1;PITHD1
prerank,positive regulation of metabolic process (GO:0009893),-0.31447943347221513,-1.1692915470927085,0.15527950310559005,0.669957224934178,1.0,15/103,7.60%,CAMK1D;LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;INSR;PRDM16;GJA1;ACACB;PPARGC1A;ELOVL6;IL18
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38540723937847116,-1.1687065000092711,0.23890784982935154,0.6698322357819705,1.0,5/35,1.24%,FLT1;PTPRM;NR2F2;COL4A3;APOE
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.559331033350116,1.1682257763598678,0.2784,0.8627177871420554,1.0,5/15,16.06%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,regulation of cellular component movement (GO:0051270),0.45167510619855566,1.1679406958159364,0.2845528455284553,0.862625593883229,1.0,11/49,11.10%,EGFR;ARAP1;CD9;ABL1;DIAPH1;TGFBR1;MEMO1;MYCBP2;RHOA;VEGFA;ERBB2
prerank,activation of protein kinase activity (GO:0032147),-0.3091179813929428,-1.1677677697534279,0.16176470588235295,0.6706848959229247,1.0,25/106,8.87%,IGF1;ADCY5;OSBPL8;ADCY1;TNIK;PAK1;WNT5A;PRKAR2B;INSR;ADCY7;CARD10;NRK;PRKAR1B;MAP4K4;PPIA;FGF1;GHR;PAK5;CCDC88A;PRKACB;PRKAR1A;ADRA2A;IL18;GAS6;PAK3
prerank,protein-containing complex assembly (GO:0065003),0.3877659608463522,1.1676886644337607,0.18162839248434237,0.8624341596936664,1.0,62/259,16.43%,FBXL7;TCF7L1;TCF7L2;REPS2;SOX9;PTK2B;FN1;HES1;ANO6;GSK3B;SEC24B;STX5;DMD;TLE2;CREBBP;MNAT1;DMTN;TRRAP;TEAD1;NSF;CSNK1A1;MDM4;SEC16A;SHANK1;SLC9A1;SAMM50;PARD3;ANKRD28;MCU;PPP6R3;SEC23A;MATN1;BCL9L;CAPZA1;TIAM1;ITGB1BP1;CNIH2;BIN2;SEC31A;ZC3H12A;SMARCA4;SEC13;SLC7A9;KMT2D;EP300;TLE3;TRADD;CUL3;MAGI1;DHX9;SEC24D;PYGO1;TLE4;SEC22B;ADAM10;PML;SAR1B;PYGO2;TRAPPC10;SEC23IP;IKBKG;CUL1
prerank,ERBB2 signaling pathway (GO:0038128),0.49240064179587767,1.1670556174848485,0.25667655786350146,0.8634534296031724,1.0,7/31,15.08%,EGFR;SHC1;ERBIN;ERBB2;CPNE3;GAB1;PRKCA
prerank,positive regulation of vacuole organization (GO:0044090),0.5909695834959379,1.1669658546872619,0.3094405594405594,0.8627230018677164,1.0,4/10,13.51%,ANXA2;RAB3GAP2;LRSAM1;SH3GLB1
prerank,protein K63-linked ubiquitination (GO:0070534),0.46669610438160564,1.1665415521460292,0.27489481065918653,0.8630518405723439,1.0,15/41,20.93%,NEDD4;TRAF3IP2;WWP2;RNF115;UBE2B;RNF126;TRAF5;RNF168;ARIH2;UBE2S;RNF135;BFAR;TRAF3;UBE2N;RNF8
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34779310703040767,-1.1664997775662385,0.1893939393939394,0.6724475729461077,1.0,17/51,9.82%,LIMCH1;PPM1E;RAPGEF3;PAK1;CCN2;LPAR1;EVL;CD47;ARHGEF15;SYNPO2;CCDC88A;SYNPO;FHOD1;RAC1;RGCC;PLEK;NF2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5833025105077968,1.1664843142040289,0.3093645484949833,0.8622137223950824,1.0,5/12,18.72%,ESR1;NCOR1;ZC3H12A;NCOR2;PPARG
prerank,protein deacylation (GO:0035601),0.508591282612019,1.1663129483172514,0.29013254786450665,0.8617670375681188,1.0,6/23,17.31%,HDAC4;ABHD17B;LYPLA2;HDAC10;LYPLAL1;SIRT6
prerank,ceramide catabolic process (GO:0046514),0.558352210594643,1.1662435818455403,0.30098684210526316,0.8609973978457377,1.0,2/14,3.83%,ACER3;HEXA
prerank,atrial septum morphogenesis (GO:0060413),0.5905902345809426,1.165820791537877,0.3316062176165803,0.8612978396183798,1.0,4/10,9.96%,NOTCH2;ISL1;GATA4;ACVR1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4595505900046709,1.165707587462862,0.2847222222222222,0.8606494897526212,1.0,8/43,11.10%,MICAL2;SMO;HES1;TGFBR2;GATA4;ACVR1;CCDC40;MEGF8
prerank,sulfur compound catabolic process (GO:0044273),-0.36887208171978664,-1.1656684561284183,0.21754385964912282,0.6729276493600476,1.0,13/38,16.83%,FMOD;OGN;DCN;GGT5;LUM;OMD;CSPG5;NCAN;IDS;HEXB;PRELP;GGT1;GALNS
prerank,positive regulation of cell development (GO:0010720),0.49477047961973575,1.1655845657583432,0.2973372781065089,0.8600098422026905,1.0,3/31,9.33%,BMP4;MYOG;NIBAN2
prerank,positive regulation of protein acetylation (GO:1901985),-0.4821519958814764,-1.1650216907427338,0.2769607843137255,0.6730865463042223,1.0,2/12,5.41%,RAPGEF3;PRKAA2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.49235637637098034,1.1648376850139834,0.27123695976154993,0.8613761732429023,1.0,5/27,4.70%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,protein insertion into membrane (GO:0051205),0.47847140817374817,1.164611422541204,0.2852983988355167,0.8610509033237072,1.0,4/32,11.04%,EGFR;STX5;EMD;TRAM2
prerank,positive regulation of axon extension (GO:0045773),0.5051864380472445,1.16436793573943,0.2748091603053435,0.8607754237516712,1.0,6/22,11.97%,NTN1;NRP1;SHTN1;VEGFA;MEGF8;ZFYVE27
prerank,inositol lipid-mediated signaling (GO:0048017),0.45483475459347616,1.164185641778629,0.2683923705722071,0.8603440706206953,1.0,10/50,4.52%,PLCE1;TNFAIP8L3;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1
prerank,diterpenoid metabolic process (GO:0016101),0.4397807234138624,1.1641239307307374,0.2597054886211513,0.8595616734544652,1.0,9/55,8.75%,GPC6;ADH7;GPC3;STRA6;RBP1;RLBP1;LRP1;GPC4;PECR
prerank,negative regulation of ossification (GO:0030279),0.5046752228388641,1.1640562311637481,0.3132716049382716,0.8587953785832008,1.0,4/23,4.96%,SOX9;PTK2B;SMAD6;TRPM4
prerank,sarcomere organization (GO:0045214),0.49941695360679694,1.1640470928396824,0.2764976958525346,0.8578355840852407,1.0,4/27,7.89%,CSRP3;KRT19;SIX4;CSRP2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4255876795546926,1.163876322883232,0.25153374233128833,0.8574083917746012,1.0,35/80,25.05%,SGSM2;ERC1;RAB6A;SNX2;RAB7B;STX5;EHD3;VPS54;GBF1;RGP1;RNF126;SNX32;VTI1A;SNX12;TBC1D10A;TBC1D5;TRAPPC10;TMEM87A;BET1L;TMEM87B;TBC1D17;RBSN;SNX8;WASHC1;VPS52;VPS51;VPS53;SURF4;UBE2O;PHETA2;TBC1D23;ARL1;VPS29;SPAG9;RAB7A
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42602126441266347,1.1628323306587014,0.25875,0.8595669990814463,1.0,17/78,12.77%,EGFR;PID1;SORBS1;ITGB1;PRKCE;MRAP;ATP2B4;RHOQ;LRP1;PLS1;AGR2;DLG1;STX8;MMP14;RANGRF;PTPN9;ZDHHC2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4226279313856274,1.1623658446435154,0.2394705174488568,0.8600927638908051,1.0,27/88,27.03%,FBXL7;PSMB2;FBXL20;FBXW11;PSMC6;FBXL6;FBXO17;FBXO4;PSMD11;PSMD1;AMN1;CUL1;PSMC1;PSMD7;FBXL8;PSMD14;FBXL4;PSMD3;CUL4A;FBXL17;FBXO27;PSMD12;FBXW5;CCNF;FBXO48;PSMD4;PSME3
prerank,negative regulation of response to stimulus (GO:0048585),0.4438394820590572,1.1623101980549162,0.26804123711340205,0.8592946860231995,1.0,9/60,6.78%,SLIT2;VPS13C;COL3A1;UBASH3B;KLF4;HHIP;KLF7;CLU;MAP3K3
prerank,positive regulation of ion transport (GO:0043270),0.4523014901021212,1.1620092880611324,0.29499323410013534,0.8592110833882631,1.0,8/48,8.65%,FHL1;ANK2;ANO6;STIM2;GDNF;DLG1;CRACR2A;P2RX4
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5901271803416435,1.1615730413277134,0.3197969543147208,0.859530890050479,1.0,9/11,39.44%,RESF1;SIRT6;TASOR;ATF7IP;MPHOSPH8;TPR;TRIM28;SETDB1;PPHLN1
prerank,regulation of lipase activity (GO:0060191),0.5667090645121914,1.161546249362788,0.3091216216216216,0.8586475956033142,1.0,2/13,9.06%,PCSK5;RHOA
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4932122812950069,1.1608568602582396,0.29066265060240964,0.858851469058723,1.0,2/31,5.82%,RNMT;MNAT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.4932122812950069,1.1608568602582396,0.29066265060240964,0.858851469058723,1.0,2/31,5.82%,RNMT;MNAT1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5565026527020227,1.1607777441113925,0.31114808652246256,0.8561836663219448,1.0,4/12,13.95%,ANAPC5;CDC16;RB1;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5565026527020227,1.1607777441113925,0.31114808652246256,0.8561836663219448,1.0,4/12,13.95%,ANAPC5;CDC16;RB1;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5565026527020227,1.1607777441113925,0.31114808652246256,0.8561836663219448,1.0,4/12,13.95%,ANAPC5;CDC16;RB1;CUL3
prerank,phospholipid biosynthetic process (GO:0008654),0.47543407997265685,1.1603442044374113,0.279887482419128,0.8565243078902743,1.0,13/36,20.33%,DHDDS;SGMS2;PIP5K1A;MBOAT1;GNPAT;MVD;CPNE3;AGK;HDHD5;CPNE1;FDPS;LPCAT1;CLN3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4567819564361871,1.1602455055898533,0.2797297297297297,0.8558775489196583,1.0,13/42,19.69%,KDM1A;SETD2;FUS;SPIDR;CHEK1;PPP4R2;MRNIP;SHLD1;RMI2;SIRT6;RAD51;WDR48;HELB
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4765398344641679,1.1600526950497683,0.28059701492537314,0.855467509933528,1.0,5/35,9.28%,PCDHB16;CDH11;PCDHB13;PCDHB9;PCDHB3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3926123899477137,1.159888384858596,0.22160356347438753,0.855038520317633,1.0,54/173,21.04%,CD55;ANK2;ATL3;SPTAN1;ERGIC1;GOLGB1;SEC24B;TMED5;ATL2;ERGIC2;STX5;TRAPPC3L;LMAN2L;GBF1;NSF;COG5;SEC16A;DYNC1I1;ARF4;SEC23A;COPA;CAPZA1;RANGRF;VTI1A;CNIH2;SEC31A;ARCN1;COG3;GOPC;SEC13;DCTN6;CUL3;SEC24D;BCAP31;SEC22B;ARFGAP3;ARFGAP1;COPG1;SAR1B;TRIP11;DYNC1LI2;NRBP2;BET1L;WHAMM;BCAP29;USO1;DCTN5;TRAPPC3;BET1;ZW10;CAPZA2;RAB1A;TMED3;SEC24A
prerank,cellular response to misfolded protein (GO:0071218),0.5239504089836382,1.1594401025191845,0.31259720062208396,0.8554513213734428,1.0,8/20,24.65%,RNF185;VCP;RNF126;CUL3;UFD1;UBE2W;UGGT2;POMT2
prerank,cell junction organization (GO:0034330),-0.32849976281045884,-1.159194731025498,0.19626168224299065,0.6875095404485826,1.0,18/71,10.39%,TJP1;OCLN;PPFIA2;PPFIBP2;GRM5;SLC6A1;VASP;PPFIBP1;ACTB;APP;OPHN1;SNCA;CLDN1;MAPT;PAK3;C1QA;SDK2;FLNC
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4726924985612742,1.1591904266626885,0.2703081232492997,0.8552449497223118,1.0,10/39,12.07%,THBS1;EFNA5;SEMA3E;FZD7;GCNT2;DMTN;JAG1;RHOA;ITGB1BP1;CORO1C
prerank,regulation of epithelial cell migration (GO:0010632),0.4511996823359572,1.1581504466590098,0.28818061088977426,0.8574882659108511,1.0,5/51,3.42%,BMPER;DOCK5;SOX9;RHOJ;PRKCE
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5525125531502322,1.158105692036771,0.3054187192118227,0.8566632150951925,1.0,2/12,6.40%,PRPS2;ADA
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3735687391445043,1.1573570093166947,0.17768595041322313,0.8580512317281656,1.0,50/348,10.42%,EGFR;BMP4;SLCO3A1;RASSF2;CARD14;NTRK3;SOX9;BMP5;NGF;PGF;CCN1;PDGFC;PTK2B;EFNA5;TGFB3;DDR2;CD44;KRAS;NIBAN1;LIMK2;BMP6;BMPR1A;INHBA;FGF2;DOCK7;ABL1;NRP1;TGFBR1;RAP1A;EIF4G1;ATP2B4;ITGA5;CD80;MAVS;RIPK2;GDF6;GDF5;FAM20A;RAP2C;PDGFA;BCAR3;GDF10;IQGAP1;GATA1;PLCG2;ACVR1;RB1CC1;AKAP9;VEGFA;CAB39
prerank,positive regulation of calcium ion import (GO:0090280),-0.4904592329464415,-1.1572537513496781,0.3025,0.6910409292316771,1.0,5/12,19.98%,PDGFRB;CXCL12;STC1;CCL2;SPHK2
prerank,UV protection (GO:0009650),0.5917914872465236,1.1567102264370865,0.3286219081272085,0.859070338682181,1.0,2/10,8.17%,SCARA3;ERCC5
prerank,regulation of epithelial cell proliferation (GO:0050678),0.41765303678728327,1.156562545785786,0.2527743526510481,0.858575719485251,1.0,16/85,12.33%,EGFR;BMP4;TCF7L2;SOX9;BMP5;BMP6;FGF2;NR4A3;SRSF6;GDF5;SIX4;LIMS1;VEGFA;ERBB2;DUSP10;NR4A1
prerank,oxoacid metabolic process (GO:0043436),-0.4050907794125961,-1.1564843607784776,0.25287356321839083,0.6915026853776131,1.0,7/27,17.19%,DDO;ENPP1;TPST1;SULT4A1;MIF;AGXT;PPA1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5864117703635289,1.1561513854714587,0.3065068493150685,0.8588585198780105,1.0,5/11,24.65%,RNF185;VCP;UFD1;UGGT2;POMT2
prerank,cardiac muscle cell action potential (GO:0086001),0.485018611788121,1.1560945606113242,0.2878787878787879,0.8580666358462812,1.0,6/30,5.27%,KCNJ2;ANK2;ATP1B1;CACNA1C;CACNA1G;DMD
prerank,striated muscle contraction (GO:0006941),-0.35284167907180297,-1.1560106545998945,0.22540983606557377,0.6911407153673113,1.0,11/53,14.28%,ATP1A2;DTNA;SLC8A1;RYR2;RCSD1;KCNQ1;STAC;ARHGEF11;CASQ2;GRK2;MYH14
prerank,regulation of tumor necrosis factor production (GO:0032680),0.407314568648131,1.1560089516737058,0.2564705882352941,0.8573805659563786,1.0,21/112,15.28%,FOXP1;THBS1;LBP;ISL1;CD2;STAT3;MAVS;CLU;IL10;TLR4;IL33;PLCG2;RARA;IRAK3;CCL3;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TWIST1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.372116990362497,1.1558193991995742,0.17073170731707318,0.8570147508464195,1.0,115/476,16.79%,EGFR;BMP4;CDH1;ZFHX3;SIX1;MAP3K5;NFIB;SOX9;HDAC4;MLLT3;LRP6;TGFB3;WNT11;GLI3;FOXO3;ZBTB16;HES1;ESR2;SHC1;KLF4;INHBA;ZIC1;FGF2;FZD7;ELF1;ZNF423;MDFIC;FOXC2;TGFBR1;EHF;FOXK1;KAT6B;CD80;GLIS2;CREBBP;ESR1;STAT3;GATA4;DDIT3;BAMBI;TBL1X;TASP1;TADA3;NFIL3;TRIM44;TGFB1I1;GDF6;IL10;PITX3;LHX2;ID2;IRF1;SIX4;TEAD1;CHEK2;FZD1;HIVEP3;RXRA;ATOH8;FOXC1;NFYA;RORA;SERTAD3;GLI2;CHUK;EGR2;NFKB1;NIBAN2;MED13;FBXW11;GATA1;CTCFL;RARA;ACVR1;PIM2;JUN;WAC;FOXE1;BRCA2;LRP5;SMAD2;RNF111;FOXK2;RGMB;NKX2-1;KAT2A;SMARCA4;TCF3;PPM1A;HNF1A;HNF4A;PAX6;EP300;HCFC1;SP3;ZXDC;NFATC1;REST;MED14;MAP2K2;HINFP;PML;EPC1;TFAP2A;THRAP3;TRIM16;CREBL2;CALCOCO1;JMJD6;ZMIZ1;MED24;NAA15;NSD1;RNF14;RET
prerank,diol biosynthetic process (GO:0034312),0.5293638302688907,1.1555987103078789,0.3074380165289256,0.8567339567162174,1.0,1/15,0.61%,ACER3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.36744368822657547,-1.1555907656921554,0.23809523809523808,0.6907143848386802,1.0,12/40,15.48%,VTN;SGIP1;B2M;INSR;CD63;DGKD;HIP1;ARRB1;CCL19;NTF3;ARRB2;GREM1
prerank,mammary gland epithelium development (GO:0061180),-0.46597387769916043,-1.155466435071803,0.29528535980148884,0.6894065644043589,1.0,7/14,25.40%,WNT4;ERBB4;CSF1R;AKT1;EPHA2;WNT3;WNT2
prerank,wound healing (GO:0042060),0.44059912873086365,1.1553992001247888,0.26504481434058896,0.8563834998748666,1.0,16/62,11.25%,AHNAK2;PPP3CA;DSP;COL3A1;FGF2;FZD7;TGFBR1;SYTL4;TSKU;NOG;GATA4;PDGFA;NF1;ITGB3;ERBB2;PLEC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.38078134856043044,-1.1550878145457608,0.2582781456953642,0.6888351042272781,1.0,15/34,22.47%,LYN;MFHAS1;LGR4;DAB2IP;CD300A;GRAMD4;TLR3;TYRO3;LRRC14;SARM1;TNFAIP3;GPS2;TREM2;SMPDL3B;CACTIN
prerank,protein monoubiquitination (GO:0006513),0.4706941807198725,1.1550484848287847,0.27448275862068966,0.8565413952507673,1.0,15/36,26.57%,UBE2B;KLHL22;RNF126;UBE2D3;WAC;CTR9;CUL3;FANCL;TRIM25;UBE2W;HUWE1;PAF1;UBE2O;UBE2R2;RNF20
prerank,calcium ion transport (GO:0006816),0.40549028561662115,1.154531438768996,0.2562874251497006,0.8571806589996712,1.0,19/113,7.26%,SLC24A3;PKD1;RAMP1;ANK2;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;ATP2B4;STIM2;ITGAV;TRPM7;CASR;CRACR2A;CACNG6;CACNA1F
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4465904182620124,1.1544688007579371,0.2716216216216216,0.8564197399582475,1.0,7/48,3.69%,THBS1;RHOJ;ANXA1;HDAC9;FGFR1;FGF2;FOXC2
prerank,regulation of glucose import (GO:0046324),-0.39964465643930414,-1.1542945850252486,0.255663430420712,0.6893228644087191,1.0,7/30,3.90%,IGF1;OSBPL8;PIK3R1;OCLN;ENPP1;PRKAG2;INSR
prerank,protein localization to chromosome (GO:0034502),0.4785482902221703,1.1540479230311098,0.3005698005698006,0.8566837555128165,1.0,12/34,19.47%,ESR1;TNKS2;RB1;WAPL;ATRX;XRCC5;MRNIP;MCM9;RPA1;LEMD2;ATR;PARP3
prerank,neuromuscular synaptic transmission (GO:0007274),0.521425932523044,1.153839487808546,0.296998420221169,0.8563673748675033,1.0,6/18,15.53%,ERC1;ERC2;KIF1B;FCHSD2;FCHSD1;CHRNB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5493072713264302,1.1536012736979826,0.3133561643835616,0.856159285994679,1.0,4/14,16.61%,PAICS;RFK;PFAS;GMPS
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4879844484044211,1.1534904076354895,0.3106508875739645,0.8555331905154393,1.0,2/26,1.54%,ACER3;CYP1B1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.43431784083215225,1.1532898931018856,0.2648578811369509,0.8551780071169007,1.0,26/63,23.64%,PLAGL1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;WAC;PRKDC;EP300;CCND1;CNOT7;PIDD1;PML;CASP2;CDKN1A;CARM1;TNKS1BP1;CNOT4;E2F1;CNOT11;CDK2;CCNB1;CNOT3
prerank,positive regulation of chromosome organization (GO:2001252),0.5529856798380922,1.1531588358787168,0.3254237288135593,0.8546193961598844,1.0,7/15,21.84%,DDX11;ATRX;PML;NBN;SIRT6;DHX36;RAD50
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.43603512753126655,-1.152895731418628,0.28225806451612906,0.6914340510291296,1.0,4/18,12.64%,BCL2;BCL2L1;CAMK2A;THEM4
prerank,negative regulation of inflammatory response (GO:0050728),-0.27830345541292606,-1.1527466945517368,0.0958904109589041,0.6901934993907217,1.0,59/182,20.32%,IGF1;LYN;ADCY5;TEK;APOE;MFHAS1;ADCY1;PPARA;PRKAR2B;GNG2;CALCRL;ADCY7;NR1H3;PPARD;GGT5;PRKAR1B;MYH9;SIRPA;RPS19;C1QTNF3;ENPP3;PRKACB;PRKAR1A;ADORA2A;GRN;LRFN5;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;MDK;CD200;PLCG1;TYRO3;NR1H4;HCK;GPR176;ADCY4;TNFRSF1A;FCGR1A;PLK2;METRNL;GGT1;AOAH;RHBDF2;SELENOS;VIPR2;CDH5;LHCGR;TNFAIP3;GPS2;TSHR;OTULIN;GPER1;RXFP1;FNDC4;TREM2
prerank,regulation of interferon-alpha production (GO:0032647),0.501786660850854,1.1526745572671435,0.3048211508553655,0.8551696836723086,1.0,11/23,18.37%,MAVS;RIPK2;SETD2;IL10;TLR4;CHUK;IFIH1;DHX9;TLR8;DHX36;PTPRS
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5224491083667725,1.1526425297898208,0.31210191082802546,0.8543277262071018,1.0,2/18,1.74%,STK39;CAMK2D
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4680305024190628,1.152633569225904,0.2953890489913545,0.8534216645063776,1.0,7/37,7.72%,EFNA5;MAPRE2;PHLDB2;GSK3B;FAM107A;GAS2L2;MARK2
prerank,SNARE complex assembly (GO:0035493),0.5835884432419667,1.1524041189618985,0.3407917383820998,0.8531809149283843,1.0,2/10,7.18%,STXBP6;CLTRN
prerank,positive regulation of B cell activation (GO:0050871),-0.3466487890023237,-1.1522793645603187,0.23104693140794225,0.6899144377867851,1.0,17/50,21.55%,BCL2;TFRC;SH3KBP1;MEF2C;VAV3;CD81;CD38;TNIP2;RIF1;MIF;CD74;CD40;BTK;XBP1;SHLD3;SYK;IL7
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.42091260509640593,-1.1522761380895916,0.2622478386167147,0.688291109697875,1.0,5/22,8.16%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,anion transmembrane transport (GO:0098656),0.4268637014666952,1.1521749844958078,0.27261146496815286,0.8529089235857873,1.0,4/67,1.31%,SLC23A1;SLC23A2;SLC5A6;LRRC8D
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3792338165131973,-1.152072039650876,0.27759197324414714,0.6872201534500642,1.0,11/34,11.56%,FLT1;SEMA6A;PRKD1;KDR;NOTCH1;DAB2IP;ERN1;SPHK1;RAMP2;FLT4;NUS1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5530619533960143,1.1518488500330895,0.33554817275747506,0.8529605320104146,1.0,3/13,7.18%,KCNB1;CACNA1G;CLTRN
prerank,regulation of apoptotic process (GO:0042981),0.37017203098223705,1.1509750290144993,0.11723446893787576,0.8545358538335688,1.0,115/676,14.50%,SLIT2;EGFR;THBS1;BMP4;RASSF2;CARD14;FSTL1;MAP3K5;GRK5;PERP;SOX9;HOXA5;NGF;ARHGAP10;EGLN3;CYP1B1;TCIM;PTK2B;NDRG1;TGFB3;ANXA1;AKAP13;WNT11;PAWR;SMAD6;FOXO3;FBXO10;CD44;ANXA4;GCLC;VAV2;ANO6;SHC1;TAX1BP1;CRADD;ITGB1;GSK3B;NOTCH2;UNC13B;ERC1;ABL1;IP6K2;SERPINB9;TIAM2;SON;CASP6;VCP;SFRP4;DNAJC3;GADD45G;CREBBP;TRIO;GDNF;CLU;RIPK2;GOLPH3;BIRC6;ARHGEF6;GAS1;IL10;BIRC7;CALHM2;SOCS2;SIX4;PLK3;ERCC5;RIPK3;WRN;NFKB1;NIBAN2;GNA13;RBM25;BCLAF1;NTSR1;GATA1;RARG;NF1;PIM2;ATM;JUN;PROK2;MTDH;VEGFA;APEX1;ARF4;DIABLO;ATF6;KRT18;ARHGEF5;ARL6IP5;USP47;COPS5;TIAM1;DDX42;UBE2Z;HTATIP2;MYD88;AATF;SOS2;DDRGK1;RNF122;YME1L1;PAK2;PRKDC;OMA1;PLSCR3;BAG3;FATE1;TRADD;PRDX5;REST;TMEM219;HTR2B;STIL;CEACAM5
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.388163969134509,-1.1507242072588324,0.26229508196721313,0.6892446872678633,1.0,7/30,8.12%,ROBO1;ARHGEF3;F11R;LPAR1;NET1;ADGRG1;RAC1
prerank,autophagy of nucleus (GO:0044804),0.5438983274739044,1.1502658398732646,0.31962025316455694,0.8558544227454065,1.0,9/16,26.19%,ULK2;WIPI2;ATG3;RB1CC1;ATG2A;WDR45B;ULK1;ATG5;ATG7
prerank,cell projection organization (GO:0030030),0.48874956393382235,1.1501318727723695,0.30626780626780625,0.8553547746338522,1.0,7/30,10.17%,RHOJ;GSN;PARVA;ITGB1;RHOQ;PDGFA;NCKAP1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3415011692458683,-1.149931695585784,0.19767441860465115,0.689811728989386,1.0,10/55,15.05%,IGF1;IGFBP2;VCAM1;TFRC;RPS3;IL18;IL6ST;CCL19;ICOSLG;JAK3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4899773119668279,-1.149612880532651,0.2849604221635884,0.6890516800087945,1.0,6/13,18.12%,NOTCH1;RYR2;RBPJ;HEY2;GSK3A;FOXF1
prerank,negative regulation of catabolic process (GO:0009895),0.44764621713607966,1.1496115201462345,0.29349269588313415,0.8560083294684423,1.0,10/47,16.62%,EGFR;HDAC4;PFKFB1;MDM4;IRAK3;NCOR1;SNX12;AZIN1;HMGCR;MAD2L1
prerank,regulation of histone deacetylation (GO:0031063),0.5536753913911975,1.1495367121268694,0.3137254901960784,0.8553281223084944,1.0,4/13,14.16%,CAMK2D;ZBTB7B;NIPBL;PRMT6
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3918456001425174,1.1495124600610378,0.2345132743362832,0.8544737411904403,1.0,26/175,14.57%,TNFRSF11B;CARD14;EDA;PTK2B;PID1;TANK;FOXO3;YBX3;NFE2L2;PSMB2;TNFRSF13B;CHUK;ERBIN;LIMS1;PSMC6;CDIP1;CCL3;CCL1;TRAF5;TNFRSF1B;ZC3H12A;TNFSF11;PSMD11;TRADD;DHX9;PSMD1
prerank,chromatin assembly or disassembly (GO:0006333),0.5737266285488766,1.1493620685572339,0.3368237347294939,0.8539991284306099,1.0,2/11,5.36%,CHAF1B;HDAC8
prerank,regulation of keratinocyte migration (GO:0051547),0.5692430705951925,1.1492962264952589,0.33554817275747506,0.8532570207592189,1.0,2/12,2.33%,ADAM9;MAPRE2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.38731887353847727,-1.149076234791627,0.26143790849673204,0.6888626900715843,1.0,8/32,12.64%,BCL2;BCL2L1;ERBB4;IFIT2;CAMK2A;HK2;BOK;THEM4
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3902093364989615,1.1482114668394805,0.24288840262582057,0.8556062460136253,1.0,35/170,16.76%,FOXP1;CDH1;PRDM6;ATP1B1;AFF3;YBX3;COQ7;NELL1;ZFP64;TSKU;LDLR;HMG20A;GDNF;C1D;PTHLH;TRIM44;TOB2;AFF4;IL10;TOB1;PCBP4;TRIM26;MEGF8;KIF16B;MKLN1;TCF19;ZC3H12A;REST;ZNF507;TRIM39;HINFP;ZNF462;GNB3;PRDM5;SCARB2
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5240750032233887,1.1480412156644828,0.319935691318328,0.8551913664720568,1.0,5/16,9.50%,TELO2;KLHL22;CLEC16A;RRAGB;SIK3
prerank,neurogenesis (GO:0022008),0.4602885398594731,1.1476273428807118,0.29045643153526973,0.8555075503754455,1.0,8/43,9.87%,SIX1;CIT;ANXA1;THOC2;NTN5;DAGLB;SIX4;BTBD3
prerank,peripheral nervous system development (GO:0007422),0.49767584312718827,1.1461881032765522,0.311178247734139,0.8589117290740287,1.0,6/23,9.90%,NGF;PMP22;GDNF;EGR2;NF1;ADGRG6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4103238242778304,1.1459515028760618,0.2668269230769231,0.8586600151040571,1.0,41/96,28.58%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5622888096651546,1.1459158157154798,0.3483535528596187,0.8578261489580244,1.0,4/11,13.41%,CLK2;C1QTNF12;ERFE;EP300
prerank,regulation of viral entry into host cell (GO:0046596),-0.3806794125740267,-1.1458155371054115,0.27631578947368424,0.6957062291921744,1.0,13/30,21.23%,LY6E;HS3ST5;TRIM14;LGALS1;IFITM1;TRIM62;IFITM3;NECTIN2;CD74;TRIM21;SNX3;P4HB;TRIM27
prerank,regulation of protein polymerization (GO:0032271),-0.3810775283881568,-1.1452500918381643,0.25165562913907286,0.6954899200497665,1.0,6/35,8.96%,ARHGAP28;ESAM;MAP2;MAPT;PAK3;COTL1
prerank,regulation of protein export from nucleus (GO:0046825),0.4990399861287224,1.1452342819909291,0.3280757097791798,0.858977788964029,1.0,6/23,17.17%,TCF7L2;GSK3B;EMD;BAG3;XPO4;BARD1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4098508418639992,-1.1452312602818737,0.28116710875331563,0.6939496373812257,1.0,11/22,17.56%,LYN;PICALM;EPHA4;ABCG1;LRRTM3;ROCK2;CASP3;GSK3A;RANBP9;ABCA2;GSAP
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3521842425841059,-1.1451413018742982,0.23134328358208955,0.6926052984626717,1.0,10/47,6.50%,IGF1R;PHLPP1;TGFBR3;FOXO1;EPHB1;RAP2A;MAP4K4;PPIA;DAB2IP;FAS
prerank,positive regulation of lipid localization (GO:1905954),0.585190258863232,1.144916441734557,0.3339191564147627,0.8590119669355006,1.0,5/11,12.52%,LRP1;IKBKE;NFKB1;HILPDA;ZC3H12A
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5436293341137892,1.1444829443017486,0.29572649572649573,0.8593642977666713,1.0,2/14,3.93%,THBS1;CMKLR1
prerank,inhibitory synapse assembly (GO:1904862),-0.49215225482438396,-1.143811778917807,0.29836829836829837,0.694592921732842,1.0,5/11,8.53%,WNT5A;GABRA2;GABRB2;GABRB3;GABRA1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4855331679027756,1.1436678369508295,0.31075110456553756,0.8609540692380868,1.0,9/27,17.95%,DDX5;CD44;SPRED2;SMYD2;KDM1A;ATM;TWIST1;KMT5A;ATR
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.44139685407295903,1.1436150870959105,0.2769640479360852,0.8601988213358963,1.0,4/51,3.93%,THBS1;PGF;ANO6;CMKLR1
prerank,chromatin organization (GO:0006325),0.3935237389499154,1.1433754409229373,0.2525832376578645,0.8600185982583245,1.0,38/132,21.13%,TCF7L1;SOX9;HDAC4;HDAC8;HMG20A;ESR1;MYSM1;SETD2;EHMT1;CHD1L;BAZ2B;TOP1;NUDT5;DDX11;RB1;BPTF;KAT2A;SMARCA4;BAZ1A;ATRX;SETD5;PBRM1;HCFC1;HDAC10;KDM4D;ZBTB1;BAZ2A;BRWD1;KAT2B;ZBTB7A;EZH1;SMARCA5;INO80;SMARCC1;SATB2;CHD1;FOXA1;HMGN2
prerank,eye morphogenesis (GO:0048592),0.5114750502677975,1.1433620533482654,0.31552587646076796,0.8591296889173932,1.0,9/19,12.18%,COL5A2;MFAP5;EFEMP1;SKI;STAT3;RARG;NF1;VEGFA;NIPBL
prerank,body fluid secretion (GO:0007589),-0.45333061959393606,-1.1433455674164703,0.28205128205128205,0.6943051139207331,1.0,4/15,9.99%,NPR1;SLC22A4;ERBB4;SLC22A2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.44631316616984373,-1.1432848438533922,0.2898172323759791,0.6928722548587087,1.0,6/18,7.94%,SHANK3;NRXN1;RIMS1;RIMS2;PRKCZ;GRIN1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.49845403905722635,-1.1430846855839834,0.3054892601431981,0.6918433079638577,1.0,3/11,5.56%,LYN;RAPGEF2;MEF2C
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.44447295862511843,1.142783917809138,0.2795275590551181,0.8599625533383576,1.0,11/48,13.69%,DOCK5;CUX1;ABL1;NRP1;FBXW8;DMTN;S100A10;LIMS1;LIMS2;PRKDC;TRIOBP
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3402250869399941,-1.1426694362616434,0.1888412017167382,0.6899208350354165,1.0,22/56,28.23%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA2;NDUFA6;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.3402250869399941,-1.1426694362616434,0.1888412017167382,0.6899208350354165,1.0,22/56,28.23%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;NDUFA1;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA2;NDUFA6;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,positive regulation of vascular permeability (GO:0043117),-0.48799977106108855,-1.1424748937708447,0.28019323671497587,0.6889014039789532,1.0,3/12,7.31%,TJP1;OCLN;PDE2A
prerank,regulation of focal adhesion assembly (GO:0051893),0.4391977575104886,1.1422551295726011,0.28897849462365593,0.8606443911019925,1.0,17/54,12.07%,THBS1;EFNA5;PHLDB2;ABL1;FAM107A;NRP1;BCAS3;VCL;PTPRA;DMTN;SLC9A1;S100A10;RHOA;LIMS1;VEGFA;ITGB1BP1;CORO1C
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5317319477121564,1.1418583741900807,0.32909379968203495,0.8609084237210887,1.0,4/17,10.78%,HDAC4;PID1;PFKFB1;NCOR1
prerank,artery development (GO:0060840),-0.40943297723380595,-1.1418370123544475,0.2804878048780488,0.6890908237419243,1.0,7/23,9.85%,ROBO1;ENG;ROBO2;TBX1;PDE2A;ACVR2B;EFEMP2
prerank,nucleosome organization (GO:0034728),0.4451874931590203,1.14145936132882,0.295364238410596,0.861122250144636,1.0,18/55,24.11%,SOX9;CHAF1B;KAT6B;SETD2;SRCAP;BPTF;SMARCA4;ATRX;VPS72;NAP1L2;SMARCA5;INO80;SMARCC1;CHAF1A;RNF8;PAF1;DMAP1;ARID1A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.41577252326052005,1.1408266357332368,0.27419354838709675,0.8620607624759872,1.0,25/84,24.76%,FZR1;ECRG4;ANAPC5;PSMB2;CDC16;ANAPC16;AURKA;PSMC6;RB1;PSMD11;CUL3;UBE2S;PSMD1;MAD2L1;PSMC1;PSMD7;PSMD14;PSMD3;ANAPC11;ANAPC10;CDK2;CCNB1;CDC20;BUB3;PSMD12
prerank,synapse assembly (GO:0007416),-0.3303726738229245,-1.1406618905272916,0.21962616822429906,0.690836374858484,1.0,18/67,9.63%,ADGRL3;DNM3;CDH2;SHANK3;SPOCK2;NRXN1;WNT5A;GRID2;GPM6A;PLXND1;KIRREL3;GABRA2;GABRB2;OBSL1;GABRB3;LRRTM3;GABRA1;SDK2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.32201232191088497,-1.1402317715139412,0.21739130434782608,0.6904315469390295,1.0,28/82,13.07%,EFNB2;LYN;EPHA7;PAK1;EPHB1;ACTB;CHN1;GRIN2B;EPHA4;EPHB4;EPHA8;PTK2;VAV3;EPHA6;GRIN1;RAC1;DNM1;PAK3;ARPC4;SDCBP;ROCK2;EFNB3;ARHGEF7;APH1B;MMP2;ARPC3;ARPC5;NGEF
prerank,cytoplasmic microtubule organization (GO:0031122),0.4318549394036085,1.139978040679167,0.27417218543046357,0.8637084423924137,1.0,14/54,16.89%,EZR;CLIP4;LIMK2;CLIP1;PCM1;DLG1;PLK3;RHOA;SLAIN2;CHP1;TUBGCP6;TUBGCP5;HOOK3;TUBGCP4
prerank,cellular response to increased oxygen levels (GO:0036295),-0.511258444920415,-1.1396364601059679,0.33163265306122447,0.6905148500529448,1.0,3/11,13.01%,FOXO1;FAS;ATP6AP1
prerank,protein polyglutamylation (GO:0018095),-0.5034406797134633,-1.1391329098269503,0.31202046035805625,0.69035207185505,1.0,5/11,15.92%,TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,fatty acid catabolic process (GO:0009062),0.42874693689866267,1.1390787620338063,0.2949547218628719,0.8655252806192965,1.0,13/67,11.30%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;PLA2G15;DECR1;ACOT8;ACADM;PECR;ACBD5;LPIN2;HACL1
prerank,RNA export from nucleus (GO:0006405),0.40601007217572577,1.138930604328812,0.2811004784688995,0.8650489230760234,1.0,42/100,28.58%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;RAN;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,positive regulation of endocytosis (GO:0045807),-0.35404310824416874,-1.13890960712794,0.2413793103448276,0.6893350589419248,1.0,5/45,1.85%,VTN;SGIP1;APOE;B2M;NEDD4L
prerank,response to ionizing radiation (GO:0010212),0.4238197753134816,1.138825836326683,0.29760403530895335,0.8644462785059166,1.0,21/70,18.55%,TANK;ANXA1;CLK2;EYA3;ATM;NABP1;MTA1;SPIDR;COP1;UIMC1;RNF168;MRNIP;KDM4D;USP28;TICRR;CDKN1A;RAD51;BRAT1;TNKS1BP1;INO80;TOPBP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3387622699047585,-1.138558655417232,0.23651452282157676,0.6886966969700905,1.0,15/57,12.29%,RPL38;RPS19;RPS16;RPS15;RPS24;RPS7;RPS25;RPL26;RPL35A;RPL11;RPL7;RPS17;NOC2L;RPL14;NPM1
prerank,dermatan sulfate metabolic process (GO:0030205),0.542887230360846,1.137952412541066,0.3283582089552239,0.866070219040905,1.0,2/13,1.65%,UST;DSE
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4347810897628497,1.1372416847322244,0.2836218375499334,0.8673293618525856,1.0,37/58,35.22%,HERC2;ATM;SMC5;UIMC1;RNF168;PRKDC;XRCC5;ERCC8;POLB;KDM2A;ZBTB7A;SMARCAL1;BARD1;NBN;ERCC1;PSMD14;UBE2N;POLA1;RNF8;RAD50;BRCC3;KAT5;POLQ;MDC1;XRCC4;POLM;IFFO1;PIAS4;BABAM2;PAXIP1;LIG4;NSMCE2;SUMO1;MRE11;BRCA1;ERCC4;ABRAXAS1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3693309449234706,1.1371205165306215,0.21274409044193218,0.8667480968521827,1.0,114/336,21.89%,FOXP1;TANK;ABL1;HERC2;VCP;UBE2B;MNAT1;SUSD6;UBR5;DDIT3;GNL1;EXO1;TRRAP;TRIP12;IKBKE;CHEK2;PLK3;CHD1L;MCM7;RAD17;CEP63;WRN;DCUN1D5;APLF;CBX5;ATM;BOD1L1;USP10;APEX1;WAC;MAPK12;IGHMBP2;NABP1;SMC5;DDX11;USP47;SMC1A;ALKBH8;AATF;SPIDR;NIPBL;RAD52;MACROD2;TNFRSF1B;ZC3H12A;SLX4;CHEK1;RNF168;PRKDC;XRCC5;CSNK1E;DYRK2;MRNIP;ERCC8;POLB;CCND1;POLE2;FANCL;MAPKAPK2;ATF2;EID3;ZBTB1;MCM9;PIDD1;KIN;HINFP;PML;ERCC3;TLK2;BCL6;RBBP8;IKBKG;SMARCAL1;XPA;VCPIP1;CASP2;YY1;RPA1;RMI2;RECQL5;USP28;BARD1;NBN;TICRR;CDKN1A;NCOA6;RAD51;ERCC1;ATR;ALKBH7;BRAT1;INO80;WDR48;TOPBP1;MOAP1;PARP3;HELB;FMR1;PARP4;RAD51C;SMC6;POLA1;WDR76;MCL1;KMT5B;E2F1;RNF8;NRDE2;NUDT1;CBX1;IRF3;RAD9B;RAD50;CUL4A
prerank,mitochondrial transcription (GO:0006390),0.5726662785066581,1.1369447117472196,0.3490909090909091,0.8663713077900885,1.0,1/10,2.23%,FOXO3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.584526047416901,1.1368545714927472,0.3373702422145329,0.865709313634854,1.0,2/10,2.33%,ADAM9;MAPRE2
prerank,positive regulation of telomere maintenance (GO:0032206),0.47181337433801457,1.1362233994797053,0.3216995447647951,0.8666680282297483,1.0,13/31,22.04%,NEK7;TNKS2;ATM;SLX4;ATRX;PML;NBN;SIRT6;ERCC1;MAP3K4;DHX36;RAD50;NAF1
prerank,double-strand break repair (GO:0006302),0.39423724557714396,1.136144113616096,0.24582869855394884,0.8659885949792375,1.0,60/158,25.94%,REV3L;HERC2;RNF138;VCP;EYA3;CHEK2;ERCC5;WRN;APLF;ATM;BRCA2;NABP1;SMC5;MTA1;PPP5C;SPIDR;RAD52;UIMC1;SLX4;RNF168;PRKDC;XRCC5;BAP1;POLB;KDM4D;MCM9;KDM2A;NSMCE1;RBBP8;SMARCAL1;YY1;RPA1;RECQL5;BARD1;NBN;RAD51;ERCC1;SMARCA5;TNKS1BP1;INO80;PSMD14;PARP3;SWSAP1;UBE2N;MAPK8;EXD2;RAD51C;SMC6;POLA1;RNF8;DDX1;RAD50;ZFYVE26;BRCC3;PARP2;BRIP1;KAT5;POLQ;MDC1;RAD51AP1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5036106417717735,-1.1361186707423456,0.32075471698113206,0.6935639450900645,1.0,7/10,20.38%,PDE4D;PDE2A;RNF157;MGRN1;APLNR;PDE3B;PDE11A
prerank,microvillus assembly (GO:0030033),0.5337545251890143,1.1360482970783292,0.33278418451400327,0.8653660837919191,1.0,5/14,7.78%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,protein import (GO:0017038),0.41420240882981924,1.1352048364374465,0.29255989911727615,0.8669776162599776,1.0,22/84,20.34%,ABCD3;PRICKLE1;NUP93;PXMP2;STAT3;IPO7;CLU;E2F3;TNPO2;ACBD5;SAMM50;SEC13;NUP153;PEX13;NUP214;NUP188;ABCD1;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,positive regulation of cell migration (GO:0030335),0.373365229981995,1.1348575489616273,0.22698072805139186,0.8671502384136262,1.0,48/253,13.00%,F3;EGFR;THBS1;DOCK5;NTRK3;SOX9;CCN1;PPP3CA;PDGFC;PTK2B;SMO;DDR2;FN1;ADAM9;SEMA3E;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;PRKCE;FAM107A;NRP1;TGFBR1;GCNT2;SHTN1;STAT3;DMTN;ELP3;RDX;PDGFA;RAB25;MMP14;ELP5;PLCG2;ACVR1;ATM;VEGFA;CCL3;SYNE2;TIAM1;NIPBL;CPNE3;DDRGK1;TRIP6;MTOR;FAM83H;PIK3R3
prerank,establishment of skin barrier (GO:0061436),0.5314016342576436,1.1346569439421568,0.3536379018612521,0.8659621728263395,1.0,1/15,0.77%,MET
prerank,regulation of water loss via skin (GO:0033561),0.5314016342576436,1.1346569439421568,0.3536379018612521,0.8659621728263395,1.0,1/15,0.77%,MET
prerank,regulation of macrophage migration (GO:1905521),0.5695379564993268,1.134535805885421,0.35877862595419846,0.8654208768705595,1.0,2/10,2.85%,PTK2B;MTUS1
prerank,positive regulation of transport (GO:0051050),-0.3108924120780411,-1.1344143524741597,0.1724137931034483,0.6964716035933535,1.0,36/85,23.30%,CAMK1D;APOE;MERTK;NEDD4L;IL15RA;ACTB;NR1H3;CD47;SIRPA;SGK1;GATA2;SNCA;HIP1R;GAS6;DOCK2;CALR;BOK;CYBA;GSK3A;CCL19;SMPD1;LYAR;CHCHD10;DOC2B;CDH3;DLL1;TREM2;SGK2;INPP5K;SPAG5;AHSG;MLC1;CD151;RAB27A;PLA2G5;PYCARD
prerank,negative regulation of viral transcription (GO:0032897),-0.47032770586066663,-1.1340112294659084,0.32891246684350134,0.6960442290299658,1.0,5/13,21.23%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27
prerank,negative regulation of mRNA processing (GO:0050686),0.5414489428026622,1.1339408076404953,0.33612040133779264,0.866275654259726,1.0,7/15,21.94%,SRSF6;PCBP4;RBMX;U2AF2;BARD1;SFSWAP;SRSF12
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3736190302408884,1.1335346069659333,0.22784810126582278,0.8665950192715227,1.0,72/259,18.07%,NTN1;PKD1;BBS9;ABLIM3;FXYD5;EZR;EXOC4;GSN;PARVA;ANO6;ITGB1;EMP1;SRGAP2;PMP22;NRP1;PDE6D;RAP1A;PTPDC1;DZIP1;VCL;RAB11FIP3;SHTN1;ABLIM2;ARL3;PIP5K1A;PCM1;EHD3;GOLPH3;DMTN;ARHGEF6;GBF1;ATAT1;CEP164;RAPGEF6;OCRL;RAP2C;EXOC5;FGD6;CFAP70;CDC14A;TMEM231;IFT46;DISC1;WDR35;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;EHD2;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;ARFIP2;SSTR3;MKS1;NUDCD3;IFT52;CEP89;KIF3B;DYNC2I1;FAM161A;HYLS1;S1PR2;TEKT2;LZTFL1;WHAMM;RILPL1
prerank,polyol biosynthetic process (GO:0046173),0.5269918619407422,1.1332311892373428,0.3291139240506329,0.866582435370511,1.0,3/16,4.05%,ACER3;FGF2;IP6K2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5564343901597391,1.1331201190068474,0.3293918918918919,0.8660104059589728,1.0,8/14,30.11%,TNKS2;BRCA2;ATRX;XRCC5;ATR;ACD;TPP1;PINX1
prerank,response to cadmium ion (GO:0046686),0.5011851098813231,1.1328280450688455,0.3293051359516616,0.8659650725860389,1.0,1/26,0.24%,EGFR
prerank,regulation of neuron death (GO:1901214),-0.32086954028787706,-1.1327239490065548,0.20218579234972678,0.6979963476437115,1.0,17/82,9.24%,EFNB2;PICALM;WNT5A;GRID2;EPHB1;DCC;CSF1;TRIM2;GRIN2B;CD34;MEF2C;PPARGC1A;SNCA;CTSZ;MAPT;FAIM2;C1QA
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3988850884135593,1.1326444827260604,0.28672150411280845,0.8655831255102181,1.0,25/112,10.16%,SMAD9;SOX9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;TGFBR1;ITGB5;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;PARD3;USP15;ACVR1;LIMS1;JUN
prerank,regulation of cell migration (GO:0030334),0.3670366499909247,1.1325079966003755,0.2069672131147541,0.8651084773230691,1.0,49/382,8.11%,SLIT2;F3;EGFR;THBS1;CDH1;TMEFF2;CLIC4;DPYSL3;NTRK3;CYP1B1;CCN1;PPP3CA;PDGFC;PTK2B;SMO;PHACTR1;LMO4;PTPRU;ADAM9;ANXA1;SEMA3E;WNT11;FOXO3;SEMA3D;SEMA3C;TWIST2;SULF1;IGFBP5;ITGB1;FGF2;LMNA;SRGAP2;SRGAP3;FAM107A;TGFBR1;SGK3;VCL;GCNT2;NOG;ZMYND8;STAT3;MGAT3;SLURP1;JAG1;ELP3;RDX;RAP2C;PDGFA;ARSB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.40825929018369256,1.1322195301372167,0.291044776119403,0.8650599243448822,1.0,20/87,9.47%,EZR;PTK2B;EFNA5;SEMA3E;PRKCD;ARHGDIB;ARHGAP44;RHOBTB1;NOTCH2;ABL1;FAM107A;RHOQ;LRP1;DMTN;ARHGAP17;PDGFA;RHOA;IQGAP1;RND3;MLST8
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.4868080896306971,-1.1320017871636934,0.30917874396135264,0.6970066561349509,1.0,3/11,13.41%,CALM1;CASQ2;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.4868080896306971,-1.1320017871636934,0.30917874396135264,0.6970066561349509,1.0,3/11,13.41%,CALM1;CASQ2;CALM3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3762409738063731,1.131607951546805,0.22659574468085106,0.8659637685489308,1.0,57/234,16.37%,SLCO3A1;CARD14;HDAC4;LRP6;EDA;SMO;DDR2;ANXA3;PLPP3;ESR2;ERC1;RAB7B;TAB3;ESR1;STAT3;MAVS;KDM1A;DDIT3;CLU;RIPK2;IL10;JUP;IKBKE;FZD1;TLR4;RIPK4;ROR1;RIPK3;CHUK;NFKB1;PLCG2;IRAK3;MTDH;VEGFA;TRIM41;TRIM26;ARHGEF5;NFKB2;COPS5;MYD88;TRAF5;DDRGK1;CARD16;SMARCA4;PPRC1;TCF3;EP300;TNFSF11;TRADD;CRTC1;DHX9;ATF2;PIDD1;IL18RAP;ZBTB7A;TAF12;IKBKG
prerank,androgen metabolic process (GO:0008209),-0.4369190976194785,-1.1311354615733011,0.30617283950617286,0.6978164597215633,1.0,14/18,44.57%,SPP1;MED1;HSD17B7;SRD5A1;SHH;HSD17B10;HSD17B11;HSD17B4;SRD5A2;HSD3B2;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,cilium organization (GO:0044782),0.37825894868514376,1.1309463172792453,0.2468220338983051,0.8670617929146264,1.0,65/209,22.66%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PARVA;PDE6D;PTPDC1;DZIP1;RAB11FIP3;ARL3;PCM1;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;TMEM231;IFT46;DISC1;WDR35;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;EHD2;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;MKS1;FAM161B;NUDCD3;IFT52;CEP89;KIF3B;DYNC2I1;FAM161A;TTC17;HYLS1;TEKT2;LZTFL1;RILPL1;IQCB1;FUZ;POC1B;IFT80;DYNC2H1;RAB1A;OFD1;CLUAP1;TSGA10IP;TRAF3IP1;TRAPPC14;FLNA;PLK4;BBS2
prerank,DNA replication checkpoint signaling (GO:0000076),0.5329599237331039,1.13082687464369,0.3541666666666667,0.8665297876738665,1.0,6/16,21.72%,RAD17;CLSPN;CDC45;TICRR;TOPBP1;RAD9B
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5190175093390039,1.1306400941172758,0.33278418451400327,0.8662233881552821,1.0,5/18,19.45%,NUP93;THOC2;DDX19B;ZC3H11A;NXF1
prerank,cortical cytoskeleton organization (GO:0030865),0.45589744077219263,1.130614896287478,0.3229901269393512,0.8653814894983685,1.0,9/41,10.17%,FMNL2;EZR;PPP2R3C;RHOBTB1;RHOQ;DLG1;RHOA;RND3;NCKAP1
prerank,cellular response to sterol (GO:0036315),0.5450769656360713,1.1306146762796399,0.32941176470588235,0.8644922462137583,1.0,5/13,12.83%,LRP6;SMO;GRAMD1C;RORA;GRAMD1A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.484270016916458,1.1305671194484976,0.33480825958702065,0.8637551076192261,1.0,9/29,15.96%,RAB6A;TRAPPC3L;NSF;COG5;COPA;VTI1A;COG3;COPG1;TRAPPC10
prerank,positive regulation of histone methylation (GO:0031062),-0.40067369833087285,-1.130159405277455,0.2706552706552707,0.6988630309653382,1.0,2/24,2.94%,AUTS2;JARID2
prerank,smooth muscle tissue development (GO:0048745),0.5762542176916076,1.1300749506881358,0.3670212765957447,0.8643397094561284,1.0,3/10,4.15%,BMP4;SMO;STRA6
prerank,icosanoid metabolic process (GO:0006690),0.454230827509373,1.129749984968541,0.30261348005502064,0.8643562095611287,1.0,6/40,7.68%,CYP1B1;MGLL;PTGIS;CYP2S1;PON3;DAGLB
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4428249391446166,1.1296114992565378,0.30148048452220727,0.8638796678403212,1.0,10/49,13.41%,SMAD6;GSK3B;PMEPA1;ISL1;CLU;ANKRD27;DACT1;LDLRAD4;PPM1A;EP300
prerank,secretory granule organization (GO:0033363),-0.5055920715115343,-1.1295161271427654,0.3176470588235294,0.6990163752906976,1.0,2/10,4.77%,SRGN;ABCA1
prerank,membrane depolarization (GO:0051899),-0.3774501663164501,-1.1295154453630727,0.2991202346041056,0.6974921493356729,1.0,11/32,16.15%,SCN7A;CACNA1E;SCN1A;CACNB4;CACNG4;CACNA1B;P2RX7;SCN3A;CACNA1I;SCN2A;SCN9A
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.539249122068695,1.1294989475558925,0.34731543624161076,0.8632894672278612,1.0,4/13,13.59%,SAE1;DESI1;DESI2;UBA5
prerank,iron ion transport (GO:0006826),-0.3482633185514779,-1.1293723016819563,0.22813688212927757,0.6963096156016526,1.0,15/47,20.54%,CP;FTH1;TFRC;SLC40A1;ABCB7;LMTK2;ATP6AP1;TTYH1;STEAP3;ATP6V1D;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.47079376397098793,1.1291709606793212,0.32689450222882616,0.8633472836748756,1.0,6/31,5.64%,ZFPM2;DSP;BMPR1A;TGFBR1;NOG;ISL1
prerank,positive regulation of signal transduction (GO:0009967),0.3724156810336783,1.1289258350565683,0.2644539614561028,0.8631751222966358,1.0,43/238,11.77%,RSPO3;SMOC2;F3;CCN3;NTRK3;PTK2B;SMO;PTGIS;SULF1;GRB10;SORBS1;CRADD;BMP6;IRS1;NRP1;TGFBR1;SLC39A14;ZBTB7B;ITGA5;CD80;CREBBP;SKI;ITGAV;STAT3;TRIM44;DMTN;JAG1;RSPO4;SHANK1;AAK1;DISC1;DRD3;DACT1;KIF7;C1QTNF12;LIMS1;LIMS2;ELF3;ITGB3;EVC;ERFE;ADAMTS3;ITGB1BP1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5682026436324117,1.1288448672345992,0.3434343434343434,0.8625377128628379,1.0,6/11,28.10%,CTR9;KMT2D;WDR82;OGT;KMT2A;SETD1B
prerank,actin filament capping (GO:0051693),0.5154514003128402,1.1287144745936486,0.3408723747980614,0.861128449237909,1.0,6/18,13.69%,VILL;ADD3;GSN;CAPZA1;ADD1;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.5154514003128402,1.1287144745936486,0.3408723747980614,0.861128449237909,1.0,6/18,13.69%,VILL;ADD3;GSN;CAPZA1;ADD1;TRIOBP
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.47864538771742293,-1.1284349644448215,0.3341708542713568,0.6972442596737021,1.0,5/12,27.46%,PCGF5;RBM15B;CDYL;METTL3;SMCHD1
prerank,dorsal/ventral pattern formation (GO:0009953),0.5069664942690703,1.128307876518311,0.3228346456692913,0.8614877760849464,1.0,6/20,9.96%,BMPR1A;MDFI;NOG;NBL1;GLI2;ACVR1
prerank,fibrinolysis (GO:0042730),-0.4726276592465711,-1.1280447030691556,0.31784841075794623,0.6967206051088053,1.0,8/13,40.76%,PLAT;HRG;PLAUR;PLG;CPB2;SERPINE1;GP1BA;F2
prerank,response to molecule of bacterial origin (GO:0002237),0.424158525765214,1.128015146047712,0.3125,0.8614880537600638,1.0,9/69,9.95%,FOXP1;LBP;SMAD6;SLPI;IL10;TLR4;CXCL2;ERBIN;IRAK3
prerank,acylglycerol homeostasis (GO:0055090),-0.41359700508682085,-1.1277106157740087,0.2768817204301075,0.6960995542552927,1.0,6/20,14.82%,APOE;NR1H3;IL18;PNPLA8;SCARB1;LPL
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3910187755691656,-1.127687673880429,0.3022598870056497,0.6946557682562148,1.0,4/27,11.35%,CSF1;IL6R;JAM3;MDK
prerank,positive regulation of cell population proliferation (GO:0008284),0.36620055216660297,1.127202250374191,0.216243654822335,0.8629696331233473,1.0,43/423,6.78%,EGFR;FOXP1;THBS1;BMP4;ACER3;ZFPM2;TCF7L2;GRK5;NTRK3;SOX9;BMP5;HDAC4;PGF;CCN1;PDGFC;PTK2B;TGFB3;PID1;DDR2;FN1;HES1;KRAS;FGFR1;SHC1;BMP6;BMPR1A;FGF2;GAB2;IRS1;GAREM1;TGFBR1;CLCF1;NR4A3;TRPM4;TGFBR2;GCNT2;ITGAV;GDNF;KDM1A;BAMBI;PTHLH;CDC25B;MAP3K3
prerank,regulation of complement activation (GO:0030449),0.45726144391550794,1.1268014984455086,0.3305785123966942,0.8631682381721916,1.0,6/40,9.24%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4173263904150055,1.1267891171239375,0.3137755102040816,0.8623199678411477,1.0,12/64,9.78%,THBS1;PTK2B;EFNA5;SEMA3E;GSK3B;VCL;PTPRA;JAG1;JUP;SLC9A1;RHOA;NF1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.43240309688386824,1.1266725525875947,0.30283505154639173,0.8617631076247515,1.0,11/56,14.50%,EGFR;ANXA1;ANAPC5;EIF4G1;CDC25B;CDC16;RDX;RB1;LSM11;CUL3;CCND1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4598618444999012,1.1260267543846219,0.30404463040446306,0.8627539861190952,1.0,4/36,5.13%,SLIT2;THBS1;FGF2;ATP2B4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4969360828651861,1.12601395386501,0.32585949177877427,0.8619181321665986,1.0,4/23,7.15%,CYP1B1;PTK2B;HES1;IL10
prerank,autophagy of mitochondrion (GO:0000422),0.46153073627569374,1.1254786380114523,0.3242506811989101,0.8626358278682418,1.0,16/38,26.30%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG5;ATG7;USP30
prerank,regulation of feeding behavior (GO:0060259),-0.5098914807970945,-1.1252561264531589,0.3310344827586207,0.6996247272549881,1.0,2/11,1.20%,LEPR;SGIP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.48687995547593504,1.1250560693098763,0.3490853658536585,0.8629433330632316,1.0,4/26,7.42%,EGFR;ANXA1;EIF4G1;RDX
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.38340090729404436,1.1249979279907818,0.2855543113101904,0.8622549751410225,1.0,23/159,9.28%,CDH1;PCDHB16;GPC6;HMCN1;CDH11;PKD1;FAT2;MPZL2;CXADR;NECTIN3;ITGB1;DSG2;ALCAM;PTPRF;TGFBR2;CLDN11;PCDHB13;CLDN16;EMB;GPC4;PCDHB9;PVR;PCDHB3
prerank,cellular response to interleukin-4 (GO:0071353),-0.5024337272760797,-1.1243445147443754,0.3249370277078086,0.7005006036330781,1.0,4/10,18.17%,LEF1;TCF7;JAK3;XBP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.43305784447850426,-1.12429073204047,0.33866666666666667,0.699137690406715,1.0,8/18,8.17%,ENG;TEK;TGFBR3;RBP4;BMP7;NOTCH1;RBPJ;S1PR1
prerank,protein polyubiquitination (GO:0000209),0.3699147192278034,1.1240819467101493,0.2338877338877339,0.863998836527977,1.0,59/297,17.17%,FBXL7;WWP1;FZR1;NEDD4;TRAF3IP2;FBXO10;UBE4B;WWP2;NPEPPS;RNF144A;RNF115;FBXO40;ANAPC5;FBXW8;UBE2B;ARIH1;MKRN3;UBR5;RNF19A;PSMB2;FBXL20;CDC16;RNF114;TRIP12;RNF126;UBE2D3;LRSAM1;FBXW11;UBE4A;TNKS2;PSMC6;FBXO17;RNF146;CBFB;TRAF5;FBXO4;HERC6;RNF168;ARIH2;ANKIB1;SMURF1;HECTD2;PSMD11;CUL3;ERCC8;UBE2S;PSMD1;RNF135;SPOP;UBE2K;CHFR;MKRN1;BFAR;CUL1;RNF14;UBE3C;PSMC1;PSMD7;BARD1
prerank,chromosome organization (GO:0051276),0.3979955104621721,1.1233417196884041,0.284688995215311,0.8652983302230687,1.0,15/99,16.47%,TCF7L1;TCF7L2;ABL1;HDAC8;HMG20A;EHMT1;RAD23B;COPS7B;COPS5;SMARCA4;HDAC10;BRWD1;ZBTB7A;CENPT;XPA
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.43653653909911894,-1.1222508684291033,0.32186732186732187,0.7028366238075286,1.0,4/16,8.43%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST8SIA1
prerank,regulation of cell population proliferation (GO:0042127),0.3615552800271273,1.1222329334153847,0.16132264529058116,0.8676811668847803,1.0,104/691,10.61%,ZBTB7C;EGFR;THBS1;BMP4;ACER3;SIX1;TCF7L2;WNT9A;GRK5;NTRK3;SOX9;TES;BMP5;HDAC4;NGF;EGLN3;PGF;CYP1B1;PDGFC;RBFOX2;PTK2B;ABI1;PTPRU;TGFB3;FN1;SMAD6;HES1;KRAS;FGFR1;SHC1;KLF4;BMP6;BMPR1A;INHBA;FGF2;GAB2;ECRG4;IRS1;LMNA;STRN;GAREM1;TGFBR1;CLCF1;AGTR1;NR4A3;P3H2;PTPN2;NPR3;NCK2;TRPM4;TGFBR2;SMYD2;SGK3;KLF10;SFRP4;GCNT2;CLMN;FRK;SKI;ITGAV;STAT3;GDNF;CLU;BAMBI;PTHLH;CDC25B;SLURP1;BIRC6;TGFB1I1;JAG1;IFI35;MYOG;IL10;BIRC7;CELF1;ID2;P3H1;IRF1;JUP;SIX4;PDGFA;MDM4;CDKN1B;KANK2;RNF126;RHOA;CTF1;RAB25;NIBAN2;TOB1;RARG;RARA;HILPDA;PIM2;LIMS1;BTG3;IGFBP6;JUN;PROK2;ELN;VEGFA;CEP131;PPP2R5C;MVD
prerank,regulation of monocyte differentiation (GO:0045655),0.5249877658095266,1.1215729361657631,0.34248788368336025,0.8688048179866082,1.0,1/14,0.25%,FOXP1
prerank,positive regulation of proteolysis (GO:0045862),0.42901944726914315,1.1215167605776675,0.31633986928104574,0.8681181919001876,1.0,13/55,15.34%,CYFIP2;PERP;TANK;ADAM9;TNP2;FBXW11;MAPK12;SH3D19;TNFRSF1B;ZC3H12A;TBC1D10A;TNIP1;IST1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3667206507887731,1.1214170887592891,0.25052410901467503,0.8675305176023126,1.0,48/291,12.91%,SLIT2;EGFR;WNT9A;SOX9;EZR;PTK2B;LBP;PID1;ADAM9;WNT11;PRKCD;IGFBP5;CAPN2;FZD7;IRS1;SLC26A6;IP6K2;NR4A3;RAP1A;PDCD4;VCP;ATP2B4;CD80;ESR1;DMTN;RRAGB;MYOG;IL10;LCOR;TLR4;CXCL2;P2RX4;RORA;RHOA;CHUK;NFKB1;SHPK;ATM;AKAP9;JUN;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;PDK3;CTR9;MTOR
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.27490494627994044,-1.1210785848991591,0.14150943396226415,0.7044044624478426,1.0,34/163,16.93%,PIK3R1;PDE4B;BCL2;PAK1;FYB1;RFTN1;INPP5D;TEC;TNFRSF21;PRKCB;MEF2C;PRKCQ;PDE4D;VAV3;CD38;PAG1;BMX;MOG;PAK3;BTRC;THEMIS;PSMB4;BLNK;PSMB3;PLCG1;PSMB8;PSME2;ICOSLG;PSMB10;MALT1;BTN3A3;LCP2;BTK;CD276
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5015293399486316,1.1206551128391697,0.35161290322580646,0.8688033898781379,1.0,10/19,21.58%,MAVS;RIPK2;SETD2;TLR4;CHUK;IFIH1;DHX9;TLR8;DHX36;IRF3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.46411545377433094,1.1205664173627812,0.3437945791726106,0.868186161795804,1.0,10/33,17.97%,EGFR;ANXA1;EIF4G1;RDX;PLCG2;DDRGK1;LSM11;CCND1;ANKRD17;ADAMTS1
prerank,protein localization to synapse (GO:0035418),0.5582939027670835,1.1205388999036705,0.3615916955017301,0.8673869800931368,1.0,5/12,10.96%,BSN;NPHS1;SHANK1;PCLO;ZDHHC15
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.5435002487937555,1.1205147398530053,0.3643926788685524,0.866588358058015,1.0,2/13,1.62%,ANK2;CACNA1C
prerank,regulation of cation transmembrane transport (GO:1904062),-0.37984511928636766,-1.1203504595524147,0.2861111111111111,0.7047855435213889,1.0,10/29,11.54%,KCNIP4;CACNA1D;KCNIP3;FGF12;KCNAB1;DPP10;CD63;KCNIP1;KCNN2;DPP6
prerank,smooth muscle contraction (GO:0006939),-0.4630797679753531,-1.1203355490645963,0.3198992443324937,0.7033369425460765,1.0,8/14,11.32%,MYLK;SLC8A1;PIK3C2A;MYH11;SMTN;ACTA2;BDKRB2;ROCK2
prerank,tyrosine metabolic process (GO:0006570),0.5580519309376327,1.1203099758317607,0.3356401384083045,0.8663284272677699,1.0,1/11,4.52%,IYD
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4526111764013003,-1.1197242895285144,0.3228915662650602,0.7034136644837569,1.0,4/14,6.13%,KIT;SEMA7A;WNT5A;GPRC5B
prerank,negative regulation of autophagy (GO:0010507),0.4290177437358462,1.1195620278128535,0.31108144192256343,0.8676106089614631,1.0,22/54,21.03%,MET;EIF4G3;DAPL1;FOXK1;TAB3;EIF4G1;KLHL22;STAT3;IL10;SMCR8;FOXK2;SNRNP70;MTOR;SMG1;HTR2B;TLK2;NRBP2;WASHC1;EIF4G2;MCL1;USP36;RUBCN
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4105346054383262,-1.1195496915719252,0.2949061662198391,0.7024033355776347,1.0,8/21,13.69%,DCN;CSGALNACT1;CHSY3;CHST3;CHSY1;UGDH;CSPG5;NCAN
prerank,cellular response to growth factor stimulus (GO:0071363),0.37486900710151805,1.1195459414811464,0.2751381215469613,0.8668007453936301,1.0,32/151,12.45%,EGFR;BMP4;NTRK3;SMAD9;SOX9;ANXA1;CD44;SHC1;KLF4;BMP6;BMPR1A;NRP1;GAREM1;TGFBR1;RAP1A;KIDINS220;TMEM100;TGFBR2;GAS1;HAS1;FOXC1;IQGAP1;ACVR1;LIMS1;EHD1;SYAP1;VEGFA;EMD;ERBB2;ITGB1BP1;NR4A1;CPNE3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.49197826077186363,1.1191856686864592,0.34762633996937214,0.8669728676999449,1.0,7/22,12.34%,PTPN3;ADAM9;TIMP2;IL10;TIMP1;SH3D19;TNFRSF1B
prerank,heart process (GO:0003015),0.5269455488252841,1.119109149853162,0.34348561759729274,0.8663236768150665,1.0,1/14,0.75%,SGCD
prerank,bone morphogenesis (GO:0060349),0.5416711357137847,1.1187727176956972,0.34602649006622516,0.8664332369763583,1.0,5/14,15.71%,LRP6;SFRP4;SKI;LRP5;TFAP2A
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3705039759242209,-1.118479892433799,0.29577464788732394,0.7036615336761471,1.0,10/33,10.27%,LRRC4C;NRG3;GRID2;GRIK2;GRIK1;LRP8;CACNA1B;EIF4EBP2;ABR;FABP5
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5040531390142853,1.1184652309370589,0.3256578947368421,0.8664419587491986,1.0,7/20,8.86%,KCNJ2;SLC12A2;ATP1B1;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5210282696573604,1.118284465650881,0.3486238532110092,0.866093707910882,1.0,5/17,4.29%,DOCK5;IGFBP5;DOCK7;NRP1;NR4A3
prerank,regulation of immune effector process (GO:0002697),0.45226990457421595,1.1180351438101297,0.3314993122420908,0.8659254713529024,1.0,6/41,9.24%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3270771353199861,-1.1177494500721845,0.25,0.7040887323037844,1.0,26/57,28.65%,DCN;KDR;PPARGC1A;TNFSF10;PDCD5;HIP1R;SPIRE1;BOK;GSK3A;BMF;BIK;CHCHD10;CAMKK2;GPER1;TREM2;DNM1L;PLAUR;PMAIP1;RALA;PYCARD;MFF;MLLT11;PINK1;HRK;FBXO7;BCL2L11
prerank,exit from mitosis (GO:0010458),-0.47447065513233677,-1.1175339988385855,0.32682926829268294,0.7031473407013438,1.0,2/12,4.67%,EPS8;CLASP2
prerank,positive regulation of cell adhesion (GO:0045785),0.4095851107660557,1.11733293772821,0.3189122373300371,0.8670781511019396,1.0,12/74,11.10%,VIT;ZFHX3;PPP3CA;ADAM9;FOXC2;ITGAV;AGR2;CHRD;ATM;LIMS1;VEGFA;ERBB2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4415977989826133,-1.117107682524617,0.3190348525469169,0.7028096424369723,1.0,4/17,13.90%,SLC7A5;PRKCQ;PRKCZ;HAVCR2
prerank,cellular component assembly (GO:0022607),0.37276404613024255,1.1168820088929405,0.2505307855626327,0.8675719845177694,1.0,47/253,12.29%,REPS2;DPYSL3;BAIAP2L1;SOX9;RHOJ;EZR;PTK2B;PAWR;CALD1;CHAF1B;RP1;HES1;GSN;PARVA;BSN;FAM107A;CREBBP;MNAT1;RHOQ;PLS1;DMTN;KRT14;PKP1;TEAD1;PDGFA;TOGARAM1;FZD1;P3H4;MDM4;HAS1;SHANK1;GRHL2;RHOA;PARD3;PCLO;LIMS1;SPAG17;LIMS2;NCKAP1;MYO9A;CCDC40;MATN1;CAPZA1;ZFYVE27;ADD1;RTN3;LIMA1
prerank,response to metal ion (GO:0010038),0.4172669867955226,1.1163518399612862,0.3055555555555556,0.8683100508192305,1.0,5/67,1.97%,THBS1;NEDD4;PPP3CA;NDRG1;ADAM9
prerank,phospholipid metabolic process (GO:0006644),0.42083738648210056,1.11630682635895,0.32061068702290074,0.8675891247931327,1.0,13/71,14.88%,TNFAIP8L3;PLPPR2;PLPP3;PNPLA3;PLA2G4F;PIP5K1A;PLA2G15;MBOAT1;GNPAT;LCAT;PLPP1;PLA2G2C;PLCD1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4983291604827318,1.1161066215420097,0.34418604651162793,0.8673040011596147,1.0,11/21,23.64%,SAMD4A;PAN3;TUT7;CNOT7;TUT4;TNKS1BP1;PNLDC1;CNOT4;CNOT11;SAMD4B;CNOT3
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.39519535189004884,-1.1161064731942916,0.2900552486187845,0.7039946591692073,1.0,6/22,14.57%,SASH1;MFHAS1;BMP2;SPHK1;PRMT1;RELL1
prerank,negative regulation of immune system process (GO:0002683),0.5272477123122428,1.1158741590142633,0.37566137566137564,0.8671559408916594,1.0,2/16,2.65%,SOX9;COL3A1
prerank,axonal transport of mitochondrion (GO:0019896),-0.48506899615580956,-1.115862224324269,0.3378995433789954,0.7031845980285938,1.0,5/11,25.77%,HIF1A;MAPT;TRAK2;NEFL;HAP1
prerank,regulation of mast cell activation (GO:0033003),-0.4944097002243029,-1.1156865440211745,0.34096109839816935,0.7022068147588026,1.0,8/10,31.95%,LYN;NECTIN2;CD84;CRLF2;TSLP;CD300LF;CD226;MILR1
prerank,response to organic cyclic compound (GO:0014070),0.42443138526017016,1.1156580074602138,0.312,0.8669257390683518,1.0,11/52,11.45%,CYP1B1;ANXA1;IGFBP5;ALPL;ESR1;STAT3;SOCS2;STRN3;DRD3;CCL3;ARL6IP5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5231716431438067,1.1153871612203117,0.3567921440261866,0.866847474416987,1.0,3/15,9.95%,TGFB3;IL10;IRAK3
prerank,cell part morphogenesis (GO:0032990),0.5387323643711324,1.1153839842821753,0.3339011925042589,0.8660096288841888,1.0,1/13,1.88%,PID1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.545525047934598,1.1150671924123463,0.3473861720067454,0.8660937500643253,1.0,5/13,19.88%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,negative regulation of cation channel activity (GO:2001258),-0.39367019655684843,-1.1150496283375633,0.27218934911242604,0.7023880524806,1.0,5/26,13.41%,KCNAB1;SLC6A9;CALM1;CASQ2;CALM3
prerank,heart looping (GO:0001947),0.44391639566077346,1.1150342026891227,0.332398316970547,0.8653555946915635,1.0,4/39,6.17%,MICAL2;SMO;TGFBR2;GATA4
prerank,regulation of telomere capping (GO:1904353),0.4831856709637772,1.114740717402567,0.34768740031897927,0.8653298046943454,1.0,7/23,18.08%,NEK7;SMG6;TNKS2;ATM;USP7;NBN;MAP3K4
prerank,regulation of double-strand break repair (GO:2000779),0.4520211161176679,1.1147308203781003,0.32162921348314605,0.8645280728926981,1.0,13/39,17.86%,UBR5;KDM1A;SETD2;TRIP12;DDX11;SPIDR;CHEK1;PPP4R2;MRNIP;TWIST1;PML;SIRT6;RAD51
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4058281205395259,1.1146993880196143,0.3157248157248157,0.863791580394766,1.0,10/80,6.03%,PLCE1;DPYSL3;CDC42EP5;ARAP1;TGFB3;PALM;NDEL1;NRP1;BCAS3;RHOQ
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4010567791064738,-1.1145356846890078,0.3,0.7022871010232158,1.0,6/21,5.79%,ATP1A2;SLC8A1;CALM1;RYR2;AKAP6;PDE4D
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.40704898540660545,-1.1144674702016968,0.33430232558139533,0.701024950532959,1.0,6/22,9.85%,AEBP1;APOE;MAP2;HSPA8;MAPT;EFEMP2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.42735446561164453,-1.114449229972833,0.2891246684350133,0.69962312472466,1.0,8/18,24.61%,MFHAS1;PPP1R16B;YWHAB;INPP5K;PPP1R35;SH3RF2;ENSA;SH2D4A
prerank,peroxisome organization (GO:0007031),0.4842437617396875,1.1144433184179674,0.34332833583208394,0.8636724717994019,1.0,4/25,11.19%,ABCD3;TMEM135;ACOT8;LONP2
prerank,regulation of mast cell degranulation (GO:0043304),-0.4511925418345887,-1.1138796072887447,0.350253807106599,0.6996540872813852,1.0,7/14,23.69%,LYN;CD300A;CD84;FES;SPHK2;SYK;STXBP2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5161473709163444,1.113782570290863,0.3548922056384743,0.8646551731508678,1.0,5/17,16.82%,DHDDS;ALG13;MVD;ALG14;ALG12
prerank,positive regulation of response to wounding (GO:1903036),-0.4021427040050871,-1.1136037548189706,0.2946708463949843,0.6989007433980311,1.0,9/24,11.35%,VTN;MYLK;OCLN;PTK2;ADRA2A;CLDN1;GRN;HBEGF;MDK
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4494593863046688,1.1135724425441316,0.31643835616438354,0.8643873115393854,1.0,14/40,20.76%,PRKCD;ABL1;SMYD2;BCLAF1;FEM1B;USP1;SMG1;NSMCE1;KMT5A;FXR2;UBE2N;FMR1;WDR76;MCL1
prerank,excitatory postsynaptic potential (GO:0060079),-0.42527618394294137,-1.1134184104416804,0.33884297520661155,0.6979989132114139,1.0,8/19,15.10%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GSK3A;AKT1;ARRB2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4390875328989937,-1.113376374723835,0.3404255319148936,0.6966620885074063,1.0,6/15,14.87%,PRKCH;CSF1;IL18;MSR1;LPL;AGT
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.43659877281705556,-1.1133085280035435,0.2967032967032967,0.6953967898803195,1.0,10/17,34.56%,ADRA2A;MFSD2A;AKT1;PDE3B;APOC1;ALK;GPLD1;PLIN5;CIDEA;TNF
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4401398780933204,-1.1129807577429953,0.31202046035805625,0.6948654671437325,1.0,5/16,7.05%,IGF1;IGFBP2;IGFBP3;IGFBP4;BMP2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.43797325809240567,1.1129364916288007,0.325452016689847,0.8653311654643416,1.0,6/43,3.97%,BMP4;CCN1;DDR2;BMP6;BMPR1A;NELL1
prerank,microtubule depolymerization (GO:0007019),-0.4250664267193879,-1.1127161481020467,0.312,0.6940656847936736,1.0,7/17,25.88%,STMN4;STMN3;NCKAP5;STMN1;STMN2;KIF19;KIF18B
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5386843967223159,1.1125734699939087,0.3458904109589041,0.8655017122725334,1.0,5/13,26.07%,SMUG1;UPP2;TDG;MBD4;NT5C
prerank,respiratory system development (GO:0060541),0.46882794111448106,1.112482283561129,0.34992458521870284,0.864928331204752,1.0,8/32,11.99%,BMP4;DISP1;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,phospholipid dephosphorylation (GO:0046839),0.45071168109182735,1.1118631887122146,0.32907801418439714,0.8657655197688756,1.0,7/37,14.00%,PLPPR2;PLPP3;MTMR12;OCRL;PIP4P2;SYNJ1;PLPP1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.4119030721948711,-1.1117216932347023,0.30277777777777776,0.6951728286604127,1.0,5/20,7.60%,IL1R1;B2M;CD81;PRKCZ;IL18
prerank,mRNA transport (GO:0051028),0.3973489846853973,1.1114316079835824,0.32100238663484487,0.8661006331019435,1.0,42/101,28.58%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;FMR1;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,regulation of chromosome organization (GO:0033044),0.49117116688262175,1.1112071509879247,0.3415384615384615,0.8658940465996515,1.0,8/22,17.31%,SMG6;HDAC8;RB1;WAPL;SMG1;XRCC5;RMI2;YLPM1
prerank,retinoid metabolic process (GO:0001523),0.40539188310413526,1.1104820023177144,0.3269476372924649,0.8671512938988547,1.0,9/71,6.11%,GPC6;CYP1B1;ADH7;GPC3;STRA6;RBP1;CYP2S1;RLBP1;LRP1
prerank,chromatin assembly (GO:0031497),0.44770635379177814,1.110346607057746,0.33835616438356164,0.8666940885902824,1.0,3/38,4.82%,SOX9;CHAF1B;KAT6B
prerank,cellular response to cadmium ion (GO:0071276),0.5019847946467713,1.1100984408583587,0.3442367601246106,0.8665704488155171,1.0,1/24,0.24%,EGFR
prerank,phospholipid catabolic process (GO:0009395),-0.38866293326359264,-1.1100747472996817,0.29577464788732394,0.698186501485182,1.0,4/24,7.65%,GPCPD1;ENPP2;ENPP6;ABHD12
prerank,negative regulation of neurogenesis (GO:0050768),-0.37452441380442614,-1.1100727306609346,0.31629392971246006,0.6967777733920226,1.0,8/34,11.55%,B2M;RAPGEF2;NOTCH1;ARHGDIA;MAG;RTN4;LINGO1;EFNB3
prerank,negative regulation of nervous system development (GO:0051961),-0.4314410449304156,-1.1100544125829432,0.31443298969072164,0.6954288088716956,1.0,3/17,4.40%,B2M;ROBO2;NOTCH1
prerank,positive regulation of protein maturation (GO:1903319),-0.48066372892506426,-1.1096224771645842,0.3581395348837209,0.6951940809395039,1.0,2/11,5.28%,CCBE1;NKD2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.38432969729424615,-1.1096096535155455,0.31486880466472306,0.6938296125460536,1.0,10/27,13.69%,DCN;CSGALNACT1;CHSY3;PXYLP1;CHST3;CHSY1;UGDH;CSPG5;XYLT2;NCAN
prerank,hyaluronan metabolic process (GO:0030212),0.49774667345212603,1.1096002666078706,0.3611532625189681,0.8671047892029248,1.0,7/23,12.35%,CD44;FGF2;HEXA;SPAM1;HAS1;SLC9A1;CHP1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.38175881617411395,1.1094409319847605,0.30493273542600896,0.8667017954463309,1.0,25/145,17.11%,FBXL7;FHL1;SFI1;PAFAH1B1;PCM1;CDC25B;PSMB2;CEP164;CEP63;AURKA;AKAP9;PSMC6;CEP131;USP47;CSNK1E;PSMD11;CCND1;PSMD1;SDCCAG8;CEP43;HAUS2;CUL1;CEP57;PSMC1;PSMD7
prerank,regulation of transferase activity (GO:0051338),0.5175274743572118,1.1091809507154697,0.36018957345971564,0.8665665504940255,1.0,9/17,23.69%,SMG6;SPTSSB;FEM1B;ATM;PPP1R3F;PARP4;EMP2;LDB2;LDB1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.557121943325201,1.1090196517311828,0.3712871287128713,0.8662026650548968,1.0,2/10,7.02%,LBP;IFI35
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4059753340511155,1.1085793486703617,0.33497536945812806,0.8665503758035286,1.0,5/80,2.97%,THBS1;MAP3K5;NGF;CD44;KLF4
prerank,positive regulation of secretion by cell (GO:1903532),0.41274169908680236,1.1084840402249905,0.315136476426799,0.8660233066135545,1.0,9/70,6.41%,SLC12A2;EZR;TGFB3;ADAM9;KCNB1;BMP6;UNC13B;SYTL4;GOLPH3
prerank,cell cycle G1/S phase transition (GO:0044843),0.4179665513609925,1.108005993137793,0.3380462724935733,0.8665650262052208,1.0,21/61,23.06%,CCNA2;INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;PIM2;GSPT1;RB1;CDKN3;CUL3;CCND1;HINFP;CUL1;CDKN1A;KHDRBS1;PPP6C;E2F1;CUL4A;CDK2
prerank,negative regulation of type I interferon production (GO:0032480),0.44114573416954694,1.1068641535833725,0.3152639087018545,0.869065731349144,1.0,17/40,21.89%,TAX1BP1;MAVS;IL10;REL;IKBKE;IFIH1;NPLOC4;RNF135;OTUD5;ACOD1;YY1;PTPRS;UFD1;TRIM25;GPATCH3;IRF3;TRAF3IP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.47404259106974533,1.1068580334893974,0.3523076923076923,0.8682535064896234,1.0,8/30,15.65%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5216783640192932,1.1064112986950867,0.34833333333333333,0.8687381132292437,1.0,5/14,14.46%,PGF;NRP1;FOXC1;VEGFA;GAB1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5015202775815661,1.1063623878962257,0.34810126582278483,0.8680582413659099,1.0,4/22,4.43%,NTRK3;NGF;RAP1A;KIDINS220
prerank,actin filament network formation (GO:0051639),0.5516442753911348,1.1060638595370544,0.36894824707846413,0.8680492810958742,1.0,2/11,6.13%,COBL;PLS1
prerank,ncRNA 3'-end processing (GO:0043628),0.5255622101205302,1.1053347538574012,0.3708609271523179,0.8692944277203618,1.0,11/14,37.56%,INTS8;INTS5;INTS6;SSB;PTCD1;INTS2;ERI1;INTS7;ELAC2;TOE1;TRNT1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4495817258644723,1.1053196161620398,0.3347457627118644,0.8685223188795159,1.0,11/37,18.00%,ENTPD6;SIDT2;PABPC4;NUDT5;ENTPD2;EXOSC7;ENTPD7;NUDT15;RNASEH2A;DFFB;RNASE6
prerank,liver development (GO:0001889),0.46273171791183093,1.105299440049319,0.3434343434343434,0.8677497068895409,1.0,7/32,11.01%,MET;COBL;ANXA1;AURKA;NF1;CCDC40;PRKCSH
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4085587496328456,1.1052121147587373,0.3248081841432225,0.8671566444964804,1.0,16/76,12.52%,CYP1B1;PTGIS;ANXA4;KLF4;TAX1BP1;CMKLR1;DDIT3;IL10;G3BP2;CHUK;COMMD1;ERBIN;IRAK3;USP7;CHP1;ZC3H12A
prerank,leukocyte cell-cell adhesion (GO:0007159),0.47244150106868904,1.1047354873086352,0.35725190839694654,0.8676646323290912,1.0,3/24,3.09%,NT5E;EZR;ITGB1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36779644828626906,1.1037381284391543,0.29577464788732394,0.8696790641960401,1.0,26/199,7.15%,EGFR;BMP4;NFIB;SOX9;BMP5;WNT11;ARHGDIB;SMAD6;HDAC9;GSK3B;DOCK7;ZNF423;LRPAP1;FOXC2;ID1;KLF7;SPRED2;NPR3;ATP2B4;RAB11FIP3;DDIT3;IL17RD;ADAMTS5;SRSF6;ABHD6;IL10
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4208447615093998,1.1036148125944252,0.3380829015544041,0.8692222318626149,1.0,22/54,23.64%,PLAGL1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;EP300;CNOT7;PIDD1;PML;CASP2;CDKN1A;CARM1;TNKS1BP1;CNOT4;E2F1;CNOT11;CCNB1;CNOT3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4624161607622791,1.1034445597677076,0.3520336605890603,0.8688446764793311,1.0,10/33,17.73%,DDX5;ESR1;KDM1A;CBFB;DDRGK1;EP300;UBA5;DNAAF4;RNF14;CARM1
prerank,sterol metabolic process (GO:0016125),-0.32165184682738046,-1.1032617943894067,0.2807017543859649,0.7090836748431613,1.0,11/60,7.19%,CYP7B1;APOE;CYP27A1;CYP26B1;PRKAG2;ABCA5;LIPA;ABCA1;PPARD;INSIG2;ABCG1
prerank,Golgi inheritance (GO:0048313),0.5538548102819749,1.1028900672077038,0.38831615120274915,0.869631173161407,1.0,4/11,16.50%,STX5;GBF1;PLK3;VCPIP1
prerank,protein modification by small protein conjugation (GO:0032446),0.3602178497575169,1.1027421864014144,0.24871531346351491,0.8692128550059174,1.0,113/361,22.88%,FBXL7;WWP1;NEDD4;FBXO10;WWP2;NFE2L2;NUP93;RNF144A;HERC2;RNF138;VCP;TRPM4;FBXW8;UBE2B;ARIH1;MKRN3;ATG3;HIF3A;TRIM44;BIRC6;CDC16;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;PIAS2;SAE1;TRIM47;UBE2F;PIAS3;KLHL13;UBE2D3;EGR2;DCUN1D5;FBXW11;RANBP2;COMMD1;UVSSA;WAC;TRIM41;TRIM7;TRIM26;USP7;TRIM55;ASB11;RNF111;SPSB2;UBE2Z;DDRGK1;IFIH1;NUP153;CTR9;FBXO4;PEX13;RNF168;ARIH2;PRKDC;SMURF1;UBA5;CUL3;UBE2S;RNF135;CCDC22;ASB1;TRIM39;UBE2K;NUP214;CHFR;MKRN1;CUL1;VCPIP1;UHRF2;RNF14;NUP188;OS9;BCL10;BARD1;MKRN2;NUP88;DTX3;USP9X;FBXO25;DCUN1D4;PIAS1;GAN;DCUN1D2;RTF1;TSPAN17;TRIM35;UBE2N;MOCS3;UBE2W;DCUN1D1;CNOT4;TRPC4AP;KLHL18;MIB1;NFX1;NUP98;RNF8;DET1;HUWE1;UBE2M;CUL7;CUL4A;ANAPC11;FBXL17;PEX2;PAF1;AAAS;ANKRD9;FBXO11
prerank,negative regulation of stress fiber assembly (GO:0051497),0.48008209813224206,1.102523808779326,0.3561643835616438,0.8690171942141541,1.0,5/24,4.75%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,positive regulation of protein processing (GO:0010954),-0.42304460182562564,-1.1022457478403296,0.3219895287958115,0.7103078270174329,1.0,4/19,5.59%,CCBE1;CLEC3B;NKD2;MYH9
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4924923984029296,1.102189367655482,0.36349693251533743,0.8690884796781548,1.0,1/23,0.11%,SLIT2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5531966528871429,1.1020146820577552,0.3715753424657534,0.8687323371511705,1.0,6/11,21.52%,FGF2;IP6K2;PPIP5K2;IP6K1;IP6K3;PPIP5K1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5184489068206353,1.101944314999811,0.3685950413223141,0.8681049395319611,1.0,2/14,1.55%,ANK2;ATP1B1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.35798010729082497,-1.101680377500367,0.3069908814589666,0.7103496650077564,1.0,11/35,13.41%,ITGA1;PDGFRB;NUAK1;CALM1;PPP4R4;CD300A;HSP90AB1;PPP1R15B;TIPRL;HSP90B1;CALM3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.47013409577097615,1.1010450343527938,0.3545878693623639,0.8698283179426645,1.0,5/22,10.33%,RASSF2;PDGFC;RAP2C;PDGFA;VEGFA
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4005694510498996,1.100956952194271,0.32883435582822085,0.8692827854552174,1.0,5/80,2.89%,THBS1;SAMD4A;SLC2A13;PRKCD;NIBAN1
prerank,myotube cell development (GO:0014904),0.5556554313658738,1.1001327781013497,0.3673469387755102,0.8706713837963611,1.0,2/10,5.66%,SIX1;SKI
prerank,natural killer cell mediated immunity (GO:0002228),0.5226162608854975,1.099931752680778,0.3815789473684211,0.8703989315860836,1.0,4/15,15.79%,RAET1E;KLRC2;PLEKHM2;LYST
prerank,mRNA export from nucleus (GO:0006406),0.3901427034561343,1.0999128280908612,0.3305687203791469,0.8696351579144208,1.0,41/102,28.58%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;SEC13;NUP153;SRRM1;SMG1;FYTTD1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;NUP88;ZC3H11A;THOC5;NXF1;SRSF2;NUP98;UPF2;ALKBH5;AAAS;FIP1L1;NUP54;CDC40;UPF3B;HNRNPA2B1;RBM8A;CPSF3;ALYREF;SRSF3;SRSF7;CPSF4;NUP155;NCBP2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.49868462020752863,1.099896341029848,0.3691588785046729,0.8688582742376031,1.0,7/19,19.80%,HIPK1;CDIP1;EP300;DYRK2;PML;USP28;SNW1
prerank,cellular response to superoxide (GO:0071451),-0.4974881832008159,-1.0995554150385696,0.3578199052132701,0.7143953561892591,1.0,4/10,19.05%,NOS3;SOD3;ATP7A;MT3
prerank,protein maturation (GO:0051604),0.39714959477515477,1.0990434887617069,0.3156596794081381,0.8704599434571232,1.0,21/95,16.60%,F3;PCSK5;DDI2;NAA40;PHEX;MMP16;TASP1;ASPRV1;XPNPEP3;MMP14;CCS;LONP2;ADAMTS3;PITRM1;NFU1;ECE1;PCSK7;ADAM10;LIPT2;CASP2;NAA15
prerank,regulation of RNA export from nucleus (GO:0046831),0.5460574228408401,1.098755418914609,0.39655172413793105,0.870416036219459,1.0,6/11,23.47%,SETD2;NUP153;DHX9;KHDRBS1;NRDE2;AKAP8L
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5589743163131002,1.098101323852517,0.3976311336717428,0.8713783008018361,1.0,2/10,8.00%,LRP6;FZD1
prerank,extracellular transport (GO:0006858),0.5354672768470938,1.0977722740603535,0.3810344827586207,0.8715470101215179,1.0,5/12,17.25%,WWP2;SPAG17;CCDC40;DNAAF4;TSG101
prerank,negative regulation of cell division (GO:0051782),-0.4608733450047201,-1.0976460538398751,0.34951456310679613,0.7181510200695949,1.0,7/11,33.65%,TXNIP;BLM;CHMP4C;E2F7;E2F8;MYC;AURKB
prerank,histone methylation (GO:0016571),0.4811239720698587,1.097350059083857,0.3610271903323263,0.8718803635937166,1.0,12/26,25.84%,SMYD2;CREBBP;EHMT1;PRMT8;CTCFL;PRMT6;NSD1;CARM1;EHMT2;PRMT5;PRMT2;SETD6
prerank,cellular response to unfolded protein (GO:0034620),-0.379172023509817,-1.097082606800019,0.328125,0.7182558649766942,1.0,9/26,20.70%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ABCB10;HSPA9
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4140235569102441,-1.0967121730513278,0.313953488372093,0.7178019017404867,1.0,7/19,17.81%,TAPT1;ARL2BP;TAF3;HK2;AKT1;CHCHD10;BCL3
prerank,arachidonic acid metabolic process (GO:0019369),0.44643127260674154,1.0965074093928167,0.3488700564971751,0.8734139552603645,1.0,6/35,7.68%,CYP1B1;MGLL;PTGIS;CYP2S1;PTGES2;DAGLB
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5416957014389008,1.0964791547976713,0.39649122807017545,0.8726915704837717,1.0,1/10,4.42%,PDE6A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.44817490479112254,-1.096368468489108,0.34541062801932365,0.7173808016403753,1.0,3/13,11.71%,ENPP1;TPST1;SULT4A1
prerank,establishment of spindle orientation (GO:0051294),0.45586632113206804,1.0960063150189727,0.3579109062980031,0.8732480383565498,1.0,10/28,22.53%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;LLGL1;GPSM2
prerank,Golgi organization (GO:0007030),0.39005360085106955,1.0959972817848225,0.33951332560834296,0.8724685198062432,1.0,39/112,22.25%,ARHGAP21;ATL3;GOLGB1;RAB43;TMED5;ATL2;BCAS3;STX5;FBXW8;RAB30;GAK;LMAN2L;GOLPH3;GBF1;PLK3;CSNK1A1;SEC16A;ATP8B1;PLEKHM2;VTI1A;COG3;NPLOC4;SEC22B;SEC23IP;TRIP11;VCPIP1;GORASP2;ARFGEF1;BET1;ZW10;CSNK1D;DYNC2H1;RAB1A;HUWE1;TMED3;VPS51;CUL7;CDC42;PRMT5
prerank,regulation of humoral immune response (GO:0002920),0.43574553861958115,1.0957977155664371,0.3674293405114401,0.8722492816707865,1.0,6/44,9.24%,CFH;CD55;CLU;CD46;CR1L;SERPING1
prerank,spindle assembly (GO:0051225),0.4068012387250268,1.0953093498175765,0.3494897959183674,0.8727748756884484,1.0,26/67,23.09%,MAPRE2;NEK7;MISP;CHEK2;TOGARAM1;ARHGEF10;CEP63;RHOA;SPICE1;NCOR1;SMC1A;TUBGCP6;PIBF1;TUBGCP5;STAG2;HAUS2;KIF3B;TUBGCP4;INO80;NEK6;STAG1;CSNK1D;OFD1;FLNA;AAAS;HAUS5
prerank,regulation of actin filament depolymerization (GO:0030834),-0.46738009408203834,-1.095011927375403,0.3556701030927835,0.7195106787077703,1.0,2/12,9.40%,PLEKHH2;PLEK
prerank,sodium ion homeostasis (GO:0055078),-0.41135610232522335,-1.094908413401826,0.34688346883468835,0.7183890103738658,1.0,5/21,4.71%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,small GTPase mediated signal transduction (GO:0007264),0.39224938506555346,1.0948414155992072,0.33847980997624705,0.8732276162381514,1.0,22/103,12.35%,PLCE1;NTN1;CCNA2;NRAS;KRAS;MRAS;SHC1;FGF2;ARHGAP31;BCR;TIAM2;SHOC2;SHTN1;ARL3;RAPGEF6;G3BP2;NF1;JUN;RB1;TIAM1;RIT1;CHP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4736508137515041,1.094581264495121,0.37070254110612855,0.8731337223559525,1.0,12/25,28.35%,CDK12;WDR43;TCERG1;NELFE;RNF168;CDK13;RECQL5;RNF8;LDB1;EAF2;HEXIM1;EAF1
prerank,cellular response to alkaloid (GO:0071312),-0.42327402428384525,-1.0943701762166351,0.33773087071240104,0.7183506768387294,1.0,7/17,16.82%,TGM2;SLC8A1;RYR2;BLM;CASQ2;CASP3;RYR3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5442463155175078,1.0940653862981073,0.3732638888888889,0.8737393184280311,1.0,2/10,9.79%,MLLT3;HOXB4
prerank,calcium ion transport into cytosol (GO:0060402),-0.4083527705901833,-1.0936408185513566,0.32326283987915405,0.7188273213108012,1.0,8/21,10.81%,GRIN2A;SLC8A1;RYR2;GRIN2B;CACNA2D1;GRIN1;JPH1;JPH2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5204900238542407,1.0930946753842128,0.3767123287671233,0.8756302725625575,1.0,5/14,10.59%,EZR;PATJ;RHOA;SYNE4;MYO9A
prerank,mitochondrial fission (GO:0000266),-0.42997051832511124,-1.0929638832834114,0.324455205811138,0.7192622902966035,1.0,6/16,23.74%,DNM3;DNM1;MTFP1;MTFR2;DNM1L;MFF
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.45525737044964354,-1.0926847326421394,0.3479381443298969,0.7185832654042763,1.0,3/12,8.24%,LYN;ELF2;CD300A
prerank,miRNA metabolic process (GO:0010586),0.493943355442237,1.0926716530871803,0.369969040247678,0.876048159614557,1.0,8/20,19.88%,DDX17;DGCR8;TUT7;DIS3L2;AGO2;TUT4;DROSHA;RAN
prerank,regulation of developmental growth (GO:0048638),-0.3585291599949611,-1.092529274049748,0.30094043887147337,0.7175554829999145,1.0,9/29,10.64%,PLCB1;IGF1;APOE;INSR;APP;GHR;SPAAR;OLFM1;MFSD2A
prerank,acute-phase response (GO:0006953),0.5511905605335337,1.092514494325764,0.3916083916083916,0.8756667652648563,1.0,2/12,6.56%,LBP;PLSCR1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4035418536696234,1.0920042345669223,0.33585858585858586,0.876302119774127,1.0,20/74,15.83%,BMP5;TGFB3;PHLDB2;TGFBR1;SPRED2;TGFBR2;GCNT2;BAMBI;IL17RD;TGFB1I1;FOXC1;LDLRAD4;BCL9L;SMAD2;TIAM1;NKX2-1;MTOR;TWIST1;WWTR1;PHLDB1
prerank,catecholamine metabolic process (GO:0006584),0.5260432809836382,1.0919000932112723,0.37055837563451777,0.8757650211672598,1.0,2/14,9.48%,SNCAIP;DRD3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36243034655193085,1.090862890270442,0.3105263157894737,0.8777700750585677,1.0,19/214,5.28%,BMPER;EGFR;TNFAIP8L3;NTRK3;CCN1;PDGFC;EZR;PTK2B;FN1;CD44;SHC1;FGF2;NOTCH2;NRP1;GAREM1;SPRED2;RAP1A;PTPN2;GCNT2
prerank,neural crest cell development (GO:0014032),-0.3329477282162932,-1.090802125295146,0.28169014084507044,0.7207314677568288,1.0,12/44,12.23%,SEMA6A;CDH2;SEMA7A;RADIL;SEMA6D;TBX1;ERBB4;TAPT1;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,regulation of transmembrane transport (GO:0034762),0.4605773800516122,1.0903451513964157,0.3603988603988604,0.8783922494194477,1.0,4/31,2.75%,KCNJ2;NEDD4;KCNJ15;WWP2
prerank,protein deneddylation (GO:0000338),0.5539028403958041,1.0903130853368759,0.4021543985637343,0.8776809265280503,1.0,4/10,27.47%,COPS7B;COPS5;COPS3;COPS2
prerank,blood circulation (GO:0008015),-0.3319449722790161,-1.090133084673239,0.3166023166023166,0.7210480369930553,1.0,15/49,11.62%,COL4A3;NOS3;SGCZ;GUCY1B1;CXCL12;NPR1;ACE;GUCY1A1;TBC1D8;ADORA2A;F5;BDKRB2;ACE2;ROCK2;STAT1
prerank,B cell differentiation (GO:0030183),0.42787164239565,1.0900922336333545,0.35841313269493846,0.8774737587877431,1.0,9/46,13.05%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,epithelial structure maintenance (GO:0010669),0.5439238333631284,1.0899790813991703,0.3821428571428571,0.8769977624807201,1.0,2/11,6.76%,CXADR;MUC6
prerank,histone H3-K9 demethylation (GO:0033169),0.5444137391731114,1.0899563974974358,0.40472175379426645,0.8762612505024684,1.0,5/11,16.67%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,positive regulation of cell differentiation (GO:0045597),0.36094708520258456,1.0899064770982143,0.3241232731137088,0.8755866382530693,1.0,46/237,11.05%,BMP4;CDON;BOC;SOX9;HOXA5;VWC2;NGF;CCN1;TGFB3;DDR2;ZBTB16;CTNNA1;FGFR1;BMP6;BMPR1A;ABL1;MEF2A;CMKLR1;NELL1;TGFBR1;AGTR1;RAP1A;TMEM100;TRPM4;TGFBR2;GCNT2;ISL1;GDNF;BAMBI;TGFB1I1;GDF6;MYOG;GDF5;ID2;NBL1;FOXC1;RHOA;NFKB1;HOXB4;ACVR1;CDS1;SYAP1;MAPK12;LRP5;BCL9L;SMAD2
prerank,RNA splicing (GO:0008380),0.3838959046537322,1.0898209870659552,0.3301549463647199,0.8750418195470512,1.0,40/95,27.42%,MBNL1;SNRNP48;SRSF11;CDK12;SYNCRIP;CELF3;FUS;TCERG1;SCAF11;SRRM1;PRPF3;SF3B1;SF3B2;PPIG;RNPC3;SRPK1;SCNM1;SNRNP35;WBP4;SNRNP40;SRSF2;TRA2B;PRPF18;NRDE2;DBR1;NOL3;ZCRB1;TXNL4A;TARDBP;LSM4;DHX8;RSRC1;SRPK2;SF3B3;RBM8A;DDX47;SMNDC1;PDCD7;PRPF6;SRSF7
prerank,positive regulation of cation channel activity (GO:2001259),-0.33434466098052346,-1.0897880824559725,0.31456953642384106,0.7205428167510315,1.0,9/40,10.81%,SHANK3;ANK3;TMSB4X;CALM1;AKAP6;ACTN2;CTSS;STAC;JPH2
prerank,sympathetic nervous system development (GO:0048485),0.5184862404330709,1.0889929708636568,0.38974358974358975,0.8765351930073053,1.0,5/15,22.06%,NRP1;GDNF;NF1;GATA3;FZD3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46696579657182413,1.08898535061325,0.36106750392464676,0.875763094974675,1.0,9/23,22.53%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;GPSM2
prerank,negative regulation of cell cycle process (GO:0010948),0.41406922453968137,1.0889810470131585,0.34554973821989526,0.8749744886472964,1.0,21/61,23.44%,BMP4;EHMT1;CBX5;EED;WAPL;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;ZFYVE19;E2F1;TOM1L1;NANOS2;E2F6;MGA;YAF2
prerank,cellular calcium ion homeostasis (GO:0006874),0.3737281883312983,1.0883174426093802,0.33029612756264237,0.8760108067961669,1.0,18/133,11.41%,SLC35G1;SLC24A3;ANK2;ATP1B1;ATP2C2;CAMK2D;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;TNNI3;DRD3;MCUB;MCU;CCL3;CCL1;SLC8B1
prerank,neuron migration (GO:0001764),-0.3354704604496629,-1.0881100283668164,0.326271186440678,0.7236444322867317,1.0,14/48,8.12%,AUTS2;ADGRL3;DCDC2;RAPGEF2;ASTN2;GPM6A;SPOCK1;SH3RF1;NDNF;MEF2C;DCX;ASTN1;NTRK2;RAC1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4024439014029031,1.0880695400512244,0.3566084788029925,0.8759414140467725,1.0,20/73,18.84%,HDAC4;POLR1G;POLR1A;CTCFL;EED;TAF1D;TAF1C;MTA1;KAT2A;EP300;POLR1F;DNMT3A;SUZ12;SF3B1;EPC1;KAT2B;DDX21;SMARCA5;RBBP7;TASOR
prerank,positive regulation of macrophage migration (GO:1905523),0.48223407993924816,1.0873661329232092,0.38311688311688313,0.87706805414231,1.0,4/19,10.91%,THBS1;CMKLR1;P2RX4;CCL3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4475402893806044,1.0868580989966332,0.35919540229885055,0.8776506616229544,1.0,8/33,13.30%,HOXA5;FOXO3;INHBA;RAB7B;STAT3;GATA1;BRD1;PRKDC
prerank,blood vessel endothelial cell migration (GO:0043534),0.47764068958392253,1.0865286137127592,0.3821656050955414,0.8777498375383466,1.0,4/22,3.98%,SLIT2;FGF2;ID1;NRP1
prerank,mismatch repair (GO:0006298),0.46669718942199495,1.0865273565801232,0.35555555555555557,0.8769627754049494,1.0,10/27,21.20%,ABL1;EXO1;SETD2;MLH3;RNASEH2A;MCM9;RPA1;ERCC1;TDG;POLD3
prerank,gonad development (GO:0008406),-0.3503014223629359,-1.0864028008828959,0.33098591549295775,0.7267375953896944,1.0,8/41,8.84%,NR2F2;WNT4;KIT;WNT5A;SALL1;MAMLD1;GATA6;BASP1
prerank,eye photoreceptor cell development (GO:0042462),0.5062206285371813,1.0857800705785678,0.40842787682333875,0.8782670942407123,1.0,3/15,10.38%,RP1;VEGFA;RPGRIP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4823915083667589,-1.0857401629028105,0.36231884057971014,0.7271255963746902,1.0,5/11,21.52%,PTPRT;NF2;SH2B3;BCL3;LEPROT
prerank,regulation of cellular metabolic process (GO:0031323),0.42642765026168616,1.0851164980515855,0.353494623655914,0.8793126123034006,1.0,10/45,13.77%,CYP1B1;PID1;COQ7;CNDP1;ARF4;KIF16B;MKLN1;EIF6;PDK3;NCOR2
prerank,protein localization to membrane (GO:0072657),0.3642727416667372,1.0849386217882218,0.3358695652173913,0.8789910107558498,1.0,37/187,13.57%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;DLG2;GAK;ARL3;PIP5K1A;EHD3;DLG1;RDX;RAPGEF6;JUP;RABEP1;SEC16A;FRMPD1;S100A10;C2CD5;FCHO2;EHD1;EHD2;ZDHHC15;ITGB1BP1;ZFYVE27;ZDHHC2;SMURF1;SH3GLB1;PRAM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4502486694336036,1.0847067290094365,0.3713490959666203,0.8788428248134269,1.0,5/35,3.98%,MET;SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,prostanoid biosynthetic process (GO:0046457),-0.43435462398902003,-1.084645848739534,0.3706467661691542,0.7285645425885642,1.0,8/15,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;MIF;CD74;PTGES3;PTGS2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4937187817239813,1.084541575134596,0.3990228013029316,0.8785072905213834,1.0,3/18,13.30%,ABL1;CD2;PRKDC
prerank,digestive tract morphogenesis (GO:0048546),0.5081917755285821,1.0844622716828813,0.37217391304347824,0.877915903201311,1.0,5/14,12.18%,STRA6;AGR2;EPHB3;ID2;NIPBL
prerank,regulation of Notch signaling pathway (GO:0008593),0.39630824093516726,1.0844316084127015,0.33123425692695213,0.8772361323739081,1.0,20/76,16.43%,EGFR;CCN3;TCIM;WWP2;CREBBP;STAT3;JAG1;CD46;AAK1;MMP14;NIBAN2;GALNT11;ELF3;ITGB1BP1;EP300;SYNJ2BP;NEPRO;KAT2B;ZBTB7A;ZMIZ1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5024751748442667,1.0843238027223476,0.3756177924217463,0.8767465536144429,1.0,3/16,5.02%,SIX1;FTO;ZBTB7B
prerank,lipid oxidation (GO:0034440),-0.45808370054411995,-1.0842538244877598,0.37371134020618557,0.7282502085259575,1.0,3/12,22.07%,PPARGC1A;ALOX12;PLA2G7
prerank,central nervous system myelination (GO:0022010),-0.46833700384158405,-1.0842343729369512,0.3789954337899543,0.72690462644143,1.0,8/11,29.10%,PLP1;TENM4;CNTNAP1;MYRF;ABCA2;SOX10;B4GALT5;B4GALT6
prerank,ubiquinone metabolic process (GO:0006743),0.5114139414432539,1.0840802755027321,0.38006230529595014,0.876609415688674,1.0,6/15,22.40%,COQ7;COQ10B;PDSS2;AIFM2;UBIAD1;COQ8A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5502258086743087,1.0840022510108616,0.38054607508532423,0.8752468695183931,1.0,1/10,1.20%,CDC42EP5
prerank,regulation of pseudopodium assembly (GO:0031272),0.5502258086743087,1.0840022510108616,0.38054607508532423,0.8752468695183931,1.0,1/10,1.20%,CDC42EP5
prerank,ubiquinone biosynthetic process (GO:0006744),0.5060030516204178,1.0837540214622914,0.38664596273291924,0.875160601888965,1.0,3/15,10.29%,COQ7;COQ10B;PDSS2
prerank,negative regulation of cell population proliferation (GO:0008285),0.35236225686933326,1.083411149667976,0.2982635342185904,0.8753117326962866,1.0,59/351,11.85%,ZBTB7C;BMP4;CCN3;WNT9A;SOX9;TES;BMP5;NGF;CYP1B1;PTK2B;ABI1;PTPRU;TGFB3;SMAD6;HES1;IGFBP5;KLF4;INHBA;LMNA;STRN;NELL1;P3H2;PTPN2;NCK2;SMYD2;KLF10;SFRP4;CLMN;NOG;FRK;SKI;PTHLH;E2F3;SLURP1;TGFB1I1;IFI35;MYOG;IL10;GDF5;CELF1;P3H1;IRF1;MDM4;CDKN1B;KANK2;NIBAN2;TOB1;RARG;NF1;PIM2;BTG3;IGFBP6;EMD;PPP2R5C;MORC3;TBRG1;DUSP10;ITGB1BP1;CDKN3
prerank,regulation of glycolytic process (GO:0006110),0.3973888477836934,1.083174364302159,0.34491634491634493,0.875189450794222,1.0,15/68,17.01%,SLC4A4;HDAC4;NUP93;PFKFB2;PFKFB1;RANBP2;NCOR1;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;PRXL2C
prerank,glycerol metabolic process (GO:0006071),-0.4887188357957867,-1.0830837691821522,0.3564356435643564,0.7285389781036212,1.0,2/10,6.98%,GK;COQ2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.46464529766199797,-1.083069562394227,0.3690773067331671,0.7271856492362689,1.0,4/12,12.01%,PIK3R1;DAB2IP;ERN1;BOK
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4178804384024071,-1.0826702351972257,0.3472584856396867,0.7268112069092162,1.0,10/18,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;CBR1;PTGES3;PTGS2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.36379616616022076,-1.08266245388454,0.3375,0.7254452516568568,1.0,14/32,21.45%,MAP2;NAV3;CLASP2;SNCA;STMN1;CAMSAP2;FKBP4;TPX2;TUBB4A;STMN2;APC2;CDH5;DYRK1A;CAMSAP1
prerank,positive regulation of cell death (GO:0010942),0.40275429988702116,1.0818667609689134,0.3611111111111111,0.8779675189469116,1.0,12/59,12.52%,BMP4;MAP3K5;GSK3B;EIF4G1;LRP1;CLU;RIPK2;CELF1;CDKN1B;RARG;HTATIP2;ZC3H12A
prerank,negative regulation of apoptotic process (GO:0043066),0.3502801908737506,1.0811392232347539,0.3066801619433198,0.8791675489290154,1.0,88/444,16.62%,EGFR;THBS1;BMP4;CARD14;SIX1;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;TGFB3;ANXA1;WNT11;PRKCD;SMAD6;CD44;ANXA4;GCLC;SHC1;KLF4;TAX1BP1;ITGB1;GSK3B;NOTCH2;ERC1;CLCF1;SERPINB9;NR4A2;SON;ITGA5;NFATC4;DNAJC3;ISL1;GDNF;GATA4;RIPK2;GOLPH3;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;NFKB1;NIBAN2;NTSR1;GATA1;PIM2;PROK2;MTDH;VEGFA;ARF4;KRT18;RB1;USP47;COPS5;UBE2Z;HTATIP2;MYD88;AATF;ZC3H12A;DDRGK1;CARD16;YME1L1;PAK2;PRKDC;BAG3;FATE1;PRDX5;HTR2B;STIL;CEACAM5;PRKCA;PIDD1;SQSTM1;ADAM10;ZFAND6;TFAP2A;DPEP1;CLEC5A;TMBIM4;BFAR;CASP2;NAA15;MAD2L1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4909820112538995,1.0805270235422624,0.3963815789473684,0.880096722307884,1.0,3/17,3.98%,SLIT2;FGF2;NRP1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.37013083673818253,1.0802397971667335,0.34513274336283184,0.8800665702022197,1.0,31/138,16.24%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;NR4A3;NR4A2;CREBBP;ESR1;MNAT1;TBL1X;E2F3;TEAD1;RXRA;RORA;RARG;MED27;RARA;NCOR1;GTF2E1;NR4A1;NR6A1;HNF4A;NCOR2;E2F2;HDAC10;ERCC3;WWTR1;KAT2B;TAF12
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.36826277682564745,-1.0801640664782226,0.32710280373831774,0.7305815833623395,1.0,7/33,16.65%,IGF1;TFRC;BCL2L1;MAPT;VAT1;AKT1;TMEM14A
prerank,positive regulation of cell motility (GO:2000147),0.36005123168076353,1.0800512552900776,0.33003300330033003,0.8798235375722704,1.0,19/205,4.10%,F3;EGFR;THBS1;NTN1;NTRK3;CCN1;PPP3CA;PDGFC;PTK2B;SMO;ADAM9;SEMA3E;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;FAM107A;TGFBR1
prerank,lymphocyte proliferation (GO:0046651),-0.38568496088485327,-1.0792713502778226,0.34513274336283184,0.7315246272507946,1.0,7/22,19.01%,BCL2;MEF2C;CTPS1;PPP3CB;CD40;FLT3;PIK3CG
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5150569585656821,1.0786625734483943,0.3829787234042553,0.882866051296833,1.0,9/16,27.51%,NAA40;CREBBP;EP300;KAT2B;NAA15;NAA35;NAA50;NAA80;NAA60
prerank,tRNA wobble base modification (GO:0002097),0.5151103649612518,1.0786187927847455,0.385,0.8822032147014532,1.0,9/14,30.53%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3;GTPBP3;DPH3;URM1
prerank,regulation of monooxygenase activity (GO:0032768),0.4704040213820342,1.0781838324892998,0.37481031866464337,0.8826346500178621,1.0,1/23,0.24%,EGFR
prerank,adipose tissue development (GO:0060612),-0.4691543290087228,-1.0781822124369904,0.3617021276595745,0.7330232651370358,1.0,5/11,25.47%,ARID5B;XBP1;DYRK1B;RORC;SH3PXD2B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5448584906199808,1.0781126512972987,0.39297658862876256,0.8820540229511894,1.0,2/10,5.21%,FN1;TSKU
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.41145735304686415,1.078102935853792,0.37581274382314694,0.8812899630224108,1.0,23/62,28.58%,MLLT3;ELOF1;MNAT1;CDK12;SETD2;AFF4;ELOA;CTR9;NELFE;ELP4;ERCC3;CDK13;CCNT1;RTF1;PAF1;EAF2;ADRM1;ERCC2;GTF2F2;GTF2H3;CCNT2;EAF1;NCBP2
prerank,pyruvate metabolic process (GO:0006090),0.41717862250907317,1.0779710313911994,0.3614457831325301,0.8809013504832234,1.0,6/52,8.47%,ME1;SLC16A1;NR4A3;PFKFB2;PFKFB1;GPI
prerank,hyaluronan catabolic process (GO:0030214),0.5053622611431251,1.0776422698880894,0.38724727838258166,0.880990708798914,1.0,6/18,12.35%,CD44;FGF2;HEXA;SPAM1;SLC9A1;CHP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4781678217960934,1.076988453302022,0.41497659906396256,0.8820583480535293,1.0,1/21,0.25%,FOXP1
prerank,quinone biosynthetic process (GO:1901663),0.510289903989714,1.0768124535024934,0.38522012578616355,0.881755132357652,1.0,3/14,10.29%,COQ7;COQ10B;PDSS2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5076559820008222,1.0764460886414635,0.38461538461538464,0.8819796392679798,1.0,2/15,1.65%,UST;DSE
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4934012500513994,1.0763410998089598,0.36984126984126986,0.8814798474268603,1.0,6/19,17.39%,PRKCD;IRS1;DAGLB;TWIST1;ABCD1;ANGPTL3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4512280941552957,1.07634058019944,0.37372262773722625,0.8807064034394264,1.0,9/29,21.87%,BMP5;SPRED2;IL17RD;LDLRAD4;NKX2-1;ADIPOR1;FUZ;FOXA1;GATA3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.2748910924942789,-1.075888902733109,0.3058823529411765,0.7377515427184984,1.0,30/152,12.59%,ADGRL4;ADGRL3;ADCY5;CACNA1D;ADCY1;LGR4;LPAR1;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;PRKACB;CHRM2;ADGRB3;ADRA2A;PDE2A;GRM8;ADGRG1;ADORA2A;S1PR1;PTH1R;ADM;RAMP2;TBXA2R;LPAR2;S1PR3;ADCY2;GPR37;ADGRB1
prerank,carbohydrate derivative transport (GO:1901264),-0.40912990579842523,-1.0757896154248618,0.3651226158038147,0.7366197894643998,1.0,7/18,12.71%,PLTP;SLC29A1;ABCG1;NPC2;MFSD2A;SLC15A2;SCARB1
prerank,ganglioside metabolic process (GO:0001573),-0.4054677615880547,-1.0757524333296737,0.3609625668449198,0.7353237671182934,1.0,12/20,28.16%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ABCA2;GM2A;ST3GAL5;NEU2;ST6GALNAC4;ST6GALNAC6;B4GALNT1;CLN6
prerank,organophosphate ester transport (GO:0015748),0.47280143332426006,1.0757207420119421,0.37648809523809523,0.8816438474240784,1.0,4/24,5.60%,TNFAIP8L3;PITPNC1;PITPNA;LDLR
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5455266035585559,1.0755760833390482,0.38687392055267705,0.8812612955375171,1.0,4/10,10.59%,EZR;RHOA;SYNE4;MYO9A
prerank,positive regulation of kinase activity (GO:0033674),0.37412264713923965,1.0751639587030946,0.3572267920094007,0.8816180618894515,1.0,10/107,4.30%,EGFR;RASSF2;MET;NTRK3;CCN1;PTK2B;LMO4;DDR2;FGFR1;RAP1A
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4260877939591929,-1.0747879649423215,0.38636363636363635,0.7364397681906214,1.0,4/15,8.93%,APOE;APP;PFDN5;PFDN2
prerank,protein polymerization (GO:0051258),0.4147105383112212,1.0747359538239631,0.362565445026178,0.8821068974161967,1.0,13/55,15.54%,COBL;GSN;MAP7D3;FGF13;FAM107A;DIAPH1;HDGFL3;WASHC5;MSRB2;PSTPIP1;UBE2S;RNF135;UBE2K
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.36362195584752677,1.074735256062572,0.35567567567567565,0.8813362907054246,1.0,36/166,16.24%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;POLR1G;NR4A3;NR4A2;CREBBP;ESR1;MNAT1;TBL1X;E2F3;TEAD1;RXRA;RORA;POLR1A;RARG;MED27;RARA;NCOR1;TAF1D;TAF1C;GTF2E1;NR4A1;NR6A1;HNF4A;POLR1F;NCOR2;E2F2;HDAC10;ERCC3;WWTR1;KAT2B;TAF12
prerank,regulation of coagulation (GO:0050818),-0.45380269892238123,-1.0744971291028267,0.39518072289156625,0.7357565347827626,1.0,8/11,40.76%,HS3ST5;HRG;F2R;FOXA2;GP1BA;F2RL1;CAV1;F2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3712980136525283,1.0741027811042696,0.3623693379790941,0.8822001298008879,1.0,25/118,13.30%,BMPER;FMNL2;NEDD4;EFNA5;PID1;SIPA1L1;PHLDB2;ARHGAP44;GSK3B;FGF2;GDNF;PDLIM5;EPHB3;MARK2;NF1;PROK2;BCL9L;ZDHHC15;ERBB2;ZMYM4;SH3D19;HTATIP2;TANC2;ZRANB1;PAK2
prerank,regulation of cell differentiation (GO:0045595),0.3675270929583472,1.0736242643913505,0.36045197740112994,0.882717995046738,1.0,16/148,7.45%,ZFHX3;SIX1;NGF;DDX5;PHLDB2;SMOC1;FGFR1;KLF4;TGFBR1;DDX17;CREBBP;ISL1;GDNF;PTHLH;LTBP4;ID2
prerank,negative regulation of cell cycle (GO:0045786),0.4022036947522323,1.073201813687261,0.3827930174563591,0.883102724754025,1.0,13/73,12.92%,BMP4;PTPN3;INHBA;PDCD4;IPO7;GAS1;IL10;CDKN1B;FOXC1;BTG3;RB1;NR4A1;ANGEL2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.39418305480199667,1.0731547339935452,0.3530150753768844,0.8824370975556747,1.0,9/78,13.04%,EGFR;PKD1;CCNA2;MNAT1;IPO7;CDKN1B;CCNYL1;CDKN3;GTPBP4
prerank,inflammatory response (GO:0006954),0.3607064143336789,1.0731453955777697,0.35753575357535755,0.881686740325027,1.0,32/195,14.99%,THBS1;PTGDR;HDAC4;TRAF3IP2;MGLL;ANXA1;HDAC9;CD44;VNN1;CMKLR1;AGTR1;NFATC4;PTGER1;STAT3;RIPK2;REL;TLR4;CXCL2;CHUK;NFKB1;PROK2;ELF3;CCL3;CDO1;CCL1;NFATC3;ABCF1;FOLR2;PRDX5;TLR1;CXCR4;MAPKAPK2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4574498846602249,1.0729878988752077,0.378698224852071,0.8813694795858791,1.0,11/25,28.35%,SCAF8;WDR43;SETD5;THOC5;CCNT1;HTATSF1;LDB1;EAF2;ALYREF;CCNT2;EAF1
prerank,determination of heart left/right asymmetry (GO:0061371),0.4268417918162679,1.0727270496025803,0.3835227272727273,0.881333460590937,1.0,4/42,6.17%,MICAL2;SMO;TGFBR2;GATA4
prerank,signal transduction by p53 class mediator (GO:0072331),0.4478028614932894,1.0726361010695733,0.39280575539568346,0.8808168694682204,1.0,6/30,12.88%,DDX5;NDRG1;FHIT;MDM4;USP10;ATRX
prerank,cellular response to light stimulus (GO:0071482),0.401372884790344,1.0722541442865736,0.36939313984168864,0.8810859211473603,1.0,15/66,18.45%,NEDD4;PRKCD;PDE6A;CREBBP;KDM1A;USP47;EP300;EIF2AK4;ZBTB1;YY1;USP28;EIF2S1;ATR;DHX36;INO80
prerank,protein phosphorylation (GO:0006468),0.3436644058948119,1.0721411971006374,0.2847011144883485,0.8805812440211508,1.0,91/479,13.69%,STK39;EGFR;BMP4;DCLK1;MAP3K5;GRK5;PKD1;MARK1;CCNA2;PTK2B;CIT;CAMK2D;ABI1;DDR2;WNK1;WNT11;PRKCD;STK19;ULK2;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ERC1;ABL1;BCR;TGFBR1;EFEMP1;CLK2;MKNK2;STK16;TGFBR2;SGK3;FRK;CDK12;CDC25B;BIRC6;MAP3K3;EPHB3;GDF6;VRK3;FAM20A;MARK2;IKBKE;CHEK2;TLR4;CSNK1A1;CSNK1G3;NLK;RIPK3;CHUK;AAK1;AURKA;SIK3;USP15;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;CAB39;SRMS;STRADA;MAPK12;CLSPN;SMAD2;ERBB2;MORC3;MAST2;HTATIP2;CDKL2;CSK;PDK3;MTOR;CSNK1G1;CHEK1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;ERN2;CDC42BPG;DYRK2
prerank,cilium assembly (GO:0060271),0.34996859837455113,1.0721345585245672,0.3312564901349948,0.8798337028757995,1.0,78/296,20.57%,PKD1;BBS9;ABLIM3;EXOC4;RP1;GSN;PARVA;DNAAF3;PDE6D;PTPDC1;DZIP1;SFI1;PAFAH1B1;RAB11FIP3;ARL3;PCM1;EHD3;ARL13A;GBF1;ATAT1;CEP164;OCRL;TOGARAM1;EXOC5;CFAP70;CDC14A;CEP63;TMEM231;IFT46;DISC1;WDR35;AKAP9;EHD1;DYNC2I2;GALNT11;RPGRIP1;ARF4;CEP131;EHD2;CCDC40;ABCC4;CCDC66;ARMC9;PIBF1;RFX2;CSNK1E;ATP6V0D1;NPHP1;CEP20;SSTR3;MKS1;SDCCAG8;NUDCD3;CEP43;IFT52;CEP89;HAUS2;TRIP11;KIF3B;CEP57;DYNC2I1;FAM161A;HYLS1;TEKT2;C2CD3;CEP97;LZTFL1;RILPL1;CEP70;RSPH9;IQCB1;GORAB;FUZ;POC1B;CSNK1D;IFT80;DYNC2H1;RAB1A
prerank,regulation of cell size (GO:0008361),0.45609516262664584,1.0720333991842266,0.38729198184568836,0.8793633361303406,1.0,7/23,12.91%,EZR;VAV2;RDX;RHOA;RARG;RAP1GAP2;MTOR
prerank,transition metal ion homeostasis (GO:0055076),-0.3770501774187449,-1.0719635987568912,0.3560371517027864,0.7412525521656067,1.0,5/28,7.01%,CP;B2M;PICALM;SLC40A1;FTL
prerank,organophosphate biosynthetic process (GO:0090407),0.44025059269499794,1.0718128702381382,0.3907563025210084,0.8791685260011752,1.0,14/37,21.52%,FGF2;IP6K2;PNPO;PIP5K1A;NFS1;MBOAT1;GNPAT;PPIP5K2;MOCOS;IP6K1;IP6K3;MOCS3;LPCAT1;PPIP5K1
prerank,protein localization to cell-cell junction (GO:0150105),-0.43002526123598483,-1.070853847635295,0.39215686274509803,0.7427978288467214,1.0,4/15,4.28%,TJP1;F11R;CGNL1;ACTB
prerank,response to endoplasmic reticulum stress (GO:0034976),0.38133244437582975,1.0707721044924947,0.36363636363636365,0.8812185305754482,1.0,25/107,19.08%,THBS1;MAP3K5;TMEM117;NIBAN1;GSK3B;ERP27;RNF185;VCP;DDIT3;AGR2;SEC16A;JUN;ATF6;DDRGK1;ERN2;UBA5;BCAP31;CREB3L1;CREB3L3;OS9;GORASP2;EIF2S1;MBTPS1;QRICH1;AIFM1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5297488371893451,1.0705614170317748,0.4078303425774878,0.8810170759559367,1.0,3/13,3.29%,ZFPM2;BMPR1A;FGF2
prerank,Notch signaling pathway (GO:0007219),-0.3070094328153849,-1.0704225172291004,0.3425925925925926,0.7425196510146103,1.0,17/59,12.48%,SORBS2;MAML3;MAML2;NOTCH3;DTX4;NOTCH1;PLXND1;RBPJ;NOTCH4;BMP2;JAG2;DTX1;HEY2;MDK;STAT1;APH1B;YBX1
prerank,establishment of vesicle localization (GO:0051650),0.48161409335712363,1.0702973024302904,0.37042925278219396,0.8809323873991932,1.0,6/18,16.37%,LIMK2;SPG11;F8A1;TMEM230;SYNJ1;IKBKG
prerank,positive regulation of translation (GO:0045727),0.385171107189884,1.0700683344142772,0.35393939393939394,0.8807601593472814,1.0,22/94,20.05%,THBS1;SAMD4A;NIBAN1;YBX3;LARP4B;MRPS27;JMJD4;ERBB2;EIF3E;EIF6;MTOR;PRKDC;DHX9;RPUSD4;PLD1;AGO2;KHDRBS1;DHX36;CIRBP;FXR2;LARP4;FMR1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5209978939203437,1.0699807425237873,0.3855421686746988,0.8802458338813741,1.0,6/14,21.94%,SRSF6;PCBP4;RBMX;U2AF2;SFSWAP;SRSF12
prerank,"base-excision repair, AP site formation (GO:0006285)",0.49869582841942484,1.0695667584315183,0.3912337662337662,0.8805907692688508,1.0,6/17,22.29%,MPG;SMUG1;ERCC5;NEIL3;TDG;MBD4
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.42935525052644447,1.0694720934825284,0.39106145251396646,0.880089968998307,1.0,5/39,7.15%,THBS1;ANO6;NFE2L2;PDCD4;IL10
prerank,secondary palate development (GO:0062009),-0.43166758959350804,-1.069376737943778,0.35903614457831323,0.7439193517939268,1.0,4/14,2.67%,LEF1;CHD7;TGFBR3;WNT5A
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.37212185166368533,-1.0693150885725058,0.3554817275747508,0.7426712171186169,1.0,7/28,10.91%,SHANK3;APOE;ADCY1;APP;EPHA4;LGMN;NSG1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.37345377873642827,-1.0692520498624978,0.35451505016722407,0.7414910547876541,1.0,5/32,5.41%,APOE;PPARA;PRKAG2;ZBTB20;PRKAA2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5021862333278867,1.0691129017401526,0.41776315789473684,0.8802846439920475,1.0,4/15,9.96%,SKI;IGSF1;DACT1;ACVR1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3855385945648256,-1.0690844106605242,0.3520710059171598,0.7405835078988039,1.0,5/24,8.12%,DCN;KDR;INF2;SPIRE1;MAPT
prerank,bicellular tight junction assembly (GO:0070830),-0.3298344848816992,-1.068996188047479,0.34191176470588236,0.7394525110182623,1.0,6/46,2.83%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,cell-cell junction organization (GO:0045216),0.3860540226401778,1.068671251604351,0.385286783042394,0.8807435841547099,1.0,9/79,3.27%,CDH1;CDH11;CTNND2;TGFB3;CXADR;NECTIN3;DSP;CTNNA1;DSG2
prerank,protein dephosphorylation (GO:0006470),0.3704152149361416,1.0682701196779345,0.3830275229357798,0.8810735558128454,1.0,29/135,13.52%,EYA2;PTPN3;PPP3CA;PTPRU;UBASH3B;PPM1H;PPTC7;EYA4;PTPRF;PTPN2;PTPRA;EYA3;PPP2R2D;PTPN21;DUSP16;DUSP11;DUSP5;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PPP5C;PPP3CC;PTPN9;ILKAP;PPM1A;DAPP1;PPP4R2
prerank,protein-containing complex disassembly (GO:0032984),0.4170557332757459,1.0676647919816282,0.38503401360544215,0.8819961778144543,1.0,7/54,9.23%,LRP6;GSK3B;WIPI2;VCP;FZD1;CSNK1A1;LIX1L
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3768213105845336,1.067586197213432,0.36666666666666664,0.8814581083647709,1.0,25/100,16.72%,FHIT;GIPC1;PRICKLE1;GSK3B;RNF144A;VCP;XPO1;ARIH1;CLU;RNF19A;CSNK1A1;COMMD1;RAD23B;WAC;ZYG11B;DESI1;USP7;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;TRIM39;TLK2;RNF14
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.46775837622721805,1.0675283505675532,0.38810641627543035,0.8808579224271014,1.0,10/23,23.16%,VCP;SEC16A;RANGRF;SEC13;NPLOC4;OS9;UFD1;FAF2;HERPUD1;SURF4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4197867935911028,1.0672436095847402,0.3708010335917313,0.8808859411857303,1.0,10/52,9.90%,MBNL1;DDX5;RBFOX2;DDX17;SRSF6;CELF1;CELF3;MBNL2;RBM25;RBMX
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4925622822481029,1.0670776040150494,0.3884430176565008,0.8805318998563206,1.0,6/18,12.35%,CTNNA1;GSK3B;MDFIC;POLR1A;OTUD7B;CHP1
prerank,response to acidic pH (GO:0010447),0.5381432245225619,1.0667486568479114,0.41243862520458263,0.8806522497321236,1.0,6/13,22.56%,GPR4;SLC9A1;CHP1;GPR65;RAB11B;PKD2L1
prerank,negative regulation of anoikis (GO:2000811),-0.4258892292573262,-1.0660030303971562,0.37681159420289856,0.7460451529033778,1.0,4/14,6.10%,TLE1;BCL2;NOTCH1;PTK2
prerank,platelet degranulation (GO:0002576),0.3679115678431928,1.0659194298240817,0.36768149882903983,0.8820695501309829,1.0,18/118,11.36%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;PDGFA;SERPING1;GTPBP2;VEGFA;ITGB3;TIMP1;ABCC4
prerank,epidermis development (GO:0008544),0.4036606289043201,1.0655686424362247,0.38451612903225807,0.8822237468305412,1.0,9/56,8.57%,KRTDAP;DSP;GRHL1;EMP1;PTHLH;KRT14;CRABP2;SPRR1A;GRHL2
prerank,cellular response to interleukin-7 (GO:0098761),0.4778300584651902,1.0653925049392192,0.3858267716535433,0.8811845547790977,1.0,6/17,15.83%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4778300584651902,1.0653925049392192,0.3858267716535433,0.8811845547790977,1.0,6/17,15.83%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,axon guidance (GO:0007411),0.35810232279280635,1.0651894623703404,0.35875402792696026,0.880975802039926,1.0,25/201,6.82%,SLIT3;SLIT2;NTN1;NFIB;EZR;SMO;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;PDLIM7;GRB10;SPTAN1;SHC1;NOTCH2;GAB2;ALCAM;KLF7;NRP1;TMEFF1;GDNF;PTPRA;EPHB3;NTN5
prerank,regulation of peptidase activity (GO:0052547),-0.4003458392713279,-1.0649488470209154,0.3506849315068493,0.7472767354814883,1.0,2/19,3.26%,CTSH;CST3
prerank,signal transduction in response to DNA damage (GO:0042770),0.4057639774079773,1.0643572441888385,0.37789904502046384,0.882474032442667,1.0,15/49,17.95%,NDRG1;ABL1;CHEK2;MDM4;RAD17;CEP63;ATM;USP10;CLSPN;ATRX;CHEK1;HINFP;USP28;NBN;ATR
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3607995382197077,1.0641541157767265,0.34682713347921224,0.8822574969301137,1.0,29/186,10.41%,NXN;TRABD2B;TCF7L2;SOX9;MLLT3;LRP6;PTPRU;WNT11;GLI3;GRB10;PRICKLE1;GSK3B;MDFI;SFRP4;TSKU;TLE2;NOG;TLE6;INVS;LRP1;DDIT3;PSMB2;CSNK1A1;NLK;DACT1;DKK3;IGFBP6;PSMC6;EMD
prerank,membrane lipid catabolic process (GO:0046466),0.5293366798124741,1.0637656180914743,0.4112478031634446,0.8825523607942399,1.0,2/10,3.98%,CYP1B1;PDXDC1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5338671462738291,1.063404809115882,0.41442953020134227,0.8828019046690023,1.0,4/10,25.61%,JUN;BAG3;NCK1;CITED2
prerank,response to ethanol (GO:0045471),-0.44075648507773174,-1.0628031843333263,0.3869346733668342,0.7514936996136833,1.0,8/14,17.12%,GRIN2A;ADCY7;GRIN2B;GRIN1;GLRA1;SDF4;GRIN3A;GOT2
prerank,neuropeptide signaling pathway (GO:0007218),-0.31120815299672866,-1.0627870419447412,0.3463203463203463,0.7501647544389736,1.0,11/58,16.19%,SORT1;RAPGEF2;GLRA1;CYSLTR1;CYSLTR2;SORCS2;GLRA3;SORCS3;GPR37;PENK;SORCS1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4380487216635393,1.0625233116753798,0.37482319660537483,0.8843391747434949,1.0,2/33,0.27%,SLIT2;THBS1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4101700490353777,1.0624515957917104,0.3825065274151436,0.8837813858122651,1.0,8/59,3.27%,CDH1;HMCN1;PKD1;FAT2;MPZL2;NECTIN3;ITGB1;DSG2
prerank,positive regulation of developmental growth (GO:0048639),-0.3246967534285499,-1.062443487596023,0.32269503546099293,0.7496753991866791,1.0,16/49,16.31%,PLCB1;NEDD4L;SEMA7A;RIMS1;RIMS2;INSR;GHR;MAPT;SYT1;RNF157;TWF2;PPIB;LIMK1;MACF1;CPNE5;CDKL5
prerank,regulation of B cell activation (GO:0050864),-0.3761040207262635,-1.0621554714782415,0.3514285714285714,0.7491254319537923,1.0,4/25,11.33%,AHR;SH3KBP1;TNIP2;SAMSN1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3946645888987073,1.0617254544732133,0.4087968952134541,0.8849891340843901,1.0,10/72,4.54%,ARHGEF28;MET;AKAP13;ARHGDIB;GPR4;COL3A1;ABL1;BCR;NRP1;CCDC125
prerank,lamellipodium assembly (GO:0030032),0.4530595152028401,1.0614216451604457,0.39039039039039036,0.8850509706063859,1.0,8/26,6.91%,ABLIM3;ITGB1;SRGAP2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,cellular protein modification process (GO:0006464),0.33919415182293067,1.0610630970185317,0.28,0.8852562223955127,1.0,182/983,15.13%,STK39;FBXL7;ST3GAL4;THBS1;BMP4;DCLK1;MSLN;FSTL1;MAP3K5;GRK5;PTP4A2;MARK1;PTPN3;UST;EGLN3;CCN1;PPP3CA;PTK2B;CAMK2D;PLOD2;PTPRU;WNK1;FN1;ANXA1;WNT11;PRKCD;GPC3;FBXO10;DSP;STK19;ZBTB16;COL3A1;IGFBP5;B3GNT2;WWP2;FGFR1;LIMK2;HIPK1;DCAF6;BMPR1A;PPM1H;GSK3B;LARGE1;LOXL1;TLK1;PRKCE;NEK7;ABL1;BCR;PTPRF;TGFBR1;PHKA2;FBXO40;CHST5;CLK2;MKNK2;WIPI2;TGFBR2;SGK3;FBXW8;PHEX;GCNT2;KLHL22;CCDC8;DNAJC3;FRK;CDK12;ATG3;PTPRA;HIF3A;CDC25B;PSMB2;BIRC6;FBXL20;MPI;ASB9;TGM3;ASB16;P3H1;FAM20A;KTN1;SOCS2;MARK2;IKBKE;CHEK2;DCAF4;PTPN21;CSNK1A1;SPRR1A;CSNK1G3;DUSP16;NLK;DUSP11;UBE2F;KLHL13;DUSP5;UBE2D3;RIPK3;CHUK;AAK1;AURKA;FBXW11;SIK3;FEM1B;TNKS2;COMMD1;USP25;PPEF2;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;PPP1R12A;PSMC6;ARF4;STRADA;PPP2R5C;COPS7B;FBXO17;JMJD4;PRKCSH;ERBB2;MORC3;TIMP1;MAST2;ASB11;COPS5;DUSP10;SPSB2;PPP5C;CDKL2;CKAP4;LRRC41;PPP3CC;MACROD2;PTPN9;MAN2A1;COG3;CSK;COP1;ILKAP;PDK3;MTOR;FBXO4;YES1;CHEK1;PPM1A;PKN2;PAK2;PRKDC;DAPP1;CSNK1E;ERN2;PPP4R2;CDC42BPG;RCN1;DYRK2;TRIOBP;PSMD11;MGAT1;CUL3;BAP1;EIF2AK4;BMP15;ERCC8;DCAF5;UBE2S;PIGU;WDTC1;SBF1;PSMD1;TGM1;CCDC22;CDK11B;MAPKAPK2;PRKCA;ST3GAL2;ASB1;CDK16
prerank,nucleic acid metabolic process (GO:0090304),0.39329491769868846,1.0608974221718603,0.37468030690537085,0.8849364989587145,1.0,18/69,23.03%,NT5E;RBFOX2;HNRNPH1;DXO;DUSP11;WRN;RBMX;ATXN2;HNRNPM;RECQL5;LSM8;TOPBP1;RAN;EXD2;DDX1;RAD50;DNASE2;DDX24
prerank,bile acid biosynthetic process (GO:0006699),-0.3830175224757223,-1.0606581405006912,0.38202247191011235,0.7516246548750041,1.0,7/24,20.37%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,RNA 3'-end processing (GO:0031123),0.3918254957155953,1.0601092765412345,0.3719115734720416,0.8863017021838466,1.0,28/69,27.50%,SRSF11;THOC2;SRSF5;SRSF6;U2AF2;SRRM1;TUT7;CASC3;CHTOP;TUT4;U2AF1L4;ZC3H11A;THOC5;SRSF2;TENT2;FIP1L1;NUDT21;CDC40;CSTF1;CPSF7;UPF3B;RBM8A;CPSF3;ALYREF;SRSF3;CLP1;SRSF7;CPSF4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43381224221649833,1.059941529889407,0.39335180055401664,0.885986874427376,1.0,10/35,23.72%,MPG;SMUG1;APEX1;POLB;RPA1;RFC1;TDG;POLD3;MBD4;RFC5
prerank,histone acetylation (GO:0016573),0.3989502279071696,1.0596979063496272,0.3700887198986058,0.885832184383601,1.0,37/69,28.31%,KAT6B;NAA40;CREBBP;TADA3;TRRAP;EP400;SGF29;CPA4;ZZZ3;BRCA2;PER1;KAT2A;BRD1;EP300;ATF2;EPC1;KAT2B;TRIM16;TAF12;BRD8;YEATS2;PHF20;PHF20L1;DMAP1;KAT5;MAP3K7;JADE2;NAA50;ING3;HAT1;KAT14;KAT6A;NAA60;TAF9;MORF4L2;TADA2A;TAF6L
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3499899455553269,-1.0596353952919508,0.3746130030959752,0.7529602857782142,1.0,9/32,10.31%,MCTP1;RIMS1;RIMS2;MCTP2;MEF2C;SYT11;SLC30A1;CAMK2A;SYN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.49204860091672137,1.0595763525008508,0.4147465437788018,0.885404121303609,1.0,5/19,5.48%,ZFPM2;BMPR1A;FGF2;TGFBR1;NOG
prerank,endoplasmic reticulum organization (GO:0007029),0.3942914780261002,1.0594973791692515,0.39097744360902253,0.8848792574160135,1.0,15/72,12.06%,ATL3;ATL2;STX5;SPTSSB;SHTN1;TLE6;GAK;LMAN2L;DOP1B;SEC16A;EMD;TRAM2;SEC31A;SEC61A1;RTN3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2794429561160369,-1.0593814338118006,0.2949640287769784,0.7522144404175047,1.0,35/117,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;CD81;ADORA2A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;PLCG1;HCK;GPR176;ADCY4;FCGR1A;PLK2;GGT1;RHBDF2;VIPR2;LHCGR;TSHR;RXFP1;TREM2;SYK;CD163
prerank,response to interleukin-1 (GO:0070555),0.3892461291274647,1.0593171293330519,0.3763837638376384,0.8846084385227503,1.0,13/73,12.52%,SOX9;HDAC4;TANK;ANXA1;PTGIS;NFKB1;RBMX;IRAK3;USP10;CCL3;CCL1;MYD88;ZC3H12A
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.46679739206801474,-1.05927071827425,0.4090909090909091,0.7511397875815569,1.0,7/11,39.64%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL12B
prerank,neurotransmitter uptake (GO:0001504),-0.4549629240324153,-1.0592141755929136,0.4054726368159204,0.7499236321308967,1.0,5/12,9.99%,ATP1A2;SLC1A3;SLC29A1;SNAP25;SLC22A2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3613653670297798,1.0581557432688369,0.38717067583046966,0.8869188808927335,1.0,21/141,8.79%,EGFR;CDH1;CYP1B1;EZR;IGFBP5;CTNNA1;SLC26A6;DIAPH1;NR4A3;RAP1A;CASP6;ESR1;GOLPH3;DMTN;MYOG;LCOR;JUP;P2RX4;ATP1A3;ATP1A1;RORA
prerank,generation of neurons (GO:0048699),0.35809848257940713,1.0570861360139177,0.3816216216216216,0.8890369836121559,1.0,28/190,9.29%,SIX1;MET;WNT9A;MARK1;CIT;WNT11;HES1;FGFR1;FGF13;FZD7;DOCK7;NRP1;ACSL3;NR4A2;ITM2C;PAFAH1B1;BHLHE40;WNT16;THOC2;ELP3;LHX2;MARK2;SIX4;FZD1;ATOH8;MAP1B;CTF1;DISC1
prerank,cellular defense response (GO:0006968),0.4312637381887156,1.0567338207990755,0.41134751773049644,0.8891816432592216,1.0,6/40,7.10%,PTK2B;LBP;ITGB1;ZNF148;BECN1;KLRC2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.39999663521732265,1.0564030106076825,0.3733850129198966,0.8893225927167192,1.0,16/59,17.70%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;BCLAF1;MED27;JUN;CBFB;CCND1;MED14;TWIST1;MED24;CDKN1A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3651753726137435,-1.056177325653026,0.3875739644970414,0.7561040102832481,1.0,4/26,5.41%,LPGAT1;PRKAG2;NR1H3;PRKAA2
prerank,cardiac muscle cell development (GO:0055013),-0.38971979823349034,-1.0561662678171224,0.33695652173913043,0.754776699793307,1.0,7/20,9.13%,SORBS2;PDGFRB;SLC8A1;MYH11;OBSL1;HEY2;PDGFRA
prerank,regulation of receptor binding (GO:1900120),-0.4667183043665476,-1.0558756052414136,0.40326340326340326,0.7541523270913272,1.0,4/10,15.94%,B2M;GREM2;ATP2A2;ATP2A3
prerank,receptor catabolic process (GO:0032801),0.4618722926058729,1.0557769096620524,0.39689922480620154,0.8902300233937477,1.0,7/24,13.51%,NEDD4;AP2A2;BECN1;AP2A1;KIF16B;SMURF1;SH3GLB1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3906514004583029,1.0555896411847843,0.3918269230769231,0.8899985099874531,1.0,32/84,22.92%,MBNL1;DDX5;RBFOX2;SON;DDX17;SRSF6;CELF1;CELF3;MBNL2;RBM39;RBM25;PCBP4;RBMX;U2AF2;REST;THRAP3;ZBTB7A;JMJD6;SRPK1;KHDRBS1;SFSWAP;CIRBP;FXR2;DAZAP1;SNW1;FMR1;TRA2B;NUP98;RBM3;SRSF12;RBM5;RBM4
prerank,regulation of ERAD pathway (GO:1904292),0.5241128038737315,1.0552907722669993,0.4184873949579832,0.8900112849719559,1.0,3/11,9.75%,USP13;RNF185;USP25
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4223981230217253,-1.0550374797366877,0.38369304556354916,0.7550168990637843,1.0,5/15,4.71%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.46990589524653803,1.0549556106190223,0.41158059467918623,0.8901458881455481,1.0,6/22,19.01%,CDK12;SCAF8;TCERG1;CDK13;THOC5;CCNT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5337339623778086,1.0541374706642714,0.4261168384879725,0.8915288320096325,1.0,2/10,1.93%,CYP1B1;WNK1
prerank,DNA alkylation (GO:0006305),0.48347612406856144,1.0539709672378659,0.4009584664536741,0.89049577142661,1.0,8/19,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,DNA methylation or demethylation (GO:0044728),0.48347612406856144,1.0539709672378659,0.4009584664536741,0.89049577142661,1.0,8/19,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,acylglycerol catabolic process (GO:0046464),0.4429510168219787,1.0538695755923861,0.4103703703703704,0.8900179951418814,1.0,6/30,19.51%,MGLL;PNPLA3;ABHD6;LYPLA2;FABP12;ABHD2
prerank,cristae formation (GO:0042407),-0.36270284851140333,-1.0537487175850782,0.38095238095238093,0.7570129081950518,1.0,9/27,16.50%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;CHCHD6;ATP5F1D;MICOS13;ATP5MC2
prerank,response to growth factor (GO:0070848),0.41693492781753194,1.0532096914705935,0.39280774550484093,0.8910625436341172,1.0,10/41,14.99%,SHC1;KLF4;BMPR1A;TGFBR1;TGFBR2;ACVR1;EMD;ERBB2;CPNE3;URI1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5391181266487283,1.053097604775423,0.4204152249134948,0.890582510077241,1.0,2/10,2.58%,PID1;GRB10
prerank,tight junction assembly (GO:0120192),-0.32224148710316036,-1.0527033049727346,0.36538461538461536,0.7583569634750967,1.0,6/49,2.83%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,cellular response to retinoic acid (GO:0071300),0.41461566294615415,1.0526203917331618,0.403899721448468,0.8911334154424805,1.0,5/42,3.31%,WNT9A;SOX9;PTK2B;WNT11;FZD7
prerank,Rap protein signal transduction (GO:0032486),-0.47097407256869744,-1.052605806055873,0.4182242990654206,0.7572487519978828,1.0,4/10,9.84%,RAPGEF3;RAPGEF2;RAP2A;RAPGEF1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4358032548205353,-1.0525519033345234,0.40145985401459855,0.7560670784314962,1.0,3/12,7.06%,IGF1R;INSR;SETX
prerank,regulation of blood circulation (GO:1903522),0.43289073525479027,1.0521592839214269,0.41930835734870314,0.8916009967770664,1.0,3/34,4.28%,KCNMB2;CAMK2D;AGTR1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.42644547533926275,-1.0515436170199643,0.39847715736040606,0.7574319334796729,1.0,3/14,11.03%,TFRC;NECTIN2;RIF1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.46944283764910805,1.0512769401730606,0.3883495145631068,0.8932635047753249,1.0,7/20,9.36%,ANK2;ATP1B1;CACNA1C;CAMK2D;DMD;SLC9A1;TNNI3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4682001890004807,1.0509870037676574,0.4087237479806139,0.8933206024106812,1.0,5/18,18.56%,EZR;RDX;SNX12;MAP2K2;RAB21
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.466988305548515,-1.05094938159494,0.4031890660592255,0.7576264496480365,1.0,3/10,10.71%,PRKAA2;KLF15;MYOCD
prerank,negative regulation of secretion (GO:0051048),-0.4715164811492291,-1.050891868353338,0.4,0.7564454961161351,1.0,7/10,29.58%,NR1H3;CD74;PTGER3;ERBB3;NRG1;VAMP8;VAMP3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.42226368468939024,1.0508230368508782,0.4122681883024251,0.8930188030530802,1.0,7/41,9.36%,BMP4;BMPR1A;TGFBR2;ISL1;GATA4;JAG1;TNNI3
prerank,regulation of chemotaxis (GO:0050920),0.4343847185041447,1.0507444677479045,0.40358744394618834,0.8924950393520983,1.0,4/30,8.65%,THBS1;PTPN2;MYCBP2;P2RX4
prerank,protein localization to vacuole (GO:0072665),-0.430820618180079,-1.0506353830088646,0.4256926952141058,0.75578888406895,1.0,5/13,14.64%,CD81;RTN4;SH3BP4;GLMP;MFSD1
prerank,regulation of actin filament-based process (GO:0032970),0.3871018905663666,1.0505870580631214,0.40152477763659467,0.8921439779723986,1.0,16/70,9.47%,EZR;EFNA5;PRKCD;ARHGAP44;RHOBTB1;ABL1;FAM107A;RHOQ;LRP1;DMTN;ARHGAP17;PDGFA;RHOA;IQGAP1;RND3;MLST8
prerank,cellular response to interleukin-15 (GO:0071350),-0.435129358657327,-1.0503770345060794,0.41075794621026895,0.7537817801158859,1.0,2/13,3.35%,PLCB1;IL15RA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.435129358657327,-1.0503770345060794,0.41075794621026895,0.7537817801158859,1.0,2/13,3.35%,PLCB1;IL15RA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4180665940546575,-1.0500229215775114,0.3953488372093023,0.7533481199300849,1.0,4/15,8.44%,TNK2;DGKD;HIP1R;SNAP91
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5246410192154205,1.0500183589722176,0.43447037701974867,0.8929526645318171,1.0,2/10,7.65%,GALNT13;POGLUT3
prerank,positive regulation of intracellular transport (GO:0032388),0.422249948483511,1.0499418348747438,0.38342696629213485,0.8924123247613877,1.0,8/38,11.28%,NEDD4;BCAS3;PCM1;PLK3;EHD1;CEP131;EHD2;CAPN10
prerank,vasoconstriction (GO:0042310),0.5125969286520523,1.0498802444347342,0.4056437389770723,0.8918669040382771,1.0,1/11,0.91%,EDNRA
prerank,protein O-linked mannosylation (GO:0035269),0.47356806640644034,1.0491253912435012,0.40822784810126583,0.8931220342141175,1.0,6/18,15.85%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4414485647009858,-1.0489461844809753,0.38095238095238093,0.7549266758420917,1.0,6/13,13.41%,ANK3;SLC8A1;CALM1;PDE4D;CASQ2;CALM3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5192099410626929,1.0486911039657505,0.4293381037567084,0.8935160311638923,1.0,3/10,10.33%,KDM1A;DISC1;VEGFA
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34494832469661174,1.0483970559504991,0.38235294117647056,0.8935120995933639,1.0,44/248,11.68%,EGFR;TCF7L2;SOX9;MLLT3;LRP6;CTNND2;PTPRU;WNK1;WNT11;GLI3;GPC3;PLEKHA4;PRICKLE1;GSK3B;FZD7;VCP;TRPM4;TMEM198;SFRP4;UBE2B;TLE2;NOG;TLE6;INVS;UBR5;DDIT3;BAMBI;TBL1X;PSMB2;JUP;CSNK1A1;CSNK1G3;USP34;NFKB1;DACT1;TNKS2;DKK3;IGFBP6;PSMC6;EMD;PRDM15;RNF146;USP47;RBMS3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.4081897538709748,-1.0477854065192682,0.3884297520661157,0.7565142649920928,1.0,5/17,17.28%,APOE;FGF1;ABCG1;KPNB1;ABCA2
prerank,retinoic acid metabolic process (GO:0042573),-0.4213686734682297,-1.0475542277262722,0.39018087855297157,0.7557819158992966,1.0,2/14,1.99%,ALDH1A2;CYP26B1
prerank,regulation of DNA binding (GO:0051101),0.4210764903033116,1.0471706654201065,0.4053672316384181,0.8959706644971661,1.0,8/44,10.16%,NGF;SMO;HES1;MDFI;SKI;KDM1A;FOXC1;JUN
prerank,striated muscle cell development (GO:0055002),-0.42933433320129294,-1.0467934390092364,0.3882063882063882,0.7564593177711652,1.0,3/14,7.07%,PGM5;TMOD1;LMOD1
prerank,regulation of endocytosis (GO:0030100),-0.3012652908785036,-1.0466870194156028,0.3865546218487395,0.7554393326456427,1.0,12/61,8.16%,APOE;PRKD1;NEDD4L;MCTP1;PICALM;CDH13;RIT2;OPHN1;SYT11;SNCA;HIP1R;SPHK1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.35660173148137614,-1.0465812410173518,0.4064516129032258,0.7543617360348993,1.0,11/32,12.33%,IL1RAPL1;NEDD4L;TNIK;RAPGEF2;HECW2;RAP2A;OBSL1;ADGRB3;HECW1;CUX2;KNDC1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.389698766712915,-1.0465436267816877,0.3785900783289817,0.7531352229210629,1.0,7/20,13.30%,BCL2;DCC;BCL2L1;FAS;BOK;CASP3;GSK3A
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4830173538049241,1.0456657709935422,0.4143835616438356,0.8992575335699509,1.0,6/16,18.31%,ANK2;GBF1;SEC16A;DDRGK1;BCAP31;BCAP29
prerank,transcription by RNA polymerase I (GO:0006360),0.4336523225996085,1.0455950805449816,0.4080717488789238,0.8987015516060993,1.0,14/34,27.33%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3;UBTF;ERCC2;RRN3;POLR1H;TAF1;GTF2H3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.44457715171946144,-1.0455847759821333,0.4387254901960784,0.7542970241450075,1.0,5/12,10.61%,PROM1;PODXL;BASP1;KLF15;PTPRO
prerank,regulation of synapse assembly (GO:0051963),-0.31894990241423055,-1.045073253460557,0.36996336996337,0.7542808524552422,1.0,11/46,9.03%,IL1RAPL1;NRXN1;ROBO2;GRID2;EPHB1;APP;MEF2C;SNCA;SRPX2;LRFN5;LRRC4B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.276471208537316,-1.0449477969049794,0.3237410071942446,0.7532910898257736,1.0,35/116,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;ADORA2A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;ADCY2;PLCG1;HCK;GPR176;ADCY4;FCGR1A;PLK2;GGT1;RHBDF2;SELENOS;VIPR2;LHCGR;TSHR;RXFP1;TREM2;SYK;CD163
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.32683939100202475,-1.0449310317708118,0.38306451612903225,0.7520414190914643,1.0,7/46,6.18%,SEMA6A;LYN;TIMP3;FBLN1;SIRPA;DAB2IP;SPRED1
prerank,plasma membrane repair (GO:0001778),0.515217328174524,1.0446666564623976,0.44694533762057875,0.9004036651761884,1.0,2/13,4.45%,AHNAK2;SYTL4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4427118171170704,1.043856548084898,0.40472673559822747,0.9017175051374515,1.0,7/23,19.22%,CCN3;IFI35;ZC3H12A;PPM1A;CPNE1;NLRP12;ADIPOR1
prerank,monocyte chemotaxis (GO:0002548),-0.3416930376838083,-1.0436725920197352,0.37267080745341613,0.7540876890508968,1.0,4/32,7.12%,FLT1;IL6R;RPS19;TNFRSF11A
prerank,protein autophosphorylation (GO:0046777),0.3572878931967499,1.0434250005275227,0.417607223476298,0.9021360957400586,1.0,26/157,10.43%,STK39;EGFR;GRK5;PTK2B;CAMK2D;DDR2;ULK2;FGFR1;GSK3B;ABL1;CLK2;MKNK2;STK16;CDK12;MAP3K3;EPHB3;MARK2;CHEK2;RIPK3;AAK1;AURKA;MARK3;SIK2;PIM2;ATM;SRMS
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35310972310426536,1.0434169778480755,0.3930131004366812,0.9014188675794714,1.0,44/182,16.23%,FOXP1;BMP4;SLC24A3;ITGB8;SMO;WWP2;KLF4;BMPR1A;ZNF148;FGF2;NOTCH2;LRPAP1;ATP2B4;LDLR;ESR1;CELF1;MOV10;ID2;TNRC6C;REL;ATOH8;CD46;NFKB1;AURKA;VEGFA;ATXN2;SMCR8;CCL3;RB1;RBMS3;SNX12;ZC3H12A;DDRGK1;ANXA7;REST;CNOT7;CREB3L1;MAP2K2;ADAM10;HINFP;RIN3;AGO2;CPNE1;XDH
prerank,natural killer cell activation (GO:0030101),0.4628679320364746,1.043414466420878,0.4156441717791411,0.9006943568498119,1.0,3/23,6.37%,PBX1;CD2;NFIL3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33932247300339224,1.0433478762013624,0.38739669421487605,0.9001247207858565,1.0,48/308,11.55%,BMP4;SIX1;SOX9;FOXD1;ADRA1B;PDGFC;SMO;LBP;BMP1;TGFB3;ZBTB16;GRB10;ADRB2;BMPR1A;INHBA;FGF2;LRPAP1;CMKLR1;TGFBR1;NLRP5;TRPM4;TGFBR2;ZBTB7B;TSKU;GCNT2;NOG;GADD45G;TLE6;GDNF;KDM1A;LRP1;BAMBI;DECR1;TGFB1I1;IL10;SIX4;EHMT1;FOXC1;SCD;NIBAN2;IL33;HILPDA;ACVR1;VEGFA;BCL9L;SMAD2;INHBB;TIAM1
prerank,cytoplasmic translational initiation (GO:0002183),0.47565685327528456,1.0432183125092607,0.43354430379746833,0.8997408015354668,1.0,8/17,23.47%,EIF4G1;EIF2D;EIF3A;EIF2S2;EIF4B;EIF2B3;RBM4;DHX29
prerank,regulation of neuron apoptotic process (GO:0043523),0.37464039204894045,1.0429477021591393,0.39740566037735847,0.8996888460764692,1.0,12/96,6.18%,SIX1;NGF;EGLN3;PTK2B;TGFB3;FOXO3;KCNB1;CLCF1;NFATC4;ISL1;GDNF;DDIT3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4295382776821408,1.0428139637251654,0.4117647058823529,0.8993109591691777,1.0,6/30,10.76%,BMP4;MLLT3;INHBA;TNFRSF13B;HOXB4;PRRC2C
prerank,protein heterooligomerization (GO:0051291),0.48475962622041335,1.0427995667999983,0.41835147744945567,0.8986272943704612,1.0,2/17,2.20%,PKD1;TMEM120A
prerank,regulation of presynapse organization (GO:0099174),0.4734002509389027,1.0426728005547572,0.42071197411003236,0.8974843062821507,1.0,3/18,8.23%,GPC6;EIF4G1;GPC4
prerank,regulation of presynapse assembly (GO:1905606),0.4734002509389027,1.0426728005547572,0.42071197411003236,0.8974843062821507,1.0,3/18,8.23%,GPC6;EIF4G1;GPC4
prerank,positive regulation of insulin secretion (GO:0032024),0.4231063376444273,1.0425455660494658,0.41631504922644164,0.8971085886627671,1.0,7/36,11.28%,TCF7L2;TRPM4;ISL1;CLTRN;AACS;MCU;CAPN10
prerank,negative regulation of MAP kinase activity (GO:0043407),0.4167843416396272,1.0425256933911062,0.4225352112676056,0.8964456984326968,1.0,7/44,11.49%,BMP4;PRKCD;PDCD4;CBLC;NF1;IRAK3;DUSP10
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.376127766407822,1.04233402762591,0.3904191616766467,0.896226519343374,1.0,24/94,19.08%,MAP3K5;DDX5;CYP1B1;TMEM117;PRKCD;FHIT;ABL1;DDIT3;IKBKE;CHEK2;ATM;DIABLO;ARL6IP5;TNFRSF1B;PRKDC;ERN2;CUL3;PML;CUL1;CASP2;CDKN1A;QRICH1;MOAP1;AIFM1
prerank,negative regulation of cell development (GO:0010721),-0.36979587949428927,-1.042238756109867,0.4183381088825215,0.7565579107859949,1.0,3/25,4.40%,IGF1;B2M;NOTCH1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.462434406316495,1.042226909159573,0.4112,0.8958183843157904,1.0,9/20,27.27%,PAICS;AMPD3;PFAS;GMPS;AK4;AK3;GMPR2;AMPD2;ADSS2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4426299489676215,1.0421683483415385,0.4243759177679883,0.8952543930474833,1.0,5/27,4.75%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,positive regulation of type I interferon production (GO:0032481),0.387167807071302,1.0419716696365189,0.41635220125786165,0.8950459043033889,1.0,23/73,18.89%,CREBBP;MAVS;POLR3D;RIPK2;SETD2;IRF1;TLR4;CHUK;NFKB1;NFKB2;MYD88;IFIH1;PRKDC;XRCC5;EP300;DHX9;RNF135;TLR8;POLR3K;POLR3F;POLR3A;DHX36;POLR3E
prerank,regulation of proteolysis (GO:0030162),0.4070878795104049,1.041785881669599,0.40288713910761154,0.8948552997909553,1.0,9/48,15.59%,CYFIP2;PERP;LTBP4;FBXW11;DNAJC1;TBC1D10A;SPOP;IST1;SERPINE2
prerank,regulation of type I interferon production (GO:0032479),0.3816561834002527,1.041691724781516,0.40892193308550184,0.8943794468436062,1.0,34/84,23.89%,TAX1BP1;CREBBP;MAVS;POLR3D;IRF1;IKBKE;NFKB1;NFKB2;MYD88;IFIH1;PRKDC;XRCC5;EP300;NPLOC4;DHX9;RNF135;OTUD5;ACOD1;POLR3K;POLR3F;POLR3A;DHX36;POLR3E;UFD1;TRIM25;TRAF3;STAT6;GPATCH3;POLA1;IRF3;TRAF3IP1;POLR3B;CRCP;RNF26
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5182386988915636,1.0416189530417173,0.4245901639344262,0.8931215985698806,1.0,4/12,12.07%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5182386988915636,1.0416189530417173,0.4245901639344262,0.8931215985698806,1.0,4/12,12.07%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.39459594020233246,1.0407537707192231,0.4254498714652956,0.8946973301437956,1.0,23/64,28.58%,MLLT3;ELOF1;MNAT1;CDK12;SETD2;AFF4;ELOA;CTR9;NELFE;ELP4;ERCC3;CDK13;CCNT1;RTF1;PAF1;EAF2;ADRM1;ERCC2;GTF2F2;GTF2H3;CCNT2;EAF1;NCBP2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5108957985798842,1.0404347644174703,0.432520325203252,0.8947840861396597,1.0,4/12,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3994968667572278,1.0396206797565892,0.40797940797940796,0.8961929618557202,1.0,10/51,10.29%,DCLK1;NGF;SRGAP2;SNX2;SHTN1;TRIO;ANKRD27;NBL1;NCKAP1;CTTN
prerank,positive regulation of protein transport (GO:0051222),0.39020426950367193,1.0395654002895132,0.41697416974169743,0.8956186116589685,1.0,16/67,13.42%,EZR;TGFB3;ADAM9;BMP6;UNC13B;ACSL3;SYTL4;BCAS3;PCM1;GOLPH3;PLK3;CNST;CEP131;ARHGEF5;CHP1;EXPH5
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.49285420780881783,1.0393385978139542,0.4342948717948718,0.8947704993878205,1.0,7/15,22.13%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.49285420780881783,1.0393385978139542,0.4342948717948718,0.8947704993878205,1.0,7/15,22.13%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.44358027256911203,-1.0393349865632813,0.3989769820971867,0.7629127474544638,1.0,2/11,3.38%,APOE;UGCG
prerank,actin cytoskeleton reorganization (GO:0031532),0.38739518002582285,1.039189544707835,0.4164490861618799,0.8944324275818053,1.0,16/63,11.28%,EZR;PHACTR1;ANXA1;SIPA1L1;CXADR;GSN;PARVA;NRP1;ANTXR1;PIP5K1A;DMTN;RHOA;CTTN;MCU;MKLN1;CAPN10
prerank,neutrophil activation (GO:0042119),0.5200632480191997,1.0390495592955238,0.45051194539249145,0.8940973806912723,1.0,1/12,2.06%,PRKCD
prerank,intracellular protein transport (GO:0006886),0.3376511892903737,1.038929010177549,0.4118257261410788,0.8937016241809009,1.0,87/304,21.15%,PKD1;SGSM2;KIF13A;GIPC1;PRICKLE1;TLK1;STX11;NUP93;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;HPS4;XPO1;STAT3;IPO7;GRTP1;E2F3;ARF3;NSF;AP4E1;RAB3GAP2;TNPO2;SEC16A;AP2A1;EIF2D;EGR2;STX8;C2CD5;EHD1;CTTN;ARF4;STRADA;DESI1;KATNB1;TBC1D2B;TBC1D13;COPA;RANGRF;STX19;TBC1D25;SEC31A;ARCN1;CHP1;SEC13;NUP153;SMURF1;TBC1D10A;BAG3;RAB24;ARFIP1;TBC1D8B;GGA2;ARFIP2;TBC1D5;ARFGAP3;SAR1B;NUP214;SEC23IP;SGSM3;SNX31;NUP188;XPO4;SCFD2;NUP88;TBC1D17;RAB5B;AP3D1;SNX13;RAB21;SNF8;USO1;SNX8;AP4M1;NUTF2;RAN;TNPO3;HEATR3;RAB5A;AP4B1;RAB1A;STX2;TMED3;RAB18
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.33434840168107965,-1.0386580760649202,0.3767123287671233,0.763408135293291,1.0,16/38,23.62%,PHLPP1;PPARA;DAG1;THEM4;AKT1;ARRB2;PHLDA3;SH2B3;RACK1;HYAL2;GPER1;TRIB3;INPP5K;EPHA2;PTPRJ;PLEKHA1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3923000713674154,1.0385478363152276,0.4059278350515464,0.8939217624511017,1.0,15/60,18.25%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;MED27;CBFB;HNF1A;CCND1;MED14;MED24;CDKN1A;DHX36
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.42079701597934094,-1.038510488328541,0.41836734693877553,0.7624888433023623,1.0,7/15,24.17%,IQGAP2;ARPC4;ARPC3;ARPC5;ARPC5L;TRIM27;ARPC1A
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.411914760212332,1.0379135630571656,0.4262295081967213,0.8949091902702058,1.0,12/40,18.52%,PTK2B;XPO1;CLU;COMMD1;RAD23B;DESI1;SMURF1;CCDC22;TRIM39;PML;CSNK2A2;CSNK2A1
prerank,regulation of store-operated calcium entry (GO:2001256),0.5107181205487366,1.037055668909241,0.4227504244482173,0.8963607125573576,1.0,4/10,14.92%,SLC8B1;HOMER2;HOMER1;GRAMD2A
prerank,anterior/posterior axis specification (GO:0009948),-0.4037918551615899,-1.0370266979915281,0.39851485148514854,0.7650540718813039,1.0,2/15,2.55%,WLS;TBX3
prerank,brain morphogenesis (GO:0048854),-0.43482501781806926,-1.0369035106211222,0.41330166270783847,0.7640830732928469,1.0,2/12,2.16%,SHANK3;CTNNA2
prerank,sphingolipid catabolic process (GO:0030149),0.4842245064185788,1.0366435424906078,0.44518272425249167,0.8967217588864127,1.0,2/15,3.98%,ACER3;PDXDC1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4222873129704489,1.0362537209431923,0.4283625730994152,0.8970311222760325,1.0,10/37,11.62%,TGFB3;IGFBP5;BMPR1A;FGF2;NR4A3;PDCD4;IL10;CDKN1B;JUN;HTR1B
prerank,amino sugar biosynthetic process (GO:0046349),0.5163179959516252,1.03619323474246,0.4379310344827586,0.8964808928865237,1.0,4/12,19.88%,NANP;RENBP;UAP1;GFPT1
prerank,sphingolipid metabolic process (GO:0006665),-0.2768105757891449,-1.0355029214350255,0.37142857142857144,0.7663959590782369,1.0,33/108,17.75%,ST6GALNAC3;ENPP2;PRKD1;CERS4;ACER2;SGMS1;ELOVL7;UGCG;CERT1;DEGS2;SMPD3;CERK;ELOVL6;CTSA;GAL3ST1;ESYT1;SPHK1;SPTSSA;SERINC1;SPNS2;HACD3;CERS1;ELOVL4;CERS2;HACD2;ORMDL3;HEXB;SMPD1;PSAP;PLPP2;ALDH3B1;ABCA2;CLN8
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.43914578280730554,-1.0354977084978465,0.43675417661097854,0.7650975450308959,1.0,6/12,26.36%,CXCL12;APP;JAM2;DOCK8;PYCARD;CCL5
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4616844865193742,1.03541276437596,0.4229559748427673,0.8978031053956145,1.0,7/22,18.25%,ESR1;MED13;PSMC6;HNF1A;MED14;MED24;DHX36
prerank,negative regulation of viral life cycle (GO:1903901),-0.4112572692683533,-1.035195643962802,0.43073047858942065,0.7646616906149012,1.0,5/15,7.63%,LY6E;PPIA;IFITM1;BST2;IFITM3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.45432677439579033,-1.0350325847758364,0.4305555555555556,0.7637496472576867,1.0,3/10,5.14%,RAPGEF2;KDR;CD34
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3429287202785182,-1.0348585513451238,0.3582089552238806,0.7629689059270357,1.0,4/35,5.03%,PAM;ACSS3;FAR2;GGT5
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.41410943200116995,-1.0348487435957552,0.4197860962566845,0.7617131981362198,1.0,8/16,8.69%,IGF1;TGFBR3;NOTCH1;ERBB4;RBPJ;AKAP6;MEF2C;EDN1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3112293896535178,-1.0347899897514226,0.3760330578512397,0.7605380908905186,1.0,21/54,15.05%,APOE;PRKD1;NOS3;AKT3;ETS1;KDR;TMSB4X;MEF2C;HIF1A;ANGPT2;GATA2;ATP5F1B;RGCC;PRCP;NUS1;PLCG1;ATP5F1A;VASH1;ACVRL1;CD40;AKT1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.48489526973281794,1.0345530918298818,0.43213728549141966,0.8992909856397305,1.0,6/16,17.86%,MCM7;WRN;MCM2;RPA1;RECQL5;RAD51
prerank,actomyosin structure organization (GO:0031032),0.37905720643050744,1.0337837148290818,0.43107769423558895,0.9005727201302066,1.0,14/75,9.48%,EPB41L5;PHACTR1;CIT;CSRP3;EPB41L2;SORBS1;ITGB1;ITGB5;TMOD3;KRT19;SIX4;CSRP2;RHOA;FRMD6
prerank,positive regulation of protein secretion (GO:0050714),0.38107953560257096,1.0337220759409749,0.42216687422166876,0.900006649898475,1.0,11/69,8.02%,TCF7L2;EZR;TGFB3;ADAM9;BMP6;UNC13B;SYTL4;ISL1;GOLPH3;AACS;TLR4
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3571438490097762,1.033633428128219,0.4254835039817975,0.8995210565461895,1.0,22/132,12.52%,SLC4A4;EZR;ADAM9;PRKCD;FOXO3;GSK3B;IRS1;PFKFB2;TPCN1;MOV10;RDX;DXO;DAGLB;PFKFB1;ZC3H18;DACT1;PIM2;MTDH;ATF6;SH3D19;TNFRSF1B;ZC3H12A
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4476427829001771,-1.0335883825132157,0.413953488372093,0.7621809505475673,1.0,5/11,26.46%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,positive regulation of developmental process (GO:0051094),0.3511592094432905,1.0334351578553846,0.4205298013245033,0.8992952802007066,1.0,28/164,12.07%,BMP4;SOX9;BMP5;FOXD1;COBL;BMP1;ZBTB16;PHLDB2;FGFR1;BMPR1A;LMNA;NLRP5;TRPM4;FOXO6;TLE6;ISL1;GDNF;AGR2;DDHD1;SHANK1;NIBAN2;AURKA;ACVR1;VEGFA;MCU;ZDHHC15;MIEF1;CORO1C
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5255295832080252,1.0333665579723696,0.4539249146757679,0.8987544960058064,1.0,3/10,7.42%,PRKCD;CD9;RDX
prerank,clathrin-dependent endocytosis (GO:0072583),-0.35972153727727774,-1.0325229980065203,0.39143730886850153,0.7636924819780462,1.0,6/26,10.34%,DNAJC6;SGIP1;PICALM;FNBP1L;SNAP91;INPP5F
prerank,regulation of organelle organization (GO:0033043),0.3761765733364481,1.032442686995773,0.4207920792079208,0.9004351074716739,1.0,21/80,15.60%,CLIC4;EZR;CAPN2;DIAPH1;STX5;MAVS;CLEC16A;EHD3;GOLPH3;RDX;MARK2;CAPN6;ARMH3;AKAP9;ARHGEF5;TBC1D25;PAK2;EP300;PRMT6;SQSTM1;SAR1B
prerank,negative regulation of axon extension (GO:0030517),-0.344359887230985,-1.032353933468756,0.4253968253968254,0.7628517451805406,1.0,11/30,13.00%,SEMA6A;SEMA7A;MAP2;SEMA6D;MAG;RTN4;SEMA5B;SEMA3G;SEMA6B;SEMA3B;TRIM46
prerank,regulation of cell division (GO:0051302),0.38238797830808996,1.0319388238917706,0.44030808729139925,0.901016349198941,1.0,16/72,15.55%,MLLT3;KIF13A;NLRP5;RAB11FIP3;BECN1;TLE6;BIRC6;SETD2;PLK3;KLHL13;AURKA;PRDM15;ENTR1;SH3GLB1;HTR2B;AHCTF1
prerank,gluconeogenesis (GO:0006094),-0.3301290853465054,-1.0315121521003654,0.40460526315789475,0.7639097800437378,1.0,13/39,21.63%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A11;SLC25A13
prerank,negative regulation of transposition (GO:0010529),0.47359242066305673,1.0313976083910947,0.444253859348199,0.9016963723077162,1.0,5/16,19.90%,MOV10;TDRD9;TUT7;TUT4;TEX15
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.41592514811011255,-1.031327151299293,0.4201474201474201,0.7630807706000339,1.0,6/13,28.42%,NOS3;ALDH4A1;GLUD1;NOS2;NOS1;DAO
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.44697839878790885,1.0312669942649018,0.42902208201892744,0.9013031960622967,1.0,5/24,8.79%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.37939355894530696,1.0309334612885312,0.4259028642590286,0.9014858524186662,1.0,7/76,6.42%,PLCE1;ADRA1B;GPR4;CMKLR1;AGTR1;ESR1;LPAR4
prerank,tRNA wobble uridine modification (GO:0002098),0.48906815466233283,1.0308725488573103,0.4193011647254576,0.9009581259170134,1.0,6/14,19.77%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3
prerank,regulation of stress fiber assembly (GO:0051492),0.3795696391107016,1.0308695639924146,0.41191381495564006,0.90025852815005,1.0,15/74,9.06%,TMEFF2;MET;SORBS3;ARAP1;TGFB3;WNT11;PHLDB2;ABL1;NRP1;TGFBR1;RHPN2;ARHGEF10;SLC9A1;S100A10;RHOA
prerank,dopamine metabolic process (GO:0042417),-0.3936030201296538,-1.0308616486755533,0.41119221411192214,0.7629517600590086,1.0,5/18,7.59%,MOXD1;MAOB;MAOA;SNCA;COMT
prerank,regulation of cell development (GO:0060284),0.4171368000083869,1.0308529392312686,0.4305750350631136,0.8996031698563756,1.0,5/36,5.39%,HDAC9;HES1;NOTCH2;DOCK7;BHLHE40
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.503749656219775,1.0308524580205203,0.467005076142132,0.898900038782427,1.0,4/12,14.50%,PLK3;WAC;PRKDC;CCND1
prerank,organophosphate catabolic process (GO:0046434),-0.4423256731204259,-1.0308023674870639,0.4192708333333333,0.7618530148202508,1.0,2/11,7.65%,ENPP2;ABHD12
prerank,regulation of astrocyte differentiation (GO:0048710),0.5184702132475457,1.0307719465797376,0.45454545454545453,0.898409314170109,1.0,4/12,7.45%,HES1;CLCF1;NOG;ID2
prerank,negative regulation of phosphatase activity (GO:0010923),0.4497525655823285,1.0304802819967966,0.41798107255520506,0.8984772520716334,1.0,9/25,20.92%,GSK3B;CRY2;STYXL1;BOD1L1;CHP1;URI1;PPP1R36;TGFB2;PTPA
prerank,response to reactive oxygen species (GO:0000302),0.4009934237158994,1.030004429089231,0.4423841059602649,0.8989329506789303,1.0,6/54,10.16%,EGFR;ADAM9;COA8;PLK3;CHUK;JUN
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4481767460024799,1.0295735330621607,0.42442748091603055,0.8993328021060006,1.0,5/23,12.52%,INHBA;DDIT3;TLR4;RARA;ZC3H12A
prerank,organic hydroxy compound transport (GO:0015850),-0.3280631708272963,-1.0292144823869962,0.4117647058823529,0.7646229000396663,1.0,5/36,6.19%,SLCO2B1;NCOA1;SLCO1C1;RBP4;SLC5A3
prerank,transcription by RNA polymerase II (GO:0006366),0.33627714274457376,1.0291960659224781,0.431513903192585,0.8996056423357351,1.0,62/305,16.24%,NR3C2;RNMT;RARB;MLLT3;DDX5;HDAC9;ESR2;NOTCH2;ELOF1;PRRX1;NR2F1;NR4A3;NR4A2;ZBTB7B;CREBBP;ESR1;MNAT1;CDK12;MBD1;TBL1X;E2F3;SETD2;AFF4;SCAF8;NFIX;TEAD1;RXRA;NFYA;RORA;NFKB1;RARG;MED27;RARA;RBMX;RPAP1;SNAPC2;TTF2;NCOR1;NABP1;TAF1C;CBFB;ELOA;GTF2E1;NR4A1;NR6A1;CTR9;NELFE;HNF4A;LSM11;NCOR2;E2F2;HDAC10;ELP4;ZBTB1;INTS8;INTS5;ERCC3;WWTR1;KAT2B;TRIP11;DDX21;TAF12
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.46098763394320175,1.0291916565374088,0.43328100470957615,0.8989106599074601,1.0,4/19,5.99%,EXT1;HS6ST2;GLCE;XYLT1
prerank,protein import into nucleus (GO:0006606),0.38569067333524193,1.029185058907045,0.423841059602649,0.8982224240336762,1.0,19/66,20.34%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;KPNA1;RGPD1;TNPO2;RANBP2;KPNA4;SEC13;NUP153;NUP214;NUP188;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,insulin receptor signaling pathway (GO:0008286),0.3747038450027524,1.0284678618151457,0.4332084893882647,0.8993611542957808,1.0,17/69,14.46%,GRB10;SORBS1;SHC1;ATP6V0A4;GSK3B;IRS1;FOXC2;SLC39A14;PTPN2;RHOQ;IDE;BCAR3;C2CD5;PIK3R3;ATP6V0D1;TCIRG1;GAB1
prerank,nuclear envelope organization (GO:0006998),0.4644843692522069,1.0283803524806516,0.4540059347181009,0.8989022032724406,1.0,8/20,22.26%,NUP93;TOR1AIP1;SUN3;EMD;TOR1B;LEMD2;TMEM170A;SUN2
prerank,cellular response to hydroxyurea (GO:0072711),0.5334250650719998,1.0282965240592443,0.45729537366548045,0.8984318613146159,1.0,5/10,20.05%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5101069623508174,1.0281175783050704,0.4607679465776294,0.8982227146358094,1.0,6/12,19.72%,UPP2;TK1;TK2;CAD;DHODH;UMPS
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.495850667399657,1.028084577123986,0.458477508650519,0.8976182633854666,1.0,3/12,5.27%,ATP1B1;WNK1;DMD
prerank,peptidyl-lysine dimethylation (GO:0018027),0.47164504813827746,1.027960258329891,0.45893719806763283,0.8972409943085683,1.0,6/18,20.81%,SMYD2;SETD2;EHMT1;KMT2D;EHMT2;ASH1L
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.43651917547894303,1.0274244719600678,0.4270353302611367,0.8979093725829203,1.0,5/26,8.79%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,myeloid leukocyte differentiation (GO:0002573),0.38740710856992616,1.0270833429105999,0.43041237113402064,0.8980734800749416,1.0,4/65,4.97%,FOXP1;BMP4;GAB2;TGFBR2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.40696116295057244,1.0270497104181064,0.4445910290237467,0.897479049899839,1.0,14/48,18.19%,ELOF1;POLR1G;POLR1A;TAF1D;TAF1C;KAT2A;CHEK1;EP300;POLR1F;SF3B1;KAT2B;DDX21;ZMIZ1;SMARCA5
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3785222833540355,1.026398458194278,0.42065491183879095,0.8984153805531631,1.0,21/72,18.37%,PLAGL1;NDRG1;CRADD;CHEK2;PLK3;MDM4;CDKN1B;AURKA;PCBP4;ATM;USP10;ATRX;EP300;CNOT7;PIDD1;PML;CASP2;NBN;CDKN1A;CARM1;TNKS1BP1
prerank,negative regulation of binding (GO:0051100),0.3705081583380915,1.0263889412430254,0.42718446601941745,0.8977502252887903,1.0,19/81,13.46%,SMO;PRKCD;GSK3B;LRPAP1;BTAF1;MDFI;KDM1A;SLPI;DISC1;AURKA;DACT1;JUN;DDX11;ITGB1BP1;WAPL;USP33;CARD16;GTPBP4;CSNK1E
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4523795288418389,1.0262128973618552,0.4368932038834951,0.8975629335024786,1.0,6/19,14.40%,KLF4;ELF1;MAVS;CBFB;IFIH1;DHX9
prerank,membrane lipid biosynthetic process (GO:0046467),0.3959769436397828,1.026022861993577,0.431758530183727,0.8973527081985697,1.0,5/58,5.31%,ST3GAL4;ACER3;PLPP3;SGMS2;SPTSSB
prerank,protein kinase A signaling (GO:0010737),0.49026557240317004,1.0260151187287003,0.44983818770226536,0.8966827111027404,1.0,2/12,7.42%,EZR;RDX
prerank,epithelium development (GO:0060429),0.3592399502652947,1.025620515633211,0.43425814234016885,0.8969484215630815,1.0,15/107,10.33%,SIX1;PKD1;SOX9;SMO;BDH2;MEOX2;ANXA4;EHF;CASP6;VCL;RIPK4;GRHL2;KANK2;DACT1;VEGFA
prerank,apoptotic process (GO:0006915),0.3417278407522773,1.02558417147035,0.42184154175588867,0.8963540691887887,1.0,45/203,17.21%,PLAGL1;CYFIP2;EGLN3;PTK2B;CIT;EFNA5;PRKCD;PAWR;ZBTB16;NOTCH2;PRKCE;MAGI3;RFK;PDCD4;CASP6;TGFBR2;CD2;PLSCR1;ARHGEF6;GDF6;YARS1;IRF1;PLK3;BCLAF1;FEM1B;MCM2;NCKAP1;CDIP1;DIABLO;BCL2L13;MYD88;MTOR;CHEK1;EP300;PLSCR3;TRADD;CXCR4;CDK11B;PIDD1;TRPC5;ERCC3;IKBKG;CASP2;MRPS30;PAK4
prerank,regulation of protein localization to centrosome (GO:1904779),0.521819960264447,1.02525163147871,0.4192982456140351,0.8965445815247333,1.0,1/10,3.24%,GSK3B
prerank,embryonic axis specification (GO:0000578),0.48344778394467525,1.0250255553252474,0.445859872611465,0.8964372566972642,1.0,2/15,2.16%,COBL;SMAD6
prerank,regulation of cell cycle process (GO:0010564),0.36357567164985394,1.024630347384832,0.4307875894988067,0.8967684975278731,1.0,29/104,22.64%,SOX9;KIF13A;TXLNG;RAB11FIP3;BECN1;CCDC8;BIRC6;SETD2;PLK3;KLHL13;AURKA;CEP85;ENTR1;CHEK1;SH3GLB1;AHCTF1;IHO1;KNSTRN;RMI2;CDK13;CSNK2A2;CSNK2A1;PDXP;YTHDF2;CUL7;CDC42;PRMT5;PLK4;ZFYVE26
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4611205309339794,1.0245844938688204,0.4407051282051282,0.8961769057913602,1.0,4/20,10.17%,FMNL2;RHOQ;DLG1;NCKAP1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.36263459767776285,-1.024451705868867,0.41642228739002934,0.7760061325794955,1.0,6/23,8.69%,SASH1;PAK1;DAB2IP;RPS3;TNFRSF11A;EDN1
prerank,regulation of kinase activity (GO:0043549),0.3642117468605235,1.024357555124894,0.42284325637910086,0.8960884152217065,1.0,7/89,2.89%,EGFR;PLCE1;MET;NTRK3;LMO4;DDR2;FGFR1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4544503912911116,-1.0241556474210585,0.42053789731051344,0.7754305061431782,1.0,2/10,11.07%,SACS;DNAJA4
prerank,regulation of ion transport (GO:0043269),0.3760070996343335,1.0240467084819604,0.4316185696361355,0.8961766077221874,1.0,12/76,10.96%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;GDNF;SYT8;P2RX4;ATP1A1;DRD3;ITGB3;PER1
prerank,proteoglycan metabolic process (GO:0006029),0.43734872581848894,1.0238190817773516,0.444947209653092,0.8960961994879982,1.0,12/26,20.11%,HS3ST4;SULF1;CHST13;FOXL1;XYLT1;B3GALT6;CHST11;CHST12;HPSE;GAL3ST4;SULF2;B4GALT7
prerank,regulation of calcium ion transport (GO:0051924),-0.3017245275197173,-1.0236633701870514,0.4092827004219409,0.775435024017606,1.0,11/54,11.40%,MYLK;CACNA1D;EPB41;BCL2;ADRA2A;ATP2B1;CACNA2D1;TRPC6;CAMK2A;CD84;CAMK2B
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.30924190969646437,-1.0231917425483452,0.3814814814814815,0.775311244017309,1.0,9/48,17.26%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18;TLR7;TLR3;CD276;FZD5
prerank,intracellular cholesterol transport (GO:0032367),0.49304189663231146,1.0221498740064394,0.4697986577181208,0.8996446793504718,1.0,3/15,8.52%,LRP6;LDLR;STARD4
prerank,polarized epithelial cell differentiation (GO:0030859),0.49683965295361815,1.0217325741980696,0.44370860927152317,0.8999862273239989,1.0,7/13,21.78%,EZR;RHOA;SYNE4;MYO9A;SCRIB;CAMSAP3;CDC42
prerank,lamellipodium organization (GO:0097581),0.4271073522825973,1.0212979553043344,0.4426229508196721,0.900401778729206,1.0,8/29,6.91%,ABLIM3;ITGB1;SNX2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.40804654556718023,1.0212237830182256,0.4301994301994302,0.8999048492287289,1.0,4/37,3.51%,HMCN1;CXADR;NECTIN3;ALCAM
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3260784741467628,-1.0211131967432117,0.36395759717314485,0.7793654116610103,1.0,8/40,9.22%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;BMP2;ZC4H2;PROX1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.386970244629768,-1.0209248781039773,0.43099273607748184,0.7786221264589384,1.0,4/18,8.09%,SHANK3;NRXN1;CACNG4;CACNG7
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.23356163000348246,-1.0208313869076366,0.41379310344827586,0.7775804101814568,1.0,67/306,13.32%,APOE;RBMS1;RPS14;FUT9;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPLP2;RPS21;RPL27A;EEF1B2;RPS29;RPS19;RPL34;RPS3;RPS8;RPS23;RPS5;RPS4X;RPL13;RPL9;RPS16;RPS15;RPS27;RPL30;ALAS1;DTX1;RPL37;RPS11;RPS24;RPL19;RPL18;RPL18A;RPS7;RPL23;RPL17;EIF4EBP2;RPL22;RPL23A;RPS20;RPS25;RPL26;RPL35A;MRPL3;RPS18;RPL11;RPL13A;GAL3ST2;RPL7;RPL36;BLM;RPS17;RPL32;RPL39;RPL14;RPS2;SET;ORC4;RPL8;POLR2G;RPL24
prerank,translesion synthesis (GO:0019985),0.4067595743769353,1.0205840901330092,0.41073825503355704,0.9007829236391224,1.0,17/42,28.48%,REV3L;VCP;USP10;NPLOC4;POLE2;ZBTB1;RPA1;UFD1;RFC1;REV1;TRIM25;POLD3;RFC5;POLK;RCHY1;POLI;PRIMPOL
prerank,regulation of dendrite development (GO:0050773),0.40776381115012894,1.0205454825615765,0.41585535465924894,0.9001962861236651,1.0,5/37,3.24%,BMP5;COBL;MARK1;NEDD4;GSK3B
prerank,protein K63-linked deubiquitination (GO:0070536),0.42603758329518154,1.0202964524782223,0.4474074074074074,0.9001456498943435,1.0,9/31,15.81%,USP13;OTUD1;USP25;USP7;OTUD7B;USP33;UIMC1;ZRANB1;OTUD5
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.43789641512483535,-1.0193970129864223,0.44862155388471175,0.7800223845973095,1.0,5/11,30.16%,AKAP6;NOS1AP;TREM2;RNF207;LRRC55
prerank,regulation of gluconeogenesis (GO:0006111),0.43419376927501085,1.019304559633197,0.44296296296296295,0.9020056344191887,1.0,8/27,15.98%,CLK2;PTPN2;NNMT;C1QTNF12;USP7;ERFE;EP300;GNMT
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4349027486850357,-1.0189742797745702,0.4504950495049505,0.7798118027570179,1.0,3/11,8.24%,LYN;TNFRSF21;CD300A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5067224774265756,1.0187525249546123,0.4589285714285714,0.9027247526751992,1.0,3/10,17.34%,KLF4;IRAK3;PALM3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.450629774665862,-1.0186198696412274,0.4566744730679157,0.7794824541193821,1.0,5/10,26.46%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,regulation of translation (GO:0006417),0.3444513843269043,1.0184404101961273,0.43243243243243246,0.9028379164323151,1.0,43/173,23.15%,THBS1;SAMD4A;EIF4G3;FOXO3;IGFBP5;NIBAN1;PAIP2;EIF4G1;SYNCRIP;LARP4B;TOB1;ETF1;GSPT1;ATXN2;ERBB2;EIF3E;EIF6;MTOR;PRKDC;EIF2AK4;MTRF1;DHX9;CNOT7;EIF2B2;PLD1;MTIF2;PUM3;DHX36;TRAP1;CIRBP;EIF4B;FXR2;LARP4;CAPRIN1;FMR1;EIF4G2;EPRS1;DDX1;RBM3;NANOS2;EIF2AK3;RBM4;SAMD4B
prerank,carbohydrate homeostasis (GO:0033500),0.38156762685978446,1.018269190987863,0.42930591259640105,0.9025931531524102,1.0,15/67,13.93%,TCF7L2;KCNB1;CRY2;IRS1;KLF7;PTPN2;STAT3;BACE2;MCU;SLC8B1;SELENOT;HNF1A;HNF4A;PAX6;ACSM2A
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3531466738600931,-1.0181778016027143,0.43526170798898073,0.7793610076753922,1.0,6/24,14.44%,ERRFI1;PRKCH;ROCK2;CTSL;ETV4;MED1
prerank,regulation of protein modification process (GO:0031399),-0.3164436498116318,-1.0177661754020408,0.41304347826086957,0.7791857002311885,1.0,17/50,20.50%,LYN;PPP1R16B;GRM5;PTK2;CCDC88A;SPRED1;PPIB;CADM4;FNIP2;ABCA2;CCDC88C;NDUFS4;CDH5;PLXNB2;HSPB1;MT3;CCAR2
prerank,actin filament organization (GO:0007015),0.35041346173214544,1.017604649909562,0.43687150837988825,0.9036267253971266,1.0,22/151,9.34%,DPYSL3;BAIAP2L1;VILL;COBL;ABI1;GSN;SHROOM3;RHOBTB1;TMOD3;FAT1;NLRP5;TLE6;NEBL;PLS1;DMTN;DLG1;GAS2L2;ARHGAP17;SHROOM4;RHOA;GAS2;RND3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3528612317415862,1.0174423174050198,0.43387470997679817,0.9033258714652701,1.0,27/129,13.71%,EGFR;WNK1;GPC3;PLEKHA4;VCP;TRPM4;TMEM198;SFRP4;UBE2B;UBR5;BAMBI;TBL1X;PSMB2;JUP;CSNK1G3;USP34;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;RNF146;USP47;CSNK1G1;PPM1A;CSNK1E;PSMD11
prerank,response to insulin (GO:0032868),-0.28496551394765895,-1.016901146011472,0.41450777202072536,0.7802944908009589,1.0,22/80,18.23%,TBC1D4;PIK3R1;SORT1;FOXO1;CPEB2;ENPP1;INSR;INSIG2;LPIN3;MYO5A;SLC25A33;GSK3A;DENND4C;AKT1;RAB15;LPIN1;RAB31;RAB13;PDE3B;SELENOS;XBP1;SLC27A1
prerank,smooth muscle cell differentiation (GO:0051145),0.4945330124884438,1.016861885495984,0.4745762711864407,0.9040506973588556,1.0,2/12,5.74%,BMP4;MRTFA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4600852278973072,1.016373352688274,0.4552590266875981,0.9046047313638351,1.0,5/16,7.95%,PDGFC;ABL1;NRP1;NR4A3;PDGFA
prerank,purine-containing compound biosynthetic process (GO:0072522),0.43562511938585563,1.0163320282666355,0.43219076005961254,0.9040110063252891,1.0,6/25,18.84%,PRPS2;PAICS;ADA;AMPD3;GMPS;DGUOK
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.35022447927951983,1.0162254714702965,0.43813847900113506,0.9036048739207142,1.0,13/138,3.84%,GUCY2C;EGFR;MET;NTRK3;NGF;PTK2B;ABI1;PTPRU;DDR2;FGFR1;SHC1;POLR1G;PTPRF
prerank,N-terminal protein amino acid modification (GO:0031365),0.4918050718690529,1.0162224754152145,0.45454545454545453,0.90292658006374,1.0,7/14,27.51%,NAA40;NAA15;METAP1D;NAA35;METAP2;NAA50;NAA60
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4592997610463092,-1.016191672011451,0.4666666666666667,0.780875373614543,1.0,2/10,2.52%,ZEB2;RAPGEF2
prerank,V(D)J recombination (GO:0033151),0.4930236805822394,1.0161914393828504,0.46296296296296297,0.902332334828054,1.0,3/11,13.30%,DCAF1;TCF3;PRKDC
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.35607280643276706,-1.0161031415014492,0.430635838150289,0.7798495596735789,1.0,4/25,3.44%,B2M;KIT;WNT5A;SLC7A5
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4103201863251712,1.0160254955781571,0.4322766570605187,0.9020551788760002,1.0,13/36,21.72%,CHEK2;RAD17;CEP63;ATM;CLSPN;CDC45;CHEK1;HINFP;USP28;NBN;ATR;E2F1;RAD9B
prerank,neuron projection fasciculation (GO:0106030),-0.4570705415238805,-1.0157993458657686,0.4675925925925926,0.7793631432810534,1.0,7/10,25.53%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3259063807302258,1.0156389200668992,0.4429868819374369,0.9023759378491854,1.0,76/509,12.09%,F3;EGFR;THBS1;NR3C2;TCF7L2;MET;TNFAIP8L3;NTRK3;SOX9;NEDD4;ADRA1B;PDGFC;TCIM;TRAF3IP2;FN1;AKAP13;WNT11;NFAT5;ADRB2;FGFR1;SHC1;ALPK1;ITGB1;FGF2;GAB2;PIK3AP1;IRS1;STRN;TGFBR1;PDCD4;TAB3;CD80;GCNT2;BECN1;WNT16;IRAK4;ESR1;ITGAV;MAVS;DDIT3;RIPK2;GOLPH3;TRIM44;MAP3K3;RRAGB;IFI35;P2RX2;REL;IKBKE;STYXL1;PDGFA;TLR4;BCAR3;P2RX4;ROR1;RHOA;CHUK;IQGAP1;MLST8;BCLAF1;USP15;PLCG2;PIM2;LIMS1;MTDH;VEGFA;GOLT1B;SMCR8;CCL3;MIER1;ERBB2;ITGB1BP1;FGF22;PPP5C;MYD88;TRAF5
prerank,cytoskeleton organization (GO:0007010),0.35570250855974483,1.015259009207877,0.4470588235294118,0.9026266621439647,1.0,19/114,11.66%,MICAL2;PLCE1;FMNL2;MARK1;ARHGAP10;STRIP2;PPP2R3C;RHOBTB1;DIAPH1;DMTN;FGD6;RHOA;RND3;PCLO;SPRYD3;CCL3;MAST2;ZMYM4;SH3D19
prerank,glial cell development (GO:0021782),-0.36218162956251443,-1.0146331472365928,0.4482758620689655,0.7811745460945564,1.0,15/25,33.98%,CDK6;APP;NRROS;MDK;CSPG5;MYRF;MT3;DLL1;TPPP;SOX10;EIF2B1;SOX4;EIF2B5;S100A9;HES5
prerank,negative regulation of developmental growth (GO:0048640),-0.3305841533452011,-1.014553804870515,0.39935064935064934,0.7800950265484969,1.0,7/30,9.85%,NKD1;MAP2;DCC;PTCH1;MAG;RTN4;SEMA3G
prerank,regulation of macrophage activation (GO:0043030),0.42359261767704076,1.014487555868762,0.44309559939301973,0.9038320326494858,1.0,5/30,9.65%,THBS1;LBP;TLR4;SHPK;IL33
prerank,neurotransmitter transport (GO:0006836),0.37306346004587154,1.0143758914371657,0.465,0.9034586057061161,1.0,2/73,0.29%,SLC38A2;SLC38A1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4659387597371571,1.0141388470484216,0.4596375617792422,0.9033976250761294,1.0,8/18,20.49%,USP15;PUM2;NPLOC4;PUM1;ANKRD17;BIRC3;UFD1;GPATCH3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.38839621926020806,1.0138582555252336,0.44881889763779526,0.9034045200493306,1.0,17/52,21.76%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;PPP3CC;ARIH2;SH3GLB1;BAP1;CSNK2A2;RNF31;MAPK8;USP36;E2F1;HUWE1;NMT1
prerank,calcium import into the mitochondrion (GO:0036444),0.5016191791474539,1.0136378288437986,0.466786355475763,0.9032915093273612,1.0,5/10,26.67%,MCUB;MCU;MICU3;MICU1;MICU2
prerank,triglyceride metabolic process (GO:0006641),-0.3173858823596009,-1.0134830249770006,0.42,0.7816818269012431,1.0,9/48,15.51%,APOE;LPGAT1;GK;LPIN3;GPAM;FABP5;DGAT1;LPL;LPIN1
prerank,positive regulation of cell aging (GO:0090343),-0.4462302974668356,-1.0131210882813753,0.4348894348894349,0.7813056836947572,1.0,3/11,10.01%,B2M;YPEL3;ABI3
prerank,histone lysine demethylation (GO:0070076),0.4355784579368388,1.0125318232315006,0.443620178041543,0.9054075153477421,1.0,7/25,16.67%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;HR
prerank,negative regulation of cytokine production (GO:0001818),0.3442523732481375,1.012339837777022,0.44937428896473264,0.9052232089053756,1.0,34/163,17.00%,THBS1;EZR;FN1;ANXA1;HDAC9;ANXA4;KLF4;TAX1BP1;INHBA;CMKLR1;PDCD4;MAVS;DDIT3;IL10;IKBKE;TLR4;RARA;IRAK3;OTUD7B;INHBB;HOMER2;ZC3H12A;IFIH1;PIBF1;NPLOC4;NPTN;RNF135;TLR8;ASB1;OTUD5;ACOD1;C5AR2;NLRP12;ABCD1
prerank,transport along microtubule (GO:0010970),0.4831731888863998,1.0121870605458974,0.4682926829268293,0.9049312045377075,1.0,7/13,21.78%,ARHGAP21;DYNC1I1;SPG11;BAG3;COPG1;CAMSAP3;CDC42
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.43477667796590064,1.0121706787061036,0.4421052631578947,0.9042872378613044,1.0,6/26,11.06%,INHBA;PTPN2;TLR4;RARA;CCL3;TCTA
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38648798537982254,1.0118373412084636,0.444015444015444,0.9044291717031666,1.0,3/57,1.06%,MAP3K5;CYFIP2;PERP
prerank,regulation of sister chromatid cohesion (GO:0007063),0.49468593608934264,1.0114520199718207,0.46337579617834396,0.9047545802292531,1.0,4/12,11.81%,HDAC8;DDX11;RB1;WAPL
prerank,organelle assembly (GO:0070925),0.33089511104992314,1.011148393357771,0.4698672114402451,0.904854131606332,1.0,115/384,24.02%,PKD1;BBS9;ABLIM3;EXOC4;MAPRE2;GSN;ULK2;PARVA;NEK7;RAB43;PDE6D;TMOD3;PTPDC1;DZIP1;WIPI2;ZFYVE1;HPS4;RAB11FIP3;BECN1;PDCD6IP;ARL3;ATG3;PCM1;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;CEP63;TMEM231;IFT46;DISC1;WDR35;RB1CC1;CDS1;EHD1;DYNC2I2;GALNT11;ARF4;CEP131;PRRC2C;ATXN2;NCOR1;EHD2;ABCC4;BIN2;VPS37A;CCDC66;TUBGCP6;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;MKS1;TUBGCP5;IST1;NUDCD3;IFT52;CEP89;HAUS2;CENPT;AMBRA1;KIF3B;DYNC2I1;FAM161A;TUBGCP4;VPS37B;GORASP2;TSG101;SMIM22;HYLS1;RBM14;EIF2S1;TEKT2;LZTFL1;RILPL1;ATG2A;INO80;CIRBP;SNF8;NEK6;IQCB1;WDR45B;FUZ;POC1B;CSNK1D;IFT80;DYNC2H1;RAB1A;YTHDF2;FLII;OFD1;CLUAP1;TRAF3IP1;HGS;UBAP2L;TRAPPC14;FLNA;ULK1;PLK4;BBS2;HAUS5;TRAPPC6A;TMEM237;DHX29;VTA1;STX12;POGZ;LSM4;MAK
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.37241777663093617,1.0108963832836866,0.44472681067344344,0.9047979818706741,1.0,13/67,10.86%,CYFIP2;PGF;PTK2B;ABI1;SULF1;VAV2;NRP1;NCK2;ITGAV;RHOA;NCKAP1;VEGFA;ITGB3
prerank,positive regulation of interferon-beta production (GO:0032728),0.4192876308137424,1.0108497152263345,0.4513788098693759,0.9042454469576091,1.0,11/33,18.01%,MAVS;POLR3D;RIPK2;IRF1;TLR4;IFIH1;DHX9;RNF135;TLR8;POLR3F;POLR3A
prerank,T cell mediated immunity (GO:0002456),0.4837560126278984,1.0107821658909133,0.4665551839464883,0.9037393271446972,1.0,4/13,8.82%,CD55;GNL1;JAG1;CD46
prerank,regulation of trophoblast cell migration (GO:1901163),0.46815738994699596,1.0106797153918863,0.4548611111111111,0.9033026836831807,1.0,4/14,16.06%,ARHGDIB;VEGFA;TIMP1;AGO2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4579653045995717,1.0105550638258245,0.4375,0.9022748283131149,1.0,9/21,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4579653045995717,1.0105550638258245,0.4375,0.9022748283131149,1.0,9/21,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,glycoprotein catabolic process (GO:0006516),-0.3970560803586754,-1.0102105424173435,0.44086021505376344,0.7874794549895728,1.0,4/17,12.53%,ADAMTS9;ADAMTS12;STT3B;CTSL
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4830902740342827,1.0100770030255064,0.46875,0.9027909732848082,1.0,2/13,7.10%,GAB2;KLRC2
prerank,negative regulation of neuron differentiation (GO:0045665),0.45006395575880004,1.0099847458667406,0.45297805642633227,0.9023509414117884,1.0,3/22,3.24%,SOX9;HES1;GSK3B
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.45364440612208806,1.0096754100329024,0.4624,0.9024693051509899,1.0,7/21,11.62%,IGFBP5;BMPR1A;FGF2;NR4A3;IL10;JUN;HTR1B
prerank,regulation of cholesterol transport (GO:0032374),-0.369226074460484,-1.0096526981836622,0.42735042735042733,0.7876497960487273,1.0,7/20,20.17%,ABCA5;NR1H3;NUS1;ABCB4;ABCA2;NR1H2;APOC1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5065405574656419,1.0093774389362005,0.4542372881355932,0.9019066195079062,1.0,2/10,8.98%,AP2A2;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5065405574656419,1.0093774389362005,0.4542372881355932,0.9019066195079062,1.0,2/10,8.98%,AP2A2;AP2A1
prerank,primary miRNA processing (GO:0031053),0.5135158504954904,1.0093396795177818,0.47758620689655173,0.9013326812674033,1.0,6/10,26.01%,SMAD2;DGCR8;PUS10;DROSHA;SRRT;HNRNPA2B1
prerank,response to hydroxyurea (GO:0072710),0.514216792730844,1.008982546936669,0.46503496503496505,0.9015872112706034,1.0,5/11,20.05%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.42185893280973874,1.0082193940247561,0.44696969696969696,0.9028323944419175,1.0,13/32,27.33%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;POLR1F;ERCC3;UBTF;ERCC2;RRN3;POLR1H;TAF1;GTF2H3
prerank,retrograde axonal transport (GO:0008090),0.474659943284902,1.0077057087890484,0.4533762057877814,0.9034584299372261,1.0,4/16,9.47%,PAFAH1B1;DLG2;KIF1C;FBXW11
prerank,glucose homeostasis (GO:0042593),0.36645058844249717,1.0075797862161733,0.45108005082592123,0.9031215264948282,1.0,18/83,13.93%,TCF7L2;LRRC8D;KCNB1;CRY2;IRS1;KLF7;FOXK1;PTPN2;STAT3;BACE2;MCU;SLC8B1;FOXK2;SELENOT;HNF1A;HNF4A;PAX6;ACSM2A
prerank,regulation of potassium ion transport (GO:0043266),0.4149778497074413,1.0074935862597791,0.4356589147286822,0.9026902895100866,1.0,3/31,1.67%,FHL1;ANK2;PTK2B
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4245452696559411,1.0071768981207145,0.4550641940085592,0.9027762860327079,1.0,2/29,2.06%,SLIT2;PRKCD
prerank,histone H4 acetylation (GO:0043967),0.4067482464971702,1.0070077331586131,0.47121820615796517,0.9025162290727122,1.0,27/47,28.08%,NAA40;TADA3;TRRAP;KANSL2;EP400;ZZZ3;BRCA2;PER1;KANSL3;KANSL1;EP300;HCFC1;MSL1;ATF2;EPC1;TRIM16;BRD8;PHF20;DMAP1;MCRS1;JADE2;OGT;ING3;HAT1;NAA60;MORF4L2;KMT2A
prerank,regulation of neuron migration (GO:2001222),-0.3514861101306868,-1.0069882065142601,0.4525316455696203,0.793170214519775,1.0,9/26,11.40%,SEMA6A;CTNNA2;RAPGEF2;NEXMIF;DAB2IP;ADGRG1;CAMK2A;MDK;CAMK2B
prerank,glycolipid metabolic process (GO:0006664),0.39331469966060484,1.0069041046819582,0.4507978723404255,0.9020833371512137,1.0,4/47,4.87%,ST3GAL4;ESYT3;HEXA;ESYT2
prerank,actin filament polymerization (GO:0030041),0.4276871823478728,1.00662905972355,0.45179856115107914,0.9021474774046656,1.0,7/29,12.98%,COBL;GSN;FAM107A;DIAPH1;WASHC5;MSRB2;PSTPIP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.43877846393676256,1.0066196076553624,0.4553846153846154,0.9015090035340031,1.0,7/21,21.25%,SMO;KIF7;EVC;ARMC9;TTC23;TEDC2;DLG5
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.45430167115992326,-1.006265151810675,0.4656319290465632,0.793781710257293,1.0,5/10,13.77%,NEXMIF;NOTCH1;NOTCH4;RGCC;PPM1F
prerank,neuron fate commitment (GO:0048663),0.48094596439412024,1.005834897220797,0.45234248788368336,0.9027947451767272,1.0,4/14,13.40%,TGFBR1;ISL1;ID2;PAX6
prerank,cellular response to cytokine stimulus (GO:0071345),0.32234609510104817,1.00559714672315,0.4842319430315361,0.9026992079892713,1.0,58/416,12.53%,STK39;F3;SLC12A2;DPYSL3;SOX9;LBP;PID1;WNK1;FN1;TANK;ANXA1;NFAT5;IL22RA1;FOXO3;PTGIS;GRB10;YBX3;SHC1;ITGB1;NFE2L2;GSK3B;FGF2;GAB2;SLC26A6;CLCF1;PTPN2;CD80;IRAK4;STAT3;SYNCRIP;IL10;IRF1;SOCS2;TLR4;CDKN1B;CXCL2;FOXC1;RORA;RHOA;CHUK;CTF1;NFKB1;SHPK;ERBIN;RBMX;IRAK3;IL18BP;VEGFA;USP10;IL20RB;CCL3;TIMP1;CCL1;PTPN9;IL5;TNFRSF1B;ZC3H12A;CSK
prerank,negative regulation of transport (GO:0051051),-0.3119607763781687,-1.0054325542801177,0.4434782608695652,0.7947719977960802,1.0,17/51,20.34%,PRKD1;MCTP1;DYSF;NR1H3;SIRPA;BST2;SYT11;CTTNBP2NL;SNCA;NDFIP2;PPM1F;RACK1;NR1H2;ERBB3;SNX3;PRTN3;NRG1
prerank,protein processing (GO:0016485),0.35822963203192326,1.0046653544795212,0.4587378640776699,0.904323555849868,1.0,19/102,15.41%,F3;PCSK5;DDI2;PRSS12;PHEX;MMP16;ASPRV1;XPNPEP3;MMP14;LONP2;ADAMTS3;YME1L1;TMPRSS2;OMA1;PITRM1;ECE1;PCSK7;PIDD1;ADAM10
prerank,cellular glucose homeostasis (GO:0001678),-0.3223935904277026,-1.0046029420562286,0.44673539518900346,0.795608827511192,1.0,9/41,7.99%,IGF1R;PIK3R1;FOXO1;ZBTB20;PRKAA2;HIF1A;PPARGC1A;ERN1;GAS6
prerank,nuclear pore complex assembly (GO:0051292),0.49886389160547967,1.004029969062473,0.4586709886547812,0.9051911224394019,1.0,5/10,22.21%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A
prerank,protein K48-linked deubiquitination (GO:0071108),0.4367526478625642,1.0039353971236884,0.46656760772659733,0.9047440665572851,1.0,8/23,16.50%,USP34;USP25;OTUD7B;USP33;BAP1;OTUD3;OTUD5;VCPIP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.42405717957257283,1.0036723708244069,0.4472511144130758,0.9047042785224738,1.0,11/29,21.59%,TANK;IKBKE;TLR4;UBE2D3;CHUK;IKBKG;TLR6;BIRC3;TRAF3;IRF3;LY96
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3373650212269117,1.0032736106120999,0.47019867549668876,0.9049958179311577,1.0,42/198,14.97%,PLCE1;TNFAIP8L3;PLPPR2;PPP3CA;PLPP3;ALPL;LIMK2;PLCB3;IP6K2;INPP4A;PLCZ1;PLA2G4F;ACP3;STAT3;PLA2G15;PFKFB2;PFKP;NUDT4;OCRL;PLCD3;PFKFB1;DUSP16;GPI;DUSP5;SHPK;PLCG2;TOP1;NUDT5;DUSP10;NADK;LCAT;MTOR;PPIP5K2;PPM1A;PAK2;AGK;SYNJ1;PLPP1;PLA2G2C;HTR2B;PLCD1;ACP4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4996238875419112,1.0031877032625371,0.4734133790737564,0.9045309468925196,1.0,2/11,7.25%,CAMK2D;CACNG6
prerank,protein sumoylation (GO:0016925),0.3911255366311782,1.0031403500475158,0.44413793103448274,0.9039842473171179,1.0,16/49,23.65%,NUP93;TRPM4;PIAS2;SAE1;PIAS3;EGR2;RANBP2;IFIH1;NUP153;NUP214;NUP188;NUP88;PIAS1;NUP98;AAAS;NUP54
prerank,regulation of protein autophosphorylation (GO:0031952),-0.32821449825446813,-1.0028057448497238,0.45918367346938777,0.7989070207332145,1.0,7/36,4.56%,ERRFI1;ENG;PDGFD;EPHA7;ENPP1;RAP2A;CALM1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.4416684057457223,1.0026652138499954,0.47345132743362833,0.9044708237514455,1.0,2/21,3.32%,FOXP1;ELF1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5087491707912044,1.0023319803476307,0.4782608695652174,0.9046059796503163,1.0,1/11,0.27%,THBS1
prerank,manganese ion transport (GO:0006828),-0.4053841034486242,-1.0021706826883008,0.44274809160305345,0.7992969074285328,1.0,6/14,8.88%,SLC30A10;TRPC3;SLC39A8;ATP2C1;TRPC4;TRPC6
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2977215749837068,-1.0018870680450631,0.4411764705882353,0.7987822611409447,1.0,15/54,19.47%,NSA2;RPL23A;RPL26;RPL35A;RPL11;SNU13;RPL7;NOC2L;RPL14;NPM1;RPL24;RPL10A;RPL3;RPL5;LAS1L
prerank,diol metabolic process (GO:0034311),-0.3766932145727889,-1.0016441325026275,0.4566929133858268,0.7981257742800869,1.0,9/19,21.19%,NOS3;DEGS2;CALM1;SPHK1;AKT1;GCH1;PLPP2;SPHK2;SGPP1
prerank,response to interleukin-6 (GO:0070741),0.5119483263549182,1.0015788747949363,0.48776223776223776,0.9057764449443322,1.0,3/10,9.30%,PID1;PTGIS;NFKB1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3944120490444616,-1.0014826006229771,0.4731182795698925,0.7972945025606634,1.0,6/16,10.31%,MCTP1;RIMS1;MCTP2;MEF2C;CAMK2A;SYN1
prerank,histone ubiquitination (GO:0016574),0.45932728160150027,1.000695614034447,0.4873323397913562,0.9072433299821894,1.0,10/21,28.99%,UBE2B;WAC;CTR9;USP22;UBE2N;RNF8;HUWE1;PAF1;RNF20;UBE2A
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.33672151023370883,-1.0005883299567813,0.43278688524590164,0.7983908277819152,1.0,9/31,20.70%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ATXN3;HSPA9
prerank,oligodendrocyte development (GO:0014003),-0.4029222882829597,-1.0001815383015507,0.47549019607843135,0.7982334908836206,1.0,10/15,33.98%,PLP1;CNTNAP1;MYRF;TPPP;SOX10;B4GALT5;B4GALT6;EIF2B1;EIF2B5;HES5
prerank,negative regulation of immune response (GO:0050777),-0.25462279758094253,-0.999559376301377,0.41904761904761906,0.7985829212196232,1.0,45/154,21.49%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;ENPP3;PRKACB;PRKAR1A;ADORA2A;CD300A;CYSLTR1;PTH1R;ADM;CYSLTR2;RAMP2;NMI;ADCY2;SAMSN1;PLCG1;TYRO3;HAVCR2;TRIM21;HCK;GPR176;ADCY4;LYAR;FCGR1A;PLK2;GGT1;RHBDF2;VIPR2;LHCGR;TNFAIP3;TSHR;SPI1;RXFP1;TREM2;SYK;TRIM27;CD163
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.49005820841664827,0.9995334972598331,0.4844827586206897,0.909407219279409,1.0,5/14,14.67%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.44605167911870386,0.9991968389679388,0.4818897637795276,0.909516539053291,1.0,11/20,32.29%,ADAM9;SPPL2A;NFKB1;ADAM10;MBTPS1;SPPL2B;TRAF6;TGFB1;ADAM17;MBTPS2;PSEN1
prerank,lipid transport (GO:0006869),0.35813431522969585,0.9980833375070705,0.47692307692307695,0.9115604105096758,1.0,12/97,8.62%,SLCO3A1;TNFAIP8L3;ABCD3;SLCO2A1;LBP;PITPNC1;PITPNA;SLC27A3;LDLR;SLC10A2;RXRA;ATP8B1
prerank,regulation of protein secretion (GO:0050708),0.3495100278254977,0.9974227814990233,0.47502903600464574,0.9125033419532267,1.0,15/119,7.50%,SLC12A2;CACNA1C;EZR;DISP1;TGFB3;ADAM9;KCNS3;KCNB1;BMP6;UNC13B;RAP1A;SYTL4;ITPR2;GOLPH3;P3H1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.35577441854146263,-0.9973745668052869,0.4380664652567976,0.8016669878315288,1.0,4/23,15.15%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.35577441854146263,-0.9973745668052869,0.4380664652567976,0.8016669878315288,1.0,4/23,15.15%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,retinal metabolic process (GO:0042574),0.48425561732779543,0.997268401194305,0.46256239600665555,0.9121950711635013,1.0,1/12,1.54%,CYP1B1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3229606569747834,-0.9971966235268553,0.47058823529411764,0.8008669490909623,1.0,6/35,8.16%,SASH1;PHLPP1;MFHAS1;DAB2IP;BMP2;SPHK1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.42715701395107464,-0.997150954126393,0.456575682382134,0.7997080062768159,1.0,2/12,6.87%,INSIG2;TAPT1
prerank,regulation of vasculogenesis (GO:2001212),-0.4036010265409343,-0.9968462627590714,0.4580152671755725,0.7992051123837354,1.0,4/14,7.41%,RAPGEF2;KDR;CD34;HEY2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4127653875145925,0.9968232696773457,0.4426705370101596,0.9126251823269855,1.0,7/30,15.73%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,proteasomal protein catabolic process (GO:0010498),0.3336419862516869,0.9966020786325138,0.48390557939914164,0.9125147610192809,1.0,36/201,17.11%,WWP1;NEDD4;UBE4B;WWP2;NFE2L2;DDI2;RNF185;VCP;UBE2B;KLHL22;DDIT3;TBL1X;PSMB2;RNF126;UBE2D3;FBXW11;FEM1B;RAD23B;PSMC6;PPP2R5C;SPSB2;MTA1;COP1;RNF122;SMURF1;PSMD11;CUL3;ERCC8;PSMD1;SPOP;PML;UBE2K;APPBP2;BFAR;PSMC1;PSMD7
prerank,peptidyl-tyrosine modification (GO:0018212),0.3765360616931206,0.9962249524397181,0.4601542416452442,0.9128014473527607,1.0,7/56,4.26%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,protein ubiquitination (GO:0016567),0.32398481584376726,0.9960110943519933,0.49138804457953394,0.9126618148521098,1.0,139/471,23.18%,FBXL7;WWP1;NEDD4;FBXO10;UBE4B;WWP2;NPEPPS;NFE2L2;RNF144A;RNF115;FBXO40;HERC2;RNF138;RNF185;VCP;FBXW8;UBE2B;KLHL22;ARIH1;MKRN3;UBR5;ATG3;HIF3A;RNF19A;TRIM44;PSMB2;BIRC6;FBXL20;CDC16;RNF114;TRIP12;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;RNF141;TRIM47;KLHL13;RNF126;UBE2D3;LRSAM1;FBXW11;UBE4A;TNKS2;COMMD1;UVSSA;PSMC6;WAC;TRIM41;TRIM7;TRIM26;USP7;TRIM55;FBXO17;RNF146;ASB11;RNF111;SPSB2;CBFB;UBE2Z;CTR9;RNF122;FBXO4;HERC6;PEX13;RNF168;ARIH2;ANKIB1;PRKDC;SMURF1;HECTD2;PSMD11;CUL3;ERCC8;UBE2S;PSMD1;RNF135;FANCL;CCDC22;SPOP;ASB1;TRIM39;UBE2K;SH3RF3;CHFR;MKRN1;BFAR;CUL1;VCPIP1;UHRF2;RNF14;UBE3C;OS9;PSMC1;PSMD7;BCL10;BARD1;MKRN2;DTX3;FBXL19;USP22;USP9X;FBXO25;TRIM25;FBXL8;GAN;RTF1;PSMD14;TSPAN17;TRIM35;UBE2N;UBE2W;FBXL4;RNF31;CNOT4;PSMD3;TRPC4AP;KLHL18;MIB1;NFX1;RNF8;DET1;HUWE1;PPIL2;CUL7;RBCK1;CUL4A;RMND5A;ANAPC11;FBXL17;PEX2;PAF1;ANKRD9;FBXW9;FBXO11;FBXO27;UBE2Q2;RNF166
prerank,positive regulation of viral genome replication (GO:0045070),-0.34598926261854523,-0.9956804309696152,0.42857142857142855,0.8009721454479514,1.0,11/29,19.04%,PPARA;TOP2B;PPIA;HACD3;NR5A2;ADARB1;TARBP2;IFIT1;ADAR;DDX3X;PPIE
prerank,positive regulation of superoxide anion generation (GO:0032930),0.47089118826330045,0.9954628689666714,0.47611202635914335,0.9133166311474991,1.0,1/13,2.06%,PRKCD
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3589051452126322,0.9954528704047375,0.47023086269744835,0.9126886441993822,1.0,17/86,12.84%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;CLU;TOGARAM1;AKAP9;NCKAP1;CTTN;KATNB1;RB1;SLAIN2;FCHSD2;FCHSD1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4937974520797796,0.9954330447497745,0.4802065404475043,0.9120772758139634,1.0,5/11,9.96%,TGFBR1;TGFBR2;GDF6;USP15;ACVR1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.35289437005024893,-0.9952028291820373,0.47604790419161674,0.8009005140789911,1.0,6/24,5.75%,VTN;EPN2;PRKCB;TMEM204;DAB2IP;HIF1A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.39613925843461806,0.9950427794238704,0.4633471645919779,0.9123101595927717,1.0,5/42,8.80%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,ethanol metabolic process (GO:0006067),0.4887896996813903,0.9949660673892289,0.46440677966101696,0.9118501180154875,1.0,2/12,4.55%,ADH7;SULT1A1
prerank,regulation of anoikis (GO:2000209),-0.38118378956723675,-0.9943288457600029,0.43360433604336046,0.8019152079941643,1.0,4/19,6.10%,TLE1;BCL2;NOTCH1;PTK2
prerank,mesenchyme morphogenesis (GO:0072132),0.46120236486715593,0.9942912789551325,0.48183254344391785,0.912821956494763,1.0,7/17,11.05%,SOX9;BMPR1A;NOG;ISL1;MDM4;ACVR1;SMAD2
prerank,response to muscle stretch (GO:0035994),0.4705161949643792,0.9939207713165451,0.4784688995215311,0.9130918507251574,1.0,4/15,8.86%,CSRP3;GSN;DMD;SLC9A1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.42605135995586607,-0.9938938193633916,0.5035799522673031,0.8018150771396791,1.0,4/12,26.92%,ANK3;SCN4B;NOS1;PKP2
prerank,endomembrane system organization (GO:0010256),0.3413545574357183,0.9937713078731036,0.5163398692810458,0.9127902893832025,1.0,62/178,24.44%,ARHGAP21;ATL3;GOLGB1;NUP93;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;RAB30;GAK;LMAN2L;GOLPH3;DOP1B;GBF1;CSNK1A1;SEC16A;ATP8B1;SUN3;WASHC5;PLEKHM2;SEC31A;SEC61A1;COG3;A4GALT;TLCD1;NPLOC4;TLCD2;SQSTM1;SEC23IP;TRIP11;HOOK3;TOR1B;GORASP2;ANXA8;ANXA8L1;LEMD2;BNIP1;ARFGEF1;AP3D1;TMCC1;ZW10;CSNK1D;DYNC2H1;RAB1A;HUWE1;TMED3;VPS51;WASHC4;PLEKHF1;CUL7;CDC42;TMEM170A;SUN2;HOOK2;EIF2AK3;SURF4;RNF26;PHETA2;ARL1;TRAPPC11
prerank,acylglycerol metabolic process (GO:0006639),-0.3234784947396519,-0.993509601852743,0.47619047619047616,0.8015677438110108,1.0,14/37,20.17%,APOE;DGKB;DGKI;GK;DGKD;ABHD12;DGKG;PGS1;DGAT1;LPL;PLAAT3;DGKE;DGKZ;APOC1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.44062926341769365,0.9933998271622415,0.4838709677419355,0.9130583286171428,1.0,7/23,13.41%,HDAC4;CLK2;PFKFB1;C1QTNF12;NCOR1;ERFE;EP300
prerank,negative regulation of synaptic transmission (GO:0050805),-0.36223326008107526,-0.9933848107984191,0.4550561797752809,0.8006333725814926,1.0,9/23,32.19%,SLC24A2;SYT11;SLC30A1;PLK2;MTMR2;ACHE;SLC24A1;DRD2;SHANK2
prerank,nervous system development (GO:0007399),0.3246055845011221,0.9930663069164425,0.5102040816326531,0.9131994267568939,1.0,55/429,10.33%,WWP1;CDH1;PCDHB16;CRIM1;DCLK1;MET;MBNL1;PKD1;ZIC4;HDAC4;NGF;PDGFC;RBFOX2;SMO;EFNA5;FN1;ZBTB16;HES1;GSN;INHBA;ZIC1;FGF13;FGF2;NOTCH2;ECRG4;GLRB;PMP22;NELL1;TGFBR1;NOG;GLIS2;STAT3;GDNF;JAG1;PCDHB13;NTN5;ELP3;DMBX1;SOX14;SNTG2;DAGLB;NBL1;TEAD1;NAGLU;GRHL2;PCDHB9;EGR2;PCDHB3;DACT1;NF1;BTBD3;ADGRG6;PCDHA1;NCKAP1;VEGFA
prerank,DNA dealkylation (GO:0035510),0.5070797725873997,0.9929471899320744,0.5053191489361702,0.912157054139152,1.0,2/10,4.65%,MPG;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5070797725873997,0.9929471899320744,0.5053191489361702,0.912157054139152,1.0,2/10,4.65%,MPG;FTO
prerank,regulation of wound healing (GO:0061041),0.39538650382858337,0.992429244638957,0.4810810810810811,0.9127583180487566,1.0,7/42,6.62%,CD109;ANXA1;ITGB1;FGF2;PRKCE;DMTN;SRSF6
prerank,establishment of protein localization to membrane (GO:0090150),0.3743633020071584,0.9923705247055766,0.4831168831168831,0.9122504418755127,1.0,20/66,20.74%,EGFR;NECTIN3;ATG3;ZDHHC11;RAB3GAP2;FRMPD1;PARD3;ZDHHC15;VPS37A;ZDHHC2;GOLGA7;ZDHHC20;SEC63;VPS37B;GORASP2;ZDHHC23;RABGEF1;ZDHHC12;NPC1;AFDN
prerank,regulation of chemokine production (GO:0032642),0.4030120000976015,0.9920723773649641,0.47391304347826085,0.9123100167976258,1.0,1/36,0.25%,FOXP1
prerank,regulation of interferon-gamma production (GO:0032649),-0.2815938303133805,-0.9919434482630217,0.44339622641509435,0.8030113840963213,1.0,16/71,17.26%,IL1R1;PDE4B;SLC7A5;CD47;SIRPA;PDE4D;IL18;GAS6;AXL;TLR7;TLR3;HAVCR2;NR1H4;VSIR;CD276;FZD5
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4191409310433074,-0.9919180788247475,0.4580335731414868,0.8018453106627788,1.0,4/11,23.30%,AGBL4;ICMT;LCMT1;ATG12
prerank,insulin secretion (GO:0030073),0.43858068275414797,0.9917763696064279,0.45977011494252873,0.9123613527381276,1.0,4/19,12.95%,ANXA1;CLTRN;SNX19;SELENOT
prerank,positive regulation of protein localization to membrane (GO:1905477),0.35219544466871927,0.9914875046730695,0.4982164090368609,0.9123815048358528,1.0,18/98,12.35%,EGFR;SORBS1;KCNB1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;AGR2;DLG1;C2CD5;ERBB2;RANGRF;MIEF1;ITGB1BP1;PPP3CC;PTPN9;CHP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32069531254333394,-0.9906283012228784,0.4691780821917808,0.8040034468008794,1.0,8/36,6.50%,BCL2;SGMS1;TPD52L1;DAPK2;PPIA;DAB2IP;RPS3;FAS
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3651293169861026,0.9906144584520995,0.464735516372796,0.9138383517342825,1.0,33/68,32.70%,POLR1G;MNAT1;SCAF8;POLR1A;TTF2;TAF1D;TAF1C;TTF1;LSM11;POLR1F;ERCC3;POLR3K;MAZ;PRMT5;FIP1L1;UBTF;NUDT21;ERCC2;CSTF1;CPSF7;CPSF3;POLR1H;CLP1;GTF2H3;CPSF4;NCBP2;POLR1C;CDK7;SMN1;CSTF3;CSTF2T;SSU72;MTERF2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4811932446980056,0.990423814794717,0.4863013698630137,0.9136584504526924,1.0,2/13,6.08%,CD44;KDM1A
prerank,regulation of hormone secretion (GO:0046883),0.4673203387222495,0.9903692426247106,0.48841059602649006,0.9131373218115155,1.0,1/15,1.98%,ANXA1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4153843445004537,0.9903021247941761,0.46153846153846156,0.9126376167666962,1.0,11/30,21.59%,TANK;IKBKE;TLR4;UBE2D3;CHUK;IKBKG;TLR6;BIRC3;TRAF3;IRF3;LY96
prerank,development of primary male sexual characteristics (GO:0046546),0.4160676274284032,0.9900889924414146,0.4890190336749634,0.9124936444752163,1.0,6/34,9.70%,SOX9;LHFPL2;INHBA;GATA4;SIX4;GATA1
prerank,cardiac muscle contraction (GO:0060048),0.4081046779462896,0.9900695435559909,0.47214076246334313,0.911887423517355,1.0,5/34,5.27%,ATP1B1;CAMK2D;CSRP3;GSN;DMD
prerank,Ras protein signal transduction (GO:0007265),0.33908149880025396,0.9894130893216154,0.47398843930635837,0.9128261654293723,1.0,23/137,10.17%,PLCE1;NTN1;CDC42EP5;CCNA2;ARHGDIB;NRAS;KRAS;MRAS;SHC1;FGF2;AGTR1;RAP1A;SHOC2;SHTN1;RAPGEF6;RAP2C;G3BP2;RHOA;ARHGAP5;GNA13;NF1;JUN;NCKAP1
prerank,embryonic hemopoiesis (GO:0035162),-0.4178459509372434,-0.989174123685792,0.46318289786223277,0.8065272563259371,1.0,5/12,17.01%,KIT;KDR;TAL1;SH2B3;FLT3LG
prerank,error-prone translesion synthesis (GO:0042276),0.43974953985488213,0.9884761860170069,0.46808510638297873,0.9144043442604307,1.0,9/21,28.48%,REV3L;POLE2;RPA1;RFC1;REV1;RFC5;POLK;POLI;PRIMPOL
prerank,glycoprotein biosynthetic process (GO:0009101),0.35732592777255917,0.9884413607338243,0.4726609963547995,0.9138348577283697,1.0,20/79,17.58%,ST3GAL4;B3GNT2;CHST13;LARGE1;FOXL1;GCNT2;XYLT1;GOLPH3;MPI;B3GALT6;CHST11;COG3;MGAT1;TNIP1;ST3GAL2;DDOST;CHST12;B3GNT9;ST8SIA2;GAL3ST4
prerank,detection of visible light (GO:0009584),0.4602225525801905,0.987986535096792,0.46286701208981,0.914287015431039,1.0,2/16,7.26%,RP1;CACNA1F
prerank,keratan sulfate metabolic process (GO:0042339),0.4165663540435356,0.9879780269941844,0.4985835694050991,0.9136588881735731,1.0,5/31,6.43%,ST3GAL4;B3GNT2;HEXA;CHST5;B4GALT1
prerank,carboxylic acid catabolic process (GO:0046395),0.4890725235647284,0.9879046931046677,0.49566724436741766,0.9131755991303718,1.0,3/12,12.24%,PON3;ACOT8;RENBP
prerank,positive regulation of actin nucleation (GO:0051127),0.48758027269738724,0.9879020674007283,0.48756218905472637,0.9125396066582357,1.0,6/11,25.40%,GSN;NCKAP1;FCHSD2;WHAMM;BRK1;CYFIP1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4519789278102918,0.9875915095915102,0.49085365853658536,0.9126767759510648,1.0,2/21,4.22%,GUCY2C;ADCY9
prerank,positive regulation of glucose metabolic process (GO:0010907),0.47326795445646497,0.987569772665986,0.49206349206349204,0.9120882060019904,1.0,3/14,8.31%,IRS1;PTPN2;NNMT
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4637619509095706,0.9872502875874813,0.4828711256117455,0.9122687093743748,1.0,3/17,10.04%,ANK2;SNTA1;AKAP9
prerank,negative regulation of developmental process (GO:0051093),0.3666854736641222,0.987147149979867,0.48692403486924035,0.9118664135758767,1.0,5/69,3.88%,BMP4;NFIB;SOX9;WNT11;KLF7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4093852389150023,0.9869095907809979,0.48755490483162517,0.9117762290416936,1.0,6/30,5.85%,NGF;STK19;SHC1;NOTCH2;SHOC2;ITGAV
prerank,bile acid metabolic process (GO:0008206),-0.34259848458599645,-0.9867154504354066,0.4659090909090909,0.8115704090127566,1.0,7/27,20.37%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.40053014645975715,-0.9866820090920868,0.4693333333333333,0.8103799259272996,1.0,8/14,19.98%,ADGRV1;WNT5A;DGKD;DGKG;FLT4;CD40;MYADM;SPHK2
prerank,regulation of mRNA catabolic process (GO:0061013),0.3488651653545636,0.9866332496134682,0.5005740528128588,0.9117775226443876,1.0,33/121,20.96%,SAMD4A;PRKCD;EIF4G1;XPO1;PSMB2;PKP1;MOV10;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;PABPC1;EXOSC7;ZC3H12A;PUM2;PSMD11;PSMD1;CNOT7;MAPKAPK2;DCP1A;PRKCA;PUM1;NUP214;PSMC1;PSMD7;EXOSC1;DHX36;FXR2;PSMD14;FMR1;PSMD3;YTHDF2
prerank,protein mannosylation (GO:0035268),0.4322597118343658,0.9866292356291082,0.46986089644513135,0.9111471104944383,1.0,6/22,15.85%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4655335905452497,0.9865945257290992,0.4958813838550247,0.9105949422650884,1.0,2/13,5.02%,SIX1;ZBTB7B
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.34304235503276137,-0.9865504938947217,0.5014492753623189,0.8094646985114845,1.0,5/25,9.40%,ITPR1;CDH13;RIT2;MAPT;PLEK
prerank,regulation of cellular response to heat (GO:1900034),0.36421554182089094,0.9864202935999853,0.4643765903307888,0.9103906814622678,1.0,21/77,17.95%,CAMK2D;GSK3B;NUP93;CREBBP;HSPA1L;MLST8;RANBP2;ATM;HSPB8;CHORDC1;SEC13;NUP153;MTOR;EP300;BAG3;MAPKAPK2;NUP214;RPA1;NUP188;NUP88;ATR
prerank,myoblast fusion (GO:0007520),0.4838508153248655,0.9859572760420977,0.4763572679509632,0.9108527888457857,1.0,3/12,6.39%,CD9;ADAM12;ADAMTS5
prerank,amyloid fibril formation (GO:1990000),-0.2968165133044891,-0.9858963496001067,0.48333333333333334,0.8099336103758404,1.0,11/51,13.12%,B2M;HSPG2;TSPAN5;CST3;ITM2B;APP;SNCA;MAPT;UBC;APH1B;MFGE8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2811963714820864,-0.9856988186587853,0.48717948717948717,0.8091854576392816,1.0,14/63,15.05%,BCL2;VCAM1;TFRC;MEF2C;VAV3;CD81;CD38;IL18;IL6ST;MIF;CCL19;CD74;CD40;JAK3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4905682972343897,0.9852340596511041,0.4991482112436116,0.9119143187543267,1.0,1/11,1.08%,SCARA3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5090618525082179,0.9850795667045764,0.5052447552447552,0.9116411553699864,1.0,2/10,5.99%,DSE;XYLT1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2649617226574932,-0.9848658570581383,0.5113636363636364,0.8101152145263729,1.0,16/94,13.84%,PLCB1;IL1R1;RPS6KA5;PELI2;ST18;NOD1;BTRC;TNIP2;UBC;PSMB4;IRAK2;PSMB3;MAPK3;PSMB8;PSME2;PSMB10
prerank,histone H2B ubiquitination (GO:0033523),0.506772341549275,0.9848416799038028,0.4819277108433735,0.9115494530825828,1.0,6/10,31.53%,WAC;CTR9;RNF8;PAF1;RNF20;DTX3L
prerank,protein heterotetramerization (GO:0051290),0.4780622307848629,0.9845209920402525,0.4819672131147541,0.9116729858297481,1.0,1/13,1.11%,PKD1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4387366329018709,0.9845078264113953,0.4658753709198813,0.9110628812580425,1.0,5/20,10.91%,LBP;PRKCE;TLR4;MTDH;CCL3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3873021548978914,-0.9844776226038096,0.4779220779220779,0.8098428693013447,1.0,6/16,19.74%,SLC30A10;PPARA;ABCB7;ASXL3;ABCD2;GPER1
prerank,DNA modification (GO:0006304),0.4401852098887912,0.9843276093439847,0.5,0.9108498595507304,1.0,9/22,29.28%,MPG;SMUG1;NEIL3;PARP3;TDG;MBD4;PARP2;EXOSC4;ACD
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.43750110993109437,0.9842347738672556,0.46337579617834396,0.9104261064713528,1.0,2/22,1.55%,ANK2;ATP1B1
prerank,regulation of organelle assembly (GO:1902115),0.3667637374413887,0.9840958709681609,0.5049261083743842,0.9101022267781428,1.0,23/72,20.37%,EZR;GSN;RABEP2;NPRL3;PDCD6IP;ATG3;RDX;KIF9;SPICE1;TBC1D2B;TBC1D13;ATXN2;TBC1D10A;STIL;TBC1D5;SDCCAG8;SGSM3;TSG101;TBC1D17;ODAD3;CEP295NL;NPRL2;RAB5A
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.39847280168713356,0.9838845239328764,0.4868238557558946,0.9099591187028446,1.0,8/36,8.47%,TCF7L2;PPP3CA;WNT11;PLCB3;PDE6A;MOV10;TNRC6C;NLK
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3273259950419065,-0.9838079974127689,0.4861111111111111,0.8103097492596674,1.0,11/33,15.05%,TGFA;DGKD;CCDC88A;ADRA2A;AFAP1L2;HIP1R;HBEGF;HIP1;CNOT9;AGT;AKT1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4903947140766501,0.9835813357500319,0.5016835016835017,0.9100333108880728,1.0,3/12,12.46%,MCM7;MCM2;CDC45
prerank,regulation of cellular component organization (GO:0051128),0.34114514877038105,0.9833844909374153,0.4908256880733945,0.9098687555507957,1.0,28/135,15.51%,PLCE1;SNCAIP;MLLT3;NEDD4;CAMK2D;STON1;ABL1;FAM107A;STON2;AGTR1;RAP1A;SGK3;LTBP4;SOCS2;ANGPTL7;RUFY1;AURKA;DCUN1D5;IRAK3;SNX12;MTOR;SETD5;HCFC1;BAP1;CDK11B;URI1;ARFGAP1;RAB4B
prerank,positive regulation of DNA binding (GO:0043388),0.41834938876744426,0.9831105265022998,0.49473684210526314,0.9098836491969889,1.0,9/31,18.72%,NGF;HES1;SKI;FOXC1;NIBAN2;RB1;TWIST1;EGF;PPARG
prerank,positive regulation of biosynthetic process (GO:0009891),0.39296591716591833,0.9828996125360286,0.4654696132596685,0.9097584237222875,1.0,3/40,2.90%,BMP4;TGFB3;SORBS1
prerank,proton transmembrane transport (GO:1902600),-0.32102980367237843,-0.9827681375328269,0.46557377049180326,0.8117423505022728,1.0,1/36,0.02%,ATP1A2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.47348950249223154,0.9827444956220703,0.4796084828711256,0.9095200728504783,1.0,4/13,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,cochlea morphogenesis (GO:0090103),0.49665456078077747,0.9826531784832522,0.493891797556719,0.9090931116067195,1.0,1/10,1.12%,SOX9
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.43821670814974995,-0.9824012158723499,0.49271844660194175,0.8113945992613796,1.0,3/10,14.44%,PRKCH;ETV4;MED1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.385512387413888,0.9823912816221544,0.4796195652173913,0.9090796768269697,1.0,8/50,15.40%,NXN;ABL1;HDAC8;U2AF2;USP4;CHP1;GTPBP4;SQSTM1
prerank,ribosome assembly (GO:0042255),-0.2998661778058407,-0.9822667390022963,0.49606299212598426,0.8104847504226877,1.0,14/47,18.86%,RPS14;RPS19;RPS5;RPS15;RPS27;RPL23A;RPL11;NPM1;RPL24;MRPS11;RPL3;RPS28;DDX3X;RPL5
prerank,prostaglandin metabolic process (GO:0006693),-0.34248575017681226,-0.981960676324949,0.4970588235294118,0.810011592237455,1.0,9/26,18.15%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;PTGES3;PTGS2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.31275285994863483,-0.9819486778517906,0.503448275862069,0.8088209880090098,1.0,10/37,14.71%,MFHAS1;PPP1R16B;CALM1;PPIA;YWHAB;TIPRL;PPP2R5A;HSP90B1;CALM3;SMPD1
prerank,DNA damage checkpoint signaling (GO:0000077),0.41867770537180843,0.9818826280115156,0.475968992248062,0.9096632655501682,1.0,11/28,20.84%,CHEK2;RAD17;CEP63;ATM;CLSPN;CHEK1;HINFP;USP28;NBN;ATR;E2F1
prerank,plasma membrane organization (GO:0007009),0.37164640550204364,0.9817909657620625,0.4897172236503856,0.9092471689330807,1.0,15/61,15.12%,AHNAK2;ANK2;DMKN;ANO6;SYTL4;PLSCR1;NSF;EHD2;BIN2;A4GALT;CAVIN2;PLSCR3;TLCD1;CXCR4;TLCD2
prerank,positive regulation of JNK cascade (GO:0046330),0.36034347739827993,0.9815043178786582,0.48350253807106597,0.9093127619628412,1.0,6/70,5.60%,RASSF2;MAP3K5;PTK2B;FZD7;GADD45G;WNT16
prerank,positive regulation of dendritic spine development (GO:0060999),-0.36334859304745304,-0.9814487296085029,0.5,0.8088664681891313,1.0,5/20,12.18%,SHANK3;APOE;LRP8;CAMK2B;CUX2
prerank,nuclear export (GO:0051168),0.35801565664674323,0.9810322633034932,0.48064918851435706,0.9097627436499723,1.0,26/80,19.88%,PKD1;XPO1;SRSF11;THOC2;SRSF5;SRSF6;EGR2;U2AF2;STRADA;DESI1;CHP1;NUP153;SRRM1;SMURF1;CASC3;CHTOP;NUP214;NUP188;XPO4;U2AF1L4;ZC3H11A;THOC5;NXF1;SRSF2;NUTF2;RAN
prerank,water transport (GO:0006833),-0.41704973844867743,-0.9809960428501803,0.48905109489051096,0.8088840317506281,1.0,2/12,7.73%,AQP11;AQP4
prerank,mRNA splice site selection (GO:0006376),0.40848600834326365,0.9809452187469103,0.4863636363636364,0.909328770560213,1.0,5/30,7.37%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.43489318906730984,-0.9807383714287081,0.4855769230769231,0.808345403789873,1.0,4/10,16.29%,LYN;GHR;JAK3;STAT5B
prerank,regulation of interferon-beta production (GO:0032648),0.3836029920414393,0.9807201050856963,0.48365122615803813,0.9092326977258874,1.0,15/46,19.31%,MAVS;POLR3D;RIPK2;IRF1;REL;TLR4;IFIH1;DHX9;RNF135;TLR8;YY1;POLR3F;POLR3A;PTPRS;TRAF3
prerank,glycerolipid metabolic process (GO:0046486),0.4852323920336432,0.9802988570681402,0.49734513274336284,0.9095864186088395,1.0,4/11,6.88%,PNPLA3;PIP5K1A;PLA2G15;DGKA
prerank,axoneme assembly (GO:0035082),0.40827667533019596,0.9802858899116837,0.4693572496263079,0.9089900670815202,1.0,5/30,10.85%,RP1;DNAAF3;TOGARAM1;SPAG17;CCDC40
prerank,telomere maintenance via recombination (GO:0000722),0.48052234129271254,0.9802817895308408,0.48403361344537815,0.9083709055726843,1.0,5/11,21.84%,SMC5;RAD51;ERCC1;SMC6;RAD50
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37454221619986156,0.9801383552215971,0.48704663212435234,0.9081147315399024,1.0,19/52,26.27%,SAMD4A;PAN3;EXOSC7;TUT7;CNOT7;DCP1A;TUT4;EXOSC1;TNKS1BP1;LSM2;PNLDC1;CNOT4;CNOT11;SAMD4B;CNOT3;LSM4;EDC3;RC3H2;PARN
prerank,mRNA 3'-end processing (GO:0031124),0.3562467906375841,0.9797105448652151,0.50375,0.9084954246457723,1.0,32/78,28.97%,SRSF11;THOC2;SRSF5;SRSF6;SCAF8;U2AF2;PABPC1;SRRM1;LSM11;CASC3;CHTOP;U2AF1L4;ZC3H11A;THOC5;SRSF2;TENT2;PAF1;FIP1L1;NUDT21;CDC40;CSTF1;CPSF7;UPF3B;RBM8A;CPSF3;ALYREF;SRSF3;CLP1;SRSF7;CPSF4;NCBP2;CPSF4L
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.315806945709436,0.9796706436257719,0.5385395537525355,0.9079522120550065,1.0,52/390,9.06%,EGFR;ARHGEF28;MET;CYFIP2;NTRK3;NGF;PGF;PDGFC;RBFOX2;PTK2B;EFNA5;ABI1;DDR2;SIPA1L1;SULF1;GRB10;ADRB2;VAV2;UBASH3B;FGFR1;SORBS1;SHC1;ATP6V0A4;GSK3B;FGF2;IRS1;FOXC2;AP2A2;POLR1G;NRP1;SPRED2;SLC39A14;NR4A3;SHOC2;PTPN2;NCK2;NFATC4;FRK;ITGAV;STAT3;RHOQ;IDE;FLRT2;EPHB3;HNRNPH1;SOCS2;PDGFA;BCAR3;FOXC1;ROR1;AP2A1;RHOA
prerank,positive regulation of signaling (GO:0023056),-0.3177988192572671,-0.9793887415289909,0.5050505050505051,0.8105309004103136,1.0,8/37,10.34%,WLS;RIMS1;GRIK2;RIMS2;SNCA;EDN1;SYT1;INPP5F
prerank,regulation of lamellipodium organization (GO:1902743),0.4676377785650415,0.9793229526160847,0.49432739059967584,0.9081432299997839,1.0,2/14,6.54%,CD44;DMTN
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2854990008677573,-0.9788084668108169,0.45614035087719296,0.8107560583205851,1.0,4/59,2.54%,ALDH1A2;CYP7B1;CYP27A1;GATM
prerank,regulation of T cell cytokine production (GO:0002724),0.46044221853108985,0.9787101077272238,0.505654281098546,0.9089584789935851,1.0,2/15,4.96%,CD55;TRPM4
prerank,dephosphorylation (GO:0016311),0.33636670194931495,0.9785002999763954,0.5131428571428571,0.9087954999320474,1.0,30/147,15.49%,PLPPR2;PTPN3;PPP3CA;PTPRU;PLPP3;ALPL;PPM1H;PTPRF;ACP3;PTPRA;PTPN21;DUSP16;DUSP11;DUSP5;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PPP5C;PPP3CC;PTPN9;ILKAP;PPM1A;DAPP1;PPP4R2;PLPP1;SBF1;ACP4;PPP4R1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4071448128254469,0.978038645886788,0.5022156573116692,0.9092834640655755,1.0,3/33,4.70%,EZR;UBASH3A;PTPN2
prerank,response to peptide (GO:1901652),0.4030000382779539,0.9780242446491167,0.5035460992907801,0.9086967047450879,1.0,9/33,20.86%,ANXA1;IRS1;STAT3;ERBIN;STAT5A;EIF2B2;STAT6;STAT4;EIF2B3
prerank,negative regulation of chemokine production (GO:0032682),-0.3960531421634824,-0.9776570963476691,0.5177664974619289,0.8124412598158219,1.0,3/14,6.45%,APOD;SIRPA;C1QTNF3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.32737014100597356,-0.9776136501783567,0.4766666666666667,0.8113339377850544,1.0,5/32,9.44%,CDK14;CDK17;TFDP2;CDK15;BACH1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.400928517506306,0.9775935938440476,0.4888268156424581,0.9090495464907601,1.0,3/36,5.13%,EGFR;NPR3;ATP2B4
prerank,GTP metabolic process (GO:0046039),0.461466017798122,0.9775841539446718,0.48111658456486045,0.9084488160332443,1.0,5/15,19.88%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,diacylglycerol metabolic process (GO:0046339),0.42985007889255805,0.9773954486930422,0.5044642857142857,0.9082640001100448,1.0,3/23,6.88%,PLCE1;PLA2G15;DGKA
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.32074091882007627,-0.9771615895475745,0.48534201954397393,0.8112664412023958,1.0,4/32,2.11%,AUTS2;PIK3R1;ENPP2;OCLN
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.34025842962128333,-0.9769975410543973,0.4984894259818731,0.8104157041663093,1.0,5/29,6.81%,RPS14;RPS21;RPS19;RPS8;RPS16
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3222328663393831,-0.9767655201049612,0.45980707395498394,0.8097555231882273,1.0,6/32,12.13%,DEFA6;PGLYRP1;RPS19;RPL30;GAPDH;RPL39
prerank,glycoprotein metabolic process (GO:0009100),0.37638699765684036,0.9767636718491237,0.4857142857142857,0.9091178747876607,1.0,19/53,20.30%,ST3GAL4;FUT8;LARGE1;GOLPH3;FBXO17;PRKCSH;MAN2A1;GANC;TNIP1;ST3GAL2;OGA;ST8SIA2;HPSE;GAL3ST4;MAN2B1;GANAB;ENGASE;B4GALT7;B3GNT6
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4427431773958714,0.976583253828685,0.4951923076923077,0.908939242112105,1.0,4/18,8.82%,ITGB8;FN1;ITGAV;CD46
prerank,translational termination (GO:0006415),0.34518322234411514,0.9764638737935615,0.4850657108721625,0.908577141515424,1.0,39/95,30.78%,MRPL33;MRPL48;MRRF;ETF1;MRPS27;GSPT1;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;ABCE1;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.38343172598263786,-0.9762864829702408,0.47619047619047616,0.8096988989741418,1.0,3/17,12.01%,BCL2;BCL2L1;BOK
prerank,camera-type eye morphogenesis (GO:0048593),0.4957159370474621,0.9758829587010484,0.4919786096256685,0.909334068124473,1.0,4/10,10.33%,LRP6;SKI;NF1;VEGFA
prerank,regulation of axonogenesis (GO:0050770),0.3801142173428428,0.9758007485168506,0.5033377837116155,0.9089056080951395,1.0,8/51,9.06%,SLIT2;NGF;SIPA1L1;GSK3B;TIAM2;EPHB3;MARK2;RHOA
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3449502843815927,0.9754225129704328,0.4923258559622196,0.9091544484314166,1.0,12/100,6.03%,EGFR;NTRK3;SOX9;NEDD4;PDGFC;FN1;FGFR1;FGF2;PIK3AP1;BECN1;WNT16;PIP5K1A
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4009416368082823,-0.9752183141017617,0.515625,0.8111489773078498,1.0,4/14,6.79%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.503986407908104,0.9743597873198104,0.5325542570951586,0.9109549376791543,1.0,2/10,3.62%,PRKCE;IRS1
prerank,protein alkylation (GO:0008213),0.4278154450055376,0.973593211407204,0.500780031201248,0.9121019207891611,1.0,11/22,28.13%,PRMT8;ETF1;GSPT1;PCMT1;METTL22;ETFBKMT;EEF1AKMT1;METTL21A;PRMT2;METTL21C;FAM98A
prerank,glycogen catabolic process (GO:0005980),0.45044843471110585,0.9735695532608595,0.49503311258278143,0.911532872646552,1.0,4/15,9.97%,PYGB;PHKA2;PHKB;RB1CC1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.40733991618176635,-0.9734627501677662,0.47858942065491183,0.8144843491050325,1.0,2/13,5.81%,EPS8;EPS8L2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3392266863435978,-0.9732784419939378,0.4883720930232558,0.813745653100531,1.0,5/24,12.10%,LPGAT1;CDS2;GPAM;PNPLA8;PGS1
prerank,negative regulation of angiogenesis (GO:0016525),0.3587385636291754,0.9731269506288521,0.5083532219570406,0.9119253752452935,1.0,8/84,5.13%,THBS1;SLC12A2;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,peptidyl-lysine methylation (GO:0018022),0.4167069394306083,0.9729313095234646,0.4984984984984985,0.9117685008915439,1.0,10/26,25.98%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;SETD6;METTL21C
prerank,dicarboxylic acid metabolic process (GO:0043648),0.38205273263869427,0.9727479921210576,0.5020632737276479,0.9115794110199648,1.0,10/52,19.44%,ME1;GCLC;ACOT8;FPGS;FOLR2;OGDH;NIT2;SLC19A1;SLC25A32;D2HGDH
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3459975323895814,-0.9726941305386263,0.5058823529411764,0.8140471848530367,1.0,8/24,18.17%,NR1H3;BCL2L1;AQP11;TMBIM6;RACK1;NR1H2;SELENOS;XBP1
prerank,innate immune response in mucosa (GO:0002227),-0.4388334932672962,-0.972666986088238,0.4823529411764706,0.8129046026998328,1.0,7/10,43.29%,DEFA6;RPL39;NOS2;CAMP;BPIFB1;DEFB1;LTF
prerank,cellular copper ion homeostasis (GO:0006878),-0.39526331609961385,-0.9724963826475994,0.5149253731343284,0.812133474502876,1.0,7/14,25.95%,APP;ATOX1;SLC31A1;MT2A;ATP7A;COX19;ABCB6
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.47813726495803877,0.9724570875192122,0.5177664974619289,0.9116582862200636,1.0,3/13,5.60%,CD9;ITGB1;LDLR
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.35708030496006343,0.972320517541789,0.5025,0.9113294285547406,1.0,6/75,4.42%,PLCE1;GRK5;MGLL;MRAP;SLC39A14;PDE6A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.26903936790693334,-0.9722198256647483,0.5082872928176796,0.8116114535993889,1.0,12/90,7.60%,LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;PRDM16;GJA1;PPARGC1A;ELOVL6;IL18
prerank,positive regulation of neurogenesis (GO:0050769),0.3659207108048749,0.9721369021430698,0.5115089514066496,0.9111156939986904,1.0,10/68,11.55%,SLIT2;NGF;CUX1;TIAM2;FBXW8;KDM1A;RHOA;DISC1;VEGFA;TIAM1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4717736377005211,0.9719494412664708,0.49838187702265374,0.9109409176773942,1.0,6/13,17.77%,BMP5;NFKB1;DKK3;ERLIN1;REST;CYP27B1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4140795571712512,0.9717141999048315,0.5066864784546805,0.9108619298691284,1.0,12/27,25.91%,TAB3;IRAK4;TLR4;IRAK3;MYD88;TNIP1;TLR1;TLR6;LY96;MAP3K7;TRAF6;CD36
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3696534195852656,-0.9716531854032766,0.4962962962962963,0.8118195528816486,1.0,5/19,9.16%,TJP1;NEXMIF;NOTCH1;NOTCH4;RGCC
prerank,photoreceptor cell development (GO:0042461),0.46137566819224524,0.9715351356416874,0.5033557046979866,0.9106320953115743,1.0,3/14,10.33%,RP1;ARL3;VEGFA
prerank,glycolytic process (GO:0006096),-0.3372348210598725,-0.9711215557547406,0.49244712990936557,0.8119175080851909,1.0,11/28,20.88%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;PFKM;ALDOA;ENO2;ENO1;PFKL
prerank,regulation of small molecule metabolic process (GO:0062012),-0.33415206596670133,-0.9710247100523405,0.461038961038961,0.8109903169273449,1.0,3/28,2.98%,APOE;PPARA;PDK1
prerank,hepaticobiliary system development (GO:0061008),0.44040034754389884,0.9707657277784628,0.5198019801980198,0.9118205765440606,1.0,2/20,1.25%,MET;COBL
prerank,chromatin remodeling (GO:0006338),0.34521976550517,0.9705942054677509,0.5211608222490931,0.9116065313104805,1.0,27/100,19.09%,SOX9;HDAC4;ESR1;MYSM1;SRCAP;CHD1L;BAZ2B;TOP1;NUDT5;RB1;BPTF;KAT2A;SMARCA4;BAZ1A;ATRX;PBRM1;CHD3;HCFC1;KDM4D;ZBTB1;BAZ2A;KAT2B;ZBTB7A;EZH1;SMARCA5;INO80;SMARCC1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.4037021256724157,-0.9704695313181252,0.5318627450980392,0.8111350415507804,1.0,5/13,15.03%,IL18;GAS6;AXL;LAMP1;TYROBP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4416486298217713,0.9699553378763535,0.49833333333333335,0.9124522141706003,1.0,5/17,9.76%,SPRED2;EIF4G1;DMTN;PARD3;PPEF2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.40251011255614866,-0.9699421002510332,0.5194174757281553,0.8113291571137793,1.0,4/13,6.24%,PPARA;NOS3;TMSB4X;PPARGC1A
prerank,regulation of inflammatory response (GO:0050727),0.3249008540039661,0.9698352419872766,0.5365591397849462,0.9120958880665357,1.0,28/190,12.34%,FOXP1;CCN3;MGLL;ANXA1;PRKCD;GPR4;PTGIS;KLF4;PIK3AP1;AGTR1;PDCD4;PTPN2;IL17RA;ISL1;IFI35;IL10;CELF1;DAGLB;TLR4;RORA;SHPK;NLRP6;IL33;CCL3;RB1;CCL1;MYD88;TNFRSF1B
prerank,phosphorylation (GO:0016310),0.31434861250237245,0.9697548397132004,0.5907692307692308,0.9116686692045535,1.0,77/385,15.49%,STK39;DCLK1;MAP3K5;GRK5;MARK1;PTK2B;CAMK2D;WNK1;WNT11;PRKCD;STK19;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ABL1;BCR;TGFBR1;CLK2;MKNK2;TGFBR2;SGK3;FRK;CDK12;STAT3;CDC25B;BIRC6;DGKA;FAM20A;MARK2;IKBKE;CHEK2;CSNK1A1;NLK;CHUK;AAK1;SHPK;AURKA;SIK3;RARA;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;STRADA;ERBB2;MORC3;MAST2;NADK;CDKL2;CSK;PDK3;MTOR;CHEK1;PKN2;PAK2;PRKDC;AGK;CSNK1E;ERN2;CDC42BPG;DYRK2;EIF2AK4;HTR2B;CDK11B;MAPKAPK2;PRKCA;CDK16;ADAM10;PPP4R1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3429741136278175,-0.9696851408501884,0.48546511627906974,0.8108317039084842,1.0,2/23,7.99%,IGF1;GAS6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.42557188312093297,0.969655273812344,0.5047318611987381,0.9112832834054863,1.0,5/20,13.41%,SMAD9;NFE2L2;VEGFA;CARF;EP300
prerank,protein glycosylation (GO:0006486),0.3351724124696281,0.9695729539299928,0.5257611241217799,0.910871163855856,1.0,30/125,20.54%,ST3GAL4;MGAT4C;FUT8;PLOD2;B3GNT2;LARGE1;GCNT2;MGAT3;B4GALT1;MPI;COG3;B4GAT1;DPM1;LARGE2;MGAT1;ST3GAL2;DDOST;POMGNT2;OGA;TMEM165;B3GNT9;ST8SIA2;ALG12;POFUT1;TUSC3;GFPT1;MGAT5;B4GALT7;B3GNT6;NPC1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4362911141650281,0.9695495954393409,0.509493670886076,0.9103185371236859,1.0,3/20,4.43%,BMP4;TGFBR1;PDCD4
prerank,regulation of neuroblast proliferation (GO:1902692),0.4465377800188768,0.969172690198435,0.5130718954248366,0.9106131558163788,1.0,4/15,10.33%,KDM1A;DISC1;NF1;VEGFA
prerank,positive regulation of hormone secretion (GO:0046887),-0.3627784171404706,-0.9691590240161126,0.5083798882681564,0.8109854236549147,1.0,3/17,8.69%,C1QTNF3;SPP1;EDN1
prerank,nucleotide-excision repair (GO:0006289),0.3451640759760839,0.9688125018490183,0.52,0.91080555951341,1.0,30/101,25.71%,MNAT1;ERCC5;CHD1L;COMMD1;RAD23B;UVSSA;SLC30A9;BRCA2;COPS7B;USP7;RNF111;COPS5;SLX4;EP300;ERCC8;POLB;ERCC3;XPA;RPA1;ERCC1;RFC1;POLA1;POLD3;CUL4A;RFC5;BRIP1;ERCC2;COPS3;POLK;XPC
prerank,regulation of neuron differentiation (GO:0045664),0.3545696967434392,0.9688011794651961,0.5229244114002478,0.9102220327201542,1.0,6/76,2.89%,ZFHX3;SIX1;VWC2;NGF;HES1;FGFR1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3503758633994053,0.9687685977074922,0.5054021608643458,0.9096810768234888,1.0,21/84,19.31%,SCARA3;LBP;PIK3AP1;TAB3;IRAK4;RIPK2;TLR4;UBE2D3;CHUK;PLCG2;IRAK3;MYD88;TNIP1;TLR1;MAPKAPK2;TLR8;IKBKG;BCL10;TLR6;BIRC3;TRAF3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4238533586017584,0.9687303489897341,0.5189274447949527,0.9091485028712687,1.0,9/22,23.24%,WDR43;ERBB2;DDX11;SMARCA4;MTOR;NOL11;WDR75;EIF2AK3;UBTF
prerank,myeloid cell differentiation (GO:0030099),-0.2980152675988201,-0.9684078619347467,0.476,0.8116855987425168,1.0,7/47,8.33%,LYN;MFHAS1;KIT;SNRK;RPS14;RPS19;TAL1
prerank,protein secretion (GO:0009306),0.3704379923730901,0.9681347192076766,0.512258064516129,0.9098539692523866,1.0,6/56,9.15%,PCSK5;ANXA1;TANGO6;LTBP2;GOLPH3;SNX19
prerank,glycosaminoglycan catabolic process (GO:0006027),0.37203000439840406,0.9679108380070514,0.5065104166666666,0.9097529252646367,1.0,15/55,14.95%,GPC6;GPC3;CD44;FGF2;HEXA;SPAM1;ARSB;NAGLU;GPC4;SLC9A1;SGSH;GLB1;CHP1;IDUA;SDC4
prerank,cellular response to amino acid starvation (GO:0034198),0.3549478072585645,0.9678948459570775,0.501891551071879,0.9091790035864428,1.0,22/71,20.10%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;EIF2S1;SZT2;CDKN1A;RHEB;ATP6V1H;NPRL2;MAPK8
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3269259558757491,-0.9677884253400469,0.49491525423728816,0.8120330514795381,1.0,8/31,17.80%,BCL2;TFDP2;HIP1R;YWHAB;BOK;GSK3A;PPP3R1;CHCHD10
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.333787889012078,-0.9675167330675339,0.5045592705167173,0.8115334549575337,1.0,9/26,20.27%,APOE;HIF1A;NOS1AP;NUS1;SCARB1;AKT1;GCH1;ATP7A;CDH3
prerank,negative regulation of bone mineralization (GO:0030502),0.45149602281371215,0.9669743577735603,0.4950980392156863,0.9105986717614014,1.0,3/13,10.91%,PTK2B;TRPM4;CCL3
prerank,ear morphogenesis (GO:0042471),0.4399138950654945,0.9665850179831916,0.5242718446601942,0.9108774563136142,1.0,3/20,5.48%,SIX1;ZIC1;NOG
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.32589768884570675,-0.9665758552673211,0.5015105740181269,0.8126275083559733,1.0,12/29,28.37%,NR1H3;DBI;PNPLA8;TMEM86B;NR1H2;PLAAT3;PLA2G4C;PLA2G5;PLA2G4E;PLBD1;PLB1;LPCAT3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4477268061787421,0.9665648165293057,0.49836065573770494,0.9103171045246407,1.0,7/15,22.79%,PLCG2;DDRGK1;CUL3;DYRK3;KLHL18;PAF1;ATAD5
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4170763432327844,0.9664096093724104,0.49165402124430957,0.9100699226128964,1.0,2/25,2.70%,EXT1;B3GNT2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.41299072025985945,-0.9663216265312138,0.5171568627450981,0.8120685265678971,1.0,6/12,14.44%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,mitotic nuclear division (GO:0140014),0.35947281962674504,0.9661666689976782,0.5158428390367554,0.9100210592492199,1.0,23/71,22.77%,SMC4;NDEL1;KLHL22;MISP;PPP2R2D;CHEK2;TOGARAM1;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;UBE2S;STAG2;KIF3B;KNSTRN;INO80;ZW10;RAN;STAG1;OFD1;FLNA;AAAS
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.35864006430728246,0.9661115100413236,0.5261780104712042,0.9095371152474501,1.0,13/69,9.79%,PLCE1;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1;PLCD3;RHOA;NF1;PI4KB
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.38002509734971246,0.9657511571254423,0.5046854082998661,0.909744469731298,1.0,8/46,6.81%,TMEFF2;FN1;PARVA;SRGAP2;NRP1;ANTXR1;ITGAV;EPHB3
prerank,limb development (GO:0060173),0.4047761751967832,0.9656357750280229,0.4962962962962963,0.9093746598015572,1.0,4/28,5.48%,PCSK5;GLI3;SMOC1;NOG
prerank,mitotic DNA replication (GO:1902969),0.4953065771022905,0.9656236283623134,0.5,0.9087892395812238,1.0,4/10,20.73%,MCM2;CDC45;GINS3;POLA1
prerank,cellular protein localization (GO:0034613),0.31936180158475275,0.9655250878016594,0.5672268907563025,0.9084102078265662,1.0,59/285,16.57%,EGFR;ANK2;CSRP3;PTPRU;WNT11;SGSM2;KIF13A;CNTLN;TLK1;STX11;ID1;RAB43;TMED5;RAB6A;HERC2;WIPI2;AP3B1;STX5;VCL;DMD;RIC3;GRTP1;ARF3;RRAGB;NSF;RAB3GAP2;AP2A1;EIF2D;STX8;EHD1;CTTN;ARF4;TBC1D2B;TBC1D13;ZDHHC15;COPA;STX19;TBC1D25;SEC31A;USP4;NIPBL;ARCN1;COG3;SEC13;SMURF1;TBC1D10A;NPHP1;RAB24;ARFIP1;TBC1D8B;PIGU;GGA2;ARFIP2;TBC1D5;ARFGAP3;SAR1B;SEC23IP;SGSM3;SNX31
prerank,regulation of insulin secretion (GO:0050796),0.3424382854123016,0.96551156477383,0.533175355450237,0.907842065983981,1.0,16/101,11.41%,CCN3;TCF7L2;CACNA1C;EFNA5;KCNS3;KCNB1;IRS1;RAP1A;ISL1;ITPR2;AACS;MCU;LRP5;CAPN10;INHBB;SLC8B1
prerank,leukotriene biosynthetic process (GO:0019370),-0.388904064350934,-0.9651442367460705,0.49740932642487046,0.8138014031920247,1.0,7/14,26.40%,GGT5;LTA4H;GGT1;GGT7;PLA2G5;ALOX5AP;MGST3
prerank,glucose metabolic process (GO:0006006),-0.27696584606930474,-0.9650733705305685,0.5039370078740157,0.8128370437163165,1.0,17/58,21.63%,APOD;RBP4;PPARD;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;AKR1A1;ENO1;DCXR;SLC25A11;SLC25A13
prerank,cellular response to lipid (GO:0071396),0.32608483249655557,0.9650309596477584,0.5348837209302325,0.9083227207683789,1.0,32/191,12.85%,EGFR;WNT9A;SOX9;PTK2B;LBP;PID1;ADAM9;WNT11;FZD7;IRS1;PDCD4;CD80;ESR1;MYOG;IL10;LCOR;TLR4;CXCL2;ATP1A3;ATP1A1;RORA;RHOA;NFKB1;SHPK;ATM;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;PDK3;CTR9
prerank,negative regulation of protein binding (GO:0032091),0.3535524467739883,0.9647404964111553,0.5171537484116899,0.9084012891401848,1.0,15/71,13.46%,PRKCD;ADRB2;GSK3B;LRPAP1;PTPRF;KDM1A;SLPI;DISC1;AURKA;DACT1;DDX11;ITGB1BP1;USP33;CARD16;CSNK1E
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.44648705986359644,0.9645198238965096,0.4948453608247423,0.9083022148537808,1.0,4/17,8.46%,TGFB3;PDCD4;IL10;CDKN1B
prerank,regulation of biomineral tissue development (GO:0070167),0.40684376757359814,0.9643383611953711,0.5276532137518685,0.9081104355758916,1.0,4/26,4.55%,SOX9;DDR2;SGMS2;TXLNG
prerank,apical protein localization (GO:0045176),-0.447279707867502,-0.9641870179933691,0.5294117647058824,0.8137212199367412,1.0,4/10,5.95%,SHROOM2;ACTB;MAL;JAM3
prerank,skeletal muscle contraction (GO:0003009),-0.36834046217041394,-0.9641512291326011,0.5186170212765957,0.8126259240946684,1.0,8/19,32.40%,RCSD1;STAC;MYH14;STAC2;CCDC78;TCAP;TNNI2;STAC3
prerank,cellular response to nitrogen compound (GO:1901699),0.4384533948691568,0.9639847106333852,0.5023547880690737,0.9082645827643826,1.0,5/20,12.88%,DDI2;ATP2B4;DDX11;SPIDR;ATRX
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25196314514980017,-0.9639834145972396,0.5256410256410257,0.8118605850059972,1.0,15/109,10.48%,PLCB1;INPP4B;PIK3R1;PDGFRB;PIP5K1B;LPGAT1;INPP5D;PLEKHA2;PIK3C2A;PIK3R6;BMX;PLEK;PTPN13;INPP5F;MTMR10
prerank,regulation of secretion (GO:0051046),-0.39330106533130593,-0.9637951589349028,0.4918918918918919,0.8111727513518651,1.0,4/13,8.64%,MYO6;SGK1;OAS2;KCNQ1
prerank,response to amino acid starvation (GO:1990928),0.35418574230211086,0.963783839261308,0.5088383838383839,0.9081403855014989,1.0,22/72,20.10%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;EIF2S1;SZT2;CDKN1A;RHEB;ATP6V1H;NPRL2;MAPK8
prerank,Rho protein signal transduction (GO:0007266),0.37064838200170136,0.9637170500498705,0.520694259012016,0.9077040808424957,1.0,9/53,9.40%,NTN1;CDC42EP5;RHOJ;ARHGDIB;AGTR1;SHTN1;RHOA;ARHGAP5;GNA13
prerank,cyclooxygenase pathway (GO:0019371),-0.42385005613299986,-0.9636212612216379,0.5095238095238095,0.8104196030629884,1.0,6/10,18.15%,PTGDS;PTGS1;HPGDS;CBR1;PTGES3;PTGS2
prerank,calcium ion homeostasis (GO:0055074),0.34284452080721145,0.963606391108863,0.5325153374233129,0.9073540855197872,1.0,15/95,11.41%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;ATP2B4;STIM2;SLC10A7;CASR;FAM20A;TNNI3;DRD3;CCL3;CCL1;SLC8B1
prerank,protein complex oligomerization (GO:0051259),0.3534295770594249,0.9634817499079164,0.5217391304347826,0.907068980861474,1.0,22/85,17.17%,LRRC8D;ATL3;TMEM120A;ATL2;MPP2;PDCD6IP;EHD3;FUS;G3BP2;SLC9A1;PRMT8;RBMX;EHD1;MCU;CUTC;ZC3H12A;YME1L1;RNF135;HOMER1;ZBTB1;JMJD6;BCL10
prerank,response to UV-B (GO:0010224),-0.40752289865280533,-0.962896085784415,0.5265700483091788,0.8110479653846794,1.0,6/12,29.85%,CRIP1;MFAP4;MME;HYAL2;RELA;IL12A
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.30933800095870523,-0.9628303310439664,0.5091575091575091,0.8100445608212012,1.0,10/39,17.23%,MYO1B;PPFIA2;FNBP1L;MYO6;MYO5A;BICDL1;ACTN4;KIF1A;MYO5C;MYO1F
prerank,regulation of cell-substrate adhesion (GO:0010810),0.38364039690790175,0.9627922071026018,0.4932249322493225,0.9080226454814173,1.0,9/42,12.07%,VIT;FZD7;GCNT2;DMTN;AGR2;RHOA;NF1;LIMS1;CORO1C
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.39294333032652845,0.962574902882893,0.5206258890469416,0.9079243442893699,1.0,8/39,12.61%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126;ERBB2;EPS15L1
prerank,intraciliary retrograde transport (GO:0035721),0.4696162838774888,0.9624854095244354,0.5035087719298246,0.9075539216548334,1.0,8/12,31.02%,WDR35;DYNC2I2;DYNC2I1;DYNC2H1;TTC21A;IFT43;TTC21B;IFT122
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.35079385954302383,-0.9624562008805868,0.4826666666666667,0.8098138340213742,1.0,4/22,3.76%,CACNA1D;GRM3;ADGRV1;CAP2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.33375644437789015,-0.962434593470969,0.5238095238095238,0.8087153489178608,1.0,5/29,4.82%,APOE;PPARA;LPGAT1;NR1H3;ZBTB20
prerank,mitochondrion transport along microtubule (GO:0047497),-0.39371678102653673,-0.9623041768697222,0.5070754716981132,0.807901626071004,1.0,2/13,8.12%,HIF1A;MAPT
prerank,GPI anchor biosynthetic process (GO:0006506),0.40418947254500615,0.9622896322997666,0.5188953488372093,0.9074068400491316,1.0,14/30,26.58%,PGAP2;PIGB;DPM1;PIGU;GPAA1;PIGL;PIGN;PIGT;PIGH;PGAP3;PIGQ;MPPE1;PIGA;PIGK
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41643273226661004,0.9621614334804386,0.5065885797950219,0.9071082936350604,1.0,4/26,6.43%,ST3GAL4;B3GNT2;CHST5;B4GALT1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.46788554953488426,0.9617453486508588,0.5188356164383562,0.9074368562188904,1.0,3/12,16.61%,PAICS;PFAS;GMPS
prerank,regulation of postsynapse organization (GO:0099175),-0.33593751759776685,-0.9617283753395673,0.5016077170418006,0.8081327542093047,1.0,11/28,17.42%,IL1RAPL1;SHANK3;PPFIA2;WNT5A;EPHA4;CFL1;ABI3;ARHGAP22;KIF1A;CDKL5;ABHD17C
prerank,electron transport chain (GO:0022900),-0.38776466321661857,-0.9614678613825038,0.48412698412698413,0.8075677362753708,1.0,4/15,11.64%,SDHA;PPARGC1A;PDIA5;CYB561
prerank,negative regulation of gene expression (GO:0010629),0.31726761652034446,0.961448618219438,0.5658031088082901,0.9074900405667651,1.0,60/302,16.23%,FOXP1;BMP4;SLC24A3;SAMD4A;ITGB8;SMO;HDAC9;IGFBP5;WWP2;KLF4;BMPR1A;ZNF148;FGF2;NOTCH2;PAIP2;ATP2B4;ESR1;SYNCRIP;IL10;CELF1;MOV10;ID2;TNRC6C;DXO;REL;ATOH8;CD46;NFKB1;AURKA;TOB1;VEGFA;NCOR1;SMCR8;CCL3;EED;RB1;RBMS3;SNX12;ZC3H12A;DDRGK1;ANXA7;NCOR2;ZC3H12D;REST;NPTN;DNMT3A;SUZ12;CNOT7;CREB3L1;ASB1;MAP2K2;ADAM10;HINFP;EPC1;NUDT12;DIS3L2;KAT2B;AGO2;CPNE1;XDH
prerank,dendritic spine morphogenesis (GO:0060997),-0.38692659029845883,-0.96131749713871,0.5094339622641509,0.8068008366489732,1.0,3/15,3.14%,DOCK10;SHANK3;EPHB1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.47735872333556884,0.9613049830966229,0.5188216039279869,0.9072281636675921,1.0,2/12,7.18%,TRPM4;CLTRN
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4515072410765114,0.9613003210490622,0.5031948881789138,0.9066463957243172,1.0,9/15,35.69%,ZC3H12A;ZC3H12D;ZC3H12C;LACTB2;ZC3H12B;DICER1;NYNRIN;RNASEH1;POP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.42814917284780063,0.9612000223944484,0.5332348596750369,0.906269662970189,1.0,2/24,1.67%,PKD1;PTK2B
prerank,positive regulation of protein deacetylation (GO:0090312),0.4562703633144698,0.9602831434218027,0.5276381909547738,0.9077122868597747,1.0,6/14,23.60%,ZBTB7B;NNMT;NIPBL;SAP30BP;AKAP8L;BRMS1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.41019419496867887,0.9602704614766407,0.516320474777448,0.9071510662407609,1.0,4/27,9.47%,MAP3K5;CHUK;NFKB1;FBXW11
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.38735881483813295,0.9600436111279014,0.5245664739884393,0.9070825865430511,1.0,9/36,15.73%,FHIT;GIPC1;F8A1;USP25;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,protein modification process (GO:0036211),0.3552368048030235,0.9594523481625896,0.5314861460957179,0.9078400069487128,1.0,31/76,25.10%,PLOD2;WWP2;ABL1;PHKA2;PHEX;ATG3;TGM3;CSNK1G3;UBE2D3;RIPK3;USP25;YES1;PRKDC;PPP4R2;BAP1;UBE2S;TGM1;GNMT;ST8SIA2;LOX;MAN2B1;TGM5;B4GALT7;PARP4;UBE2M;FBXO11;PIGH;GGCX;MCRS1;DUSP12;FBXW2
prerank,regulation of pH (GO:0006885),0.4793793646339777,0.9590513299523441,0.5279187817258884,0.9081301855862052,1.0,3/11,8.86%,ATP6V0A4;ATP1A4;SLC9A1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.44938813343100037,0.9582558276923855,0.5173553719008265,0.9092894781895307,1.0,7/16,19.22%,FOXK1;RORA;FOXK2;PDK3;GNB3;SCARB2;ADIPOR1
prerank,aerobic respiration (GO:0009060),-0.3512812464505821,-0.9581834900329302,0.5322128851540616,0.813456613267558,1.0,10/20,30.52%,UQCRH;UQCR10;ME3;ATP5F1D;MTFR2;UQCRC1;UQCRB;SDHC;BLOC1S1;UQCRC2
prerank,telomere maintenance (GO:0000723),0.37193814647888485,0.9580592690844845,0.5201560468140443,0.9091343784805951,1.0,16/50,21.97%,STN1;WRN;ATM;APEX1;SMC5;PRKDC;XRCC5;RPA1;NBN;RAD51;ATR;PARP3;SMC6;POLD3;RAD50;TEN1
prerank,cellular response to ionizing radiation (GO:0071479),0.3748300450531156,0.957994058378521,0.5121621621621621,0.9087051562192223,1.0,14/47,18.45%,TANK;KDM1A;WRN;ATM;SPIDR;NIPBL;XRCC5;KDM4D;TLK2;CDKN1A;RAD51;ATR;TNKS1BP1;INO80
prerank,cellular response to UV (GO:0034644),0.35731586070721233,0.9579128116310608,0.5166240409207161,0.9082893554753506,1.0,20/76,18.45%,NEDD4;PRKCD;CREBBP;KDM1A;TIMP1;USP47;CARD16;CHEK1;EP300;EIF2AK4;ZBTB1;XPA;YY1;USP28;EIF2S1;CDKN1A;ERCC1;ATR;DHX36;INO80
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3473871117403058,-0.9577720301540624,0.5164179104477612,0.8133378090234091,1.0,6/24,15.92%,AGBL4;TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,mitotic spindle assembly (GO:0090307),0.3764657651924319,0.957729615893882,0.5189340813464236,0.9081027414889796,1.0,14/42,22.77%,MISP;CHEK2;TOGARAM1;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;STAG2;KIF3B;STAG1;OFD1;FLNA;AAAS
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4698751274486288,0.9575310833534383,0.5119453924914675,0.9079474677916618,1.0,4/12,27.59%,FDX1;STARD3NL;AKR1B1;STAR
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.417569773880222,-0.9574337892680043,0.5299760191846523,0.812997235779824,1.0,4/10,18.51%,LPGAT1;NR1H3;NR1H2;ABCD2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3668179369613146,0.9573498964527706,0.531496062992126,0.9065591920521807,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,COPII vesicle coating (GO:0048208),0.3668179369613146,0.9573498964527706,0.531496062992126,0.9065591920521807,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,vesicle coating (GO:0006901),0.3668179369613146,0.9573498964527706,0.531496062992126,0.9065591920521807,1.0,24/61,21.04%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3922334423831978,-0.9571634459691055,0.5092592592592593,0.8124695532440182,1.0,2/13,2.14%,GRM3;ADGRV1
prerank,lymphocyte chemotaxis (GO:0048247),0.38983896624225167,0.957080714066853,0.5300699300699301,0.9065651261828224,1.0,1/34,0.48%,SLC12A2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3599341444523588,0.9569470062827077,0.5320754716981132,0.9062954581283508,1.0,9/69,7.86%,SIX1;NGF;PTK2B;TGFB3;CLCF1;NFATC4;ISL1;GDNF;SIX4
prerank,cell cycle G2/M phase transition (GO:0044839),0.33231120665772484,0.9569271067055056,0.5495915985997666,0.9057426441253037,1.0,18/129,10.57%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;CEP63;AURKA;FBXW11;AKAP9;PPP1R12A;CEP131;FBXL6
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.42167057822654963,0.9548259449637264,0.5161290322580645,0.9086666989404227,1.0,8/20,25.13%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.42167057822654963,0.9548259449637264,0.5161290322580645,0.9086666989404227,1.0,8/20,25.13%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.42167057822654963,0.9548259449637264,0.5161290322580645,0.9086666989404227,1.0,8/20,25.13%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,cell chemotaxis (GO:0060326),0.35515350209420404,0.954600999528368,0.5243741765480896,0.9085510209408018,1.0,7/60,6.03%,CCN3;PRKCD;PARVA;NRP1;AGTR1;DEFB130A;PIP5K1A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3231192480216292,0.9545720165919214,0.5647840531561462,0.908035452526333,1.0,53/184,24.76%,FZR1;PKD1;ANAPC5;SFI1;PAFAH1B1;PCM1;PSMB2;CDC16;ID2;CEP164;ANAPC16;CDC14A;CEP63;AURKA;AKAP9;PSMC6;CEP131;CSNK1E;PSMD11;CUL3;UBE2S;PSMD1;SDCCAG8;ERCC3;CEP43;HAUS2;CUL1;MAD2L1;CEP57;PSMC1;PSMD7;INO80;CEP70;NEK6;PSMD14;ZW10;CSNK1D;PSMD3;KLHL18;E2F1;OFD1;ANAPC11;ANAPC10;PLK4;CDK2;CCNB1;HAUS5;RIOK2;CNTRL;CDC20;ERCC2;BUB3;PSMD12
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.41814260088864064,-0.9545601961997215,0.5420560747663551,0.8175878408729181,1.0,2/11,1.94%,SLC30A10;PPARA
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.35501521530506713,0.9543438147043579,0.5431472081218274,0.9079666159015927,1.0,8/72,6.97%,RBFOX2;FGFR1;FGF2;SPRED2;SHOC2;NOG;FLRT2;HNRNPH1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4497647846505217,0.9542448426197823,0.5263157894736842,0.9076096218267031,1.0,3/13,15.84%,PTGIS;NNMT;NUDT12
prerank,regulation of defense response (GO:0031347),0.34989951170825834,0.9537550275964836,0.5272277227722773,0.9081320076645409,1.0,12/76,11.93%,FOXP1;MGLL;ANXA1;PIK3AP1;AGTR1;CELF1;IRF1;DAGLB;SHPK;NLRP6;ERAP1;MYD88
prerank,modified amino acid transport (GO:0072337),-0.3819572119837855,-0.9537055371767366,0.521505376344086,0.818507660949166,1.0,2/15,0.29%,SLC6A13;SLC16A12
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.44153592938663205,0.9536862112243416,0.5297029702970297,0.9076983781201868,1.0,8/16,30.86%,PAICS;AMPD3;PFAS;GMPS;AMPD2;ADSS2;NUDT2;ATIC
prerank,negative regulation of cyclase activity (GO:0031280),-0.3868232124362231,-0.9536663113598679,0.514018691588785,0.8174371779371254,1.0,2/14,2.14%,GRM3;ADGRV1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3728675014626403,0.9535769442467037,0.517426273458445,0.9073409099719368,1.0,10/47,12.52%,SIX1;ZBTB16;CMKLR1;TRPM4;ZBTB7B;ID2;CDS1;SYAP1;LRP5;ZC3H12A
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.43308701468220445,0.9535688088529904,0.5299684542586751,0.9067686097851647,1.0,3/20,6.40%,MET;MRAP;ADA
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3727654218678819,0.9534803937395486,0.5384615384615384,0.9063901513974438,1.0,17/48,20.84%,HIPK1;ABL1;IKBKE;CHEK2;ATM;CDIP1;TNFRSF1B;PRKDC;EP300;DYRK2;PML;CASP2;USP28;MOAP1;SNW1;MCL1;E2F1
prerank,mRNA destabilization (GO:0061157),0.3847504490370348,0.9521734822941259,0.5378266850068776,0.9087078900281508,1.0,16/38,26.47%,FTO;CELF1;MOV10;ZC3H12A;ZC3H12D;TUT7;PUM1;DIS3L2;TUT4;DHX36;YTHDF2;TARDBP;ROCK1;YTHDF3;RC3H2;MEX3D
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3305503299481594,0.9520117296869606,0.5545134818288394,0.9084774833751185,1.0,18/128,10.57%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;CEP63;AURKA;FBXW11;AKAP9;PPP1R12A;CEP131;FBXL6
prerank,negative regulation of stem cell differentiation (GO:2000737),0.47267570832446504,0.9514763650220373,0.5258764607679466,0.909031637903738,1.0,3/12,14.21%,HES1;JAG1;REST
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3780444553072514,-0.9514148791725672,0.5177664974619289,0.821745408775325,1.0,5/15,10.42%,AEBP1;TIE1;NOTCH1;EFEMP2;FGFR4
prerank,response to unfolded protein (GO:0006986),-0.2913504761930745,-0.9512697936687964,0.5122950819672131,0.8209567419225396,1.0,13/48,20.70%,HSPA8;DAB2IP;OPTN;ERN1;HSP90AB1;STT3B;TMBIM6;HSPA13;DNAJB5;PACRG;HSPB1;HSPE1;HSPA9
prerank,mitotic recombination (GO:0006312),0.4463508474299712,0.9511983537272003,0.5212418300653595,0.9090705705024871,1.0,6/15,21.84%,SMC5;RAD52;RAD51;ERCC1;SMC6;RAD50
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4078011743946113,0.9504951494927614,0.5223880597014925,0.9100079346203592,1.0,6/25,13.30%,FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,ketone body metabolic process (GO:1902224),0.47997022834746916,0.9504437565189021,0.5526315789473685,0.9095389975097617,1.0,2/10,7.70%,BDH2;AACS
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4560011474793046,0.9503564856289566,0.5015873015873016,0.9091451622351083,1.0,5/13,16.06%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4453115086170455,0.9501378017141623,0.5132013201320133,0.9090303639692688,1.0,3/14,9.88%,ANXA1;CD80;RARA
prerank,synapse organization (GO:0050808),0.32894076567470887,0.9501041358609443,0.5533869115958668,0.908523758945413,1.0,9/125,3.84%,CDH1;PCDHB16;GPC6;CTNND2;NEDD4;SEMA3E;UNC13B;CAST;PTPRF
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4412699345919912,0.9499467972239062,0.5133858267716536,0.9082919946207275,1.0,3/16,5.24%,MRAP;SLC39A14;ACP3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4084956420414362,-0.9497366564967656,0.5345268542199488,0.8235863091032318,1.0,5/10,23.96%,ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5MC3
prerank,regulation of gene silencing by RNA (GO:0060966),0.36805575939363655,0.9497047296150603,0.5258964143426295,0.9076642545829204,1.0,16/50,23.65%,NUP93;EIF4G1;RANBP2;SEC13;NUP153;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.36805575939363655,0.9497047296150603,0.5258964143426295,0.9076642545829204,1.0,16/50,23.65%,NUP93;EIF4G1;RANBP2;SEC13;NUP153;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,response to lipopolysaccharide (GO:0032496),0.3286497479705878,0.949525914659241,0.5489313835770528,0.9074917952299779,1.0,28/138,17.77%,FOXP1;LBP;ADAM9;SMAD6;PDCD4;CD80;SLPI;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;ERBIN;IRAK3;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9;MAPKAPK2;OTUD5;ACOD1;SBNO2;BCL10;PALM3;CYP27B1
prerank,positive regulation of cellular process (GO:0048522),0.3069880825069537,0.9493582139749199,0.6242424242424243,0.9072685661584499,1.0,74/565,11.81%,EGFR;THBS1;BMP4;ACER3;ZFHX3;GRK5;NTRK3;SOX9;BMP5;HDAC4;LRP6;PGF;PPP3CA;PDGFC;PTK2B;LBP;TGFB3;FN1;PRKCD;HES1;KRAS;FGFR1;SHC1;BMP6;FGF2;FZD7;GAB2;IRS1;LMNA;GAREM1;TGFBR1;CLCF1;EIF4G1;TRPM4;TGFBR2;GCNT2;KLHL22;ISL1;ITGAV;GDNF;LRP1;BAMBI;PTHLH;RIPK2;CDC25B;CELF1;P2RX2;PDGFA;TLR4;CDKN1B;P2RX4;CHRD;CTF1;RAB25;EGR2;MMP14;PARD3;BCLAF1;RARA;HILPDA;ATM;PROK2;VEGFA;CEP131;MVD;LRP5;ERBB2;SMC5;TIMP1;CAPN10;USP47;TIAM1;ITGB1BP1;FGF22
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3845894681939076,0.9491806409035587,0.5240793201133145,0.9070667991147304,1.0,18/36,26.54%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;E2F1;E2F6;MGA;YAF2;PCGF6;RBBP4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3365872362107021,-0.9485457771687608,0.5188679245283019,0.8253030658287035,1.0,6/25,10.81%,TMTC2;ANK3;SLC8A1;SNCA;GRIN1;JPH2
prerank,inositol phosphate metabolic process (GO:0043647),0.37653488104574406,0.9481970878416071,0.5271966527196653,0.9086774234760089,1.0,10/46,9.84%,PLCE1;PLCB3;FGF2;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,histone H4-K16 acetylation (GO:0043984),0.4353112503952145,0.9479743764402793,0.5449010654490106,0.9085754787643969,1.0,10/19,28.08%,KANSL2;KANSL3;KANSL1;HCFC1;MSL1;PHF20;MCRS1;JADE2;OGT;KMT2A
prerank,organelle organization (GO:0006996),0.3093577808311481,0.9476835567952904,0.6369230769230769,0.9086229415044846,1.0,56/388,13.09%,MICAL2;PLCE1;ABCD3;FMNL2;MARK1;ARHGAP21;ARHGAP10;STRIP2;ATL3;CXADR;VPS13C;PNPLA3;GOLGB1;DIAPH1;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;PDCD6IP;RAB30;TMEM135;GAK;LMAN2L;GOLPH3;DOP1B;DMTN;GBF1;GABPB1;CSNK1A1;KIF9;FGD6;SEC16A;ATP8B1;VPS13D;PCLO;PLEKHM2;HILPDA;NRF1;SPRYD3;CCL3;LONP2;MAST2;MTX2;ZMYM4;SH3D19;MTFR1;SEC31A;SEC61A1;WDR81;COG3;MTX3;ZRANB1;PPRC1;YME1L1
prerank,mononuclear cell differentiation (GO:1903131),0.4063724134979124,0.9475446057450879,0.5153374233128835,0.9083574564942023,1.0,1/24,0.28%,BMP4
prerank,spliceosomal complex assembly (GO:0000245),0.36715359811648657,0.9474668044304022,0.5357624831309041,0.9079484990253536,1.0,19/46,28.17%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3;SCAF11;GCFC2;SF3B1;SRPK1;DDX1;NOL3;RBM5;TXNL4A;LUC7L;CELF4;SRPK2;SNRNP200;PRPF6;KHDC4
prerank,UV-damage excision repair (GO:0070914),0.47691697534278865,0.9473349779335962,0.5283333333333333,0.9076666395549381,1.0,6/12,25.71%,XPA;ERCC1;INO80;POLA1;POLD3;XPC
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3203003872999435,-0.9471124670254102,0.5714285714285714,0.8276165675495522,1.0,5/31,14.78%,PLCB1;MDK;TLR3;CCL19;CD40
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3909452237343172,0.9470329578464837,0.5118343195266272,0.9071500840025719,1.0,17/32,31.60%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,tRNA export from nucleus (GO:0006409),0.3909452237343172,0.9470329578464837,0.5118343195266272,0.9071500840025719,1.0,17/32,31.60%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4082916593907332,0.9469738378134933,0.5390625,0.9067073982926532,1.0,6/22,16.13%,IRF1;CD46;DUSP10;CBFB;KAT2A;BCL6
prerank,carnitine metabolic process (GO:0009437),0.4631659211212575,0.946772663072488,0.5351170568561873,0.906573025366899,1.0,3/12,8.43%,TMLHE;CPT1C;ACADM
prerank,membrane depolarization during action potential (GO:0086010),0.40447887349945844,0.9467673019589609,0.5450310559006211,0.9060103468358877,1.0,3/26,3.27%,KCNJ2;CACNA1C;CACNA1G
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3860077839786822,-0.9465924434631627,0.522077922077922,0.8277001827899396,1.0,4/14,18.15%,OSMR;IL6ST;PTGER3;PTGS2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2998298692149314,-0.946284331574716,0.5543859649122806,0.8272924255580866,1.0,16/42,24.26%,IL6R;DEFA6;OPTN;RPS19;RPL30;GSDMD;ADGRB1;CHGA;TREM2;SELP;MPEG1;PYCARD;ROMO1;MR1;NOS2;AQP1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.34062403329995594,-0.9462800047324588,0.5174418604651163,0.8261526653663784,1.0,6/25,10.44%,EPHA4;OPHN1;HSP90AB1;RPS7;RPL23;RPL11
prerank,muscle tissue morphogenesis (GO:0060415),0.44196435103982945,0.9462692308460948,0.5388429752066116,0.9065464761214916,1.0,1/16,0.28%,BMP4
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.35912403366030055,-0.945804791913,0.5466666666666666,0.8261678100008719,1.0,3/21,3.09%,IGF1;KDR;CTSH
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.393735356444298,0.9455889966787605,0.5346097201767305,0.9074540714194418,1.0,10/29,17.73%,ISL1;ESR1;STRN3;KANK2;CBFB;DDRGK1;KMT2D;UBA5;DNAAF4;CARM1
prerank,positive regulation of inflammatory response (GO:0050729),-0.25523935718921414,-0.9451411187613616,0.6010362694300518,0.8266758361345791,1.0,23/86,15.34%,ETS1;WNT5A;OSMR;APP;CD47;RPS19;GPRC5B;CD81;PDE2A;SNCA;IL18;GRN;NAPEPLD;IL6ST;TLR7;NINJ1;NMI;MDK;TLR3;LPL;AGT;NUPR1;TNFRSF1A
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.34249324908298284,-0.94492105581786,0.5101449275362319,0.8260122698504385,1.0,7/22,8.95%,PLA2R1;SPRED1;RPS15;RPL37;RPS7;RPL23;RPS20
prerank,positive regulation of TOR signaling (GO:0032008),0.3817596866000792,0.944785729946303,0.5424929178470255,0.9086622439240669,1.0,9/40,12.78%,TELO2;KLHL22;CLEC16A;GOLPH3;RRAGB;MLST8;SIK3;SMCR8;SEC13
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3753682427019322,0.9447703637118305,0.5362903225806451,0.9081199882869512,1.0,6/43,8.96%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4209709363270551,0.9445682925963579,0.5273556231003039,0.907985232321121,1.0,6/21,15.41%,ADAM9;SPPL2A;BACE2;RBMX;ERAP1;ADAM10
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32422160910455095,0.9444301430977784,0.5767138193688792,0.90771316320624,1.0,41/151,20.83%,ST3GAL4;ACER3;PCSK5;PLPP3;SGMS2;INHBA;LARGE1;DMD;SPTSSB;GOLPH3;NANP;NFS1;TYW5;SLC44A3;LPIN2;ELOVL5;TYW1;CDO1;LCAT;KDSR;CHKB;MOCOS;PLPP1;TNIP1;GSTM4;ST3GAL2;CEPT1;GSTA2;GAL3ST4;CSNK2A2;CSNK2A1;GSTT1;CERS6;CERS5;MOCS3;LPCAT1;ARG1;B3GNT6;PLA2G4A;HACD4;NMRAL1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2682740710864752,-0.944190420187802,0.5829383886255924,0.826595320482418,1.0,10/75,9.65%,PLCB1;GPCPD1;PDGFRB;PLA1A;SERINC5;ENPP6;ABHD12;SERINC1;PLEK;ABHD3
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4306162828867949,0.944009845011863,0.5166931637519873,0.9080577590868085,1.0,2/19,3.93%,THBS1;CMKLR1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.345679848314929,0.9437984931940878,0.546583850931677,0.9079455283859504,1.0,11/75,11.31%,BMP4;LRP6;PRKCD;ABL1;IPO7;CBLC;CDKN1B;NF1;IRAK3;LRP5;RB1
prerank,regulation of mRNA stability (GO:0043488),0.3276032859073409,0.9431732918932018,0.5824053452115813,0.9086463244222435,1.0,38/145,20.96%,SAMD4A;PRKCD;FTO;EIF4G1;XPO1;GDNF;FASTKD1;PSMB2;CELF1;FUS;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;PABPC1;EXOSC7;PUM2;PSMD11;PSMD1;MAPKAPK2;DCP1A;PRKCA;PUM1;THRAP3;NUP214;PSMC1;PSMD7;EXOSC1;DHX36;CIRBP;FXR2;PSMD14;TENT5D;FMR1;PSMD3;E2F1;YTHDF2
prerank,Golgi to plasma membrane transport (GO:0006893),0.36849640525023997,0.9428652583938741,0.5181695827725438,0.908719978923143,1.0,13/47,14.84%,STXBP6;EXOC4;KIF13A;ARL3;GOLPH3;NSF;EXOC5;RABEP1;COMMD1;GOPC;GOLGA7;GGA2;CCDC22
prerank,protein export from nucleus (GO:0006611),0.4073026774125141,0.9428287042054202,0.5340236686390533,0.9082283697944598,1.0,12/27,19.88%,PKD1;XPO1;DUSP16;EGR2;STRADA;DESI1;CHP1;SMURF1;NUP214;XPO4;NUTF2;RAN
prerank,regulation of cellular respiration (GO:0043457),-0.3708092528107739,-0.9427038393635264,0.5187165775401069,0.8289868296776473,1.0,3/17,4.04%,CBFA2T3;IFNAR1;PRDM16
prerank,response to thyroid hormone (GO:0097066),-0.3955474997497022,-0.9421807277725086,0.529113924050633,0.8291005740804464,1.0,6/13,14.44%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,regulation of phospholipase C activity (GO:1900274),0.44657375575181313,0.9421756152027386,0.5371621621621622,0.909060064693967,1.0,5/15,5.80%,NTRK3;FGFR1;FGF2;ABL1;ESR1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4506174947464744,0.9420596640524791,0.5264026402640264,0.9087572305522361,1.0,5/15,17.78%,IL17RA;STAT3;TLR4;MYD88;TLR6
prerank,mitochondrial translational termination (GO:0070126),0.33631625146728256,0.9418423273846362,0.5407047387606319,0.9086664794173512,1.0,36/88,30.78%,MRPL33;MRPL48;MRRF;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,neural crest cell migration (GO:0001755),0.3911670131478939,0.9418206939302982,0.5421511627906976,0.9081299184613948,1.0,7/36,8.04%,FN1;SEMA3E;SEMA3D;SEMA3C;NRP1;GDNF;PITX2
prerank,response to organonitrogen compound (GO:0010243),0.38537483028854,0.9417578509948104,0.5171919770773639,0.9077143871418929,1.0,6/38,12.91%,GLRB;RNF185;VCP;DRD3;IRAK3;MTOR
prerank,negative regulation of cellular component organization (GO:0051129),0.3463558028229249,0.9412539833845744,0.5513784461152882,0.9082239147776843,1.0,11/74,13.41%,TMEFF2;BMP6;GSK3B;ISL1;CLU;RDX;LRSAM1;IRAK3;VEGFA;XRCC5;EP300
prerank,female gonad development (GO:0008585),-0.36032136427592043,-0.9412478503845431,0.5683060109289617,0.8301386887557053,1.0,2/19,1.97%,NR2F2;KIT
prerank,sister chromatid segregation (GO:0000819),0.3931545034326114,0.9409848106364272,0.5356622998544396,0.9082259911578672,1.0,8/31,19.88%,SMC4;KLHL22;RB1;SMC1A;KNSTRN;INO80;ZW10;RAN
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3105461588371565,-0.9409832235357232,0.58125,0.8296037720511521,1.0,5/33,5.56%,PRKG1;APOD;OGN;IGFBP3;MEF2C
prerank,microtubule nucleation (GO:0007020),0.41934800042529335,0.940452708652373,0.5369458128078818,0.9088020930540653,1.0,7/19,20.18%,NDEL1;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4;CSNK1D
prerank,protein homooligomerization (GO:0051260),0.3306923961312773,0.9402908516489042,0.5853658536585366,0.908563694735731,1.0,15/114,10.04%,KCNJ2;DISP1;ATL3;TMEM120A;SCARA5;ATL2;TRPM4;MPP2;PDCD6IP;EHD3;FUS;G3BP2;PRMT8;RBMX;EHD1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4478811007921012,0.9402564207445415,0.5297113752122241,0.908071366579112,1.0,3/13,9.99%,DDX5;SPRED2;ATM
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4670578854438598,0.940103365096332,0.559931506849315,0.9078188158453989,1.0,4/11,22.05%,YBX3;RIPK3;BIRC3;FZD9
prerank,nuclear pore organization (GO:0006999),0.44747404240647265,0.9400003079627083,0.545751633986928,0.9074953302254692,1.0,6/14,23.65%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A;NUP54
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.47814187209552894,0.9398248085314225,0.5400696864111498,0.9073593257809411,1.0,4/10,7.23%,SOX9;ZBTB16;GDF6;GDF5
prerank,regulation of platelet aggregation (GO:0090330),-0.357351294118003,-0.9397054581617801,0.5427807486631016,0.8314633678940148,1.0,4/17,5.72%,LYN;PRKG1;F11R;PRKCQ
prerank,positive regulation of bone resorption (GO:0045780),-0.3961015131817906,-0.9395193798347736,0.5411764705882353,0.8307756710521874,1.0,4/11,13.71%,TNFRSF11A;SPP1;ATP6AP1;PLEKHM1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4287908024330742,0.9394338881109094,0.5250836120401338,0.90762458300853,1.0,4/16,5.27%,ANK2;CACNA1C;CAMK2D;DMD
prerank,positive regulation of cell projection organization (GO:0031346),0.33048078870818637,0.9393432802670911,0.5702764976958525,0.9072539810807808,1.0,17/115,9.06%,SLIT2;DPYSL3;NTRK3;NGF;PTK2B;CUX1;RAP1A;KIDINS220;TIAM2;FBXW8;P3H1;MARK2;STYXL1;FZD1;ARSB;ROR1;RHOA
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4112114477031995,0.9391845199512603,0.5396341463414634,0.9070343860886091,1.0,8/21,25.13%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,positive regulation of transmembrane transport (GO:0034764),0.4494477346364716,0.9389909747594707,0.50814332247557,0.9068983616845903,1.0,5/13,13.72%,ANO6;SLC26A6;NR4A3;C2CD5;AZIN1
prerank,positive regulation of autophagy (GO:0010508),-0.26597285424599043,-0.9389404612643283,0.6195652173913043,0.8310371599677465,1.0,9/81,5.91%,RNF152;PRKD1;DCN;FOXO1;KDR;TRIM14;PRKAA2;OPTN;PIK3C2A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3377480792235713,0.9387240375621015,0.5678571428571428,0.9069186721457053,1.0,6/108,3.05%,F3;MAP3K5;NGF;EGLN3;GSN;CRADD
prerank,membrane raft organization (GO:0031579),0.44309215785937056,0.938448832579543,0.5464926590538336,0.9069376675230909,1.0,6/15,22.24%,ANXA2;S100A10;ABCA7;CLN3;NPC1;EMP2
prerank,apical junction assembly (GO:0043297),0.3673331390421355,0.9382058385229298,0.5704607046070461,0.9068902547419592,1.0,15/53,13.88%,MPP7;CTNNA1;STRN;VCL;PDCD6IP;CLDN11;DLG1;CLDN16;PATJ;GRHL2;RHOA;PARD3;PKN2;PAK2;WDR1
prerank,regulation of phospholipase activity (GO:0010517),0.4793896421377632,0.9380176613059934,0.5483304042179262,0.9067185876577881,1.0,2/10,6.11%,FGFR1;LRP1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4026069328424853,-0.9376792515502027,0.5314861460957179,0.8329072906411484,1.0,3/10,6.54%,APOE;ABCA1;PRKACB
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4782095783176513,0.9375574408993496,0.5572916666666666,0.9071354846591063,1.0,2/11,12.52%,ANXA1;ZC3H12A
prerank,ncRNA transcription (GO:0098781),0.4486154684422219,0.9373678911418106,0.5207986688851913,0.9069722414728236,1.0,2/13,10.26%,POLR1G;SNAPC2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.45698575049734,0.9370648468068073,0.5495652173913044,0.9070766520366967,1.0,4/11,10.91%,P2RX2;P2RX4;PLCG2;CCL3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.34680756711098937,0.9368614386805797,0.5503778337531486,0.9069592660473544,1.0,16/72,20.49%,CARD14;PSMB2;REL;CHUK;FBXW11;PSMC6;NFKB2;PSMD11;PSMD1;CUL1;PSMC1;PSMD7;TLR6;BIRC3;PSMD14;PSMD3
prerank,cellular senescence (GO:0090398),0.3959627441707515,0.9366864251166958,0.5392592592592592,0.9067803823203527,1.0,7/27,20.63%,PRKCD;ECRG4;ID2;SMC5;PML;CDKN1A;SMC6
prerank,response to tumor necrosis factor (GO:0034612),0.33754112142122383,0.9366285304018945,0.5578313253012048,0.9063463160798956,1.0,16/91,15.93%,PID1;TANK;ADAM9;AFF3;YBX3;NFE2L2;CHUK;ERBIN;CCL3;CCL1;ZC3H12A;TRADD;DHX9;ADAM10;ZFAND6;ACOD1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32395277336445316,0.9365248482638464,0.5725534308211474,0.906006419656163,1.0,30/149,16.37%,SLCO3A1;CARD14;EDA;ERC1;RAB7B;TAB3;STAT3;CLU;RIPK2;TLR4;RIPK4;ROR1;RIPK3;CHUK;NFKB1;IRAK3;MTDH;NFKB2;MYD88;TRAF5;DDRGK1;CARD16;EP300;TNFSF11;TRADD;DHX9;PIDD1;IL18RAP;ZBTB7A;IKBKG
prerank,DNA recombination (GO:0006310),0.3877070973237085,0.9362417995125119,0.5615050651230101,0.906086749335253,1.0,11/37,21.84%,EXO1;WRN;IGHMBP2;RAD52;HDAC10;RPA1;RECQL5;RAD51;ERCC1;RAD51C;RAD50
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.39333179583081584,0.9362051401208732,0.5372492836676218,0.905602673510561,1.0,5/27,10.11%,MARK1;GSK3B;NDEL1;DISC1;MBOAT1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.34628036884705915,-0.9361680499709736,0.5625,0.8353557218693562,1.0,4/22,5.71%,LYN;MFHAS1;NR1H3;DAB2IP
prerank,regulation of mitochondrial fusion (GO:0010635),0.45941985794880646,0.9358133502100662,0.5440931780366056,0.9058943974178547,1.0,4/11,22.23%,PID1;OMA1;HUWE1;BNIP3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3308704800247467,-0.9356112188464858,0.5470588235294118,0.8356036475780976,1.0,7/24,24.71%,DACH1;RPS3;BLM;ACVRL1;TERF2IP;H1-0;DFFA
prerank,response to steroid hormone (GO:0048545),0.3898701204889982,0.9354210214363796,0.5380281690140845,0.9062023946073658,1.0,2/31,1.84%,THBS1;TGFB3
prerank,metanephric mesenchyme development (GO:0072075),0.47157165643733523,0.9353505479847548,0.531986531986532,0.9057811592372723,1.0,2/10,7.86%,SIX1;SIX4
prerank,positive regulation of immune effector process (GO:0002699),0.40051424388153495,0.9352739862592996,0.5356037151702786,0.905383445171924,1.0,3/27,8.82%,LBP;IL10;CD46
prerank,megakaryocyte differentiation (GO:0030219),-0.4132763515471013,-0.9350871641928725,0.5493975903614458,0.8357220253194122,1.0,5/11,19.90%,KIT;TAL1;MED1;SH2B3;CDKN2B
prerank,negative regulation of DNA binding (GO:0043392),0.3995787959696929,0.9350262011312993,0.536923076923077,0.9053463671506878,1.0,5/28,10.16%,SMO;MDFI;KDM1A;GATA1;JUN
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4439488507707524,0.9349606646307959,0.53,0.9049506864723745,1.0,2/13,1.19%,SOAT1;RAMP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.45749067155703205,0.934899429464088,0.518918918918919,0.9045063840618021,1.0,4/11,16.00%,DDX11;SMARCA4;MTOR;NOL11
prerank,plasma membrane invagination (GO:0099024),0.3886768558437201,0.9348461565512262,0.5415384615384615,0.9040543418759847,1.0,5/29,11.89%,GULP1;GSN;SNX18;RHOA;BIN2
prerank,negative regulation of neuron death (GO:1901215),0.339137570099875,0.934305000899538,0.5731414868105515,0.9046723582821488,1.0,10/93,6.04%,SIX1;NGF;PTK2B;TGFB3;GSK3B;CLCF1;EIF4G1;NFATC4;ISL1;GDNF
prerank,cell proliferation in forebrain (GO:0021846),0.4716320035686285,0.9337092993808584,0.545144804088586,0.9053940178631328,1.0,2/10,6.12%,DOCK7;PCM1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3786920941902304,-0.9335449431794098,0.5501222493887531,0.8383028634060969,1.0,2/13,3.90%,IGF1;INSR
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.44264863540240573,0.9335233387148753,0.5359477124183006,0.9052546405666904,1.0,4/13,8.82%,FSTL1;NOG;NBL1;CD46
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3425281214731772,0.9330513447433064,0.5811648079306072,0.9056832183947998,1.0,17/85,13.46%,USP13;PRICKLE1;GSK3B;RNF144A;RNF185;VCP;ARIH1;CLU;RNF19A;CSNK1A1;PSMC6;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3530327759084916,0.933028549886635,0.5303797468354431,0.9051759224670431,1.0,9/65,8.96%,EGFR;PTPN3;ARAP1;RNF115;PTPN2;AGR2;CBLC;BCAR3;RNF126
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4551805395946851,0.9323262440304149,0.5448504983388704,0.9061120539070744,1.0,4/14,11.92%,PPP3CA;PPTC7;PPP2R2D;PPP5C
prerank,positive regulation of phospholipase activity (GO:0010518),0.4102263810159965,0.9321670025962865,0.5401785714285714,0.9058945165125267,1.0,7/22,10.39%,NTRK3;FGFR1;FGF2;AGTR1;ESR1;GNA13;ARF4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.33883242232872807,0.9316871639035345,0.5783132530120482,0.9063679555292132,1.0,23/88,15.63%,VPS13A;STXBP6;EXOC4;VPS13C;GOLGB1;CLINT1;ARL3;DOP1B;GBF1;EXOC5;AP4E1;RABEP1;AP2A1;COMMD1;SNAP23;KIF16B;SH3D19;GOPC;SCAMP2;GOLGA7;CCDC22;PUM1;MON2
prerank,post-translational protein modification (GO:0043687),0.30750762353859407,0.9316401227453116,0.6446280991735537,0.90591092351432,1.0,60/332,17.11%,FBXL7;BMP4;MSLN;FSTL1;PTP4A2;CCN1;FN1;GPC3;FBXO10;ZBTB16;IGFBP5;DCAF6;FBXO40;FBXW8;KLHL22;CCDC8;DNAJC3;HIF3A;PSMB2;FBXL20;ASB9;ASB16;KTN1;SOCS2;DCAF4;UBE2F;KLHL13;FBXW11;FEM1B;COMMD1;PSMC6;COPS7B;FBXO17;PRKCSH;TIMP1;ASB11;COPS5;SPSB2;CKAP4;LRRC41;COP1;FBXO4;RCN1;PSMD11;CUL3;BMP15;ERCC8;DCAF5;WDTC1;PSMD1;CCDC22;ASB1;ADAM10;MXRA8;CALU;CUL1;ASB14;NUCB1;PSMC1;PSMD7
prerank,negative regulation of lyase activity (GO:0051350),-0.3653098652016653,-0.931447494760179,0.5485436893203883,0.8420721146660586,1.0,2/16,2.14%,GRM3;ADGRV1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4037087885585106,0.9313691144658651,0.5382113821138211,0.9059035915701915,1.0,10/22,27.37%,GSK3B;CRY2;STYXL1;BOD1L1;MGAT5;PTPA;LGALS3;ROCK1;IKBKB;FKBP1B
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.38631413348779575,-0.9304570695416505,0.5405405405405406,0.8433887559588251,1.0,2/12,3.90%,IGF1;INSR
prerank,protein localization to kinetochore (GO:0034501),0.44058427569082304,0.9303438857369918,0.552772808586762,0.9074954777245855,1.0,7/14,28.25%,CENPT;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.34811782416061,-0.9303203513648529,0.5454545454545454,0.8425539299817251,1.0,6/19,20.68%,DDO;ALDH7A1;ASPA;GOT2;AASS;GCDH
prerank,protein targeting to lysosome (GO:0006622),0.40692110058403347,0.9300758455957856,0.5365126676602087,0.9075049039144912,1.0,2/20,6.20%,NEDD4;CLU
prerank,RNA biosynthetic process (GO:0032774),0.39127417499504563,0.9298108669556266,0.5409153952843273,0.9074978780978912,1.0,13/31,25.79%,TTF2;TTF1;PRIM2;TAF12;TAF4;NCOA6;PRIM1;SMARCA5;HELB;POLA1;PRMT5;GTF2B;TAF13
prerank,cell cycle checkpoint signaling (GO:0000075),0.45437879385472923,0.9294953007494088,0.5512605042016807,0.9076210409005679,1.0,6/12,21.60%,NABP1;CHFR;PRCC;ZWILCH;ZW10;WEE1
prerank,hexose biosynthetic process (GO:0019319),-0.2945467286050217,-0.9292537716878667,0.5868055555555556,0.8439546035852158,1.0,13/42,21.63%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A11;SLC25A13
prerank,regulation of adaptive immune response (GO:0002819),-0.36170862948957333,-0.9291062276834391,0.5596816976127321,0.8431647033230173,1.0,7/18,23.30%,AHR;ADCY7;IL6ST;SAMSN1;IRF7;TRIM27;PYCARD
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3594007086819274,-0.9289319535813446,0.5344827586206896,0.8424165906960615,1.0,2/18,5.66%,CORO2B;CEP120
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3474888045942394,0.928923566095351,0.5477707006369427,0.9082227740151896,1.0,9/62,4.51%,NGF;AKAP13;GPR4;MAPRE2;STK19;COL3A1;SHC1;NOTCH2;SHOC2
prerank,negative regulation of defense response (GO:0031348),0.3404804322815861,0.9284732621996256,0.5815691158156912,0.9086186434993515,1.0,11/77,11.31%,CCN3;PRKCD;PTGIS;KLF4;PTPN2;TRAFD1;ISL1;IL10;RORA;IRAK3;RB1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3139972641814989,0.9283758441044264,0.6090712742980562,0.9082886242214442,1.0,23/190,11.11%,SLIT2;THBS1;CCN3;CIT;TANK;PHLPP2;NPRL3;ATP2B4;UBE2B;PDE10A;ESR1;DDIT3;IFI35;RORA;DRD3;PPEF2;NF1;MARK3;USP10;PPP2R5C;PRDM15;PER1;OTUD7B
prerank,microtubule bundle formation (GO:0001578),0.36439376561219855,0.9280986384148682,0.5657708628005658,0.9083448142780124,1.0,8/42,12.35%,RP1;CLIP1;GAS2L2;TOGARAM1;CAPN6;CCDC40;CCDC66;CHP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.28413035161183275,-0.9280233451330481,0.5669291338582677,0.8434776078322613,1.0,22/49,28.72%,BCL2;SGMS1;BCL2L1;DAPK2;NOC2L;BOK;BMF;NUPR1;RACK1;DDX3X;P4HB;DNM1L;NDUFA13;PLAUR;PMAIP1;PYCARD;CYLD;PINK1;BCL2L2;SRC;BCL2L11;SIAH1
prerank,reticulophagy (GO:0061709),0.4553764049189257,0.9274684776782709,0.5592654424040067,0.9091588529975182,1.0,6/12,22.15%,ULK2;RB1CC1;DDRGK1;UBA5;ATG2A;ULK1
prerank,receptor metabolic process (GO:0043112),0.358362983998027,0.9268791844368743,0.5653370013755158,0.9098333824358824,1.0,7/53,6.25%,RAMP1;NEDD4;CD9;ITGB1;BECN1;LRP1;EHD3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.45124099856799177,0.9264813534849574,0.5526315789473685,0.9101194704646821,1.0,6/12,28.92%,MAVS;IFIH1;DHX9;COLEC12;RALB;ZCCHC3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.47140978106446674,0.9263270303084992,0.5652892561983471,0.9093305428814766,1.0,3/10,10.78%,HDAC4;PFKFB1;NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),0.47140978106446674,0.9263270303084992,0.5652892561983471,0.9093305428814766,1.0,3/10,10.78%,HDAC4;PFKFB1;NCOR1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.39288278979661767,-0.9253220210077266,0.523936170212766,0.8488027631697489,1.0,3/12,8.93%,APOE;PFDN5;PFDN2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.43023727495420616,0.9250185242931779,0.5265625,0.9115949759592787,1.0,5/15,16.06%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,positive regulation of response to external stimulus (GO:0032103),0.32144494857037853,0.9249877911652861,0.5867287543655413,0.9111203743233744,1.0,29/128,18.15%,THBS1;GPR4;THBD;BMP6;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;LRSAM1;USP15;IL33;CCL3;CCL1;PUM2;TRADD;TNIP1;DHX9;TLR8;PRKCA;PUM1;ACOD1;ANKRD17;ABCC1;NLRP12;POLR3F;ADAM8
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.42945801933090566,0.9248578212929346,0.543171114599686,0.9108521191680873,1.0,2/17,3.69%,ADAM9;FOXC2
prerank,muscle filament sliding (GO:0030049),-0.29675659347799255,-0.9246452272972026,0.5714285714285714,0.8481858246277594,1.0,6/38,8.73%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,actin-myosin filament sliding (GO:0033275),-0.29675659347799255,-0.9246452272972026,0.5714285714285714,0.8481858246277594,1.0,6/38,8.73%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.39003228435386983,0.924448136978283,0.5443786982248521,0.9111528548228751,1.0,11/29,27.33%,MNAT1;ERCC5;CHD1L;RAD23B;ERCC3;XPA;RPA1;CUL4A;ERCC2;XPC;GTF2H3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3309704470598486,-0.9242766830865071,0.5520231213872833,0.8478865949010079,1.0,10/26,22.47%,LGR4;TLR3;TYRO3;LRRC14;IRF7;GPS2;BIRC2;TREM2;SMPDL3B;CACTIN
prerank,negative regulation of blood coagulation (GO:0030195),0.37261704730860984,0.9239161860362193,0.5785714285714286,0.9116856942738817,1.0,2/38,2.98%,F3;THBD
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.42024720822234013,0.9236830859588805,0.5551948051948052,0.9116173472242635,1.0,2/18,4.54%,MET;CCDC125
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4056024730057687,0.9236608557980486,0.562406015037594,0.911119130598995,1.0,4/24,3.98%,SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3453234722640523,0.9234486042646378,0.5762273901808785,0.9109967924704809,1.0,18/69,22.98%,UBE4B;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;EDEM2;UFD1;TRIM25;ECPAS;FAF2;HERPUD1;FBXO27
prerank,receptor-mediated endocytosis (GO:0006898),0.31958609093232604,0.9233183351744241,0.6127167630057804,0.9107158301071916,1.0,21/132,10.29%,RAMP1;LRP6;NEDD4;PDLIM7;CD9;ADRB2;COLEC11;ITGB1;AP2A2;IGF2R;LDLR;GAK;CLTB;LRP1;HPX;AP4E1;GPR107;AP2A1;FCHO2;PI4KB;CTTN
prerank,icosanoid secretion (GO:0032309),0.45429256735903434,0.923311084847535,0.5425709515859767,0.9101815744190049,1.0,3/12,11.36%,ANXA1;DRD3;ABCC4
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4083816599534711,-0.9227461299189395,0.5390243902439025,0.8503385329553732,1.0,4/10,23.01%,ENPP2;PNPLA8;PLA2G7;PLA2G5
prerank,vesicle organization (GO:0016050),-0.2843454743392043,-0.9226993688054542,0.6108949416342413,0.8493361282503213,1.0,9/46,17.52%,SORT1;FNBP1L;SRGN;CD34;DNM1;AKTIP;EPS15;DNAJC13;EXOC8
prerank,cellular response to interleukin-12 (GO:0071349),-0.2829927352674592,-0.9222589913141088,0.6022727272727273,0.8492548285233996,1.0,12/48,14.81%,PLCB1;CNN2;CD47;SIRPA;PPIA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1
prerank,negative regulation of DNA replication (GO:0008156),0.45342467541648435,0.9221289825093478,0.533106960950764,0.9121284364221809,1.0,4/13,17.95%,RAD17;WAPL;GTPBP4;ATR
prerank,DNA methylation (GO:0006306),0.4096322078871165,0.9220969821621676,0.5616224648985959,0.9116451381872785,1.0,8/23,25.91%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,brain development (GO:0007420),0.32142110369787846,0.9217360832949753,0.6009227220299884,0.9118296539233686,1.0,16/136,9.78%,SLC23A1;PBX3;ZFHX3;NFIB;ADGRL2;PBX1;ZIC1;TGFBR2;PAFAH1B1;DMBX1;SHROOM4;GRHL2;PAFAH1B2;EGR2;FBXW11;NF1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.43408189027196065,0.9217137424474723,0.5686274509803921,0.9113240574644574,1.0,4/15,22.02%,USP46;ZDHHC12;CLN3;STXBP1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3261401464070505,0.9210987254941001,0.5770609318996416,0.9120964987035645,1.0,9/98,5.19%,THBS1;PID1;ANXA2;KLF4;INHBA;AGTR1;EIF4G1;TGFBR2;SFRP4
prerank,heart contraction (GO:0060047),0.3652862178964857,0.9209868721109403,0.5688202247191011,0.9117961380754954,1.0,4/41,5.27%,SGCD;ATP1B1;CSRP3;DMD
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.31438680975439376,-0.9208104390582943,0.5981012658227848,0.8515494398402317,1.0,7/29,11.18%,WNT5A;SAMHD1;IFNAR2;HSP90AB1;NLRC5;USP18;RNASEL
prerank,cellular iron ion homeostasis (GO:0006879),-0.27149067230420876,-0.9201258288674733,0.6065573770491803,0.8519888430409728,1.0,9/55,13.01%,CP;FTH1;TFRC;SLC40A1;FTL;ABCB7;SLC22A17;BOLA2;ATP6AP1
prerank,membrane repolarization (GO:0086009),0.4487193090457191,0.9198108539357907,0.5547945205479452,0.91366659480574,1.0,2/15,1.55%,KCNJ2;ATP1B1
prerank,regulation of intracellular signal transduction (GO:1902531),0.29699469712375853,0.9197463250180644,0.6922290388548057,0.9132512578727635,1.0,98/420,18.55%,EGFR;RASSF2;MOB3B;NTRK3;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;EZR;AKAP13;ARHGDIB;VAV2;USP2;HIPK1;ARHGAP44;ARHGAP31;BCR;SRGAP2;SRGAP3;CMKLR1;TIAM2;TELO2;SMYD2;ARAP2;TRIO;ITGAV;PIP5K1A;RHOQ;GATA4;EXO1;DLG1;ARHGEF6;RRAGB;OCRL;ARHGAP17;EHMT1;STYXL1;CHEK2;PLK3;MDM4;RAD17;RHOA;STARD13;ITFG2;ARHGAP5;WRN;GNA13;AURKA;MLST8;PLCG2;ATM;VEGFA;MYO9A;PPP2R5C;USP7;ARHGEF5;TIAM1;TRAF5;SOS2;ARHGAP40;CASTOR2;MTOR;CHEK1;PAK2;EP300;CHD3;TNFSF11;DYRK2;PIDD1;SQSTM1;PML;ZFAND6;CPNE1;TAF12;RBBP8;NEK8;IKBKG;TMBIM4;RPA1;RMI2;TOP3A;NLRP12;TAF4;VRK2;BARD1;PAK4;PRKAR2A;AKAP12;NBN;TRIP10;KMT5A;EHMT2;ATR;RBBP7;CSNK2A2;CSNK2A1;TOPBP1
prerank,DNA-dependent DNA replication (GO:0006261),0.3227882680119995,0.919378569045552,0.6099773242630385,0.9134757777522542,1.0,43/128,28.48%,REV3L;PSMB2;MCM7;WRN;MCMBP;MCM2;PSMC6;CDC45;BAZ1A;PSMD11;PRIM2;POLG2;POLB;PSMD1;POLE2;DDX21;RPA1;GINS3;RECQL5;PSMC1;PSMD7;PRIM1;RAD51;TOPBP1;RFC1;PSMD14;HELB;PSMD3;POLA1;POLD3;NOC3L;CDK2;RFC5;PSMD12;ORC3;SRPK2;CDK2AP1;PSMD4;PSME3;PSMD2;MCM6;RECQL;PRIMPOL
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.36545783019466965,-0.9189293051466145,0.5528455284552846,0.8536337613986532,1.0,2/14,6.51%,ENPP1;ENPP3
prerank,regulation of hydrolase activity (GO:0051336),0.34042384217897836,0.9186263271963023,0.5782828282828283,0.914463819604617,1.0,17/71,11.77%,EFNA5;SIPA1L1;VAV2;ARHGAP44;PAFAH1B1;ADAP1;EPHB3;RDX;RAPGEF6;OCRL;FGD6;RAB3GAP2;WRN;FBXW11;NF1;ARHGEF5;ITGB1BP1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.44047071194027543,0.918507751664324,0.5555555555555556,0.9141598380297811,1.0,4/14,14.99%,YBX3;MYD88;ANGEL2;MAPKAPK2
prerank,cellular response to nutrient levels (GO:0031669),0.34925617753751365,0.9181413862380388,0.5851472471190781,0.9143555015107234,1.0,13/62,12.91%,KCNB1;FAM107A;WIPI2;EIF4G1;KLF10;ZFYVE1;VPS41;CLEC16A;RRAGB;WRN;INHBB;USP33;MTOR
prerank,neuron apoptotic process (GO:0051402),-0.35135026989184553,-0.9180824772751994,0.5632183908045977,0.8544595500254211,1.0,5/19,7.55%,BCL2;TNFRSF21;APP;FAS;GAPDH
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.37433626947451626,-0.9180140408031059,0.5597014925373134,0.8535010654253958,1.0,5/14,23.56%,BCL2L1;TMBIM6;SELENOS;XBP1;CREB3
prerank,glycogen metabolic process (GO:0005977),0.3841674079688259,0.9179968113688849,0.5665171898355755,0.9141114541256918,1.0,5/27,8.72%,PYGB;PPP1R3C;GSK3B;PHKA2;PHKB
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.333200321752809,0.9178128093207478,0.5807228915662651,0.9139469923156317,1.0,12/87,12.33%,RBFOX2;CD44;FGFR1;FGF2;SPRED2;SHOC2;FLRT2;HNRNPH1;KIF16B;ITGB1BP1;FGF22;NR4A1
prerank,regulation of biosynthetic process (GO:0009889),-0.39083701137666216,-0.9172661021585993,0.5632754342431762,0.854085197783348,1.0,6/11,35.33%,SNCA;SLC25A33;SPHK2;MID1IP1;GSTP1;CCN6
prerank,regulated exocytosis (GO:0045055),0.3060467896019158,0.917114221711153,0.6220302375809935,0.9148073614443296,1.0,23/173,11.36%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;DNAJC5;CLTRN;SYT8;ARHGAP17;PDGFA;SERPING1;GTPBP2;PCLO;VEGFA;ITGB3;TIMP1;ABCC4
prerank,regulation of interleukin-17 production (GO:0032660),-0.30778483556430186,-0.9170106618538897,0.5902140672782875,0.8535391545291963,1.0,5/31,8.16%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,cellular response to leucine starvation (GO:1990253),0.4694025691064134,0.9167855220494732,0.5790408525754884,0.9149489595153288,1.0,3/10,14.01%,RRAGB;MTOR;EIF2AK4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.36782404005441144,0.9164474069702497,0.5880681818181818,0.9151182156438329,1.0,7/39,13.67%,TCF7L2;ISL1;AACS;MCU;CAPN10;SELENOT;TNFSF11
prerank,receptor internalization (GO:0031623),0.3590224051911262,0.9163593710777913,0.5676056338028169,0.9147514573936008,1.0,5/44,6.11%,RAMP1;NEDD4;CD9;ITGB1;LRP1
prerank,negative regulation of receptor binding (GO:1900121),0.46451809698745794,0.9162329482936036,0.5685920577617328,0.9144518410951771,1.0,3/10,7.15%,PTPRF;NOG;IL10
prerank,I-kappaB phosphorylation (GO:0007252),0.4519281579340364,0.9160444877903614,0.5553571428571429,0.9143001094762102,1.0,3/10,9.10%,ERC1;TLR4;CHUK
prerank,mRNA stabilization (GO:0048255),0.37224724848824137,0.915846178086419,0.5777777777777777,0.9141824881430184,1.0,16/40,24.60%,YBX3;GDNF;SYNCRIP;FUS;PABPC1;MYD88;ANGEL2;DHX9;MAPKAPK2;THRAP3;CIRBP;TENT5D;E2F1;TARDBP;TAF15;TENT5C
prerank,DNA packaging (GO:0006323),0.4281923292204063,0.9158320152907077,0.5631067961165048,0.9136685727571721,1.0,6/16,27.45%,CHAF1B;AIFM1;CHAF1A;RBBP4;HAT1;KAT6A
prerank,negative regulation of axonogenesis (GO:0050771),-0.3246484942218084,-0.9153009020614594,0.5869565217391305,0.8563990447456422,1.0,9/27,13.00%,MAP2;DCC;ARHGDIA;MAG;RTN4;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4594631052230166,0.9151507770354744,0.551304347826087,0.9139671711733215,1.0,1/10,2.06%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4594631052230166,0.9151507770354744,0.551304347826087,0.9139671711733215,1.0,1/10,2.06%,PRKCD
prerank,regulation of fatty acid oxidation (GO:0046320),0.42514071303580125,0.9150960382950771,0.5712,0.9135435373942602,1.0,2/16,4.29%,SOX9;NR4A3
prerank,histone H4-K8 acetylation (GO:0043982),0.4395441241959579,0.9149133484638022,0.5705128205128205,0.912843462958752,1.0,8/15,26.12%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;MCRS1;JADE2;OGT
prerank,histone H4-K5 acetylation (GO:0043981),0.4395441241959579,0.9149133484638022,0.5705128205128205,0.912843462958752,1.0,8/15,26.12%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;MCRS1;JADE2;OGT
prerank,regulation of superoxide anion generation (GO:0032928),0.42548341989229627,0.9147601922908649,0.5633116883116883,0.9126331973226491,1.0,2/14,12.04%,PRKCD;AATF
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37222950021138274,0.9147408508825217,0.5531609195402298,0.9121309248820504,1.0,16/38,21.59%,BMP6;POLR3D;PLSCR1;IFI35;USP15;PUM2;DHX9;TLR8;PRKCA;PUM1;ACOD1;ANKRD17;POLR3F;ADAM8;AKIRIN2;LY96
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.38615613014325273,0.9145843698894458,0.5720588235294117,0.911916420745646,1.0,12/31,14.36%,EZR;DLG2;PDCD6IP;DLG1;MARK2;RHOA;PARD3;SYNE4;ERBIN;MYO9A;WDR1;SYNJ2BP
prerank,positive regulation of MAPK cascade (GO:0043410),0.29734886878886746,0.9145461494423779,0.6628029504741834,0.9114531881433737,1.0,17/245,4.30%,BMPER;EGFR;TNFAIP8L3;NTRK3;ADRA1B;PDGFC;PTK2B;CD44;ADRB2;FGFR1;SHC1;MID1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A
prerank,second-messenger-mediated signaling (GO:0019932),-0.2524790643132199,-0.9143973292369272,0.6618357487922706,0.8573963045158848,1.0,13/82,8.69%,APOE;CCR9;NOS3;MCTP1;GUCY1B1;RYR2;NDNF;MCTP2;DGKD;GUCY1A1;CHRM3;SPHK1;EDN1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.44736515827439954,0.9142664030863111,0.5604026845637584,0.91145936710199,1.0,5/12,20.93%,TCERG1;NELFE;RNF168;RECQL5;RNF8
prerank,T cell receptor signaling pathway (GO:0050852),-0.2317308736490656,-0.9138954758926999,0.6949152542372882,0.8574676352727792,1.0,23/138,14.58%,PIK3R1;PDE4B;PAK1;FYB1;RFTN1;INPP5D;TEC;TNFRSF21;PRKCQ;PDE4D;PAG1;MOG;PAK3;BTRC;THEMIS;PSMB4;PSMB3;PLCG1;PSMB8;PSME2;ICOSLG;PSMB10;MALT1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.34342870159853994,0.9132970568550057,0.5903141361256544,0.9129056017449245,1.0,9/64,11.30%,CYP1B1;MGLL;PNPLA3;ACSL3;SLC27A3;ACOT8;DAGLB;ELOVL5;HACL1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.34171413638514225,0.9127842606223968,0.5839598997493735,0.9134055497998599,1.0,5/73,4.92%,F3;NGF;EGLN3;CRADD;VCP
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.36494251045653087,0.9126348422270728,0.5771349862258953,0.9131633950069286,1.0,6/41,10.85%,CYP1B1;MGLL;ACOT8;DAGLB;SCD;ELOVL5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.32080757299334706,0.9123094560332986,0.6050119331742243,0.9132780003185847,1.0,17/107,11.41%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;SLC39A14;ATP2B4;STIM2;SLC10A7;CASR;TNNI3;DRD3;SLC30A9;CCL3;SLC39A13;CCL1;SLC8B1
prerank,regulation of mRNA processing (GO:0050684),0.3807063979166517,0.9119320330471914,0.5481586402266289,0.9134768007484977,1.0,8/32,18.05%,SLTM;SON;RBM39;DHX9;CDK11B;JMJD6;SRPK1;KHDRBS1
prerank,mitotic spindle organization (GO:0007052),0.3104214714283703,0.9117718442835288,0.6168757126567845,0.9132802257322853,1.0,57/153,28.16%,NDEL1;CLIP1;VCP;TBCE;PAFAH1B1;XPO1;MISP;CHEK2;TOGARAM1;ARHGEF10;DYNC1I1;RHOA;SPICE1;AURKA;RANBP2;SMC1A;SEC13;PIBF1;DCTN6;STIL;RMDN1;AHCTF1;STAG2;CENPT;KIF3B;MAD2L1;NEK9;DYNC1LI2;SPDL1;ZWILCH;NEK6;CENPQ;ZW10;RAN;STAG1;NUP98;PTPA;OFD1;FLNA;SUN2;GPSM2;AAAS;KIF2C;CCNB1;CDC20;SKA2;BUB3;TTK;MECP2;CENPU;PCNT;SPC24;WDR62;KIF18A;CEP192;CENPK;CENPC
prerank,establishment of mitotic spindle localization (GO:0040001),0.37805236603492715,0.9117450656926925,0.5652173913043478,0.9127994501831357,1.0,5/28,9.47%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3430309623379259,-0.9114584109458668,0.6086956521739131,0.8618773451129498,1.0,5/20,21.43%,NR2F2;MYOCD;HHEX;INCA1;CEBPA
prerank,protein homotrimerization (GO:0070207),0.4291129453054995,0.9112483374604574,0.5576271186440678,0.9126937164101424,1.0,2/14,3.77%,DISP1;SCARA5
prerank,protein trimerization (GO:0070206),0.4291129453054995,0.9112483374604574,0.5576271186440678,0.9126937164101424,1.0,2/14,3.77%,DISP1;SCARA5
prerank,negative regulation of hydrolase activity (GO:0051346),-0.27766458873043814,-0.911146850882749,0.6059322033898306,0.861462257675749,1.0,10/49,12.55%,CPEB2;MAP2;F11R;LRCH1;CST3;DAB2IP;GMIP;CAMK2A;SH3BP4;EGLN1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3917116849759583,-0.9111226810215488,0.5632458233890215,0.8603901354051169,1.0,3/12,13.55%,ACSL1;FADS2;SCP2
prerank,cranial nerve development (GO:0021545),-0.39286590660706133,-0.9110415011784165,0.5793450881612091,0.859459250195691,1.0,2/11,4.30%,CHD7;SALL1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.31872494044220656,0.9110359422836344,0.6224852071005917,0.9126168756310469,1.0,25/113,17.95%,TRABD2B;MPP7;GSK3B;UNC13B;EIF4G1;VCP;ESR1;CLU;CLTRN;TLR4;ERCC5;CHD1L;ATM;PSMC6;VEGFA;MYD88;SPIDR;IL5;SH3GLB1;ERCC3;XPA;RPA1;TLR6;ERCC1;ATR
prerank,intracellular sterol transport (GO:0032366),-0.3821138184511132,-0.9107213493556734,0.5682382133995038,0.8590573606337577,1.0,3/13,9.42%,ABCA1;ABCG1;NPC2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3869747116767604,0.9106093976005042,0.576138147566719,0.9129560279201141,1.0,7/24,17.86%,PID1;MRAP;RHOQ;DMTN;ITGB1BP1;PPFIA1;LZTFL1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2982393003326378,-0.9103967748098843,0.6090225563909775,0.8586733279291585,1.0,14/40,20.15%,UNC13C;RIMS1;RIMS2;SYT7;SNCA;SNAP25;SYT1;BLOC1S6;PIP5K1C;SYT10;RAB3A;SYT2;CPLX1;DOC2B
prerank,positive regulation of interleukin-6 production (GO:0032755),0.33861565994340964,0.9103477217864125,0.5863354037267081,0.9129369382979964,1.0,17/68,17.78%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;TLR4;IL33;PLCG2;MYD88;IFIH1;TLR1;DHX9;TLR8;TWIST1;BCL10;TLR6
prerank,regulation of actin filament-based movement (GO:1903115),0.45216079133358117,0.9103175427526224,0.5625,0.9124641381795223,1.0,1/10,1.49%,ANK2
prerank,snRNA metabolic process (GO:0016073),0.4205798922665315,0.9100634362676625,0.587378640776699,0.9124277311952262,1.0,10/17,32.88%,ZCCHC8;INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;MEPCE;INTS7
prerank,mitochondrial translation (GO:0032543),0.3210970358648912,0.9091586530035651,0.630071599045346,0.9136890048325588,1.0,40/104,30.78%,MRPL33;EARS2;MRPL48;MRRF;MRPS27;MTIF3;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;NOA1;MRPL21;MRPL42;MRPS30;MTIF2;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MTRF1L;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,positive regulation of cell growth (GO:0030307),0.32586155025926233,0.9088270225850974,0.5988095238095238,0.9138231404132912,1.0,7/96,5.51%,EGFR;NTN1;NGF;TGFBR1;EIF4G1;KLHL22;SHTN1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33616470374572555,0.9087001421535782,0.6094147582697201,0.9135499579235749,1.0,21/76,20.97%,PRICKLE1;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;CSNK1A1;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;SMURF1;CSNK1E;CCDC22;RNF14;PIAS1;DVL1;CSNK1D;DET1
prerank,peptide metabolic process (GO:0006518),0.336934750809123,0.9086292117065445,0.5800756620428752,0.9131515613259767,1.0,10/75,9.27%,PCSK5;NPEPPS;CPQ;DMD;MGAT3;IDE;MMACHC;GSR;NLN;BACE2
prerank,mammary gland development (GO:0030879),-0.3366210328221735,-0.9085646151554213,0.5824468085106383,0.8617999813153182,1.0,4/21,6.08%,WNT4;TBX3;ERBB4;NOTCH4
prerank,ribosomal small subunit assembly (GO:0000028),-0.3514863838533209,-0.9085593474086936,0.58994708994709,0.8606936752988781,1.0,5/16,7.26%,RPS14;RPS19;RPS5;RPS15;RPS27
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4448357562395519,0.9083852423428082,0.5678571428571428,0.9131178894065909,1.0,3/11,9.27%,SOAT1;ITM2C;BACE2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4272266314635079,0.9082492646288292,0.5834710743801653,0.9128758842774702,1.0,4/14,25.94%,FUS;MRNIP;WDR48;RAD51AP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3445701880859773,0.9082017997062367,0.5942408376963351,0.9124398345476906,1.0,11/65,12.91%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;MDM4;RORA;HILPDA;VEGFA;CARD16;MTOR
prerank,cardiac myofibril assembly (GO:0055003),0.439475216764782,0.9080115201330234,0.5986733001658375,0.9122959168042989,1.0,3/15,5.92%,CSRP3;MEF2A;NEBL
prerank,regulation of oxidoreductase activity (GO:0051341),0.443422724480847,0.9073952265071886,0.5867346938775511,0.9130023393156147,1.0,3/13,23.78%,ABL1;SZT2;ECSIT
prerank,embryonic heart tube development (GO:0035050),0.4285175000621942,0.9073067693449974,0.5605095541401274,0.9126370795914271,1.0,4/14,11.10%,HES1;PITX2;ACVR1;MEGF8
prerank,regulation of response to external stimulus (GO:0032101),0.3154867334392364,0.9071892187653282,0.6047058823529412,0.9123549892492404,1.0,13/121,9.56%,FOXP1;CD55;MGLL;ANXA1;PIK3AP1;AGTR1;PDE6A;CELF1;IRF1;DAGLB;P2RX4;SHPK;NLRP6
prerank,positive regulation of stem cell proliferation (GO:2000648),0.42041271536430136,0.906447442649845,0.5620094191522763,0.9132925369934285,1.0,2/17,6.08%,LTBP3;KDM1A
prerank,zinc ion transmembrane transport (GO:0071577),-0.3287675853463209,-0.9062208497926865,0.6028985507246377,0.8649373723546071,1.0,7/22,17.41%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4505324043745699,0.9059218037483904,0.5886402753872634,0.9138778922382412,1.0,3/12,11.54%,STX11;SNAP23;STX19
prerank,neuromuscular process (GO:0050905),0.41876482107460544,0.905679942859496,0.5882352941176471,0.9138409596398296,1.0,5/16,13.59%,STRA6;PAFAH1B1;MYCBP2;SHANK1;UBA5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4541627647784131,0.9054627524921036,0.5751295336787565,0.9137359799527044,1.0,6/10,27.54%,TLR4;MYD88;TLR6;MIA3;CD36;TICAM1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3478579783637849,-0.9052371024688238,0.5631578947368421,0.8660849075264854,1.0,7/18,25.55%,DCP2;RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2
prerank,C4-dicarboxylate transport (GO:0015740),0.4255181867644605,0.9050077964614398,0.5723577235772358,0.9141026577328415,1.0,1/14,1.31%,LRRC8D
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3362930963315524,0.9048529094469142,0.5914948453608248,0.9138676447433998,1.0,7/67,4.26%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.41361414781340583,0.9048326299574617,0.5870253164556962,0.9133736501765167,1.0,3/20,2.43%,SEMA3E;SEMA3D;SEMA3C
prerank,adherens junction organization (GO:0034332),0.3496802385234357,0.9048087860226766,0.5851063829787234,0.9128964599251583,1.0,7/48,8.83%,CDH1;CDH11;NECTIN3;CTNNA1;VCL;JUP;PVR
prerank,negative regulation of TOR signaling (GO:0032007),-0.2981950782726044,-0.9047266944964625,0.6172413793103448,0.866194067363715,1.0,12/36,23.10%,RNF152;PRKAA2;SPAAR;TNFAIP8L1;SH3BP4;GSK3A;TMEM127;DEPTOR;MINAR1;DDIT4;CASTOR1;SESN1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.3097838856526358,-0.9046660906588315,0.5871559633027523,0.8652248030617629,1.0,9/27,19.60%,SIRPA;C1QTNF3;SYT11;GAS6;CD200;ARRB1;SELENOS;TNFAIP3;CX3CL1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4046473508114361,-0.9045593562251896,0.6131386861313869,0.8643448970860774,1.0,3/10,5.75%,VTN;PRKCB;HIF1A
prerank,copper ion transport (GO:0006825),-0.40142024808319354,-0.9043461170150698,0.5810473815461347,0.8637310516567143,1.0,7/11,22.02%,ATOX1;SLC31A1;STEAP3;ATP7A;COX17;STEAP2;STEAP4
prerank,oligosaccharide metabolic process (GO:0009311),0.35469434523733245,0.9042603942384829,0.6066024759284732,0.913503703504065,1.0,2/46,1.56%,ST3GAL4;FUT8
prerank,histone H3-K36 demethylation (GO:0070544),-0.40750501874563927,-0.9040556302036256,0.5970149253731343,0.8634119059690292,1.0,2/10,7.27%,KDM7A;KDM2B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.43757765093299655,0.903566567556107,0.5812395309882747,0.9143720500723268,1.0,5/13,20.93%,TCERG1;NELFE;RNF168;RECQL5;RNF8
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3785481234452005,-0.9024463110635215,0.5763888888888888,0.8659925415797536,1.0,6/12,24.85%,MAOA;DDC;SMS;ATP7A;SLC22A3;SLC29A4
prerank,COPII-coated vesicle budding (GO:0090114),0.33796791438664836,0.9022232586465821,0.6,0.9165524661953306,1.0,30/68,26.90%,SEC24B;STX5;NSF;SEC16A;ANKRD28;PPP6R3;SEC23A;CNIH2;SEC31A;SEC13;CUL3;SEC24D;SEC22B;SAR1B;TRAPPC10;SEC23IP;USO1;TRAPPC3;PPP6C;BET1;CSNK1D;PPP6R1;RAB1A;SEC24A;TRAPPC6A;TRAPPC9;MIA3;AREG;TBC1D20;PEF1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4425433368009952,0.9021993133783064,0.568935427574171,0.9160661444858952,1.0,3/12,14.53%,ERLIN1;PIBF1;WDTC1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3803959546690539,0.9020261172897119,0.5925373134328358,0.915893887782111,1.0,4/27,9.06%,NFAT5;CD44;NR4A3;RHOA
prerank,T cell activation involved in immune response (GO:0002286),-0.3823620966909871,-0.9010175270907472,0.6116504854368932,0.868114384844752,1.0,3/12,14.81%,MDK;CD74;LCP1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3181119570804565,-0.9008427587617186,0.6114457831325302,0.8673711812663554,1.0,16/25,25.93%,RBPJ;DGKD;CCDC88A;AFAP1L2;HIP1R;RTN4;HIP1;CNOT9;AGT;AKT1;NUP62;GPER1;PLAUR;PDE6G;HAP1;DOK1
prerank,regulation of cell-cell adhesion (GO:0022407),0.3626351450868434,0.9008354562930901,0.5918079096045198,0.9177695040601833,1.0,5/39,6.81%,CDH1;EFNA5;ADA;JAG1;EPHB3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4208734654985029,0.9006180159021588,0.5688816855753647,0.9176521455790091,1.0,3/16,15.79%,RAET1E;PLEKHM2;LYST
prerank,mRNA processing (GO:0006397),0.2950743505387971,0.9004233941488834,0.6929547844374343,0.9175014124717268,1.0,97/287,27.50%,RNMT;DDX5;SON;SNRNP48;RBM6;SRSF11;MNAT1;THOC2;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;CELF1;FUS;USP49;RBMX;U2AF2;TCERG1;PABPC1;DDX42;ZCCHC8;SNRNP70;SCAF11;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;KIN;CHTOP;SF3B1;SF3B2;ERCC3;RNPC3;PRCC;U2AF1L4;RBM14;ESS2;ZC3H11A;LSM8;LSM2;SNRNP35;WBP4;THOC5;SNRNP40;SRSF2;SNW1;PNN;TRA2B;PRPF18;DBR1;ALKBH5;SRSF12;ZCRB1;RNGTT;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;AKAP8L;LSM4;NUDT21;CDC40;SUGP1;ERCC2;CSTF1;DHX8;PPIL1;RSRC1;CHERP;CPSF7;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;PRKACA;GTF2H3;SRSF7;CPSF4
prerank,negative regulation of response to wounding (GO:1903035),0.42103971669478946,0.9002537585771543,0.5801526717557252,0.917315568333092,1.0,2/19,3.29%,CD109;FGF2
prerank,negative regulation of macroautophagy (GO:0016242),0.381662688829416,0.9001944476895862,0.5913818722139673,0.9168974314744545,1.0,13/26,26.48%,CLEC16A;TMEM39A;SMCR8;MTOR;SMG1;SEC22B;NRBP2;USP36;RUBCN;LZTS1;CHMP4A;CHMP4B;PHF23
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.33420275072589567,-0.9001718127407231,0.6127167630057804,0.8678164119648951,1.0,5/23,11.62%,PARP14;NR1H3;HSP90AB1;NLRC5;STAT1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3598714264102306,-0.9000414323375142,0.6032171581769437,0.8670047462951697,1.0,6/16,17.49%,ACE;ADM;PRCP;KLK2;GSK3A;GPR37L1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3921486569189542,-0.9000411259449186,0.5848101265822785,0.8658972221795612,1.0,1/11,3.89%,AHR
prerank,anterograde axonal transport (GO:0008089),0.36392888340750523,0.8999844655960787,0.5908440629470673,0.9167921955893625,1.0,9/37,18.89%,AP3B1;KIF1B;DLG2;KIF1C;KIF3B;RAB27B;AP3D1;RAB21;AP3S1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.41594155248624626,0.8998305957648071,0.6022187004754358,0.9165664836343796,1.0,2/17,3.80%,NFE2L2;VNN1
prerank,myelin assembly (GO:0032288),0.45495011567097604,0.8998100792837479,0.5748709122203098,0.9160773021586787,1.0,2/10,3.78%,CD9;PMP22
prerank,regulation of GTPase activity (GO:0043087),0.30593922370819104,0.8994861418265363,0.6757940854326396,0.9161802420661714,1.0,33/177,11.77%,ARAP1;EFNA5;WNK1;WNT11;SGSM2;SIPA1L1;MAPRE2;VAV2;ARHGAP44;ITGB1;GSK3B;SRGAP2;NDEL1;RAP1A;SNX18;BCAS3;ADAP1;EPHB3;RDX;RAPGEF6;OCRL;RGP1;BCAR3;FGD6;RAB3GAP2;S100A10;NF1;LIMS1;CCL3;ERBB2;ARHGEF5;CCL1;ITGB1BP1
prerank,long-term memory (GO:0007616),-0.334620672249542,-0.8991124922770445,0.625,0.866914215050825,1.0,3/19,5.67%,APOE;RASGRF1;SGK1
prerank,regulation of protein targeting to membrane (GO:0090313),0.37413595326985205,0.8985476136512855,0.5981735159817352,0.9175191400668741,1.0,7/28,12.35%,KCNB1;DMTN;C2CD5;ERBB2;MIEF1;ITGB1BP1;CHP1
prerank,bone development (GO:0060348),0.3625863846857952,0.898289763380302,0.5896358543417367,0.91752463916529,1.0,7/39,7.50%,LRP6;AKAP13;SULF1;SFRP4;SKI;SLC10A7;P3H1
prerank,negative regulation of secretion by cell (GO:1903531),-0.28231429839614436,-0.8981516697971234,0.6357388316151202,0.8680084864817025,1.0,7/38,9.55%,IL1RAPL1;APOE;GRM7;NOTCH1;SYT11;SNCA;SLC30A1
prerank,protein ADP-ribosylation (GO:0006471),-0.3112312275140305,-0.8980885936073342,0.6261398176291794,0.8670423427522219,1.0,9/28,22.12%,PARP14;ART3;PARP16;PARP8;TIPARP;PARP11;SIRT5;PARP10;HPF1
prerank,regulation of microglial cell activation (GO:1903978),-0.3600947792461636,-0.8979657551578586,0.5844155844155844,0.8662368251709968,1.0,6/15,20.32%,SYT11;GRN;SPHK1;TTBK1;CX3CL1;TREM2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.32316821302562676,0.8977820455684334,0.6271820448877805,0.9180343531201469,1.0,11/85,12.18%,PIEZO2;ATP6V0A4;COL11A1;TBL1X;P2RX2;P2RX4;ROR1;CDC14A;SLC52A3;HOMER2;NIPBL
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3889472240713532,0.8971245394610077,0.5911111111111111,0.9187897960199288,1.0,11/26,28.10%,SETD2;CTR9;KMT2D;SETD5;ETFBKMT;KMT5B;WDR82;METTL21C;OGT;KMT2A;SETD1B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.24636277363153408,-0.8970586085084965,0.7383720930232558,0.8671592881133262,1.0,34/87,28.23%,IMMP2L;NDUFB9;NDUFAF4;SLC25A33;NDUFA8;NDUFC1;UQCC2;NDUFB11;NDUFAF8;NDUFB8;NDUFB3;COA3;PET100;NDUFA1;NDUFA3;SCO1;CHCHD4;COX18;NDUFS4;COX17;NDUFA11;NDUFA13;NDUFB7;COX20;FOXRED1;SDHAF3;NDUFA2;NDUFA6;COX19;DMAC1;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,microtubule-based transport (GO:0099111),0.4386125391355328,0.897051157859648,0.6091370558375635,0.9184157842861566,1.0,4/12,14.77%,DYNC1I1;SPAG17;CCDC40;DNAAF4
prerank,establishment of protein localization to organelle (GO:0072594),0.3314687678158411,0.8965178714237171,0.5989650711513583,0.9189330254420873,1.0,18/72,20.34%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;TNPO2;LRSAM1;ZDHHC15;SEC13;NUP153;NUP214;NUP188;NUP88;TSPAN17;NUTF2;RAN;TNPO3;HEATR3
prerank,response to light stimulus (GO:0009416),0.34414946683061814,0.8964806563823948,0.6136662286465178,0.9184708632399934,1.0,11/55,20.10%,UBE4B;CRY2;UBE2B;ERCC5;USP1;UVSSA;ERCC8;ERCC3;CIRBP;REV1;MAPK8
prerank,T cell homeostasis (GO:0043029),0.45384273617415427,0.8954496661834707,0.5612244897959183,0.9199372385747355,1.0,2/10,9.08%,PPP2R3C;RIPK3
prerank,negative regulation of response to external stimulus (GO:0032102),0.31928998824870386,0.8953805532926782,0.6437054631828979,0.9195432554629499,1.0,13/105,9.95%,CCN3;CD109;PRKCD;PTGIS;KLF4;FGF2;PTPN2;TRAFD1;ISL1;IL10;RORA;DRD3;IRAK3
prerank,regulation of mitochondrion organization (GO:0010821),0.3463653864597562,0.8953242261977653,0.607764390896921,0.9191337140384582,1.0,13/47,22.59%,PID1;GSK3B;GOLPH3;EP300;OMA1;PLSCR3;PRMT6;SQSTM1;SREBF1;CSNK2A2;USP36;PARL;RHOT1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3043813464177382,-0.8950514898121487,0.6428571428571429,0.8705300467132713,1.0,12/29,36.92%,DDO;ALDH4A1;SARDH;CBS;GOT2;HSD17B10;ACADSB;DAO;THNSL2;AADAT;GSTZ1;IL4I1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3259453552625905,-0.8949923989140798,0.6475644699140402,0.8695515992575718,1.0,6/24,13.42%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.45939659918361736,0.8949869634174105,0.5976430976430976,0.9192478897384397,1.0,1/10,2.86%,ANO6
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.34428613910954875,-0.8949630256108891,0.6284153005464481,0.868526670287387,1.0,2/16,3.90%,IGF1R;INSR
prerank,positive regulation of heart rate (GO:0010460),0.4083923615234361,0.8946284466997888,0.5912052117263844,0.9194484024514211,1.0,2/17,4.96%,ADRA1B;TRPM4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3327002122181938,-0.8941517790066649,0.6147540983606558,0.8692785845553765,1.0,13/21,32.98%,SLC30A10;PPARA;ABCB7;SIRT5;ABCD2;MT3;MMP3;SLC18A2;PINK1;PAX2;PLIN5;SIRT2;PARK7
prerank,regulation of programmed cell death (GO:0043067),0.3047691990342447,0.8939083621533395,0.6552486187845303,0.9203347036987418,1.0,21/161,11.89%,ACER3;PERP;SOX9;NDRG1;FBXO10;CRADD;ABL1;CASP6;VCP;CREBBP;CLU;GAS1;KANK2;RIPK3;WRN;RBM25;RARG;ATM;APEX1;DDX42;HTATIP2
prerank,regulation of establishment of protein localization (GO:0070201),-0.37177123424799063,-0.8938761071313198,0.599009900990099,0.8687740065743692,1.0,4/13,20.32%,CORO2B;CEP120;CTSD;TREM2
prerank,regulation of mitotic nuclear division (GO:0007088),-0.27211282345838606,-0.893778662414208,0.6627450980392157,0.8678886430200289,1.0,9/55,9.16%,IGF1;TGFA;PDGFRB;INSR;BMP7;OBSL1;CDK5RAP2;EDN1;RGCC
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3307949664678193,0.8936976184226743,0.6254728877679697,0.9202350347978214,1.0,13/70,11.31%,TMEFF2;FN1;PARVA;SRGAP2;NRP1;ANTXR1;ITGAV;EPHB3;GRHL2;RHOA;RAB25;ITGB3;RB1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3016282351341065,-0.8936610960300345,0.6127946127946128,0.867035664619635,1.0,10/31,13.72%,SHANK3;PPFIA2;EPHA4;LRP8;CFL1;ABI3;CAMK2B;CUX2;NGEF;KIF1A
prerank,regulation of macrophage differentiation (GO:0045649),-0.35839925113518345,-0.8936264783516688,0.6,0.8660087629457955,1.0,2/15,3.43%,IL34;CSF1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.43298929858079344,0.8934379374148543,0.585,0.920233623671194,1.0,4/13,19.88%,RENBP;UAP1;SLC35A3;GFPT1
prerank,protein autoubiquitination (GO:0051865),0.34334280329719585,0.8931563308294393,0.6129441624365483,0.9202593952213121,1.0,17/61,20.93%,WWP2;RNF115;RNF185;UBE2B;RNF141;UBE2D3;LRSAM1;RNF146;RNF122;CUL3;ERCC8;SH3RF3;BFAR;UHRF2;CNOT4;NFX1;RNF8
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.39160964711755497,0.8930732692135551,0.5846599131693199,0.9198876930310826,1.0,3/22,7.15%,CYP1B1;HES1;IL10
prerank,negative regulation of translational initiation (GO:0045947),0.44049396288743264,0.8930564432766435,0.6023688663282571,0.9193965992542581,1.0,7/13,26.50%,PAIP2;EIF3E;EIF2AK4;AGO2;FMR1;RBM4;EIF2AK1
prerank,axonogenesis (GO:0007409),0.295316827747891,0.8930052831827507,0.694560669456067,0.9189874682270686,1.0,29/237,9.35%,SLIT3;SLIT2;EZR;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;ULK2;PDLIM7;GRB10;SPTAN1;SHC1;NOTCH2;DOCK7;GAB2;KLF7;NRP1;SHTN1;ISL1;GDNF;PTPRA;EPHB3;EMB;SPG11;MAP1B;GLI2;NIBAN2;PARD3
prerank,negative regulation of protein depolymerization (GO:1901880),-0.328539418284935,-0.8929775609631259,0.61198738170347,0.8664132059286962,1.0,3/24,4.67%,PLEKHH2;NAV3;CLASP2
prerank,regulation of autophagosome assembly (GO:2000785),0.36913640886444954,0.892965290870325,0.6131386861313869,0.918544018989234,1.0,18/33,29.16%,NPRL3;RAB3GAP2;TMEM39A;LRSAM1;SMCR8;SH3GLB1;SEC22B;NPRL2;RAB5A;PIP4K2A;CHMP4A;CHMP4B;RAB3GAP1;PHF23;PIKFYVE;RALB;IFT88;FEZ2
prerank,organonitrogen compound catabolic process (GO:1901565),0.3378250108848545,0.8923219607687055,0.5974025974025974,0.9193119086946875,1.0,10/57,12.91%,NPEPPS;CPQ;PDXDC1;PLA2G15;IDE;LRSAM1;GADL1;ERAP1;RENBP;MTOR
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3357720549400451,-0.8922713327295024,0.606951871657754,0.8668778724651385,1.0,12/21,36.92%,PAG1;SAMSN1;DUSP3;JAK3;TNFAIP3;LAPTM5;FOXJ1;LST1;FCGR2B;FGL1;TNFAIP8L2;IL4I1
prerank,positive regulation of innate immune response (GO:0045089),0.381233991382024,0.8915898117041089,0.6032210834553441,0.9202379237675773,1.0,11/30,20.32%,LBP;MAVS;POLR3D;PLSCR1;IFI35;DHX9;TLR8;UBE2K;POLR3F;ADAM8;AKIRIN2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3387515189876513,0.8910555715790115,0.6248399487836107,0.9207562029275687,1.0,19/62,23.65%,NUP93;EIF4G1;STAT3;RANBP2;SEC13;NUP153;PUM2;DHX9;PUM1;NUP214;AGO2;NUP188;NUP88;PPARG;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,mitotic cell cycle phase transition (GO:0044772),0.29913092835951677,0.8910283976682504,0.683695652173913,0.9202974630623724,1.0,55/203,23.09%,FBXL7;CCNA2;INHBA;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;E2F3;CDC25B;CDC16;PPP2R2D;CEP164;CHEK2;PLK3;CDKN1B;CEP63;AURKA;FBXW11;ACVR1;PIM2;AKAP9;PPP1R12A;GSPT1;CEP131;FBXL6;RB1;CDKN3;CSNK1E;CUL3;UBE2S;CCND1;SDCCAG8;HINFP;CEP43;HAUS2;CUL1;CEP57;CDKN1A;KHDRBS1;CEP70;FBXL8;PPP6C;CSNK1D;ARPP19;E2F1;OFD1;CCNG1;WEE1;CUL4A;PLK4;FBXL17;CDK2;CCNB1;HAUS5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.34050587601892346,-0.8909010649481821,0.5808219178082191,0.8687273222373006,1.0,4/18,7.22%,APOE;CTSC;VGLL4;CD81
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2960499388709653,-0.8907584108226393,0.6329113924050633,0.8679823615125404,1.0,8/30,20.70%,HSPA8;ERO1A;HSPA13;PTGES3;CHCHD4;DNAJB5;HSPE1;HSPA9
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.450225827898516,0.8907136128681329,0.5926544240400667,0.9203853820067815,1.0,5/11,20.05%,STAT3;PUM2;DHX9;PUM1;FMR1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.425014626143458,0.8906978945927111,0.5595238095238095,0.9198903567243852,1.0,7/13,29.21%,ALG13;ALG14;ALG12;ALG3;DPAGT1;ALG9;MPDU1
prerank,steroid biosynthetic process (GO:0006694),-0.2663927154532224,-0.8905610747129188,0.673728813559322,0.8673336541982561,1.0,11/56,20.37%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;SCP2;CH25H;SC5D;SRD5A1;OSBPL7;SLC27A2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.3869912143929887,-0.8904337518334798,0.6137931034482759,0.8665715993504987,1.0,5/12,15.05%,PPARA;FUT9;MDK;ASS1;AKT1
prerank,regulation of metal ion transport (GO:0010959),-0.3431073462764783,-0.8903211090132594,0.6191780821917808,0.8657391058152883,1.0,5/16,11.40%,SLC30A10;EPB41;BCL2;CACNA2D1;CAMK2B
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4341684661620918,0.8900625226753234,0.5920826161790017,0.9206037876854726,1.0,4/13,12.67%,KPNA1;RGPD1;RANBP2;KPNA4
prerank,cellular glucan metabolic process (GO:0006073),0.4391853076230513,0.8900402992522823,0.5929054054054054,0.9201285661388865,1.0,3/11,8.72%,PPP1R3C;GSK3B;PHKB
prerank,mRNA metabolic process (GO:0016071),0.31716303904285376,0.8897001585759831,0.6375757575757576,0.920307883188998,1.0,23/90,22.13%,DDX5;SON;SRSF11;SRSF5;CELF1;DXO;U2AF2;TCERG1;SCAF11;LSM11;ZC3H12D;PRPF3;KIN;SF3B2;NUDT12;DIS3L2;LSM2;SRSF2;PRPF18;YTHDF2;ALKBH5;SSB;NANOS2
prerank,ribosomal large subunit assembly (GO:0000027),-0.30400875060756666,-0.8890310168342941,0.6758241758241759,0.8674786854397678,1.0,10/24,29.29%,RPL23A;RPL11;FASTKD2;RPL24;RPL3;RPL5;RPLP0;RRS1;DDX28;RSL24D1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3590870310504821,0.8882789680610552,0.624113475177305,0.9225633760867002,1.0,19/38,29.26%,UBN1;CABIN1;HIRA;ATRX;CENPT;SMARCA5;RBBP7;CENPQ;HJURP;IPO4;CENPU;RBBP4;CENPX;NASP;HAT1;CENPK;CENPC;CENPW;CENPL
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.28197465313930786,-0.8880901982770169,0.6556776556776557,0.8683812443492626,1.0,5/37,5.75%,APOD;PPARA;ADCY7;SIRPA;HIF1A
prerank,cellular protein catabolic process (GO:0044257),-0.2596994735345166,-0.8873798098344567,0.7086956521739131,0.8688262647521701,1.0,12/59,14.58%,CTSC;CTSH;ADAMTS12;DAB2IP;CTSB;CTSZ;CTSS;LGMN;CTSL;MYLIP;AFG1L;MALT1
prerank,ceramide metabolic process (GO:0006672),0.3424540554641925,0.8862866145623568,0.6317934782608695,0.9259558671774061,1.0,5/49,6.16%,ACER3;PLPP3;SGMS2;SPTSSB;PLA2G15
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2831213028971525,-0.8861889934371477,0.6917293233082706,0.8702950399888143,1.0,11/44,20.37%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;ALOX12;SCP2;CH25H;SC5D;OSBPL7;SLC27A2
prerank,cellular response to lectin (GO:1990858),0.313601006595617,0.8860327814354485,0.6378698224852071,0.9254181594352546,1.0,22/104,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.313601006595617,0.8860327814354485,0.6378698224852071,0.9254181594352546,1.0,22/104,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30349594939695357,0.8856692451971908,0.6837416481069042,0.9255881384441254,1.0,22/161,10.41%,TCF7L2;SOX9;MLLT3;LRP6;PTPRU;WNT11;GLI3;PRICKLE1;GSK3B;SFRP4;TLE2;NOG;TLE6;INVS;DDIT3;PSMB2;CSNK1A1;DACT1;DKK3;IGFBP6;PSMC6;EMD
prerank,regulation of steroid metabolic process (GO:0019218),-0.3249301590630043,-0.885452874729905,0.6325301204819277,0.8708324404986174,1.0,5/23,20.99%,APOE;ABCG1;NR1H4;ABCA2;RORC
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.35510909035771615,0.8852308889071244,0.6230661040787623,0.9259280339960914,1.0,16/45,26.47%,FOXO3;GCNT2;ZC3H7A;ATXN2;PER1;PUM2;TDRD7;PUM1;PUM3;LARP4;MATR3;RBM3;NUDT21;CYFIP1;RBM4B;MEX3D
prerank,arachidonate transport (GO:1903963),0.45193096723259496,0.8850956308097321,0.6120996441281139,0.9251644292606117,1.0,2/10,9.48%,ANXA1;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.45193096723259496,0.8850956308097321,0.6120996441281139,0.9251644292606117,1.0,2/10,9.48%,ANXA1;DRD3
prerank,response to interferon-beta (GO:0035456),-0.316923522012797,-0.8848757133346438,0.6088154269972452,0.8710208984251424,1.0,6/22,11.62%,IFITM1;BST2;AIM2;IFNAR2;IFITM3;STAT1
prerank,regulation of cation channel activity (GO:2001257),0.31888402197652815,0.8844218804085008,0.6446886446886447,0.9259813556577006,1.0,10/89,6.71%,ANK2;PTK2B;CAMK2D;AHNAK;SLMAP;ITGB1;FGF13;DLG2;DMD;DLG1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.32905407360309297,0.8842401275187036,0.6370370370370371,0.925821587423167,1.0,11/72,13.07%,SLIT2;PRKCD;FGF13;HDGFL3;LDLR;CLU;SHANK1;KANK4;KATNB1;LIMA1;SSH3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.37340595708547775,0.8842107566639538,0.6002928257686676,0.9253652919014567,1.0,3/27,1.94%,PDGFC;DDR2;FN1
prerank,negative regulation of platelet activation (GO:0010544),0.40585794307566647,0.8841131270811973,0.5940902021772939,0.9250388448816342,1.0,4/16,7.95%,PRKCD;CD9;THBD;PDGFA
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.44218389080145604,0.884097294364847,0.5843478260869566,0.9245543879285488,1.0,3/11,14.21%,NR4A3;IL10;REST
prerank,regulation of tube diameter (GO:0035296),-0.36827283862272087,-0.8832172747741782,0.628428927680798,0.8724469126266526,1.0,5/13,11.32%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,vascular process in circulatory system (GO:0003018),-0.36827283862272087,-0.8832172747741782,0.628428927680798,0.8724469126266526,1.0,5/13,11.32%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3750794670836389,-0.8829982467446943,0.615979381443299,0.871854867408725,1.0,6/13,24.31%,OAS2;IL6ST;STAT1;CRLF1;OASL;JAK1
prerank,mitochondrial protein processing (GO:0034982),0.43332954054077716,0.8827322886506441,0.5911413969335605,0.9266420670058959,1.0,7/11,27.57%,PMPCB;YME1L1;OMA1;IMMP1L;SPG7;MIPEP;STOML2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.32989866809766233,0.8824526304940126,0.6302414231257941,0.9266440647927578,1.0,13/66,17.78%,FOXP1;ISL1;STAT3;RIPK2;TLR4;CCL3;MYD88;ZC3H12A;CARD16;TLR8;TRIM16;NLRP12;TLR6
prerank,regulation of embryonic development (GO:0045995),-0.2944544904004544,-0.8823602196947795,0.6567656765676567,0.872179497827727,1.0,10/34,16.18%,PLCB1;INSR;CLASP2;SOX17;CFL1;DAG1;NR2C2;WDPCP;RBM19;RPS6KA6
prerank,heme catabolic process (GO:0042167),0.4276644926522467,0.8823330804648187,0.6151315789473685,0.9258323832492027,1.0,2/14,6.32%,ABCG2;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4276644926522467,0.8823330804648187,0.6151315789473685,0.9258323832492027,1.0,2/14,6.32%,ABCG2;HMOX2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.39055901484516364,0.8819628172515972,0.5971337579617835,0.9260572148248299,1.0,3/21,4.96%,SOX9;PTK2B;TRPM4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.31224690346162637,0.881893724731228,0.6444708680142688,0.9256765297550765,1.0,22/105,17.17%,PRKCD;NRAS;KRAS;TAB3;CREBBP;PSMB2;MUC6;KLRC2;CHUK;NFKB1;FBXW11;PLCG2;PSMC6;PAK2;EP300;PSMD11;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2821049854508438,0.8818771948842077,0.7898989898989899,0.9251918728373528,1.0,67/532,12.62%,F3;TNFRSF11B;CARD14;EDA;PTK2B;LBP;CAMK2D;TRAF3IP2;FN1;ANXA1;ANXA2;PRKCD;IL17RE;IL22RA1;FOXO3;CD44;GRB10;PITPNA;SHC1;MID1;ITGB1;FGF2;GAB2;IRS1;IP6K2;CLCF1;PDCD4;TAB3;CD80;IL17RA;IRAK4;STAT3;RIPK2;PSMB2;MAP3K3;IFI35;IL10;IRF1;SOCS2;CDKN1B;CXCL2;FOXC1;RORA;TNFRSF13B;CHUK;CTF1;NFKB1;FBXW11;IL33;IRAK3;LIMS1;IL18BP;PSMC6;CDIP1;VEGFA;IL20RB;TRIM26;CCL3;CAPZA1;TIMP1;CCL1;MYD88;TRAF5;IL5;TNFRSF1B;CSK;SMARCA4
prerank,regulation of cholesterol esterification (GO:0010872),-0.38213117256986,-0.8813878398028575,0.6099773242630385,0.873160297637895,1.0,5/10,20.17%,APOE;ABCG1;AGT;ABCA2;APOC1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3541976939970334,-0.8813401980322411,0.6098191214470284,0.8722086695132373,1.0,1/15,0.45%,LEF1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.4254037039330496,0.8812014765652059,0.5848434925864909,0.9259673651341103,1.0,6/13,19.88%,XPO1;LTV1;EIF6;NUP88;ABCE1;RAN
prerank,glucan catabolic process (GO:0009251),0.4069937314217875,0.8810418775898705,0.5775577557755776,0.9257658046995202,1.0,3/15,8.72%,PYGB;PHKA2;PHKB
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.38094684578223675,0.8808252798375522,0.6057401812688822,0.9256993799704666,1.0,1/24,0.43%,PLCE1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3931677530774244,-0.8807243267718344,0.5849056603773585,0.8724717848997241,1.0,3/10,19.98%,RAPGEF3;PIH1D1;SPHK2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3544868871217003,0.8805604290789567,0.6121883656509696,0.9256874264657668,1.0,10/37,18.52%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;PML;TLK2;CSNK2A2;CSNK2A1
prerank,mitotic chromosome condensation (GO:0007076),0.37833071800123935,0.8804019552629957,0.592814371257485,0.9254736352721764,1.0,11/26,29.51%,SMC4;RB1;NCAPH2;KMT5A;CSNK2A2;CSNK2A1;CCNB1;AKAP8L;MCPH1;NCAPD3;SMC2
prerank,regulation of microtubule nucleation (GO:0010968),-0.3862997951931898,-0.8801299913819143,0.6426799007444168,0.8726823425978706,1.0,2/10,11.69%,PAK1;ARHGEF7
prerank,positive regulation of cilium assembly (GO:0045724),-0.33495833067267733,-0.8800768765763465,0.649867374005305,0.87171788646963,1.0,3/18,6.87%,CEP120;CCDC88A;TAPT1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3656237025514343,-0.8796660876770775,0.6275510204081632,0.8715753561308085,1.0,3/14,9.51%,RPS3;CD81;NECTIN2
prerank,ncRNA export from nucleus (GO:0097064),0.3534864403053655,0.8796124660149667,0.6028571428571429,0.9264814963649969,1.0,19/36,31.60%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;NUP155;NCBP2;XPOT;RAE1;NOL6;TSC1;SEH1L
prerank,cellular response to cAMP (GO:0071320),0.3663429286729172,0.87954335582468,0.6077265973254086,0.926080318013038,1.0,6/30,10.04%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN;AKAP9
prerank,long-chain fatty acid transport (GO:0015909),-0.29931038568891394,-0.8788723736917206,0.6229508196721312,0.8722562384851775,1.0,7/30,10.64%,ACSL1;APOE;PRKAG2;ACACB;PRKAA2;FABP5;MFSD2A
prerank,negative regulation of proteolysis (GO:0045861),0.3589996302391936,0.8787604836441154,0.6458923512747875,0.9270682420544334,1.0,9/34,15.59%,PTPN3;TIMP2;GAS1;IL10;DNAJC1;TIMP1;SNX12;ACP4;SERPINE2
prerank,hexose metabolic process (GO:0019318),-0.28095535157141033,-0.8783850585766516,0.7133105802047781,0.8722223335535932,1.0,12/39,23.44%,APOD;PPARD;PGM1;ALDOC;ALDOA;AKR1A1;PMM2;DCXR;KHK;CHST1;GALT;FUCA1
prerank,regulation of osteoclast differentiation (GO:0045670),0.3613523601617139,0.8783567735009679,0.6143497757847534,0.9273550657641849,1.0,6/33,13.67%,UBASH3B;TLR4;CCL3;TCTA;MTOR;TNFSF11
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3443059152012547,0.878303736819469,0.637906647807638,0.9269396518973342,1.0,8/47,10.77%,FOXO3;KLF4;INHBA;AGTR1;EIF4G1;CNDP1;NFKB1;ATXN2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.35802202911311254,0.8780664117878891,0.6115007012622721,0.9268624941205894,1.0,7/35,13.30%,HOXA5;FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3440444364716618,0.8780456345805291,0.5947802197802198,0.9263827138617968,1.0,11/44,11.77%,SORBS3;TGFB3;WNT11;ABL1;NRP1;TGFBR1;ARHGEF10;S100A10;RHOA;ARHGEF5;ITGB1BP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3195764972264522,0.8775812488990832,0.6427656850192062,0.926768318877937,1.0,7/73,4.29%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1;NR4A3
prerank,cardiac muscle cell differentiation (GO:0055007),0.38996413216620474,0.8775425743592188,0.6105919003115264,0.926334586381345,1.0,4/21,10.33%,AKAP13;CXADR;ACVR1;VEGFA
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41795092909993586,0.8774769648213488,0.6312399355877617,0.9259530995764604,1.0,4/15,8.86%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.379624035804607,0.8774532491165565,0.6348228043143297,0.9254973061098039,1.0,6/26,11.71%,MET;CLIP1;TOGARAM1;AKAP9;KATNB1;SLAIN2
prerank,response to retinoic acid (GO:0032526),0.3286265663050045,0.8771592424163343,0.6338582677165354,0.9255378323854004,1.0,9/59,9.99%,WNT9A;SOX9;PTK2B;WNT11;FZD7;RXRA;RARG;RARA;ATM
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.29167904664875094,-0.8770254565723073,0.6482758620689655,0.8740852486352241,1.0,4/34,8.56%,RBP4;WNT5A;SLC7A5;LACC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3824171409358304,0.8770071595626413,0.5965463108320251,0.9253170498444885,1.0,1/22,1.39%,CD55
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.41447786421979554,0.8769182396279995,0.6116666666666667,0.9249840294845699,1.0,6/15,22.63%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1
prerank,tRNA transport (GO:0051031),0.35775317350197006,0.8765769659062712,0.6104651162790697,0.9251469430878209,1.0,18/35,31.60%,NUP93;RANBP2;SEC13;NUP153;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;TOMM20;NUP155;XPOT;RAE1;NOL6;SEH1L
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3663383124157569,-0.8759674730961327,0.629156010230179,0.87521543505715,1.0,2/13,7.48%,RNF152;SPAAR
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.3614136787356138,-0.8751917164521406,0.6225,0.8758460654696707,1.0,4/13,17.50%,NR1H3;AQP11;NUPR1;NR1H2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.32947060312017407,0.8750788784788969,0.6271637816245007,0.927444475236847,1.0,16/59,21.83%,TANK;ERC1;TAB3;RIPK2;REL;TLR4;CHUK;IRAK1BP1;TRADD;TLR8;IKBKG;BCL10;BIRC3;RNF31;LY96;RBCK1
prerank,homotypic cell-cell adhesion (GO:0034109),0.3507318342148158,0.8747377794971545,0.6035665294924554,0.9275703273383794,1.0,10/39,14.96%,FN1;PLPP3;UBASH3B;VCL;CLIC1;GATA1;ITGB3;DSC2;CEACAM5;GNAS
prerank,ERAD pathway (GO:0036503),0.3162587281263546,0.8746641365875184,0.6600741656365884,0.9271978600748998,1.0,19/83,22.98%,UBE4B;USP13;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;UFD1;TRIM25;ECPAS;UGGT2;FAF2;HERPUD1;FBXO27
prerank,regulation of cytokine production (GO:0001817),-0.22843345422886252,-0.8745828124516314,0.8050847457627118,0.8760527190824092,1.0,27/126,15.89%,CADM1;LYN;RPS6KA5;PLA2R1;LGR4;DTX4;SRGN;CD47;SIRPA;C1QTNF3;SYT11;ADRA2A;AFAP1L2;ATP2B1;GAPDH;MOG;RGCC;ACE2;MIF;BCL6B;ICOSLG;LURAP1;TRIM21;AGT;TRIM56;BTN3A3;NLRP4
prerank,positive regulation of stem cell differentiation (GO:2000738),0.41145084132907106,0.8744320238386043,0.6029411764705882,0.9271411440381797,1.0,5/16,9.79%,SOX9;LTBP3;GATA4;FOXC1;HOXB4
prerank,import into nucleus (GO:0051170),0.31864114240637326,0.8733434193158898,0.6370757180156658,0.9286797691195124,1.0,17/73,20.34%,PRICKLE1;NUP93;STAT3;IPO7;E2F3;TNPO2;HTATIP2;SEC13;NUP153;NUP214;NUP188;GEMIN8;NUP88;NUTF2;RAN;TNPO3;HEATR3
prerank,tRNA modification (GO:0006400),0.3342060965085334,0.8731712760649016,0.6418300653594772,0.9284868119184337,1.0,24/62,30.94%,TYW5;ELP5;MTO1;TYW1;ALKBH8;TRMT13;PUS10;METTL6;CTU2;TRMT10A;TARBP1;TRDMT1;MOCS3;METTL1;SSB;PUSL1;QTRT1;THADA;GTPBP3;PUS7;THUMPD2;URM1;TRMT12;FTSJ1
prerank,negative regulation of hippo signaling (GO:0035331),0.42118262638788007,0.8730981836697189,0.6156351791530945,0.9281032333862643,1.0,2/12,9.89%,CIT;MARK3
prerank,regulation of cell motility (GO:2000145),0.3049592084212269,0.8728225781470178,0.680365296803653,0.9281101007079424,1.0,12/121,7.73%,EGFR;NTN1;LMO4;FGF2;ABL1;LMNA;DIAPH1;CCDC125;SGK3;MGAT3;CCDC25;MEMO1
prerank,regulation of exosomal secretion (GO:1903541),0.3900161504522917,0.8726817923396485,0.594383775351014,0.9278635562413562,1.0,8/19,25.05%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;ATP9A;RAB7A
prerank,negative regulation of JUN kinase activity (GO:0043508),0.44524953092743325,0.8726266129122707,0.5815972222222222,0.9274547143515623,1.0,2/10,11.49%,PDCD4;DUSP10
prerank,selective autophagy (GO:0061912),0.3315525316653686,0.8724508244212577,0.6395348837209303,0.9272629610211671,1.0,22/56,26.67%,ULK2;BECN1;DYNC1I1;ACBD5;RB1CC1;ATM;WDR81;DDRGK1;UBA5;SQSTM1;AMBRA1;DYNC1LI2;NBR1;ATG2A;UBE2N;ULK1;LGALS8;UBE2V1;RAB7A;ATG5;USP30;PCNT
prerank,ncRNA metabolic process (GO:0034660),0.35124136781463283,0.8724283314560644,0.6164383561643836,0.9267910819835625,1.0,10/37,19.88%,DDX17;ZCCHC8;TDRD9;DGCR8;TUT7;AGO2;TDRD12;TUT4;DROSHA;RAN
prerank,tRNA methylation (GO:0030488),0.35823807100877997,0.8722446850835127,0.624633431085044,0.9266147100794813,1.0,18/34,33.55%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;DALRD3;TRDMT1;METTL1;TRMT1L;THADA;GTPBP3;THUMPD2;TRMT12;FTSJ1;METTL2A;METTL2B;TRMT44
prerank,regulation of G0 to G1 transition (GO:0070316),0.3519004098553896,0.8719543991331082,0.6228571428571429,0.9266422924996126,1.0,18/38,26.54%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;EPC1;RBBP8;RRM2;EHMT2;RAD51;RBBP7;E2F1;E2F6;MGA;YAF2;PCGF6;RBBP4
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.35634543510663047,0.8715559437085448,0.6109589041095891,0.9269167263466332,1.0,11/33,23.06%,TELO2;STN1;ANKRD28;PPP6R3;RPA1;RAD51;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.355671779502553,-0.8715547573351897,0.6517412935323383,0.8812763154292779,1.0,3/14,5.04%,PRKD1;LOXL3;CD63
prerank,lymphocyte differentiation (GO:0030098),0.3237374594674773,0.8714039182437707,0.6442687747035574,0.9267127171867092,1.0,8/68,7.15%,HDAC4;PBX1;HDAC9;ITGB1;CLCF1;PTPN2;NFIL3;IL10
prerank,presynapse organization (GO:0099172),-0.4018992201301026,-0.8713166803376283,0.6433734939759036,0.880713319074051,1.0,2/10,7.72%,WNT5A;LRRTM3
prerank,global genome nucleotide-excision repair (GO:0070911),0.3754900440326207,0.8712958483363007,0.6352201257861635,0.9264168785952456,1.0,10/26,27.33%,CHD1L;RAD23B;RNF111;ERCC3;XPA;ERCC1;CUL4A;ERCC2;XPC;GTF2H3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4038491010588041,0.8712879887558397,0.6108374384236454,0.9259277042583551,1.0,2/17,3.11%,CD55;BMP6
prerank,regulation of viral genome replication (GO:0045069),-0.26433313983748535,-0.8710725549188585,0.7253218884120172,0.8801962253890618,1.0,19/56,21.26%,PPARA;PPIA;IFITM1;BST2;IFITM3;OAS2;PROX1;HACD3;RNASEL;NR5A2;ADARB1;TARBP2;IFIT1;ADAR;DDX3X;PPIE;OASL;PARP10;BANF1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3636978471308153,-0.8710458996861296,0.650990099009901,0.879183234724369,1.0,3/14,15.03%,CSF1;ATP6AP1;TYROBP
prerank,regulation of translational initiation (GO:0006446),0.3284332281598756,0.870936899374503,0.6654040404040404,0.9260776225942148,1.0,21/63,24.56%,EIF4G3;PAIP2;EIF4G1;NCK2;DNAJC3;EIF3E;EIF2AK4;EIF2B2;AGO2;MTIF2;KHDRBS1;EIF4B;FMR1;EIF4G2;YTHDF2;DDX1;NCK1;EIF2AK3;RBM4;CDC123;YTHDF3
prerank,activation of adenylate cyclase activity (GO:0007190),0.36083832366491886,0.8706462194542094,0.6307471264367817,0.9261190233937437,1.0,3/35,4.22%,EDNRA;ADRB2;ADCY9
prerank,lipid modification (GO:0030258),0.35575816297500057,0.870446606101904,0.6326241134751773,0.9259800774670757,1.0,5/37,10.30%,PLPPR2;PLPP3;DGKA;MBOAT1;MBOAT4
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3224620405053466,-0.8703253686145676,0.6404494382022472,0.879592343823236,1.0,4/20,17.28%,APOE;KPNB1;NR1H4;ABCA2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.44840486011799263,0.8698717158512661,0.5936395759717314,0.9265212944478342,1.0,2/10,10.19%,ESR1;PSMC6
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3075964857108885,0.869688607722067,0.6785290628706999,0.9263318739829363,1.0,22/104,19.01%,LRP6;CCNA2;ADRB2;ABL1;TELO2;MNAT1;CDK12;CDKN1B;RHOA;PPEF2;SYAP1;CAB39;LRP5;RB1;CDKN3;GTPBP4;CCND1;MAP2K2;TSG101;CDKN1A;SNF8;CCNT1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2241728165853204,-0.869460076716665,0.8367346938775511,0.880347741706665,1.0,37/158,17.19%,TNFRSF19;PRKD1;WLS;LPAR1;TFRC;PELI2;NOD1;PRKCB;TRIM14;LGALS1;GJA1;ATP2C1;BST2;CXXC5;GPRC5B;TNFSF10;TRIM62;GAPDH;LITAF;ZDHHC17;CFLAR;TNIP2;TMED4;SLC44A2;CCL19;NDFIP2;EDAR;CD74;LURAP1;MALT1;TRIM21;CD40;TNFRSF1A;PLK2;CASP1;TIFA;TSPAN6
prerank,negative regulation of MAPK cascade (GO:0043409),0.3174176654129871,0.8692105393901418,0.6744186046511628,0.9267449452085825,1.0,14/87,11.77%,BMP4;EZR;PRKCD;SPRED2;PTPN2;DLG1;CBLC;TLR4;PPEF2;NF1;IRAK3;PRDM15;DUSP10;ITGB1BP1
prerank,neuron development (GO:0048666),0.29831491093149093,0.8690201581122388,0.6984126984126984,0.9266053952693855,1.0,12/141,6.04%,VSX1;PBX3;NEDD4;PBX1;WNK1;RP1;GSK3B;DOCK7;HDGFL3;THOC2;ARL3;GDNF
prerank,regulation of gastrulation (GO:0010470),-0.36149938297048656,-0.8688419508056264,0.6501305483028721,0.8806059702972763,1.0,6/14,18.30%,TENM4;CLASP2;OSR1;DAG1;RACK1;LHX1
prerank,pre-miRNA processing (GO:0031054),-0.35830971048263743,-0.8678491676040778,0.622107969151671,0.8816848507589914,1.0,5/14,17.95%,LIN28B;AGO4;TARBP2;ADAR;AGO1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3711374961873177,-0.8676044014425734,0.6177215189873417,0.881107301396606,1.0,4/12,17.28%,CLCN2;KPNB1;H6PD;ABCA2
prerank,lipoprotein catabolic process (GO:0042159),-0.38657581190790724,-0.8675033888007592,0.6331658291457286,0.8802595082427705,1.0,4/11,17.42%,APOE;NOTUM;CTSD;ABHD17C
prerank,regulation of urine volume (GO:0035809),-0.3814806707056246,-0.867086781036689,0.6183908045977011,0.880061124403174,1.0,6/10,29.23%,NPR1;ADM;HYAL2;INPP5K;HAS2;TFAP2B
prerank,negative regulation of blood pressure (GO:0045776),-0.36119355292997557,-0.866812111568854,0.6498740554156172,0.8795746115452217,1.0,8/13,33.83%,NOS3;PRCP;GPR37L1;NOS2;NOS1;DRD2;BMPR2;APLN
prerank,membrane fusion (GO:0061025),-0.2816466210060554,-0.8650930998562731,0.6787003610108303,0.8820235598900932,1.0,3/33,3.39%,DNM3;RIMS1;DYSF
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3797243600613972,0.865088660654283,0.6308623298033282,0.9334124272230856,1.0,4/24,10.71%,MAP7D3;FGF13;HDGFL3;KATNB1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2820360698463503,-0.8650019370861024,0.6900958466453674,0.8811567418631476,1.0,7/37,8.16%,CEMIP;PRKAG2;BMP7;CALM1;APP;SPRED1;SPHK1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3548763638119705,0.8648211250469866,0.6225626740947076,0.9334191558043483,1.0,12/38,16.93%,TANK;ESR1;RORA;USP10;PER1;OTUD7B;ZC3H12A;PPM1A;TNIP1;CCDC22;TRIM39;NLRP12
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3320990723379114,-0.8647831237114955,0.6282051282051282,0.8805982210438283,1.0,7/18,24.31%,ST18;IL6R;IL6ST;STAT1;SPI1;CEBPA;JAK1
prerank,regulation of MAP kinase activity (GO:0043405),0.30914058246969217,0.8647100984677404,0.6645962732919255,0.9331400761138536,1.0,14/92,11.10%,EGFR;BMP4;PDGFC;PRKCD;FGFR1;FGF2;CDK12;CBLC;PDGFA;PPEF2;NF1;IRAK3;VEGFA;ERBB2
prerank,purine ribonucleotide transport (GO:0015868),0.4076514577727763,0.8646650321519479,0.6274193548387097,0.9327094453208941,1.0,1/16,1.31%,LRRC8D
prerank,JNK cascade (GO:0007254),0.3523731086960354,0.8645839557587184,0.6497252747252747,0.9323407819376354,1.0,4/40,6.91%,MAP3K5;TAB3;RIPK2;ARHGEF6
prerank,DNA strand elongation (GO:0022616),0.3988872408222646,0.8642651637574652,0.6363636363636364,0.9324304083938971,1.0,6/18,21.84%,MCM7;GINS3;NBN;POLA1;POLD3;RAD50
prerank,endothelial cell differentiation (GO:0045446),0.41755492518061305,0.8641347445807078,0.6365159128978225,0.9321772709903006,1.0,2/12,6.70%,FSTL1;JAG1
prerank,positive regulation of GTPase activity (GO:0043547),0.29448888255127537,0.8639007105851942,0.7231947483588621,0.93210916770077,1.0,43/188,15.09%,NTRK3;ARAP1;WNT11;SGSM2;SIPA1L1;MAPRE2;ITGB1;GSK3B;DOCK7;BCR;SRGAP2;NDEL1;RAP1A;SNX18;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;RAPGEF6;RGP1;BCAR3;ARHGEF10;S100A10;NF1;LIMS1;TBC1D2B;TBC1D13;CCL3;ERBB2;ARHGEF5;CCL1;TIAM1;TBC1D25;CORO1C;RAP1GAP2;ASAP3;ARHGAP42;SIPA1L2;TBC1D10A;TBC1D8B;RSU1;TBC1D5
prerank,adenine nucleotide transport (GO:0051503),0.4015490254379393,0.8638434120343167,0.6222222222222222,0.9317055997856367,1.0,1/17,1.31%,LRRC8D
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4179535895826665,0.8634257683916443,0.6077057793345009,0.9319540517601188,1.0,2/11,12.52%,PTGIS;ZC3H12A
prerank,pore complex assembly (GO:0046931),0.3842678314295699,0.8634111646982804,0.6298507462686567,0.9314705862534344,1.0,8/19,22.21%,ANO6;NUP93;NUP153;ADAM10;AHCTF1;AFDN;NUP98;TMEM170A
prerank,negative regulation of histone methylation (GO:0031061),-0.39418968570653123,-0.8633950514579983,0.6481481481481481,0.8824221830071637,1.0,3/10,19.39%,JARID2;MTF2;AASS
prerank,macrophage activation involved in immune response (GO:0002281),0.4164078870497323,0.8627715057994736,0.6165540540540541,0.9321550616375822,1.0,3/13,9.84%,LBP;IFI35;PLCG2
prerank,determination of left/right symmetry (GO:0007368),0.34730473143745144,0.8621792414272847,0.6366197183098592,0.9328112689953079,1.0,11/36,21.70%,SMO;PITX2;GALNT11;CCDC40;MEGF8;STIL;DNAAF4;KIF3B;ODAD3;OFD1;ODAD2
prerank,cellular response to oxidative stress (GO:0034599),0.299888013818269,0.8619557298605454,0.6942823803967327,0.9327385520007823,1.0,13/118,10.18%,EGFR;PRKCD;FOXO3;NFE2L2;ABL1;WNT16;GPX8;MGAT3;VKORC1L1;GSR;CHUK;JUN;CCS
prerank,tRNA metabolic process (GO:0006399),-0.33287375825874754,-0.8617898784439221,0.6552631578947369,0.8846097245268771,1.0,6/17,25.73%,DARS2;POP5;POP7;SARS1;DTD1;RPP21
prerank,polyol metabolic process (GO:0019751),0.3415049198130957,0.8617423881093146,0.6343490304709142,0.9326238269811985,1.0,9/46,9.84%,PLCE1;PLCB3;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3976820116149896,0.8615241611635263,0.622792937399679,0.9325120303198223,1.0,2/17,6.08%,CD44;KDM1A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3011469403171983,0.8615029601332928,0.711340206185567,0.932047768788226,1.0,27/124,17.11%,TCF7L2;PPP3CA;WNT11;PLCB3;PRICKLE1;FZD7;AP2A2;PDE6A;SFRP4;PSMB2;MOV10;TNRC6C;FZD1;NLK;AP2A1;RHOA;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;NFATC1;PSMD1;CELSR3;AGO2;PSMC1;PSMD7
prerank,cellular response to starvation (GO:0009267),0.2950568498658136,0.8612775269837987,0.7160633484162896,0.9319593742568685,1.0,38/147,20.10%,MAP3K5;FOXO3;DAPL1;NPRL3;WIPI2;KLF10;ZFYVE1;BECN1;VPS41;CLEC16A;RRAGB;ITFG2;WRN;MLST8;SIK2;INHBB;USP33;ZC3H12A;CASTOR2;SEC13;MTOR;SH3GLB1;ATP6V0D1;EIF2AK4;TCIRG1;ATF2;ATP6V0E1;SREBF1;EIF2S1;SZT2;CDKN1A;GAS2L1;EHMT2;RHEB;WDR45B;ATP6V1H;NPRL2;MAPK8
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3925800347639554,0.8612026565599569,0.6427480916030535,0.9315944626961186,1.0,8/19,25.50%,MTOR;PRDX5;ZNF76;POLR3F;DHX36;ICE2;TENM1;AR
prerank,histone H2A acetylation (GO:0043968),0.40335376231284703,0.8611298133528511,0.6265822784810127,0.9312198714374146,1.0,8/16,27.77%,NAA40;TRRAP;EP400;EPC1;BRD8;DMAP1;ING3;MORF4L2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3474811545902366,0.8606598297665836,0.6444444444444445,0.9316035903319643,1.0,15/40,29.96%,WRN;BOD1L1;DDX11;ATRX;MCM9;SMARCAL1;RAD51;ATR;FANCM;EXD2;FAM111A;CENPX;ALYREF;PRIMPOL;RFWD3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3461637092055396,0.8605984131718247,0.6433666191155493,0.9312031232040362,1.0,22/37,32.66%,PCM1;IFT46;WDR35;DYNC2I2;CEP131;IFT52;TRIP11;KIF3B;DYNC2I1;IFT80;DYNC2H1;CLUAP1;TRAF3IP1;IFT88;IFT43;TTC21B;IFT27;IFT122;IFT74;KIF17;IFT22;KIFAP3
prerank,intermediate filament organization (GO:0045109),0.3982451027277818,0.8604593258288538,0.6373801916932907,0.930946124421862,1.0,3/17,7.23%,DSP;KRT14;PKP1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.32961060948740634,-0.8601770625054403,0.6626506024096386,0.8868248807183755,1.0,6/18,15.05%,PPARA;PAG1;DUSP3;ASS1;AKT1;JAK3
prerank,proteoglycan biosynthetic process (GO:0030166),0.3601869892442829,0.8601122299874431,0.6440422322775264,0.9310892430696167,1.0,7/31,11.26%,EXT1;CHST13;GLCE;FOXL1;XYLT1;B3GALT6;CHST11
prerank,positive regulation of exosomal secretion (GO:1903543),0.4057623000822341,0.859968150277393,0.629881154499151,0.9308688610653876,1.0,7/15,25.05%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;RAB7A
prerank,microtubule anchoring at centrosome (GO:0034454),0.43550610121960165,0.8599402552291228,0.6335616438356164,0.9304205612932086,1.0,2/10,6.12%,NIN;PCM1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.30244651820457197,-0.859807361680502,0.6629834254143646,0.8864742106641413,1.0,12/25,27.88%,SHANK3;MEF2C;CACNG4;CACNG7;GSG1L;SHISA9;RELN;CNIH3;SHISA8;CACNG8;CACNG3;MAPK8IP2
prerank,negative regulation of organelle assembly (GO:1902116),0.35205588606140814,0.8597788949352148,0.6412103746397695,0.9302236347389438,1.0,10/35,17.98%,LIMK2;STYXL1;TMEM39A;SMCR8;KAT2A;SEC22B;KAT2B;RBM14;CEP97;CDK10
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.40641853631748676,0.8593283556115145,0.627318718381113,0.9305390200304339,1.0,4/14,16.59%,USP15;PUM2;PUM1;ANKRD17
prerank,hemidesmosome assembly (GO:0031581),-0.3687187882438526,-0.8592316778412653,0.6305882352941177,0.8865542647432424,1.0,4/11,14.93%,ITGA6;DST;LAMC2;LAMC1
prerank,mitotic cytokinesis (GO:0000281),0.3370254684430647,0.8591559067392078,0.6589358799454298,0.9303706451700963,1.0,7/47,12.32%,CIT;SNX18;SON;PDCD6IP;ARL3;TTC19;CNTROB
prerank,alanine transport (GO:0032328),-0.3789741409930908,-0.8590882341547029,0.6269662921348315,0.8858352999689785,1.0,4/10,24.06%,SLC6A6;SLC6A17;SLC36A2;SLC7A10
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3847227195670966,0.8588333574438092,0.6198473282442748,0.9304752037556999,1.0,8/21,18.25%,MED13;BCLAF1;JUN;HNF1A;MED14;TWIST1;MED24;DHX36
prerank,cellular response to virus (GO:0098586),0.35818204727997455,0.8587270778780495,0.6382660687593423,0.9301607264986514,1.0,9/30,23.94%,VWCE;GBF1;CHUK;ZC3H12A;IFIH1;RRP1B;FMR1;IRF3;LGALS8
prerank,cellular response to lipopolysaccharide (GO:0071222),0.30389710340996623,0.8585589804024913,0.6623981373690337,0.9299655793016416,1.0,19/101,12.85%,LBP;ADAM9;PRKCE;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;MTDH;TRIM41;CCL3;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3637617687524366,0.8584195875273856,0.6337209302325582,0.9297195128889427,1.0,12/29,24.60%,GDNF;PKP1;FUS;PABPC1;THRAP3;CIRBP;TENT5D;FMR1;NBAS;E2F1;TAF15;TENT5C
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.36506950369066393,0.8578760660944982,0.6208955223880597,0.9302385586054891,1.0,11/25,27.02%,SCAF11;SRRM1;PRPF3;SF3B1;SNRNP40;TRA2B;DBR1;TXNL4A;SF3B3;SMNDC1;PRPF6
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.33263077475200453,0.8578413152613767,0.652232746955345,0.9298105208996069,1.0,7/54,13.04%,NXN;HDAC8;PIAS3;U2AF2;USP4;CHP1;GTPBP4
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3657954529174161,-0.8572372138080331,0.6643026004728132,0.888491358242965,1.0,4/12,12.02%,PARP16;PARP8;TIPARP;PARP11
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2962877194306365,0.8572131696707932,0.7068965517241379,0.9304587976729536,1.0,49/148,24.83%,USP2;HIPK1;SMYD2;EXO1;EHMT1;CHEK2;PLK3;MDM4;RAD17;WRN;AURKA;MLST8;ATM;PPP2R5C;USP7;MTOR;CHEK1;EP300;CHD3;DYRK2;PML;TAF12;RBBP8;RPA1;RMI2;TOP3A;TAF4;BARD1;NBN;KMT5A;EHMT2;ATR;RBBP7;CSNK2A2;CSNK2A1;TOPBP1;PAK1IP1;PHF20;CCNG1;RAD9B;RAD50;PRMT5;CDK2;TAF15;RFC5;BRIP1;POU4F1;PIP4K2A;KAT5
prerank,mRNA catabolic process (GO:0006402),0.3343487280270763,0.8569638605114137,0.6697986577181209,0.9304264973229994,1.0,12/44,22.13%,DDX5;DXO;ZC3H12D;TUT7;THRAP3;NUDT12;DIS3L2;TUT4;LSM2;NBAS;YTHDF2;NANOS2
prerank,N-glycan processing (GO:0006491),-0.3213805247387871,-0.8568140135824995,0.6853658536585366,0.8882893279095587,1.0,5/18,8.43%,ST8SIA4;MAN1C1;ST8SIA6;MAN2A2;ST8SIA1
prerank,calcium ion import (GO:0070509),0.36206528132558125,0.8566207743931399,0.6302395209580839,0.9305411098901373,1.0,6/28,10.38%,CACNA1C;CACNA1G;CASR;CACNA1F;MCUB;MCU
prerank,regulation of lipid metabolic process (GO:0019216),0.30984619076776476,0.8564221722352452,0.6857825567502986,0.9304124106915272,1.0,23/88,19.22%,TNFAIP8L3;CHD9;CREBBP;TBL1X;ID2;RXRA;NFYA;RORA;SCD;MVD;NCOR1;HNF4A;NCOR2;PLPP1;HMGCR;GNB3;SREBF1;CARM1;NCOA6;FDPS;PPARG;ABCA7;ADIPOR1
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.28640557945149026,-0.8561310930046246,0.6887417218543046,0.8885753668249855,1.0,7/34,9.70%,RUNX1T1;FOXO1;ENPP1;WNT5A;GATA2;CCDC85B;LRP3
prerank,synaptic vesicle transport (GO:0048489),0.4115914935344297,0.8560275624806707,0.6326164874551972,0.9306409636399233,1.0,3/11,13.79%,SPG11;TMEM230;SYNJ1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3412273545607961,-0.8556210390463781,0.664804469273743,0.8885776321044098,1.0,5/16,24.07%,CLDN5;CLDN1;CLDN10;CLDN18;CLDN14
prerank,apoptotic nuclear changes (GO:0030262),-0.310801395348775,-0.8551272815786554,0.656891495601173,0.8885224719853667,1.0,10/24,24.71%,CECR2;BLCAP;CASP3;ACVR1C;KPNB1;FOXL2;GPER1;TOP2A;H1-0;DFFA
prerank,nucleocytoplasmic transport (GO:0006913),-0.2777584268295452,-0.8550943368523412,0.7326007326007326,0.8875324859953372,1.0,11/40,23.40%,ATXN1;BACH2;ANP32A;NPM1;SNRPG;MALT1;DDX20;NUP205;RBM15B;NXT2;PHAX
prerank,GPI anchor metabolic process (GO:0006505),0.3702467149335647,0.8547710163448864,0.6477611940298508,0.932427011437492,1.0,11/26,26.24%,PGAP2;PIGB;DPM1;PIGU;PIGL;PIGN;PIGH;PGAP3;PIGQ;MPPE1;PIGA
prerank,autophagosome organization (GO:1905037),0.33723829577877834,0.8545293098101846,0.6696891191709845,0.932408127474884,1.0,15/50,26.19%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG5;ATG7
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.25058304777602636,-0.8544041748574325,0.7669902912621359,0.8878742747423387,1.0,24/70,27.10%,ENPP2;SLC44A1;NR1H3;LPIN3;DBI;ABHD3;PNPLA8;MFSD2A;SLC44A2;CHKA;TMEM86B;LPIN1;NR1H2;SLC27A1;PLAAT3;PCYT1B;PLA2G4C;PLA2G7;PLA2G5;PEMT;ACHE;PLA2G4E;PLBD1;PLB1
prerank,cellular response to hexose stimulus (GO:0071331),0.37131781165790534,0.8542995240668946,0.6450151057401813,0.9323378550262412,1.0,4/23,4.23%,KCNB1;UNC13B;SLC26A6;SLC39A14
prerank,oogenesis (GO:0048477),-0.3382493239024707,-0.8539834594826876,0.6573604060913706,0.8876949010741138,1.0,5/15,21.08%,FMN2;MDK;NANOS3;TRIP13;METTL3
prerank,endocytic recycling (GO:0032456),0.3309094908075706,0.8539560092978278,0.6493860845839018,0.932453845351067,1.0,22/50,25.05%,RAB11FIP3;EHD3;ANKRD27;EHD1;EHD2;ENTR1;SNX12;CCDC22;SNX31;SNF8;WASHC1;VPS52;VPS51;SNX4;RAB11B;RAB35;VPS53;CMTM6;VPS26C;SNX17;VPS29;RAB7A
prerank,negative regulation of GTPase activity (GO:0034260),-0.31249022391972436,-0.8536897139623234,0.664576802507837,0.8873035178428016,1.0,10/22,20.86%,CPEB2;F11R;LRCH1;DAB2IP;GMIP;SH3BP4;RASA4;PLXNB3;GPSM1;HRAS
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37859229030325786,0.8536228807760301,0.6507177033492823,0.9325675033819213,1.0,3/20,6.03%,PID1;MRAP;RHOQ
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3017154810988113,-0.8535227166664245,0.6567164179104478,0.8866147039928892,1.0,8/25,19.74%,CEMIP;AKAP6;SNCA;PLCG1;TRPC1;APLNR;CX3CL1;GPER1
prerank,autophagosome assembly (GO:0000045),0.3355731022291944,0.8531742615327104,0.6636363636363637,0.932926083269386,1.0,16/52,26.19%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;SMURF1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG5;ATG7
prerank,membrane lipid metabolic process (GO:0006643),-0.3134063263176167,-0.8530444592411259,0.6768802228412256,0.8865708300793848,1.0,5/22,8.25%,ST3GAL6;CERK;GAL3ST1;SPHK1;SERINC1
prerank,regulation of rRNA processing (GO:2000232),0.4015139441364585,0.8528178323101465,0.6402640264026402,0.933090668435212,1.0,6/16,23.13%,WDR43;KAT2B;USP36;YTHDF2;WDR75;RIOK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30313997733302833,-0.8519091508671194,0.6753623188405797,0.8878831385045713,1.0,9/24,20.74%,BCL2;CXCL12;BCL2L1;TPT1;MIF;CD74;TRIAP1;CCAR2;ING2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2727755320350991,-0.8518514022512139,0.7127272727272728,0.8869663722217392,1.0,14/41,22.47%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;NR1H4;VSIR;SELENOS;TNFAIP3;CX3CL1;CHRNA7;TRIM27;CACTIN
prerank,positive regulation of peptidase activity (GO:0010952),0.38044592485795015,0.8514663718922586,0.627831715210356,0.9350937023244297,1.0,4/20,12.53%,TANK;VCP;MAPK12;DDRGK1
prerank,neuromuscular process controlling balance (GO:0050885),-0.3607649754122274,-0.851293018150311,0.6428571428571429,0.8870337349718087,1.0,2/12,4.46%,NRXN1;PCDH15
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3216288575376763,-0.8511161321302793,0.6899441340782123,0.8863481687547232,1.0,1/18,0.71%,LYN
prerank,neutrophil degranulation (GO:0043312),0.27571191487929,0.850529123998921,0.8307849133537207,0.9362939776794248,1.0,72/425,16.11%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,positive regulation of cytokine production (GO:0001819),0.27815256423930984,0.8503795842578136,0.7952182952182952,0.9360737575527825,1.0,41/292,14.40%,F3;FOXP1;CYP1B1;LBP;ANXA1;SULF1;RAB7B;ZBTB7B;CD80;IL17RA;CREBBP;ISL1;CD2;STAT3;MAVS;GATA4;DDIT3;POLR3D;RIPK2;IL10;IRF1;TLR4;RORA;CD46;NFKB1;IL33;PLCG2;RARA;HILPDA;NFKB2;CCL1;MYD88;KAT2A;IFIH1;PRKDC;PIBF1;XRCC5;EP300;HTR2B;TLR1;DHX9
prerank,neurotrophin signaling pathway (GO:0038179),0.3799613224182279,0.8500898972946622,0.6417445482866043,0.9361020167482672,1.0,3/21,4.43%,NGF;RAP1A;KIDINS220
prerank,positive regulation of neuron death (GO:1901216),0.33305186109526475,0.8499349672419682,0.662873399715505,0.935890934378071,1.0,8/46,10.91%,MAP3K5;FOXO3;GSK3B;DDIT3;CLU;TLR4;NF1;CCL3
prerank,neutrophil mediated immunity (GO:0002446),0.2754952804187375,0.8498526796891152,0.8391038696537678,0.9355475620302164,1.0,73/432,16.11%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;IRAK4;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.37913213107395705,0.8496922712611116,0.6618819776714514,0.935356231758305,1.0,5/20,15.02%,PID1;MRAP;RHOQ;CSK;PPFIA1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.38662091288586975,0.8496841532429419,0.632183908045977,0.9348767387800757,1.0,3/18,5.51%,PTK2B;BCAS3;SHTN1
prerank,positive regulation of hydrolase activity (GO:0051345),0.29441001754966517,0.8495327208062348,0.7209567198177677,0.9346799274591246,1.0,24/137,11.35%,ARAP1;WNT11;SGSM2;MAPRE2;ITGB1;GSK3B;SRGAP2;NDEL1;RAP1A;SNX18;BCAS3;RAPGEF6;RGP1;BCAR3;S100A10;RHOA;RIPK3;WRN;NF1;LIMS1;MAPK12;CCL3;ERBB2;CCL1
prerank,TOR signaling (GO:0031929),-0.2990150893808613,-0.849416238330914,0.6952380952380952,0.8885562749945367,1.0,7/26,15.05%,PRR5L;CCDC88A;EIF4EBP2;TIPRL;EIF4EBP1;RICTOR;AKT1
prerank,regulation of vacuole organization (GO:0044088),0.3798591425032466,0.8492777924431156,0.639871382636656,0.9346649395256877,1.0,2/20,4.76%,ANXA2;NPRL3
prerank,positive regulation of T cell activation (GO:0050870),-0.2468918334075369,-0.8488087147853577,0.7478991596638656,0.8886909993708106,1.0,15/62,19.67%,VCAM1;TFRC;CD47;SIRPA;PRKCQ;RHOH;CD81;IL6ST;MDK;CCL19;JAK3;CD276;DOCK8;XBP1;CCL2
prerank,response to peptide hormone (GO:0043434),0.33844591008405384,0.8486906027959417,0.6575342465753424,0.9352257832559271,1.0,12/43,20.86%,ANXA1;IGFBP5;IRS1;ZBTB7B;STAT3;EIF6;STAT5A;EIF2B2;TRIM16;STAT6;STAT4;EIF2B3
prerank,response to cytokine (GO:0034097),0.29154244492927783,0.8477800215325056,0.7193763919821826,0.9364355399293044,1.0,28/141,15.69%,DPYSL3;HDAC4;PID1;ADAM9;ANXA1;NFAT5;AFF3;COL3A1;PTPN2;TIMP2;STAT3;PLSCR1;SETD2;REL;IKBKE;RHOA;IRAK3;IL18BP;TIMP1;MYD88;PTPN9;IFNLR1;CXCR4;MAPKAPK2;PRKCA;ADAM10;PML;DDOST
prerank,neutrophil activation involved in immune response (GO:0002283),0.2747105690730099,0.8476396577700133,0.840122199592668,0.9362005216780745,1.0,72/428,16.11%,CD55;ANXA3;ANXA2;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;VNN1;DIAPH1;IGF2R;RAP1A;RAB6A;UBR4;BRI3;VCP;VCL;ACP3;DNAJC3;FRK;ITGAV;TIMP2;HMOX2;B4GALT1;DNAJC5;CYSTM1;CRACR2A;SLPI;PTGES2;PKP1;DERA;JUP;RAP2C;ARSB;GPI;PAFAH1B2;RHOA;IQGAP1;NFKB1;CAB39;KCMF1;SNAP23;AMPD3;GLB1;BIN2;CKAP4;TNFRSF1B;CPNE3;TMEM179B;ATP11A;XRCC5;TOM1;PSMD11;RAB24;TCIRG1;GOLGA7;PSMD1;IST1;ADAM10;RAB4B;DDOST;PLD1;CLEC5A;NIT2;CPNE1
prerank,telomere organization (GO:0032200),0.3366886098216286,0.8476362632462691,0.681757656458056,0.935709508784445,1.0,12/43,21.84%,STN1;WRN;ATM;APEX1;PRKDC;XRCC5;RPA1;NBN;ATR;PARP3;POLD3;RAD50
prerank,hemopoiesis (GO:0030097),0.30783038197245677,0.8475982308651373,0.6920245398773006,0.9352813992931993,1.0,10/87,7.15%,BMP4;MFAP5;ZBTB16;HIPK1;INHBA;NOTCH2;MKNK2;TGFBR2;JAG1;IL10
prerank,regulation of autophagy (GO:0010506),0.2815138480729967,0.8475524477143157,0.7627302275189599,0.9348789010859289,1.0,36/216,13.55%,MET;NEDD4;EXOC4;EIF4G3;FOXO3;USP13;DAPL1;GSK3B;ABL1;FOXK1;TAB3;EIF4G1;KLHL22;STAT3;DDIT3;TPCN1;RRAGB;IL10;WDR41;MLST8;SNX32;PIM2;RB1CC1;ATM;MTDH;USP10;SMCR8;CISD2;ATF6;FOXK2;USP33;ZC3H12A;MTOR;EP300;SH3GLB1;ATP6V0D1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3512452549562646,0.847533054285336,0.657856093979442,0.9344183344509757,1.0,4/33,7.15%,TCF7L2;NFE2L2;CAST;IL10
prerank,negative regulation of catalytic activity (GO:0043086),-0.3101938936053883,-0.847402573656733,0.7,0.8904665767310417,1.0,7/24,20.98%,NOTCH1;NES;CAMK2A;IFIT1;MT3;CCAR2;CAND1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4300931818193414,0.8471980929458927,0.6472663139329806,0.9345439655000448,1.0,1/11,1.20%,BMP5
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3819326615194752,-0.8469428843824075,0.6689814814814815,0.8903578978509556,1.0,4/10,15.41%,PARP14;NF2;INPP5F;SH2B3
prerank,lipid homeostasis (GO:0055088),-0.25510257272449793,-0.8467733753341363,0.7702127659574468,0.8896479654451419,1.0,16/57,22.05%,APOE;NR1H3;ABCA1;ZBTB20;PRKAA2;ABCG1;PNPLA8;ABCB4;ORMDL3;ABCA2;CLN8;XBP1;DDX3X;TREM2;CEBPA;USF2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4329598977992205,0.8465005708214531,0.6513605442176871,0.9352914559163311,1.0,4/10,16.65%,TUT7;DIS3L2;CHFR;TUT4
prerank,mitochondrial translational elongation (GO:0070125),0.3033958753876408,0.8463603184717711,0.7072570725707257,0.935056268276259,1.0,33/88,30.78%,MRPL33;MRPL48;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;MRPL9;MRPS34;MRPS16
prerank,regulation of TORC1 signaling (GO:1903432),0.34338842587417545,0.8461305986233607,0.6642651296829971,0.9349778897962708,1.0,9/33,12.58%,TELO2;KLHL22;CLEC16A;RRAGB;ITFG2;SIK3;ATM;SMCR8;CASTOR2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3396826641796974,-0.8461119039123279,0.6740196078431373,0.8898977788282045,1.0,1/16,0.56%,AUTS2
prerank,granulocyte differentiation (GO:0030851),-0.321175382119512,-0.8456758354163217,0.7209302325581395,0.8896786058375713,1.0,3/18,8.33%,LEF1;CBFA2T3;TAL1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3917438756768923,0.8453392798216294,0.6429780033840947,0.9359224347554093,1.0,2/17,5.73%,ANK2;SNTA1
prerank,fluid transport (GO:0042044),0.399309015997918,0.8450736631955285,0.6299483648881239,0.9359314184953387,1.0,2/12,9.82%,SLC26A6;AQP6
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.30835476022587704,0.8445372486559236,0.6938775510204082,0.936433847248512,1.0,6/70,3.61%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.36276999232407325,0.84436962282577,0.6611940298507463,0.9362275286059749,1.0,5/26,10.84%,EFNA5;KLF7;TRPM4;CLTRN;LRP5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.36945448901721256,-0.8443342234511008,0.6572890025575447,0.8913749178542655,1.0,2/12,10.36%,CYP26B1;CALR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3076125038883827,0.8436601609323706,0.6871008939974457,0.9369882569690372,1.0,6/71,3.61%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3738832191529788,-0.8435777074457335,0.6697674418604651,0.8917585841086461,1.0,3/11,11.99%,PAK1;RAC1;STMN1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3850142446860775,0.843239657971665,0.653160453808752,0.9372495275896496,1.0,2/18,3.80%,NFE2L2;VNN1
prerank,cellular response to fluid shear stress (GO:0071498),0.4019622271935258,0.8431323008162845,0.6539735099337748,0.9369441870433185,1.0,2/12,3.18%,KLF4;NFE2L2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.33278839648718855,0.8429002545086856,0.6689466484268126,0.9368760125686832,1.0,4/45,3.02%,CAMK2D;PRKCD;CD44;MID1
prerank,RNA stabilization (GO:0043489),0.3459237115360258,0.842765180104526,0.6624649859943977,0.9366314537329657,1.0,15/33,27.24%,GDNF;FUS;PABPC1;THRAP3;DHX36;TRDMT1;CIRBP;TENT5D;E2F1;TENT2;NAF1;TAF15;TENT5C;PARN;VIP
prerank,cell-substrate junction assembly (GO:0007044),0.34806544628912467,0.8423426267164843,0.6785206258890469,0.9369146131091521,1.0,8/33,12.78%,FN1;SORBS1;BCR;PIP5K1A;KRT14;CTTN;PLEC;TRIP6
prerank,positive regulation of receptor internalization (GO:0002092),-0.30376186744272293,-0.8421230712676293,0.6887608069164265,0.8935131737793052,1.0,6/22,15.48%,INSR;CD63;ARRB1;NTF3;ARRB2;GREM1
prerank,cellular amino acid catabolic process (GO:0009063),-0.229847354643966,-0.841588440360558,0.7801418439716312,0.8934674216549661,1.0,29/87,28.90%,NOS3;DDO;ALDH7A1;ASPA;BCKDHB;ALDH4A1;QDPR;IVD;SARDH;MCCC2;CBS;ECHS1;GOT2;BCKDHA;AASS;GCDH;GLDC;GLUD1;NOS2;SHMT2;HAL;NOS1;HSD17B10;ACADSB;ALDH5A1;DAO;CRYM;BCKDK;ABAT
prerank,response to histamine (GO:0034776),-0.37297571435887583,-0.8410403154554291,0.6413301662707839,0.8935009792736939,1.0,4/10,15.04%,GABRB1;GABRB2;GABRB3;HRH1
prerank,myelination (GO:0042552),0.323417344350268,0.8407428916209361,0.6798365122615804,0.9392427642479186,1.0,8/46,9.90%,ACER3;MARVELD1;PMP22;SKI;ARHGEF10;PARD3;NF1;ADGRG6
prerank,positive regulation of lipid storage (GO:0010884),0.37439095646213083,0.8406529310431973,0.6650717703349283,0.9389106174496623,1.0,5/21,12.52%,IKBKE;NFKB1;HILPDA;EHD1;ZC3H12A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2667517664158878,-0.8403242130345675,0.7527675276752768,0.89388361681929,1.0,14/43,22.47%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;NR1H4;VSIR;SELENOS;TNFAIP3;CX3CL1;CHRNA7;TRIM27;CACTIN
prerank,positive regulation of protein kinase activity (GO:0045860),0.28660779480112913,0.8403175559368721,0.7446569178852643,0.9390534398575577,1.0,20/148,10.86%,RASSF2;CCN1;PTK2B;DDR2;PRKCD;ADRB2;RAP1A;TELO2;TGFBR2;CLU;MARK2;RHOA;RIPK3;IQGAP1;SYAP1;VEGFA;CAB39;STRADA;CLSPN;ITGB3
prerank,cellular lipid catabolic process (GO:0044242),0.3566188192249392,0.839984776737855,0.65,0.9391522497274604,1.0,5/27,9.62%,CYP1B1;PLA2G15;ACOT8;ACBD5;LPIN2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3278663727729908,-0.8399198499714269,0.6963350785340314,0.8936595314684329,1.0,6/17,18.39%,CLDN5;F11R;S1PR3;ROCK2;TNFRSF1A;CDH5
prerank,response to axon injury (GO:0048678),0.3832683842316388,0.8392634051951648,0.6591276252019386,0.9399204709923094,1.0,1/18,0.87%,DPYSL3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.30595056618099997,0.8387270792973465,0.7221526908635795,0.9404330994651348,1.0,27/80,27.58%,PRICKLE1;FAM107A;KDM1A;RIPK2;BIRC7;MYCBP2;DCUN1D5;COMMD1;MTA1;FBXO4;CUL3;BCL10;FANCM;BIRC3;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;HUWE1;TSPYL5;SMAD7;TRAF6;ARRDC3;PHF23;CENPX;PEF1;RCHY1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.35899784918643307,0.8386251703057408,0.6741405082212257,0.9401195809108416,1.0,5/28,11.71%,MET;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,endosome organization (GO:0007032),0.3417577574062659,0.837894890091498,0.6846473029045643,0.9409444597189985,1.0,13/41,23.96%,EEA1;WASHC5;CORO1C;SQSTM1;HOOK3;ANXA8;ANXA8L1;TMCC1;WASHC4;PLEKHF1;HOOK2;RNF26;PHETA2
prerank,positive regulation of macroautophagy (GO:0016239),0.3320309820506271,0.8377997673561615,0.6881868131868132,0.9406228997188698,1.0,12/48,17.03%,ADRB2;RAB3GAP2;PAFAH1B2;LRSAM1;VPS13D;WAC;HSPB8;SMCR8;SH3GLB1;BAG3;IKBKG;SCOC
prerank,regulation of protein localization to cell surface (GO:2000008),-0.27552431152252377,-0.8376275491829479,0.7233333333333334,0.8969069163232503,1.0,5/33,8.73%,NEDD4L;PICALM;GPM6B;HSP90AB1;ACTN2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.36119268038613733,0.8374902458944125,0.6882352941176471,0.9406849550694277,1.0,9/26,14.84%,GSK3B;ATP2B4;SLC9A1;PLCG2;HOMER2;CHP1;RCAN1;DYRK2;LMCD1
prerank,DNA replication initiation (GO:0006270),0.34389435689170395,0.8370736994487483,0.676595744680851,0.940962226661065,1.0,12/37,25.30%,MCM7;MCM2;CDC45;PRIM2;POLE2;RPA1;PRIM1;TOPBP1;POLA1;NOC3L;CDK2;ORC3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2948387544646893,0.8370636215215957,0.7436208991494532,0.9404907026515117,1.0,16/101,11.55%,EGFR;PKD1;PDGFC;TCIM;ADRB2;FGFR1;FGF2;TELO2;ATP2B4;PDGFA;RHOA;SYAP1;VEGFA;CAB39;ERBB2;CCNYL1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3438148250466792,-0.8369150198461683,0.6984924623115578,0.8972191784135615,1.0,6/15,25.55%,RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.38653731475500985,0.8369043934278356,0.6362126245847176,0.9402848518965331,1.0,3/16,8.72%,PYGB;PHKA2;PHKB
prerank,toxin transport (GO:1901998),0.4218453985925762,0.8368880271101062,0.6433566433566433,0.9398287148365538,1.0,3/10,15.41%,ANTXR1;ANTXRL;ADAM10
prerank,regulation of protein ubiquitination (GO:0031396),0.2932261049939485,0.8364752593174686,0.7303634232121923,0.9400805489212202,1.0,23/108,21.00%,NXN;PRICKLE1;FAM107A;TGFBR1;HDAC8;RIPK2;BIRC7;MYCBP2;COMMD1;U2AF2;USP4;CHP1;FBXO4;GTPBP4;CUL3;SQSTM1;BCL10;PER2;BIRC3;UBE2N;WASHC1;DCUN1D1;HUWE1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.30164958479056825,0.8362638208298483,0.7220216606498195,0.939976403861708,1.0,18/86,20.49%,EGLN3;NFE2L2;CREBBP;DDIT3;HIF3A;PSMB2;PSMC6;VEGFA;CHEK1;EP300;PSMD11;BAG3;PSMD1;PSMC1;PSMD7;INO80;PSMD14;PSMD3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.30527762027083194,-0.8360340689743939,0.7470238095238095,0.8978908932084176,1.0,6/26,13.42%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2988705513713627,0.8358213545957709,0.7172330097087378,0.9402876038768534,1.0,8/93,7.11%,RASSF2;MAP3K5;PTK2B;MID1;FZD7;GADD45G;WNT16;GDF6
prerank,positive regulation of lyase activity (GO:0051349),-0.34195934735666544,-0.8351607559431531,0.7238805970149254,0.8985390521088921,1.0,2/14,1.98%,CACNA1D;NOS3
prerank,histone H3 acetylation (GO:0043966),0.3325443955808944,0.8350389918017086,0.6704067321178121,0.9412113372342847,1.0,23/40,30.09%,KAT6B;TADA3;SGF29;BRCA2;PER1;KAT2A;BRD1;KAT2B;TRIM16;TAF12;YEATS2;PHF14;LDB1;MAP3K7;JADE2;KAT14;KAT6A;NAA60;TAF9;TADA2A;TAF6L;TADA1;TAF5
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4029469211456629,0.8346757469005575,0.6447811447811448,0.9413856343487593,1.0,2/13,3.29%,FGFR1;FGF2
prerank,presynapse assembly (GO:0099054),-0.3375499224810645,-0.8344085267876216,0.7055555555555556,0.898814866719661,1.0,3/16,7.72%,IL1RAPL1;WNT5A;LRRTM3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.31293257257485096,0.8343501590611189,0.7127003699136868,0.9414958436329668,1.0,7/75,5.13%,THBS1;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,regulation of establishment of planar polarity (GO:0090175),0.3020413787608811,0.8343092251981385,0.7311827956989247,0.941076695236094,1.0,26/88,23.10%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;AP2A1;RHOA;DACT1;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMC1;PSMD7;PSMD14;DVL1;FZD2;PSMD3;CDC42;FZD3;SPEF1;CELSR1
prerank,peptide hormone secretion (GO:0030072),0.36105619377314485,0.8342953087554068,0.6799387442572741,0.9406161350347337,1.0,3/26,9.15%,ANXA1;LTBP4;SNX19
prerank,regulation of cellular component size (GO:0032535),0.34635670076671654,0.8338969543349426,0.6788321167883211,0.9408509703697948,1.0,7/30,15.69%,EZR;VAV2;RDX;RARG;RAP1GAP2;MTOR;RIN3
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.31799368176893883,-0.8330959772019525,0.692722371967655,0.9002777905636745,1.0,3/18,8.02%,DCN;KDR;SPIRE1
prerank,regulation of axon extension (GO:0030516),0.3353859588406353,0.832969998655137,0.6902777777777778,0.9419891342581916,1.0,4/37,5.51%,NTN1;GSK3B;ABL1;SHTN1
prerank,positive regulation of viral life cycle (GO:1903902),-0.30005849574276844,-0.8326592035899435,0.6950146627565983,0.900121397126518,1.0,5/22,19.12%,LGALS1;AXL;TYRO3;CD74;P4HB
prerank,glutathione derivative metabolic process (GO:1901685),-0.31568874468507546,-0.8324986937650507,0.7267441860465116,0.8983662880797066,1.0,9/20,26.40%,HPGDS;GSTA4;MGST1;GSTK1;ESD;AKR1A1;GSTM1;GSTA3;MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.31568874468507546,-0.8324986937650507,0.7267441860465116,0.8983662880797066,1.0,9/20,26.40%,HPGDS;GSTA4;MGST1;GSTK1;ESD;AKR1A1;GSTM1;GSTA3;MGST3
prerank,muscle cell development (GO:0055001),0.34778622082074173,0.8324383651031055,0.666191155492154,0.9423804986666757,1.0,6/30,6.08%,ANK2;CXADR;HES1;DMD;NEBL;KDM1A
prerank,regulation of response to oxidative stress (GO:1902882),-0.3693683584640216,-0.8320690341632512,0.7025641025641025,0.8981229990818108,1.0,3/11,19.67%,MCTP1;STOX1;GGT7
prerank,triglyceride biosynthetic process (GO:0019432),-0.326099887774133,-0.8315263146607124,0.6888888888888889,0.8980831673906157,1.0,6/18,15.51%,LPGAT1;GK;LPIN3;GPAM;DGAT1;LPIN1
prerank,DNA conformation change (GO:0071103),0.3775186588194353,0.831466101808319,0.6447368421052632,0.9436682082001615,1.0,7/17,27.45%,ABL1;TOP1;ERCC3;TOP3A;TOP1MT;HAT1;KAT6A
prerank,MAPK cascade (GO:0000165),0.2715729753133907,0.8314631341884212,0.8305785123966942,0.9431871653607549,1.0,37/295,11.10%,EGFR;MET;MAP3K5;SOX9;PTPN3;NRAS;KRAS;MRAS;SPTAN1;FGFR1;SHC1;FGF13;FGF2;IRS1;MEF2A;PDE6D;SHOC2;DLG2;ITGAV;GDNF;IL17RD;PTPRA;PSMB2;DLG1;MAP3K3;PDGFA;ABHD17B;DUSP5;CHUK;NFKB1;FBXW11;NF1;MARK3;PSMC6;MAPK12;CCL3;ERBB2
prerank,regulation of nervous system development (GO:0051960),0.33267522907191077,0.8314391800284168,0.6887052341597796,0.9427419168474233,1.0,9/37,22.51%,HES1;DOCK7;BHLHE40;TNFRSF1B;PER2;HEYL;YTHDF2;HES3;HES7
prerank,negative regulation of viral process (GO:0048525),-0.24545284463910014,-0.8313571501160263,0.8046511627906977,0.8973647125296685,1.0,22/57,27.94%,TRIM14;PPIA;IFITM1;BST2;TRIM62;IFITM3;OAS2;PROX1;RNASEL;STAT1;TRIM21;IFIT1;OASL;PARP10;TRIM27;BANF1;RSAD2;IFITM2;TRIM8;CCL5;TRIM32;TRIM6
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.35559419141417603,0.8310722251341954,0.6734397677793904,0.9428744357067153,1.0,3/28,6.18%,MAP3K5;TMEM117;DDIT3
prerank,axonal fasciculation (GO:0007413),-0.35610931123121414,-0.8309852717075682,0.6763990267639902,0.897071465299612,1.0,7/12,25.53%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,regulation of amyloid-beta clearance (GO:1900221),0.38936573051381085,0.829995721084971,0.6650246305418719,0.94428051620951,1.0,3/16,6.20%,LRPAP1;LRP1;CLU
prerank,regulation of acute inflammatory response (GO:0002673),-0.31904288026179384,-0.8297863434979116,0.6994818652849741,0.8983406546189996,1.0,2/18,10.57%,OSMR;IL6ST
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37724616445187265,0.8295387037276502,0.6777777777777778,0.9446160921246209,1.0,11/18,37.33%,CDC25B;CCND1;RAD51C;CCNB1;MECP2;RAD51B;DTL;BRD4;RAB11A;FBXO5;CDK1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.41519712958722793,0.829441480428829,0.6597582037996546,0.9443023197894573,1.0,5/11,33.14%,RENBP;UAP1;GFPT1;GNPDA1;AMDHD2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.24514332852469753,-0.8294372926617559,0.8127659574468085,0.8979899964985644,1.0,20/55,24.09%,BCL2;TPD52L1;BCL2L1;DAB2IP;RPS3;TNFSF10;FAS;WWOX;BOK;BMF;AGT;NUPR1;RACK1;TNFSF12;HYAL2;GPER1;DNM1L;PMAIP1;PYCARD;G0S2
prerank,triglyceride catabolic process (GO:0019433),0.372425633237541,0.8293278835655326,0.6557632398753894,0.944036880305027,1.0,1/19,3.45%,PNPLA3
prerank,regulation of immune response (GO:0050776),0.2853282123435348,0.829124098270041,0.7447795823665894,0.9439162030042946,1.0,11/135,9.51%,FOXP1;CXADR;COL3A1;ITGB1;RAET1E;SPPL2A;PLSCR1;IRF1;PVR;RIPK3;TREML1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.35824564123517105,0.8289601057302007,0.6656441717791411,0.9437247744767289,1.0,6/24,17.02%,NFE2L2;DDIT3;VEGFA;ATF6;CREB3L1;CREB3L3
prerank,cellular protein-containing complex assembly (GO:0034622),-0.21252868334624445,-0.8285180920102847,0.9259259259259259,0.8987338100807626,1.0,30/159,17.09%,TCF4;FMOD;SGIP1;PICALM;IMMP2L;RPL38;PIK3C2A;PDE4DIP;SNCA;HIP1R;MAPT;HSP90AB1;RTN4;HIP1;DNAI4;HOPX;COX7A2;NSG1;BIN1;POMP;CYBA;CASQ2;EIF4H;ANLN;EPS15;PTGES3L;GPX4;PTGES3;CHCHD4;HIGD1B
prerank,protein tetramerization (GO:0051262),0.3069604963182586,0.8284946521843684,0.7175866495507061,0.944071491754458,1.0,2/67,1.11%,KCNJ2;PKD1
prerank,melanosome organization (GO:0032438),0.35077015518864374,0.8284788600335267,0.6691285081240768,0.9436140052903753,1.0,6/26,18.17%,KIF13A;AP3B1;HPS4;PMEL;LYST;AP3D1
prerank,lipid droplet organization (GO:0034389),0.37970898819584076,0.8283985488126436,0.6816770186335404,0.9432687243229356,1.0,9/22,26.41%,PNPLA3;ZFYVE1;HILPDA;CDS1;SMIM22;RAB18;FAF2;BSCL2;RAB3GAP1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.39359057629395244,0.8280323687920378,0.6592082616179001,0.9434189065637333,1.0,4/13,10.33%,SEMA3E;NRP1;TGFBR2;VEGFA
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.349055811021625,0.8279933691511736,0.6652236652236653,0.9430007282792033,1.0,10/29,27.05%,ABL1;DCUN1D5;FEM1B;DCUN1D4;DCUN1D2;UBE2N;DCUN1D1;SMAD7;ARRDC3;FEM1A
prerank,cellular response to gamma radiation (GO:0071480),0.390529406963002,0.8279869752149012,0.6602564102564102,0.9425303838510759,1.0,6/17,17.95%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,nucleoside salvage (GO:0043174),0.4210777786483082,0.8275682751542492,0.6707317073170732,0.9427693882162546,1.0,3/10,15.90%,UPP2;TK1;TK2
prerank,cholesterol transport (GO:0030301),0.3265111822579941,0.827397126628508,0.6858345021037868,0.9426063967934636,1.0,7/45,12.80%,SOAT1;TSKU;LDLR;CLU;STARD4;LIMA1;LCAT
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4035001458558889,0.827253897620592,0.6733333333333333,0.94238946688648,1.0,2/12,6.12%,NIN;PCM1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.36421208415000683,0.827186646794219,0.6645669291338583,0.9420322631515998,1.0,2/20,2.86%,NT5E;ANO6
prerank,epithelial cell morphogenesis (GO:0003382),0.3811859212372538,0.8270009659285796,0.7012578616352201,0.9418651291368917,1.0,3/17,9.21%,MET;GRHL2;RAB25
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.33098531686055754,0.8269179817414875,0.7030386740331491,0.9415244469806314,1.0,8/42,10.33%,PTK2B;GSK3B;ABL1;NRP1;JUP;S100A10;LIMS1;VEGFA
prerank,long-term synaptic potentiation (GO:0060291),0.3668817037990706,0.8265098766812724,0.6570561456752656,0.9417775255499069,1.0,3/21,5.30%,PTK2B;MPP2;NFATC4
prerank,platelet aggregation (GO:0070527),0.34092266027270657,0.826315652536187,0.6695156695156695,0.9416060155086322,1.0,6/33,10.86%,FN1;UBASH3B;VCL;CLIC1;GATA1;ITGB3
prerank,mitochondrial transport (GO:0006839),-0.24153495523037533,-0.825931679882259,0.8054474708171206,0.902434991115494,1.0,19/53,28.61%,BCL2;BCL2L1;TIMM17A;TOMM7;STARD3;TMEM14A;MFN2;COX18;TOMM40;ABCB10;TOMM22;SLC25A13;PMAIP1;MFF;SLC25A4;TMEM14C;BCS1L;SLC25A31;FBXO7
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3589978601035938,0.8256107335245633,0.6762917933130699,0.9423400209593249,1.0,8/23,27.47%,RAD23B;COPS7B;COPS5;XPA;CUL4A;COPS3;XPC;COPS2
prerank,"transcription, DNA-templated (GO:0006351)",0.2778881240777628,0.82555550785181,0.8021390374331551,0.9419575072476215,1.0,52/207,23.80%,RNMT;MLLT3;DDX5;FOXO3;MEF2A;NR4A2;ZBTB7B;MNAT1;MBD1;AFF4;NFIX;NFYA;NFKB1;RBMX;RPAP1;SNAPC2;TTF2;TAF1C;CBFB;PPP5C;TTF1;ELOA;GTF2E1;CTR9;NELFE;HOXD3;BAZ2A;ERCC3;EPC1;CREBL2;TRIP11;DDX21;TAF12;POLR3K;TAF4;NCOA6;POLR3A;SMARCA5;CCNT1;RTF1;E2F1;NFX1;NFIC;RNGTT;THAP1;PRMT5;PAF1;UBTF;DRG1;TAF15;EAF2;CRCP
prerank,histone mRNA catabolic process (GO:0071044),0.3930549454157292,0.825537317666703,0.6622516556291391,0.9415151591526745,1.0,9/15,32.47%,ATM;TUT7;TUT4;TENT2;SSB;ERI1;EXOSC4;MTPAP;XRN1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.34404425070227285,0.8251469999808939,0.6940836940836941,0.9417052926638148,1.0,8/34,14.97%,UBASH3B;PTPRF;PTPN2;DUSP16;DUSP5;DUSP10;PTPN9;ACP4
prerank,iron ion transmembrane transport (GO:0034755),0.42493121657293476,0.8243517316126693,0.6701754385964912,0.9426356574135009,1.0,2/10,4.23%,SCARA5;SLC39A14
prerank,protein localization to condensed chromosome (GO:1903083),0.4013602278345365,0.8241747588901761,0.6605166051660517,0.9424584320838002,1.0,6/12,28.25%,SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,energy reserve metabolic process (GO:0006112),0.3664176336674828,0.8240983043616957,0.6545166402535658,0.9421242791624318,1.0,3/19,3.24%,PID1;PPP1R3C;GSK3B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.28684089271461805,-0.8239418716239578,0.7272727272727273,0.9051491720591636,1.0,6/26,12.65%,MFHAS1;NR1H3;RTN4;NINJ1;CYBA;TLR3
prerank,regulation of primary metabolic process (GO:0080090),0.2875572850663044,0.823433834122765,0.7528216704288939,0.9427921777408264,1.0,31/126,19.37%,TNFAIP8L3;CHD9;CREBBP;LDLR;TBL1X;PSMB2;ID2;RXRA;NFYA;SCD;PSMC6;MVD;NCOR1;HNF4A;PSMD11;AZIN1;NCOR2;PLPP1;PSMD1;HMGCR;NQO1;PSMC1;PSMD7;SREBF1;CARM1;NCOA6;FDPS;PPARG;ABCA7;ADIPOR1;PSMD14
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.4168703411855744,0.8233202206644523,0.6632478632478632,0.9425024351679584,1.0,2/10,6.40%,WNK1;ADA
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2865731590813924,0.8233008381331044,0.7653890824622532,0.9420624350641074,1.0,7/117,5.06%,ME1;SLC5A6;SLC16A1;ADH7;VNN1;ACSL3;CYP2S1
prerank,regulation of protein localization (GO:0032880),-0.24733450389412664,-0.8231843245953235,0.7990654205607477,0.9054936963349637,1.0,12/58,16.40%,PICALM;MAP2;RABGAP1L;TRIM14;HSP90AB1;TRIM46;MMD;PPM1F;WDPCP;TRIM21;CTSD;RACK1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3507612898958521,0.8225844701279387,0.6950146627565983,0.9428282622663132,1.0,10/29,18.03%,ZC3H7A;SMAD2;DGCR8;PUM2;PUS10;TUT7;PUM1;AGO2;TUT4;DROSHA
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2691057291988703,-0.8220286848036392,0.7712418300653595,0.9065111195270057,1.0,12/37,22.75%,BCL2;BCL2L1;RPS3;RPS7;BOK;BMF;NUPR1;RACK1;NACC2;MSX1;DNM1L;PMAIP1
prerank,response to cAMP (GO:0051591),0.3286870560450432,0.8219857441414407,0.6962025316455697,0.9433834903912071,1.0,5/37,6.54%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN
prerank,RNA catabolic process (GO:0006401),0.3161442703742559,0.8218831921483855,0.7113821138211383,0.9430782674087712,1.0,13/46,22.71%,SIDT2;DXO;PABPC4;EXOSC7;ZC3H12D;RNASEH2A;NUDT12;DIS3L2;RNASE6;LSM2;YTHDF2;NANOS2;RNASE3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2907533621915147,-0.8214946403735995,0.7298136645962733,0.906496315206556,1.0,7/25,20.70%,HSPA8;ERO1A;HSPA13;PTGES3;DNAJB5;HSPE1;HSPA9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4094195934721252,0.8212497071373336,0.6620450606585788,0.9436821880986053,1.0,2/10,11.31%,CLU;RB1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3746463743193902,0.8212311649644101,0.6645264847512039,0.9432385040011999,1.0,4/18,12.77%,MISP;STX8;MMP14;ZDHHC2
prerank,regulation of cell adhesion (GO:0030155),0.2829504050200629,0.8211828318268104,0.7682648401826484,0.9428388278832224,1.0,21/129,15.41%,ZFHX3;PPP3CA;PTK2B;EFNA5;ARHGDIB;GPR4;ABL1;ITGAV;EPHB3;CHRD;ATM;PPP1R12A;VEGFA;ERBB2;ITGB1BP1;ZDHHC2;CXCR4;RSU1;PRKCA;PLXNA2;ADAM10
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2923475133536866,0.8211080265526924,0.7476303317535545,0.9425004028060544,1.0,16/95,12.85%,LBP;ADAM9;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;TRIM41;MYD88;TNFRSF1B;ZC3H12A;CARD16;CTR9
prerank,cellular response to UV-A (GO:0071492),-0.35609695867688707,-0.8209355260049839,0.6921182266009852,0.9064702383881793,1.0,9/11,41.63%,CERS1;MMP2;MME;MMP3;OPN3;OPN5;MMP9;MMP1;OPN1SW
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4127046761499107,0.8208969693677907,0.6552315608919382,0.9423840884370686,1.0,2/11,6.08%,CD44;KDM1A
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.32814045350262233,-0.8204581962558032,0.6848958333333334,0.9063415566252051,1.0,6/15,19.73%,RYR2;SRP14;ZFAND2A;SPCS3;SEC61G;SPCS1
prerank,RNA processing (GO:0006396),0.27368556316602494,0.8202034840990874,0.7823204419889502,0.9430811559737106,1.0,66/176,27.42%,MBNL1;SON;DDX17;SNRNP48;RBM6;SRSF11;CDK12;SRSF5;SYNCRIP;HNRNPH1;CELF1;CELF3;RBM39;FUS;PABPC4;DUSP11;U2AF2;TCERG1;ZCCHC8;SCAF11;SRRM1;TUT7;PRPF3;KIN;SF3B1;SF3B2;PPIG;RNPC3;TUT4;SRPK1;SCNM1;DROSHA;SNRNP35;WBP4;SNRNP40;SRSF2;TSEN54;PRPF18;NRDE2;ALKBH5;TENT2;NOL3;RBM3;ZCRB1;RNGTT;FASTKD5;RBM5;RBM4;TARDBP;AKAP8L;LSM4;NUDT21;DHX8;RSRC1;SRPK2;BICD1;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;DDX47;PDCD7;PRPF6;CLP1;PRKACA;SRSF7
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3776108580207609,0.819608459296713,0.65,0.9436586290852639,1.0,3/18,10.56%,COX16;COA8;SCO2
prerank,receptor signaling pathway via STAT (GO:0097696),0.3494243941484036,0.818846720996229,0.6971080669710806,0.9445145348261492,1.0,9/25,20.46%,PKD1;CLCF1;STAT3;SOCS2;CTR9;STAT5A;PIAS1;STAT6;STAT4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.39838891906310414,0.8187140341254792,0.684931506849315,0.9442807615097781,1.0,6/13,21.09%,SEC16A;TMEM30B;BCAP31;SAR1B;EDEM2;TM9SF4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.31173678625325646,-0.8181728045807326,0.7213541666666666,0.9093408987221602,1.0,6/18,15.26%,VCAM1;SLC39A8;ITGA4;JAM2;ADD2;GCNT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.36910607022062303,0.8179588757705415,0.6785714285714286,0.945064891547366,1.0,2/20,2.69%,TCIM;ADRB2
prerank,protein targeting to membrane (GO:0006612),0.2995822414341782,0.8178115810862858,0.7441574415744158,0.9448373487714177,1.0,31/83,26.99%,ABCD3;PXMP2;ATG3;ZDHHC11;ACBD5;PARD3;ZDHHC15;SEC61A1;VPS37A;ZDHHC2;PEX13;GOLGA7;ZDHHC20;SEC63;VPS37B;ABCD1;ZDHHC23;RABGEF1;ZDHHC12;SRPRA;SLC25A17;PEX2;GET3;SIL1;PEX26;ZDHHC24;CHMP4A;CHMP4B;SRP19;PIKFYVE;CHM
prerank,response to muramyl dipeptide (GO:0032495),0.39586000759127193,0.817600235458961,0.6444805194805194,0.9446946683715052,1.0,3/12,10.67%,RIPK2;ERBIN;TRIM41
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2816045120110124,-0.8173930344273569,0.7585139318885449,0.9096794853067162,1.0,7/27,14.71%,PPP1R16B;CALM1;PPIA;BMP2;PPP2R5A;CALM3;SMPD1
prerank,RNA metabolic process (GO:0016070),-0.21195458107015083,-0.8173819413389238,0.9236111111111112,0.9086851016632982,1.0,31/127,20.24%,RBPMS;RBMS1;NOVA1;ATXN1;APOBEC1;HNRNPA0;ADARB2;ELAVL4;SETX;METTL14;AGO4;RNASEL;CELF2;FASTKD2;POLR2G;HNRNPH3;ADARB1;DDX20;TFIP11;ADAR;PABPN1;PCBP1;PCBP3;POLR2K;RNASE4;AGO1;DDX54;DDX3X;MTREX;NUFIP1;RNASEH2B
prerank,maturation of 5.8S rRNA (GO:0000460),0.3824137769319155,0.8171656863077189,0.6905487804878049,0.9449615078995423,1.0,9/17,22.69%,C1D;MPHOSPH6;EIF6;RPF1;PRKDC;RRP15;WDR12;URB1;FTSJ3
prerank,replicative senescence (GO:0090399),0.40018020945836125,0.8170057423869775,0.6556776556776557,0.944763587144723,1.0,5/12,17.95%,WNT16;CHEK2;ATM;CHEK1;ATR
prerank,regulation of catabolic process (GO:0009894),0.36955499202130926,0.8169689156025869,0.6645569620253164,0.9443519938194933,1.0,8/18,29.11%,ITGB1;CHEK2;ZDHHC2;SNF8;HGS;ODC1;FAF1;ZDHHC7
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.39639071208576016,0.8168545184487834,0.6788685524126455,0.9440722011150205,1.0,2/12,5.64%,CD80;ISL1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3840132640555728,0.8165774597489718,0.6650717703349283,0.9440725278265119,1.0,2/15,6.11%,DDR2;LRP1
prerank,cardiac ventricle development (GO:0003231),0.3709619626782817,0.81652859994122,0.6630434782608695,0.9436879443868462,1.0,5/20,8.35%,HES1;STRA6;GATA4;TMEM65;MDM4
prerank,amide biosynthetic process (GO:0043604),0.31722706544054,0.8162579110662735,0.7091152815013405,0.9436848195347353,1.0,5/47,6.96%,PCSK5;SGMS2;DMD;SPTSSB;NANP
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2907722675575435,-0.8162449379745512,0.7455089820359282,0.9096829016913137,1.0,5/23,15.10%,CADM1;PIK3R6;NECTIN2;LAMP1;ARRB2
prerank,positive regulation of growth (GO:0045927),0.3135573145949096,0.8161332596775264,0.7347715736040609,0.943422053356945,1.0,17/64,20.41%,EGFR;TGFBR1;EIF4G1;KLHL22;AGR2;MMP14;ERBB2;USP47;ADAM10;CEP43;DDX49;DNPH1;BRAT1;INO80;CSNK2A1;TGFB2;EIF4G2
prerank,positive regulation of transferase activity (GO:0051347),0.2758239627555895,0.8160476928411458,0.7784090909090909,0.9430914217448777,1.0,8/142,3.44%,EGFR;MET;NTRK3;LMO4;DDR2;FGFR1;KLF4;NEK7
prerank,regulation of glucose metabolic process (GO:0010906),0.333716608679548,0.8158829315498599,0.7272727272727273,0.9429077074345537,1.0,9/34,19.22%,IRS1;FOXK1;RORA;USP7;FOXK2;PDK3;GNMT;GNB3;ADIPOR1
prerank,maturation of LSU-rRNA (GO:0000470),-0.28407011009937083,-0.8158526296447567,0.7810457516339869,0.9093635185689837,1.0,10/26,25.89%,NSA2;SNU13;RPL7;RPL10A;NIFK;LAS1L;RPL7A;RPL35;NHP2;ZNHIT6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3009022152141789,-0.8154733188173625,0.7651933701657458,0.9090570805418002,1.0,3/22,12.94%,NR2F2;MYOCD;HHEX
prerank,purine-containing compound salvage (GO:0043101),0.3963212726788264,0.8152143757055816,0.6814449917898193,0.9435725983128868,1.0,5/12,24.85%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3516809185356852,0.8148913974466188,0.6813353566009105,0.9436614529069818,1.0,3/24,4.29%,PID1;COQ10B;NR4A3
prerank,negative regulation of cell adhesion (GO:0007162),0.3016656022838215,0.8147770689303718,0.7334167709637046,0.943368214349852,1.0,7/72,6.70%,CDH1;CYP1B1;ARHGDIB;FZD7;GCNT2;DMTN;JAG1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.387664137392056,0.8144339845128177,0.6760330578512397,0.9434705702511328,1.0,7/13,29.16%,TMEM39A;SMCR8;SEC22B;CHMP4A;CHMP4B;PHF23;FEZ2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.36648700509407306,-0.8141381627141407,0.6924829157175398,0.9104443687848031,1.0,2/10,13.57%,CD81;CD74
prerank,cellular response to hypoxia (GO:0071456),0.285168149370915,0.8141373362148262,0.7808535178777394,0.9435240840042198,1.0,24/126,18.30%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;CREBBP;HIF3A;PSMB2;PLK3;MDM4;RORA;HILPDA;PSMC6;VEGFA;CARD16;MTOR;EP300;PSMD11;PSMD1;TWIST1;PSMC1;PSMD7;ADAM8;AK4
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3466333644029092,0.8138939657335735,0.6842900302114804,0.9434557556838602,1.0,2/30,3.24%,BMP5;GSK3B
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3109358849823661,-0.8137497810321738,0.7002583979328165,0.9101496243272456,1.0,2/17,4.38%,CTNNA2;WASF3
prerank,ovarian follicle development (GO:0001541),0.3934708840624826,0.8131713254999007,0.6837748344370861,0.9441903808027742,1.0,4/13,15.26%,INHBA;VEGFA;INHBB;EIF2B2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2851998521886006,0.8129856012285588,0.7557160048134778,0.944047234675322,1.0,24/109,17.17%,PPP3CA;VAV2;SHC1;GAB2;NR4A3;TAB3;PSMB2;CHUK;NFKB1;FBXW11;PLCG2;JUN;PSMC6;MAP2K4;NFATC3;PAK2;PSMD11;NFATC1;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,positive regulation of organelle assembly (GO:1902117),-0.25388919656412234,-0.8125139154221291,0.7785714285714286,0.9112907332789126,1.0,5/44,6.87%,ASAP1;CNOT6L;CEP120;CCDC88A;TAPT1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.39263209571749796,0.8124591397038707,0.671118530884808,0.9444512008784091,1.0,2/15,6.08%,CD44;KDM1A
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3434263957937047,0.8123144181175541,0.7016248153618907,0.944218071977397,1.0,4/27,9.48%,GPR4;AGTR1;LPAR4;DRD3
prerank,serine family amino acid metabolic process (GO:0009069),0.37882880484788606,0.8119364567584962,0.6706081081081081,0.9443506645000637,1.0,2/16,11.23%,GCLC;CDO1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3736723096753119,0.8118227967637166,0.6750788643533123,0.9440656313098613,1.0,3/18,9.84%,LBP;IFI35;PLCG2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.34578839499804725,-0.8117947517540482,0.7097560975609756,0.9115490505899853,1.0,4/12,12.59%,SLC5A3;GRIN1;CYBA;ADGRB1
prerank,glycerolipid catabolic process (GO:0046503),0.3621527621032693,0.8116910640315187,0.6946688206785138,0.9437974081823148,1.0,7/19,20.46%,MGLL;PLA2G4F;ABHD6;LYPLA2;GDPD3;ABHD2;PLA2G4A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.32754220523043853,0.8116621154898334,0.7077826725403817,0.943369950727917,1.0,15/35,31.65%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4;DHX36;NAF1;HNRNPA2B1;PARN;MAPK15;ACD;CCT6A;TCP1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3885951497187219,0.811590533400352,0.6919275123558485,0.9430259831386588,1.0,4/15,18.25%,MKNK2;VCP;ZC3H12A;DHX36
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3187513014307763,0.811538505352234,0.7400275103163686,0.9426519329738658,1.0,6/41,8.37%,PTPRU;PLPP3;CD44;GCNT2;IL10;DENND6A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.33061871470206217,0.8112739619612476,0.7122507122507122,0.9426344070380541,1.0,3/35,4.54%,MET;ARHGAP44;CCDC125
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33254851797918944,0.8107101398371539,0.7136929460580913,0.9431341190439124,1.0,13/37,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,genitalia development (GO:0048806),0.4047028557391236,0.810185592720841,0.6666666666666666,0.9435143919643467,1.0,2/12,4.15%,PKD1;STRA6
prerank,ruffle organization (GO:0031529),-0.311777491973922,-0.8101414807789388,0.7338501291989664,0.913273323026014,1.0,8/16,23.62%,RAC1;PLEK;CSF1R;AIF1L;CORO1B;ARF6;INPP5K;PLEKHA1
prerank,dendrite morphogenesis (GO:0048813),0.33348150647322355,0.8100071057067337,0.7340876944837341,0.9433569943414352,1.0,8/35,11.72%,CTNND2;PHACTR1;MEF2A;KLF7;EPHB3;SHANK1;BTBD3;FARP1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.31648542288147563,-0.8098395996097706,0.7421052631578947,0.9128369586508007,1.0,3/15,13.93%,ACACB;ACSS1;ACLY
prerank,cellular response to insulin stimulus (GO:0032869),0.2814583772716075,0.8098260088464565,0.791907514450867,0.9431596301909334,1.0,25/124,16.00%,HDAC9;GRB10;SORBS1;SHC1;ATP6V0A4;GSK3B;IRS1;FOXC2;SLC39A14;PTPN2;RHOQ;IDE;BCAR3;C2CD5;LPIN2;SYAP1;CAPN10;INHBB;PIK3R3;PRKDC;ATP6V0D1;TCIRG1;GAB1;ATP6V0E1;KAT2B
prerank,vacuolar acidification (GO:0007035),0.3590581639305379,0.8098045049476501,0.7104430379746836,0.9427285288357901,1.0,6/21,20.33%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H;CLN3
prerank,postreplication repair (GO:0006301),0.3212648029900774,0.8098009921078929,0.7570093457943925,0.9422675356115342,1.0,17/45,28.99%,VCP;UBE2B;USP10;ZBTB1;NSMCE1;RPA1;RFC1;REV1;TRIM25;UBE2N;POLD3;RFC5;UBE2V1;POLK;POLI;PRIMPOL;UBE2A
prerank,protein-containing complex subunit organization (GO:0043933),0.2893260311290874,0.8090527182462148,0.7811764705882352,0.9430607673179722,1.0,27/109,21.80%,REPS2;SOX9;PTK2B;HES1;CREBBP;MNAT1;DMTN;TEAD1;MDM4;SHANK1;PARD3;MATN1;CAPZA1;SLC7A9;MAGI1;PML;IKBKG;TUBGCP4;GPAA1;ZW10;CAPZA2;NUP98;DET1;EPRS1;SPG7;LLGL1;DLG4
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3741789511216841,0.8089565980323162,0.6955810147299509,0.9427571587007926,1.0,6/17,22.63%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1
prerank,positive regulation of reproductive process (GO:2000243),0.3322306560327208,0.8088806585571053,0.7015781922525107,0.9424204976944548,1.0,4/31,11.38%,LHFPL2;INHBA;VEGFA;INHBB
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3507559167065564,-0.8084554146440158,0.7017167381974249,0.9142028505084385,1.0,2/10,11.03%,JARID2;RIF1
prerank,RNA transport (GO:0050658),0.2996146559972468,0.8083984097719052,0.7337579617834394,0.9427355106400256,1.0,20/71,20.05%,TGFBR2;SIDT2;SRSF11;THOC2;SRSF5;SRSF6;U2AF2;ATXN2;NUP153;SRRM1;CASC3;CHTOP;NUP214;NUP188;U2AF1L4;ZC3H11A;THOC5;NXF1;SRSF2;FMR1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.39465284853408855,0.8080984090306834,0.6794019933554817,0.9427605855973339,1.0,2/12,3.31%,PTK2B;NOTCH2
prerank,neuron projection morphogenesis (GO:0048812),0.28058663081574653,0.807964716329292,0.7921348314606742,0.9425248444823744,1.0,21/137,10.29%,DCLK1;NGF;CTNND2;DOCK7;ALCAM;SRGAP2;MEF2A;KLF7;SHTN1;ISL1;TRIO;ANKRD27;EPHB3;NBL1;SHANK1;MAP1B;IQGAP1;PARD3;BTBD3;NCKAP1;CTTN
prerank,positive regulation of interleukin-10 production (GO:0032733),0.33938543196074467,0.807959847062938,0.7057057057057057,0.9420645211856289,1.0,5/30,13.31%,STAT3;TLR4;CD46;PLCG2;PIBF1
prerank,Golgi ribbon formation (GO:0090161),0.3870988455402044,0.8077827968264223,0.6716171617161716,0.941880029930251,1.0,4/13,16.16%,TMED5;GOLPH3;VTI1A;TRIP11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3760314886476841,0.8075151415318527,0.6762820512820513,0.9418676189149109,1.0,3/15,10.80%,ADAM9;EHD1;EHD2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.28343606320606596,0.8074181853609038,0.7578215527230591,0.941550967165818,1.0,14/110,13.52%,TRABD2B;MPP7;GSN;GSK3B;VCP;ISL1;CLU;KIF9;VEGFA;RB1;SPIDR;EP300;SH3GLB1;HCFC1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3672705522104212,0.8074100859358683,0.6823899371069182,0.9410961201161704,1.0,3/18,6.18%,USP13;RNF185;DDIT3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.3643053291482388,-0.8070977511947748,0.7180722891566265,0.9155677654089561,1.0,3/10,20.32%,IL18;ROCK2;HRG
prerank,mitotic nuclear membrane organization (GO:0101024),0.3126007689069447,0.8068399562000542,0.7509881422924901,0.9411216465556564,1.0,15/51,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3126007689069447,0.8068399562000542,0.7509881422924901,0.9411216465556564,1.0,15/51,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,snRNA processing (GO:0016180),0.37115195322971556,0.8058090867798392,0.6913996627318718,0.9424135655151217,1.0,8/16,32.88%,INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;INTS7
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.38777491716437573,0.8055855695940369,0.7048387096774194,0.9423172736172991,1.0,3/13,11.93%,PIK3AP1;IRAK4;MYD88
prerank,regulation of secretion by cell (GO:1903530),0.31151124457173174,0.8052112690164045,0.7294117647058823,0.9424540737979297,1.0,5/54,7.94%,SNCAIP;DISP1;ANXA1;P3H1;NSF
prerank,presynaptic endocytosis (GO:0140238),0.35541721374170027,0.8050478663722582,0.7119155354449472,0.942269187866862,1.0,5/24,13.79%,STON1;STON2;SYT8;FCHO2;SYNJ1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3956425357686316,0.804916199295534,0.7061855670103093,0.9420213253550279,1.0,1/12,1.74%,CAMK2D
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.38084268568449664,0.804478187804331,0.7140495867768595,0.9422690510254018,1.0,1/17,0.28%,BMP4
prerank,dendritic cell migration (GO:0036336),-0.3199085205142157,-0.8042212658158239,0.6956521739130435,0.9195004990996363,1.0,4/16,19.01%,EPS8;CCL19;CCR5;PIK3CG
prerank,intracellular lipid transport (GO:0032365),0.3624658082949749,0.8041693816227972,0.7080645161290322,0.942296205669994,1.0,1/21,0.92%,ABCD3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2989477364876282,-0.8040172585201887,0.7675675675675676,0.9188534634779699,1.0,5/21,10.26%,MFHAS1;PPP1R16B;PPP4R4;YWHAB;TIPRL
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.38620473199710814,0.8035142489719764,0.6867088607594937,0.9429153334938826,1.0,4/15,18.30%,ENTPD6;ENTPD2;ENTPD7;AK4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.29725307725505457,0.8034285624095735,0.7635903919089759,0.9425924056926086,1.0,21/72,27.47%,MNAT1;ERCC5;UVSSA;COPS7B;USP7;COPS5;EP300;ERCC8;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;COPS3;POLK;GTF2H3;COPS2
prerank,neutrophil migration (GO:1990266),-0.236857490777309,-0.8032701753320299,0.85,0.9190561889877299,1.0,13/58,20.93%,PECAM1;PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;PRTN3;SYK
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3663780672496296,-0.8030397963573209,0.711864406779661,0.9184362141076924,1.0,4/10,25.03%,PRKCZ;IL18;SPHK2;TSLP
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3496691332375518,0.8030169691442882,0.7004680187207488,0.9427951620099192,1.0,7/24,20.76%,FOXO3;DDIT3;NF1;CCL3;TFAP2A;TGFB2;MCL1
prerank,peptide catabolic process (GO:0043171),0.3507003741219189,0.8030151932597135,0.6881028938906752,0.9423349836987349,1.0,7/23,15.90%,NPEPPS;CPQ;XPNPEP1;IDE;ERAP1;ECE1;DPEP1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3546003074491342,0.8029820357204674,0.6824427480916031,0.9419392128670612,1.0,5/22,8.86%,CAMK2D;MEF2A;NR4A3;P2RX4;SLC9A1
prerank,stem cell differentiation (GO:0048863),0.31935225604342515,0.8023751384211979,0.716927453769559,0.9424519800570096,1.0,7/39,15.26%,MLLT3;LRP6;SETD2;HOXB4;PSMD11;HTR2B;PUM1
prerank,snRNA 3'-end processing (GO:0034472),0.36553679259217636,0.8023217399786859,0.7225806451612903,0.9420889933936347,1.0,10/19,32.88%,EXOSC7;INTS8;INTS5;INTS6;INTS1;INTS2;EXOSC4;EXOSC2;EXOSC3;INTS7
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3304056224003796,0.8014754670860517,0.7142857142857143,0.9430320093684229,1.0,5/34,9.36%,ANK2;ATP1B1;P2RX4;SLC9A1;TNNI3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2897292475001765,0.8004440594097387,0.7863961813842482,0.9441868773452183,1.0,23/85,22.06%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;AP2A1;RHOA;PSMC6;TIAM1;DAAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMC1;PSMD7;PSMD14;DVL1;FZD2;PSMD3;CDC42;FZD3
prerank,nitric oxide metabolic process (GO:0046209),0.3834444085328796,0.8003671645139345,0.6773109243697479,0.9438488930771392,1.0,1/14,1.54%,CYP1B1
prerank,activation of GTPase activity (GO:0090630),0.2950930193598144,0.7999007034156567,0.772289156626506,0.9441342585991278,1.0,25/89,16.46%,NTRK3;SGSM2;SIPA1L1;DOCK7;BCR;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;ARHGEF10;TBC1D2B;TBC1D13;ARHGEF5;TIAM1;TBC1D25;CORO1C;RAP1GAP2;ARHGAP42;SIPA1L2;TBC1D10A;TBC1D8B;TBC1D5;GPR65;SGSM3
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2952314266594154,-0.7996371342586314,0.6949152542372882,0.9232544506421433,1.0,3/19,12.82%,MAOB;CYBA;PRDX4
prerank,RNA destabilization (GO:0050779),0.3691175132282062,0.799636289145389,0.7124802527646129,0.9441173461724137,1.0,9/18,26.47%,FTO;CELF1;DXO;ZC3H18;PUM1;YTHDF2;ROCK1;YTHDF3;MEX3D
prerank,regulation of immunoglobulin production (GO:0002637),0.35615688078379004,0.7994145806338321,0.7164634146341463,0.9439912373457391,1.0,3/23,8.47%,CLCF1;IL10;GPI
prerank,multivesicular body assembly (GO:0036258),0.3353402519091901,0.799350511769573,0.7190201729106628,0.943631771028611,1.0,10/30,25.39%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,nitric oxide biosynthetic process (GO:0006809),0.3883068225234012,0.7990120768019231,0.7013651877133106,0.9437116065047665,1.0,1/13,1.54%,CYP1B1
prerank,peptidyl-arginine modification (GO:0018195),-0.31919547152848826,-0.7983478603636219,0.7570621468926554,0.9244288389138436,1.0,10/15,36.08%,ART3;PRMT1;KRTCAP2;PADI2;PRMT7;PARK7;ART1;PADI1;PADI4;ART4
prerank,muscle contraction (GO:0006936),0.281601728341411,0.7981119368964991,0.8018648018648019,0.9447137740779521,1.0,11/126,5.73%,EDNRA;SORBS3;CALD1;SORBS1;ITGB5;MYOM3;TMOD3;VCL;DMD;MYBPC2;SNTA1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.35479241856524346,0.7980533626434405,0.7091454272863568,0.9443509485122684,1.0,2/22,6.60%,NFE2L2;PSMB2
prerank,negative regulation of translation (GO:0017148),0.28869364240762424,0.7979829551783825,0.7741935483870968,0.9440091557006118,1.0,24/87,24.56%,SAMD4A;IGFBP5;FTO;PAIP2;SYNCRIP;CELF1;TOB1;EIF3E;EIF2AK4;CNOT7;PUM1;AGO2;DHX36;FXR2;CAPRIN1;FMR1;YTHDF2;EPRS1;NANOS2;EIF2AK3;RBM4;SAMD4B;ROCK1;YTHDF3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3486723770392621,0.7976157102085468,0.7031484257871065,0.9441834308668948,1.0,9/23,21.60%,PLK3;NABP1;CHEK1;CHFR;PRCC;ZFYVE19;ZWILCH;ZW10;WEE1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.28498208335869457,-0.7975007017309174,0.7617647058823529,0.92476705440489,1.0,1/25,0.18%,IGF1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3961382706799319,0.7971751383121595,0.6943462897526502,0.9439714137413286,1.0,1/10,7.26%,CACNA1F
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3961382706799319,0.7971751383121595,0.6943462897526502,0.9439714137413286,1.0,1/10,7.26%,CACNA1F
prerank,regulation of actomyosin structure organization (GO:0110020),0.39454595878757437,0.7969893603994002,0.6970198675496688,0.9438262938731186,1.0,3/13,12.39%,AKAP13;SLC9A1;ASAP3
prerank,membrane protein proteolysis (GO:0033619),0.32473266314825233,0.7969391411758464,0.7212885154061625,0.9434403002373681,1.0,15/37,25.84%,ADAM9;SPPL2A;BACE2;NFKB1;RBMX;ERAP1;CLPP;ADAM10;RET;MBTPS1;PARL;SPPL2B;TRAF6;SPPL3;NAPSA
prerank,mesoderm formation (GO:0001707),0.36326828826936974,0.7968896694168296,0.7058823529411765,0.943065242266639,1.0,3/17,11.05%,ITGB1;ITGB3;SMAD2
prerank,regulation of interleukin-6 production (GO:0032675),0.2837763927397774,0.7961208239413483,0.7900355871886121,0.9438411691249246,1.0,23/96,17.78%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;IL10;TLR4;IL33;PLCG2;IRAK3;MYD88;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TLR8;TWIST1;C5AR2;NLRP12;BCL10;TLR6
prerank,cardiac cell development (GO:0055006),0.3942199144801174,0.7960810815845807,0.6959578207381371,0.9434466855677711,1.0,3/11,10.33%,CXADR;JAG1;VEGFA
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.33725957013904917,0.7958019020723139,0.7333333333333333,0.9434282202074022,1.0,3/26,6.17%,NFE2L2;VNN1;GATA4
prerank,positive regulation of cyclase activity (GO:0031281),-0.3262977371488063,-0.7955937794296568,0.7293233082706767,0.9269473116779133,1.0,2/14,1.98%,CACNA1D;NOS3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.35588388647369706,0.795453627947656,0.7174603174603175,0.943540278232132,1.0,3/18,8.08%,GSK3B;RAP1A;SLC4A8
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3839248551447062,0.7951570662732735,0.6982892690513219,0.9435649317821563,1.0,4/13,19.95%,HES1;PIGU;EGF;MGAT5
prerank,phospholipid transport (GO:0015914),0.3053708736747643,0.7949683214451149,0.7268106734434562,0.9433980042168125,1.0,9/52,12.74%,TNFAIP8L3;PITPNC1;ATP10A;PITPNA;LDLR;ATP8B1;TMEM30B;ATP9B;ATP11A
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.28956437446497213,-0.7945188485485171,0.7663043478260869,0.9277204771600618,1.0,6/21,17.67%,CYP26B1;PPARD;LPIN3;AGXT;LPIN1;NUDT19
prerank,regulation of phosphate metabolic process (GO:0019220),0.37558825910571164,0.794234311687147,0.7057851239669422,0.9441364349401972,1.0,5/16,17.17%,SMG6;MCM7;RAD17;GNB3;BARD1
prerank,negative regulation of immune effector process (GO:0002698),0.3842780456713837,0.7936380414714894,0.6957264957264957,0.9446782712420153,1.0,1/13,1.39%,CD55
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3451197014802914,0.7935595205190576,0.7109375,0.9443543186486207,1.0,6/24,12.35%,KCNB1;C2CD5;ERBB2;MIEF1;ITGB1BP1;CHP1
prerank,mitotic sister chromatid segregation (GO:0000070),0.28580557693269937,0.7935365457060941,0.7916666666666666,0.9439310810892939,1.0,34/98,30.35%,SMC4;BECN1;KLHL22;PDCD6IP;RB1;SMC1A;NIPBL;PIBF1;CUL3;NCAPH2;DIS3L2;KNSTRN;KMT5A;INO80;CSNK2A2;CSNK2A1;SPDL1;ZW10;RAN;KIF2C;CCNB1;TEX14;AKAP8L;POGZ;CHMP4A;CHMP4B;NAA50;KIF18A;MCPH1;CENPK;NCAPD3;SMC2;PINX1;RAD21L1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.262339019317702,0.7931887551314102,0.8727465535524921,0.9440395166498661,1.0,88/264,27.50%,DDX5;DDX17;SNRNP48;RBM6;SRSF11;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;FUS;USP49;RBMX;U2AF2;PABPC1;DDX42;ZCCHC8;SNRNP70;SCAF11;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;SF3B1;SF3B2;RNPC3;PRCC;CDK13;SRPK1;U2AF1L4;GEMIN8;RBM14;SCNM1;ESS2;LSM8;LSM2;SNRNP35;WBP4;SNRNP40;SRSF2;SNW1;PNN;TRA2B;DDX1;DBR1;SRSF12;ZCRB1;PRMT5;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;LSM4;NUDT21;CDC40;SUGP1;CSTF1;DHX8;PPIL1;CELF4;RSRC1;CHERP;CPSF7;SRPK2;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;SRSF7;CPSF4
prerank,fatty acid transmembrane transport (GO:1902001),0.3600473179556434,0.792796026145637,0.7122861586314152,0.9442138487167256,1.0,1/19,0.92%,ABCD3
prerank,B cell activation (GO:0042113),0.29394659895931863,0.7925771944519018,0.7486910994764397,0.9440906512923968,1.0,9/68,13.05%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24468995379301367,-0.7922779878584735,0.8450704225352113,0.9303907325130236,1.0,13/45,18.82%,WNT5A;APP;AIM2;GSDMD;P2RX7;CCL19;MALT1;LPL;TYROBP;CASP1;FZD5;GBP5;HSPB1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3586760085249513,0.7921174161726843,0.7106109324758842,0.9444186449167064,1.0,8/20,22.64%,CELF1;MOV10;TNRC6C;EIF6;CNOT7;AGO2;NRDE2;TNRC6A
prerank,nuclear membrane reassembly (GO:0031468),0.30451687461790033,0.791972492707366,0.7744845360824743,0.9441961096223966,1.0,15/54,25.39%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,regulation of stem cell differentiation (GO:2000736),0.2885967792786024,0.7917822240815922,0.7800982800982801,0.944035670170672,1.0,16/89,17.11%,HES1;BMPR1A;ABL1;GDNF;PSMB2;JAG1;GATA1;HOXB4;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMC1;PSMD7
prerank,negative regulation of receptor internalization (GO:0002091),0.3783944833199166,0.7917096466106527,0.6818181818181818,0.9437047935442062,1.0,5/12,21.80%,LRPAP1;ATXN2;RIN3;ANKRD13D;DLG4
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.35562278749052845,-0.7916488521570182,0.7209876543209877,0.9303604498656326,1.0,4/10,41.93%,ARRB2;CX3CR1;FCGR2B;KLRC1
prerank,T cell activation (GO:0042110),0.29347873156516074,0.7913004632596837,0.7717948717948718,0.9438932420627799,1.0,7/69,6.40%,PPP3CA;CXADR;CD44;PTPN2;NCK2;CD2;ADA
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2677763988799244,-0.7912502844186229,0.7933130699088146,0.9299989925551991,1.0,11/28,25.44%,NOD1;MAP2K6;LACC1;UBC;IRAK2;RPS27A;TNFAIP3;OTULIN;TAB1;RELA;CYLD
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.32565507579831254,-0.7910401095451807,0.7309644670050761,0.9293303583581792,1.0,4/13,18.72%,ADHFE1;IDH2;GOT2;PHYH
prerank,regulation of lipid kinase activity (GO:0043550),-0.3427094211957832,-0.7909357156842721,0.7281795511221946,0.9284919344870148,1.0,3/11,14.00%,PIK3R1;PPP2R5A;RBL1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3129248846532348,-0.7906707150929945,0.7347480106100795,0.9279367591260493,1.0,4/16,15.12%,CECR2;CASP3;KPNB1;FOXL2
prerank,protein localization to cell junction (GO:1902414),0.3498810321859953,0.7906036855608226,0.717741935483871,0.9445798356847865,1.0,5/22,9.64%,DSP;BSN;NPHS1;SHANK1;PCLO
prerank,telomere maintenance via telomerase (GO:0007004),0.334024701140268,0.7898445711678673,0.7225352112676057,0.9453464598272713,1.0,9/28,23.06%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,regulation of necroptotic process (GO:0060544),0.3418696712671178,0.7895588274798961,0.722473604826546,0.9453416795802428,1.0,3/23,9.08%,YBX3;PDCD6IP;RIPK3
prerank,negative regulation of transferase activity (GO:0051348),0.32941224674604996,0.7895238205905029,0.7119402985074627,0.9449442905328784,1.0,3/28,8.46%,GSK3B;ABL1;CDKN1B
prerank,positive regulation of viral process (GO:0048524),-0.23527143810937223,-0.7893956183816129,0.8874458874458875,0.9289762056910066,1.0,15/60,19.04%,PPARA;PPIA;HACD3;AXL;NELFCD;NR5A2;POLR2G;TYRO3;ADARB1;TARBP2;IFIT1;ADAR;POLR2K;DDX3X;PPIE
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3353378821101507,0.7892772174412845,0.7409024745269287,0.9449004155127391,1.0,5/28,13.94%,NGF;CRADD;DIABLO;BAG3;TRADD
prerank,regulation of interleukin-2 production (GO:0032663),0.30900235796381265,0.7891394335574508,0.7466666666666667,0.9446487814819078,1.0,5/43,11.69%,EZR;ANXA1;CD80;PLCG2;HOMER2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.23391251633403065,-0.7890927120091857,0.8879668049792531,0.928443536378624,1.0,7/54,12.41%,RNF152;NEDD4L;UBE2E2;RFFL;KLHL3;ZNRF1;HACE1
prerank,stress-activated MAPK cascade (GO:0051403),0.3025428204005911,0.7890215798030296,0.7714285714285715,0.9443889414048321,1.0,7/61,9.47%,MAP3K5;TAB3;RIPK2;ARHGEF6;CHUK;NFKB1;FBXW11
prerank,regulation of protein neddylation (GO:2000434),-0.3538763299133601,-0.7890080486564849,0.7035294117647058,0.9275928255573455,1.0,5/10,18.86%,HIF1A;RPL11;DCUN1D3;EPAS1;RPL5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3265244947374628,0.7886838983014212,0.7402597402597403,0.9444760158136454,1.0,4/29,7.68%,PKD1;CLCF1;STAT3;SOCS2
prerank,defense response to bacterium (GO:0042742),0.27909504448569367,0.7877379390244511,0.7850467289719626,0.9455409499926959,1.0,8/105,8.02%,LBP;ANXA3;PRKCD;SHC1;DEFB130A;MAVS;SLPI;TLR4
prerank,regulation of fibroblast proliferation (GO:0048145),0.31250815955175926,0.7876400984450129,0.7357723577235772,0.9452423539523916,1.0,8/45,11.14%,PDGFC;DDR2;FN1;SKI;PDGFA;NF1;EMD;MORC3
prerank,serine family amino acid catabolic process (GO:0009071),-0.3534221142131463,-0.7872980612642854,0.7554479418886199,0.9293630285953395,1.0,5/10,33.18%,CBS;GLDC;SHMT2;DAO;THNSL2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.29137113645080337,0.7871763918848746,0.7689393939393939,0.9454975159249073,1.0,6/70,5.85%,NGF;HIPK1;CRADD;INHBA;GSK3B;ITGAV
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.2882766342548649,-0.7870412903389327,0.7592067988668555,0.9287475834660216,1.0,4/22,14.43%,ALDH1A2;LGMN;CUBN;CBR1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2735066753594954,0.7870306884049774,0.8009259259259259,0.9452983673021962,1.0,24/119,15.04%,PLEKHA4;FGF2;TTC7A;PIK3C2B;IP6K2;INPP4A;MTMR12;PIP5K1A;ARF3;OCRL;SOCS2;RUFY1;PI4KB;PLCG2;CDS1;PGAP2;PIGB;PIK3R3;DPM1;SMG1;SYNJ1;PIGU;SBF1;PITPNM3
prerank,protein-DNA complex assembly (GO:0065004),0.27810141339058203,0.7869496901798402,0.8119158878504673,0.9449795054533903,1.0,25/116,20.49%,SOX9;CHAF1B;KAT6B;MNAT1;PSMB2;ERCC5;CHD1L;MCM7;MCM2;RAD23B;PSMC6;ATRX;PSMD11;PSMD1;ERCC3;XPA;RPA1;PSMC1;PSMD7;NAP1L2;RAD51;SMARCA5;PSMD14;CHAF1A;PSMD3
prerank,negative regulation of cell communication (GO:0010648),0.35504561423888686,0.7865773180306422,0.7218934911242604,0.9451155715886727,1.0,4/21,10.43%,UBASH3B;HHIP;ACVR1;SRMS
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3700193908470786,0.7854678701417991,0.7106518282988871,0.9464597933403522,1.0,5/15,26.50%,TLR4;MYD88;TLR6;CD36;EIF2AK2
prerank,heme biosynthetic process (GO:0006783),0.351216995152791,0.7853224984767836,0.7342143906020558,0.9462496809515224,1.0,7/22,22.22%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1
prerank,regulation of fat cell differentiation (GO:0045598),0.2896782005081898,0.7850920649974084,0.7854500616522812,0.9461638944835106,1.0,11/74,10.84%,ZFPM2;ZBTB16;CMKLR1;FTO;TRPM4;TRIO;ID2;RORA;CDS1;SYAP1;LRP5
prerank,nucleoside phosphate catabolic process (GO:1901292),0.38480827151143715,0.7848185235967616,0.6971235194585449,0.946139975832513,1.0,5/13,14.67%,ENTPD6;ENTPD2;SMPDL3A;ENTPD7;NUDT15
prerank,positive regulation of cellular component organization (GO:0051130),0.27477959404589003,0.7846610076236745,0.7948717948717948,0.9459337744835475,1.0,10/107,6.20%,TRABD2B;TGFB3;GPC3;MPP7;ATP10A;GSK3B;TGFBR1;VCP;LRP1;CLU
prerank,neuron projection organization (GO:0106027),0.37142057349353375,0.7842921988920675,0.7184,0.9460492447425762,1.0,3/15,8.76%,GSK3B;PLS1;ATP1A3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3408652832796898,0.7837119411487363,0.749613601236476,0.9465431828688188,1.0,9/24,15.60%,SEC24B;IDE;SEC23A;ERAP1;SEC31A;SEC13;SEC24D;BCAP31;SAR1B
prerank,cardiocyte differentiation (GO:0035051),0.40319729158869,0.7833691959042498,0.7,0.9466602267332355,1.0,1/10,2.03%,AKAP13
prerank,negative regulation of cilium assembly (GO:1902018),0.38825609498909275,0.7831110654947114,0.706953642384106,0.94658336583653,1.0,3/12,17.98%,LIMK2;CEP97;CDK10
prerank,interstrand cross-link repair (GO:0036297),0.30381053743148845,0.7830929668163249,0.7516254876462939,0.9461600842511957,1.0,16/53,20.93%,VCP;USP1;SLX4;RNF168;FANCL;MCM9;XPA;RPA1;RAD51;ERCC1;ATR;FANCM;NEIL3;WDR48;FAAP24;RNF8
prerank,regulation of hemopoiesis (GO:1903706),0.394991132357402,0.7830120520752242,0.7142857142857143,0.9458332705282559,1.0,3/10,11.74%,CREBBP;MYSM1;CBFB
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3322191605980924,-0.7828607525665664,0.7383863080684596,0.934252620728715,1.0,4/13,19.67%,KDR;EDN1;SELENOS;CCL2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.34137557899502863,0.7826238081745225,0.7312977099236642,0.9459784965853354,1.0,8/21,27.26%,CDC25B;CCND1;DYRK3;RAD51C;ATAD5;CCNB1;MECP2;RAD51B
prerank,histone H2A monoubiquitination (GO:0035518),-0.3079781310600247,-0.782566787546433,0.7556675062972292,0.9336737219033528,1.0,2/17,7.27%,PCGF5;KDM2B
prerank,regulation of interleukin-10 production (GO:0032653),-0.2432985585852273,-0.7825116898861222,0.8645833333333334,0.9327460464151552,1.0,26/44,40.80%,TNFRSF21;CD47;CD34;PRKCZ;TYROBP;JAK3;VSIR;DLL1;SYK;PYCARD;TSLP;HSPD1;CD28;HMGB1;TRIB2;FCGR2B;INAVA;IL23A;FOXP3;IRF4;LILRA5;F2RL1;IL12B;CD274;ISG15;XCL1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3514660993124719,0.7823068256168361,0.7115072933549432,0.9460054623206964,1.0,3/18,11.06%,TLR4;CCL3;TCTA
prerank,protein acetylation (GO:0006473),0.3312070431620996,0.7822430346159526,0.7342342342342343,0.9456501623873769,1.0,16/30,27.51%,NAA40;CREBBP;EP300;KAT2B;NAA15;DSCC1;NAA35;GTF2B;KAT5;NAT10;ESCO1;NAA50;NAA80;HAT1;KAT6A;NAA60
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.34384243397625813,0.7820313666957915,0.7407407407407407,0.9455228612235158,1.0,8/22,25.76%,ERI3;EXOSC7;WDR12;KRI1;URB1;FTSJ3;ERI2;ERI1
prerank,male gonad development (GO:0008584),0.32773768972242623,0.7818130563733616,0.747093023255814,0.9454138653800562,1.0,5/34,9.70%,SOX9;INHBA;GATA4;SIX4;GATA1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.31287249287046387,0.7810462407990436,0.739010989010989,0.9461867564387785,1.0,6/38,8.65%,PTGIS;KLF4;ATP2B4;CLU;TLR4;P2RX4
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3213593630928867,0.7807895397185394,0.7439024390243902,0.9461575843851904,1.0,4/35,8.47%,CYP1B1;HES1;IL10;NLK
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3103796754320572,0.7807143181729369,0.7608108108108108,0.945829555293279,1.0,16/44,24.56%,FTO;CELF1;MOV10;TNRC6C;TOB1;PABPC1;ZC3H12A;CNOT7;PUM1;AGO2;DHX36;YTHDF2;NANOS2;TNRC6A;ROCK1;YTHDF3
prerank,replication fork processing (GO:0031297),0.31579298292679264,0.7806511010847114,0.7474747474747475,0.9454763280848139,1.0,15/38,29.96%,WRN;BOD1L1;BRCA2;DDX11;ATRX;SMARCAL1;RAD51;ATR;FANCM;EXD2;FAM111A;CENPX;ALYREF;PRIMPOL;RFWD3
prerank,primary alcohol metabolic process (GO:0034308),0.3381553895380927,0.7804735493727203,0.7503949447077409,0.9453102450262497,1.0,2/25,2.10%,CYP1B1;ADH7
prerank,positive regulation of cellular component movement (GO:0051272),0.3377279093628569,0.7803572831830005,0.7211093990755008,0.9450340501402893,1.0,4/24,10.33%,NTN1;TGFBR1;CCDC25;VEGFA
prerank,positive regulation of response to stimulus (GO:0048584),0.3127573024425584,0.7802156412359198,0.773371104815864,0.9447938753867582,1.0,12/40,21.87%,PRKCD;CD80;MAVS;BCLAF1;IFIH1;DHX9;HOMER1;NSMCE1;FXR2;FMR1;TGFB2;GATA3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.32143449879969954,0.7799267123752619,0.7556497175141242,0.9447722983045467,1.0,4/33,6.40%,CYP1B1;ADAM9;FOXC2;ADA
prerank,cellular response to ATP (GO:0071318),-0.3142122146386725,-0.779453153256335,0.7538461538461538,0.9364917683712702,1.0,4/14,16.82%,P2RY1;P2RX7;HSP90B1;RYR3
prerank,chromosome condensation (GO:0030261),0.32098958806744776,0.7791393326516564,0.7464985994397759,0.9455924919390349,1.0,15/36,29.51%,SMC4;RB1;ERN2;NCAPH2;DFFB;KMT5A;CSNK2A2;CSNK2A1;AIFM1;CCNB1;AKAP8L;MCPH1;NCAPD3;ACIN1;SMC2
prerank,protein acylation (GO:0043543),-0.24962472583228248,-0.7788858147412129,0.8389261744966443,0.9363688412654791,1.0,6/38,10.54%,ZDHHC14;FOXO1;ZDHHC1;ZDHHC17;SPHK1;ZDHHC9
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3084569478642071,0.7788638503251077,0.7521367521367521,0.9455945272924926,1.0,11/47,14.53%,PTGIS;CLK2;ATP2B4;NFKB1;C1QTNF12;ERFE;MPV17L;ZC3H12A;ERLIN1;EP300;WDTC1
prerank,error-free translesion synthesis (GO:0070987),0.3447251248077615,0.7787007787197998,0.7247706422018348,0.9454151683391335,1.0,6/22,19.04%,VCP;NPLOC4;RPA1;UFD1;RFC1;REV1
prerank,sphingoid metabolic process (GO:0046519),0.3795613765326716,0.7786454433345853,0.7199312714776632,0.945062001994971,1.0,4/12,18.02%,PLPP3;KDSR;PLPP1;NAAA
prerank,tRNA aminoacylation (GO:0043039),0.31471444416037186,0.7784388088808314,0.7365439093484419,0.9449226287263242,1.0,2/37,7.54%,WARS2;YARS1
prerank,defense response to protozoan (GO:0042832),-0.3231852512006107,-0.7784102685651808,0.7690355329949239,0.936084996593358,1.0,3/12,14.78%,GBP7;GBP4;CD40
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.31219999580409086,0.7783063549064432,0.7584803256445047,0.944680856779009,1.0,14/42,28.48%,VCP;WRN;USP10;ZBTB1;RPA1;RFC1;REV1;TRIM25;POLA1;POLD3;RFC5;POLK;POLI;PRIMPOL
prerank,coenzyme A metabolic process (GO:0015936),-0.31397689545814084,-0.7776615057162855,0.776595744680851,0.9362258760764268,1.0,3/14,13.93%,PANK1;ACOT7;ACLY
prerank,regulation of histone methylation (GO:0031060),0.3777712329048086,0.7772086119938783,0.7184300341296929,0.945948232910097,1.0,7/13,24.19%,NNMT;CTCFL;CTR9;CHTOP;NSD1;PAF1;MTHFR
prerank,regulation of receptor recycling (GO:0001919),0.36588958386909526,0.7771489706082377,0.715927750410509,0.945592553630686,1.0,4/16,14.13%,ANXA2;NSF;KIF16B;ECE1
prerank,regulation of T cell proliferation (GO:0042129),0.2939686106487384,0.7764390861418953,0.7874213836477988,0.9462366843728943,1.0,12/61,21.71%,ANXA1;NCK2;CD80;IL10;CD46;RIPK3;TNFRSF1B;SDC4;ARG1;DLG5;LGALS3;NCK1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.32114937385164116,-0.7763529288523446,0.7481662591687042,0.9371618123426081,1.0,4/13,22.54%,CDK5RAP2;ANAPC15;XRCC3;LCMT1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.39605399108059963,0.7761513082321241,0.7118055555555556,0.9462116067552938,1.0,1/10,1.69%,SMOX
prerank,regulation of viral release from host cell (GO:1902186),0.3440508686636,0.7756072415975643,0.7230769230769231,0.9465981446377576,1.0,7/21,21.12%,TRIM26;PML;VPS37B;TSG101;TRIM25;TRIM35;MID2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.24054631580803817,-0.7752920857010824,0.870722433460076,0.937732300439106,1.0,10/46,14.81%,PLCB1;CNN2;PPIA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1
prerank,negative regulation of protein transport (GO:0051224),0.33272369437325305,0.7752174583908682,0.7345971563981043,0.9467696132667823,1.0,6/25,15.11%,WWP2;DRD3;SNX12;CSK;SERGEF;HMGCR
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3174801954797266,0.7747274358062092,0.7619047619047619,0.9470397076512128,1.0,18/36,30.06%,NECTIN3;KIF13A;GOLPH3;NSF;GOLGA7;GGA2;GORASP2;RILPL1;GOLGA4;AFDN;BBS2;SYS1;RAB7A;GGA1;GOLPH3L;VAMP2;VAMP4;RAB10
prerank,positive regulation of T cell differentiation (GO:0045582),0.3159478238141793,0.7746329599710569,0.7579250720461095,0.946732671556514,1.0,11/36,21.87%,GLI3;VNN1;CD46;GLI2;DUSP10;ZBTB1;BCL6;ZMIZ1;ADAM8;NKAP;GATA3
prerank,cholesterol efflux (GO:0033344),0.3509205288421771,0.7745638360465379,0.7444444444444445,0.9463972388737277,1.0,2/20,5.21%,SOAT1;TSKU
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3441606094625647,-0.7743750468363596,0.7576470588235295,0.9380686628247944,1.0,3/10,12.88%,APOD;SNCA;NDRG4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2946676566761003,0.7741345869006473,0.7948051948051948,0.9465990950815981,1.0,7/56,9.69%,CIT;SNX18;SON;PDCD6IP;ARL3;RHOA;TTC19
prerank,regulation of macroautophagy (GO:0016241),0.27204032966708847,0.7740251853383912,0.8078758949880668,0.9463194115152384,1.0,29/105,23.30%,NEDD4;EXOC4;CLEC16A;RRAGB;PAFAH1B2;MLST8;SNX32;RB1CC1;WAC;SMCR8;TBC1D25;MTOR;SMG1;SH3GLB1;ATP6V0D1;ATP6V0E1;IKBKG;SCOC;NRBP2;RHEB;CAPN1;ATP6V1H;MAPK8;CLN3;USP36;ULK1;BNIP3;LZTS1;SESN3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30889378427983594,-0.7737229085244488,0.754054054054054,0.938046513859852,1.0,6/15,18.90%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1;C3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.29242813456446515,0.7735363888075272,0.7768817204301075,0.9466381193979905,1.0,11/51,22.04%,NEK7;SMG6;STN1;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4;TEN1;NAF1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2408519942053879,-0.7732036051289742,0.864406779661017,0.9377958988628935,1.0,4/42,8.83%,CECR2;ACTB;SMARCA2;MBD2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3685136726757474,0.7723113776982516,0.7355371900826446,0.9480711886777516,1.0,3/15,12.34%,ADAM9;SH3D19;TNFRSF1B
prerank,motile cilium assembly (GO:0044458),0.3809935675545923,0.7720934118899444,0.7087542087542088,0.9479910457579319,1.0,4/12,22.83%,DNAAF3;CCDC40;RSPH9;RSPH6A
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.32116363808685333,-0.7720364289653782,0.7830188679245284,0.938601324042134,1.0,2/13,6.68%,DDO;ASPA
prerank,neuron projection extension (GO:1990138),0.32309206182662425,0.77199918906108,0.7351664254703328,0.947689902650604,1.0,6/32,9.15%,ULK2;ALCAM;NRP1;SPG11;MAP1B;IQGAP1
prerank,neural tube development (GO:0021915),0.36801144105648,0.771681422340821,0.7321711568938193,0.9477466664249993,1.0,3/15,9.55%,PKD1;GRHL2;DACT1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3707882843139529,0.7711794612918798,0.7185430463576159,0.9480843065420728,1.0,4/12,17.00%,IRS1;NR4A3;TWIST1;ABCD1
prerank,histone H2A ubiquitination (GO:0033522),0.36373520208424986,0.7703481376866487,0.7431340872374798,0.9489198061670396,1.0,5/17,20.93%,UBE2B;RNF168;RNF2;PCGF1;RNF8
prerank,negative regulation of reproductive process (GO:2000242),0.3532891944066861,0.7702329729797467,0.7512038523274478,0.9486439550282599,1.0,2/17,2.53%,ARHGDIB;SULF1
prerank,regulation of leukocyte migration (GO:0002685),0.35663837072603105,0.770063485109302,0.7355371900826446,0.9484607447113168,1.0,2/16,10.33%,ANXA1;VEGFA
prerank,positive regulation of cell killing (GO:0031343),-0.31344032623351337,-0.76981784447101,0.7892030848329049,0.9409369343132146,1.0,3/13,12.36%,WNT5A;RAC1;CYBA
prerank,neural crest cell differentiation (GO:0014033),0.34992115432174103,0.7696839312562286,0.7329093799682035,0.9485871181749304,1.0,1/18,1.38%,LRP6
prerank,positive regulation of exocytosis (GO:0045921),-0.2487243538712927,-0.7694019333829416,0.8581314878892734,0.9405244121393794,1.0,8/35,17.48%,CADPS;SMPD3;CLASP2;SNCA;SDCBP;ATP6AP1;RAB15;RAB3A
prerank,protein import into peroxisome matrix (GO:0016558),-0.3282898437971077,-0.7693002835252215,0.7723970944309927,0.9396858659538212,1.0,2/12,10.19%,PEX5L;PEX6
prerank,axonemal dynein complex assembly (GO:0070286),0.33315972458269494,0.7688492187884503,0.7381316998468607,0.9494275914373014,1.0,6/27,21.70%,DNAAF3;DNAH8;CCDC40;DNAAF4;ODAD3;ODAD2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3167517557728291,0.7686643617723989,0.7575757575757576,0.9492862937710921,1.0,7/32,18.08%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.28934201097389095,0.768372455480676,0.8026315789473685,0.9492812723381628,1.0,13/56,19.31%,LBP;ALPK1;TAB3;IRAK4;TLR4;PLCG2;MYD88;TLR1;MAPKAPK2;TLR8;BCL10;TLR6;TRAF3
prerank,negative regulation of bone remodeling (GO:0046851),0.3838788629025645,0.7681168132569175,0.7075630252100841,0.9492767381363751,1.0,1/11,2.84%,UBASH3B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3248384111812467,0.7679790806562823,0.7443267776096822,0.9490426174435819,1.0,5/30,11.05%,FSTL1;SFRP4;LTBP4;DKK3;SMAD2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.224486857226458,-0.7678865462083995,0.8927038626609443,0.9407442916718532,1.0,20/62,23.83%,BCL2;CXCL12;BCL2L1;PPIA;TPT1;NOC2L;HYOU1;TMBIM6;AKT1;SELENOS;XBP1;HSPB1;DDX3X;ENO1;CCAR2;NME5;NDUFA13;PLAUR;CREB3;SNAI2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3351237080384538,-0.7676011667334585,0.7712264150943396,0.9401780162281106,1.0,4/11,17.24%,NES;PLEK;TRPV4;STMN2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.35853224082614493,0.7671923001118425,0.7259615384615384,0.949809090995439,1.0,1/15,2.06%,PRKCD
prerank,fatty acid metabolic process (GO:0006631),0.26720538934045457,0.7660478628912157,0.8236658932714617,0.9511367303040276,1.0,24/115,19.78%,ABCD3;PNPLA3;ACSL3;SLC27A3;PON3;PLA2G15;ACOT8;CPT1C;ACADM;ACBD5;LPIN2;ACOT12;GNPAT;HACL1;ACSM2A;ACSM2B;ANGPTL3;NAAA;ALKBH7;PER2;PPARG;ACOT11;ADIPOR1;NDUFAB1
prerank,rRNA transcription (GO:0009303),0.357334008310817,0.7659688084398,0.7532679738562091,0.9508134462429904,1.0,1/17,3.73%,POLR1G
prerank,leukotriene metabolic process (GO:0006691),-0.2900242583592662,-0.7659310859432082,0.8236914600550964,0.9415739394697966,1.0,7/19,26.40%,GGT5;ALOX12;LTA4H;GGT1;PLA2G5;ALOX5AP;MGST3
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3366696501058495,-0.7658224803304798,0.7632241813602015,0.9407387850248285,1.0,4/10,24.28%,RIF1;TFIP11;DCLRE1B;TERF2IP
prerank,negative regulation of cell activation (GO:0050866),-0.3146027845052003,-0.7654152509494411,0.7813333333333333,0.9403638944122854,1.0,4/14,11.73%,APOE;NOS3;PDGFRA;CD200
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2773331012587558,0.7653199520079252,0.7982565379825654,0.9513820850175179,1.0,20/88,21.90%,TRABD2B;MPP7;GSK3B;VCP;PDCD6IP;CLU;VEGFA;SPIDR;SLX4;SH3GLB1;SDC4;PRKCA;TSG101;EMILIN1;ERCC1;SNF8;CDC42EP2;SDC1;LGALS3;HGS
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.28260812276477965,0.7646902128598736,0.8082706766917294,0.9519270977657351,1.0,17/72,20.01%,TAX1BP1;HIPK1;ELF1;PTPN2;SPPL2A;TRIM44;CHUK;IRAK3;CBFB;TRADD;IKBKG;VRK2;PALM3;ABCE1;BIRC3;PIAS1;RNF31
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3610735538711633,0.764647028757497,0.7463175122749591,0.9515533928859163,1.0,4/14,16.42%,AGR2;COPS5;DDRGK1;BFAR
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3134050356677387,0.7646458481798784,0.8040816326530612,0.9511160923490467,1.0,7/36,11.49%,EZR;DLG1;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3438373987705459,0.7640908411125076,0.7563291139240507,0.9515028518188745,1.0,3/21,10.04%,ANK2;SNTA1;AKAP9
prerank,maturation of SSU-rRNA (GO:0030490),-0.2525318574253327,-0.7637229658204674,0.8422712933753943,0.9417842174323273,1.0,8/34,18.62%,RPS14;RPS19;RPS8;RPS16;SNU13;MRPS11;RPS28;TSR3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.365428859073352,0.7636046438752954,0.7168,0.9518157636286267,1.0,2/13,9.33%,NEDD4;NIBAN2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.20796193754073047,-0.7634442997835762,0.9254658385093167,0.9412014792858169,1.0,24/84,23.20%,IGF1;APOE;RTN1;RPS3;GAPDH;NTRK2;SPHK1;RTN4;CALR;RPL13A;BIN1;YBX1;CNOT9;ORMDL3;RACK1;NANOS3;DDX3X;CHRNA7;GGA3;CPEB3;BTG2;IGF2BP1;RTN2;PATL2
prerank,sulfur amino acid metabolic process (GO:0000096),0.3361545109370271,0.7632109046975893,0.7586206896551724,0.9519589102651195,1.0,5/24,18.40%,GCLC;GADL1;CDO1;DPEP1;ADO
prerank,positive regulation of behavior (GO:0048520),0.38097012234896266,0.7629899689683548,0.7309027777777778,0.9518643846953992,1.0,2/10,4.29%,STRA6;NR4A3
prerank,phospholipid translocation (GO:0045332),0.32578748237254435,0.7623604126081241,0.753956834532374,0.9523882235013378,1.0,8/28,13.74%,ATP10A;ANO6;PLSCR1;ATP8B1;TMEM30B;ATP9B;ATP11A;PLSCR3
prerank,negative regulation of viral release from host cell (GO:1902187),0.3725774247299364,0.7623482787647201,0.7333333333333333,0.9519618181686331,1.0,4/13,21.12%,TRIM26;PML;TRIM35;MID2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.38212006889853994,0.7617924192755737,0.7610474631751227,0.9523797009580804,1.0,5/11,24.11%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A
prerank,regulation of centrosome cycle (GO:0046605),0.33455478243901104,0.7617796506379059,0.7574334898278561,0.9519599203608738,1.0,3/21,10.51%,PDCD6IP;AURKA;CEP131
prerank,cellular response to leucine (GO:0071233),0.3838009164265617,0.7615938430566382,0.7469026548672566,0.9513871164527431,1.0,2/10,12.91%,KLHL22;MTOR
prerank,response to leucine (GO:0043201),0.3838009164265617,0.7615938430566382,0.7469026548672566,0.9513871164527431,1.0,2/10,12.91%,KLHL22;MTOR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3358777913192894,0.7615305992744442,0.759018759018759,0.951050647122026,1.0,10/24,28.33%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1;FXN;SUCLA2;RSAD1
prerank,protein homotetramerization (GO:0051289),0.2942947824579256,0.7614322806926537,0.7961956521739131,0.950756083464543,1.0,1/49,0.28%,KCNJ2
prerank,cellular response to inorganic substance (GO:0071241),-0.29173612214745503,-0.7613025962808491,0.8011204481792717,0.9431704834888078,1.0,5/21,14.13%,FOXO1;GUCY1B1;KCNC2;BLM;NSMCE3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.36428616816348747,0.7608854132835947,0.7585089141004863,0.951114586237641,1.0,5/16,23.32%,MOV10;ZC3H12A;ZC3H12D;DHX36;TARDBP
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.33861710284500574,0.7608574326289269,0.7415185783521809,0.9507180435754327,1.0,8/22,27.33%,CHD1L;RAD23B;ERCC3;XPA;CUL4A;ERCC2;XPC;GTF2H3
prerank,positive regulation of nervous system process (GO:0031646),-0.29739309449164686,-0.76020030517071,0.7834224598930482,0.9437463304272272,1.0,3/18,4.47%,RIMS1;RIMS2;TENM4
prerank,protein transport (GO:0015031),0.24776854953773572,0.7601912529074468,0.9219712525667351,0.951290130412253,1.0,78/332,21.15%,RAMP1;SGSM2;KIF13A;ATP6V0A4;TANGO6;TLK1;STX11;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;SLC10A7;LMAN2L;LRP1;CLU;GRTP1;GOLPH3;ARF3;NSF;RAB3GAP2;AP2A1;RUFY1;LRSAM1;EIF2D;STX8;EHD1;CTTN;ARF4;TBC1D2B;TBC1D13;COPA;ARL6IP5;STX19;TBC1D25;SEC31A;ARCN1;SCAMP2;SEC13;ATP6V0D1;TOM1;TBC1D10A;RAB24;TCIRG1;ARFIP1;GOLGA7;TBC1D8B;GGA2;ARFIP2;TBC1D5;ARFGAP3;COPG1;SAR1B;ATP6V0E1;SEC23IP;SGSM3;KIF3B;SNX31;SCFD2;TBC1D17;RAB5B;AP3D1;GOLGA4;SNX13;RAB21;PPARG;USO1;SNX8;ATP6V1H;AP4M1;RAB5A;RAB1A;TVP23A;STX2;TMED3;RAB18
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3004691934932867,0.7599524408755851,0.7833109017496636,0.95121552373852,1.0,12/46,13.91%,DOCK7;ZNF423;FOXC2;ID1;NPR3;DDIT3;ADAMTS5;ABHD6;TLR4;RB1;TLE3;ACOT13
prerank,regulation of multicellular organismal development (GO:2000026),0.32782003193329806,0.7599054983144167,0.7762762762762763,0.9508466713483221,1.0,9/25,21.87%,MYSM1;TRIP12;EHMT1;NIPBL;KAT2A;HPSE;DHX36;TDG;GATA3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3590975507291432,0.759257383090107,0.768,0.9513678470778789,1.0,9/17,30.90%,ZC3H14;CTR9;NELFE;CCNT1;NUDT21;CPSF7;RNF20;NCBP2;VIRMA
prerank,pinocytosis (GO:0006907),-0.34648283715214256,-0.759034774685347,0.7906976744186046,0.9443585022703591,1.0,6/10,34.42%,DOCK2;AHSG;PYCARD;PPT1;SNX5;MAPKAPK3
prerank,pentose-phosphate shunt (GO:0006098),0.3808188107845125,0.7588974053884271,0.7321131447587355,0.9514639196956269,1.0,3/11,13.89%,DERA;SHPK;RPIA
prerank,histone H3-K4 methylation (GO:0051568),0.3320894019495271,0.7582140893529513,0.77526395173454,0.9520348263333441,1.0,12/26,36.26%,KMT2C;CTR9;KMT2D;WDR82;OGT;KMT2A;SETD1B;ASH2L;PAXIP1;TET2;WDR5;DPY30
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2756565435570166,-0.7581089344150634,0.821917808219178,0.9447319646642534,1.0,6/22,19.98%,WNT5A;SLC7A5;LACC1;BTK;TRIL;SPHK2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2517126216385078,-0.7577782959739819,0.8422712933753943,0.9442010449635495,1.0,3/31,8.24%,LYN;TNFRSF21;CD300A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2510780767868449,0.7573608558561908,0.9057203389830508,0.9528785088493,1.0,78/241,27.50%,DDX5;SNRNP48;RBM6;SRSF11;SRSF5;SRRM2;SRSF6;SYNCRIP;HNRNPH1;FUS;USP49;RBMX;U2AF2;PABPC1;DDX42;ZCCHC8;SNRNP70;SRRM1;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;CASC3;U2SURP;SF3B1;SF3B2;RNPC3;PRCC;U2AF1L4;RBM14;ESS2;LSM8;LSM2;SNRNP35;WBP4;SNRNP40;SRSF2;SNW1;PNN;TRA2B;DBR1;SRSF12;ZCRB1;PRPF40B;RBM5;SRRT;FIP1L1;RBM4;TXNL4A;LSM4;NUDT21;CDC40;SUGP1;CSTF1;DHX8;PPIL1;RSRC1;CHERP;CPSF7;UPF3B;SF3B3;HNRNPA2B1;HNRNPUL1;RBM8A;CPSF3;RBM4B;SMNDC1;GTF2F2;SNRNP200;PDCD7;ALYREF;PRPF6;SRSF3;CLP1;SRSF7;CPSF4
prerank,negative regulation of kinase activity (GO:0033673),0.28614677068215993,0.7571929238093085,0.8111254851228978,0.9526863037885613,1.0,12/62,15.82%,LRP6;UBASH3B;CDKN1B;NF1;SMCR8;RB1;CEP85;ITGB1BP1;CHP1;PAK2;WWTR1;CEP43
prerank,positive regulation of cellular protein localization (GO:1903829),-0.21590338759070454,-0.7571613287647718,0.9342723004694836,0.944058771665681,1.0,9/69,9.16%,TFRC;CARD10;PRKAA2;CCDC88A;SLC5A3;SYT11;MAPT;HSP90AB1;RTN4
prerank,cellular response to calcium ion (GO:0071277),0.2858425249557825,0.7571007628290608,0.8134517766497462,0.9523900976812066,1.0,10/67,12.45%,CLIC4;CAMK2D;MEF2A;DMTN;SYT8;IQGAP1;PLCG2;CARF;ADD1;CPNE3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3745663684913516,0.7570541652532998,0.717687074829932,0.9520171358110526,1.0,2/12,6.08%,CD44;KDM1A
prerank,negative regulation of interleukin-2 production (GO:0032703),0.345940310662877,0.7560153509719088,0.7596153846153846,0.9530888302896691,1.0,1/18,1.66%,EZR
prerank,negative regulation of T cell activation (GO:0050868),-0.2476397320754194,-0.7559803013385663,0.8598726114649682,0.944733232008156,1.0,6/35,15.05%,RIPOR2;TNFRSF21;PAG1;DUSP3;HAVCR2;JAK3
prerank,regulation of phosphatase activity (GO:0010921),0.3304988286966327,0.7550910069369066,0.7606973058637084,0.9539970785226842,1.0,8/24,20.92%,RIPK3;PPP6R3;PPP6R2;CHP1;URI1;PPP1R36;PPP6R1;PTPA
prerank,carbohydrate catabolic process (GO:0016052),-0.2395859362045603,-0.7548813613605702,0.8724137931034482,0.9452244100016994,1.0,13/38,21.39%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;MAN2C1;PFKM;ALDOA;ENO2;ENO1;PFKL;NEU2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.32517944453214154,-0.7542560325482908,0.7711442786069652,0.9430913075650715,1.0,2/11,11.80%,PANK1;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.32517944453214154,-0.7542560325482908,0.7711442786069652,0.9430913075650715,1.0,2/11,11.80%,PANK1;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.32517944453214154,-0.7542560325482908,0.7711442786069652,0.9430913075650715,1.0,2/11,11.80%,PANK1;ACOT7
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2616747128566821,0.7539589442924947,0.8686987104337632,0.9552696351196112,1.0,42/125,27.11%,NDEL1;CLIP1;TBCE;PAFAH1B1;XPO1;SETD2;DYNC1I1;AURKA;RANBP2;SEC13;DCTN6;STIL;RMDN1;AHCTF1;CENPT;KIF3B;MAD2L1;NEK9;DYNC1LI2;SPDL1;ZWILCH;NEK6;CENPQ;ZW10;RAN;NUP98;PTPA;SUN2;GPSM2;KIF2C;CCNB1;CDC20;SKA2;BUB3;TTK;MECP2;CENPU;TACC3;PCNT;SPC24;WDR62;KIF18A
prerank,regulation of dephosphorylation (GO:0035303),-0.30488231068178095,-0.7537144923451853,0.7821522309711286,0.9428538301393212,1.0,8/15,31.72%,PPP1R16B;SMG7;INPP5K;MTMR2;SRC;MTMR3;SMG5;CDK5RAP3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.32844447294205364,0.7536785294021757,0.7757847533632287,0.9552372807691035,1.0,6/24,10.33%,MAPRE2;ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,focal adhesion assembly (GO:0048041),0.335875604112851,0.7529280277372992,0.750392464678179,0.9558676790527781,1.0,5/21,12.78%,SORBS1;BCR;PIP5K1A;CTTN;TRIP6
prerank,cardiac atrium morphogenesis (GO:0003209),0.35975644164731446,0.7524443668584263,0.7606973058637084,0.956155621940629,1.0,4/16,6.17%,NOTCH2;NOG;ISL1;GATA4
prerank,negative regulation of intracellular protein transport (GO:0090317),0.33035603026991345,0.7521790791577314,0.7586750788643533,0.9561224330651548,1.0,5/22,17.17%,MDFIC;DMTN;ITGB1BP1;CHP1;BARD1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.28698902167298396,-0.7517120150991302,0.8050139275766016,0.9446376547365001,1.0,7/18,23.44%,ADAMTS9;SAMHD1;STT3B;AOAH;NEU2;FBXO44;FUCA1
prerank,negative regulation by host of viral transcription (GO:0043922),0.36912541516294683,0.7516761064893115,0.7531531531531531,0.9563787296522434,1.0,3/12,14.21%,JUN;CCL3;REST
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.258279807624347,-0.7512146228852941,0.8459016393442623,0.9443077427759325,1.0,9/28,22.05%,CTSC;DAB2IP;PTK2;ECSCR;NUPR1;OSBPL7;TREM2;PSMC5;PSMC3
prerank,positive regulation of telomere capping (GO:1904355),0.3407872926854434,0.7510782005750369,0.7378151260504202,0.9568322515527161,1.0,2/17,9.58%,NEK7;TNKS2
prerank,multivesicular body organization (GO:0036257),0.3147609888195253,0.7509647036762439,0.7752161383285303,0.9565768180542158,1.0,10/31,25.39%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3421455803208516,0.7504095272278556,0.7258064516129032,0.9569645491433257,1.0,2/18,6.20%,SLC2A13;CLU
prerank,P-body assembly (GO:0033962),0.371496199835042,0.7502956643873147,0.7345890410958904,0.9566913189867451,1.0,7/12,38.23%,ATXN2;LSM4;EDC3;DYNC1H1;LSM14A;EIF4ENIF1;LIMD1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.3250586210903345,-0.7495857002966675,0.7662037037037037,0.9456596785968734,1.0,2/10,19.05%,SNCA;MT3
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2983662576229706,0.7495695643266375,0.793859649122807,0.9573097753630471,1.0,14/41,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;SCARB2;NUP188;NUP88;NUP98;AAAS;NUP54
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.38364165674932715,0.74880625563416,0.7652173913043478,0.9579597944881156,1.0,2/10,11.74%,ZBTB7B;CBFB
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.35569657615299904,0.748119832471926,0.7487684729064039,0.9585048588027519,1.0,1/15,1.40%,NGF
prerank,iron ion homeostasis (GO:0055072),0.28652010370761927,0.7469817626923939,0.8172323759791122,0.9596795668933742,1.0,6/58,6.32%,BDH2;ABCG2;NEO1;BMP6;SCARA5;HMOX2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3545642258230132,0.7465323689279157,0.7636655948553055,0.959914795482034,1.0,6/16,26.09%,RB1;SMC1A;NIPBL;DSCC1;POGZ;NAA50
prerank,cellular response to interleukin-6 (GO:0071354),0.3287396920633212,0.7460673661339224,0.7924528301886793,0.960130946703041,1.0,5/26,12.85%,PID1;PTGIS;STAT3;NFKB1;CTR9
prerank,oligodendrocyte differentiation (GO:0048709),0.33255321141134864,0.7459996914893146,0.776,0.9597845554635127,1.0,1/19,1.12%,SOX9
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28830978057030976,0.7452677080176909,0.8214285714285714,0.9604180146686757,1.0,14/53,20.59%,PKD1;XPO1;F8A1;COMMD1;RAD23B;PSMC6;DESI1;DDRGK1;NUDT15;DNAAF4;PSMD14;FMR1;TMF1;RHBDF1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33879849062791023,0.7451438129808908,0.7748031496062993,0.9601523389591693,1.0,6/18,23.24%,WDR43;ERBB2;FLNA;WDR75;EIF2AK3;UBTF
prerank,outer dynein arm assembly (GO:0036158),0.36007169372371145,0.7447720323936241,0.7634228187919463,0.9602413636786015,1.0,7/14,33.36%,DNAH8;DNAAF4;ODAD3;ODAD2;DNAH5;ODAD1;DNAL1
prerank,regulation of cellular catabolic process (GO:0031329),0.2794522682586572,0.7446150945951793,0.8350785340314136,0.960013650469545,1.0,12/62,13.41%,USP13;ABL1;DDIT3;RRAGB;WDR41;ATM;USP10;SMCR8;CISD2;LONP2;USP33;EP300
prerank,regulation of JUN kinase activity (GO:0043506),0.3092911441020837,0.7442194710544237,0.7864357864357865,0.9601219397378203,1.0,5/33,11.49%,MAP3K5;PDCD4;PPEF2;ARHGEF5;DUSP10
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3694944199140322,0.7439675120937119,0.7606837606837606,0.960043035312653,1.0,2/11,18.83%,IL10;CIITA
prerank,nucleic acid-templated transcription (GO:0097659),0.296880501610948,0.7439183600699798,0.7931506849315069,0.9596719393712291,1.0,11/42,23.59%,MEF2A;NR4A2;PPP5C;HOXD3;BAZ2A;EPC1;CREBL2;POLR3A;E2F1;THAP1;DRG1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.22581970558187142,-0.74372227428324,0.8923076923076924,0.9524116856621149,1.0,14/51,19.86%,WNT5A;APP;AIM2;GSDMD;P2RX7;CCL19;MALT1;LPL;TYROBP;CASP1;FZD5;GBP5;HSPB1;TMED10
prerank,steroid metabolic process (GO:0008202),-0.2136313169683363,-0.7433315053209788,0.9086538461538461,0.9518889021038465,1.0,4/72,4.75%,CYP7B1;CYP27A1;CYP26B1;LIPA
prerank,regulation of macrophage cytokine production (GO:0010935),0.35117714515589976,0.7430992543273365,0.743455497382199,0.9604001919977038,1.0,3/13,9.95%,TGFB3;PLCG2;IRAK3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.35652136731411926,0.7430105698340074,0.7545909849749582,0.9600856044573988,1.0,4/13,21.09%,RIC3;RANGRF;ABCA7;TM9SF4
prerank,magnesium ion transport (GO:0015693),0.3624830992352952,0.7428802672823027,0.7512953367875648,0.9598496644239926,1.0,4/12,19.67%,CNNM4;NIPAL2;MRS2;TUSC3
prerank,cellular macromolecule catabolic process (GO:0044265),0.28819746163998583,0.7428605154942789,0.8098404255319149,0.95944602644629,1.0,10/49,18.00%,SIDT2;IDE;CHEK2;PABPC4;FBXO17;EXOSC7;RNASEH2A;DFFB;OGA;RNASE6
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3428363293803143,0.7424018167264235,0.779874213836478,0.9596306463415463,1.0,7/17,15.59%,HES1;CLCF1;ID2;EGR2;TNFRSF1B;CXCR4;SERPINE2
prerank,cellular response to oxygen levels (GO:0071453),-0.33884818916799353,-0.7420429964101435,0.7816901408450704,0.9526007292442653,1.0,2/10,13.01%,CPEB4;ATP6AP1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3483574718075283,0.7417884858369547,0.7576243980738363,0.9600953235530536,1.0,2/16,4.92%,PID1;VCP
prerank,regulation of microtubule polymerization (GO:0031113),0.29499431695743894,0.74178006694087,0.8175388967468176,0.959672917537255,1.0,6/40,11.71%,MET;ABL1;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,regulation of myoblast fusion (GO:1901739),0.3717630370589139,0.7417602773965644,0.7474226804123711,0.9592682155556553,1.0,3/11,10.80%,MYOG;EHD1;EHD2
prerank,telomere capping (GO:0016233),0.34295881858617316,0.7416595319751488,0.7616747181964574,0.958993037967816,1.0,5/16,21.97%,STN1;PRKDC;NBN;RAD50;TEN1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3699562739631522,0.7414786874796527,0.7632027257240205,0.9588205473655066,1.0,3/11,8.65%,LMNA;ATP2B4;P2RX4
prerank,negative regulation of B cell activation (GO:0050869),0.32483342331341,0.7411217037431111,0.7636080870917574,0.9588646860626229,1.0,5/21,9.99%,INHBA;IL10;ID2;TNFRSF13B;ATM
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.257131114163426,-0.7410034463905492,0.830945558739255,0.9530423037486386,1.0,4/23,15.12%,CECR2;CASP3;KPNB1;FOXL2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3390106063416314,-0.7405120730581806,0.786046511627907,0.9526963403957274,1.0,5/10,18.22%,CORO2B;MAPT;NDFIP2;PPM1F;SNX3
prerank,defense response to tumor cell (GO:0002357),0.36285935783007156,0.7404529285975854,0.736283185840708,0.9593532207732044,1.0,2/10,11.68%,KLF4;RBMS3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2279275930949797,-0.7402535868879245,0.8974358974358975,0.9520696255922136,1.0,15/47,23.96%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;CHCHD6;ATP5F1D;MICOS13;ATP5MC2;MTX1;ATP5ME;HSPA9;NDUFA13;ROMO1;ATP5MC3
prerank,filopodium assembly (GO:0046847),0.34379748509639224,0.7402256631962519,0.7702060221870047,0.9592237764951616,1.0,3/16,8.20%,EZR;SRGAP2;FGD6
prerank,glutamate metabolic process (GO:0006536),0.3382661338638174,0.7401928072653225,0.7674418604651163,0.9588301752370804,1.0,2/19,12.51%,GCLC;FPGS
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.34727196699995677,0.7401626351455941,0.7556634304207119,0.9584406618896089,1.0,4/16,8.86%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3535212299155821,0.7399836391176429,0.7763578274760383,0.9582530245246115,1.0,2/15,10.43%,SMOX;SRM
prerank,membrane organization (GO:0061024),0.24847437962855803,0.7398945833618777,0.9141039236479321,0.9579396590675567,1.0,31/227,13.79%,EGFR;REPS2;ANK2;ADRB2;STX11;NUP93;AP2A2;STON2;IGF2R;PDCD6IP;LDLR;GAK;CLTB;TOR1AIP1;OCRL;RABEP1;SUN3;AP2A1;AAK1;FCHO2;CTTN;EMD;SNAP23;GAPVD1;CORO1C;CHP1;A4GALT;EPS15L1;SH3GLB1;TLCD1;SYNJ1
prerank,pseudouridine synthesis (GO:0001522),0.364284767869063,0.739696921625161,0.7626262626262627,0.9577966926594106,1.0,7/13,30.74%,PUS10;PUS7L;PUSL1;TRUB2;PUS7;GAR1;RPUSD2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.31600058136509623,0.7395861969800147,0.7817919075144508,0.9575117656903235,1.0,4/25,8.65%,KLF4;CLU;TLR4;P2RX4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.32862446488720765,-0.7390956871680217,0.7805486284289277,0.9525481282684263,1.0,9/11,49.28%,CCT8;WRAP53;TERF1;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2509847987542784,0.7389280026364862,0.9022222222222223,0.9580010155828165,1.0,42/172,20.46%,PLEKHA4;FGF2;PNPLA3;PIK3C2B;INPP4A;MTMR12;ETNK1;PIP5K1A;PLSCR1;DGKA;ARF3;OCRL;DDHD1;RUFY1;SLC44A3;LPIN2;PI4KB;PLCG2;CDS1;GNPAT;CPNE3;LCAT;PIK3R3;CHKB;AGK;SYNJ1;SBF1;PITPNM3;CEPT1;HDHD5;PLD1;CPNE1;LCLAT1;CSNK2A2;CSNK2A1;VAC14;LPCAT1;TAMM41;GPAT3;CLN3;RAB5A;PLA2G4A
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.33110328236810577,0.7381330520479342,0.7767295597484277,0.9586820560777656,1.0,6/20,20.27%,TGFBR1;DCUN1D5;ZMIZ1;DCUN1D2;WASHC1;DCUN1D1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.367113856714567,0.7381077840709833,0.7395833333333334,0.9582938324174145,1.0,1/11,2.48%,GSN
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3293063026571015,0.7379268223461029,0.7891472868217054,0.9581226609107916,1.0,3/22,9.48%,AHNAK;DMD;DRD3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3182200594969633,0.737506970890517,0.7916666666666666,0.9582723697154804,1.0,3/25,9.84%,ANXA1;CD80;PLCG2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.32354273895855823,-0.7373690805397007,0.7889182058047494,0.9538136373624398,1.0,5/11,18.23%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1
prerank,synaptic vesicle localization (GO:0097479),0.34765997923668346,0.7372266845670644,0.7535714285714286,0.9582384221240067,1.0,3/13,13.79%,SPG11;TMEM230;SYNJ1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.29677648451623184,-0.73712078830077,0.7979539641943734,0.953143447218069,1.0,6/16,21.52%,PARP14;NF2;INPP5F;SH2B3;BCL3;LEPROT
prerank,establishment of spindle localization (GO:0051293),0.3468505833022048,0.7365832589105131,0.7597292724196277,0.958704204955111,1.0,2/14,5.56%,NLRP5;TLE6
prerank,regulation of innate immune response (GO:0045088),0.2812562384008657,0.7363299844219687,0.8303341902313625,0.9586413142189604,1.0,16/57,20.32%,TRAFD1;POLR3D;PLSCR1;IFI35;IRF1;IRAK3;ERAP1;DHX9;RNF135;TLR8;ACOD1;POLR3F;ADAM8;ABCE1;BIRC3;AKIRIN2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3100121840378239,0.7359677187522514,0.7978560490045942,0.958704220954754,1.0,2/32,2.23%,PRKCD;FOXO3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.341187279831497,0.7357848174517525,0.7632,0.9585208031088447,1.0,5/18,16.00%,ESR1;NCOR1;ZC3H12A;NCOR2;KAT2B
prerank,histone monoubiquitination (GO:0010390),0.32278991149589714,0.7353922982209642,0.7848837209302325,0.9586245020579058,1.0,5/24,15.25%,WAC;CTR9;RNF168;RNF2;PCGF1
prerank,protein N-linked glycosylation (GO:0006487),0.2708320294167712,0.7347050773046719,0.8436692506459949,0.959105752991232,1.0,15/66,20.11%,MGAT4C;FUT8;ALG13;MGAT3;B4GALT1;DPM1;MGAT1;ALG14;DDOST;TMEM165;ALG12;TUSC3;GFPT1;MGAT5;B4GALT7
prerank,sensory perception of taste (GO:0050909),0.3754921686741811,0.7344496033967648,0.7754010695187166,0.959038191749084,1.0,3/10,25.91%,TAS1R3;PKD2L1;CD36
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24286220298990654,-0.7342183201332528,0.8639240506329114,0.9558599944529255,1.0,9/32,19.51%,SLC44A1;LPIN3;ABHD3;MFSD2A;SLC44A2;CHKA;LPIN1;SLC27A1;PCYT1B
prerank,myofibril assembly (GO:0030239),0.29494971835224304,0.7341766823426713,0.8218793828892006,0.9590072641918509,1.0,5/42,7.89%,CSRP3;TMOD3;KRT19;SIX4;CSRP2
prerank,protein oxidation (GO:0018158),0.3664133649324733,0.7341651281618603,0.7542662116040956,0.9585945976555271,1.0,4/11,22.49%,LOXL1;LOXL4;LOX;TMX3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.35009502320051195,0.7340749755070625,0.7508417508417509,0.9582854458793488,1.0,2/13,9.06%,NFAT5;RHOA
prerank,organelle fission (GO:0048285),-0.2639771304068877,-0.7339897298448411,0.8207282913165266,0.9551486776187116,1.0,3/24,8.37%,DNM3;SEC16B;DNM1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2927479086821013,0.7328858403683729,0.809593023255814,0.9595674636570964,1.0,8/40,19.43%,PID1;ABL1;VCP;ARL6IP5;RNF122;ABCD1;PYCR1;SLC25A36
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2563254221381689,-0.7327160932596998,0.8757763975155279,0.9556929457528113,1.0,4/30,14.46%,DACH1;DCP2;CERS1;ACVRL1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2939374978931799,-0.7325979328886995,0.8005181347150259,0.9548613379376868,1.0,6/14,27.40%,ABCG1;APH1B;ADAM19;DYRK1A;NCSTN;PSENEN
prerank,prostanoid metabolic process (GO:0006692),-0.3079774513949176,-0.7320917557545403,0.8115577889447236,0.954479219061287,1.0,2/13,12.39%,PTGS1;HPGDS
prerank,negative regulation of metabolic process (GO:0009892),0.2850914544945875,0.731714156264672,0.8373333333333334,0.9607767088642405,1.0,9/54,8.02%,DOCK7;ZNF423;FOXC2;ID1;NPR3;DDIT3;ADAMTS5;ABHD6;TLR4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.32782862275655056,-0.7312887267331495,0.7806603773584906,0.9544871953065804,1.0,1/10,2.18%,PCGF5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3265672130996781,0.7306480075017793,0.7847533632286996,0.9617677730409455,1.0,5/22,13.19%,DUSP16;DUSP5;DUSP10;PPP5C;PPM1A
prerank,Fc receptor signaling pathway (GO:0038093),0.25531937868406246,0.7294672339344083,0.8892900120336944,0.9629768086611042,1.0,23/110,17.17%,PPP3CA;VAV2;SHC1;GAB2;TAB3;PSMB2;CHUK;NFKB1;FBXW11;PLCG2;JUN;PSMC6;MAP2K4;NFATC3;PAK2;PSMD11;NFATC1;PSMD1;IKBKG;CUL1;PSMC1;PSMD7;BCL10
prerank,positive regulation of viral transcription (GO:0050434),0.3183279248495781,0.7293875958138716,0.7947932618683001,0.9626594718804827,1.0,4/25,19.01%,MDFIC;NELFE;DHX9;CCNT1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2641311677365507,0.7290780771654971,0.8790035587188612,0.9626482635918268,1.0,21/88,23.15%,SAMD4A;IGFBP5;NELL1;PAIP2;SYNCRIP;RGP1;NFKB1;TOB1;DNAJC1;CNOT7;SERPINE2;DHX36;FXR2;CAPRIN1;FMR1;CLN3;EPRS1;NANOS2;EIF2AK3;RBM4;SAMD4B
prerank,neutrophil chemotaxis (GO:0030593),-0.21653159204290526,-0.7290355155003793,0.9392712550607287,0.9562658778564889,1.0,21/53,31.61%,PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;SYK;JAML;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;PIK3CD
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.34387644313477467,0.7290078984891558,0.7792207792207793,0.9623189053632213,1.0,2/14,5.64%,CD80;ISL1
prerank,regulation of telomerase activity (GO:0051972),0.2827644293726472,0.7283401950625681,0.8346994535519126,0.9627719810560659,1.0,6/45,13.34%,KLF4;NEK7;SMG6;GRHL2;ATM;XRCC5
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3097835665177492,0.7282237507305004,0.7985611510791367,0.9625022897193228,1.0,4/26,8.65%,KLF4;CLU;TLR4;P2RX4
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3295459376115616,-0.7281507404991042,0.7927710843373494,0.9563439410756144,1.0,2/10,9.40%,ACTN2;PLEK
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.31198995605775265,-0.7277420215299852,0.8267326732673267,0.9558583037763612,1.0,12/12,68.83%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5;GNL3;GNL3L;TCP1;CCT6A
prerank,regulation of cell projection organization (GO:0031344),-0.2943003378382246,-0.7275303717866256,0.8252688172043011,0.9551173295388606,1.0,5/13,20.81%,MFSD2A;CCL19;MACF1;TREM2;ERMN
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.20902935420644256,-0.7272452968666384,0.9324894514767933,0.9544737601558432,1.0,15/61,22.05%,PPARA;PRKAG2;FGFR4;PSMB4;PSMB3;PSMB8;PSME2;PSMB10;NR1H4;SIRT5;PDK2;PDK4;PSMC5;PSMD9;PSMC3
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.23221680744816647,-0.7267798284599455,0.9205298013245033,0.9540500855130044,1.0,7/40,14.09%,DEFA6;PGLYRP1;GBP7;GBP4;GSDMD;RPL39;CHGA
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.32364339062347813,0.7258159033365335,0.8028391167192429,0.9653181011918401,1.0,5/20,13.41%,CLK2;C1QTNF12;NCOR1;ERFE;EP300
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.33387020361298453,0.7257847599354198,0.7915993537964459,0.9649306073609952,1.0,6/16,26.24%,PIGB;PIGL;PIGN;PIGH;PIGQ;PIGA
prerank,axonal transport (GO:0098930),0.293594420344148,0.7255903252782344,0.8233576642335766,0.9647569337650392,1.0,8/36,18.89%,AP3B1;KIF1B;PAFAH1B1;FBXW11;KIF3B;AP3D1;RAB21;AP3S1
prerank,rRNA 3'-end processing (GO:0031125),0.3630056626604453,0.7253731501867628,0.7534722222222222,0.9646353800147882,1.0,2/10,11.56%,ERI3;EXOSC7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.32913428753672236,0.7234001595131574,0.7948303715670436,0.9668775602129586,1.0,1/20,1.20%,BMP5
prerank,synaptic vesicle membrane organization (GO:0048499),0.33282128873939987,0.7230793917636322,0.805921052631579,0.9668819874700899,1.0,8/17,29.86%,STX11;SNAP23;STX19;AP3D1;STX2;SYNGR2;SNAP47;STX1A
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3652132173936894,0.7229854141674622,0.7842105263157895,0.9665888080939031,1.0,4/11,24.33%,ATL2;VCPIP1;BNIP1;STX18
prerank,regulation of cellular localization (GO:0060341),0.2817139485287845,0.7215151865213041,0.8644736842105263,0.9680976993346176,1.0,4/46,6.08%,CAMK2D;EFNA5;GSN;KDM1A
prerank,placenta development (GO:0001890),-0.30436434903750786,-0.7212640863755745,0.8025641025641026,0.9595921290451273,1.0,5/12,29.83%,PTK2;E2F7;ADAM19;E2F8;SOD1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.299088838366823,-0.7210850743172837,0.8461538461538461,0.9588698732727062,1.0,5/14,19.19%,RFFL;GAS6;CCDC3;TRAIP;GPS2
prerank,cellular respiration (GO:0045333),-0.23083284271677215,-0.7209916062014875,0.9080882352941176,0.9580081105036637,1.0,19/41,30.52%,SDHA;PPARGC1A;UQCRH;UQCR10;ME3;CYCS;ATP5F1D;NDUFS4;MTFR2;COX4I2;COX10;SLC25A13;ETFRF1;UQCRC1;UQCRB;SDHC;BLOC1S1;MTLN;UQCRC2
prerank,cellular response to interleukin-1 (GO:0071347),0.24774780477873662,0.7208857200899161,0.9153498871331829,0.9685352007108806,1.0,27/143,17.11%,SOX9;TANK;PTGIS;TAB3;IRAK4;RIPK2;PSMB2;MAP3K3;CHUK;NFKB1;FBXW11;RBMX;IRAK3;PSMC6;USP10;CCL3;CCL1;MYD88;ZC3H12A;PSMD11;PSMD1;SQSTM1;ACOD1;IKBKG;CUL1;PSMC1;PSMD7
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.33148067662497055,0.7206919496498647,0.7811993517017828,0.9683531320915303,1.0,5/19,16.43%,PPP2R3C;MMP14;PRKDC;ZBTB1;ZMIZ1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.26566445480868495,-0.7200396715857988,0.8233618233618234,0.9582283183629778,1.0,8/19,32.98%,GSK3A;FZD5;CAMKK2;DNM1L;PINK1;FBXO7;HTRA2;PARK7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3139786100534115,0.7198177512775323,0.7965571205007824,0.969134430649185,1.0,2/24,5.27%,CAMK2D;DMD
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3192927640908052,0.7193831993747616,0.7975077881619937,0.9692849467163951,1.0,6/21,12.07%,EFNA5;VCL;PTPRA;SLC9A1;RHOA;CORO1C
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.36859119740409685,0.7184668771127395,0.8,0.9700587308536692,1.0,3/10,14.30%,PARD3;PLPP1;HTR2B
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.277933046337031,0.7178148441713146,0.8409090909090909,0.9705035575273915,1.0,12/54,20.01%,TAX1BP1;HIPK1;PTPN2;SPPL2A;CHUK;CARD16;TRADD;UBE2K;CPNE1;IKBKG;BIRC3;RNF31
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.341720038363947,0.7177605037220268,0.7898423817863398,0.9701480333097304,1.0,6/14,22.56%,ETNK1;LPIN2;CHKB;CEPT1;ETNPPL;ETNK2
prerank,lipid biosynthetic process (GO:0008610),0.26449922049163854,0.7175317342899659,0.8768844221105527,0.9700201705064956,1.0,15/77,20.36%,ABCD3;PIP5K1A;AGPS;SCD;MBOAT1;PDSS2;GNPAT;MVD;ACSM2A;ACSM2B;HMGCR;SREBF1;NDUFAB1;LPCAT1;CYP19A1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3236807489113845,0.7169079294507501,0.7883096366508688,0.9703697774231054,1.0,4/20,27.59%,FDX1;STARD3NL;AKR1B1;STAR
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2954990289295104,0.7167958641186001,0.8046647230320699,0.9700728259218973,1.0,4/36,7.15%,ADRB2;ITGB1;NRP1;IL10
prerank,glycosphingolipid metabolic process (GO:0006687),0.28038748532118496,0.7163376432375427,0.8187919463087249,0.9702238349595165,1.0,4/42,4.87%,ESYT3;LARGE1;HEXA;ESYT2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.30042259541456356,-0.7161302702177983,0.8325581395348837,0.961880820459569,1.0,3/12,17.86%,ABCC9;KCNJ8;ABCC8
prerank,endoderm development (GO:0007492),0.3411440636303972,0.7158068247401971,0.7993254637436762,0.9704760838580961,1.0,3/13,11.13%,GATA4;DUSP5;KIF16B
prerank,microtubule anchoring (GO:0034453),-0.2969410383811028,-0.715639551899997,0.8292079207920792,0.9614328449551595,1.0,2/12,10.39%,CLASP2;DAG1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.27106882145657124,-0.7155721495541411,0.8461538461538461,0.9605433355008836,1.0,8/16,34.82%,ACSS1;ACLY;GCDH;DIP2A;PPT1;HSD17B8;PPCS;SLC25A1
prerank,regulation of neuron projection arborization (GO:0150011),-0.27993225501864294,-0.7153222987766266,0.8350785340314136,0.9598346189017712,1.0,4/15,17.37%,WNT5A;MFSD2A;MACF1;GRIP1
prerank,macrophage chemotaxis (GO:0048246),-0.3147121763192537,-0.7151880774524342,0.7870370370370371,0.959011173132622,1.0,5/10,27.20%,TAFA4;EDNRB;CCL2;CCL5;CXCL17
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.2788731775531444,-0.7145124532013615,0.839572192513369,0.9588330748897061,1.0,1/17,0.71%,LYN
prerank,regulation of receptor internalization (GO:0002090),0.2866095041396282,0.7138465254976497,0.8328651685393258,0.9726538035414779,1.0,11/35,21.80%,LRPAP1;SFRP4;VEGFA;ATXN2;MKLN1;TBC1D5;RIN3;EGF;FMR1;ANKRD13D;DLG4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2752997139192473,-0.7135976069660896,0.8773333333333333,0.95888716440365,1.0,1/17,2.28%,LPGAT1
prerank,innate immune response (GO:0045087),0.23763107078326984,0.7132662560599174,0.9488272921108742,0.9729969204289671,1.0,45/217,19.48%,PTK2B;LBP;COLEC11;ALPK1;VNN1;ANKHD1;FRK;IRAK4;MAVS;RIPK2;SETD2;SLPI;KLRC2;ZDHHC11;REL;TLR4;CLPB;CHUK;TREML1;PLCG2;SRMS;TRIM26;CAPZA1;MYD88;IFIH1;YES1;IFNLR1;S100B;RNF135;TLR8;TRIM39;PML;CLEC5A;IKBKG;ANKRD17;SRPK1;BCL10;CYP27B1;RNASE6;POLR3A;TTC4;PPARG;CIITA;TRIM25;TRIM35
prerank,granulocyte chemotaxis (GO:0071621),0.27169257217819376,0.7131667951758147,0.8569553805774278,0.9727012906876227,1.0,6/55,11.35%,ANXA1;CXADR;GBF1;CXCL2;CCL3;CCL1
prerank,icosanoid biosynthetic process (GO:0046456),-0.31500794719945097,-0.7130642866365109,0.8329238329238329,0.9584843782089478,1.0,4/10,26.40%,LTA4H;PLA2G5;ALOX5AP;MGST3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.36435979639109334,0.7127837791944519,0.7832167832167832,0.9727642044668519,1.0,2/10,6.13%,TSKU;PLS1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3355446603034013,0.7126683332834135,0.8225538971807629,0.9720596151550871,1.0,3/15,18.89%,AP3B1;AP3D1;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3355446603034013,0.7126683332834135,0.8225538971807629,0.9720596151550871,1.0,3/15,18.89%,AP3B1;AP3D1;AP3S1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3242317978917904,0.7126675119766727,0.8022328548644339,0.9716342645999584,1.0,5/19,10.33%,ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,regulation of exocytosis (GO:0017157),0.2831604420474396,0.7126604823101542,0.8344283837056504,0.9712165678275531,1.0,4/46,7.94%,STXBP6;ANXA1;SYTL4;NSF
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2586159917363168,0.712466610301853,0.8849878934624698,0.97102028578593,1.0,23/83,21.89%,INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;PIM2;GSPT1;RB1;CDKN3;CDC45;CUL3;CCND1;CDK16;HINFP;CUL1;RRM2;CDKN1A;KHDRBS1;PPP6C;POLA1;E2F1;CUL4A
prerank,heterocycle biosynthetic process (GO:0018130),0.3488077719503875,0.7122066698632179,0.8034591194968553,0.9709296505987445,1.0,4/14,19.77%,NFS1;MOCOS;PYCR1;MOCS3
prerank,nuclear membrane organization (GO:0071763),0.3230284983047255,0.7120930790227087,0.7969465648854962,0.9706464151148401,1.0,6/19,25.39%,TOR1AIP1;EMD;TOR1B;TARDBP;AKAP8L;CHMP4B
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2898874405487533,0.7112801633364886,0.8239339752407153,0.9712678082046606,1.0,13/39,27.33%,ERCC5;CHD1L;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3239277867664693,0.7110725178675025,0.7938461538461539,0.9711049920642507,1.0,5/20,18.03%,ZC3H7A;PUM2;PUM1;AGO2;DROSHA
prerank,amyloid-beta metabolic process (GO:0050435),0.3307345583987509,0.710859127286934,0.8081123244929798,0.9709595642270606,1.0,3/16,9.27%,MGAT3;IDE;BACE2
prerank,mRNA methylation (GO:0080009),-0.2858132143047686,-0.7108224587772078,0.8481012658227848,0.9600361832416107,1.0,5/15,30.67%,METTL14;METTL3;ZC3H13;METTL16;METTL8
prerank,embryonic digit morphogenesis (GO:0042733),0.3200729983374411,0.710142766568355,0.8006430868167203,0.9714493570617285,1.0,3/18,5.59%,GLI3;NOG;CREBBP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3319582091831195,0.7100694578078178,0.7750410509031199,0.9711193558225987,1.0,3/15,7.35%,FGFR1;MFRP;CELF1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3119703722302429,-0.7099366701230175,0.8170426065162907,0.9590987808257566,1.0,11/11,68.83%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3119703722302429,-0.7099366701230175,0.8170426065162907,0.9590987808257566,1.0,11/11,68.83%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,nuclear body organization (GO:0030575),-0.30013467745137634,-0.7099106843110757,0.8163771712158809,0.9581692025994134,1.0,1/12,2.38%,ETS1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.239146667595541,0.70947423610177,0.9454545454545454,0.971477210603999,1.0,54/208,20.01%,TRAF3IP2;TANK;AKAP13;ALPK1;TAB3;IRAK4;ESR1;MAVS;RIPK2;MAP3K3;REL;IKBKE;ROR1;RORA;RHOA;CHUK;PLCG2;PIM2;MTDH;GOLT1B;USP10;PER1;MIER1;OTUD7B;PPP5C;MYD88;TRAF5;ZC3H12A;CARD16;PPM1A;TRADD;TNIP1;HTR2B;S100B;CCDC22;TRIM39;PIDD1;SQSTM1;ZFAND6;CPNE1;DDX21;IKBKG;ANKRD17;NLRP12;BCL10;TLR6;DHX36;BIRC3;NEK6;TRIM25;TRAF3;UBE2N;SLC20A1;RNF31
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3108914488096264,-0.7089524374281665,0.8036117381489842,0.9582757548193183,1.0,6/10,25.89%,RUVBL1;PIH1D1;RUVBL2;NUFIP1;SHQ1;ZNHIT6
prerank,cholesterol homeostasis (GO:0042632),0.26714302383382615,0.7089383286001437,0.8660598179453837,0.9717359892017167,1.0,10/64,13.28%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A
prerank,RNA interference (GO:0016246),0.3291414486742614,0.7085380465283735,0.7987711213517665,0.9718161205509782,1.0,5/17,21.21%,CELF1;DHX9;AGO2;DROSHA;NRDE2
prerank,cellular amide metabolic process (GO:0043603),0.24849690637998495,0.7081371224568597,0.8932515337423312,0.971914740520253,1.0,15/102,14.00%,SLC5A6;PLPP3;VNN1;PLA2G15;ACOT8;NNMT;NLN;ACOT12;ACOT9;FPGS;FOLR2;ACOT13;ACSM2A;ACSM2B;PLPP1
prerank,sphingolipid biosynthetic process (GO:0030148),0.26341645154639187,0.7072409603186294,0.8868894601542416,0.972597840655177,1.0,5/71,5.31%,ACER3;PLPP3;SGMS2;LARGE1;SPTSSB
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.29505683915369557,0.7066527159145812,0.8258928571428571,0.9725079895602988,1.0,6/29,13.93%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.29505683915369557,0.7066527159145812,0.8258928571428571,0.9725079895602988,1.0,6/29,13.93%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,negative regulation of RNA splicing (GO:0033119),0.31988330177221724,0.7063521231171881,0.8108108108108109,0.9724421112864017,1.0,4/19,10.14%,SRSF6;PCBP4;RBMX;U2AF2
prerank,protein targeting (GO:0006605),0.24548237076628227,0.7062497168450842,0.90625,0.9721590407861089,1.0,32/118,22.42%,GIPC1;LTBP2;HPS4;ATG3;ZDHHC11;AP4E1;PARD3;KATNB1;ZDHHC15;LONP2;HACL1;SEC61A1;VPS37A;ZDHHC2;TIMM23;PITRM1;GOLGA7;BCAP31;TIMM17B;ZDHHC20;ZFAND6;SEC63;SRPRB;VPS37B;ZDHHC23;RABGEF1;AP4M1;ZDHHC12;AP4B1;DNAJC19;SRPRA;TOMM34
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2735921379237948,-0.705392830236829,0.8605263157894737,0.9610186853570682,1.0,6/17,26.66%,LPGAT1;PLAAT3;PLA2G4C;PLA2G5;PLA2G4E;PLBD1
prerank,spermatid development (GO:0007286),-0.23274275152405324,-0.7053799089679529,0.8855421686746988,0.9600735400822994,1.0,12/32,31.44%,NECTIN2;JAM2;CDYL;TDRD5;ING2;NME5;YTHDC2;DPY19L2;CCDC63;RSPH1;ZMYND15;SOX30
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.29469318263164446,-0.7048180326587461,0.8211382113821138,0.9596827991159761,1.0,2/14,10.73%,ERN1;CPSF6
prerank,lipid translocation (GO:0034204),0.3121172792175406,0.7037058577890496,0.8071748878923767,0.9748861389965222,1.0,8/21,19.16%,ATP10A;ATP8B1;TMEM30B;ATP9B;ATP11A;ABCC1;RFT1;ABCA7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3382199632244737,0.7035868665256076,0.7940691927512356,0.9746144355843221,1.0,4/13,17.17%,MDFIC;CHP1;NUP153;BARD1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.29495175385398376,0.7032385001816074,0.8328445747800587,0.974616769857722,1.0,3/30,6.54%,PRKCD;PTPN2;DMTN
prerank,cellular response to dsRNA (GO:0071359),0.3357699281129987,0.7031324906671583,0.8104575163398693,0.9743314426426469,1.0,9/15,35.28%,MAVS;IFIH1;DHX9;COLEC12;RALB;ZCCHC3;MUL1;RIOK3;CGAS
prerank,regulation of viral transcription (GO:0046782),-0.2331042918421427,-0.7028183466859022,0.9423076923076923,0.9608066943060588,1.0,8/39,17.61%,TRIM14;TRIM62;IFITM3;NELFCD;POLR2G;TRIM21;TARBP2;POLR2K
prerank,organelle fusion (GO:0048284),0.3149476881926692,0.7025635348279593,0.8132716049382716,0.9746421636412858,1.0,6/22,26.30%,EEA1;MIEF1;SPG7;MIGA1;MIEF2;USP30
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.29491700887805516,0.702169839385465,0.828696925329429,0.9747129565729954,1.0,7/30,14.72%,KIF13A;GOLPH3;NSF;SEC16A;KRT18;GOLGA7;GGA2
prerank,regulation of microtubule depolymerization (GO:0031114),0.30544654472514343,0.7020890067982064,0.8199404761904762,0.9743905852397163,1.0,4/25,10.71%,FGF13;HDGFL3;MAP1B;KATNB1
prerank,secondary alcohol metabolic process (GO:1902652),0.27879186307321124,0.7017197271400714,0.8535564853556485,0.9744366707345281,1.0,6/42,12.80%,SOAT1;FDX1;TSKU;RXRA;EBP;LCAT
prerank,respiratory chain complex IV assembly (GO:0008535),0.31778271175275585,0.7014628899886749,0.8195121951219512,0.9743306504294484,1.0,3/21,10.56%,COX16;COA8;SCO2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.31565875304396007,0.7005632418151645,0.8237179487179487,0.9749937154958171,1.0,12/20,27.61%,FOXC1;NIBAN2;RB1;DDRGK1;PAX6;EP300;TWIST1;GATA3;POU4F1;GTF2B;TRAF6;TGFB1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.29710624632118804,0.7004747626790814,0.8272327964860908,0.9746816706026206,1.0,9/30,19.18%,DSE;CHST13;HEXA;ARSB;CHST11;IDUA;CHST12;BGN;CHPF2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.31824093518339697,0.7000128971653549,0.8167701863354038,0.9748169636049094,1.0,6/19,24.85%,ADA;AMPD3;DGUOK;POLD3;GMPR2;AMPD2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24976859235942098,0.6997416211452223,0.9002375296912114,0.9747410532685555,1.0,33/94,29.62%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AKAP9;CEP131;CSNK1E;NPHP1;MKS1;SDCCAG8;CEP43;CEP89;HAUS2;CEP57;C2CD3;CEP97;CEP70;IQCB1;CSNK1D;OFD1;PLK4;HAUS5;CNTRL;PCNT;PRKACA;NPHP4;CEP192;CEP290;ODF2;RPGRIP1L;CEP83;YWHAE
prerank,sterol homeostasis (GO:0055092),0.26376927358725105,0.6997357041630663,0.8764629388816645,0.9743280659455585,1.0,13/65,17.39%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A;PLA2G12B;ABCD1;ANGPTL3
prerank,copper ion homeostasis (GO:0055070),-0.27078507009061836,-0.6991064631848565,0.8740157480314961,0.9637200958833567,1.0,4/17,11.45%,APP;ATOX1;SLC31A1;MT2A
prerank,Golgi to lysosome transport (GO:0090160),0.3422927544628987,0.6981228781578369,0.7918088737201365,0.9758907489732306,1.0,5/11,20.33%,GAK;EHD3;RBSN;AP4M1;CLN3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3312293815957792,0.6976050110058957,0.8218954248366013,0.9761212718012455,1.0,2/15,3.62%,PRKCE;IRS1
prerank,lipoprotein transport (GO:0042953),-0.3097265391248979,-0.6970801312792917,0.8179723502304147,0.9647986966347504,1.0,3/10,16.68%,PRKCB;ZDHHC17;VMP1
prerank,cellular response to glucose stimulus (GO:0071333),0.28710408572865476,0.6967798274972951,0.8425655976676385,0.9767048894143365,1.0,6/30,12.95%,KCNB1;UNC13B;SLC39A14;CLTRN;PDK3;SELENOT
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.2908294911937489,-0.6960738201396321,0.85,0.964830770488392,1.0,5/13,14.47%,DCN;CSPG5;NCAN;IDS;HEXB
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.34905624144684033,0.6956932116717566,0.7978910369068541,0.9775680957485055,1.0,2/10,9.65%,TLR4;IL33
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3470980691481404,0.6949703424902138,0.8169717138103162,0.978008134346569,1.0,1/11,4.28%,AGTR1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.33583592220914193,0.6941735392837155,0.8118971061093248,0.9785319722071424,1.0,5/13,24.11%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.29655547965898016,-0.6939863996470816,0.8778625954198473,0.9658934497554906,1.0,1/12,4.99%,APOBEC1
prerank,lipid droplet formation (GO:0140042),0.3667703258664692,0.6935670526984196,0.8014059753954306,0.9788356016289388,1.0,3/10,17.29%,ZFYVE1;CDS1;SMIM22
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.30941859021755813,0.6933301576618136,0.8348484848484848,0.9786799616139734,1.0,2/22,4.79%,EDEM3;RNF185
prerank,Notch signaling involved in heart development (GO:0061314),0.3555950243584295,0.6927122597811909,0.8166089965397924,0.9789855012712316,1.0,3/11,10.23%,NOTCH2;JAG1;GALNT11
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3105094137132871,0.6925797160447787,0.8367346938775511,0.9787391918417663,1.0,4/21,13.89%,DERA;GPI;SHPK;RPIA
prerank,cobalamin metabolic process (GO:0009235),0.31563819090740836,0.6920852424179829,0.814935064935065,0.978924700983172,1.0,7/17,26.36%,MMACHC;CD320;ABCC1;MMAB;MMADHC;CTRC;LMBRD1
prerank,positive regulation of double-strand break repair (GO:2000781),0.2734006949978199,0.6918843813924229,0.8426183844011143,0.9787603586097054,1.0,10/39,20.83%,FUS;DDX11;SPIDR;PRKDC;MRNIP;KDM4D;SHLD1;WDR48;PARP3;KMT5B
prerank,renal filtration (GO:0097205),0.3530044243895039,0.6917223736525504,0.8023648648648649,0.9785278565744149,1.0,4/10,18.91%,SULF1;XPNPEP3;TBC1D8B;SULF2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.28952416652010543,0.691556241982114,0.8577777777777778,0.9783022479371147,1.0,1/30,0.92%,ABCD3
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3024583860358371,0.6912501851134912,0.8460291734197731,0.9782289291774952,1.0,4/23,9.36%,DSG2;ISL1;ID2;TNNI3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2866504762641055,-0.6909292028577848,0.8425925925925926,0.9678975846666229,1.0,1/12,5.72%,PRKCQ
prerank,aromatic amino acid family metabolic process (GO:0009072),0.35716804571078725,0.6908711825645338,0.8059964726631393,0.9782457325342515,1.0,2/10,15.68%,IYD;KYAT1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2936881326398053,-0.6907860302330542,0.8233766233766234,0.9670880289281472,1.0,4/12,20.32%,IL18;TTBK1;NUPR1;TREM2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.28865720657973826,-0.6896311839147552,0.8530120481927711,0.9672624647018254,1.0,2/13,7.41%,TMSB4X;HEY2
prerank,protein catabolic process (GO:0030163),-0.1989462546171434,-0.6895993584406608,0.970954356846473,0.9663448676571025,1.0,4/59,5.71%,APOE;ADAMTS9;HSPA8;DAB2IP
prerank,glutathione metabolic process (GO:0006749),0.27920144233051997,0.6895420832581871,0.8618331053351573,0.9794532859709134,1.0,7/38,18.75%,GCLC;MMACHC;GSR;GSTM4;DPEP1;GSTA2;GSTT1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.2968693426171457,-0.6894188589646386,0.8427230046948356,0.9655554661992487,1.0,3/12,7.63%,LY6E;IFITM1;IFITM3
prerank,positive regulation of cell cycle process (GO:0090068),0.24628158300489153,0.6888474879373985,0.9243902439024391,0.9798379394039001,1.0,14/91,13.95%,CIT;GIPC1;PRKCE;CDC25B;PLSCR1;CDC14A;RHOA;AURKA;DRD3;LRP5;DDX11;ATRX;PKN2;CUL3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2778595509078623,0.6884422921109877,0.8627450980392157,0.9799243817658746,1.0,9/39,17.83%,TTC7A;PIK3C2B;IP6K2;SOCS2;PI4KB;PIK3R3;SMG1;IP6K1;IP6K3
prerank,proteasome assembly (GO:0043248),0.3472971631280606,0.6883803626593801,0.8139931740614335,0.9795821459654951,1.0,5/11,26.85%,PSMG2;PSMD11;PSMG1;ADRM1;PSMD4
prerank,cellular response to interferon-gamma (GO:0071346),0.24707641305015063,0.6881826077542728,0.905982905982906,0.9794025852507047,1.0,11/88,11.35%,CAMK2D;PRKCD;CD44;MID1;SLC26A6;SYNCRIP;IRF1;TLR4;TRIM26;CCL3;CCL1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.27100509922454424,-0.6879756159114704,0.8482587064676617,0.9659202993403933,1.0,1/13,2.07%,PRR5L
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.24952495855801649,-0.6876010273521247,0.8919597989949749,0.9653392018922328,1.0,4/21,11.35%,TOX;NES;PROX1;MDK
prerank,aminoglycan metabolic process (GO:0006022),0.34074883850311877,0.6874860068759546,0.8,0.9797728152550517,1.0,3/10,20.11%,XYLT1;B3GALT6;B4GALT7
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2959747175289086,-0.6864333510312438,0.8555304740406321,0.9655117940534959,1.0,1/10,6.79%,PRKAR1A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.260950969343351,-0.6863853494952943,0.8737113402061856,0.9646048836252954,1.0,2/19,4.62%,SLCO1C1;APP
prerank,folic acid metabolic process (GO:0046655),0.30771422852442004,0.6862924307566568,0.8236245954692557,0.9808232562960417,1.0,10/18,36.19%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1;MTRR;DHFR;PM20D2
prerank,inner dynein arm assembly (GO:0036159),0.3452488920378658,0.686274822972934,0.8278829604130808,0.9804243503632454,1.0,2/10,14.77%,CCDC40;DNAAF4
prerank,regulation of Golgi organization (GO:1903358),0.3179832971789907,0.6859204475225731,0.8370967741935483,0.9803957368732674,1.0,8/17,24.33%,STX5;EHD3;ARMH3;AKAP9;MAP2K2;RBSN;CAMSAP3;STX18
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.28595155300766206,0.685897771490882,0.849194729136164,0.9800013508390172,1.0,3/30,6.20%,CD44;KDM1A;CLU
prerank,regulation of synapse organization (GO:0050807),0.2916840324656818,0.6848486164047107,0.8474074074074074,0.9807823218480484,1.0,7/26,16.26%,NEDD4;ABL1;PDLIM5;ABHD17B;SETD5;GRIPAP1;SLITRK2
prerank,histone exchange (GO:0043486),0.28019510619354215,0.6847975751448513,0.8629943502824858,0.9804337933516055,1.0,17/37,29.26%,SRCAP;VPS72;CENPT;SMARCA5;RBBP7;CENPQ;RNF8;HJURP;DMAP1;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.33140957872695337,0.6847125476807556,0.8324607329842932,0.9801121644141324,1.0,6/12,30.46%,SEC61A1;SEC63;GET3;CHMP4A;CHMP4B;SEC61B
prerank,gene silencing by miRNA (GO:0035195),0.2877019014865793,0.684633454066903,0.8485273492286115,0.9797766289460788,1.0,11/32,22.92%,ZC3H7A;MOV10;TNRC6C;EIF6;PUM2;CNOT7;PUM1;AGO2;RAN;TNRC6A;RBM4
prerank,mitochondrial membrane organization (GO:0007006),-0.2305644191553028,-0.6846183111646356,0.896551724137931,0.9653357787263301,1.0,11/32,25.84%,BCL2;BCL2L1;CHCHD6;MICOS13;MFN2;MTX1;HSPA9;MFN1;PMAIP1;RCC1L;SLC25A4
prerank,positive regulation of myelination (GO:0031643),0.3441464231663083,0.6842296083289938,0.8415672913117547,0.9798236721276491,1.0,3/11,12.34%,EGR2;PARD3;TNFRSF1B
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.24707038839574957,-0.6833331902892857,0.8803191489361702,0.9655841614502458,1.0,7/21,23.56%,BCL2L1;BOK;TMBIM6;SELENOS;XBP1;PMAIP1;CREB3
prerank,phosphate ion homeostasis (GO:0055062),0.3525419474714787,0.6829485910297718,0.8051724137931034,0.9808983933789825,1.0,2/10,7.17%,SFRP4;SLC34A2
prerank,sterol biosynthetic process (GO:0016126),-0.22327993178320893,-0.682171930773267,0.9251700680272109,0.9657612229388053,1.0,7/33,17.54%,PRKAG2;INSIG2;ACLY;HSD17B7;CH25H;SC5D;ACAT2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.30599333241456556,0.6820534084404986,0.8419497784342689,0.9814848922648152,1.0,1/21,1.40%,NGF
prerank,negative regulation of JNK cascade (GO:0046329),0.2889361775906274,0.6820301922086915,0.8814285714285715,0.9810931572545887,1.0,6/31,11.49%,PDCD4;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.3426754515206669,0.6813326467624476,0.84,0.9814681317043573,1.0,1/10,3.18%,NFE2L2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2502737953345257,-0.6811633042054642,0.901595744680851,0.9657229466681869,1.0,1/19,1.24%,APOE
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.31195079086115995,-0.6810896152057698,0.8709677419354839,0.9648488757074183,1.0,10/10,68.83%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5;TCP1;CCT6A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3024518192963708,0.6809525007492944,0.8411949685534591,0.9814913677268292,1.0,7/19,30.40%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1
prerank,striated muscle cell differentiation (GO:0051146),0.31967941104111297,0.6808117189614703,0.8449367088607594,0.9812207551416589,1.0,2/16,5.66%,AKAP13;SKI
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3152062902683047,0.6798222077941731,0.8045977011494253,0.9819039162447504,1.0,3/16,8.83%,RAET1E;KLRC2;PVR
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.33123660916551145,0.6797576266284212,0.8285256410256411,0.981564047393109,1.0,5/15,25.48%,CHEK2;RAD17;ATF2;RAD9B;MDC1
prerank,negative regulation of signaling (GO:0023057),0.2970922601950776,0.6794051132679255,0.8194842406876791,0.9815571957534217,1.0,4/25,10.43%,UBASH3B;HHIP;ACVR1;SRMS
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.30002700863734083,0.6792143064578537,0.872093023255814,0.9813650895936248,1.0,10/21,29.50%,MCUB;MCU;SLC8B1;FATE1;BCAP31;MICU3;MICU1;MICU2;PDZD8;ANXA6
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25240041606514835,0.6789683399362415,0.9265822784810127,0.9812485421476518,1.0,25/73,28.08%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;KITLG;PSMC1;PSMD7;DHX36;PSMD14;PSMD3;YTHDF2;GATA3;LDB1;PSMD12;EIF2AK2;PSMD4;PSME3;PSMD2;KMT2A
prerank,female gamete generation (GO:0007292),-0.22839933123366796,-0.678949793080676,0.9016393442622951,0.9657574812686105,1.0,7/29,21.08%,DIAPH2;FMN2;SPO11;MDK;NANOS3;TRIP13;METTL3
prerank,regulation of defense response to virus (GO:0050688),0.3227897802245657,0.6789322916946174,0.8133561643835616,0.9808755940573759,1.0,6/14,26.70%,IFNLR1;DHX9;TRAF3;TRAF3IP1;RNF26;PPM1B
prerank,erythrocyte development (GO:0048821),-0.3014667341406598,-0.6785829821306604,0.8631346578366446,0.9651503524130552,1.0,5/10,18.68%,ALAS1;MED1;SH2B3;LYAR;ABCB10
prerank,negative regulation by host of viral process (GO:0044793),0.33980362154479604,0.6784773711346513,0.8151986183074266,0.9809518668990239,1.0,2/10,14.01%,ZC3H12A;EIF2AK4
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.33465609613150343,0.6783733291318321,0.8258706467661692,0.980659944989772,1.0,2/11,12.07%,CD44;CORO1C
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.24877275453536227,0.6780868058578635,0.9178082191780822,0.9805681035121939,1.0,12/74,17.11%,EGLN3;NFE2L2;CREBBP;HIF3A;PSMB2;PSMC6;VEGFA;EP300;PSMD11;PSMD1;PSMC1;PSMD7
prerank,regulation of centriole replication (GO:0046599),0.3076144260715802,0.6779301798228764,0.8210862619808307,0.9803223493417466,1.0,7/17,22.38%,SPICE1;KAT2A;STIL;KAT2B;RBM14;CEP295NL;PLK4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.31325855663705615,0.6776894986124653,0.8347107438016529,0.9801863104833448,1.0,5/16,20.83%,PRKDC;KDM4D;SHLD1;PARP3;KMT5B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2930787181625625,0.6768763754103914,0.8432267884322678,0.9807009952478734,1.0,5/23,17.55%,MTMR12;OCRL;PIP4P2;SYNJ1;MTMR11
prerank,positive regulation of defense response (GO:0031349),0.24465558122076558,0.6764649861566948,0.9323671497584541,0.980745949769561,1.0,20/89,18.15%,GPR4;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;LRSAM1;IL33;CCL3;CCL1;TRADD;TNIP1;DHX9;TLR8;ABCC1;NLRP12;POLR3F;ADAM8
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.28553311544367466,0.6759579942216524,0.8571428571428571,0.9808954024288974,1.0,9/29,23.06%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,acyl-CoA metabolic process (GO:0006637),0.27409386163629385,0.6759411062679164,0.8575581395348837,0.9804928529311974,1.0,7/35,14.30%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B;OGDH
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.2840951093819806,0.6758008673407352,0.8582089552238806,0.9802359054981418,1.0,4/28,9.01%,MAPRE2;ABL1;GAS2L2;MAP1B
prerank,regulation of keratinocyte proliferation (GO:0010837),0.30189429421135194,0.6753566781816841,0.817629179331307,0.9803283570977689,1.0,3/22,6.62%,NOTCH2;KLF9;SRSF6
prerank,transferrin transport (GO:0033572),-0.22345099280803477,-0.6753466738022794,0.9297124600638977,0.9670661338609635,1.0,10/33,20.54%,TFRC;LMTK2;ATP6AP1;STEAP3;ATP6V1D;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.252700137711951,0.6749912345653706,0.9232736572890026,0.9803159326161743,1.0,23/70,28.08%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMC1;PSMD7;PSMD14;PSMD3;YTHDF2;GATA3;LDB1;PSMD12;EIF2AK2;PSMD4;PSME3;PSMD2;KMT2A
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.25058341581974114,0.6745499631625729,0.9164588528678305,0.980401259448247,1.0,21/72,25.15%,DXO;ERCC5;CHD1L;ZC3H12A;DCP1A;ERCC3;IHO1;XPA;RPA1;ERCC1;RNASE6;RFC1;EXD2;DDX1;POLD3;RAD50;CUL4A;RFC5;EDC3;ERCC2;POLK
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.31400923884955045,0.6737757402858328,0.8369905956112853,0.9808483967029853,1.0,9/18,35.46%,RNF185;OS9;EDEM2;UGGT2;MAN1B1;SEL1L;SYVN1;RNF5;RNF103
prerank,negative regulation of cellular metabolic process (GO:0031324),0.27214090037175664,0.6736123465355972,0.8813559322033898,0.9806133002071766,1.0,12/37,21.80%,LRPAP1;ITGAV;NFKB1;ATXN2;NCOR1;ITGB3;AATF;RIN3;TFAP2A;TRAP1;ANKRD13D;DLG4
prerank,receptor clustering (GO:0043113),0.2785288489483888,0.6731624344984799,0.8844984802431611,0.9807198429438164,1.0,10/27,23.27%,DLG2;DLG1;ITGB1BP1;SYNJ2BP;SCRIB;DVL1;DLG4;FLNA;LRP4;NRXN2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2828312361922733,0.6720413416631665,0.891970802919708,0.9815014506278448,1.0,12/29,32.48%,EXOSC7;CNOT7;DCP1A;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;CNOT8;EXOSC2;DIS3;EXOSC3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.28311256440402405,0.6718328730157348,0.8685376661742984,0.9813079268174026,1.0,9/26,25.45%,ALPK1;TAB3;RIPK2;IFIH1;IKBKG;UBE2N;UBE2V1;MAP3K7;TRAF6
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.30912800384238814,0.6715988732786758,0.826797385620915,0.9811582852722847,1.0,3/17,8.83%,RAET1E;KLRC2;PVR
prerank,response to gamma radiation (GO:0010332),0.2962248858925768,0.6711221164807479,0.8652694610778443,0.9812565526362137,1.0,6/24,17.95%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,cellular response to chemical stress (GO:0062197),0.23763730444611217,0.6709054707212184,0.9346016646848989,0.9810860913135566,1.0,12/96,12.52%,LRRC8D;FOXO3;NFE2L2;ABL1;GPX8;MGAT3;VKORC1L1;GSR;ATM;CCS;RAD52;ZC3H12A
prerank,establishment of melanosome localization (GO:0032401),-0.2522808480421603,-0.6706925131440095,0.8871391076115486,0.9701415737142735,1.0,7/19,26.31%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,mRNA modification (GO:0016556),-0.24510050251256285,-0.670568271901665,0.8945868945868946,0.9693004085365471,1.0,22/22,75.53%,METTL14;METTL3;TRUB1;ZC3H13;METTL16;METTL8;TRMT10C;DKC1;CBLL1;PUS1;NSUN2;PUS3;TRMT61A;TRMT61B;CMTR1;TRMT6;VIRMA;RPUSD2;PCIF1;PUS7;TRUB2;WTAP
prerank,necroptotic process (GO:0070266),0.3213743665734462,0.6702339269454461,0.8152542372881356,0.9814135416287711,1.0,3/16,9.08%,TRPM7;TLR4;RIPK3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.28149513606780385,0.6699373806055953,0.8753581661891118,0.981308625955207,1.0,4/31,7.51%,KCNB1;CACNA1G;CLTRN;SYT8
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.33584757284525063,0.6698346815661754,0.8336192109777015,0.981014893088603,1.0,2/11,9.48%,ADRB2;DRD3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2564028979646694,0.6697781218738219,0.9140625,0.9806638436705156,1.0,16/50,28.47%,CCNA2;MNAT1;CDKN1B;CDKN3;GTPBP4;CCND1;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNF;CDKN2C;CCNE2;CCNT2;GADD45A
prerank,nuclear transport (GO:0051169),-0.26450942362177393,-0.669726085285991,0.9015544041450777,0.9690472119090379,1.0,6/16,22.44%,ANP32A;NPM1;NUP205;RBM15B;BANF1;NXT2
prerank,translational elongation (GO:0006414),0.23661741751021667,0.6687458944463176,0.9390681003584229,0.9813174133940888,1.0,36/101,30.78%,MRPL33;MRPL48;GTPBP2;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPS28;MRPS35;MRPL52;MRPL38;MRPL57;EEF2K;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL11;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPL19;MRPS18C;LTN1;MRPL9;MRPS34;MRPS16
prerank,protein localization to lysosome (GO:0061462),0.28185809194728295,0.6666113563813456,0.8717579250720461,0.9832301043760453,1.0,1/28,1.48%,NEDD4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3318599507549017,0.6663177634643359,0.8083333333333333,0.9831272593101098,1.0,3/10,20.75%,FEM1B;THOC5;WDR76
prerank,lipoprotein localization (GO:0044872),-0.2926292505655348,-0.6661265976126084,0.8504901960784313,0.9710727238276717,1.0,3/11,16.68%,PRKCB;ZDHHC17;VMP1
prerank,cellular response to glucose starvation (GO:0042149),0.25990394159507485,0.6657337434426416,0.8956043956043956,0.9833131413082002,1.0,6/41,13.51%,FOXO3;BECN1;ITFG2;SIK2;ZC3H12A;SH3GLB1
prerank,regulation of exit from mitosis (GO:0007096),0.2744462686946657,0.6654856238165285,0.8744525547445255,0.9831437662691367,1.0,11/38,24.59%,ANAPC5;CDC16;ANAPC16;CDC14A;UBE2S;MAD2L1;ZW10;ANAPC11;ANAPC10;CDC20;BUB3
prerank,intestinal lipid absorption (GO:0098856),0.3269686054027757,0.6649658584509457,0.8403908794788274,0.9832703267221157,1.0,2/11,12.29%,LDLR;LIMA1
prerank,lytic vacuole organization (GO:0080171),0.27585027943052487,0.6643081626129469,0.8903508771929824,0.983554181506931,1.0,14/32,29.29%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;MBTPS1;CLN3;HOOK2;TFEB;GAA;GNPTAB;ZKSCAN3;TPP1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24220767890300934,0.662996530652621,0.9402241594022416,0.9841368175441582,1.0,21/78,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24220767890300934,0.662996530652621,0.9402241594022416,0.9841368175441582,1.0,21/78,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,sensory perception of smell (GO:0007608),-0.284602347624129,-0.6628451098796049,0.8848039215686274,0.9729113949275447,1.0,11/11,71.57%,SYT10;DRD2;OMP;ADCY3;GFY;OBP2B;SLC24A4;MKKS;UBR3;BEST2;BBS4
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23972354099509036,0.6626302342864301,0.9405204460966543,0.9841124956161881,1.0,22/82,23.67%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AURKA;AKAP9;CEP131;CSNK1E;SDCCAG8;CEP43;HAUS2;CEP57;CEP70;DYRK3;CSNK1D;OFD1;PLK4;ATAD5;CDK2;HAUS5;CNTRL
prerank,ncRNA catabolic process (GO:0034661),0.28025405617106824,0.6616233028618788,0.8887195121951219,0.9847579793201312,1.0,12/28,32.48%,EXOSC7;ZCCHC8;ERN2;DIS3L2;TUT4;PARN;NUDT16L1;EXOSC4;EXOSC2;DIS3;XRN1;EXOSC3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.25915398406612206,-0.6605912137463511,0.8851174934725848,0.9737821638328273,1.0,5/15,18.86%,RPS7;RPL23;RPL11;LIMK1;RPL5
prerank,regulation of T cell differentiation (GO:0045580),0.2727064141926484,0.6597985454823657,0.8794117647058823,0.9862511939816374,1.0,6/33,16.43%,ABL1;CD2;CBFB;KAT2A;ZBTB1;ZMIZ1
prerank,regulation of histone modification (GO:0031056),0.3157343817997672,0.6590173839218696,0.8566610455311973,0.9866141947958726,1.0,5/13,24.19%,NNMT;SETD5;UBE2N;AKAP8L;MTHFR
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24814878579950458,0.6587667703038926,0.9292267365661862,0.98646228548836,1.0,15/68,19.88%,SULT1A1;RHOQ;PTHLH;ACOT8;ACOT12;AMPD3;ACOT9;ENTPD7;ACOT13;ACSM2A;ACSM2B;AK4;AK3;ACOT11;RAN
prerank,maintenance of protein location in nucleus (GO:0051457),-0.24634377511565098,-0.6587393576705787,0.9106628242074928,0.9742976143495787,1.0,5/20,17.81%,ARL2BP;TAF3;SP100;CHCHD10;BCL3
prerank,regulation of cilium movement (GO:0003352),0.33363615085638476,0.6585675549706642,0.857397504456328,0.9862407330987717,1.0,4/10,30.04%,CCDC40;ODAD2;CFAP43;DNAH11
prerank,lysosome organization (GO:0007040),0.2676521521002141,0.6579562021697577,0.8978723404255319,0.986472465060685,1.0,16/36,29.41%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;TMEM165;MBTPS1;CLN3;HOOK2;TFEB;GAA;GNPTAB;ZKSCAN3;TPP1;VPS33A
prerank,positive regulation of histone modification (GO:0031058),-0.2189304721145413,-0.6573198130705686,0.9588607594936709,0.9744950756687907,1.0,9/33,20.74%,RPS6KA5;PPARGC1A;ARRB1;MAPK3;APLNR;CTBP1;RUVBL2;SART3;ING2
prerank,mitochondrion distribution (GO:0048311),0.32049567086856784,0.6571945235703667,0.8500851788756388,0.9868568498354152,1.0,1/12,3.86%,MEF2A
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3277848108777063,0.6561855269966637,0.8658940397350994,0.9874538571160855,1.0,3/11,19.50%,GATA4;REST;LANCL1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2609057049712746,0.6559190539012488,0.8898550724637682,0.9873153259507478,1.0,13/41,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;NUP88;NUP98;AAAS;NUP54
prerank,macroautophagy (GO:0016236),0.22928484031127822,0.6549242344367805,0.9543859649122807,0.9878956434422621,1.0,33/118,26.25%,WIPI2;VCP;ZFYVE1;BECN1;VPS41;ATG3;LIX1L;ACBD5;RB1CC1;VPS37A;TCIRG1;HDAC10;TBC1D5;SQSTM1;AMBRA1;VPS37B;TSG101;NBR1;CSNK2A2;CSNK2A1;SNF8;ATG4B;CLN3;HGS;ULK1;VTA1;TOMM20;PIP4K2A;CHMP4A;CHMP4B;ATG5;ATG7;LIX1
prerank,positive regulation of isotype switching (GO:0045830),-0.2580003254524611,-0.6549098003517585,0.9004739336492891,0.9754741603997192,1.0,4/15,19.41%,TFRC;RIF1;CD40;SHLD3
prerank,protein autoprocessing (GO:0016540),-0.25897348869410153,-0.6548198746298896,0.90625,0.9745972173365625,1.0,4/17,16.76%,CASP4;CTSL;MYRF;CASP1
prerank,positive regulation of secretion (GO:0051047),0.3270101980126199,0.65353833568777,0.8453947368421053,0.9889008312766615,1.0,1/11,4.38%,ACSL3
prerank,positive regulation of immune response (GO:0050778),0.24569115270334557,0.6534979539966734,0.9384010484927916,0.9885190355886336,1.0,12/64,20.32%,POLR3D;PLSCR1;IFI35;IL10;CD46;EIF2AK4;DHX9;TLR8;POLR3F;ADAM8;TGFB2;AKIRIN2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.30573181694993223,0.6531641943936722,0.8667687595712098,0.9884226187915601,1.0,1/18,1.90%,DDR2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.276631756739912,0.652751863874913,0.8944365192582026,0.9883966543597366,1.0,8/30,23.37%,FUT8;DPM1;MGAT1;DDOST;TUSC3;MGAT5;UGGT2;ASGR2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.27928089031305187,0.6527400041586298,0.8724409448818897,0.988000872400728,1.0,8/26,23.13%,ANAPC5;CDC16;RB1;CUL3;NEK6;ANAPC11;CCNB1;RIOK2
prerank,vasodilation (GO:0042311),0.30834385855993524,0.6519580973274245,0.8359621451104101,0.9883387510994961,1.0,1/13,2.69%,ADRB2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.32515357550870594,0.6514671981865401,0.8438030560271647,0.9879857003188084,1.0,5/11,22.92%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.32515357550870594,0.6514671981865401,0.8438030560271647,0.9879857003188084,1.0,5/11,22.92%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,peptidyl-asparagine modification (GO:0018196),0.27419216396736046,0.6511523726690243,0.8865248226950354,0.987888883771979,1.0,8/31,23.37%,FUT8;DPM1;MGAT1;DDOST;TUSC3;MGAT5;UGGT2;ASGR2
prerank,regulation of protein processing (GO:0070613),0.296986199692495,0.651073621600234,0.8918495297805643,0.987555287474979,1.0,7/21,20.33%,GAS1;TNP2;SNX12;ACP4;SERPINE2;ADAM8;CLN3
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.22203423663344107,-0.651018512320729,0.9573170731707317,0.9765411265428224,1.0,5/29,14.61%,CXCL12;GAS6;LGMN;CALR;JAM2
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.2784554997273745,-0.6505783103018921,0.9019607843137255,0.9759277002526795,1.0,2/12,8.24%,EPHB1;HSP90AB1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2700818648133021,0.6505018434231881,0.9160739687055477,0.9877406918029759,1.0,13/31,32.48%,EXOSC7;CNOT7;DCP1A;DIS3L2;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;CNOT8;EXOSC2;DIS3;EXOSC3
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3095443927442493,0.6501956987194049,0.8762711864406779,0.9876260249450056,1.0,3/13,17.36%,BCAP31;OS9;EDEM2
prerank,cilium-dependent cell motility (GO:0060285),-0.2372141857909948,-0.6486319095257207,0.9388888888888889,0.9764460691919039,1.0,7/22,30.47%,CFAP44;CFAP54;DNAH3;EFHC2;CCDC39;TEKT5;EFHC1
prerank,indolalkylamine catabolic process (GO:0046218),0.33530002510670337,0.6484136764278398,0.8419301164725458,0.9889334265498666,1.0,10/10,66.49%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT
prerank,negative regulation of protein kinase activity (GO:0006469),0.23760429927756713,0.6481650417459051,0.9493827160493827,0.9887396811322309,1.0,17/88,15.82%,LRP6;UBASH3B;ABL1;CDKN1B;NF1;LRP5;SMCR8;RB1;CEP85;DUSP10;ITGB1BP1;CORO1C;CHP1;PAK2;ACP4;WWTR1;CEP43
prerank,regulation of neurogenesis (GO:0050767),0.24588617357517192,0.6479246975526874,0.9098039215686274,0.9885740308602885,1.0,13/55,22.51%,HES1;DOCK7;BHLHE40;PCM1;PAX6;REST;HOOK3;PER2;HEYL;SNW1;YTHDF2;HES3;HES7
prerank,protein destabilization (GO:0031648),0.26792747576934833,0.6475612674868881,0.8908045977011494,0.9885137660194058,1.0,5/32,13.95%,GSN;CREBBP;FBXW11;EP300;CUL3
prerank,negative regulation of double-strand break repair (GO:2000780),0.27264924758580783,0.6470439926097823,0.8913362701908958,0.9885853789031055,1.0,6/30,19.69%,UBR5;TRIP12;TWIST1;SHLD1;RMI2;HELB
prerank,myeloid dendritic cell activation (GO:0001773),0.32126912646953926,0.646465338431099,0.8514851485148515,0.9887290429483352,1.0,1/12,4.97%,TGFBR2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.322432209867288,0.6463989196137889,0.8506711409395973,0.9883903345170756,1.0,4/11,28.58%,BARD1;DHX36;PAF1;NCBP2
prerank,macrophage migration (GO:1905517),0.30793372094628607,0.6461206483187356,0.8641765704584041,0.9882358931034488,1.0,2/13,10.91%,P2RX4;CCL3
prerank,endodermal cell fate commitment (GO:0001711),-0.2892348033051248,-0.6458607284722726,0.8762376237623762,0.9775330592846349,1.0,1/10,4.97%,SOX17
prerank,cellular response to amino acid stimulus (GO:0071230),0.26521113515934286,0.6448561667408274,0.9132947976878613,0.98901528037853,1.0,5/33,12.91%,CAPN2;KLHL22;RRAGB;CASTOR2;MTOR
prerank,positive regulation of ATPase activity (GO:0032781),0.256572638223606,0.6444048916199705,0.918809201623816,0.9890278309117237,1.0,3/41,6.56%,ATP1B1;TOR1AIP1;PLSCR1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.29846200699950437,0.6442372179289816,0.8932676518883416,0.9887705153890919,1.0,4/18,21.20%,MCM7;GINS3;POLA1;POLD3
prerank,regulation of spindle assembly (GO:0090169),0.2744188635559575,0.6441722223276161,0.877643504531722,0.9884252102539273,1.0,10/25,34.46%,PDCD6IP;CEP97;GPSM2;DRG1;CHMP4B;SENP6;RNF4;DYNC1H1;CHMP3;CHMP2B
prerank,cellular response to radiation (GO:0071478),0.2560351789168812,0.6440563433477443,0.907563025210084,0.9881405365620753,1.0,7/40,18.45%,TANK;SPIDR;KDM4D;CDKN1A;RAD51;TNKS1BP1;INO80
prerank,lysosome localization (GO:0032418),0.26480901682606844,0.6428327039830148,0.9117647058823529,0.9888905477333789,1.0,3/37,4.45%,NDEL1;NR4A3;SYTL4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.27480358710744385,0.6427281270000628,0.8926380368098159,0.9885841075055201,1.0,10/24,35.43%,STN1;TNKS2;SLX4;TEN1;NAT10;ACD;PINX1;XRN1;ERCC4;TINF2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23941905456379434,0.6422640931499295,0.94375,0.9886224523013314,1.0,26/69,31.75%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;ICE2;CCNT1;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;INTS2;TAF13;GTF2F2;GTF2A2;TAF9;CCNT2;SNAPC4;NCBP2;TAF5;INTS3;CDK7;TAF8
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3110475495901418,0.6422208040661074,0.8657937806873978,0.9882522825503145,1.0,5/15,22.21%,ATL2;ZFYVE27;RTN3;RAB18;TMEM170A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2495876140188202,-0.641559711355641,0.8959390862944162,0.9796751909847022,1.0,3/15,10.26%,SAMHD1;NLRC5;USP18
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.31071990717813236,0.6412432596565039,0.8707592891760905,0.9887588421776512,1.0,7/13,32.01%,FIP1L1;NUDT21;CPSF7;CPSF4;NCBP2;CPSF4L;CSTF2T
prerank,sulfur amino acid catabolic process (GO:0000098),0.3299362511226449,0.641014555838085,0.858603066439523,0.9885579859816399,1.0,2/10,18.40%,GADL1;ADO
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.25913957458591264,-0.6408486763100596,0.8707317073170732,0.9792491593978527,1.0,1/15,2.62%,HECW2
prerank,regulation of transposition (GO:0010528),0.30560612718940305,0.6402998024862717,0.8526863084922011,0.9888190449922009,1.0,13/13,69.46%,TDRD9;TEX15;PIWIL4;PIWIL2;SIRT7;AICDA;PIWIL1;BTBD18;UBR2;MYBL1;DDX4;SMYD5;SPOCD1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3107764740087999,0.6402370024440435,0.8807829181494662,0.9884643337670244,1.0,1/13,4.05%,BMS1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.32721972988669223,0.639004664318945,0.8658318425760286,0.9891853075486376,1.0,2/10,10.04%,DLGAP4;AKAP9
prerank,eosinophil migration (GO:0072677),0.2971162807275955,0.6380044746668918,0.8737864077669902,0.9893123776275464,1.0,4/14,22.59%,CCL3;CCL1;LGALS3;CCL7
prerank,eosinophil chemotaxis (GO:0048245),0.2971162807275955,0.6380044746668918,0.8737864077669902,0.9893123776275464,1.0,4/14,22.59%,CCL3;CCL1;LGALS3;CCL7
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2865539658565955,0.637989413051374,0.8782742681047766,0.9889197173243865,1.0,3/21,10.71%,FGF13;HDGFL3;KATNB1
prerank,canonical glycolysis (GO:0061621),0.27802458971348964,0.6378638632722351,0.896875,0.9882183418345987,1.0,4/24,11.53%,FOXK1;PFKP;GPI;FOXK2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.27802458971348964,0.6378638632722351,0.896875,0.9882183418345987,1.0,4/24,11.53%,FOXK1;PFKP;GPI;FOXK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.28829589584455395,-0.6376858189043086,0.8922018348623854,0.9805419358784415,1.0,5/10,32.00%,CALM1;CALM3;GNB5;GPR35;DRD2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.27385673999990473,-0.6360435856430832,0.9012345679012346,0.9807263074242654,1.0,5/11,28.41%,ENPP3;SLC19A3;SLC25A19;DCK;THTPA
prerank,glucan biosynthetic process (GO:0009250),-0.27561692612514915,-0.6355118230659208,0.8762135922330098,0.9792277128643067,1.0,3/12,11.63%,GBE1;PGM1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.27561692612514915,-0.6355118230659208,0.8762135922330098,0.9792277128643067,1.0,3/12,11.63%,GBE1;PGM1;PGM2L1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3073216215627932,0.6351702397858882,0.8731466227347611,0.9902460358796403,1.0,5/13,25.27%,DDRGK1;BFAR;ABCA7;NCK1;PTPN1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2489182231061503,-0.6337084426198545,0.8940886699507389,0.9795098808622682,1.0,7/16,33.56%,TOP2B;EME2;TOP2A;MUS81;EME1;RMI1;CENPS
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.29143821159561223,0.6333133509793673,0.8839590443686007,0.9914246811404874,1.0,7/17,28.25%,RB1;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.2901113827877305,0.6327009976602588,0.8737864077669902,0.991541968061401,1.0,7/18,26.36%,MMACHC;CD320;ABCC1;MMAB;MMADHC;CTRC;LMBRD1
prerank,regulation of aerobic respiration (GO:1903715),-0.2543348619324274,-0.6322549516732447,0.8994708994708994,0.9795739602260187,1.0,5/15,18.52%,CBFA2T3;SLC25A33;COX7A2;UQCC2;ATP7A
prerank,plasma membrane tubulation (GO:0097320),0.3052500618830216,0.6322268536061909,0.8805970149253731,0.9915423298657257,1.0,4/13,18.07%,EHD2;BIN2;CAVIN2;WHAMM
prerank,negative regulation of T cell proliferation (GO:0042130),0.26985576264692396,0.6319992909438968,0.9243323442136498,0.9913197454891816,1.0,6/28,21.25%,CD80;IL10;SDC4;SCRIB;ARG1;DLG5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3180478254121715,0.6319869351927792,0.8499184339314845,0.9909233044844215,1.0,2/10,18.03%,AGO2;DROSHA
prerank,zinc ion transport (GO:0006829),0.2846056756325466,0.6319524617862154,0.8870229007633588,0.9905441603521249,1.0,4/21,11.18%,SLC39A11;SLC39A14;SLC30A9;SLC39A13
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.23060407407626343,0.631778002113829,0.9600997506234414,0.9902985056191946,1.0,21/79,24.07%,AP2A2;SEC24B;KLC1;DYNC1I1;AP2A1;SEC23A;CAPZA1;SEC31A;SEC13;DCTN6;SEC24D;SAR1B;KIF3B;DYNC1LI2;DCTN5;CAPZA2;AP1S1;SEC24A;KIF2C;AP2B1;DCTN4
prerank,snRNA transcription (GO:0009301),0.23480867803664418,0.6307673534340217,0.9450686641697877,0.9907598003590987,1.0,26/70,31.75%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;ICE2;CCNT1;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;INTS2;TAF13;GTF2F2;GTF2A2;TAF9;CCNT2;SNAPC4;NCBP2;TAF5;INTS3;CDK7;TAF8
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.28563863655593646,0.6300665231355391,0.8945783132530121,0.9909541534591543,1.0,2/19,5.07%,CUX1;FBXW8
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2480658330547162,0.629673809161777,0.922971114167813,0.9908861282336964,1.0,16/50,27.88%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;NQO1;PSMC1;PSMD7;PSMD14;PSMD3;ODC1;OAZ2;PSMD12;PSMD4;PSME3;PSMD2
prerank,rRNA modification (GO:0000154),-0.23075069457440534,-0.6287801851813356,0.930939226519337,0.98085733079619,1.0,10/21,36.16%,TSR3;BUD23;NOP10;TFB2M;NHP2;FBL;DIMT1;TRMT112;FBLL1;TFB1M
prerank,stress granule assembly (GO:0034063),0.27992364033443107,0.6281458793478457,0.9138755980861244,0.9917899648857028,1.0,8/20,25.89%,PRRC2C;ATXN2;EIF2S1;CIRBP;YTHDF2;UBAP2L;YTHDF3;BICD1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.30154446140477065,0.6280818666845052,0.891156462585034,0.9914376384062812,1.0,4/13,14.40%,MAVS;TRIM44;IFIH1;DHX9
prerank,positive regulation of telomerase activity (GO:0051973),0.2555456671476632,0.6279804294179033,0.9164222873900293,0.9911274862727715,1.0,3/33,8.57%,KLF4;NEK7;GRHL2
prerank,response to amino acid (GO:0043200),0.2587695407660643,0.6273895002837042,0.9119318181818182,0.9912176760035579,1.0,3/31,6.98%,CAPN2;GLRB;RRAGB
prerank,negative regulation of hormone secretion (GO:0046888),0.3125688032243557,0.6272831134299126,0.8593481989708405,0.9909027933622545,1.0,1/10,5.34%,RAB11FIP3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23629020004021017,0.6272095270497696,0.9417344173441734,0.9905695737297376,1.0,14/52,22.70%,SHC1;LMNA;DNAJC3;DDX11;SEC31A;ADD1;ERN2;ATP6V0D1;ARFGAP1;SRPRB;GFPT1;CUL7;SRPRA;DNAJB11
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2263828964089516,0.6264985873361074,0.9643705463182898,0.9907654830359501,1.0,19/91,18.56%,STON1;ABL1;NRP1;STON2;ITGAV;GAS1;NSF;RUFY1;RAB25;USP7;SNX12;ARFGAP1;MAP2K2;RAB4B;PLD1;BET1L;RAB5B;MBTPS1;RAB21
prerank,mitotic cytokinetic process (GO:1902410),0.2810572283890278,0.6264912593769313,0.8918083462132921,0.9903671437522577,1.0,3/20,12.32%,PDCD6IP;RHOA;CNTROB
prerank,epithelial cell development (GO:0002064),-0.23304066604796325,-0.6264854214079614,0.9483695652173914,0.9814196991296078,1.0,2/20,7.15%,WNT5B;ACTA2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.28729118920512237,0.6258338195272485,0.8874801901743264,0.9905220355477697,1.0,2/17,11.35%,ANO6;CCL1
prerank,sterol transport (GO:0015918),0.27934822822274596,0.6257868860162166,0.8954041204437401,0.9901620899350336,1.0,6/19,27.66%,LDLR;LCAT;OSBPL5;NPC1;CD36;OSBPL2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24823622138723964,0.6254523612075481,0.924901185770751,0.9900394454060787,1.0,10/46,21.66%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;LPCAT1;GPAT3;PLA2G4A;ABHD5
prerank,melanosome localization (GO:0032400),-0.23338170472846284,-0.6249637808318274,0.927170868347339,0.981417318928387,1.0,7/21,26.31%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.2622307734792014,-0.6248840715186843,0.8973105134474327,0.9805297419189204,1.0,3/13,11.03%,CD81;SEC16B;BRSK2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.21435544073088558,0.6247455188474186,0.9874285714285714,0.990230113403147,1.0,45/132,28.48%,RPSA;LUC7L2;SRSF5;SRSF6;CELF1;CELF3;EIF2D;EIF6;EIF3A;SCAF11;BRIX1;PRKDC;XRCC5;GCFC2;DHX9;SF3B1;EIF2S2;NLE1;SRPK1;GEMIN8;EIF4B;PRPF18;DDX1;NOL3;NAF1;PRMT5;RBM5;TXNL4A;DHX29;LSM4;NUDT21;MDN1;LUC7L;MRPL20;CELF4;CPSF7;SRPK2;SNRNP200;PRPF6;MRPS7;CLP1;RAMAC;KHDC4;TGS1;PWP2
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.24820672943402725,-0.6247371273459807,0.9310344827586207,0.9796907986205463,1.0,6/16,33.68%,AHR;TNFSF8;IL12A;CD22;LST1;TNFSF9
prerank,cholesterol metabolic process (GO:0008203),0.23436456666587854,0.6242375205690563,0.9494163424124513,0.9902533384793153,1.0,12/68,18.72%,SOAT1;FDX1;TSKU;RXRA;LBR;MVD;EBP;LCAT;HMGCR;ANGPTL3;FDPS;OSBPL5
prerank,nuclear membrane disassembly (GO:0051081),0.3008205053340013,0.6228609363057351,0.8793103448275862,0.9909930214044205,1.0,6/14,23.47%,CNEP1R1;PRKCA;NEK9;NEK6;CCNB1;AKAP8L
prerank,steroid catabolic process (GO:0006706),-0.2737443532466721,-0.6227241226232669,0.9072398190045249,0.9799889103769375,1.0,7/10,39.68%,SPP1;HSD11B1;HSD17B11;HSD17B14;CYP24A1;FGF23;YWHAH
prerank,cellular response to pH (GO:0071467),0.29356324360342795,0.6208394155425342,0.909967845659164,0.9922466122604013,1.0,7/17,33.97%,SLC9A1;CHP1;RAB11B;PKD2L1;MCOLN1;GPR68;IMPACT
prerank,negative regulation of viral genome replication (GO:0045071),-0.19873477800971517,-0.6203351989587176,0.975609756097561,0.9805017101380978,1.0,21/40,34.56%,IFITM1;BST2;IFITM3;OAS2;PROX1;RNASEL;IFIT1;OASL;PARP10;BANF1;INPP5K;RSAD2;IFITM2;CCL5;TRIM6;SHFL;OAS3;ISG20;BTBD17;HMGA2;TNF
prerank,synaptic vesicle recycling (GO:0036465),0.2630238761983396,0.6203105060410784,0.9104046242774566,0.992267728073316,1.0,4/31,9.53%,STON1;STON2;SYT8;FCHO2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.27348158515821863,0.620234382930473,0.9149606299212598,0.9919274484655286,1.0,9/23,25.01%,KIF1B;KIF1C;DYNC1I1;F8A1;HOOK3;MAP6;HOOK2;MYO10;CCDC186
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23297967163829436,0.6192212310175321,0.956140350877193,0.9923368219797567,1.0,11/71,13.71%,CAPN2;DDI2;VCP;PDCD6IP;IDE;ZYG11B;OTUD7B;ZRANB1;YME1L1;CLPP;OMA1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2584575093411566,0.6176289371511139,0.922740524781341,0.9932427237381183,1.0,6/33,17.67%,GCLC;FPGS;KYAT1;CAD;NIT2;PYCR1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2923521285947508,0.6174841870891916,0.9046052631578947,0.9929633895466455,1.0,16/16,70.79%,RIPK3;KLRD1;CYRIB;FADD;IL23R;AGER;LILRB1;CEACAM1;PTPRC;KLRC1;XCL1;IL12B;IL23A;IL12RB1;IL12A;STX7
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2182772718757601,-0.6173366354875232,0.96996996996997,0.9813413178302124,1.0,6/24,19.18%,NOD1;MAP2K6;UBC;IRAK2;RPS27A;TNFAIP3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2661378922517776,0.6169882086685873,0.9151234567901234,0.9929434308389009,1.0,6/25,19.32%,FOXK1;PFKP;GPI;FOXK2;ADPGK;GAPDHS
prerank,histone lysine methylation (GO:0034968),0.2567294217006798,0.6157874496400062,0.9294605809128631,0.9934760041560946,1.0,11/33,33.60%,SMYD2;KMT2D;PRDM5;EHMT2;WDR82;SETD6;KMT2A;SETD1B;ASH2L;PAXIP1;SMYD3
prerank,modulation by host of viral genome replication (GO:0044827),0.2955448363972368,0.6155034719612645,0.8638655462184874,0.9932896628612691,1.0,5/13,28.43%,ZC3H12A;EIF2AK4;FMR1;TBC1D20;VAPA
prerank,programmed necrotic cell death (GO:0097300),0.2900130097524077,0.614973560156326,0.8826446280991735,0.99329099115293,1.0,3/18,9.08%,TRPM7;TLR4;RIPK3
prerank,positive regulation of cellular respiration (GO:1901857),0.3023088587226201,0.6145933985132339,0.8679245283018868,0.9931849684651944,1.0,2/11,14.01%,VCP;IFNLR1
prerank,positive regulation of rRNA processing (GO:2000234),0.31713455297049503,0.6145611646188178,0.8875219683655536,0.9928053160432516,1.0,3/10,23.13%,WDR43;WDR75;RIOK2
prerank,protein insertion into ER membrane (GO:0045048),-0.1991511613518408,-0.6144058589419495,0.9771241830065359,0.9821706827243231,1.0,11/37,24.02%,APP;MMGT1;CYB5A;UBE2J2;TRAM1;SEC61G;SERP1;EMC7;OTOF;SGTA;EMC6
prerank,regulation of protein acetylation (GO:1901983),0.305953156519849,0.6140021294550557,0.8741258741258742,0.9928185703284262,1.0,1/12,3.24%,GSK3B
prerank,vitamin D metabolic process (GO:0042359),-0.25555074172912573,-0.6133924033672719,0.927860696517413,0.981861226738294,1.0,2/13,12.00%,LGMN;CUBN
prerank,phagosome maturation (GO:0090382),0.25022104412992163,0.6133077802073241,0.9258202567760342,0.992975052907874,1.0,5/35,15.77%,ATP6V0A4;RAB43;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,regulation of protein metabolic process (GO:0051246),0.24328044575489513,0.6133016851727753,0.9477211796246648,0.9925779427337953,1.0,14/44,23.34%,KLF4;LDLR;LTBP4;CNDP1;CHEK2;ZDHHC2;SPOP;SNF8;ABCA7;TRAF3;MAPK8;HGS;PARL;ODC1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2846269835133168,0.6115391335798228,0.8915470494417863,0.993528689097567,1.0,4/14,17.00%,IRS1;LONP2;TWIST1;ABCD1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.30258040044086515,0.6112707432551738,0.8946515397082658,0.9933341431603107,1.0,3/12,17.33%,WDR18;NBN;TICRR
prerank,renal absorption (GO:0070293),0.3165251332244567,0.6099555501872335,0.8863636363636364,0.9939099900226457,1.0,1/10,2.48%,GSN
prerank,regulation of mitotic spindle assembly (GO:1901673),0.27534909324446244,0.609278663898138,0.9223454833597464,0.9940138873852877,1.0,4/19,25.39%,PDCD6IP;CEP97;DRG1;CHMP4B
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.29948716501764283,0.6090412342323279,0.8963210702341137,0.9938081001041063,1.0,1/11,5.97%,MAVS
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2820572452571106,0.6084250017115349,0.9123630672926447,0.993874366608125,1.0,4/18,11.14%,SKI;NF1;EMD;MORC3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2474534511925564,0.6079398471539182,0.9401709401709402,0.9938224333119753,1.0,15/33,32.50%,SCAF8;TTF2;LSM11;MAZ;FIP1L1;NUDT21;CSTF1;CPSF7;CPSF3;CLP1;CPSF4;NCBP2;CSTF3;CSTF2T;SSU72
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.30780065386168864,0.6070496734088724,0.8911917098445595,0.9941127365106194,1.0,5/10,32.29%,ACADM;ETFA;ETFDH;ACADS;ACADVL
prerank,rRNA pseudouridine synthesis (GO:0031118),0.30101133905191724,0.6057712152157664,0.8849557522123894,0.9946455832348227,1.0,5/10,30.74%,RPUSD4;NAF1;RPUSD1;GAR1;RPUSD2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.22928962129821814,0.6055554387581172,0.9629629629629629,0.9944186899547811,1.0,19/67,20.37%,RABEP2;ATG3;DMTN;RDX;ATP8B1;P2RX4;TBC1D2B;TBC1D13;TBC1D10A;TBC1D5;SDCCAG8;PLD1;SGSM3;ABITRAM;TBC1D17;FXR2;ODAD3;FMR1;RAB5A
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.2900233165240566,0.6048413494192451,0.901453957996769,0.9945362619925346,1.0,5/16,21.66%,LDLR;DAGLB;CNEP1R1;SREBF1;ABHD5
prerank,leukocyte tethering or rolling (GO:0050901),0.27599342020186723,0.6047897039089155,0.9226973684210527,0.9941833530435683,1.0,2/17,6.41%,ITGB1;GOLPH3
prerank,cellular response to acid chemical (GO:0071229),0.25346128607766455,0.6046701890150664,0.9237410071942446,0.9938694595105158,1.0,4/27,12.91%,CAPN2;RRAGB;VEGFA;MTOR
prerank,establishment of protein localization to extracellular region (GO:0035592),0.24602081882725868,0.6046426613093379,0.9396433470507545,0.9934925395723083,1.0,3/39,6.41%,TANGO6;LTBP2;GOLPH3
prerank,protein prenylation (GO:0018342),-0.2700225960331408,-0.6041940847550288,0.9357798165137615,0.9860158479326305,1.0,10/10,73.02%,PTAR1;CHML;FNTB;RCE1;AIPL1;RABGGTA;FNTA;PGGT1B;RABGGTB;CHM
prerank,negative regulation of innate immune response (GO:0045824),0.24574153872235147,0.6040938977349719,0.9247467438494935,0.9934633976901626,1.0,8/34,15.93%,PTPN2;TRAFD1;SERPING1;USP15;IRAK3;FAM3A;CNOT7;ACOD1
prerank,phosphatidic acid metabolic process (GO:0046473),0.23777778685321369,0.6021446199222127,0.944954128440367,0.9944584009289114,1.0,10/48,21.66%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;LPCAT1;GPAT3;PLA2G4A;ABHD5
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.1820935313739946,-0.6016328340021684,1.0,0.9864704840596942,1.0,13/53,21.94%,CALCRL;CHRM2;HTR2C;CHRM3;HTR2A;AGT;HRH1;LHCGR;TSHR;CCL2;LPAR3;NPY;HTR1F
prerank,mitochondrial genome maintenance (GO:0000002),0.29855598557614055,0.5996372712124318,0.916256157635468,0.9958151879259084,1.0,4/11,21.48%,MEF2A;TOP3A;SLC25A36;MPV17
prerank,protein lipidation (GO:0006497),0.22987852421777258,0.5992755094818624,0.9640102827763496,0.9956633682233658,1.0,22/59,26.24%,WIPI2;PGAP2;ZDHHC15;HHAT;PIGB;ZDHHC2;DPM1;PIGU;ZDHHC20;ZDHHC23;PIGL;WDR45B;PIGN;ZDHHC12;PIGH;PGAP3;PIGQ;ZDHHC5;MPPE1;ATG5;ATG7;PIGA
prerank,regulation of stem cell population maintenance (GO:2000036),0.27645420296113216,0.5983878604170302,0.9168,0.9958727149023865,1.0,3/18,14.21%,WDR43;KAT2A;REST
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.28198446445265696,0.598373434374428,0.9151414309484193,0.9954842698509366,1.0,5/14,25.59%,DDX18;WDR12;URB1;FTSJ3;ZNHIT3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.25475282804456834,0.5978344198780007,0.9428152492668622,0.9954552309130378,1.0,14/27,35.69%,ZC3H12A;ZC3H12D;ZC3H12C;RNASE6;LACTB2;PARN;CPSF3;CSTF3;XRN1;ZC3H12B;DICER1;NYNRIN;RNASEH1;POP1
prerank,positive regulation of histone deacetylation (GO:0031065),0.28870347204224855,0.5976023612735333,0.9061976549413735,0.9952245384678311,1.0,3/12,12.18%,ZBTB7B;VEGFA;NIPBL
prerank,positive regulation of chromatin organization (GO:1905269),0.29334053286334855,0.5972106504410013,0.9005059021922428,0.9951035395567094,1.0,3/12,19.56%,MIER1;ATRX;UBE2N
prerank,fatty acid biosynthetic process (GO:0006633),0.22197440367304277,0.5963231170817699,0.9627249357326478,0.9953106183472796,1.0,12/63,21.57%,ABCD3;SCD;ELOVL5;ACSM2A;ACSM2B;GSTM4;ABCD1;ABHD2;NDUFAB1;TECR;HACD4;MCAT
prerank,regulation of cell aging (GO:0090342),0.2951701273038422,0.5954127654713978,0.9067796610169492,0.9955411566915203,1.0,1/11,3.71%,LMNA
prerank,intracellular protein transmembrane transport (GO:0065002),0.23769926569080457,0.5937041049448468,0.9578651685393258,0.9962980982914206,1.0,12/42,24.31%,C2CD5;SEC61A1;TIMM23;TIMM17B;SEC63;AIFM1;DNAJC19;PEX2;GRPEL2;PEX7;PEX26;TOMM20
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2690124549834898,0.5928478156782702,0.9256329113924051,0.9964394312985643,1.0,1/20,1.74%,CAMK2D
prerank,transcription preinitiation complex assembly (GO:0070897),0.2959248345654745,0.5911764145559975,0.9065108514190318,0.997113856140504,1.0,5/12,27.16%,TAF12;GTF2B;GTF2A2;TAF7L;TAF1
prerank,regulation of centrosome duplication (GO:0010824),0.24996268169383365,0.5904640411652687,0.9520958083832335,0.997176953875089,1.0,9/29,25.88%,PDCD6IP;SPICE1;CEP131;STIL;CEP295NL;NAT10;CHMP4B;FBXW5;CCNF
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.25358526318378843,0.5899928488200592,0.9480712166172107,0.9970939833423869,1.0,11/27,32.75%,CTPS2;GSR;RRM2;AK4;AK9;AK1;NUDT13;AK5;AK6;CMPK1;DTYMK
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.21105931570536582,-0.5893825715856537,0.9683908045977011,0.9917246226878131,1.0,2/23,7.16%,CALM1;NMT2
prerank,histone mRNA metabolic process (GO:0008334),0.2541332358083571,0.5889946626375403,0.9448698315467075,0.9973269804412748,1.0,12/27,32.47%,ATM;LSM11;TUT7;TUT4;TENT2;SSB;ERI1;CPSF3;EXOSC4;NCBP2;MTPAP;XRN1
prerank,phospholipid homeostasis (GO:0055091),0.29557427266414416,0.5884344187984922,0.9233449477351916,0.9972783217115433,1.0,5/11,22.90%,HNF4A;TLCD1;TLCD2;ANGPTL3;FABP3
prerank,protein-DNA complex disassembly (GO:0032986),-0.23469469759475906,-0.5871418505582242,0.9650537634408602,0.9918471299111269,1.0,3/16,12.95%,RPL23;SMARCD1;SET
prerank,regulation of ATP metabolic process (GO:1903578),0.22614816979401503,0.5868290199429501,0.9609690444145357,0.997914298141164,1.0,16/54,23.65%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NUP214;ZBTB7A;NUP188;ABCD1;NUP88;AK4;NUP98;ATP5IF1;AAAS;NUP54
prerank,regulation of nuclear division (GO:0051783),0.26320410234213953,0.5856762757108295,0.9333333333333333,0.9982255711913243,1.0,5/20,22.25%,CCDC8;CDK13;PDXP;CUL7;PRMT5
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.27375798084937475,0.5854453003653369,0.9188767550702028,0.9979627694095896,1.0,2/18,11.88%,GSK3B;MPV17L
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2943318059129999,0.58479231242029,0.9111111111111111,0.9979783102324591,1.0,11/11,70.59%,PARN;EXOSC4;EXOSC2;EXOSC3;EXOSC5;TENT4B;LARP7;DKC1;EXOSC10;FBLL1;FBL
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.29340808699029075,0.5794925570004134,0.9032846715328468,1.0,1.0,5/12,23.08%,CNEP1R1;PRKCA;NEK9;NEK6;CCNB1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2589540146988125,0.579479500921934,0.9323899371069182,1.0,1.0,4/19,19.88%,MPI;RENBP;UAP1;GFPT1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.28772203798387885,0.5792569051479772,0.9180327868852459,1.0,1.0,4/11,29.36%,PRDX5;PXDN;PRDX2;PRDX3
prerank,regulation of cytoplasmic translation (GO:2000765),0.27681644758558893,0.5785171440761449,0.9142394822006472,1.0,1.0,4/14,20.05%,YBX3;DHX9;DHX36;FMR1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.24764468664712946,0.578319354756956,0.9472049689440993,0.99992105927212,1.0,6/25,15.69%,LRPAP1;ITGAV;ATXN2;ITGB3;NEU3;RIN3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.24755759956505058,0.5780795186148778,0.9525316455696202,0.9996566679933477,1.0,8/27,22.56%,ETNK1;PLA2G15;LPIN2;CHKB;CEPT1;NAAA;ETNPPL;ETNK2
prerank,protein targeting to mitochondrion (GO:0006626),0.22429887547177846,0.5770003817956145,0.9675236806495264,0.9999072913459307,1.0,16/52,27.36%,SAMM50;PMPCB;AGK;TIMM23;PITRM1;BCAP31;TIMM17B;IMMP1L;AIFM1;DNAJC19;TOMM34;GRPEL2;TOMM20;HSPA4;TIMM9;MIPEP
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.25732342747644577,-0.5763405995056868,0.9276018099547512,0.9957546103539039,1.0,4/10,21.10%,HK2;PFKM;PFKL;GFPT2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2904905211307293,0.5760905609098994,0.9118136439267887,1.0,1.0,4/10,28.58%,DHX36;PAF1;NUDT21;NCBP2
prerank,negative regulation of interferon-beta production (GO:0032688),0.290378636548398,0.5757495196628817,0.9189655172413793,0.9998733970302482,1.0,5/10,29.58%,REL;YY1;PTPRS;PPM1B;RELB
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2242316740965578,0.574568158312583,0.9669421487603306,1.0,1.0,11/48,17.93%,NUP93;RANBP2;EIF6;SEC13;NUP153;EP300;NOA1;NUP214;ZBTB7A;NUP188;NUP88
prerank,RNA methylation (GO:0001510),0.2176339350397081,0.5742615199810308,0.9741267787839586,0.9999492567074961,1.0,29/60,35.56%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;TRDMT1;METTL1;FTSJ3;WTAP;MRM2;THADA;GTPBP3;TGS1;NSUN4;PCIF1;METTL5;THUMPD2;TRMT12;VIRMA;FTSJ1;NOP2;MEPCE;METTL2A;METTL2B;TRMT44;NSUN3;TRMT6;CMTR1
prerank,response to exogenous dsRNA (GO:0043330),0.2645241349507968,0.5738829697871859,0.9525316455696202,0.9997602298715998,1.0,4/18,14.40%,MAVS;IRAK3;IFIH1;DHX9
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.25108967542481686,0.5732439687030606,0.9382716049382716,0.9993350215522295,1.0,7/22,20.27%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.25108967542481686,0.5732439687030606,0.9382716049382716,0.9993350215522295,1.0,7/22,20.27%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.21158968275516096,0.5707826658609512,0.978562421185372,1.0,1.0,12/67,17.11%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMC1;PSMD7
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.24506034773776986,-0.5705991552144399,0.9264705882352942,0.9972613392253487,1.0,1/12,4.28%,ACTB
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2774398279013962,0.568941844198853,0.9037800687285223,1.0,1.0,2/11,13.79%,OCRL;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2774398279013962,0.568941844198853,0.9037800687285223,1.0,1.0,2/11,13.79%,OCRL;SYNJ1
prerank,dendritic cell chemotaxis (GO:0002407),0.2676220913883914,0.5659214052223654,0.9296235679214403,1.0,1.0,2/14,14.55%,TRPM4;CXCR4
prerank,receptor recycling (GO:0001881),0.28875174399101416,0.5657019038473559,0.9228130360205832,1.0,1.0,4/10,29.80%,EHD3;RAB11B;PHETA2;SORL1
prerank,phasic smooth muscle contraction (GO:0014821),0.28574584182187746,0.5653791405970429,0.9488536155202821,1.0,1.0,2/10,14.30%,GDNF;HTR2B
prerank,tryptophan catabolic process (GO:0006569),0.2843512648295775,0.5628221047768589,0.9222042139384117,1.0,1.0,11/11,71.58%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;AFMID
prerank,mitochondrion organization (GO:0007005),0.19058320710499602,0.5625194558146017,0.9978046103183315,1.0,1.0,22/165,15.23%,PID1;CXADR;VPS13C;MEF2A;GABPB1;SAMM50;VPS13D;NRF1;MIEF1;MTX2;MTFR1;WDR81;MTX3;PPRC1;YME1L1;HCFC1;TIMM23;OMA1;PITRM1;POLG2;BCAP31;TIMM17B
prerank,inositol phosphate catabolic process (GO:0071545),0.27067888661298634,0.5621705725314747,0.9136442141623489,1.0,1.0,2/12,13.79%,OCRL;SYNJ1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.22761615661184437,-0.5621095499186554,0.9770114942528736,0.9996139157990356,1.0,7/16,26.94%,SLC25A33;COX7A2;UQCC2;NUPR1;ATP7A;SHMT2;PINK1
prerank,mitochondrial fusion (GO:0008053),0.26126195083885595,0.5619226238888384,0.9206349206349206,1.0,1.0,6/18,27.57%,MIEF1;SPG7;MIGA1;MIEF2;USP30;STOML2
prerank,regulation of isotype switching (GO:0045191),0.2637419007342193,0.5598825205054643,0.9225473321858864,1.0,1.0,4/14,20.83%,IL10;SHLD1;PARP3;KMT5B
prerank,DNA catabolic process (GO:0006308),0.2743079530475174,0.5589615046215646,0.9137055837563451,1.0,1.0,11/11,72.59%,DFFB;REXO4;DNASE1L1;DNASE1L3;DNASE1L2;DNASE1;SETMAR;FBH1;ISG20;XRN2;MUS81
prerank,aggrephagy (GO:0035973),0.23989945738773444,0.5583021786542126,0.9444444444444444,1.0,1.0,10/27,28.53%,DYNC1I1;ACBD5;WDR81;SQSTM1;DYNC1LI2;UBE2N;UBE2V1;ATG5;PCNT;IFT88
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.21615999090107244,0.5565076710467356,0.9714673913043478,1.0,1.0,16/53,27.88%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;NQO1;PSMC1;PSMD7;PSMD14;PSMD3;ODC1;OAZ2;PSMD12;PSMD4;PSME3;PSMD2
prerank,defense response to fungus (GO:0050832),0.2538160798828065,0.556099434248304,0.9452495974235104,1.0,1.0,3/17,17.17%,PLCG2;FAM3A;BCL10
prerank,regulation of myelination (GO:0031641),-0.19839713881770907,-0.5550189484667933,0.9732142857142857,1.0,1.0,2/25,4.47%,TNFRSF21;TENM4
prerank,alpha-amino acid metabolic process (GO:1901605),-0.1737936678316866,-0.5549400681777991,0.996031746031746,1.0,1.0,15/45,27.23%,ASPA;ASPG;KYAT3;ASS1;NOX4;ASNS;DDAH2;CBS;GOT2;ATP7A;SLC25A13;PYCR2;GLUD1;NAT8L;GPT2
prerank,regulation of cilium assembly (GO:1902017),0.2137118674994118,0.5532251762449122,0.9846350832266325,1.0,1.0,25/62,28.75%,LIMK2;RABEP2;ATG3;TBC1D2B;TBC1D13;ENTR1;TBC1D10A;TBC1D5;SDCCAG8;SGSM3;CEP97;CDK10;TBC1D17;ODAD3;FUZ;ARHGAP35;KCTD17;CROCC;ATG5;TBC1D20;TBC1D19;BBS4;MAPK15;IFT88;TBC1D15
prerank,positive regulation of catalytic activity (GO:0043085),0.22829499706539239,0.5524363934015889,0.9685714285714285,1.0,1.0,5/37,15.51%,ABL1;BCAS3;WRN;XRCC5;CHTOP
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.26534626546096046,0.5516561805622957,0.9299145299145299,1.0,1.0,6/12,31.60%,RMDN1;KIF2C;CENPC;CHAMP1;MAD1L1;SEH1L
prerank,tRNA 5'-end processing (GO:0099116),-0.2177364760993165,-0.5496513310338941,0.9623655913978495,1.0,1.0,10/15,41.96%,POP5;POP7;RPP21;HSD17B10;PRORP;RPP25L;RPP25;RPP40;TRMT10C;RPP14
prerank,negative regulation of cholesterol transport (GO:0032375),0.27973606697691067,0.5482410177483737,0.9347079037800687,1.0,1.0,1/10,9.30%,NFKB1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.24885602403438553,0.5479541421631955,0.9496062992125984,1.0,1.0,3/20,13.93%,ACSL3;SCD;ACSM2A
prerank,negative regulation of DNA recombination (GO:0045910),-0.17440857986224892,-0.547388874976633,0.9926739926739927,1.0,1.0,12/43,29.98%,RIF1;BLM;POLR2G;POLR2K;SHLD3;TERF2IP;H1-0;UBQLN4;SMCHD1;POLR2L;TERF1;RADX
prerank,mucosal immune response (GO:0002385),-0.21531896479895707,-0.5460060042907846,0.9598997493734336,1.0,1.0,2/15,12.13%,DEFA6;RPL39
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.24433363733456817,0.5455631639909418,0.9570552147239264,1.0,1.0,2/23,10.11%,PLA2G4F;MBOAT1
prerank,cilium movement (GO:0003341),0.21506855068619068,0.5450302441600198,0.9865229110512129,1.0,1.0,11/47,22.90%,CFAP70;SPAG17;CCDC40;DNAAF4;TEKT2;RSPH9;ODAD3;ODAD2;CAMSAP3;RSPH6A;SPEF1
prerank,gas transport (GO:0015669),-0.24167261267231221,-0.5450096548502892,0.9403669724770642,1.0,1.0,6/10,34.16%,CA2;AQP1;MYC;MB;NGB;RHAG
prerank,phagosome acidification (GO:0090383),0.23089781725192787,0.5442123285570913,0.9698795180722891,1.0,1.0,5/26,19.59%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H
prerank,nucleus organization (GO:0006997),0.21406714733993099,0.5439434903962929,0.9773333333333334,1.0,1.0,12/47,25.39%,NUP93;PDCD6IP;SUN3;LEMD2;PITPNB;USP36;NUP98;TMEM170A;SUN2;NUP54;CHMP4A;CHMP4B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.23132095828684573,0.541257955801932,0.958904109589041,1.0,1.0,3/29,8.83%,RAET1E;KLRC2;PVR
prerank,autophagosome maturation (GO:0097352),0.2230575707893446,0.5407699108790002,0.9642857142857143,1.0,1.0,3/32,9.23%,WIPI2;VCP;LIX1L
prerank,cardiolipin metabolic process (GO:0032048),0.2574779597826274,0.540130773629767,0.9525368248772504,1.0,1.0,4/13,20.46%,PLSCR3;LCLAT1;TAMM41;PLA2G4A
prerank,cellular response to interferon-beta (GO:0035458),0.25595391983387994,0.5393616427768466,0.9361344537815126,1.0,1.0,3/14,15.93%,IRF1;UBE2K;ACOD1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2281121764153542,0.5388944792842173,0.9601181683899557,1.0,1.0,3/31,8.47%,CLCF1;IL10;GPI
prerank,protein localization to phagophore assembly site (GO:0034497),0.2694776814622749,0.538831993945465,0.933786078098472,1.0,1.0,1/11,4.80%,WIPI2
prerank,regulation of TOR signaling (GO:0032006),0.20332036137047982,0.5386274112172968,0.9961038961038962,1.0,1.0,8/67,12.78%,TELO2;NPRL3;GOLPH3;RRAGB;ITFG2;MLST8;SMCR8;SEC13
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.23781835312195818,-0.5371949625080642,0.9631449631449631,1.0,1.0,3/10,24.02%,MMGT1;EMC7;EMC6
prerank,positive regulation of DNA recombination (GO:0045911),0.227128874245075,0.5370713581657812,0.9833333333333333,1.0,1.0,11/27,33.47%,FUS;MRNIP;SHLD1;WDR48;KMT5B;ERCC2;RAD51AP1;PAXIP1;ZCWPW1;ACTR2;KMT5C
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.22885347595788103,-0.5353396116364769,0.9802955665024631,1.0,1.0,8/13,40.80%,NECTIN2;MR1;STX7;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,myelin maintenance (GO:0043217),0.2695411673175274,0.5339531012843697,0.948306595365419,1.0,1.0,3/10,17.00%,CLU;CXCR4;ABCD1
prerank,determination of bilateral symmetry (GO:0009855),0.22919666872177843,0.5339303557834059,0.975609756097561,1.0,1.0,7/24,21.70%,PITX2;GALNT11;STIL;DNAAF4;KIF3B;ODAD3;ODAD2
prerank,lysine metabolic process (GO:0006553),0.2645568979382632,0.5339138654473301,0.9471890971039182,1.0,1.0,6/12,28.57%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,lysine catabolic process (GO:0006554),0.2645568979382632,0.5339138654473301,0.9471890971039182,1.0,1.0,6/12,28.57%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19651585638338048,0.5310663248803023,0.9924050632911392,1.0,1.0,12/70,17.11%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMC1;PSMD7
prerank,regulation of response to interferon-gamma (GO:0060330),0.2545283188031389,0.5303521058393982,0.9622950819672131,1.0,1.0,1/14,4.70%,PTPN2
prerank,mitochondrial gene expression (GO:0140053),0.20790404297583953,0.5267461759490156,0.9806629834254144,1.0,1.0,20/42,36.04%,FOXO3;GFM2;NOA1;MRPS28;MRPL57;FASTKD5;MRPL47;MRPS7;MRPL23;MRPS21;MRPS2;MRPS18A;MRPS34;MRPS16;PTCD3;GATC;QRSL1;MRPS24;NDUFA7;MRPS15
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.20503604709432194,-0.5264752645702773,0.9817708333333334,1.0,1.0,5/17,26.54%,MMGT1;EMC7;SGTA;EMC6;GET4
prerank,glycine metabolic process (GO:0006544),0.2574373056572883,0.5262928369960549,0.9375,1.0,1.0,3/12,23.48%,GCAT;DLD;SDSL
prerank,mRNA polyadenylation (GO:0006378),0.22552513357800857,0.5259966445534263,0.9675036927621861,1.0,1.0,10/26,32.50%,SCAF8;PABPC1;TENT2;PAF1;FIP1L1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,RNA polyadenylation (GO:0043631),0.22552513357800857,0.5259966445534263,0.9675036927621861,1.0,1.0,10/26,32.50%,SCAF8;PABPC1;TENT2;PAF1;FIP1L1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,methylguanosine-cap decapping (GO:0110156),-0.22816018580670303,-0.5257525779651262,0.9508196721311475,1.0,1.0,5/10,35.39%,DCP2;PATL2;LSM1;EDC4;DCP1B
prerank,modulation by host of symbiont process (GO:0051851),0.21962219465396907,0.5230137254375914,0.9673105497771174,1.0,1.0,11/31,23.32%,JUN;CCL3;SMARCA4;EP300;REST;RRP1B;CCNT1;SNW1;CHD1;SAP30BP;TARDBP
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.16077586566214655,-0.5228876512559844,0.9961538461538462,1.0,1.0,21/46,38.67%,HK2;TIMM17A;TOMM7;AKT1;MFN2;CHCHD4;TOMM40;TOMM22;RALA;ROMO1;MFF;PINK1;FBXO7;TOMM40L;HSPD1;GRPEL1;TOMM20L;TIMM13;HK1;TIMM44;TOMM5
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2220088615734324,0.5221413741151928,0.9695121951219512,1.0,1.0,6/28,20.83%,PRKDC;MRNIP;KDM4D;SHLD1;PARP3;KMT5B
prerank,mitotic metaphase plate congression (GO:0007080),0.20285399474429106,0.5214899988031587,0.9864130434782609,1.0,1.0,16/51,30.11%,BECN1;PDCD6IP;PIBF1;CUL3;RMDN1;SPDL1;ZW10;KIF2C;CCNB1;CHMP4A;CHMP4B;KIF18A;CENPC;CHAMP1;MAD1L1;PINX1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.25109616610681373,0.521289388838924,0.9429065743944637,1.0,1.0,5/13,27.02%,USP4;PRPF3;LSM2;SRSF12;PRPF6
prerank,antibacterial humoral response (GO:0019731),-0.2074308476433246,-0.5193228000073075,0.9727047146401985,1.0,1.0,2/16,12.13%,DEFA6;RPL39
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.235465746931306,0.5183945040943098,0.9681528662420382,1.0,1.0,5/16,28.58%,SFSWAP;WBP4;SRSF12;SNRNP200;NCBP2
prerank,lipoxygenase pathway (GO:0019372),0.24937094310739955,0.5168251911209701,0.9548387096774194,1.0,1.0,1/14,5.77%,PON3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2576557869106485,0.5164225142917963,0.936026936026936,1.0,1.0,1/11,7.33%,TAS1R3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.17945957597362755,-0.514683658601618,0.9840764331210191,1.0,1.0,1/25,1.89%,SORT1
prerank,DNA biosynthetic process (GO:0071897),0.2400563163284541,0.5146715228950569,0.9590834697217676,1.0,1.0,3/16,21.20%,WRN;POLA1;POLD3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.24487367627346263,0.5123304730489204,0.9507389162561576,1.0,1.0,6/14,33.15%,TSEN54;DDX1;CLP1;CPSF4;RTCB;TRPT1
prerank,isotype switching (GO:0045190),0.2648824965626092,0.5104042848961686,0.9536878216123499,1.0,1.0,4/10,33.06%,RNF168;RNF8;EXOSC3;LIG4
prerank,regulation of spindle organization (GO:0090224),-0.1948630997236875,-0.5096231828879891,0.9844559585492227,1.0,1.0,18/18,80.54%,MAP9;TPX2;NUP62;GNAI1;CLTC;FSD1;PSRC1;NUMA1;ANKRD53;DYNC1H1;RNF4;DCTN1;BORA;RAE1;SENP6;TACC3;GPSM2;PARP3
prerank,peptidyl-methionine modification (GO:0018206),0.25224141742850836,0.5075863585123371,0.9560067681895094,1.0,1.0,4/12,27.51%,NAA15;METAP1D;METAP2;NAA60
prerank,rRNA catabolic process (GO:0016075),0.23424214982475466,0.5065250850071991,0.9639344262295082,1.0,1.0,7/16,32.48%,EXOSC7;ERN2;EXOSC4;EXOSC2;DIS3;XRN1;EXOSC3
prerank,regulation of lymphocyte activation (GO:0051249),-0.2120165792861405,-0.504840441055186,0.9836829836829837,1.0,1.0,4/12,30.02%,PAG1;THEMIS2;CCL5;CRTAM
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.22977115963982492,0.5047912147871471,0.9711538461538461,1.0,1.0,4/20,19.50%,CLU;PSMG2;PSMG1;BBS12
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.24930622654594925,0.5037680696006969,0.9776357827476039,1.0,1.0,3/13,18.62%,NRP1;PLXNA2;PLXNB1
prerank,CENP-A containing chromatin organization (GO:0061641),0.21368996103887047,0.5020126367141785,0.992503748125937,1.0,1.0,13/29,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.21368996103887047,0.5020126367141785,0.992503748125937,1.0,1.0,13/29,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,phagosome-lysosome fusion (GO:0090385),0.2532010689008554,0.5018872282484691,0.9559859154929577,1.0,1.0,1/10,4.75%,RAB7B
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2244496118936126,0.5015432395047571,0.9731743666169895,1.0,1.0,2/20,8.78%,AUH;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2244496118936126,0.5015432395047571,0.9731743666169895,1.0,1.0,2/20,8.78%,AUH;HIBCH
prerank,phosphate ion transport (GO:0006817),0.2316491585773885,0.5011036489674487,0.9623824451410659,1.0,1.0,5/16,29.42%,SLC34A2;SLC25A14;SLC20A1;SLC25A3;SLC37A1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.2515263468914458,0.5000255995657722,0.9459016393442623,1.0,1.0,2/10,15.98%,USP7;GNMT
prerank,protein import into mitochondrial matrix (GO:0030150),0.23275339970200895,0.49894207714290467,0.9671875,1.0,1.0,5/18,24.31%,TIMM23;TIMM17B;DNAJC19;GRPEL2;TOMM20
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.21650962256593773,0.49725059527032917,0.9739263803680982,1.0,1.0,6/24,18.84%,EED;DNMT3A;SUZ12;EPC1;RBBP7;TASOR
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2502019232716337,0.496080142658461,0.9680672268907563,1.0,1.0,3/10,23.08%,KNSTRN;CDC42;CCNB1
prerank,regulation of T cell activation (GO:0050863),0.19608865580915558,0.49607770128714135,0.993006993006993,1.0,1.0,5/42,13.67%,ABL1;CD2;KAT2A;TNFRSF1B;TNFSF11
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.25125733127126965,0.49592417489130697,0.9511754068716094,1.0,1.0,3/10,20.49%,NPLOC4;UFD1;GPATCH3
prerank,regulation of lymphocyte migration (GO:2000401),-0.22174956658346207,-0.49376088121471634,0.9817767653758542,1.0,1.0,6/10,39.41%,JAM2;AKT1;WASL;MSN;CCR6;SPN
prerank,piRNA metabolic process (GO:0034587),0.21861125816145316,0.49264473788673574,0.9775280898876404,1.0,1.0,18/19,68.89%,TDRD9;TDRD12;TEX15;MAEL;PIWIL4;EXD1;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MYBL1;DDX4;FKBP6
prerank,kinetochore organization (GO:0051383),-0.20489067614786488,-0.4925619782088887,0.9775561097256857,1.0,1.0,8/13,38.44%,CENPA;DLGAP5;NUF2;CENPF;NDC80;CDT1;CENPE;CENPH
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.19045044852606446,-0.4925081088041831,0.9915730337078652,1.0,1.0,5/19,29.26%,POLR2G;POLR2K;TERF2IP;POLR2L;TERF1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.19045044852606446,-0.4925081088041831,0.9915730337078652,1.0,1.0,5/19,29.26%,POLR2G;POLR2K;TERF2IP;POLR2L;TERF1
prerank,melanosome transport (GO:0032402),0.22540928013846087,0.49245441166794124,0.9726688102893891,1.0,1.0,1/18,3.59%,MLPH
prerank,pigment granule transport (GO:0051904),0.22540928013846087,0.49245441166794124,0.9726688102893891,1.0,1.0,1/18,3.59%,MLPH
prerank,negative regulation of centrosome duplication (GO:0010826),0.24069988372074813,0.4916129941061667,0.9567567567567568,1.0,1.0,3/11,17.59%,KAT2A;KAT2B;RBM14
prerank,rRNA methylation (GO:0031167),0.21727386934673348,0.4911181321293662,0.9801223241590215,1.0,1.0,22/22,78.30%,METTL15;FTSJ3;MRM1;MRM2;NSUN4;METTL5;NOP2;NSUN3;MRM3;ZCCHC4;MTERF4;NSUN5;TFB1M;FBLL1;TRMT112;DIMT1;FBL;METTL16;TFB2M;FDXACB1;BUD23;EMG1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.24453929199096158,0.4902952347241631,0.9535283993115319,1.0,1.0,10/10,75.56%,MTHFR;MTHFD2L;DHFR;TYMS;MTHFD2;MTHFD1;SHMT1;MTHFD1L;MTHFS;SHMT2
prerank,steroid hormone biosynthetic process (GO:0120178),0.20845352323141797,0.48743808853356996,0.9865067466266867,1.0,1.0,7/29,27.59%,FDX1;STARD3NL;CYP19A1;DHCR7;HSD17B2;AKR1B1;STAR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.23658439648078788,0.48686261675873593,0.9565217391304348,1.0,1.0,7/11,37.64%,AGK;TIMM9;TIMM29;TIMM22;TIMM10;TIMM8B;TIMM10B
prerank,heterochromatin assembly (GO:0031507),-0.1790840098745282,-0.48637234358096987,0.9880597014925373,1.0,1.0,12/20,42.62%,MBD2;ZNFX1;SMCHD1;SUV39H1;SIRT2;HMGA2;H3-3A;CDKN2A;BEND3;POLE3;HELLS;CENPV
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.1958309788409619,-0.48512213169639623,0.9949109414758269,1.0,1.0,15/15,80.44%,ERN1;TSEN15;FAM98B;TSEN34;RTRAF;CPSF1;ZBTB8OS;TSEN2;CSTF2;TRPT1;RTCB;CPSF4;CLP1;DDX1;TSEN54
prerank,regulation of endocytic recycling (GO:2001135),0.2414730941764685,0.48506223006092,0.9667250437828371,1.0,1.0,4/11,23.43%,EHD1;EHD2;RAB11B;ATP9A
prerank,meiosis I (GO:0007127),0.20761354356429396,0.4844569674177916,0.9865671641791045,1.0,1.0,23/23,79.27%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZCWPW1;ZSCAN21;HSF2BP;BRDT;PTTG1;MEIOB;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;SGO1;MEIKIN;MOV10L1;MYBL1;DDX4;BCL2L11;SLC25A31;ING2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.21658283553515528,-0.4826976838451651,0.9833333333333333,1.0,1.0,3/10,28.35%,MFSD2A;MTMR2;MTMR3
prerank,protein palmitoylation (GO:0018345),0.2031755310262087,0.48257413765550233,0.9824046920821115,1.0,1.0,8/30,20.27%,ZDHHC11;ZDHHC15;HHAT;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,intracellular pH reduction (GO:0051452),0.19715892800285278,0.4817635241666859,0.9942528735632183,1.0,1.0,5/33,19.59%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1;ATP6V1H
prerank,homocysteine metabolic process (GO:0050667),-0.20866201443397459,-0.4816002813917189,0.9878640776699029,0.9997685870560749,1.0,2/11,16.84%,NOX4;CBS
prerank,regulation of intracellular transport (GO:0032386),0.19146559688280795,0.47866110630267966,0.9944444444444445,1.0,1.0,10/38,25.27%,NDEL1;GAS1;CAPN10;GRIPAP1;NUP214;RAB11B;AAAS;RBM4;ATP9A;PTPN1
prerank,tRNA processing (GO:0008033),0.18150284800161243,0.47864416728562764,0.9986824769433466,1.0,1.0,23/61,35.69%,TYW5;ELP5;CTU2;TRMT10A;TRDMT1;TSEN54;METTL1;DDX1;SSB;QTRT1;PTCD1;FARS2;CLP1;CPSF4;URM1;FTSJ1;RTCB;KARS1;TRPT1;ELAC2;WDR4;TRMT6;POP1
prerank,negative regulation of defense response to virus (GO:0050687),-0.21893045443133316,-0.47800707136830867,0.9882075471698113,0.9994442518373794,1.0,10/10,78.13%,TARBP2;TSPAN6;PCBP2;C1QBP;ITCH;MUL1;ILRUN;PPM1B;RNF26;TRAF3IP1
prerank,regulation of cytoplasmic transport (GO:1903649),0.232764069318891,0.4777897044549323,0.9827288428324698,1.0,1.0,3/11,23.43%,USP7;MAP2K2;ATP9A
prerank,phagolysosome assembly (GO:0001845),0.23255428249451549,0.47515554519217723,0.9674657534246576,1.0,1.0,1/12,4.75%,RAB7B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.23351904547497734,0.47406022295966366,0.9671848013816926,1.0,1.0,1/11,5.94%,STAT3
prerank,regulation of mitotic spindle organization (GO:0060236),0.18961779627357533,0.4724220389662719,0.9901408450704225,1.0,1.0,13/35,34.46%,PDCD6IP;CEP97;PARP3;GPSM2;DRG1;CHMP4B;TACC3;RAE1;BORA;DCTN1;DYNC1H1;CHMP3;CHMP2B
prerank,chromatin remodeling at centromere (GO:0031055),0.1988184768253386,0.4691359197514207,1.0,1.0,1.0,13/31,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,midbody abscission (GO:0061952),0.21370910484643907,0.46636883895484993,0.9827856025039123,1.0,1.0,1/17,5.43%,PDCD6IP
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.20044425512777317,0.46442495550260404,0.9895209580838323,1.0,1.0,4/26,15.93%,TRAFD1;IRAK3;CARD16;ACOD1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.19453738557710823,0.46182411034547943,0.9942112879884226,1.0,1.0,9/31,24.31%,TIMM23;TIMM17B;AIFM1;DNAJC19;PEX2;GRPEL2;PEX7;PEX26;TOMM20
prerank,homologous chromosome segregation (GO:0045143),-0.16905572045733047,-0.46016751647470683,1.0,1.0,1.0,1/20,6.12%,FMN2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.18990520434427774,-0.4601609189123495,0.9856459330143541,1.0,1.0,13/13,81.03%,BMF;PMAIP1;VDAC2;BCL2L11;BNIP3L;BAD;BLOC1S2;RTL10;RHOT2;BAX;RHOT1;BNIP3;MOAP1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.2373357882293986,0.4597290361485232,0.9791666666666666,1.0,1.0,3/10,25.08%,ZC3H12A;SMAD7;RC3H2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.20011093570065425,-0.45916320828961893,0.9904534606205251,0.9994476778519092,1.0,5/11,41.90%,BLM;FBH1;TIMELESS;GMNN;LIG3
prerank,male meiosis I (GO:0007141),0.20752229059399702,0.45906677749676805,0.9827315541601256,1.0,1.0,16/16,79.27%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZSCAN21;HSF2BP;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;SLC25A31;ING2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.19021645383505337,-0.45711356406416165,0.9874371859296482,0.9987955076100493,1.0,4/13,30.87%,BOLA2;YAE1;GLRX5;ISCA2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.20280091103107192,0.45699950843459086,0.9830246913580247,1.0,1.0,2/20,9.08%,PDCD6IP;RIPK3
prerank,secondary alcohol biosynthetic process (GO:1902653),0.19379017261258327,0.4534852632056478,0.9925925925925926,1.0,1.0,8/30,28.05%,LBR;MVD;EBP;HMGCR;FDPS;DHCR7;HMGCS1;FDFT1
prerank,RNA modification (GO:0009451),0.17585669444418414,0.4529241186502423,0.9960264900662251,1.0,1.0,19/54,32.85%,TYW5;ELP5;CTU2;JMJD6;TRDMT1;PUS7L;METTL1;SSB;FTSJ3;QTRT1;NAT10;PARN;MRM2;NSUN4;PUS7;URM1;FTSJ1;NOP2;MEPCE
prerank,pre-replicative complex assembly (GO:0036388),0.1701096487174663,0.4485230968934714,0.9987163029525032,1.0,1.0,16/64,28.32%,PSMB2;MCM7;MCM2;PSMC6;PSMD11;PSMD1;PSMC1;PSMD7;PSMD14;PSMD3;PSMD12;ORC3;PSMD4;PSME3;PSMD2;MCM6
prerank,lymphocyte migration (GO:0072676),0.1817043895447833,0.44543461337597134,0.9944055944055944,1.0,1.0,7/32,22.59%,CCL3;CCL1;RET;ADAM8;GATA3;CCL15;CCL7
prerank,synaptonemal complex organization (GO:0070193),0.21551739883060572,0.4453166194037236,0.9934426229508196,1.0,1.0,1/15,8.20%,P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.21551739883060572,0.4453166194037236,0.9934426229508196,1.0,1.0,1/15,8.20%,P3H4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.20768081022282292,0.44340031501346766,0.9773095623987034,1.0,1.0,5/14,29.33%,MRPS27;RPUSD4;MPV17L2;TRUB2;FASTKD3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.18758247973355102,0.44153849265326756,0.9955489614243324,1.0,1.0,29/29,81.28%,P3H4;IHO1;ANKRD31;RAD21L1;RNF212B;ZCWPW1;SIRT7;MEI4;REC8;PRDM9;MEIOB;RNF212;KASH5;SYCE1;SYCE3;SYCE2;SYCP1;TERB1;TERB2;HORMAD1;BAG6;RAD21;MAJIN;TEX11;SYCP2;STAG3;TEX12;TRIP13;FANCD2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.19971649321785087,0.4375902273637607,0.9841269841269841,1.0,1.0,3/18,14.77%,SPAG17;CCDC40;DNAAF4
prerank,transcription by RNA polymerase III (GO:0006383),0.187785129999373,0.43726849399534895,0.9926578560939795,1.0,1.0,12/27,34.11%,SNAPC2;POLR3K;SNAPC5;ICE2;CRCP;SNAPC4;POLR3GL;GTF3C3;GTF3C2;GTF3C1;GTF3A;RO60
prerank,centromere complex assembly (GO:0034508),0.17757570461020608,0.43334446485259265,1.0,1.0,1.0,14/36,29.26%,CENPT;SMARCA5;RBBP7;CENPQ;HJURP;POGZ;CENPU;RBBP4;CENPX;NASP;CENPK;CENPC;CENPW;CENPL
prerank,tRNA 5'-leader removal (GO:0001682),0.20679264235042993,0.4293703554466112,0.9869281045751634,1.0,1.0,13/13,79.34%,RPP38;SSB;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP25L;PRORP;RPP21;POP7;POP5
prerank,metallo-sulfur cluster assembly (GO:0031163),0.18846823667600066,0.4293004652998102,0.9954887218045113,1.0,1.0,3/22,17.46%,NFS1;NFU1;NUBP2
prerank,sensory perception of chemical stimulus (GO:0007606),0.19978654323381673,0.41996069496338734,0.9919354838709677,1.0,1.0,6/15,37.01%,GNAS;CD36;BBS4;BEST2;UBR3;MKKS
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18426849258942019,0.4198334632888978,0.9924471299093656,1.0,1.0,6/24,25.15%,POLB;RPA1;RFC1;POLD3;RFC5;POLK
prerank,ESCRT III complex disassembly (GO:1904903),0.20907607331157446,0.41856195171243654,0.9916666666666667,1.0,1.0,10/10,79.11%,IST1;VTA1;CHMP2B;CHMP5;CHMP2A;VPS4B;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,ESCRT complex disassembly (GO:1904896),0.20907607331157446,0.41856195171243654,0.9916666666666667,1.0,1.0,10/10,79.11%,IST1;VTA1;CHMP2B;CHMP5;CHMP2A;VPS4B;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17471577457390136,0.4143942188955985,0.9985754985754985,1.0,1.0,5/31,20.36%,NFS1;MOCOS;PYCR1;MOCS3;CYP19A1
prerank,cholesterol biosynthetic process (GO:0006695),0.17383198861405993,0.41322724547347134,0.9942528735632183,1.0,1.0,5/31,18.59%,LBR;MVD;EBP;HMGCR;FDPS
prerank,B cell mediated immunity (GO:0019724),-0.18365238049960123,-0.4070048452664131,1.0,1.0,1.0,4/10,36.15%,CD74;CARD9;FCGR2B;SLA2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.18872494313337324,0.4067681921838754,0.9886178861788618,1.0,1.0,4/16,25.16%,SHLD1;RMI2;HELB;POLQ
prerank,regulation of lipid catabolic process (GO:0050994),0.18590428757032404,0.4056323249101184,0.9922239502332815,1.0,1.0,6/19,28.55%,LONP2;ABCD1;ANGPTL3;TYSND1;BSCL2;PRKAA1
prerank,peptidyl-amino acid modification (GO:0018193),0.2052719630802897,0.4040213152504389,0.9880952380952381,1.0,1.0,3/10,25.09%,FKBP10;METAP1D;METAP2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.16756438759982273,-0.39899244940564615,1.0,1.0,1.0,4/12,29.32%,GRN;CLN6;PPT1;ATP6AP2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.17030759573132453,-0.39835067632573395,1.0,1.0,1.0,12/12,82.99%,XPR1;SLC25A11;SLC37A3;SLC25A10;SLC20A2;SLC37A4;SLC25A30;SLC37A2;SLC37A1;SLC25A3;SLC20A1;SLC25A14
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.18474357199768168,0.39284172459277744,0.9983974358974359,1.0,1.0,5/16,25.39%,TMEM50B;SNF8;VTA1;CHMP4A;CHMP4B
prerank,covalent chromatin modification (GO:0016569),-0.15920852071502584,-0.38893265741494254,0.9951219512195122,1.0,1.0,3/14,21.85%,MBD2;MT3;HLCS
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.19183889239196772,0.38688137451960297,0.9947643979057592,1.0,1.0,1/11,11.74%,CBFB
prerank,negative regulation of ATPase activity (GO:0032780),0.18002113154054672,0.385075611288708,0.9983922829581994,1.0,1.0,5/16,34.05%,TNNI3;ATP5IF1;THADA;TSC1;PPIF
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.1568405851698374,-0.38255887192426846,1.0,0.9993243485594027,1.0,15/15,84.34%,QDPR;AADAT;GSTZ1;IL4I1;KYNU;IDO1;ACMSD;KMO;FAH;TAT;HAAO;HGD;IDO2;TDO2;KYAT1
prerank,regulation of mitochondrial translation (GO:0070129),0.1646491020722703,0.36859975808015144,0.9969183359013868,1.0,1.0,7/21,31.21%,MRPS27;RPUSD4;MPV17L2;TRUB2;MALSU1;FASTKD3;MTG2
prerank,positive regulation of translational initiation (GO:0045948),0.16973856409726637,0.3679531142780113,0.9983552631578947,1.0,1.0,5/18,24.56%,MTOR;KHDRBS1;YTHDF2;CDC123;YTHDF3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.18145869947275928,0.3652071975759032,0.9965156794425087,1.0,1.0,10/10,81.87%,OS9;YOD1;SVIP;DERL2;UBAC2;UBE2G2;DERL3;INSIG1;UBE2J1;ERLEC1
prerank,tryptophan metabolic process (GO:0006568),0.18523633168037154,0.3648326575463193,0.9967741935483871,1.0,1.0,11/11,81.49%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;ATP7A
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.1576114991242213,0.3551395071356447,0.9984126984126984,1.0,1.0,6/19,32.47%,STN1;TEN1;NAT10;ACD;PINX1;XRN1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.175966747221429,0.34813818337523467,1.0,1.0,1.0,2/10,18.45%,ATRX;INO80
prerank,chromatin disassembly (GO:0031498),0.1694100538196832,0.34637494727030665,1.0,1.0,1.0,5/14,29.48%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.1694100538196832,0.34637494727030665,1.0,1.0,1.0,5/14,29.48%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,B cell activation involved in immune response (GO:0002312),0.1685604871617803,0.33878481843147656,1.0,1.0,1.0,13/13,83.16%,RNF168;RNF8;EXOSC3;LIG4;CD40LG;MSH2;GAPT;CD19;MSH6;FCGR2B;GPR183;BATF;CD180
prerank,iron-sulfur cluster assembly (GO:0016226),0.14355403010980655,0.3333578121777942,1.0,1.0,1.0,3/24,17.46%,NFS1;NFU1;NUBP2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.1426597148062067,0.32850533089098216,1.0,1.0,1.0,23/23,85.75%,SAMM50;AGK;MOAP1;HSPA4;TIMM9;BAX;TIMM29;TIMM22;TIMM10;TIMM8B;TIMM10B;MAIP1;TOMM70;BAD;HSP90AA1;TIMM13;BCL2L11;ROMO1;PMAIP1;NDUFA13;TOMM22;COX18;BMF
prerank,spliceosomal snRNP assembly (GO:0000387),0.1291498993963783,0.3254548447300414,1.0,0.999739672471281,1.0,38/38,87.12%,USP4;PRPF3;GEMIN8;LSM2;SRSF12;PRMT5;LSM4;PRPF6;TGS1;SNUPN;SMN1;SNRPD2;SNRPD1;SNRPE;SNRPD3;CD2BP2;SART1;GEMIN5;PRPF8;COIL;GEMIN2;GEMIN6;GEMIN4;PRPF19;PRPF31;SNRPC;STRAP;SNRPB;SNRPF;GEMIN7;CLNS1A;PRMT7;SART3;WDR77;DDX20;SRSF10;SNRPG;AAR2
